Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transport across blood-brain barrier (GO:0150104),-0.5162717614124162,-2.123143529848195,0.0,0.031079715912569646,0.027,27/83,9.95%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;ABCC4;INSR;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC1A1;SLC2A13;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,vascular transport (GO:0010232),-0.5203637966063773,-2.1166059043252563,0.0,0.016041143696810138,0.027,27/81,9.95%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;ABCC4;INSR;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC1A1;SLC2A13;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,positive regulation of nuclear division (GO:0051785),-0.665471908330547,-2.1146856981595215,0.0,0.011362476785240515,0.028,11/25,17.91%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;EDN1;SIRT2;EGF;EDN3
prerank,amino acid import across plasma membrane (GO:0089718),-0.6793740893813938,-2.0804177010057288,0.0,0.018547572399436725,0.067,9/24,5.43%,SLC1A3;SLC6A13;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLC6A6;SLC1A1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.6156195824661859,-2.0320768426631632,0.003952569169960474,0.03589205902161269,0.149,11/33,6.93%,PTPRM;PTPRG;DCN;MCC;SP100;NR2F2;ADAMTS9;ACVRL1;DAB2IP;THBS1;SLIT2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.8514410129935659,-2.0262477885669536,0.0,0.03275066838098737,0.16,6/10,4.61%,RAPGEF2;LYN;GAS6;AXL;CXCL12;LGALS9
prerank,vitamin D metabolic process (GO:0042359),0.9203130471173079,2.0081448156079973,0.0,0.30869415043259757,0.209,1/13,0.03%,CUBN
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.6083509539569254,-1.9880659188372063,0.0,0.050415023047117584,0.266,15/36,9.55%,PTPRM;DCN;SP100;NR2F2;ADAMTS9;ACVRL1;NOTCH1;DAB2IP;THBS1;FGF2;RGCC;SLIT2;TGFB1;MECP2;PPARG
prerank,cell-substrate junction assembly (GO:0007044),0.7680257150327162,1.9802390155438636,0.001336898395721925,0.30369909945472384,0.369,5/33,1.13%,FN1;ITGB4;SORBS1;ACTN2;LAMC2
prerank,aorta development (GO:0035904),-0.7475079194776528,-1.9753541433379607,0.0,0.051381788403844976,0.305,9/14,13.14%,PDGFRB;JAG1;ADAMTS9;ROBO1;PKD2;ROBO2;PDE2A;TBX2;TBX1
prerank,cobalamin metabolic process (GO:0009235),0.839199920918953,1.9176183944496923,0.001519756838905775,0.7449286025002381,0.777,2/17,2.70%,CUBN;AMN
prerank,tetrapyrrole metabolic process (GO:0033013),0.8246284839543787,1.910917409028146,0.0015267175572519084,0.631873948701029,0.804,2/18,2.70%,CUBN;AMN
prerank,aorta morphogenesis (GO:0035909),-0.678561113452124,-1.9090849920192055,0.0,0.11017146608434185,0.572,6/17,3.06%,PDGFRB;JAG1;ENG;ADAMTS9;MYLK;ACVRL1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6536132354071216,1.9080084762451406,0.0011695906432748538,0.5334714444369161,0.815,7/76,1.73%,ADRA1B;AGTR1;GPR4;LPAR1;CHRM1;ACTN2;LPAR4
prerank,regulation of acrosome reaction (GO:0060046),-0.7921395579660906,-1.9027063567432874,0.0,0.10777643421294313,0.598,2/10,7.05%,PLCB1;GLRA1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.7525281880150638,-1.8942842640928348,0.002512562814070352,0.10891571998686429,0.644,6/12,7.35%,ADAMTS12;DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7609103261212713,1.8926873509453284,0.002793296089385475,0.5910810323817266,0.875,4/27,1.73%,AGTR1;GPR4;LPAR1;LPAR4
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7633145664990584,-1.8808878504065418,0.0,0.11671602991897795,0.701,5/11,5.61%,MECOM;ETV6;WNT5A;CD34;RUNX1
prerank,ganglioside biosynthetic process (GO:0001574),-0.7007046568721755,-1.8726645240192605,0.0027548209366391185,0.11946024801134089,0.735,8/15,16.52%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.7764961861253663,-1.872285287838738,0.0,0.11142865889391329,0.736,5/10,9.61%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,steroid metabolic process (GO:0008202),0.6573719670902713,1.8633055436867692,0.0,0.7989227249753494,0.956,12/72,8.86%,CUBN;SULT1A1;FDFT1;STARD3;SULT2B1;HSD17B14;DHRS4;NPC1;CYP39A1;CYP51A1;MSMO1;FDX1
prerank,endothelial cell differentiation (GO:0045446),-0.7233549649744161,-1.8614563558140935,0.002824858757062147,0.11870446335639503,0.777,8/12,16.87%,JAG1;ACVRL1;TIE1;KDR;KDM6B;SCUBE1;BMPR2;SOX18
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.7321348542352671,1.8430647770693722,0.002777777777777778,0.9225859156132811,0.979,6/30,2.50%,GPR4;LPAR1;RTN4R;PRAG1;LPAR4;AKAP13
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7755180301178206,-1.834814361632121,0.0,0.1512003114859487,0.864,5/10,7.35%,DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,heterotypic cell-cell adhesion (GO:0034113),0.747088875344804,1.831218943879588,0.001466275659824047,0.9579397764233432,0.988,6/25,2.88%,CXADR;DSG2;PARVA;CD200;NINJ1;ITGB7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7666423988646037,-1.827314772729005,0.002403846153846154,0.15581140311386907,0.885,7/10,14.09%,GHR;LYN;STAT5B;JAK2;STAT5A;STAT3;STAT6
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.8913472302822528,1.8198190739536426,0.0,0.9950141547924504,0.995,3/10,1.69%,DPP4;CCL5;PODXL
prerank,regulation of complement activation (GO:0030449),0.6790768274080203,1.8173742699126787,0.0051813471502590676,0.9350735430579653,0.995,6/40,3.30%,CD55;CLU;CFHR1;C8A;CFH;CD81
prerank,sulfation (GO:0051923),0.8548059111193902,1.815087871488546,0.0,0.8825422569406597,0.995,3/11,3.25%,UST;SULT1A1;SULT2B1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7264136656299235,-1.80872188768583,0.008152173913043478,0.17996158084858874,0.925,4/11,1.08%,PLCB1;IGF1;GHR;PIK3R1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8686430991310716,1.8061167288980045,0.0016366612111292963,0.9044884616857539,0.998,1/11,0.18%,AGTR1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5729497572999336,-1.8043029907986077,0.0,0.17946029510806344,0.931,9/27,9.40%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT
prerank,acidic amino acid transport (GO:0015800),-0.6417029099112866,-1.8023792751185197,0.005649717514124294,0.17409653768444253,0.938,6/17,8.32%,SLC1A3;SLC6A13;SLC1A2;SLC6A6;SLC1A1;SLC6A1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6581100858821899,-1.8008225666283273,0.0056657223796034,0.16800233532462763,0.942,8/16,9.74%,IGF1;ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,regulation of immune effector process (GO:0002697),0.6727462746460311,1.7991415176025916,0.006435006435006435,0.9115254455908464,1.0,6/41,3.30%,CD55;CLU;CFHR1;C8A;CFH;CD81
prerank,cell-matrix adhesion (GO:0007160),0.6114320567185857,1.798627486783801,0.0,0.8547531233337556,1.0,12/95,2.88%,FN1;ITGB4;SORBS1;ITGA10;MSLN;CD44;ITGB8;LYPD5;ACTN2;ITGBL1;EMP2;ITGB7
prerank,epithelial structure maintenance (GO:0010669),0.8418020800275351,1.7971180165153589,0.003284072249589491,0.8148176907656549,1.0,2/11,1.02%,CXADR;VSIG1
prerank,myofibril assembly (GO:0030239),0.6734769972705941,1.7943650334298118,0.007751937984496124,0.7923326157020203,1.0,8/42,5.16%,PGM5;MYOM2;KRT19;ACTN2;TMOD3;TMOD2;CSRP3;LMOD3
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7562631321569105,1.7881331777285543,0.006944444444444444,0.8022051870465239,1.0,2/22,4.90%,CUBN;UBIAD1
prerank,sarcomere organization (GO:0045214),0.7190027954477576,1.7870357512527113,0.006925207756232687,0.7695533274964227,1.0,4/27,3.70%,MYOM2;KRT19;ACTN2;CSRP3
prerank,positive regulation of nervous system development (GO:0051962),-0.5157872127369411,-1.7850901987811252,0.0,0.19026072424483617,0.967,20/42,20.27%,IL1RAPL1;NRXN1;GRID2;TGM2;EPHB2;NLGN1;CLSTN2;SERPINF1;LRRC4B;DLG5;SYNDIG1;NLGN3;BDNF;MME;SRPX2;SOX11;EPHB3;OPRM1;NUMB;CX3CR1
prerank,regulation of humoral immune response (GO:0002920),0.6619783359960588,1.7849206905276251,0.0050568900126422255,0.7479589334268149,1.0,6/44,3.30%,CD55;CLU;CFHR1;C8A;CFH;CD81
prerank,vitamin transport (GO:0051180),0.6984412910788687,1.7795966877992546,0.007052186177715092,0.7546808448856107,1.0,2/29,2.70%,CUBN;AMN
prerank,positive regulation of vasoconstriction (GO:0045907),0.8162542542103645,1.7789670210009003,0.0015128593040847202,0.7253722210959567,1.0,2/13,2.71%,ADRA1B;CAV1
prerank,cell-cell junction organization (GO:0045216),0.6129371088406376,1.7786958708992813,0.001184834123222749,0.6957020131530766,1.0,17/79,8.51%,CDH1;CXADR;SDK1;DSG2;CDH13;NECTIN3;TJP2;TJP1;OCLN;PKP4;LIMS2;CTNNA1;CSK;TGFB2;PVR;ANG;PARD6B
prerank,regulation of vasoconstriction (GO:0019229),0.7127259465809798,1.773193563739843,0.0054869684499314125,0.7048433184028012,1.0,3/27,2.71%,ADRA1B;AGTR1;CAV1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8037153482745019,1.7731666614769435,0.0015384615384615385,0.6769692689292732,1.0,3/14,1.41%,ANK2;ACTN2;GAL
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.5323486738234913,-1.771809546902952,0.0,0.2092323090888279,0.98,12/34,17.91%,IGF1;PDGFRB;TGFA;INSR;ANAPC11;RGCC;IGF2;LRP5;ANAPC7;EDN1;EGF;EDN3
prerank,regulation of cell-cell adhesion (GO:0022407),0.6728345245286949,1.7702789829103218,0.00535475234270415,0.6711043106118683,1.0,8/39,5.93%,DPP4;CDH1;B4GALNT2;WNT1;PODXL;SPINT2;FLOT2;EFNA5
prerank,integrin-mediated signaling pathway (GO:0007229),0.6135575677528762,1.7675586596939035,0.0023781212841854932,0.6643787804348222,1.0,20/73,12.62%,FN1;ITGB4;ITGA10;ITGB8;ITGBL1;ADAM10;ITGB7;LAMA5;PTK2B;FYB2;FBLN1;PTPRA;ILK;CDC42;ADAMTS1;TXK;ADAM15;PTN;BCAR1;DOCK1
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6922822145663385,-1.7660645175746903,0.002702702702702703,0.21229451111247166,0.982,3/12,3.48%,PLEKHH2;SEMA5A;LIMA1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8185937068334705,1.7641951431094358,0.005008347245409015,0.6624864754082838,1.0,4/12,5.46%,CLU;LDLR;PFDN1;CRYAB
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.49529527505645077,-1.764165082528226,0.004032258064516129,0.20745209085899713,0.984,18/43,17.39%,BMP6;IGF1;PRKD1;WNT4;ZHX3;BMPR1B;RUNX2;IL6R;FBN2;ACVR2A;LRP5;CCN4;CCN1;IL6ST;BMPR2;SOX11;CTNNBIP1;SUCO
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.630644294107604,-1.76398143959244,0.014619883040935672,0.19993588958644368,0.985,8/16,14.67%,IGF1;TRPC3;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,phosphate ion homeostasis (GO:0055062),-0.7302610460937767,-1.7595912472273652,0.004750593824228029,0.20151686769117735,0.986,4/10,12.51%,ENPP1;XPR1;SFRP4;FGFR4
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4821914040315692,-1.7550234166716823,0.005917159763313609,0.20438135763703633,0.989,21/56,14.00%,PTPRJ;IL1RAPL1;CNTNAP2;TEK;NRXN1;CLDN5;GRID2;KDR;TSC1;EPHB2;NLGN1;CLSTN2;ROCK1;LRRC4B;DLG5;MYOC;MAP4K4;SYNDIG1;NLGN3;BDNF;SRPX2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.6330240187991043,1.7544069667309032,0.0035714285714285713,0.7062313110164805,1.0,21/67,16.76%,FN1;CDH13;UTRN;DOCK5;EMP2;CDK6;LIMS2;S100A10;PTK2B;DMTN;ILK;CDC42;NPNT;DOCK1;SFRP1;RREB1;GSK3B;FLNA;TESK1;ABL1;CRK
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7893876422753634,1.7531641152603379,0.010355029585798817,0.6906157482008243,1.0,3/17,2.53%,ADRA1B;AKAP13;ADCY9
prerank,cGMP-mediated signaling (GO:0019934),-0.683013303500406,-1.753090083693545,0.005194805194805195,0.20168972484308265,0.989,5/13,9.70%,IRAG1;PDE3A;GUCY1B1;PDE9A;PDE2A
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7165358807752982,-1.75082857473594,0.010443864229765013,0.199879334272128,0.99,5/11,9.46%,RAPGEF2;LYN;LGALS9;PIK3CB;PIK3CD
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7169436147441994,1.7453613544223674,0.0084985835694051,0.7198674112499598,1.0,5/25,2.71%,CXADR;FGF13;DSG2;ANK2;CAV1
prerank,regulation of intracellular pH (GO:0051453),0.6814000933858962,1.741891570036468,0.010810810810810811,0.720317570078006,1.0,14/34,16.72%,SLC9A2;CFTR;SLC9A4;SLC4A2;TMEM165;CHP1;SLC9A7;SLC9A6;SLC9A8;GPR89B;GPR89A;SLC9A1;ATP5F1B;SLC4A4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5689948610058839,-1.7403825487699336,0.0034602076124567475,0.2161026656896882,0.993,10/22,14.67%,IGF1;CAMK2D;NOTCH1;LMCD1;ROCK1;PDE9A;GLRX3;IL6ST;MTPN;EDN1
prerank,regulation of amyloid fibril formation (GO:1905906),0.7730032693121403,1.7383414317566104,0.009569377990430622,0.7211642690600509,1.0,4/15,5.46%,CLU;LDLR;PFDN1;CRYAB
prerank,positive regulation of synapse assembly (GO:0051965),-0.5585126608897806,-1.736016627236266,0.007220216606498195,0.21780865425825016,0.994,12/27,14.00%,IL1RAPL1;NRXN1;GRID2;EPHB2;NLGN1;CLSTN2;LRRC4B;DLG5;SYNDIG1;NLGN3;BDNF;SRPX2
prerank,entry into host (GO:0044409),0.793066725159689,1.7348957177211817,0.007849293563579277,0.7223725193589768,1.0,3/13,7.18%,CDH1;CXCR4;CBLL1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7059178756284198,-1.7343330835231585,0.010282776349614395,0.214337630267037,0.995,4/11,2.87%,MERTK;GAS6;AXL;CXCL12
prerank,bone morphogenesis (GO:0060349),-0.6520260664850658,-1.7324165165800078,0.005571030640668524,0.21207335563871055,0.995,7/14,14.51%,CYP26B1;BMPR1B;LRP6;FGFR2;LRP5;SFRP4;BMPR2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5594517945245014,-1.7309190368872966,0.006600660066006601,0.20890725175149347,0.995,9/24,13.03%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;TGFB1;RORA;IL6ST;FLT4
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5933047199668737,-1.728040963861268,0.0030581039755351682,0.2085070188507248,0.995,10/19,13.12%,HS6ST2;NDST3;HS6ST3;CSGALNACT1;XYLT1;XYLT2;EXTL3;HS3ST3B1;EXT2;B3GAT3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6821561306410884,-1.7279677581985824,0.010230179028132993,0.2029529835964661,0.995,3/12,2.57%,IL34;LYN;PTK2
prerank,positive regulation of ion transport (GO:0043270),0.6290116083214363,1.7224510684752885,0.005012531328320802,0.7863351965111077,1.0,10/48,8.11%,ANK2;CHRM1;ACTN2;STIM2;CCL5;FHL1;GDNF;AHCYL1;ANK3;RAB3B
prerank,actomyosin structure organization (GO:0031032),0.6037775917833614,1.7205832466283655,0.003472222222222222,0.7775074349892591,1.0,12/75,5.16%,SORBS1;PGM5;MYOM2;PHACTR1;KRT19;ACTN2;TJP1;TMOD3;TMOD2;CSRP3;EPB41L1;LMOD3
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.8363144918790881,1.7178790878711916,0.011804384485666104,0.7755289147971223,1.0,1/10,0.04%,FN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.600254785414928,-1.7159627737538654,0.016172506738544475,0.22172659807235592,0.999,9/19,12.41%,ZFPM2;NOTCH1;FGF2;RUNX1;GLI1;ERBB4;FGFR2;TBX2;RBP4
prerank,striated muscle cell development (GO:0055002),0.7786079602034245,1.712183795050752,0.0192,0.7935295721902167,1.0,4/14,5.16%,PGM5;TMOD3;TMOD2;LMOD3
prerank,negative regulation of response to wounding (GO:1903035),0.7387125258154422,1.710682199335703,0.0237741456166419,0.7822762144271095,1.0,6/19,11.15%,CD109;RTN4R;EPHA4;ALOX5;CASK;CERS2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6952922420762374,1.7082445479769135,0.011157601115760111,0.7799272596852068,1.0,7/27,5.55%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,phospholipid dephosphorylation (GO:0046839),0.6465080453560409,1.708219901712183,0.02546916890080429,0.7610021080046482,1.0,1/37,0.01%,PLPPR2
prerank,peptide cross-linking (GO:0018149),0.6965438643021585,1.7075836353843523,0.015214384508990318,0.7468076931062002,1.0,1/25,0.04%,FN1
prerank,neuron cell-cell adhesion (GO:0007158),-0.6448533593449496,-1.7033721961542225,0.01856763925729443,0.24447319961003916,1.0,8/14,17.65%,NRXN3;NRXN1;NCAM2;NLGN1;ASTN2;NLGN3;RET;ASTN1
prerank,autonomic nervous system development (GO:0048483),0.7525878069029961,1.701791494509592,0.020771513353115726,0.7670539678394401,1.0,2/17,3.93%,FN1;GDNF
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8023180219376869,1.7003725617067615,0.016233766233766232,0.7585439005444727,1.0,1/12,0.05%,FZR1
prerank,glycerolipid catabolic process (GO:0046503),-0.5745746582756522,-1.6990496239484316,0.0121580547112462,0.24836202014326822,1.0,10/19,21.53%,PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1;ABHD12;PNPLA6;ABHD2;PLA2G4C;GDPD3
prerank,dendrite self-avoidance (GO:0070593),-0.623558238379556,-1.6980302252840291,0.0058997050147492625,0.24496978285768894,1.0,7/16,10.40%,PALLD;EMB;NEXN;DSCAML1;BSG;CNTN6;ROBO4
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6464661006462031,-1.6949103202706837,0.019337016574585635,0.24656097208980943,1.0,9/14,14.09%,GHR;PIK3R1;LYN;STAT5B;PTK2;JAK2;STAT5A;STAT3;STAT6
prerank,phospholipid metabolic process (GO:0006644),0.5867329633465583,1.6906764384789428,0.00936768149882904,0.8057794235240245,1.0,3/71,1.69%,PLPPR2;PLB1;FDFT1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.7533630369870608,1.6904524175595739,0.015337423312883436,0.7893917954076302,1.0,5/15,7.00%,DAXX;CPEB2;ZC3H12A;MKNK2;GSTO1
prerank,heart morphogenesis (GO:0003007),-0.4632833005017811,-1.6801989826504966,0.0,0.27447142964948973,1.0,17/50,14.37%,FLRT2;ENG;INSR;NOS3;PTK2;ACVRL1;TBX3;NOTCH1;EPHB4;SOX17;CHD7;HEYL;TBX2;MEGF8;TBX1;RYR2;NIPBL
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7468961690774917,1.67682646394469,0.02040816326530612,0.8632510866569638,1.0,3/15,7.51%,CD55;GLI3;NKAP
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6918989398219478,1.6760345005025932,0.0196078431372549,0.8510318103552396,1.0,4/23,5.24%,DPP4;MCU;RIPOR2;MOSPD2
prerank,regulation of lamellipodium organization (GO:1902743),0.7687142938355283,1.6749074286939127,0.020030816640986132,0.8407996013367891,1.0,6/14,12.50%,CD44;CAPZB;TWF1;DMTN;CDC42;PDPN
prerank,negative regulation of developmental growth (GO:0048640),0.654096426586651,1.669766164406868,0.02257636122177955,0.8587491641160547,1.0,6/30,4.17%,FGF13;RTN4R;OSTN;CDKN1A;GDF15;DUSP10
prerank,dopamine metabolic process (GO:0042417),-0.5860433077126818,-1.669571024544758,0.014326647564469915,0.29534844403132526,1.0,6/18,12.66%,MOXD1;SNCAIP;MAOB;MAOA;GCH1;DRD2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.8074975747508131,1.6686417415590449,0.014975041597337771,0.8489236050160487,1.0,2/10,1.00%,DPP4;ADTRP
prerank,lipid modification (GO:0030258),0.6450502798767839,1.6673445322209628,0.019305019305019305,0.8405710209035003,1.0,2/37,1.64%,PLPPR2;MBOAT2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7175049401478477,1.6665401296959768,0.015698587127158554,0.8303094172654285,1.0,1/16,0.19%,CLDN11
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.54672186913928,1.6664653100399645,0.0010799136069114472,0.8155068227987134,1.0,16/140,4.61%,ADRA1B;CD55;AGTR1;GPR4;LPAR1;CCR4;LPAR4;CACNA1A;CAV1;CXCR4;PTGFR;CACNB3;CCR10;ACKR2;ACKR4;ACKR3
prerank,smooth muscle contraction (GO:0006939),-0.6303616500083742,-1.6610136962114173,0.01366120218579235,0.3119334068042205,1.0,6/14,11.94%,SLC8A1;MYLK;SMTN;ROCK1;MYH11;ACTA2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.7250757239199431,1.6598528950272813,0.02023121387283237,0.8427105095216454,1.0,3/20,2.53%,ADRA1B;AKAP13;ADCY9
prerank,protein localization to cell-cell junction (GO:0150105),0.7531074450849552,1.659805558836007,0.030120481927710843,0.8280188969214641,1.0,7/15,10.88%,TJP2;TJP1;ARHGEF18;LSR;ACTB;JAK1;ACTG1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5445772224112901,-1.6520381302466716,0.024054982817869417,0.329889607330052,1.0,12/24,21.46%,PDE3A;RAPGEF2;PDE4D;PDE3B;GNAI1;PDE2A;PRKAR2B;PDE11A;PEX5L;PRKAR1B;CGAS;APLNR
prerank,phospholipid catabolic process (GO:0009395),-0.5441778269642177,-1.6517294420220943,0.01048951048951049,0.323659937914495,1.0,9/24,21.53%,PLA2G4A;GPCPD1;ENPP2;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6009717832777519,-1.650870578605037,0.030120481927710843,0.3191728083736403,1.0,7/15,14.67%,IGF1;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,negative regulation of platelet activation (GO:0010544),-0.5827401467218454,-1.6459962512236215,0.014204545454545454,0.32587665262639676,1.0,5/16,7.06%,PRKG1;NOS3;PDGFRA;SERPINE2;SH2B3
prerank,regulation of extracellular matrix organization (GO:1903053),-0.6089686255385911,-1.645632397315257,0.014749262536873156,0.32016117675870936,1.0,6/15,5.61%,AEBP1;FAP;TIE1;NOTCH1;RIC1;RUNX1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6621179465395343,-1.6438722847924245,0.01876675603217158,0.3190929466747821,1.0,9/11,28.10%,ADIPOR2;CD34;NDNF;KDR;GATA2;PRCP;SRF;MCAM;HPSE
prerank,aggrephagy (GO:0035973),0.646327361746225,1.6410062083380355,0.027586206896551724,0.9410150247474364,1.0,11/27,18.32%,CFTR;DYNC1I1;VIM;WDFY3;DYNC1LI2;UBE2N;DYNC1H1;UBC;RPS27A;HDAC6;PARK7
prerank,regulation of feeding behavior (GO:0060259),-0.6609833648078189,-1.6406265596740208,0.02912621359223301,0.32140128055988587,1.0,5/11,11.29%,LEPR;AGRP;SGIP1;CFAP20;STAT3
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6833296321480304,-1.6343532552940632,0.020671834625323,0.332324071303727,1.0,7/10,18.97%,GABRG3;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7284434213037337,1.634305794397325,0.031496062992125984,0.973897146175646,1.0,5/15,8.24%,SMO;GDNF;SOX9;BMP4;SIX1
prerank,positive regulation of cyclase activity (GO:0031281),-0.6064679800645338,-1.6332549803332737,0.013850415512465374,0.3293632976636711,1.0,3/14,2.44%,CACNA1C;STIM1;NOS3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5755413370080104,-1.6325276176041068,0.0345821325648415,0.32527064559759106,1.0,5/17,4.30%,CACNA1C;SLC8A1;GJC1;GJD3;ATP1B1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6443574845637148,-1.630995901161084,0.016260162601626018,0.3237589761307082,1.0,2/12,1.05%,PTPRJ;CBLB
prerank,central nervous system neuron development (GO:0021954),-0.6005696332862254,-1.628110470126226,0.019943019943019943,0.3252728841941995,1.0,8/15,19.12%,MAP2;RAPGEF2;NTRK2;LHX6;GBA2;B4GALT5;ARHGAP35;HSP90AB1
prerank,mucosal immune response (GO:0002385),0.7292041111728946,1.627819166279233,0.02599388379204893,1.0,1.0,3/15,10.04%,RAB17;OTUD7B;RNASE3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6764103404307347,1.6274854047730816,0.030165912518853696,0.9914343682583076,1.0,1/21,0.05%,FZR1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6860284648210188,1.627093189252522,0.033381712626995644,0.9777689460065453,1.0,5/22,7.04%,CD44;KLF4;GCNT2;FLOT2;MAPK7
prerank,nuclear membrane disassembly (GO:0051081),0.7288899005429046,1.6269118454827,0.028963414634146343,0.9633680898874697,1.0,1/14,0.10%,PRKCB
prerank,nucleoside catabolic process (GO:0009164),0.7747883736872191,1.6230373965358031,0.018092105263157895,0.9760171037718384,1.0,5/11,9.63%,NT5E;NT5C1A;NT5C3A;UPP2;DERA
prerank,cellular response to amino acid starvation (GO:0034198),0.5734915423839728,1.6228232250561967,0.012910798122065728,0.9625931520391886,1.0,6/71,3.92%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.5115065714123984,-1.6208186646462017,0.01730103806228374,0.33973344635464053,1.0,9/26,13.03%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;TGFB1;RORA;IL6ST;FLT4
prerank,selective autophagy (GO:0061912),0.58110249760537,1.6200877076467735,0.02822085889570552,0.9670879774792301,1.0,19/56,18.32%,CFTR;DYNC1I1;VIM;DDRGK1;TEX264;WDFY3;LGALS8;RAB7A;ULK1;MAP1LC3B;RB1CC1;DYNC1LI2;UBE2N;DYNC1H1;UFM1;UBC;RPS27A;HDAC6;PARK7
prerank,sodium ion import across plasma membrane (GO:0098719),0.715769841249039,1.6189394693861663,0.0364741641337386,0.9602152996465966,1.0,2/17,0.16%,SLC9A2;SLC9A4
prerank,response to amino acid starvation (GO:1990928),0.5717002702220199,1.6173935566545437,0.012941176470588235,0.9560080253652333,1.0,6/72,3.92%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6776744927110773,1.6164291747227109,0.04105571847507331,0.9484132674341693,1.0,4/20,5.98%,B3GALT1;B4GALNT2;ST3GAL4;FUT8
prerank,embryonic heart tube development (GO:0035050),-0.6059323834781382,-1.616284268397193,0.03488372093023256,0.346142052016973,1.0,6/14,16.87%,IFT122;SOX17;TBX2;MEGF8;RYR2;SOX18
prerank,regulation of cellular pH (GO:0030641),0.6425764998963969,1.6137613890927593,0.03185595567867036,0.9539533879134651,1.0,10/29,16.72%,SLC9A2;SLC9A4;SLC4A2;CHP1;SLC9A7;SLC9A6;SLC9A8;SLC9A1;ATP5F1B;SLC4A4
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5086575524677968,-1.6121145667277565,0.007662835249042145,0.35201955652156164,1.0,9/29,9.40%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6359282898150522,-1.610250668847054,0.017632241813602016,0.3514423931033721,1.0,3/11,9.05%,SEMA5A;STMN2;NES
prerank,regulation of transferase activity (GO:0051338),0.6985669133456773,1.6088225271069432,0.028700906344410877,0.974848420416063,1.0,8/17,15.81%,SPTSSB;EMP2;NABP2;FEM1A;JMJD8;FEM1B;PINX1;HMBOX1
prerank,response to iron ion (GO:0010039),-0.6428242668242643,-1.6082909137013464,0.024861878453038673,0.3513042810616938,1.0,5/12,13.41%,BMP6;HIF1A;BCL2;B2M;FXN
prerank,neural crest cell migration (GO:0001755),0.6224952749301605,1.6077354306173055,0.031292517006802724,0.9684770670621127,1.0,4/36,3.93%,FN1;SEMA3D;SEMA3B;GDNF
prerank,negative regulation of cell adhesion (GO:0007162),0.5656905580691513,1.6076021494080959,0.016666666666666666,0.9558446300409571,1.0,17/72,7.46%,CDH1;CDH13;ANGPT1;B4GALNT2;WNT1;PLXNB1;PODXL;ADAM10;PLXNA2;SPINT2;GCNT2;RIPOR2;FBLN1;DUSP1;DMTN;CBLL1;ERBB3
prerank,hemidesmosome assembly (GO:0031581),0.7579184627512836,1.6059977539914765,0.04180064308681672,0.9535894443540289,1.0,4/11,10.71%,ITGB4;LAMC2;LAMC1;PLEC
prerank,regulation of fibroblast proliferation (GO:0048145),0.5988204350825924,1.6033145862303635,0.02544529262086514,0.9585367825161939,1.0,7/45,5.55%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,positive regulation of bone mineralization (GO:0030501),-0.4684519422649279,-1.602570264498611,0.015151515151515152,0.3614031481692046,1.0,10/35,8.61%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;PKDCC;TGFB1;FBN2;ACVR2A
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5010952025319628,-1.60248461137364,0.018656716417910446,0.3558972105935836,1.0,10/27,21.53%,PLA2G4A;GPCPD1;ENPP2;PNPLA8;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3
prerank,diterpenoid metabolic process (GO:0016101),0.5757286719099649,1.6015155221036796,0.019777503090234856,0.9584503816344145,1.0,12/55,10.23%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;SDC4;GPC3;PECR;AKR1B10
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6330090387862257,-1.6014591313567417,0.03116883116883117,0.35309025144940165,1.0,7/13,9.74%,ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,epithelial cell migration (GO:0010631),0.61928794525979,1.6012914615898746,0.03038309114927345,0.9473114179537562,1.0,5/37,3.63%,DPP4;CDH13;KANK1;FAT2;KANK2
prerank,stabilization of membrane potential (GO:0030322),-0.5829281308489812,-1.5999449878075387,0.027247956403269755,0.3515987803090601,1.0,9/16,31.71%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNN4;KCNK6;KCNK4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.7190876590939189,1.599908655513715,0.030911901081916538,0.9442073505603631,1.0,5/14,11.37%,NT5E;NT5C1A;NT5C3A;UPP2;UMPS
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.7068801102855504,1.5994720675637573,0.033690658499234305,0.9349582726507837,1.0,4/16,9.08%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,keratinocyte differentiation (GO:0030216),0.6392902069933102,1.5973924814309264,0.036193029490616625,0.9369577521610115,1.0,2/29,0.41%,WNT16;SCEL
prerank,T cell activation (GO:0042110),0.5605940907210311,1.5967206567536405,0.023752969121140142,0.930140930217315,1.0,3/69,0.58%,DPP4;CXADR;CD44
prerank,regulation of establishment of cell polarity (GO:2000114),0.7085779943590341,1.590512903520974,0.044642857142857144,0.9606531374483609,1.0,12/16,18.76%,KANK1;GSN;RAP1B;PTK2B;RIPOR2;KRIT1;BCAS3;ARFGEF1;CDH5;SHTN1;ROCK2;KIF20B
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7727897476413876,1.5857004130391343,0.028523489932885907,0.9826849070129181,1.0,4/10,9.08%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6798438756702269,1.5852884081478016,0.044072948328267476,0.9735414537213015,1.0,3/18,2.16%,FN1;ITGB8;CD200
prerank,contractile actin filament bundle assembly (GO:0030038),0.7182519447999091,1.5850152042258012,0.030257186081694403,0.9526091102555834,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,stress fiber assembly (GO:0043149),0.7182519447999091,1.5850152042258012,0.030257186081694403,0.9526091102555834,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6086673539113625,-1.5838924683602975,0.03529411764705882,0.3905090737459461,1.0,5/13,9.61%,ENG;KDR;COL4A1;SEMA3E;NOTCH4
prerank,muscle tissue development (GO:0060537),0.7303439666090576,1.581824532587543,0.03755868544600939,0.9618609559765164,1.0,5/13,7.10%,PGM5;SMO;STRA6;CSRP3;BMP4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.7471721445874389,1.581035452408722,0.04081632653061224,0.9559723770343568,1.0,1/11,0.37%,CDH13
prerank,water transport (GO:0006833),0.736278805235186,1.5804480829235292,0.03354632587859425,0.9492072668476309,1.0,3/12,12.50%,CFTR;AQP1;PDPN
prerank,cholesterol biosynthetic process (GO:0006695),0.6169230301970212,1.5797985785708535,0.033602150537634407,0.9429758259532981,1.0,13/31,18.49%,FDFT1;DHCR7;HMGCR;FDPS;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,regulation of cell communication (GO:0010646),0.6132876901334652,1.5795017067148107,0.04161248374512354,0.9344630368273364,1.0,4/35,1.94%,CXADR;ANK2;GRK5;VEPH1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.6195162445926332,1.5784542084213324,0.03260869565217391,0.9309347865334415,1.0,13/30,18.49%,FDFT1;DHCR7;HMGCR;FDPS;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5614693666162657,-1.5774728090045436,0.0364741641337386,0.40296001689110106,1.0,4/18,6.90%,IGF1;IGFBP2;IL18;IGF2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.6016071695208277,1.5768474244724817,0.030183727034120734,0.9311209375015609,1.0,9/39,7.04%,CDH1;ADTRP;B4GALNT2;WNT1;KLF4;PODXL;SPINT2;AKNA;MAPK7
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.47893889288992386,-1.5765753409568062,0.019230769230769232,0.3998516606816288,1.0,18/34,25.15%,GRID2;GABRG3;GRIN2A;GRIN2B;LRRK2;GLRA1;GABRG2;GABRG1;GABRA3;DRD2;NLGN3;MPP2;GABRA1;GABRE;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6434283520613953,-1.5762162062999165,0.0583756345177665,0.39542851457609923,1.0,4/10,4.96%,ACER2;NEXMIF;PDE3B;CYP1B1
prerank,endothelial cell migration (GO:0043542),0.60382189208374,1.5747980076560337,0.045272969374167776,0.9346008930729623,1.0,3/37,2.03%,DPP4;CDH13;EMP2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.7305307762380355,1.5737080567228554,0.04251968503937008,0.9318001905022525,1.0,1/12,0.10%,PRKCB
prerank,protein localization to cell surface (GO:0034394),0.6341424380294074,1.5734833882714496,0.03428571428571429,0.9232852227501833,1.0,9/26,12.55%,ANGPT1;ANK2;EMP2;PIGU;WNT11;PTPRU;UNC50;GGA1;MESD
prerank,camera-type eye morphogenesis (GO:0048593),-0.669877363126552,-1.571078825185992,0.03233830845771144,0.4045305322413881,1.0,6/10,23.22%,IFT122;LRP6;TBX2;NF1;KDM2B;TENM3
prerank,icosanoid secretion (GO:0032309),-0.6270846309195388,-1.5708606992918328,0.029556650246305417,0.3994690367830636,1.0,4/12,12.66%,ABCC4;PNPLA8;ACE;DRD2
prerank,sterol transport (GO:0015918),0.6799153432429708,1.568386649530238,0.04424778761061947,0.9474362942282027,1.0,4/19,6.53%,LDLR;CAV1;STARD3;NPC1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6389756001594086,1.568181953855734,0.04219409282700422,0.9392034718046199,1.0,7/26,7.67%,FGFR1;EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6728229399761754,-1.5677026053041163,0.02564102564102564,0.40223717173987616,1.0,4/10,7.06%,PRKG1;RDX;SERPINE2;SH2B3
prerank,carbohydrate biosynthetic process (GO:0016051),0.6489804789126115,1.5671550760795043,0.04899135446685879,0.9360215833456027,1.0,4/21,5.98%,B3GALT1;B4GALNT2;ST3GAL4;FUT8
prerank,mesoderm formation (GO:0001707),0.6815288651870207,1.5662645490968707,0.033182503770739065,0.9322177866403122,1.0,2/17,3.12%,ITGB4;CRB2
prerank,cellular component maintenance (GO:0043954),-0.6316103516658969,-1.5662040595495559,0.020887728459530026,0.4012047198426002,1.0,4/12,13.00%,INSR;IGF1R;MTMR2;CLDN1
prerank,cellular response to alcohol (GO:0097306),0.5806708540446522,1.5656617344567472,0.04271356783919598,0.9265320058858013,1.0,7/42,7.75%,CDH1;CFTR;SMO;PTGFR;CTNNA1;GOLPH3;ADCY6
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5538098316321625,1.5654765076891148,0.02364066193853428,0.9184068878149609,1.0,18/70,10.13%,FN1;POF1B;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;ANTXR1;TMEFF2;UNK;PXN;ILK;SRCIN1;LAMC1;OPHN1;GRHL2;DACT2;LAMB2
prerank,base conversion or substitution editing (GO:0016553),-0.6242654078898894,-1.5618529432048656,0.03674540682414698,0.40808669564684996,1.0,5/11,22.90%,ADAR;ADARB1;ADARB2;APOBEC1;NUDT16
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7062631898625432,1.560378788249561,0.03414634146341464,0.9421939392558364,1.0,3/14,5.90%,CD55;CD81;RASAL3
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5776770075496099,1.5602502055562184,0.04076433121019108,0.9339581433250421,1.0,12/46,8.12%,FN1;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;ANTXR1;TMEFF2;PXN;ILK;SRCIN1;LAMC1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.626182185623489,1.5572886324432176,0.045779685264663805,0.9432193184988058,1.0,5/26,6.40%,ANK2;ACTN2;FHL1;WWP2;STK39
prerank,epithelial cell development (GO:0002064),0.6495594330865573,1.556662341172987,0.051470588235294115,0.9382513469181746,1.0,6/20,9.48%,POF1B;ROS1;WNT5B;GRHL2;PDZD7;DACT2
prerank,vasoconstriction (GO:0042310),-0.6338315095595137,-1.556461315613224,0.03968253968253968,0.4175182549375337,1.0,7/11,29.16%,SLC8A1;ACTA2;EDNRB;EDN1;EDN3;HTR2B;PIK3C2A
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6874628450869708,1.5559072735521255,0.04122137404580153,0.934215902229689,1.0,1/15,0.04%,DPP4
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5959732981110016,1.554650514991453,0.04461942257217848,0.9331782246495386,1.0,9/41,10.84%,CD44;TJP1;CCL5;PODXL;GCNT2;PTPRU;ANK3;DENND6A;JAK1
prerank,positive regulation of lyase activity (GO:0051349),-0.5878454904199476,-1.5539600340013988,0.038922155688622756,0.41920508316761307,1.0,6/14,17.83%,CACNA1C;STIM1;NOS3;NF1;FXN;ISCU
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5493069930926592,1.55317548766631,0.03348729792147806,0.9340097822015665,1.0,16/72,10.05%,GPR4;LPAR1;RTN4R;KANK1;PRAG1;LPAR4;AKAP13;EPS8L2;KANK2;DLC1;RIPOR2;ARHGEF18;CCDC125;OPHN1;BCR;RAF1
prerank,regulation of gastrulation (GO:0010470),0.7128074743313404,1.5530881299207822,0.04141104294478527,0.9260549556043364,1.0,3/14,3.12%,PHLDB2;DAG1;CRB2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6046870527210032,1.551571284343351,0.050734312416555405,0.9269997242955478,1.0,10/32,16.87%,FHIT;DDX5;EP300;PMAIP1;PHLDA3;PPP1R13B;PML;PDK2;USP28;POU4F1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5442511529172359,-1.550373802355082,0.043478260869565216,0.4251417218875739,1.0,9/19,9.62%,DCN;SEMA6A;CCBE1;ROBO1;XDH;DAB2IP;PIK3CB;TSPAN12;ADAMTS3
prerank,neutrophil activation (GO:0042119),0.7190890688572779,1.5481756289715973,0.05853658536585366,0.9396995902699061,1.0,3/12,11.87%,CCL5;IL15;FCER1G
prerank,embryonic axis specification (GO:0000578),0.6938172727965207,1.547038180532338,0.05172413793103448,0.9383024867258052,1.0,5/15,8.81%,WNT1;COBL;SMAD6;FZD5;CXXC4
prerank,regulation of cholesterol esterification (GO:0010872),0.7487108649508849,1.5469304639677082,0.033277870216306155,0.9307150295498384,1.0,3/10,11.79%,AGTR1;ABCA2;STARD4
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5793870525742186,1.5460078547552272,0.03430749682337993,0.9284748178187743,1.0,18/47,16.76%,DOCK5;KANK1;LIMS2;S100A10;FBLN1;EFNA5;DMTN;ILK;CDC42;PDPN;DOCK1;RREB1;ITGB1BP1;ACTN4;FLNA;TESK1;ABL1;CRK
prerank,lamellipodium assembly (GO:0030032),0.6308705301404784,1.5428720586394526,0.04507042253521127,0.9396168676865357,1.0,6/26,7.19%,CDH13;SRGAP2;ABLIM2;ABLIM1;DMTN;GOLPH3
prerank,regulation of cell killing (GO:0031341),0.6723119087226249,1.54280258785006,0.04185351270553064,0.9319559422752235,1.0,3/16,7.30%,CD55;CFH;TGFB2
prerank,regulation of axon regeneration (GO:0048679),0.7222455328687732,1.5427965399104056,0.05714285714285714,0.9240161225172022,1.0,6/12,20.04%,RTN4R;EPHA4;CERS2;PTN;STK24;RTN4RL1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5754343482829316,-1.542449892370187,0.034482758620689655,0.44358077186282024,1.0,8/16,19.87%,INSR;IRAK3;GSPT1;OGFOD1;IGF1R;CLN3;SHFL;UPF1
prerank,actin cytoskeleton reorganization (GO:0031532),0.5400731013210454,1.541889876543189,0.025089605734767026,0.921756229179668,1.0,10/63,6.32%,CXADR;PHACTR1;PARVA;PTK7;GSN;SIPA1L1;GAB1;MCU;ANTXR1;DMTN
prerank,protein localization to plasma membrane (GO:0072659),0.5120312387214465,1.5411357743260434,0.012048192771084338,0.918644442614774,1.0,27/129,10.26%,CDH1;FGF13;NECTIN3;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;RAP1A;CD81;S100A10;CACNB3;EHD1;FLOT2;FYB2;RAMP1;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6082647391578299,1.5389371253669764,0.04200542005420054,0.9243841339653157,1.0,3/32,1.91%,FZR1;FOXN3;CDKN1A
prerank,negative regulation of neuron projection development (GO:0010977),0.5562373399470121,1.5385183075121385,0.03663003663003663,0.9193453246896192,1.0,8/56,2.91%,LPAR1;RTN4R;KANK1;PRAG1;NGEF;EPHA4;EFNB2;ITM2C
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5490894266079157,1.5360871927257511,0.035842293906810034,0.9270405184525652,1.0,10/61,4.49%,GPR4;MAPRE2;LPAR1;NOTCH2;RTN4R;PRAG1;LPAR4;AKAP13;NGF;EPO
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6811275148529672,1.5346412195345376,0.07020280811232449,0.9283484988145841,1.0,6/15,11.30%,KLF4;TJP1;PKM;JMJD8;JAK1;S100A1
prerank,striated muscle tissue development (GO:0014706),0.6154422620363098,1.5343692635948047,0.05611510791366906,0.92255368947794,1.0,6/29,4.00%,PGM5;SGCG;SGCD;CAV1;CSRP3;BMP5
prerank,negative regulation of potassium ion transport (GO:0043267),0.7241051265080516,1.534083339757821,0.05032467532467533,0.9167956525197298,1.0,4/13,6.40%,ACTN2;CAV1;PTK2B;STK39
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6400463624462895,-1.531380131197599,0.0427807486631016,0.4721109104267434,1.0,3/10,6.54%,PLA2G4A;ENPP2;PNPLA8
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7124893360322658,1.531272792000631,0.057283142389525366,0.9271528193644798,1.0,4/12,8.24%,SMO;GDNF;SOX9;SIX1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7202174409356521,1.5292759162851488,0.05351170568561873,0.9251770983080531,1.0,9/12,21.48%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;MELTF;RCC2;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7202174409356521,1.5292759162851488,0.05351170568561873,0.9251770983080531,1.0,9/12,21.48%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;MELTF;RCC2;AP1AR
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5563987177009035,-1.5288848114159945,0.04155124653739612,0.4741668008341818,1.0,4/16,6.54%,GUCY1B1;NOS3;NDNF;GUCY1A1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4837260322558212,-1.5284359368417617,0.04081632653061224,0.4698025507240317,1.0,7/25,11.67%,PDE4D;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6863827731315568,1.5246761441069316,0.0698051948051948,0.9448700383866636,1.0,5/13,5.49%,CDH13;LDLR;SREBF2;CD81;CD9
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6900533703667175,1.5228946454679455,0.05555555555555555,0.9488445143692728,1.0,5/15,8.59%,SCEL;FGFR1;CELF1;TGFB2;RAI2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5974177956466372,-1.5220133014869976,0.043373493975903614,0.4849426174667445,1.0,2/12,5.68%,IL1R1;IL18
prerank,non-motile cilium assembly (GO:1905515),-0.4576917005246997,-1.5201484894314292,0.03859649122807018,0.48506556620689056,1.0,18/30,33.40%,CEP250;IFT122;TTC8;GORAB;C2CD3;BBS1;CSNK1D;BBS4;ARL13B;FUZ;RPGRIP1L;TMEM17;TMEM107;PIBF1;IFT88;CCDC13;IFT57;DISC1
prerank,dicarboxylic acid transport (GO:0006835),-0.47851090016817904,-1.519965482326213,0.043478260869565216,0.47997225033404045,1.0,5/28,5.43%,SLC1A3;SLC13A3;SLC26A7;SLC1A2;SLC1A1
prerank,negative regulation of cell development (GO:0010721),-0.4753265213562735,-1.5187078959750544,0.02912621359223301,0.4782382542690715,1.0,7/25,15.04%,IGF1;FBN1;NOTCH1;APPL2;B2M;PTHLH;SORL1
prerank,camera-type eye development (GO:0043010),-0.4936593339425784,-1.5174902543331068,0.04745762711864407,0.47668240590413175,1.0,14/25,25.00%,CACNA1C;LAMA1;FBN1;IFT122;CYP1B1;FBN2;NES;NF1;TSKU;RAB3GAP1;ALDH1A3;TENM3;PAX2;FOXL2
prerank,hemopoiesis (GO:0030097),-0.37651832752995645,-1.5174076193737893,0.008620689655172414,0.47147063182179966,1.0,26/87,14.82%,FLT1;MECOM;JAG1;TEK;KIRREL3;KITLG;SNRK;MFAP5;ETV6;WNT5A;CD34;KDR;RUNX2;RUNX1;SH2B3;TGFB1;FGFR2;KIT;NOTCH4;TP53;TIRAP;MEIS1;FLT4;KAT6A;TOX;FLT3LG
prerank,regulation of neuron death (GO:1901214),0.5213214468750126,1.517101946323325,0.03682393555811277,0.9779242170192977,1.0,27/82,18.32%,EGLN3;CLU;DAXX;PPARGC1A;CCL5;MAP3K5;EFNB2;CD200;FOS;CTSZ;GPR75;EGLN2;CHMP4A;CHMP4B;CHP1;CD200R1;GSK3B;MEF2C;EIF4G1;NENF;SNCB;IKBKG;ITGB2;SIGMAR1;RILPL1;GPNMB;PARK7
prerank,positive regulation of lipid storage (GO:0010884),0.6507628125147378,1.5161426564701952,0.04878048780487805,0.9760859388899319,1.0,4/21,3.63%,SREBF2;ZC3H12A;IKBKE;EHD1
prerank,negative regulation of wound healing (GO:0061045),0.6055189819826804,1.5160942887488527,0.06741573033707865,0.9689873102235292,1.0,5/28,6.15%,CD109;PHLDB2;ADTRP;ALOX5;THBD
prerank,regulation of hemopoiesis (GO:1903706),0.7187822871347112,1.5150574659263643,0.06529209621993128,0.9685105634098516,1.0,4/10,12.48%,PRKCB;LGALS3;PTN;MYSM1
prerank,maturation of 5.8S rRNA (GO:0000460),0.6625504459417063,1.5144390860808221,0.04644412191582003,0.9652510510398455,1.0,7/17,14.43%,NSA2;PES1;MAK16;EIF6;MPHOSPH6;MTREX;RPF1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5097635361706994,-1.5133968592503444,0.03125,0.4780125643472201,1.0,11/23,26.51%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;EGF;SPHK1;BMP7;STOX1;TRIM6;RIPK2
prerank,retinoid metabolic process (GO:0001523),0.527923433669521,1.5132215754639158,0.0337995337995338,0.9657343412662669,1.0,13/71,10.23%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;DHRS13;SDC4;GPC3;ALDH8A1;AKR1B10
prerank,protein localization to cell periphery (GO:1990778),0.4984023974016637,1.5120023143808312,0.013043478260869565,0.9662980807035937,1.0,28/133,10.26%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;CAV1;RAP1A;CD81;S100A10;CACNB3;EHD1;FLOT2;ARL3;FYB2;RAMP1;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,lymphocyte mediated immunity (GO:0002449),0.7105586243389349,1.5119232414333348,0.06462035541195477,0.9598822962480716,1.0,1/12,0.15%,CD55
prerank,defense response to tumor cell (GO:0002357),0.7313706113586036,1.5118508449665098,0.07516339869281045,0.9533863342689328,1.0,3/10,5.85%,KLF4;DAPK1;RBMS3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5250347225843184,1.5103732699755226,0.04423748544819558,0.9554034005379116,1.0,22/78,14.97%,FZR1;CLU;TRIB2;CAV1;ZYG11B;NFE2L2;SH3RF2;NUB1;ELOB;DDRGK1;PLK3;RBX1;SUMO2;COP1;BCAP31;HSPBP1;CSNK1E;PIAS1;GSK3A;DDA1;GSK3B;MDM2
prerank,focal adhesion assembly (GO:0048041),0.6367029834901361,1.5098220285118833,0.059941520467836254,0.9521275681696564,1.0,4/21,8.94%,SORBS1;ACTN2;DLC1;BCR
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.6148894518789709,-1.50834529022579,0.05851063829787234,0.4886087811315877,1.0,6/11,18.98%,IL34;TGFB1;ID2;HSF1;RIPK1;CSF1
prerank,modulation by host of symbiont process (GO:0051851),0.5880218077966394,1.508108134525517,0.06307490144546649,0.9557291341439335,1.0,10/31,12.43%,NAPEPLD;CCL5;HPN;EP300;SMARCB1;POU2F3;JUN;SMARCA4;AQP1;SP1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6280325657590426,-1.506942678414809,0.04207920792079208,0.48771246508955435,1.0,1/10,0.31%,ABCA1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4312660484612143,-1.5067447266841327,0.02242152466367713,0.483108683673225,1.0,13/39,9.61%,ENG;GLI2;TIE1;KDR;COL4A1;PKD2;FGF2;SEMA3E;SLIT2;SALL1;LRP6;LRP5;NOTCH4
prerank,positive regulation of defense response (GO:0031349),0.508375581450095,1.5060582364481947,0.02528735632183908,0.9614949176010681,1.0,21/89,16.22%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;FEM1A;TNFRSF1A;POLR3B;NMI;TLR4;POLR3C;TNIP1;MEF2C;TLR3;DHX9;ZBP1;POLR3G
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5819944743344007,1.5029578314210492,0.05739795918367347,0.9742500053802614,1.0,5/37,4.87%,CXADR;ALCAM;NECTIN3;CRB2;PTPRD
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4962202417386482,1.5028041775453722,0.011866235167206042,0.9685024911195426,1.0,16/142,6.03%,ADRA1B;CD55;AGTR1;LPAR1;CCR4;CACNA1A;CAV1;ATP1A2;CXCR4;PTGFR;CCR10;ACKR2;ACKR4;ACKR3;CAV2;CCRL2
prerank,myelin maintenance (GO:0043217),0.7324259573597848,1.5022851942983018,0.07654723127035831,0.964948053427002,1.0,3/10,2.86%,CLU;ABCD1;CXCR4
prerank,glutamate receptor signaling pathway (GO:0007215),-0.45155639010552406,-1.5018556952213558,0.016260162601626018,0.4937934052637019,1.0,12/37,6.78%,PLCB1;GRIK2;GRID2;GRM3;GRM7;GRIN2A;GRIA3;GRIA2;GRM8;GRIN2B;GRM5;GRIK3
prerank,positive regulation of protein import (GO:1904591),0.592452746218481,1.4991111004306708,0.06732117812061711,0.976991195345755,1.0,10/30,15.76%,CDH1;ZC3H12A;MAVS;BAG3;ARHGEF5;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,positive regulation of inflammatory response (GO:0050729),0.5098235989023511,1.4989911306784724,0.03420752565564424,0.9710581603053234,1.0,20/86,16.20%,AGTR1;GPR4;NAPEPLD;IL17RA;NUPR1;NINJ1;IL15;IL16;CD81;NFKBIA;FEM1A;LBP;TNFRSF1A;NMI;TLR4;TNIP1;VAMP7;TLR3;DHX9;ZBP1
prerank,positive regulation of heart rate (GO:0010460),0.6683788162943258,1.498763294917634,0.05623100303951368,0.9657143255665331,1.0,1/17,0.06%,ADRA1B
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7206306583040505,1.4983969896376093,0.060995184590690206,0.9615539733086669,1.0,3/10,6.58%,CD55;CD81;ZBTB7B
prerank,skin development (GO:0043588),0.5371148714672912,1.4983708619699043,0.03588516746411483,0.9553316173549845,1.0,5/65,2.21%,WNT16;ITGB4;SCEL;WNT10A;COL5A2
prerank,mitochondrion localization (GO:0051646),-0.5181771748801067,-1.4970743000154902,0.04610951008645533,0.5032268895630957,1.0,9/19,17.19%,MARK1;LRRK2;MTM1;BRAT1;MFN1;ZBED3;TRAK2;ATCAY;MSTO1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5680590919021066,-1.4967191408982996,0.05405405405405406,0.4990800832670055,1.0,5/13,8.88%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5875828649348158,1.4966404497013805,0.06283422459893048,0.959069505058251,1.0,14/35,16.59%,BAIAP2L1;NOTCH2;NTRK3;TJP1;PTK2B;DAPK3;HAX1;CDC42;BCAS3;RAPGEF3;TRPM2;HRAS;ARHGDIB;ABL1
prerank,regulation of T cell cytokine production (GO:0002724),0.6528759399226073,1.4966107016972594,0.0700152207001522,0.9529577844022742,1.0,4/15,11.12%,CD55;FZD5;FOXP3;TRPM4
prerank,apoptotic cell clearance (GO:0043277),-0.4602274682569606,-1.4963472636892547,0.024475524475524476,0.49514499020388175,1.0,14/30,25.74%,RHOBTB1;TGM2;GAS6;MEGF10;THBS1;NR1H3;XKR6;ITGAV;HMGB1;TXNDC5;RHOBTB2;TYROBP;RHOH;LRP1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5875212294233836,-1.4946236964031279,0.05965909090909091,0.49567340738912613,1.0,3/14,6.93%,PRKG1;IGFBP5;SLIT2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.7384684736223477,1.4944705404456957,0.06645056726094004,0.9593481933945935,1.0,2/10,1.46%,MAPRE2;MMP9
prerank,regulation of keratinocyte migration (GO:0051547),0.7074270137173404,1.493885205751778,0.0768025078369906,0.956452361243265,1.0,2/12,1.46%,MAPRE2;MMP9
prerank,extracellular structure organization (GO:0043062),0.4801913631279585,1.493821178394812,0.010362694300518135,0.9507823379922273,1.0,23/204,3.91%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;ADAMTS7;DAG1;ADAMTSL5;COL5A2;ITGB7;LAMA5;COL6A1
prerank,cellular response to UV-A (GO:0071492),0.7188842939861171,1.4937735923722475,0.06633499170812604,0.9450381925246537,1.0,3/11,4.49%,OPN1SW;MMP9;TIMP1
prerank,negative regulation of autophagy (GO:0010507),0.5338916283226302,1.4932425643127318,0.04315659679408138,0.9422057171124485,1.0,12/54,14.72%,DAPL1;NRBP2;NUPR1;SNRNP70;TAB3;RUBCN;SMCR8;WDR6;EIF4G2;FOXK1;EIF4G1;WASHC1
prerank,regulation of developmental growth (GO:0048638),-0.4631306448483943,-1.4928862665554101,0.035842293906810034,0.49620127087141713,1.0,5/29,2.25%,PLCB1;IGF1;GHR;INSR;STAT5B
prerank,negative regulation of cell projection organization (GO:0031345),0.5478369319197185,1.4927199899189356,0.05172413793103448,0.9391512639191478,1.0,9/48,7.75%,LPAR1;RTN4R;KANK1;PRAG1;EPHA4;EFNB2;ITM2C;PTPN9;ADCY6
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6339183444334444,1.492280031869711,0.061046511627906974,0.9358540197732581,1.0,3/21,1.81%,NT5E;NUDT4;NT5C1A
prerank,purine nucleotide catabolic process (GO:0006195),0.6964067185970689,1.491258921352011,0.06828528072837632,0.9358801972531501,1.0,3/13,7.01%,NT5E;NT5C1A;NT5C2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6254829251419791,1.490452996900399,0.06092124814264487,0.9347713733074521,1.0,3/22,6.12%,SORBS1;CREBL2;CREB1
prerank,second-messenger-mediated signaling (GO:0019932),0.5101827929462464,1.49015632544141,0.028968713789107765,0.9306913817706284,1.0,13/82,6.77%,AGTR1;NUDT4;CCR4;CXCR4;MCU;PPP2CA;RCAN1;CCR10;ACKR2;ACKR4;ACKR3;CCRL2;DDAH2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6027518336580308,1.489901457655514,0.05994550408719346,0.9264357597815935,1.0,4/27,2.71%,FGF13;DSG2;ANK2;CAV1
prerank,external encapsulating structure organization (GO:0045229),0.4793464097348407,1.489423398346852,0.010362694300518135,0.9235334616472656,1.0,23/205,3.91%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;ADAMTS7;DAG1;ADAMTSL5;COL5A2;ITGB7;LAMA5;COL6A1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6719059505811202,1.4894228818666855,0.05844155844155844,0.9179700070590291,1.0,5/14,8.76%,CCL5;ADAM10;PTK2B;STK39;OXSR1
prerank,energy reserve metabolic process (GO:0006112),-0.5179500033856484,-1.4893926255259575,0.0658682634730539,0.5018731056354273,1.0,4/19,5.93%,PID1;PRKAG2;LEPR;PHKA1
prerank,regulation of cell junction assembly (GO:1901888),0.596980575691577,1.4891657461936527,0.06318681318681318,0.9139447765264085,1.0,6/27,3.21%,RAB17;PDLIM5;TJP1;OCLN;RAP1B;RAP1A
prerank,sphingoid metabolic process (GO:0046519),-0.6079953487594579,-1.4891117117199062,0.059113300492610835,0.497706560337966,1.0,7/12,32.97%,DEGS2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5927828782092888,1.4879848352282288,0.06721536351165981,0.9154560749912922,1.0,8/30,10.26%,CLU;CD44;YJU2;ACKR3;BCL2L1;FBXO5;DDX39B;TWIST1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6971696024265939,1.4875299113880187,0.09350237717908082,0.9124628093415547,1.0,2/11,1.09%,CD44;KANK1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.4445250911757541,-1.4869908746038356,0.044,0.4995287588209014,1.0,11/34,9.40%,FLT1;PDGFRB;PRKD1;TEK;PIK3R1;PTK2;PDGFRA;DAB2IP;FGF2;TGFB1;KIT
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.675616939743779,1.4869671742552526,0.0861244019138756,0.9101864361270298,1.0,4/13,14.07%,B4GALNT2;NAGK;UAP1L1;GFPT1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5938104770510442,-1.4855550119154088,0.07857142857142857,0.49927076843104845,1.0,6/11,28.36%,LYN;TNFRSF21;CD300A;RC3H1;TYROBP;FCGR2B
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5580501728745062,1.4852490373221956,0.06727037516170763,0.9145733864715807,1.0,8/44,5.23%,BAIAP2L1;GSN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;LMOD3;FCHSD1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5858484098180703,1.4834935549919441,0.07114093959731543,0.9189383667596711,1.0,12/34,16.76%,DOCK5;LIMS2;S100A10;DMTN;ILK;CDC42;DOCK1;RREB1;FLNA;TESK1;ABL1;CRK
prerank,Golgi localization (GO:0051645),0.6991405111459477,1.4823874827228265,0.0718954248366013,0.9196206454663005,1.0,8/11,19.73%,ARHGAP21;CDC42;YWHAZ;RIPOR1;COPG1;TBCCD1;HOOK3;UVRAG
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5201401381770145,-1.482368879348403,0.05405405405405406,0.5046633357090505,1.0,9/18,13.35%,IL34;DAAM2;NOTCH1;PTPRZ1;TNFRSF21;TENM4;NF1;SLC45A3;TNFRSF1B
prerank,regulation of protein modification process (GO:0031399),0.5425127537564708,1.4822344069760818,0.0440251572327044,0.9152081679045825,1.0,13/50,14.69%,FN1;SESN2;PPP2CA;KDM4D;HSPB1;SPRED3;PML;PPP1R16A;ABCA2;RABL3;PLXNB2;FLCN;CCDC88A
prerank,aortic valve morphogenesis (GO:0003180),-0.45096663325461694,-1.4821478012338252,0.02702702702702703,0.5005530921353183,1.0,12/30,9.16%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7278810857999835,1.4820291137973145,0.05555555555555555,0.9110230861782144,1.0,5/10,11.66%,HDAC5;SMARCB1;PIH1D1;KMT2A;RAPGEF3
prerank,platelet aggregation (GO:0070527),0.5912254662096537,1.4819012853561693,0.06233062330623306,0.906465523821052,1.0,7/33,10.88%,FN1;HSPB1;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.6243681331475937,1.4816943287057713,0.07994186046511628,0.9024335658771249,1.0,10/19,21.54%,SREBF2;HAX1;FZD5;GSK3A;VDAC1;DNM1L;HDAC6;PARK7;SREBF1;FBXW7
prerank,cardiac muscle cell differentiation (GO:0055007),0.6283141656979382,1.481336885536246,0.07132667617689016,0.8993448975240954,1.0,2/21,2.50%,CXADR;AKAP13
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5422253552500248,-1.4802827657111273,0.044854881266490766,0.5017249623170152,1.0,5/15,5.36%,PRKD1;SEMA5A;NOTCH1;THBS1;FGF2
prerank,UV protection (GO:0009650),0.7006839088875741,1.479852239892374,0.08347245409015025,0.9021955036047205,1.0,2/10,2.75%,SCARA3;FEN1
prerank,endodermal cell differentiation (GO:0035987),0.5807506880669167,1.4794705371218195,0.0667574931880109,0.8991868768102637,1.0,3/31,3.91%,FN1;MMP9;COL6A1
prerank,vasculature development (GO:0001944),-0.5258787411386783,-1.4793417279828673,0.043227665706051875,0.5000088806202052,1.0,8/16,16.87%,ERRFI1;PDGFRB;ACVRL1;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18
prerank,aminoglycan metabolic process (GO:0006022),-0.6149505024432258,-1.4787423925149814,0.0703883495145631,0.49725671494726287,1.0,8/10,34.47%,XYLT1;XYLT2;B3GAT3;B4GALT7;CLN6;B3GAT1;CHST9;B3GALT6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6917555176651782,1.4786354235865147,0.07768595041322314,0.8984137324557141,1.0,4/12,11.47%,VSIG1;SOX9;MUC6;TLR4
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5869123283677717,1.4780202527835948,0.08403361344537816,0.8967763225385972,1.0,9/28,15.76%,CDH1;ZC3H12A;MAVS;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4546248886689153,-1.4776141885256286,0.04044117647058824,0.49651424292105734,1.0,5/30,6.90%,IGF1;IGFBP2;LGALS9;IL18;IGF2
prerank,negative regulation of transmembrane transport (GO:0034763),0.7215267527192709,1.4772351576189837,0.06565656565656566,0.8959647504836621,1.0,1/10,0.10%,PRKCB
prerank,negative regulation of cholesterol transport (GO:0032375),0.7219701125957263,1.477136175546119,0.07401315789473684,0.891790340454042,1.0,2/10,9.64%,SREBF2;ABCA2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5666958551224147,-1.476355621954649,0.07228915662650602,0.49601534182217905,1.0,5/14,27.98%,MOXD1;ALDH9A1;SLC5A7;SLC22A2;CHAT
prerank,homotypic cell-cell adhesion (GO:0034109),0.5777048454129484,1.4762014015719733,0.056451612903225805,0.8919703031602484,1.0,9/39,10.88%,FN1;TJP2;HSPB1;ILK;DSC2;STXBP1;CLIC1;ACTB;ACTG1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5525711178702414,1.4757571528532625,0.06299212598425197,0.8896024660916438,1.0,15/43,20.76%,FZR1;FOXN3;CDKN1A;NABP2;MRE11;HUS1B;TOPBP1;ABRAXAS1;DONSON;NBN;INTS3;TAOK3;CDK5RAP3;NABP1;CHFR
prerank,negative regulation of protein transport (GO:0051224),0.598678597760013,1.4755969464007506,0.07369942196531792,0.8855878134236932,1.0,8/25,14.15%,ADTRP;WWP2;HMGCR;CSK;CYP51A1;SNX12;SERGEF;RHBDF2
prerank,inhibitory synapse assembly (GO:1904862),0.695271549474481,1.4755678232816816,0.09253246753246754,0.8810632258887009,1.0,2/11,1.56%,FGF13;PLXNB1
prerank,negative regulation of nervous system development (GO:0051961),-0.5203618985771638,-1.4725325883491782,0.048295454545454544,0.503928883520814,1.0,6/17,15.04%,NOTCH1;APPL2;ROBO2;B2M;SLIT1;SORL1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4789223481768519,1.4721701408235424,0.016025641025641024,0.8943889849873896,1.0,17/159,7.45%,CDH1;CXADR;CLDN11;ALCAM;SDK1;DSG2;CDH13;NECTIN3;GPC6;FAT2;CRB2;GPC4;PTPRD;MYOT;PTPRF;TGFB2;PVR
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6614119265858722,1.4698075122367416,0.08504398826979472,0.9021850758299651,1.0,2/16,1.56%,AGTR1;JCAD
prerank,establishment of melanosome localization (GO:0032401),0.6208460579606686,1.4696739087919208,0.076103500761035,0.8980578616229785,1.0,4/19,9.12%,RAB17;MLPH;BLOC1S6;MYO5A
prerank,limb development (GO:0060173),-0.4674827565647051,-1.469166030951777,0.05782312925170068,0.5105075917158817,1.0,8/28,10.12%,PCSK5;SMOC1;ZNRF3;IFT122;BMPR1B;SALL1;CHD7;MEGF8
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5209698620941642,1.4686677247484936,0.049528301886792456,0.8988906425369922,1.0,17/72,8.64%,FN1;WNT16;FGFR1;NTRK3;CCL5;PLXNB1;PDGFC;GAB1;EPO;HAX1;SOX9;MYDGF;TGFB2;ERBB3;UNC5B;MAZ;PTPN6
prerank,atrial septum development (GO:0003283),0.667893912465388,1.4677385554487135,0.07849293563579278,0.899600916787117,1.0,4/13,12.42%,ANK2;NOTCH2;TGFB2;DAND5
prerank,regulation of gluconeogenesis (GO:0006111),0.5902654808564641,1.4674355260165428,0.07593123209169055,0.8967249403443306,1.0,10/27,18.38%,PPARGC1A;OGT;EP300;ZNF692;NNMT;PDK2;PTPN2;PGP;DDB1;SDHAF3
prerank,pigment granule transport (GO:0051904),0.6230725986768397,1.466938351817484,0.07926829268292683,0.8901078902755143,1.0,4/18,9.12%,RAB17;MLPH;BLOC1S6;MYO5A
prerank,melanosome transport (GO:0032402),0.6230725986768397,1.466938351817484,0.07926829268292683,0.8901078902755143,1.0,4/18,9.12%,RAB17;MLPH;BLOC1S6;MYO5A
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5631648170628825,-1.4662649257920892,0.07957559681697612,0.5149636800167934,1.0,2/13,2.28%,KCNT2;KCNK5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6803275303324797,1.465822175792132,0.08562197092084006,0.8914619304592708,1.0,2/13,2.20%,B3GALT1;B4GAT1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5508572129802654,1.4654943349858938,0.06631299734748011,0.8887658886388491,1.0,22/42,21.07%,EPRS1;QARS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;EEF1E1;TARS1;YARS1;HARS2;SARS1;SARS2;TARS3;FARSA;FARSB;DARS2;NARS1;YARS2
prerank,purine-containing compound catabolic process (GO:0072523),0.6922942409315918,1.4642878003455488,0.07465007776049767,0.8905698979133917,1.0,3/13,7.01%,NT5E;NT5C1A;NT5C2
prerank,T cell mediated immunity (GO:0002456),0.6698134343863382,1.463678394304289,0.0877742946708464,0.8894037919672658,1.0,2/13,2.03%,CD55;EMP2
prerank,positive regulation of cell death (GO:0010942),0.5244833111929124,1.4633693454869319,0.0687960687960688,0.8865494806729092,1.0,12/59,7.10%,CLU;DAXX;MAP3K5;EFNB2;ZC3H12A;CELF1;PRR7;FOS;HP;HPR;RARG;BMP4
prerank,neutrophil chemotaxis (GO:0030593),0.5290956539600793,1.4631630378506915,0.07142857142857142,0.8832486527637684,1.0,4/53,8.46%,CXADR;CCL5;TGFB2;LGALS3
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5825242239651418,1.462126897478198,0.06428571428571428,0.8842716600583687,1.0,5/29,8.73%,SORBS1;LDLR;CREBL2;CREB1;CHP1
prerank,response to interferon-alpha (GO:0035455),-0.5379778928469615,-1.4619558206371939,0.0547112462006079,0.5237415672380528,1.0,6/16,12.56%,GAS6;AXL;ADAR;IFNAR2;IFITM3;KLHL20
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5449692772020166,-1.4618293766335866,0.07017543859649122,0.5195518893511253,1.0,6/17,18.23%,PCSK5;NR1H3;SORT1;NR1H2;LPL;PCSK6
prerank,regulation of protein import into nucleus (GO:0042306),0.560738959769428,1.460354408375088,0.07017543859649122,0.8887566880101909,1.0,13/36,17.24%,CDH1;ZC3H12A;MAVS;BMP4;CHP1;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA;UFM1;SUFU
prerank,cellular response to fluid shear stress (GO:0071498),0.6754882766379411,1.4597548422011424,0.09180327868852459,0.8876766008035263,1.0,8/12,19.92%,KLF4;SREBF2;NFE2L2;MAPK7;HDAC3;MEF2C;ASS1;KLF2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6985659574953746,1.4588366220910984,0.0940032414910859,0.8879988247645475,1.0,3/11,6.40%,ACTN2;CAV1;STK39
prerank,lipoprotein transport (GO:0042953),0.6947308347208171,1.4585361836955508,0.10234899328859061,0.8853016003190167,1.0,2/10,6.01%,PRKCB;UNC119
prerank,regulation of peptide hormone secretion (GO:0090276),0.5156148388517138,1.4580945695471923,0.05200945626477541,0.8833507507688093,1.0,7/67,6.51%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;ALOX5;ABCC8
prerank,positive regulation of neuron death (GO:1901216),0.5377052283574949,1.4575603338703482,0.059045226130653265,0.8819826040998375,1.0,11/46,11.47%,CLU;DAXX;MAP3K5;EFNB2;NUPR1;FOXO3;FOS;TGFB2;TLR6;SRPK2;TLR4
prerank,dendritic spine organization (GO:0097061),-0.46027585649057584,-1.4572726679968815,0.060714285714285714,0.5301685171924537,1.0,7/26,12.29%,INSR;SHANK3;DOCK10;PAK3;EPHB2;IGF1R;MTMR2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3616798944447141,-1.457109634563367,0.005649717514124294,0.5260475275357485,1.0,26/75,19.25%,PTPRJ;NR2F2;SLC8A1;SLC8A3;LYN;PKIG;DAB2IP;IRAK3;APC;SH2B3;PIK3CB;LRP6;IPO5;LRP5;PRKAR2B;NF1;RASIP1;CD300A;SORL1;MYOCD;HHEX;INCA1;PRKAR1B;SPRY1;SPRY4;PAQR3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6393805564368846,1.4560542261034097,0.08160237388724036,0.8855987524199778,1.0,5/18,6.40%,MMP9;CAV1;ATP1A2;EPO;STK39
prerank,negative regulation of angiogenesis (GO:0016525),-0.35897540693104923,-1.4557856380517458,0.0,0.5256816465642156,1.0,34/84,18.31%,PTPRM;DCN;SULF1;SEMA6A;TEK;ADAMTS9;CLDN5;EPN2;PDE3B;SLC12A2;DAB2IP;THBS1;SEMA3E;RGCC;GTF2I;COL4A2;THBS2;PIK3CB;SERPINF1;ROCK1;MECP2;PPARG;ISM1;NPR1;AMOT;AGO1;SPARC;STAB1;NAXE;HHEX;MINAR1;HSPG2;SPRED1;VASH1
prerank,negative regulation by host of viral transcription (GO:0043922),0.686966338057239,1.4552937063983753,0.06962025316455696,0.8855349474356973,1.0,3/12,8.69%,CCL5;POU2F3;JUN
prerank,proteoglycan biosynthetic process (GO:0030166),-0.44973678238317033,-1.455193658210341,0.06785714285714285,0.5230704293169595,1.0,16/31,17.04%,IGF1;NDST3;CSGALNACT1;XYLT1;BMPR1B;CHST8;XYLT2;EXTL3;PXYLP1;HS3ST3B1;EXT2;CANT1;B3GAT3;BMPR2;CHST10;B4GALT7
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6483181813573154,1.455023289524897,0.09165302782324058,0.8827857264065625,1.0,7/14,19.24%,PPARGC1A;PMAIP1;NNMT;IRS2;PTPN2;DDB1;GPLD1
prerank,adherens junction organization (GO:0034332),0.5352076323705198,1.454997908033966,0.08667529107373868,0.8787396864427152,1.0,8/48,7.71%,CDH1;CDH13;NECTIN3;TJP1;CTNNA1;CSK;PVR;ANG
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5277757008917725,1.453767138055218,0.060024009603841535,0.8810709732336257,1.0,6/59,2.48%,CDH1;SDK1;DSG2;CDH13;NECTIN3;FAT2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5934509020691074,1.4537010906300416,0.08262108262108261,0.8773261071946956,1.0,1/22,0.15%,CD55
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5236486116354883,1.4530143025536533,0.07398273736128237,0.8768858242129379,1.0,18/57,18.81%,FZR1;FOXN3;CDKN1A;MRE11;FBXO31;SDE2;CCND1;MDC1;HUS1B;TOPBP1;ABRAXAS1;CDK2;DONSON;NBN;CHEK2;ATF2;TAOK3;CDK5RAP3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6903245364286196,1.4523934693967677,0.0859375,0.8759846220432101,1.0,2/12,4.17%,CD44;GCNT2
prerank,aminoglycan catabolic process (GO:0006026),0.5848979477425087,1.451999841624715,0.06770098730606489,0.8740880949721452,1.0,8/28,10.20%,GPC6;GPC1;GPC4;NAGLU;SDC4;GLB1;GPC3;GUSB
prerank,amino acid transport (GO:0006865),0.5362000209430013,1.4501206074615494,0.07872078720787208,0.8796307580487622,1.0,11/49,12.61%,SLC7A14;SLC36A3;SH3BP4;SLC36A4;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;PDPN;SLC25A44
prerank,activin receptor signaling pathway (GO:0032924),-0.5348988577738031,-1.449089721341538,0.08059701492537313,0.5386841842596342,1.0,8/15,35.34%,ACVR1B;ACVR2A;SMAD3;ACVR1C;ACVR1;SMAD2;ACVR2B;AMHR2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5976359270229596,1.4487487098365948,0.08274894810659186,0.8826709173446353,1.0,7/24,9.50%,PHLDB2;TJP1;ARAP1;DLC1;TMEFF2;ARHGEF18;RHPN2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.6616357930688467,1.4483221062981422,0.08892355694227769,0.8809552169881875,1.0,6/13,12.71%,CLU;NUPR1;ALOX5;USP19;EIF2AK3;LPCAT3
prerank,dermatan sulfate metabolic process (GO:0030205),0.6738792097361376,1.4471861563995068,0.08722741433021806,0.8828235098110357,1.0,3/13,4.44%,UST;CHST12;DSE
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.6174531630603177,1.4470495257369442,0.09821428571428571,0.8796172775376973,1.0,12/21,23.70%,DAG1;ADAM10;SPPL2B;PRTN3;HM13;BACE1;SPPL3;PRKCQ;SPPL2A;ADAM17;APH1A;PSEN1
prerank,granulocyte chemotaxis (GO:0071621),0.5209139302713397,1.4459732862404489,0.07544757033248081,0.8811715911663741,1.0,4/55,8.46%,CXADR;CCL5;TGFB2;LGALS3
prerank,endoderm formation (GO:0001706),0.5676535458596405,1.4457256137326446,0.08344549125168237,0.8785517662150029,1.0,4/35,5.50%,FN1;MMP9;COL6A1;DUSP1
prerank,heterochromatin organization (GO:0070828),-0.5472601589084445,-1.4432533738826503,0.07027027027027027,0.5537703575583176,1.0,6/14,17.54%,MECOM;PRDM16;SMCHD1;HMGA2;HP1BP3;SETDB2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5682660406006249,1.44273275403562,0.07222222222222222,0.8899854722842377,1.0,4/31,11.03%,FZR1;ARRDC3;DCUN1D5;DCUN1D1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.537617209204896,1.4424583622159097,0.07125,0.8874115147845093,1.0,16/48,16.76%,DOCK5;FBXW8;LIMS2;S100A10;PTPRD;DMTN;ILK;CDC42;DOCK1;RREB1;CAPRIN2;SS18L2;FLNA;TESK1;ABL1;CRK
prerank,response to laminar fluid shear stress (GO:0034616),0.69780575172687,1.441315970409547,0.08609271523178808,0.889452077460052,1.0,5/10,7.04%,KLF4;SREBF2;SMAD6;NFE2L2;MAPK7
prerank,epidermis development (GO:0008544),0.5209750353931448,1.4408591680531884,0.06125,0.8878321395301095,1.0,10/56,9.05%,SCEL;LAMC2;EDA2R;WNT10A;CCN2;FLOT2;POU2F3;OVOL2;TGM5;GRHL2
prerank,detection of visible light (GO:0009584),0.6344498323916739,1.440308901739383,0.09226190476190477,0.8867344801599158,1.0,8/16,21.25%,RP1;CACNA2D4;GNAQ;CNGB1;PDE6B;GNA11;ABCA4;TULP1
prerank,regulation of protein processing (GO:0070613),-0.4801163406404728,-1.4400624497249692,0.06060606060606061,0.5594846007145702,1.0,9/21,25.44%,CCBE1;RUNX1;SERPINE2;LRRK2;CLN3;NKD2;GAS1;BAG2;ADAM8
prerank,regulation of cell morphogenesis (GO:0022604),0.574569706733912,1.4397592491129985,0.08111888111888112,0.8856376748951301,1.0,12/30,18.09%,CD44;FMNL2;ZMYM6;CAPZB;EFNA5;MOV10;STRIP1;ZMYM4;PDPN;CAMSAP1;NTNG2;WTIP
prerank,negative regulation of complement activation (GO:0045916),0.69646572549579,1.4391106285261552,0.10702875399361023,0.8852177670046704,1.0,1/10,0.15%,CD55
prerank,epidermal cell differentiation (GO:0009913),0.5451114692889132,1.4380150561195708,0.07483870967741936,0.8870738900989126,1.0,2/41,0.41%,WNT16;SCEL
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3499494319295347,-1.4372065365703695,0.0,0.5645381396207818,1.0,47/107,20.88%,GRIK2;CDH2;NRG3;SLC8A3;GRID2;GRM3;SNCAIP;GRM7;LRRC4C;LGI1;SLC12A2;GRM8;DLGAP1;MCTP2;SYT1;GRM5;GRIK3;LRRK2;NLGN1;CLSTN2;LRP8;CNTNAP4;DGKI;GRIK4;GRIK1;DRD2;TMEM108;NLGN3;BDNF;CAMK2A;MCTP1;CLN3;KCNMB4;BAIAP3;GRM1;CPLX2;NPTX1;KCTD13;CACNA1B;FMR1;CX3CR1;STX1B;PXK;RIMS1;GRIK5;TPRG1L;DGKZ
prerank,amino acid import (GO:0043090),-0.49364594652649235,-1.4369772342644322,0.06363636363636363,0.5606493835862255,1.0,7/21,8.32%,SLC1A3;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC1A1;SLC6A1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.601143564947546,1.436359683678872,0.1085383502170767,0.8917532163293459,1.0,4/23,3.62%,ANK2;ATP1A2;DIAPH1;PTK2B
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5518613226357789,-1.4362973456964525,0.0790273556231003,0.5584242296913234,1.0,7/13,21.18%,ENTPD1;ENPP1;ITPA;ENPP3;ENTPD3;ENTPD5;ENTPD6
prerank,GPI anchor biosynthetic process (GO:0006506),0.5756937957561808,1.4355248741106295,0.06869220607661823,0.8923499155450878,1.0,12/30,19.78%,PIGU;GPAA1;PIGZ;PGAP2;PIGT;PIGA;DPM2;PIGX;PIGN;PIGS;PIGP;PIGQ
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5942499688710915,-1.4354189082036564,0.10732984293193717,0.5568923651503092,1.0,5/10,14.89%,PDE3A;PDE4D;PDE3B;PDE2A;PDE11A
prerank,dendritic cell differentiation (GO:0097028),-0.48208457693739226,-1.4352295636493209,0.056962025316455694,0.5531250516288476,1.0,5/22,4.61%,LYN;GAS6;AXL;CAMK4;LGALS9
prerank,Rho protein signal transduction (GO:0007266),0.5202232670711041,1.4349651028135881,0.06832298136645963,0.891362613907521,1.0,15/53,16.37%,AGTR1;CDH13;CELSR1;EPS8L2;CDC42EP4;CDC42EP5;ARHGAP29;CDC42;GNA13;RHOA;PDPN;RHOU;ARHGDIB;RIPOR1;ARHGEF1
prerank,cellular response to organonitrogen compound (GO:0071417),0.4818051932617365,1.433832551035375,0.04788418708240535,0.8930308101859715,1.0,22/99,14.13%,CDH1;CFTR;RAP1B;RAP1A;DIAPH1;CTNNA1;SESN2;SH3BP4;DMTN;SOX9;AANAT;CAPN2;GOLPH3;HTR1B;ACTB;EZR;AQP1;RAPGEF3;SFRP1;CPEB3;TRPM2;MEF2C
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5622943840693848,-1.4334070967995824,0.09066666666666667,0.5503412497895365,1.0,4/12,10.76%,IGF1;STIMATE;LMCD1;CHERP
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5622943840693848,-1.4334070967995824,0.09066666666666667,0.5503412497895365,1.0,4/12,10.76%,IGF1;STIMATE;LMCD1;CHERP
prerank,regulation of MAP kinase activity (GO:0043405),-0.357033099190626,-1.4333277088849465,0.018018018018018018,0.5463470540689724,1.0,34/92,21.08%,FLT1;PDGFRB;PDGFD;KSR1;PTPRJ;IL34;LYN;ROBO1;DAB2IP;FGF2;CDK12;IRAK3;LRRK2;SH2B3;PIK3CB;TGFB1;TPD52L1;EZH2;PIK3R6;KIT;NF1;CD300A;EDN1;SORL1;PIK3R5;EGF;EDN3;SPRY1;SPRY4;PAQR3;CD40;MST1R;FLT3;BMP7
prerank,positive regulation of exocytosis (GO:0045921),0.5521208039904447,1.4322481072875652,0.0901749663526245,0.8974805375471777,1.0,15/35,20.61%,CFTR;SYTL4;UNC13D;SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;RAB2B;TSG101;RAB9A;RAB27A;ATP6AP1
prerank,response to acidic pH (GO:0010447),0.6600415349660841,1.4321711471087415,0.10673234811165845,0.8941224849573552,1.0,5/13,15.87%,GPR4;CHP1;RAB11FIP5;PKD2L1;SLC9A1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5700227447824435,-1.4320654673383575,0.07754010695187166,0.5460852615516487,1.0,4/13,8.11%,LEF1;LGALS9;IL18;TNFRSF21
prerank,cell-cell junction maintenance (GO:0045217),0.6768939225164687,1.4310624711808582,0.09411764705882353,0.8959747815286588,1.0,4/11,17.54%,TJP1;PRTN3;NLGN2;F2R
prerank,cellular response to cadmium ion (GO:0071276),0.5988136226410601,1.4305241332975138,0.07725947521865889,0.8949721960372595,1.0,5/24,8.69%,DAXX;MMP9;FOS;MAPK9;JUN
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6782241710602644,1.4302754513236258,0.1126984126984127,0.8924215871047493,1.0,1/12,0.12%,CFTR
prerank,aortic valve development (GO:0003176),-0.417613139163041,-1.4302743679289458,0.030418250950570342,0.5475800526541358,1.0,15/34,14.51%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL;TNFRSF1B;SLIT3;BMPR2
prerank,embryonic appendage morphogenesis (GO:0035113),0.6674086155989758,1.4298455213026353,0.11735537190082644,0.8907840910541517,1.0,2/12,7.30%,MBNL1;TGFB2
prerank,myoblast fusion (GO:0007520),0.6761827106334124,1.4295856040860488,0.0794912559618442,0.8882838360291611,1.0,3/12,5.49%,ADAM12;CD81;CD9
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6834937204188395,1.4291782916758935,0.105,0.8865909666278275,1.0,2/12,2.20%,B3GALT1;B4GAT1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4698270625190134,-1.4290052373891775,0.07255520504731862,0.5473280762687179,1.0,7/25,9.55%,ERRFI1;CBLB;SLC6A9;EPHB2;ZFYVE28;SOCS5;PPARG
prerank,B cell receptor signaling pathway (GO:0050853),0.558853828831481,1.4283052761515147,0.07250341997264022,0.8874053248642402,1.0,2/32,0.33%,PRKCB;NFATC2
prerank,endothelial cell proliferation (GO:0001935),-0.522410544690017,-1.4282317342049606,0.06936416184971098,0.5457984066576776,1.0,5/17,4.72%,TEK;SEMA5A;ACVRL1;CD34;BMPER
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6818174442915245,1.4281995291886815,0.11075441412520064,0.8843019844140391,1.0,2/11,7.20%,EGLN3;EGLN2
prerank,purine nucleotide metabolic process (GO:0006163),0.5926582334632782,1.4280861761122972,0.09028727770177838,0.8813203493089757,1.0,4/24,7.01%,NT5E;NT5C1A;FHIT;NT5C2
prerank,nuclear migration (GO:0007097),0.6477554981488384,1.4275860012051884,0.10163934426229508,0.8804168527193517,1.0,9/13,24.12%,DOCK7;SYNE3;PAFAH1B1;DYNC1H1;SUN2;TMEM201;HOOK3;CEP120;PCM1
prerank,calcium import into the mitochondrion (GO:0036444),0.7084369576432119,1.426915499227333,0.08135593220338982,0.8802798318510815,1.0,5/10,10.81%,MCU;MCUB;MICU1;AFG3L2;MCUR1
prerank,actin filament depolymerization (GO:0030042),0.6839110073315918,1.426296018560373,0.1046875,0.879610566662212,1.0,4/11,8.01%,GSN;MICAL2;TWF1;MICAL1
prerank,epiboly involved in wound healing (GO:0090505),0.6300504928327195,1.4259927957422167,0.08755760368663594,0.8776661357479735,1.0,7/16,15.76%,CD44;TMEFF2;TOR1A;RHOA;DDR1;PDPN;FLNA
prerank,tRNA aminoacylation (GO:0043039),0.5355120108581004,1.4259101014875812,0.08753315649867374,0.8745524787592532,1.0,19/37,21.07%,EPRS1;QARS1;VARS1;FARS2;HARS1;LARS2;AARS1;EEF1E1;TARS1;YARS1;HARS2;SARS1;SARS2;GATB;FARSA;FARSB;DARS2;NARS1;YARS2
prerank,regulation of multicellular organism growth (GO:0040014),-0.5320888380748241,-1.4257728273252441,0.08108108108108109,0.5498356385890301,1.0,5/15,13.45%,IGF1;GHR;STAT5B;STAT5A;MFSD2A
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5795169853197295,1.424733719661474,0.09475218658892129,0.876796637279103,1.0,5/25,6.93%,CFTR;ANK2;ACTN2;STK39;ANK3
prerank,negative regulation of protein metabolic process (GO:0051248),0.5242927065877688,1.4245683247200793,0.0660024906600249,0.8742436163650668,1.0,11/48,12.26%,CLU;LDLR;PFDN1;FLOT2;HMGCR;CRYAB;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,neural tube closure (GO:0001843),0.5469325964712572,1.4243603295551395,0.0873015873015873,0.8718041981327568,1.0,8/34,9.05%,CELSR1;COBL;LMO4;DLC1;TSC2;TGFB2;DVL3;GRHL2
prerank,regulation of neuron apoptotic process (GO:0043523),0.4808435783405775,1.4240564003309286,0.03854875283446712,0.8699940539750376,1.0,18/96,10.75%,EGLN3;CRLF1;PPARGC1A;NRBP2;NUPR1;NGF;FOXO3;PTK2B;GDNF;CLCF1;EGLN2;TGFB2;ERBB3;UNC5B;SIX1;KCNB1;SRPK2;SOD2
prerank,lipoprotein localization (GO:0044872),0.6740380866925189,1.423985873374981,0.11276948590381426,0.8669975808548659,1.0,2/11,6.01%,PRKCB;UNC119
prerank,protein K11-linked ubiquitination (GO:0070979),0.5668265699816997,1.4235757817122818,0.09833795013850416,0.8657522641588558,1.0,1/27,0.05%,FZR1
prerank,artery morphogenesis (GO:0048844),-0.434616083486165,-1.4235624245232512,0.05434782608695652,0.5527733559188283,1.0,11/30,14.51%,PDGFRB;JAG1;ENG;ADAMTS9;NOTCH1;PKD2;TBX2;NF1;HPGD;TBX1;BMPR2
prerank,AMP metabolic process (GO:0046033),0.6611708048148721,1.423102627276092,0.08874801901743265,0.8646279548823215,1.0,4/13,9.97%,NT5E;NT5C1A;NUDT2;AK3
prerank,positive regulation of ossification (GO:0045778),-0.413138065970076,-1.4229389954934177,0.06374501992031872,0.5503822557002965,1.0,11/39,8.61%,BMP6;ADGRV1;WNT4;SLC8A1;WNT5A;KL;BMPR1B;PKDCC;TGFB1;FBN2;ACVR2A
prerank,positive regulation of vascular permeability (GO:0043117),0.6473019992614337,1.4215277280650067,0.11305732484076433,0.868863281130563,1.0,4/12,2.07%,ANGPT1;TJP2;TJP1;OCLN
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6857718502046897,1.4206516725982783,0.09948542024013722,0.8698061479524197,1.0,1/10,0.10%,PRKCB
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.680089825952942,1.4200155713839089,0.09921259842519685,0.8696326774710386,1.0,3/12,4.44%,UST;CHST12;DSE
prerank,response to UV-A (GO:0070141),0.6509852805902232,1.4193509708192944,0.1024,0.869570260916303,1.0,4/14,9.90%,OPN1SW;MMP9;TIMP1;CCND1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6779487951858848,1.4193163045611625,0.12460063897763578,0.8632274338799768,1.0,3/10,14.48%,KLF4;MAPK7;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6779487951858848,1.4193163045611625,0.12460063897763578,0.8632274338799768,1.0,3/10,14.48%,KLF4;MAPK7;WNK1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6211325103246848,1.4182431340586066,0.09104704097116843,0.8650418058648096,1.0,2/18,2.07%,PRKCB;OCLN
prerank,sensory perception of pain (GO:0019233),-0.4847940777021961,-1.4163524873598434,0.07028753993610223,0.5678433143950651,1.0,16/21,38.14%,RETREG1;PTGES;MME;OPRM1;OPRK1;NIPSNAP1;TRPA1;CHRNA4;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,transport along microtubule (GO:0010970),0.6327412013064782,1.4156367559945298,0.10845295055821372,0.8741078275780213,1.0,4/13,9.06%,DYNC1I1;ARHGAP21;CDC42;BAG3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5700341934220191,1.4153941304791378,0.09636871508379888,0.872128473151659,1.0,10/27,16.74%,CD44;DDX5;PMAIP1;YJU2;SPRED3;TWIST1;EEF1E1;MDM2;ATR;KDM1A
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6342933303400954,1.4149038757922898,0.11343283582089553,0.8712811920138755,1.0,3/15,2.72%,CDH13;NTRK3;IL16
prerank,intraciliary retrograde transport (GO:0035721),-0.5656883060174874,-1.4145630148809114,0.10256410256410256,0.5696422265050662,1.0,7/12,27.88%,IFT122;TTC21B;WDR19;IFT43;DYNC2LI1;DYNC2I2;IFT140
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5218651049058117,1.4142694748908384,0.08900523560209424,0.8709525713169057,1.0,14/46,15.76%,CDH1;ZC3H12A;MAVS;TCF7L2;BAG3;ZIC1;HDAC3;RAPGEF3;UBR5;GSK3B;NEDD4;ZPR1;DHX9;FLNA
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.4883651077784432,-1.413782019046158,0.07216494845360824,0.567895435687206,1.0,7/19,12.13%,PTPRJ;TEK;KDR;TSC1;ROCK1;MYOC;MAP4K4
prerank,positive regulation of cation channel activity (GO:2001259),0.5374833575373478,1.4127540945882175,0.09354413702239789,0.8745342597724558,1.0,7/40,8.10%,ANK2;ACTN2;GAL;STAC3;ANK3;GSTO1;JPH2
prerank,regulation of wound healing (GO:0061041),0.5322320911493245,1.412750970436211,0.07581699346405228,0.8713454750875103,1.0,12/42,17.54%,CD109;KANK1;OCLN;CAV1;ALOX5;DMTN;CASK;ACTG1;ARFGEF1;HRAS;CRK;F2R
prerank,replicative senescence (GO:0090399),0.6668402175339954,1.4126202347215906,0.11631663974151858,0.8687560377758154,1.0,1/12,0.08%,WNT16
prerank,antibacterial humoral response (GO:0019731),0.631997221913392,1.412476664530657,0.11472868217054263,0.8663162122519898,1.0,6/16,19.63%,SLPI;ANG;RNASE3;PLA2G6;RNASE7;JCHAIN
prerank,cardiac cell development (GO:0055006),0.6793694720676545,1.4120131089404393,0.11968503937007874,0.8653238094756269,1.0,1/11,0.07%,CXADR
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5431384487021317,1.4119911448157183,0.07388535031847134,0.8623153059261063,1.0,7/42,3.62%,CDH13;UTRN;EMP2;GFUS;CDK6;S100A10;PTK2B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6798403922433336,1.4110511548055524,0.14383561643835616,0.8634538552960778,1.0,9/10,30.28%,ACADL;ACADM;IVD;GCDH;ACAD11;ETFDH;ETFB;ETFA;ACADVL
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6524552062928972,1.41073919144474,0.11496062992125984,0.8618736669714615,1.0,5/12,12.71%,SOAT1;DGAT1;ACSL3;SOAT2;LPCAT3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6500439189590828,1.4087224360548651,0.1342062193126023,0.8687285623911352,1.0,6/12,19.38%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,nucleotide catabolic process (GO:0009166),0.6351847920255955,1.407509687959242,0.10714285714285714,0.8712008840768409,1.0,4/16,9.63%,NT5E;NT5C1A;NT5C2;DERA
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5901231829811935,-1.407242879226346,0.07591623036649214,0.5848285897962932,1.0,6/10,12.28%,DCN;KDR;BCL2;LRRK2;MYOC;RACK1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4926824374461179,1.4069219700615083,0.06265060240963856,0.8709668462525729,1.0,17/66,16.01%,CDH1;LIMK2;ZC3H12A;MAVS;SESN2;ORMDL3;LARP7;BAG3;ZIC1;HDAC3;EIF2AK3;PINX1;UBR5;ZPR1;FLNA;MEPCE;TESK1
prerank,primary neural tube formation (GO:0014020),0.5534403546689949,1.4069181988117032,0.10441767068273092,0.8678998151018102,1.0,7/30,9.05%,CELSR1;COBL;LMO4;DLC1;TSC2;TGFB2;GRHL2
prerank,tube closure (GO:0060606),0.5495866047511428,1.4047729804156217,0.09772423025435073,0.875199766512621,1.0,7/31,9.05%,CELSR1;COBL;LMO4;DLC1;TSC2;TGFB2;GRHL2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5244034243269001,1.4047203298931779,0.10273081924577374,0.8723672504662578,1.0,6/43,6.58%,PRKCB;SORBS1;KANK1;OGT;TSC2;ZBTB7B
prerank,artery development (GO:0060840),-0.46454444131375594,-1.4046174447027087,0.07692307692307693,0.5893840430091278,1.0,9/23,14.51%,ENG;ROBO1;ACVRL1;PKD2;ROBO2;PDE2A;NF1;TBX1;BMPR2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6520602646422752,1.4042950354639678,0.10466988727858294,0.8714861948053685,1.0,2/12,6.58%,SORBS1;ZBTB7B
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3875761609104739,-1.4033909809668714,0.05825242718446602,0.5890036847547047,1.0,21/48,23.32%,ROBO1;GAS6;IRAK3;NR1H3;SLIT2;SH2B3;PARP14;RFFL;SAMHD1;PPARG;NLRC5;PADI2;SLIT3;NR1H2;PELI3;CCDC3;CNOT7;TRAIP;SIGIRR;GPS2;YTHDF2
prerank,estrogen metabolic process (GO:0008210),0.6259246640861621,1.4027376872693285,0.1092814371257485,0.8759300509568833,1.0,3/15,11.40%,SULT1A1;HSD17B14;HSD17B11
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4768215864503272,1.4026434777963934,0.06152125279642058,0.8733118189877973,1.0,19/100,8.64%,FN1;WNT16;FGFR1;NTRK3;PIK3IP1;CCL5;PLXNB1;PDGFC;GAB1;EPO;TSC2;HAX1;SOX9;MYDGF;TGFB2;ERBB3;UNC5B;MAZ;PTPN6
prerank,muscle contraction (GO:0006936),0.46945806082396,1.4025053523048185,0.04121475054229935,0.8708707182745403,1.0,15/126,7.31%,SORBS1;MYOM2;UTRN;ACTN2;CALD1;VIM;TMOD3;SGCA;TMOD2;LMOD3;MYOT;CRYAB;GAMT;PXN;SNTB1
prerank,aminoglycan biosynthetic process (GO:0006023),0.5042091063178031,1.401476261714647,0.08427672955974842,0.8727800900697648,1.0,10/49,9.20%,B3GALT1;GPC6;GPC1;HEXA;B4GAT1;GPC4;GCNT2;SDC4;GPC3;EXT1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6427859791459132,1.4011057912190934,0.12145110410094637,0.8715934828298806,1.0,2/13,3.92%,RNF152;SESN2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.49036399981455986,1.4010904162066617,0.06783625730994151,0.8686769989979684,1.0,12/68,16.05%,CUBN;AMN;CYB5R3;GSTO1;NNMT;SHMT1;ALDH1L2;PCCA;SLC19A2;ALDH1L1;VNN1;MMAB
prerank,signal transduction by p53 class mediator (GO:0072331),0.5511125293354046,1.401049722474506,0.10152990264255911,0.8659099873677477,1.0,12/30,18.10%,FHIT;NDRG1;DDX5;PMAIP1;SESN2;PPP1R13B;USP10;ATRX;PDK2;POU4F1;NBN;TRIAP1
prerank,tRNA metabolic process (GO:0006399),0.5955562918998836,1.4006381134146833,0.13129770992366413,0.8648777858464581,1.0,10/17,21.07%,FARS2;TRPT1;POP1;AARS1;THG1L;RPP21;DTD1;SARS1;DARS2;YARS2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5645695563494264,1.4006343920523396,0.10201149425287356,0.8619663155933291,1.0,4/24,6.02%,CLU;CD44;ACKR3;BCL2L1
prerank,negative regulation of defense response to virus (GO:0050687),0.6719552955834982,1.4000708465814418,0.12641815235008103,0.8616159183732207,1.0,6/10,24.50%,PPM1B;TARBP2;MUL1;ILRUN;PCBP2;C1QBP
prerank,catecholamine metabolic process (GO:0006584),-0.5198136473743065,-1.4000684315156764,0.08743169398907104,0.5961444268093384,1.0,4/14,23.43%,SNCAIP;DRD2;RNF180;DDC
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5986342293968175,1.3996413247458523,0.1037593984962406,0.8577642339299476,1.0,6/21,7.67%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5986342293968175,1.3996413247458523,0.1037593984962406,0.8577642339299476,1.0,6/21,7.67%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,cation transmembrane transport (GO:0098655),0.5163350560516342,1.3993818042517452,0.08997429305912596,0.8561617611212282,1.0,13/44,15.34%,TRPM3;ATP1A2;TRPM8;ABCC8;SFXN3;SLC36A4;SFXN1;TRPM6;SLC25A38;TRPM4;PKD2L1;TRPM2;SLC7A3
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4580156533370497,1.3993436915045583,0.03908794788273615,0.8534977005213167,1.0,41/144,16.02%,CDH1;SREBF2;BBC3;ZC3H12A;MAVS;PMAIP1;CD81;PPP1R13B;ANK3;BAD;PLK3;TCF7L2;FZD5;CHP1;BAG3;YWHAB;ZIC1;MIEF2;YWHAQ;MYO1C;HDAC3;KCNB1;BCAS3;AKAP5;SAE1;RAPGEF3;YWHAZ;VPS11;NPEPPS;RHOU;GSK3A;UBR5;GSK3B;ITGB1BP1;HRAS;ZPR1;RNF31;FLNA;E2F1;ITGB2;RIPOR1
prerank,N-terminal protein amino acid modification (GO:0031365),0.6406337217888072,1.398871487694959,0.1216,0.8528891893608825,1.0,8/14,21.20%,PDF;NAA40;NTMT1;AANAT;NAA15;NAA10;NAA35;METAP1D
prerank,regulation of cellular protein localization (GO:1903827),0.5126858169631532,1.3986375821677723,0.08015267175572519,0.8512526180723079,1.0,12/45,11.57%,GPC6;PRKAA2;GPC1;NDEL1;GPC4;GPC3;DVL3;SUMO3;ABCA2;TOR1A;RAB11FIP5;CSNK1E
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6495503083083243,1.398542020361415,0.10655737704918032,0.8489179806138605,1.0,2/13,6.58%,SORBS1;ZBTB7B
prerank,response to cadmium ion (GO:0046686),0.5769496378834215,1.39821704879648,0.09530791788856305,0.8475418471062253,1.0,5/26,8.69%,DAXX;MMP9;FOS;MAPK9;JUN
prerank,basement membrane organization (GO:0071711),-0.54420468204327,-1.3981327229150264,0.08847184986595175,0.5986883448301665,1.0,8/14,9.23%,FLRT2;NID1;NID2;COL4A1;LAMB1;NTN4;NTNG1;RAMP2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4881184065354316,1.3981147006547405,0.08443908323281062,0.8452641641974276,1.0,14/63,14.72%,DAPL1;NUPR1;TIMP4;TIMP1;HP;TIMP2;TAB3;RUBCN;WDR6;EIF4G2;FOXK1;GSK3A;EIF4G1;WASHC1
prerank,regulation of endocytic recycling (GO:2001135),0.656733868750437,1.39798440161282,0.13509060955518945,0.8431646050650885,1.0,3/11,10.93%,ACTN2;EHD1;ATP9A
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6656836460494243,1.3979140432097634,0.13705583756345177,0.8407305346211474,1.0,5/10,14.48%,CCL5;ADAM10;STK39;OXSR1;WNK1
prerank,negative regulation of blood pressure (GO:0045776),-0.5541752616575375,-1.3973376851849704,0.11452513966480447,0.5973320884099677,1.0,8/13,39.38%,NOS3;DRD2;BMPR2;PRCP;GPR37L1;NOS2;APLN;DRD3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5760890853860833,1.3962597037101185,0.11773049645390071,0.845321558896443,1.0,5/24,9.98%,NT5E;CCL5;GFUS;MSN;EZR
prerank,respiratory system development (GO:0060541),-0.4198974146036838,-1.3957571501637704,0.06015037593984962,0.598514573403371,1.0,14/32,17.48%,GLI2;FGF2;CHD7;FGFR2;LOXL3;SPEF2;SMCHD1;BASP1;NPHP3;RBP4;ZIC3;ABCA3;FGF9;DISP1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5469574596480586,1.3956251021255228,0.10554089709762533,0.8454051036590473,1.0,6/32,7.41%,SORBS1;PRKAA2;CREBL2;CREB1;AVIL;EIF6
prerank,nucleotide biosynthetic process (GO:0009165),-0.491263109853898,-1.39553516571422,0.11635220125786164,0.5950909660380408,1.0,5/18,11.67%,ME1;HPRT1;PRPSAP2;RRM1;PNP
prerank,positive regulation of phospholipase activity (GO:0010518),0.5814183275896968,1.3944915929049808,0.12535211267605634,0.8477310484429254,1.0,4/22,1.40%,AGTR1;FGFR1;NTRK3;CCL5
prerank,regulation of lymphocyte migration (GO:2000401),0.6799716621794787,1.3940050525175174,0.12399355877616747,0.8472923481561289,1.0,5/10,20.78%,ADTRP;MSN;SLC8B1;JAM2;MIA3
prerank,regulation of cell death (GO:0010941),0.47280439780197253,1.3939631737857714,0.06487695749440715,0.8447847946771424,1.0,17/94,8.73%,WNT16;CLU;SRGAP2;CCL5;CCN2;ZC3H12A;WNT11;CELF1;PRR7;HP;HPR;CRYAB;CTSZ;GPR75;BMP4;CHMP4B;CHP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6791421136770215,1.3936264605987647,0.13240418118466898,0.8436465556706213,1.0,2/10,6.93%,CAV1;ANK3
prerank,actin polymerization or depolymerization (GO:0008154),0.5195065809764077,1.393505158331467,0.08427672955974842,0.8414433804924581,1.0,13/50,9.90%,COBL;VILL;GSN;MICAL2;DIAPH1;CORO7;ENAH;AVIL;TWF1;ANG;MSRB2;MICAL1;ABI1
prerank,platelet degranulation (GO:0002576),0.46427569214695985,1.3934987453457839,0.04400440044004401,0.8387879889701896,1.0,16/118,8.83%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;VEGFB
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5192078597984626,-1.3926750115970263,0.09855072463768116,0.5999441935660021,1.0,7/15,22.17%,GNAS;UBR3;DRD2;GNAL;BBS4;SYT10;ADCY3
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5994818709026286,1.392601841566841,0.11982248520710059,0.8401201531083211,1.0,4/17,9.31%,KLF4;ANXA4;OTUD7B;TLR6
prerank,regulation of cellular component movement (GO:0051270),0.509571336689515,1.3925866865127163,0.07908163265306123,0.8375455666464457,1.0,23/49,20.46%,PRAG1;ARAP1;YTHDF1;ARHGAP18;CDK6;DIAPH1;DAPK3;CD9;ERBB3;RAF1;RHOA;ZSWIM8;PDPN;MEMO1;TGFBR3;IGBP1;ACTN4;ABL1;HDAC6;ROCK2;ADAM17;HBEGF;ZSWIM6
prerank,tricarboxylic acid metabolic process (GO:0072350),0.6546381183375524,1.3922941935919373,0.12762520193861066,0.8362720630239218,1.0,10/12,25.62%,IDH3G;GLUD1;ACO2;IDH3A;ASS1;ACO1;SIRT4;ACLY;IDH1;IDH2
prerank,filopodium assembly (GO:0046847),0.613398039096739,1.3919901122936567,0.10397553516819572,0.8350378606841591,1.0,2/16,0.87%,RAB17;SRGAP2
prerank,protein localization to cell junction (GO:1902414),0.5818529740153979,1.3911532352335203,0.10872675250357654,0.8360872422108135,1.0,6/22,10.84%,TJP2;TJP1;BSN;ARHGEF18;PCLO;JAK1
prerank,cell junction organization (GO:0034330),0.4840238314073582,1.3910450172697635,0.06635622817229336,0.8339836702459436,1.0,15/71,11.68%,CXADR;SDK1;TJP2;TJP1;OCLN;LIMS2;MYOT;TGFB2;ILK;CDC42;OPHN1;GRHL2;ACTB;ACTG1;RHOA
prerank,cell chemotaxis (GO:0060326),0.4963456226266272,1.3908969633621786,0.07814407814407814,0.8319583167842934,1.0,10/60,6.03%,AGTR1;LPAR1;CCR4;PARVA;CXCR4;CCR10;ACKR2;ACKR4;ACKR3;CCRL2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.46409938244655247,-1.390801874658908,0.0875,0.6018995080162572,1.0,10/21,13.12%,SULF1;HS6ST2;NDST3;HS6ST3;XYLT1;XYLT2;EXTL3;HS3ST3B1;EXT2;B3GAT3
prerank,extracellular matrix organization (GO:0030198),0.4421708445059802,1.3907973089658352,0.01016260162601626,0.8298279735997067,1.0,29/276,4.66%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;COL25A1;CD44;ITGB8;LAMA4;TMPRSS6;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;ADAMTS7;DAG1;ADAMTSL5;ADAM10;GSN;COL5A2;ITGB7;LAMA5;COL6A1;TIMP1;COL6A3
prerank,manganese ion transport (GO:0006828),-0.5261180819792006,-1.3898207586692073,0.11666666666666667,0.6010349190799813,1.0,6/14,10.78%,SLC30A10;TRPC3;TRPC4;SLC39A8;TRPC6;TRPC5
prerank,negative regulation of leukocyte migration (GO:0002686),0.6641024225659314,1.3897082624542958,0.1396103896103896,0.8322618271281986,1.0,3/10,4.00%,ADTRP;CD200;BMP5
prerank,presynapse organization (GO:0099172),-0.5933589351615489,-1.3893493191794835,0.1025,0.5985550928259247,1.0,5/10,15.61%,WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,regulation of T cell chemotaxis (GO:0010819),0.6457327198891664,1.3891219141023887,0.1485148514851485,0.8323199651574339,1.0,5/11,14.48%,CCL5;ADAM10;STK39;OXSR1;WNK1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4815076444391809,1.3889575326303407,0.08314087759815242,0.8304502084349056,1.0,17/68,14.12%,WNT16;WNT1;WNT10A;WNT11;CAV1;DIXDC1;WNT6;RARG;DVL3;WNT5B;TCF7L2;FZD5;CSNK1E;WNT3;SFRP1;GATA3;GSK3B
prerank,negative regulation of protein secretion (GO:0050709),0.5239463342113253,1.3887817328376075,0.10723860589812333,0.828649933997273,1.0,12/38,17.54%,ADTRP;CD200;HMGCR;RAB11FIP3;CYP51A1;KCNB1;RAB11FIP5;SFRP1;SERGEF;RHBDF2;RAB11FIP1;F2R
prerank,regulation of mast cell activation (GO:0033003),-0.5701638500161759,-1.388495497834935,0.11951219512195121,0.5974600481911017,1.0,8/10,40.88%,LYN;PLSCR1;CD84;CRLF2;CD300LF;MILR1;TSLP;CD226
prerank,response to ATP (GO:0033198),-0.4840046546398655,-1.3881235778078715,0.0953757225433526,0.5948197622280407,1.0,8/18,27.87%,TRPC3;ABCC9;SSH1;P2RY1;P2RY12;DGKQ;CIB2;TAF1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6205587156676662,1.3877573247935338,0.11178247734138973,0.8305429640575831,1.0,7/17,16.59%,BAIAP2L1;NTRK3;HAX1;CDC42;BCAS3;HRAS;ABL1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6690260482594701,1.3873489595976047,0.145,0.8297887998629403,1.0,3/10,11.47%,ADTRP;TLR6;TLR4
prerank,proteoglycan metabolic process (GO:0006029),-0.4434458032736247,-1.386943022156871,0.08552631578947369,0.5948373780753013,1.0,7/26,6.02%,IGF1;ADAMTS12;SULF1;CSGALNACT1;XYLT1;BMPR1B;CHST8
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5079697162645193,1.3867216535011444,0.08695652173913043,0.8299413428400264,1.0,16/49,19.06%,CLU;SMAD6;EP300;CRYAB;NLRP2B;PPM1A;CDC42;PYDC1;RAF1;LDLRAD4;GSK3B;ULK1;PRKCZ;HDAC6;PARK7;PMEPA1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.41031757576683664,-1.3865616354716115,0.05106382978723404,0.5921251849116078,1.0,11/39,14.42%,ERRFI1;PTPRJ;TGFA;ITGA1;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;EPS15
prerank,membrane raft organization (GO:0031579),0.6346482704433927,1.3865142978113796,0.11538461538461539,0.8282488697583501,1.0,5/15,6.89%,EMP2;S100A10;FLOT2;NPC1;ANXA2
prerank,protein localization to membrane (GO:0072657),0.44399393318940383,1.3863560688055239,0.03455497382198953,0.8264251661555032,1.0,36/187,10.56%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;MAGI2;CAV1;ITGB7;RAP1A;CD81;S100A10;CACNB3;EHD1;FLOT2;ARL3;FYB2;RAMP1;FRMPD1;NPC1;SYNE3;ANK3;CPE;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;NDC1;MYO5A;EZR;KCNB1;SYNJ2BP
prerank,circulatory system development (GO:0072359),0.4628849123331141,1.3856500898848607,0.059782608695652176,0.8269344394252706,1.0,16/118,7.46%,FN1;CXADR;NTRK3;PDLIM5;NXN;CDKN1A;MICAL2;AKAP13;STRA6;CRB2;FOXC2;TSC2;SOX9;RBM20;TGFB2;ERBB3
prerank,regulation of stress fiber assembly (GO:0051492),0.49557859670754156,1.3853029880921672,0.0912280701754386,0.8260079509279127,1.0,29/74,18.58%,PHLDB2;LPAR1;TJP1;ARAP1;CCN2;WNT11;S100A10;DLC1;TMEFF2;ARHGEF18;PXN;CDC42;ARHGEF5;RHPN2;ACTG1;RAPGEF3;RHOA;ASAP3;SFRP1;ARHGEF10L;ITGB1BP1;CCDC88A;SLC9A1;TESK1;ABL1;PFN2;PPFIA1;FHOD1;ROCK2
prerank,positive regulation of protein sumoylation (GO:0033235),0.6730684364615171,1.3847971194719497,0.13442622950819672,0.8257102567824048,1.0,5/10,12.98%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,ketone body metabolic process (GO:1902224),-0.579895531386885,-1.3845239564695684,0.11471321695760599,0.5951868425101297,1.0,4/10,9.33%,ACSS3;HMGCLL1;HMGCS2;BDH1
prerank,cellular response to cAMP (GO:0071320),0.5587791278960574,1.3844231623104957,0.1006993006993007,0.8248137392106618,1.0,8/30,11.66%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.42954817952670576,-1.3843462968020332,0.06810035842293907,0.5920599672968757,1.0,11/29,15.24%,GRIK2;SLC4A10;SHISA6;EPHB2;NETO1;SHISA9;DRD2;CAMK2A;MCTP1;NCDN;CLN3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46784367547625816,1.3837589336525904,0.06971428571428571,0.8250786667766565,1.0,18/95,9.20%,UST;ANGPT1;GPC6;ST3GAL4;GPC1;CHST12;HEXA;B4GAT1;GPC4;GCNT2;DSE;CHST11;SDC4;PRELP;CHPF;GPC3;CHST13;EXT1
prerank,steroid hormone biosynthetic process (GO:0120178),0.5504126191618047,1.3836637983331264,0.1083676268861454,0.8230809533522766,1.0,6/29,11.40%,STARD3;HSD17B14;DHCR7;SRD5A3;FDX1;HSD17B11
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.42150198907818515,-1.3816609055908615,0.03418803418803419,0.5967521198443471,1.0,13/33,17.97%,IGF1;PIK3R1;NYAP2;PIK3CB;PIK3CD;IGF1R;NF1;HTR2A;EDN1;PIK3R5;MYO16;SIRT2;PIK3R2
prerank,macrophage differentiation (GO:0030225),0.6349566601972895,1.380636696172903,0.14037854889589904,0.8338139875118181,1.0,4/13,8.25%,MMP9;IL15;BMP4;CDC42
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6042750820437053,1.3803889484173284,0.12330827067669173,0.8323958628098489,1.0,12/18,18.76%,KANK1;RAP1B;PTK2B;RIPOR2;KRIT1;LLGL2;BCAS3;ARFGEF1;CDH5;SHTN1;ROCK2;KIF20B
prerank,extracellular matrix disassembly (GO:0022617),0.5003013356158649,1.3790977426219446,0.08990147783251232,0.8354156843398826,1.0,14/53,11.14%,CD44;TMPRSS6;MMP9;ADAM10;HPN;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6513983146000011,1.3788294539722414,0.12155591572123177,0.8341209338209382,1.0,5/12,11.74%,PPARGC1A;ABCD1;MTLN;TWIST1;IRS2
prerank,transepithelial transport (GO:0070633),0.6209399609460874,1.3786085179357717,0.13097072419106318,0.8326502411991269,1.0,1/15,0.07%,CXADR
prerank,regulation of cell adhesion (GO:0030155),0.45229556311444685,1.3785290057891757,0.058823529411764705,0.8305695259423918,1.0,20/129,7.77%,GPR4;CDH13;ANGPT1;CCL5;PLXNB1;EPHA4;PODXL;ADAM10;PKP4;PLXNA2;CXCR4;PTK2B;PPP2CA;RIPOR2;FBLN1;DUSP1;EFNA5;CBLL1;ERBB3;ZFHX3
prerank,melanosome localization (GO:0032400),0.5729661368632583,1.3783447758575236,0.13263785394932937,0.828949703470664,1.0,4/21,9.12%,RAB17;MLPH;BLOC1S6;MYO5A
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.40197560692450174,-1.3776914612278202,0.06637168141592921,0.6055973129216731,1.0,10/40,8.61%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;PKDCC;TGFB1;FBN2;ACVR2A
prerank,regulation of neuron differentiation (GO:0045664),-0.34200636170346266,-1.3769929216546375,0.02631578947368421,0.6043688869925917,1.0,24/76,15.09%,TCF4;ZEB1;VWC2;NREP;MOSMO;BRINP3;NRCAM;BIN1;DTX1;LRRK2;ZFHX2;NLGN1;ROCK1;ID2;TIAM1;HEYL;IMPACT;BEND6;NEPRO;ARHGEF2;BDNF;MMD;GPRC5B;BRINP2
prerank,cholesterol transport (GO:0030301),0.5193460114181642,1.3760140597830326,0.10736579275905118,0.8363678709599354,1.0,11/45,16.50%,CLU;LDLR;SOAT1;CAV1;STARD3;NPC1;SOAT2;STARD4;VPS4A;OSBPL5;RELCH
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.576245923378578,1.3753871057302753,0.09985315712187959,0.8366926312332382,1.0,6/23,8.24%,SMO;GDNF;SOX9;BMP4;WNT5B;SIX1
prerank,Wnt signaling pathway (GO:0016055),0.4631786339568197,1.3752252426760994,0.06235827664399093,0.8350978848077176,1.0,16/92,8.66%,WNT16;WNT1;NXN;WNT10A;WNT11;DIXDC1;GPC4;WNT6;RARG;WLS;CPE;DVL3;WNT5B;TCF7L2;FZD5;RBX1
prerank,positive regulation of telomere maintenance (GO:0032206),0.533602288396494,1.3749715337261543,0.09814323607427056,0.8337813517095183,1.0,13/31,19.38%,NEK7;NABP2;MRE11;MAPK15;MAP3K4;ATRX;PML;TNKS2;NBN;PRKCQ;RAD50;PPP1R10;PNKP
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5762399578480119,1.3749549286275,0.12312312312312312,0.8314562055729523,1.0,3/21,7.63%,PRKCB;CD81;NFAM1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5287444456637024,1.3745941731971696,0.1062992125984252,0.8306100923224098,1.0,7/37,11.45%,PHLDB2;MAPRE2;PRKAA2;MAP6;EFNA5;GAS2L1;EPHA3
prerank,actin filament bundle assembly (GO:0051017),0.5375073981826329,1.3742285983483145,0.10079575596816977,0.8297914913106901,1.0,8/33,9.98%,BAIAP2L1;PAWR;CALD1;ESPN;DMTN;ADD1;MICAL1;EZR
prerank,cellular response to starvation (GO:0009267),0.449011494371508,1.374005981846517,0.04707112970711297,0.828448307566537,1.0,11/147,3.92%,DAPL1;RNF152;PRKAA2;ATP6V1B1;MAP3K5;SREBF2;CDKN1A;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3475022851744553,-1.3740057014124696,0.028169014084507043,0.6102048571405755,1.0,31/75,18.31%,PTPRM;DCN;SULF1;SEMA6A;TEK;WNT4;CLDN5;PDE3B;DAB2IP;THBS1;SEMA3E;RGCC;GTF2I;COL4A2;THBS2;SERPINF1;ROCK1;MECP2;PPARG;ISM1;NPR1;AMOT;AGO1;SPARC;STAB1;NAXE;HHEX;MINAR1;HSPG2;SPRED1;VASH1
prerank,blood circulation (GO:0008015),0.5076291262999004,1.3738021537266092,0.09875,0.8270816697414148,1.0,7/49,4.49%,AGTR1;SGCG;F5;COL4A3;SGCD;CYB5R3;EPO
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6498095475703924,1.3735422708495673,0.13821138211382114,0.8259478603424792,1.0,2/11,10.41%,ACTN2;SNX33
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4127199061744359,-1.3722981799552307,0.0728744939271255,0.6122741167053296,1.0,7/34,5.16%,FLT1;PRKD1;SEMA6A;VEGFC;KDR;NOTCH1;DAB2IP
prerank,regulation of pH (GO:0006885),0.6455156255757127,1.3715972058607597,0.14049586776859505,0.832043601118283,1.0,7/11,21.40%,ATP6V1B1;SLC9A7;PDK2;SLC26A4;SLC9A1;ATP6AP1;ATP1A4
prerank,receptor-mediated endocytosis (GO:0006898),0.4481731218157835,1.3710946415753573,0.05026737967914439,0.8317837242096192,1.0,34/132,17.09%,CUBN;LDLR;AMN;CAV1;CD81;CLTB;AP2A2;FCHSD2;ASGR1;GPR107;ACKR3;HP;HPR;RAMP1;CD9;CAV2;STAB2;GRK2;HYOU1;AP2A1;FCER1G;WASF1;LMBR1L;PDLIM7;NEDD4;ARHGAP27;HSPH1;HSP90AA1;AP4E1;ITGB2;CANX;LRP3;COLEC12;LRP2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5864400449944566,1.3705960461201152,0.10869565217391304,0.8316983120661593,1.0,4/20,6.40%,ACTN2;MMP9;EPO;STK39
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6306464380709882,1.3705473775771404,0.14906832298136646,0.829623703639833,1.0,5/13,16.74%,CD44;YJU2;TWIST1;MDM2;KDM1A
prerank,positive regulation of neuron migration (GO:2001224),-0.5719809097117634,-1.3704138690782723,0.09944751381215469,0.6143979462708454,1.0,5/11,14.37%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL
prerank,regulation of inclusion body assembly (GO:0090083),-0.5620930460030421,-1.37038760239742,0.11838790931989925,0.6107066364968124,1.0,7/11,30.86%,SNCAIP;SACS;DNAJB2;BAG5;DNAJB1;HSPA1B;HSPA2
prerank,regulation of transmembrane transport (GO:0034762),0.5341547690792026,1.369554642620773,0.08943089430894309,0.8315982870229898,1.0,4/31,4.55%,PRKCB;OCLN;WWP2;KCNJ13
prerank,response to organonitrogen compound (GO:0010243),-0.39760729100469766,-1.3683277845130264,0.053061224489795916,0.6134522225871029,1.0,15/38,21.14%,IRAK3;KAT7;RCN3;GLRA1;DNAJB12;SEL1L;DRD2;GLRA3;SYVN1;DHFR;GLRA2;ERLEC1;BRSK2;GLRB;UBXN6
prerank,cardiac muscle cell development (GO:0055013),0.5885561969178439,1.368068732703583,0.1282051282051282,0.8355986940548354,1.0,3/20,3.70%,CXADR;PDLIM5;CSRP3
prerank,positive regulation of calcium ion import (GO:0090280),-0.5435492812934517,-1.3669185332173945,0.12406947890818859,0.6144192886159221,1.0,2/12,2.87%,PDGFRB;CXCL12
prerank,cellular response to interleukin-6 (GO:0071354),-0.4295731422756671,-1.3669105663130183,0.09364548494983277,0.6107761517313136,1.0,15/26,27.67%,PID1;PTGIS;ST18;IL6R;JAK2;PTPRT;STAT3;IL6ST;SMAD4;SOCS3;YAP1;SPI1;CBL;FER;CEBPA
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5709681741281378,-1.36644215577019,0.12176165803108809,0.608626533558994,1.0,5/11,7.35%,SEMA6A;ADAMTS9;EPN2;THBS1;PIK3CB
prerank,cellular response to organic cyclic compound (GO:0071407),0.45180239736202293,1.366215204982364,0.05297297297297297,0.8412355770907604,1.0,25/141,11.66%,CDH1;CFTR;ADTRP;NCOA3;CCL5;RORC;RAP1B;ZC3H12A;ATP1A2;RAP1A;DIAPH1;CTNNA1;FAM210B;INSIG1;LCOR;DMTN;MSN;AANAT;GOLPH3;ADCY6;ACTB;EZR;ARL6IP5;AQP1;RAPGEF3
prerank,maturation of LSU-rRNA (GO:0000470),0.5625512861281492,1.365962850397846,0.11813186813186813,0.8398538357392581,1.0,8/26,14.85%,NSA2;NOP2;PES1;MAK16;EIF6;RPL10A;RPF1;DDX18
prerank,negative regulation of cytokine production (GO:0001818),0.4385321297112944,1.3655249139254877,0.06546990496304118,0.8393057909580058,1.0,22/163,10.18%,FN1;KLF4;TRIB2;CD200;ZC3H12A;IKBKE;TWSG1;ABCD1;MAVS;HOMER2;HOMER3;ANXA4;TRIM25;IRF3;OTUD7B;LGR4;SRGN;PTPN6;FOXP3;TLR6;EZR;PPP1R11
prerank,tight junction assembly (GO:0120192),0.49509700076995394,1.3650197264135955,0.10970996216897856,0.8391329830977416,1.0,8/49,10.88%,CLDN11;POF1B;OCLN;LSR;PATJ;PARD6B;GRHL2;ACTG1
prerank,nucleic acid metabolic process (GO:0090304),0.47778004756400155,1.3645369075960527,0.08775981524249422,0.8387372975863392,1.0,21/69,19.65%,NT5E;GTF2F1;FEN1;RBFOX2;POLR2H;POLR2A;XRN2;HNRNPH2;DNASE1L2;POLG;TOPBP1;DNASE1L1;DUSP11;POLR2C;RAD50;WTAP;HNRNPA3;PTBP1;POLR2E;DXO;PCBP2
prerank,positive regulation of biosynthetic process (GO:0009891),0.5183605651649006,1.3639488536677873,0.1124031007751938,0.8389017986174861,1.0,8/40,11.47%,SORBS1;CCL5;VIM;CREBL2;CREB1;BMP4;TLR6;TLR4
prerank,regulation of response to oxidative stress (GO:1902882),0.651917119863929,1.3637599163175569,0.14826498422712933,0.8373985788275864,1.0,3/11,5.15%,ABCD1;SELENON;ALOX5
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.39936029431703823,-1.3633143414303275,0.08571428571428572,0.6152763382080856,1.0,15/36,23.33%,SGMS1;FAS;DAB2IP;DEPTOR;BCL2;TPD52L1;DAPK2;TMBIM6;BDNF;NR4A2;CX3CR1;TRAF1;CX3CL1;CYLD;ASAH2
prerank,nitrogen compound transport (GO:0071705),0.4457291427184187,1.3633105389732048,0.055793991416309016,0.8371136896528675,1.0,21/141,13.30%,CUBN;SLC7A14;SCAMP5;AMN;RAMP1;SLC48A1;SLC3A1;RAB7A;ARRDC3;SLC25A47;NDC1;TOM1;ARL6IP5;SLC7A6;SLC1A4;AQP1;SCAMP2;SLC25A45;PDPN;SLC18A1;CHMP1A
prerank,positive regulation of locomotion (GO:0040017),-0.4327454732767803,-1.3624973041730333,0.09608540925266904,0.6142578540018224,1.0,14/27,33.15%,PDGFRB;SPOCK2;THBS1;TGFB1;CFAP20;RARRES2;P2RY12;CCL19;AKT2;PPM1F;TRIM32;AIF1;CAVIN1;TREM2
prerank,regulation of insulin secretion (GO:0050796),0.4623625144979045,1.3624180299565838,0.07427937915742794,0.8386096585787788,1.0,19/101,12.95%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;MCU;ALOX5;EFNA5;ABCC8;GLUD1;CDK16;BAD;TCF7L2;KCNB1;ITPR3;RAPGEF3;IRS2;KCNA5;SFRP1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6114542828651178,1.362001007795567,0.1640378548895899,0.8381937888358945,1.0,4/13,10.78%,GLUL;ACOT8;GLUD1;ACSF3
prerank,actin filament bundle organization (GO:0061572),0.5349851084799025,1.361770206829612,0.1164021164021164,0.8369207913427463,1.0,8/33,9.98%,BAIAP2L1;PAWR;CALD1;ESPN;DMTN;ADD1;MICAL1;EZR
prerank,"phototransduction, visible light (GO:0007603)",0.6280244531263994,1.3615864458392455,0.13322884012539185,0.8354055366024074,1.0,5/14,15.52%,RP1;GNAQ;CNGB1;PDE6B;GNA11
prerank,response to cAMP (GO:0051591),0.5237559325240014,1.3607920684631418,0.11198945981554677,0.8365294678303086,1.0,8/37,11.66%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4430815015062445,-1.3597410735873123,0.1037037037037037,0.6198354209162164,1.0,6/27,5.43%,SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC7A5;SLC1A1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.32296432915119655,-1.3592580421711953,0.014285714285714285,0.617834675197453,1.0,40/138,13.47%,FLT1;PTPRG;ROR1;PDGFRB;EPHA7;TEK;IL31RA;INSR;MPZL1;MERTK;LIFR;LYN;PTK2;AXL;TIE1;KDR;PDGFRA;ACVR1B;EPHB2;EPHB4;PIK3CB;NTRK2;ERBB4;ACVR2A;JAK2;ROR2;FGFR2;KIT;AHI1;RYK;NPR1;PTPRT;BLNK;IGF1R;IL6ST;FGFR4;BDNF;FLT4;EPHA5;RET
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.6182310357718461,1.3592243021957042,0.12700729927007298,0.8409827667979533,1.0,7/16,19.78%,PIGZ;PIGA;DPM2;PIGX;PIGN;PIGP;PIGQ
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5975448231147491,1.3582367942030242,0.1409090909090909,0.8430370718486322,1.0,3/16,6.02%,CLU;ACKR3;BCL2L1
prerank,regulation of RNA splicing (GO:0043484),0.4747530559833571,1.3578700453317072,0.10151691948658109,0.8422848401183225,1.0,18/69,15.25%,MBNL1;AHNAK;AHNAK2;CELF1;SON;SNRNP70;POLR2A;RBM20;LARP7;HNRNPH2;SRPK2;HABP4;SRRM4;RPS26;SRPK1;GRSF1;ZPR1;MBNL2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.521689191246036,1.3575889909750207,0.11543624161073826,0.8412300138927057,1.0,6/39,6.40%,UTRN;ANK2;FHL1;WWP2;AHCYL1;STK39
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6042745972420144,1.3567376907430124,0.1443932411674347,0.8426795974767355,1.0,1/15,0.18%,AGTR1
prerank,regulation of calcium ion transport (GO:0051924),0.491749574919419,1.35550530151729,0.09987819732034105,0.8458146110575604,1.0,6/54,3.48%,ANK2;STIM2;CCL5;IL16;HOMER2;HOMER3
prerank,transition metal ion transport (GO:0000041),-0.4121676171243389,-1.3550665546199263,0.09652509652509653,0.6281313161162779,1.0,10/35,12.55%,SLC30A10;TRPC3;TRPC4;SLC39A8;TFRC;ATOX1;TRPC6;TRPC5;TTYH1;SLC30A1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5502127369813435,1.354977774575697,0.14305364511691884,0.845694906479077,1.0,6/27,6.09%,PHLDB2;TJP1;ARAP1;DLC1;TMEFF2;ARHGEF18
prerank,aerobic respiration (GO:0009060),0.5795255812395679,1.3549308046704118,0.1378809869375907,0.8436745710026201,1.0,9/20,17.99%,SDHB;UQCRC2;ME3;UQCRC1;MTFR1L;MDH2;SLC25A14;UQCRH;MTFR2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.45675117817887523,1.354771295585031,0.06408839779005525,0.8421734200146488,1.0,28/101,17.28%,AGTR1;CYFIP2;KLF4;OGT;VIM;SAMD4A;YTHDF1;NFKBIA;RPS4X;PERP;MSN;EIF4A3;UPF3A;EIF6;BAD;EZR;VPS11;POLDIP3;PLXNB2;CPEB3;FXR1;EIF4G1;UPF3B;PYM1;HSP90AA1;EEF2;STUB1;TBC1D10A
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6516086503795342,1.3530836673167432,0.15409309791332262,0.8471372315459286,1.0,4/10,12.13%,ADTRP;CD200;RIPOR2;CD200R1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5037553046550104,1.3527525503821098,0.12040557667934093,0.8463043513940377,1.0,11/43,10.85%,KLF5;KLF4;DDX5;FOXO3;FOS;SOX9;BMP4;TGFB2;JUN;NFIB;SMARCA4
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.47924356377361754,1.3525929975535902,0.0959902794653706,0.8447355874192695,1.0,19/62,18.32%,CLU;MMP9;YBX3;NFE2L2;EPO;ACKR3;HSPB1;BCL2L1;MAPK7;NDUFS3;SOD2;CREB3;HYOU1;OPA1;MDM2;VNN1;CDKN2D;ARMC10;PARK7
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5689635778032731,-1.352350457331512,0.13636363636363635,0.6333946998214601,1.0,3/10,5.43%,SLC1A3;SLC1A2;SLC1A1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.42491516944613145,-1.352129027024514,0.10097719869706841,0.6305315268824729,1.0,7/26,7.58%,SHANK3;RDX;SYNPO;TSC1;SYNPO2;ALMS1;ROCK1
prerank,lamellipodium organization (GO:0097581),0.5459042776115667,1.3519652304778278,0.11901504787961696,0.8452968593843255,1.0,8/29,14.69%,CDH13;ABLIM2;ABLIM1;DMTN;GOLPH3;ARFIP2;WASF1;CCDC88A
prerank,postsynaptic membrane organization (GO:0001941),-0.49806451371650884,-1.3516455017819433,0.1023391812865497,0.6285553543300513,1.0,5/17,12.88%,GPHN;NRXN1;SHANK3;NLGN1;NLGN3
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2945344812283473,-1.3514947206544141,0.0,0.6255649544560059,1.0,71/224,21.39%,PDE7B;SLC1A3;UNC13B;GRIK2;KCND2;NRXN1;NOVA1;CACNA1E;GRM3;GRM7;GABRG3;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;PTCHD1;DLGAP1;SLC1A1;SYT1;RIT2;GRIN2B;GABRB1;GRM5;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;SLC6A1;LRP6;CHRM3;PLP1;PRKAR2B;APBA1;SNAP25;DTNA;HCRTR2;MBP;GRIK4;GRIK1;GABRA3;NLGN3;GLRA3;HTR2A;AMPH;GLRA2;GABRB2;KCNMB4;CHRM2;MPZ;GRM1;KCNQ3;GABRA1;NPTX1;PRKAR1B;RPS6KA1;GABRE;OPRK1;RPS6KA3;CACNA1B;GLRB;KCNK3;HRH1;GRIA4;GABARAP;KCNIP2;SYT10;ATXN3
prerank,protein polymerization (GO:0051258),0.492591769044486,1.3511228968572773,0.10419313850063533,0.8468645474646785,1.0,10/55,9.82%,FGF13;COBL;GSN;DIAPH1;CORO7;ANG;MSRB2;CHMP4A;CHMP4B;HDGFL3
prerank,positive regulation of reproductive process (GO:2000243),-0.4098380154487882,-1.3510335023530142,0.08540925266903915,0.6237121096945111,1.0,5/31,7.05%,PLCB1;PDE3A;LHFPL2;ACVR1B;GLRA1
prerank,axonal transport of mitochondrion (GO:0019896),-0.5388494601396691,-1.350633713146264,0.12433862433862433,0.6213254722676474,1.0,5/11,15.34%,HIF1A;SYBU;ACTR10;NEFL;TRAK2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5928517287799897,1.3500151743517887,0.15052160953800298,0.8492973463171002,1.0,4/17,7.30%,CCL5;PODXL;FOXC2;TGFB2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3752602892041415,-1.349468685433595,0.07547169811320754,0.6214105134798669,1.0,16/46,12.88%,CDH2;NRXN1;SHANK3;GRM3;GRM7;GRM8;SYT1;GRM5;GRIK3;LRRK2;NLGN1;CACNG8;DGKI;GRIK1;DRD2;NLGN3
prerank,regulation of blood circulation (GO:1903522),0.5289942554585048,1.3487821273129257,0.12162162162162163,0.8524502767547255,1.0,2/34,0.75%,AGTR1;CELF2
prerank,neutrophil migration (GO:1990266),0.48020346901484257,1.3484741847616082,0.10817610062893082,0.851560378729177,1.0,2/58,1.40%,CXADR;CCL5
prerank,negative regulation of macrophage activation (GO:0043031),0.6055034406041225,1.3482591390242409,0.15695067264573992,0.8503207801395117,1.0,3/16,2.49%,LDLR;CD200;ZC3H12A
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5622172823194579,1.347964053036692,0.13576642335766423,0.8494128673061133,1.0,8/23,16.68%,ATP6V1B1;SLC12A8;SLC9A7;SLC12A4;PDK2;SLC26A4;SLC9A1;SLC12A6
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6115278005842395,1.3477124856961369,0.15644171779141106,0.8483726429882117,1.0,3/15,4.44%,UST;CHST12;DSE
prerank,bile acid and bile salt transport (GO:0015721),-0.431420999624985,-1.347616389392961,0.1223021582733813,0.6238542583854739,1.0,4/24,3.34%,ABCC4;SLCO2B1;SLCO1C1;NCOA1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5388824026098135,1.3470777992806517,0.14060446780551905,0.8488804608676175,1.0,8/29,15.03%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;LPCAT3;TMEM86B;PLA2G6
prerank,response to sterol (GO:0036314),0.633085505908519,1.3468702656222624,0.15396825396825398,0.8476324006619644,1.0,5/11,12.21%,RORC;INSIG1;PMVK;ABCA2;TGFBR2
prerank,response to muscle stretch (GO:0035994),-0.501238947873753,-1.346748864325883,0.10610932475884244,0.6231036841074801,1.0,4/15,2.57%,DMD;CDH2;SLC8A1;PTK2
prerank,regulation of autophagy (GO:0010506),0.4310661517924125,1.3465849082074928,0.04058272632674298,0.8466598825503613,1.0,54/216,15.78%,DAPL1;RNF152;PRKAA2;ATP6V1B1;SREBF2;TPCN1;NUPR1;ZC3H12A;EEF1A1;EP300;FOXO3;DAPK3;DAPK1;HSPB1;MTDH;ORMDL3;SH3BP4;USP10;RHEB;HAX1;MAPK15;TRIM21;BAD;TAB3;EXOC7;EXOC4;RUBCN;FZD5;CAPNS1;SMCR8;MTMR3;OSBPL7;WDR6;EIF4G2;FOXK1;TFEB;EXOC8;VPS26B;GSK3A;PIP4K2C;VDAC1;GSK3B;EIF4G1;GAPDH;ULK1;NEDD4;ATP6V1D;FLCN;WASHC1;ATP6V1E1;DNM1L;PLK2;RB1CC1;ATP6V0D1
prerank,response to glucocorticoid (GO:0051384),-0.43678202797680854,-1.3463015235798999,0.08771929824561403,0.6210848147118425,1.0,8/26,21.30%,SLIT2;BCL2L11;SLIT3;PDCD7;ADAM9;ZFP36;NR3C1;GOT1
prerank,melanocyte differentiation (GO:0030318),-0.5528414802153476,-1.345876258366915,0.11140583554376658,0.6190715432746188,1.0,5/11,14.48%,ENPP1;MITF;KIT;LRMDA;MREG
prerank,triglyceride catabolic process (GO:0019433),-0.46410546493538174,-1.3449039008119663,0.10869565217391304,0.6191447922544475,1.0,9/19,44.38%,LPL;PNPLA3;FABP7;PNPLA2;LIPH;LIPC;FABP4;FABP12;FABP5
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6248887693618693,1.3442522232343583,0.1568627450980392,0.8542591404028784,1.0,4/12,10.44%,ACOT8;ABCD1;ELOVL1;FADS1
prerank,microtubule nucleation (GO:0007020),-0.46691399114989596,-1.3435032643568268,0.10903426791277258,0.6201228020453348,1.0,9/19,15.64%,CLASP2;CCDC57;RANBP9;TUBGCP2;NDE1;TPPP;GOLGA2;CSNK1D;SLAIN2
prerank,fatty acid beta-oxidation (GO:0006635),0.4943172096059122,1.342046501164595,0.1057810578105781,0.8614472427795917,1.0,24/51,23.50%,ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;MTLN;HADHA;ACAT2;CPT2;SLC25A17;ECI2;ACADM;AUH;HADHB;IVD;ECHS1;PEX2;DECR2;HSD17B10;CRAT;MECR;GCDH;DECR1;ACAD11
prerank,regulation of fibroblast migration (GO:0010762),-0.47056489136759294,-1.341886522597329,0.10476190476190476,0.6215567888376636,1.0,9/20,17.07%,PTK2;THBS1;FGF2;APPL2;TGFB1;RFFL;GNA12;CLN3;PRR5L
prerank,regulation of macrophage differentiation (GO:0045649),-0.5016172876414748,-1.3417580506236566,0.12968299711815562,0.6185706053271605,1.0,6/15,18.98%,IL34;ID2;HSF1;RIPK1;C1QC;CSF1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4870408724059664,1.3407219629389608,0.10902255639097744,0.8649080619717731,1.0,15/55,11.13%,CD44;GPC6;GPC1;HEXA;GPC4;NAGLU;SDC4;PRELP;GLB1;GPC3;ARSB;STAB2;CHP1;GUSB;HEXB
prerank,proton transmembrane transport (GO:1902600),0.5242946867040932,1.3405943747465139,0.1270053475935829,0.8632743564333661,1.0,14/36,23.08%,SLC36A3;ATP6V1B1;ATP1A2;HVCN1;SLC25A14;SLC25A27;ATP6V0D1;SLC9A1;ATP5F1B;ATP1A1;ATP1A3;ATP1A4;ATP6V0E1;SLC4A11
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6327626946053695,1.3403446432486372,0.15890850722311398,0.8622079262807334,1.0,4/12,9.69%,ANK2;DIAPH1;PTK2B;MTLN
prerank,apical junction assembly (GO:0043297),0.47849311264324057,1.3401906579915401,0.11152416356877323,0.8607501592273894,1.0,7/53,9.05%,CLDN11;POF1B;OCLN;CTNNA1;PATJ;PARD6B;GRHL2
prerank,negative regulation of immune effector process (GO:0002698),0.6101808935468449,1.3394983778424634,0.17883755588673622,0.8614731978572554,1.0,1/13,0.15%,CD55
prerank,positive regulation of response to stimulus (GO:0048584),0.5030784976933269,1.3390728462606514,0.12105263157894737,0.8611196549751838,1.0,13/40,15.36%,IL15;MAVS;SELENON;YPEL3;NSMCE4A;TGFB2;ILK;CDKN2AIP;EEF1E1;GATA3;FXR1;MYC;DHX9
prerank,regulation of platelet aggregation (GO:0090330),-0.46929082113622544,-1.3389610731272308,0.13496932515337423,0.6243314975329914,1.0,4/17,7.06%,PRKG1;LYN;SERPINE2;SH2B3
prerank,heart development (GO:0007507),0.4410022823009989,1.3387176720414238,0.06389776357827476,0.8604159855605924,1.0,22/150,7.46%,FN1;CXADR;SGCG;NTRK3;PDLIM5;CDKN1A;MICAL2;SGCD;AKAP13;STRA6;CSRP3;FOXC2;BMP5;DLC1;TSC2;SOX9;BMP4;MEF2D;RBM20;TGFB2;GPC3;ERBB3
prerank,regulation of cell differentiation (GO:0045595),0.4409839288695792,1.3384277637006035,0.06434599156118144,0.8594384075138859,1.0,25/148,10.44%,PRKCB;PHLDB2;FGFR1;KLF4;MBOAT2;DAG1;RORC;EMP2;CCN2;DDX5;CDK6;NGF;GDNF;PPP2CA;PPP1R13L;FLOT2;ALOX5;LTBP4;PLEKHB2;ZFHX3;SIX1;LGALS3;CDK5RAP1;RAF1;FADS1
prerank,cAMP-mediated signaling (GO:0019933),-0.43169128805520596,-1.3381883052232835,0.08223684210526316,0.623409500301295,1.0,8/24,9.70%,PDE7B;KSR1;PDE3A;RAPGEF2;PDE4D;CAP2;ADCY1;PDE2A
prerank,negative regulation of hormone secretion (GO:0046888),0.6361353026259803,1.3380285551279976,0.15357766143106458,0.8589773693862202,1.0,3/10,16.04%,RAB11FIP3;RAB11FIP5;RAB11FIP1
prerank,regulation of macrophage migration (GO:1905521),0.639618344658911,1.3368255346734852,0.15924657534246575,0.8620456535046797,1.0,4/10,12.13%,CD200;CD81;PTK2B;CD200R1
prerank,mRNA splice site selection (GO:0006376),0.5262163107480248,1.3367227095389824,0.1322314049586777,0.8603524536494405,1.0,13/30,20.77%,CELF2;CELF1;LUC7L3;KHDC4;SF3A2;SRSF9;ISY1;LUC7L2;SRSF1;SRSF5;SF3A3;SFSWAP;PUF60
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5764431134060767,1.3365707249370886,0.13956834532374102,0.8589081307019198,1.0,5/19,11.74%,ABCD1;ABHD5;MTLN;TWIST1;IRS2
prerank,positive regulation of protein metabolic process (GO:0051247),0.4447947846214003,1.3363583985572989,0.07941834451901567,0.8576890494133719,1.0,26/110,19.92%,FZR1;AGTR1;CLU;KLF4;WWP2;NFKBIA;MAPK7;EGLN2;GPC3;RAB7A;ABCA2;GSK3A;GSK3B;EIF4G1;NEDD4;RAB1B;PLK2;DDB1;NSF;PRMT1;ROCK2;ASB5;RNF41;APP;IDE;KLF2
prerank,renal filtration (GO:0097205),-0.5552295327091209,-1.336195027346792,0.16844919786096257,0.6262449901477848,1.0,2/10,3.16%,SULF1;CD34
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5873947590885679,1.3356552736317229,0.16691729323308271,0.8585392026512219,1.0,5/17,10.75%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,vesicle transport along microtubule (GO:0047496),0.5467751418093102,1.33511737231719,0.15236686390532544,0.8586371977559708,1.0,5/23,10.51%,DYNC1I1;NDEL1;KIF13A;KIF1C;PAFAH1B1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5733557533114472,-1.3350484604646888,0.14578005115089515,0.6268421533475174,1.0,6/10,34.05%,LGALS9;CX3CR1;ARRB2;FCGR2B;CEACAM1;LILRB1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5579031026998446,-1.3341938984928858,0.12878787878787878,0.6261552392895404,1.0,2/10,1.17%,ZEB2;RAPGEF2
prerank,blood vessel morphogenesis (GO:0048514),-0.36476188636789336,-1.3340008061628956,0.07106598984771574,0.6234754317519209,1.0,21/54,14.35%,FLT1;ENG;LAMA1;CDH2;CCBE1;GLMN;KDR;COL4A1;CYP1B1;SLC1A1;ID1;TGFB1;SOX17;LRP5;RAMP2;NF1;LOX;RASIP1;FLT4;TBX1;EGFL7
prerank,bicellular tight junction assembly (GO:0070830),0.4899137523308866,1.3337776621029476,0.11825192802056556,0.8621506132879754,1.0,6/46,9.05%,CLDN11;POF1B;OCLN;PATJ;PARD6B;GRHL2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4622991053658894,-1.3326224461044018,0.11214953271028037,0.6245763257334922,1.0,9/17,13.35%,IL34;NOTCH1;SERPINE2;BIN1;TGFB1;PTPRZ1;ID2;TENM4;TNFRSF1B
prerank,endothelial cell development (GO:0001885),-0.43024867901958597,-1.3324705191569224,0.10472972972972973,0.6219421491733901,1.0,10/25,10.40%,COL22A1;RAPGEF2;PECAM1;PDE4D;RDX;PPP1R16B;COL18A1;COL15A1;PDE2A;ROBO4
prerank,histone H3-K4 trimethylation (GO:0080182),0.6403876816040479,1.332346916092636,0.17263843648208468,0.8659377148839235,1.0,3/11,8.99%,OGT;BEND3;KMT2A
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3774492091940271,-1.3313933232963808,0.09012875536480687,0.6220879701989153,1.0,9/43,7.59%,ERRFI1;PTPRJ;TGFA;ITGA1;CBLB;DAB2IP;SH3KBP1;ZFYVE28;SOCS5
prerank,positive regulation of chromosome organization (GO:2001252),0.5934153457151792,1.33114751822635,0.15160796324655437,0.8690669989129403,1.0,7/15,18.43%,FEN1;MRE11;ATRX;PML;NBN;RAD50;PPP1R10
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5138763486151015,-1.331073882613715,0.1575,0.6197258895821621,1.0,7/13,14.90%,LTBP1;FBN1;GREM2;FBN2;CD46;NRROS;CHRDL1
prerank,lipid phosphorylation (GO:0046834),-0.5493824137938278,-1.3306740237138126,0.14898989898989898,0.6177956303282162,1.0,7/10,23.18%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,cellular response to chemokine (GO:1990869),0.4986544771598869,1.3301388324789882,0.125,0.8712659492745811,1.0,10/46,11.68%,CCL5;ZC3H12A;PTK2B;ACKR3;RIPOR2;DUSP1;GPR75;STK39;OXSR1;RHOA
prerank,positive regulation of calcium ion transport (GO:0051928),0.49959543624337205,1.329988595504599,0.13297872340425532,0.8697563967387045,1.0,4/36,2.71%,ANK2;STIM2;CCL5;CAV1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6612116786748699,1.32978565070891,0.1812191103789127,0.868548978415502,1.0,1/10,0.41%,CLU
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.502527038914804,-1.3275872019649895,0.1387434554973822,0.6243814669687137,1.0,3/14,12.46%,OSMR;PTGS2;IL6ST
prerank,regulation of protein secretion (GO:0050708),0.43976067822993253,1.3272913391957704,0.08724100327153762,0.8768865382938599,1.0,20/119,10.62%,DPP4;ITPR2;ADTRP;CCL5;CACNA1A;SYTL4;RAP1A;HMGCR;ALOX5;ABCC8;GOLPH3;TGFB2;ANG;CYP51A1;LLGL2;APBB1;EZR;KCNB1;IER3IP1;ITPR3
prerank,positive regulation of glucose import (GO:0046326),0.5620891833903081,1.3272404568158631,0.16172106824925817,0.875028769122994,1.0,4/21,5.18%,SORBS1;OCLN;CREBL2;RHOQ
prerank,SNARE complex assembly (GO:0035493),0.6473336739664904,1.3270932636078285,0.1791044776119403,0.8736781079653858,1.0,5/10,21.80%,STXBP6;STXBP1;VAMP1;UVRAG;VAMP2
prerank,regulation of telomere capping (GO:1904353),0.5475623590832144,1.3261231601591,0.14014598540145987,0.8755806009865917,1.0,10/23,20.87%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;NBN;PRKCQ;RAD50;PNKP;TERF2
prerank,cellular response to dsRNA (GO:0071359),0.5828280944264681,1.3259367013863272,0.1933534743202417,0.8742561529635995,1.0,6/15,19.38%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,negative regulation of macroautophagy (GO:0016242),0.5399572861304061,1.3258799107197483,0.13528591352859135,0.8724126218707416,1.0,8/26,9.74%,NRBP2;NUPR1;TSC2;TMEM39A;CHMP4A;CHMP4B;RUBCN;SMCR8
prerank,regulation of RNA metabolic process (GO:0051252),0.47019121466374003,1.3245878639460924,0.10966981132075472,0.8757412279296852,1.0,19/59,19.65%,MBNL1;AHNAK;AHNAK2;CELF1;SON;SNRNP70;RBM20;HNRNPH2;SRRM4;RASA1;GRSF1;MBNL2;OAS2;IGF2BP1;IGF2BP2;BRDT;IGF2BP3;PTBP1;PCBP2
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.44042444916880646,-1.3235850801263997,0.11182108626198083,0.6338097289831989,1.0,9/22,15.71%,APPL2;LRRK2;PTPRZ1;ID2;NES;GATA2;TAFA1;TOX;KDM2B
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3616849707336891,-1.3235624916507116,0.08823529411764706,0.6307316157593841,1.0,17/56,9.97%,FLT1;PDGFRB;TEK;INSR;LYN;PTK2;TPST1;KDR;PDGFRA;EPHB2;ABI2;PKDCC;ERBB4;JAK2;FGFR2;KIT;ABL2
prerank,sodium ion transmembrane transport (GO:0035725),0.45224344702244323,1.3231812464749475,0.10091743119266056,0.8795094362690475,1.0,6/84,2.83%,SLC9A2;SLC9A4;ASIC5;SCN3A;NALCN;ATP1A2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4463585955928062,-1.3231624287006165,0.0967741935483871,0.6286814614795094,1.0,8/22,14.66%,CACNA1C;STIM1;ADGRV1;GRM3;CAP2;NF1;DRD2;EDNRB
prerank,membrane protein proteolysis (GO:0033619),0.5144385628500425,1.3226697402944947,0.14868421052631578,0.8796669006726275,1.0,16/37,21.32%,TMPRSS6;DAG1;ADAM10;AFG3L2;NAPSA;SPPL2B;PRTN3;CTSH;HM13;BACE1;SPPL3;PRKCQ;SPPL2A;ADAM17;RHBDD1;APH1A
prerank,cardiac muscle tissue development (GO:0048738),0.48210118631906373,1.3220089154970287,0.11887254901960784,0.8803440472971412,1.0,7/50,4.00%,SGCG;NOTCH2;SGCD;AKAP13;GJB6;CSRP3;BMP5
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5833543206094408,1.3219055465663123,0.16203703703703703,0.8787696992976262,1.0,3/16,7.82%,CLU;HMGCR;CYP51A1
prerank,positive regulation of insulin secretion (GO:0032024),0.5218210780131075,1.3218863010300914,0.12005457025920874,0.8768002608397059,1.0,14/36,20.41%,CFTR;MCU;GLUD1;BAD;TCF7L2;TRPM4;IRS2;AACS;PLA2G6;NLGN2;STX4;GPLD1;GPER1;SOX4
prerank,regulation of filopodium assembly (GO:0051489),0.49828882587618606,1.3218105726040301,0.14227086183310533,0.8750798661167871,1.0,11/38,13.39%,RAB17;ARAP1;PALM;RIPOR2;RHOQ;CAPZB;DMTN;CDC42;BCAS3;FXR1;TRPM2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5390458644115482,1.321067560609033,0.1574468085106383,0.8762032993901678,1.0,6/24,9.74%,EPHA4;PTK2B;NUB1;LATS1;PKD1;ATP5IF1
prerank,DNA methylation (GO:0006306),0.5459743772024197,1.3205518069623576,0.1490857946554149,0.8763684887607661,1.0,11/23,25.56%,FOS;BEND3;ATRX;ZFP57;DNMT3A;PPM1D;KMT2E;N6AMT1;BAZ2A;TEX15;EHMT1
prerank,protein homotrimerization (GO:0070207),-0.5033160779408475,-1.3187234638155105,0.13812154696132597,0.6363834702450373,1.0,11/14,37.62%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;ASIC1;ALOX5AP;STEAP4;P2RX3
prerank,protein trimerization (GO:0070206),-0.5033160779408475,-1.3187234638155105,0.13812154696132597,0.6363834702450373,1.0,11/14,37.62%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;ASIC1;ALOX5AP;STEAP4;P2RX3
prerank,negative regulation of immune system process (GO:0002683),0.5856563072430765,1.318260696484248,0.15773353751914243,0.8841286056992291,1.0,4/16,9.13%,ADTRP;CD200;SOX9;FOXP3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.4857148996636337,-1.317778463843964,0.14534883720930233,0.6362581428747208,1.0,4/16,3.96%,PDGFRB;PDGFD;PTPRJ;PDGFRA
prerank,fatty acid oxidation (GO:0019395),0.478054665251325,1.3177553161381264,0.11956521739130435,0.8842200377935254,1.0,17/57,14.66%,PPARGC1A;ABCD1;ADH7;ECHDC1;ACADL;EHHADH;PECR;MTLN;HADHA;ACAT2;CPT2;SLC25A17;ECI2;ACADM;AUH;HADHB;ILVBL
prerank,alanine transport (GO:0032328),0.6302061243732158,1.317384156030428,0.16896551724137931,0.8837910196851283,1.0,3/10,11.01%,SLC36A3;SLC36A4;SLC1A4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.42439309823465243,-1.316179330426754,0.13494809688581316,0.6383619630214281,1.0,12/23,21.94%,IFNGR1;IFNGR2;NR1H3;PARP14;JAK2;PPARG;NLRC5;IRGM;NR1H2;CDC37;HSP90AB1;SOCS3
prerank,negative regulation of T cell differentiation (GO:0045581),0.6350689649924057,1.316018930161234,0.16901408450704225,0.8877104469292701,1.0,2/10,7.10%,GLI3;BMP4
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.425496023176811,-1.3156912059961614,0.13468013468013468,0.6367726720678758,1.0,12/25,25.15%,GRID2;GRIN2A;GRIN2B;LRRK2;GLRA1;DRD2;NLGN3;MPP2;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,positive regulation of blood coagulation (GO:0030194),0.5872249024535294,1.3151451663738079,0.165402124430956,0.8892916303680355,1.0,6/17,18.10%,ST3GAL4;THBD;DMTN;ANO6;F2R;USF1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5133823368744218,-1.3149646150444647,0.1509433962264151,0.6361531911939224,1.0,6/13,16.64%,WNT5A;SEMA7A;IRAK3;TGFB1;GPRC5B;CD74
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5567181134991536,1.3149101040872584,0.15384615384615385,0.8882378609865187,1.0,3/22,9.13%,NFATC2;DUSP10;FOXP3
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3752764574564949,-1.314467830965649,0.07563025210084033,0.6345227162070363,1.0,16/44,22.93%,PTPRJ;LYN;DAB2IP;IRAK3;SH2B3;PIK3CB;DNAJA1;NF1;CD300A;SORL1;PDCD4;SPRY1;SPRY4;PAQR3;BMP7;HYAL2
prerank,regulation of cytoplasmic translation (GO:2000765),0.6007703209872096,1.3136735247829723,0.16561514195583596,0.8914380434295351,1.0,6/14,15.36%,CPEB2;YBX3;UNK;PKM;CPEB3;DHX9
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5291733832451,-1.313569961715352,0.16237113402061856,0.6342096134276463,1.0,4/12,16.72%,LYN;RUNX1;CD300A;RC3H1
prerank,arachidonate transport (GO:1903963),-0.5592134051098272,-1.3135337307534027,0.17349397590361446,0.6283675593839368,1.0,3/10,12.66%,PNPLA8;ACE;DRD2
prerank,arachidonic acid secretion (GO:0050482),-0.5592134051098272,-1.3135337307534027,0.17349397590361446,0.6283675593839368,1.0,3/10,12.66%,PNPLA8;ACE;DRD2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.31758799057568177,-1.3134175141993547,0.024793388429752067,0.6257592063198695,1.0,34/101,19.67%,FLT1;PDGFRB;PDGFD;CEMIP;IL34;RAPGEF2;ROBO1;WNT5A;PKD2;DAB2IP;FGF2;RGCC;LRRK2;DIPK2A;TGFB1;TPD52L1;EZH2;CCNY;PIK3R6;KIT;ETAA1;IRGM;HMGA2;SPDYA;EDN1;PIK3R5;EGF;INCENP;EDN3;TCIM;MAP2K1;CIB1;CD40;MST1R
prerank,response to interleukin-6 (GO:0070741),-0.5546527823799412,-1.3130988790377744,0.14177215189873418,0.6238885748498901,1.0,3/10,10.43%,PID1;PTGIS;PTPRT
prerank,T cell differentiation in thymus (GO:0033077),0.5948780093895186,1.3127401785370045,0.17050691244239632,0.8934105332086574,1.0,4/14,19.66%,GLI3;RABL3;MR1;ADAM17
prerank,regulation of intracellular protein transport (GO:0033157),0.5224024011161665,1.3117445673266237,0.13788300835654596,0.895630640516467,1.0,13/32,24.28%,PTPN14;NDEL1;BMP4;PLK3;GCC2;BCAS3;RIPOR1;KIF20B;VAMP2;SIRT7;TPR;PCM1;ICE1
prerank,dendritic spine morphogenesis (GO:0060997),-0.48380347834164694,-1.3116161838457456,0.13387978142076504,0.6253539613053327,1.0,4/15,6.24%,SHANK3;DOCK10;PAK3;EPHB2
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.45013906665646586,-1.3115710009644799,0.15562913907284767,0.6226015098775174,1.0,7/20,10.28%,IGF1;PDGFRB;IGFBP5;VTN;ACE;SLIT2;CCN4
prerank,negative regulation of cellular protein localization (GO:1903828),0.5091172741010678,1.3114120437766925,0.12810457516339868,0.8950031318651256,1.0,12/34,20.05%,ACTN2;CTNNA1;RIPOR2;OTUD7B;NSFL1C;LATS1;SNX33;GSK3B;FLCN;ROCK2;ILRUN;MAPT
prerank,B cell homeostasis (GO:0001782),-0.5431473733335761,-1.3111314336730702,0.14950980392156862,0.6210286471863964,1.0,5/10,21.35%,LYN;DOCK10;NCKAP1L;TNFAIP3;DOCK11
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5726654964869481,1.3107685599323236,0.17565485362095531,0.8958366336501563,1.0,5/17,13.07%,CAV1;SOX9;KLF7;MAFG;GATA3
prerank,negative regulation of cell death (GO:0060548),0.4470916232612663,1.3104095423411823,0.1267123287671233,0.8953366274487504,1.0,21/88,15.76%,WNT16;CLU;SRGAP2;PPARGC1A;CD200;CCN2;WNT11;KANK2;BMP4;CHMP4A;CHMP4B;TIGAR;VPS4B;CD200R1;GSK3B;EIF4G1;DUS2;BNIP3L;NENF;CHMP2A;IKBKG
prerank,establishment of spindle orientation (GO:0051294),0.5164289790509936,1.3097118179662695,0.16275862068965516,0.8962481713723583,1.0,11/28,22.78%,NDEL1;MAP4;NSFL1C;LLGL2;PAFAH1B1;INSC;ZW10;NUMA1;MISP;LLGL1;ITGB1
prerank,positive regulation of telomere capping (GO:1904355),0.5697684669321643,1.3095026844964741,0.16591251885369532,0.8951020103998354,1.0,7/17,19.38%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;PRKCQ;PNKP
prerank,nuclear membrane organization (GO:0071763),0.5614596703446348,1.30922706235315,0.16840536512667661,0.8942761866933495,1.0,9/19,24.02%,NSFL1C;CHMP4B;TOR1A;VPS4A;TOR1AIP1;CHMP2A;GPER1;TMEM43;UBXN2A
prerank,apoptotic process (GO:0006915),0.4171365549190156,1.3085814481983513,0.07539267015706806,0.8949691537212009,1.0,47/203,16.69%,EGLN3;RNF152;NOTCH2;CYFIP2;PAWR;OGT;BBC3;CXCR4;EP300;PMAIP1;PTK2B;DAPK3;PPP2CA;DAPK1;ZBTB16;DLC1;AHCYL1;PPP1R15A;NUDT2;NFKBIA;TSC2;IRF3;EFNA5;BCL2L1;ERBB3;BAD;TNFRSF10B;PLK3;DPF2;RAF1;ADAM15;FEM1B;PLSCR3;TGFBR2;FXR1;VDAC1;MYC;YARS1;ING4;PAX3;GAPDH;MDM2;IKBKG;ITGB2;PAK6;PDE1B;ERCC2
prerank,synapse assembly (GO:0007416),0.4607643398112449,1.3083373999422157,0.1278648974668275,0.8939726722683459,1.0,4/67,1.56%,CDH1;FGF13;SDK1;PLXNB1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5870771045355035,1.308292838707134,0.17884914463452567,0.892184469584372,1.0,8/15,20.98%,REEP3;RTN3;ZFYVE27;TMEM33;ATL2;REEP4;RAB10;ARL6IP1
prerank,zymogen activation (GO:0031638),0.4960156472558529,1.3081880689423662,0.15303430079155672,0.8906924050964079,1.0,8/39,9.77%,CYFIP2;HP;HPR;PRSS12;PERP;KLKB1;BAD;KLK1
prerank,cellular component disassembly (GO:0022411),0.47492102745775067,1.3081504596161146,0.1353658536585366,0.8888687726059324,1.0,13/53,11.14%,CD44;TMPRSS6;MMP9;ADAM10;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12
prerank,negative regulation of axonogenesis (GO:0050771),0.5260850205444981,1.3069014702497095,0.15256588072122051,0.892219072804374,1.0,2/27,0.75%,FGF13;RTN4R
prerank,calcium-mediated signaling (GO:0019722),0.4449468809293446,1.306869929432223,0.11060948081264109,0.8904175687139809,1.0,14/93,6.32%,AGTR1;NUDT4;ANK2;CCR4;CXCR4;MCU;PTGFR;RCAN1;CCR10;ACKR2;ACKR4;ACKR3;CCRL2;DMTN
prerank,macrophage chemotaxis (GO:0048246),0.6372414452868472,1.3060871551560458,0.17922948073701842,0.8916231432853694,1.0,3/10,17.06%,CCL5;LGALS3;TAFA4
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.559064680477475,1.3060393650000268,0.16496350364963502,0.8898569051210037,1.0,4/19,6.00%,CLU;RTN1;FLOT2;RTN3
prerank,nucleosome assembly (GO:0006334),0.5130417875160599,1.305802942409051,0.16016713091922005,0.8888866956029912,1.0,10/31,18.54%,DAXX;GRWD1;ASF1A;SOX9;KAT6B;ATRX;UBN1;IPO4;SPTY2D1;H3-3A
prerank,negative regulation of cell motility (GO:2000146),0.4392481179130449,1.3057913779183172,0.10816777041942605,0.8869931977017464,1.0,19/108,8.64%,CDH1;SRGAP3;SRGAP2;KANK1;EPHA4;DAG1;MAGI2;WNT11;SPINT2;FOXO3;DUSP10;PTPRU;DLC1;TMEFF2;FBLN1;MAPK15;CCDC125;SLURP1;PIP5KL1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.43870507154353666,-1.30540943218921,0.13758389261744966,0.6355067142829586,1.0,9/21,10.03%,ENPP1;NOS3;GAS6;NOTCH1;ECM1;ASPN;TGFB1;ROCK1;BCOR
prerank,protein K63-linked ubiquitination (GO:0070534),0.4939742638261148,1.3047158831169774,0.130779392338177,0.889465051618436,1.0,19/41,22.58%,RNF152;WWP2;RNF5;TRIM21;MAGEL2;UBE2B;RNF126;PELI1;NEDD4;BFAR;UBE2N;PRPF19;STUB1;ZFP91;ARIH2;TRAF3IP2;TRIM5;RNF168;UBE2V1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5190977842175969,-1.3045097406672586,0.14824797843665768,0.6353204332555952,1.0,7/12,21.35%,ABCA1;NR1H3;PPARG;ITGAV;NR1H2;PPARA;ABCG1
prerank,sterol biosynthetic process (GO:0016126),0.5089723051077686,1.3035363045304487,0.17438692098092642,0.8924548618851956,1.0,13/33,18.49%,FDFT1;DHCR7;HMGCR;FDPS;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5524815551354324,1.3034078748527471,0.14348462664714495,0.8910697275899552,1.0,8/22,17.87%,PPP2CA;DUSP10;PPM1B;DUSP1;PPM1A;PPM1D;PPP2CB;PDP1
prerank,regulation of cell population proliferation (GO:0042127),0.4068594526768888,1.3031793001306882,0.005,0.8900987485758971,1.0,97/691,9.14%,FN1;DPP4;EGLN3;AGTR1;CDH13;CLU;FGFR1;ZBTB7C;PTPN14;CRLF1;CHRM1;IGFBP6;NTRK3;CNOT6;WNT1;TFAP2C;KLF4;LAMC2;TJP1;TFAP2D;COL4A3;PDGFC;EFNB2;CDKN1A;GRK5;ADAM10;SMAD6;EMP2;NIBAN2;CD200;MAGI2;NUPR1;IL15;CDK10;CELF1;CDK6;PDF;SULT2B1;NGF;CD81;RBFOX2;PTGFR;TNFSF13;PTK2B;KANK2;SGK3;TNFRSF8;NOP2;GDNF;BMP5;HDAC4;GCNT2;CLCF1;TIMP1;EPO;PTPRU;DLC1;CIAO1;DOT1L;NACC1;S100A11;CDK4;RARG;RPS4X;TSC2;SH3BP4;JUND;FOXM1;ZBTB17;KRAS;SOX9;TES;DDRGK1;SHC1;MAPK15;CGREF1;BMP4;TGFB2;TGFB1I1;CCND2;ERBB3;STAT4;SLURP1;ROMO1;FGF22;SIX1;FBXO5;TCF7L2;MAZ;ADAMTS1;PTPN6;JUN;SSR1;PML;IL7R;FOXP3;BRD7
prerank,peripheral nervous system development (GO:0007422),0.5359721290731483,1.3027247340689245,0.13872832369942195,0.8899594431530834,1.0,6/23,10.80%,GPC1;NGF;GDNF;GFRA3;ERBB3;ADGRG6
prerank,metal ion transport (GO:0030001),-0.3280951148877277,-1.3026483168485723,0.05223880597014925,0.638193454220462,1.0,20/86,13.77%,ITPR1;CACNA1C;CALCRL;SLC8A1;SLC8A3;CACNA1E;TRPC3;TUSC3;TRPC4;PKD2;SLC39A8;SELENOK;PANX1;RAMP2;TPT1;CACNG8;TRPC5;SLC30A1;CAMK2A;RYR2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5064535052402828,-1.302489608761782,0.13866666666666666,0.6357974142329436,1.0,10/12,33.90%,PIK3R1;DAB2IP;BCL2L11;BAX;BOK;ERN1;BAK1;XBP1;PTPN1;ATF6
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4278259519893057,-1.3015427260487675,0.1527777777777778,0.6357606982370007,1.0,6/26,7.59%,ERRFI1;TGFA;CBLB;NCK2;ZFYVE28;SOCS5
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5454907349811502,1.301525963076607,0.15994020926756353,0.8927920944165629,1.0,3/20,8.63%,CD55;CD81;FZD5
prerank,sensory perception (GO:0007600),-0.36442786871613214,-1.2999659103780645,0.0966183574879227,0.637666792306986,1.0,26/45,36.39%,GNAS;ADGRV1;PCDH15;TTC8;RETREG1;ADORA2A;PTGES;MME;GNAL;OPRM1;BBS4;OPRK1;NIPSNAP1;WHRN;NTSR2;TRPA1;CHRNA4;CDH23;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;CLRN1
prerank,regulation of phosphorylation (GO:0042325),0.4343040471562546,1.2999299523030372,0.09793253536452666,0.8974911210423906,1.0,18/120,9.79%,FN1;CCL5;OGT;CDKN1A;EMP2;EP300;SESN2;PPP2CA;KDM4D;HSPB1;NUP93;BMP4;EIF6;ILK;ANG;PML;NDC1;JMJD8
prerank,regulation of microtubule-based process (GO:0032886),0.5024082437909463,1.2999008450684224,0.14701986754966886,0.8956754778610561,1.0,10/36,15.58%,PHLDB2;PRKAA2;DIAPH1;MAP6;EFNA5;EPHA3;MARK4;MEMO1;GSK3B;IGBP1
prerank,heart process (GO:0003015),0.5828496419748619,1.299432516824168,0.2015873015873016,0.8956551514049149,1.0,2/14,2.26%,SGCG;SGCD
prerank,regulation of cation channel activity (GO:2001257),0.44453297352074117,1.2992882785483075,0.11587485515643106,0.8943792551337677,1.0,11/89,4.49%,FGF13;ANK2;ACTN2;SLMAP;AHNAK;MMP9;CACNB3;PTK2B;SELENON;DAPK1;EPO
prerank,regulation of protein localization to nucleus (GO:1900180),0.486093497651365,1.2988468405038018,0.155893536121673,0.8943046142716078,1.0,20/43,23.45%,LIMK2;GLUL;CTNNA1;SESN2;ORMDL3;OTUD7B;BMP4;LATS1;SUMO3;EIF2AK3;GSK3B;FLCN;TESK1;PARK7;ILRUN;CDK5RAP3;BYSL;TPR;WWTR1;LATS2
prerank,cell junction assembly (GO:0034329),0.434077644072969,1.2980692452563658,0.12348401323042998,0.8957425327789105,1.0,13/100,9.57%,FN1;CDH1;SDK1;TJP1;PKP4;LIMS2;ILK;CDC42;PARD6B;FZD5;OPHN1;GRHL2;ACTB
prerank,GPI anchor metabolic process (GO:0006505),0.5308113460669468,1.296864356143823,0.15915119363395225,0.8989742885647074,1.0,9/26,19.78%,PIGU;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;GPLD1;PIGQ
prerank,regulation of phospholipase activity (GO:0010517),0.6356905625733178,1.2967659972523051,0.20063694267515925,0.8974602833997364,1.0,1/10,0.48%,FGFR1
prerank,digestive tract morphogenesis (GO:0048546),-0.49023909801969423,-1.296467842065294,0.15466666666666667,0.6455045341061382,1.0,9/14,17.95%,PDGFRA;GLI1;SOX17;ID2;FGFR2;NIPBL;BBS7;SOX11;EPHB3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4864601280263931,-1.2964660274762703,0.16,0.642652755510452,1.0,6/16,14.33%,HIF1A;NPR3;NOS1AP;PIK3CB;GCH1;DHFR
prerank,smooth muscle cell differentiation (GO:0051145),-0.5103963033972191,-1.2964530469320927,0.17142857142857143,0.6398702688619106,1.0,9/12,21.98%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR;HEY1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.44932704116398725,1.2954046856804569,0.12320574162679426,0.9011701592358761,1.0,10/75,11.12%,SLC9A2;SLC9A4;SLC12A8;ATP1A2;KCNJ13;SLC39A6;SLC9A7;SLC9A6;SLC12A4;TRPM4
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5390532922917761,-1.2953510719258388,0.16037735849056603,0.6404453004411476,1.0,3/11,6.57%,CAMK2D;NOS1AP;BIN1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.2920635990083289,-1.2951244222759335,0.017241379310344827,0.6383753509451356,1.0,34/150,12.63%,PDGFRB;HIP1;PTPRJ;TGFA;ENG;TEK;PIK3R1;INSR;KITLG;SEMA5A;PTK2;ESR1;GAS6;AXL;MFHAS1;PDGFRA;KL;THBS1;FGF2;IL18;IGF2;PIK3CB;TGFB1;ERBB4;FGFR2;KIT;GAB2;PIK3CD;PIK3AP1;IGF1R;MYOC;TXN;FGFR4;GRB2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5581772487155986,1.2941355419451732,0.16640746500777606,0.9045461371655177,1.0,5/18,13.52%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5070210358767409,1.2938090831823923,0.15853658536585366,0.9040436175899774,1.0,2/33,3.88%,DPP4;FOXC2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.43613845385962435,1.2937348150692398,0.11222222222222222,0.9024607613706954,1.0,15/108,7.62%,EGLN3;NLRP2;COL4A3;MAP3K5;UACA;GSN;BBC3;PMAIP1;NGF;PRR7;DAPK1;DLC1;MUL1;BAD;TNFRSF10B
prerank,mesenchyme morphogenesis (GO:0072132),-0.4655826079328144,-1.2931757926320715,0.14836795252225518,0.6413667714602871,1.0,6/17,9.74%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.47343215506515557,1.2931579501357202,0.14268292682926828,0.9030698351884802,1.0,14/54,15.51%,NSA2;NLE1;NOP2;PES1;PPAN;MAK16;EIF6;SDAD1;NIP7;RPL10A;RPF1;HEATR3;PAK1IP1;RPL14
prerank,regulation of leukocyte migration (GO:0002685),0.5795616818296773,1.2927317265088716,0.17956656346749225,0.9028684451523893,1.0,2/16,3.30%,ADTRP;CD81
prerank,regulation of potassium ion transport (GO:0043266),0.5136938345277183,1.292643707060647,0.17066290550070523,0.9013745663570321,1.0,5/31,6.93%,ANK2;ACTN2;FHL1;PTK2B;ANK3
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.5419492113671681,-1.2920627834317473,0.18298969072164947,0.6419235165944283,1.0,4/10,7.33%,SOX5;ACVRL1;BMPR1B;PKDCC
prerank,cellular response to oxidative stress (GO:0034599),0.4341304902475945,1.291878099695246,0.11829134720700986,0.9025943358092899,1.0,20/118,11.37%,WNT16;PRKAA2;PPARGC1A;MMP9;CPEB2;ZC3H12A;FOXO3;FOS;SESN2;MGAT3;DAPK1;NFE2L2;NUDT2;PXN;ROMO1;MAPK9;JUN;SOD2;AGAP3;PDK2
prerank,intestinal absorption (GO:0050892),0.5826667623801519,1.291586181889088,0.19092331768388107,0.9019658497996617,1.0,1/13,1.22%,TJP2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5659333451982766,1.2915608177055997,0.16326530612244897,0.900211176954661,1.0,3/16,7.45%,RAET1E;LAMP1;PVR
prerank,synaptic membrane adhesion (GO:0099560),0.578951866259911,1.2914676965380487,0.18305597579425115,0.8987288943584651,1.0,4/14,6.85%,GPC6;GPC4;PTPRD;PTPRF
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.44221376243379157,1.2912071729292174,0.13472706155632985,0.8979542627932322,1.0,21/80,15.03%,CLU;VIM;EPHA4;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TNFRSF1A;ABCA2;POLDIP3;SP1;PLXNB2;CPEB3;FXR1;GSK3A;SMPD2;UPF3B;PYM1;PLA2G6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5739915183208582,1.2908416160872498,0.17719568567026195,0.8976106607239123,1.0,1/17,0.15%,CD55
prerank,protein hydroxylation (GO:0018126),0.5800342280039983,1.2907830871875807,0.18250377073906485,0.8960059112175238,1.0,1/15,0.09%,EGLN3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4200437206474613,1.2907468963869746,0.07270811380400422,0.8943302374490556,1.0,35/173,14.73%,CD55;ANK2;DYNC1I1;F5;NRBP2;ANK1;PEF1;ERGIC1;COPA;SPTBN2;TMED1;TFG;CAPZB;CTSZ;ANK3;ERGIC2;IER3IP1;BCAP31;ZW10;HYOU1;TRAPPC1;SPTAN1;MCFD2;VTI1B;ERGIC3;NAPA;GOLGB1;COG8;ARF4;PREB;SEC23A;VAMP7;ATL2;RAB1B;CNIH1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3385723395510865,-1.2900033764870849,0.08588957055214724,0.6453103194927975,1.0,21/67,13.03%,FLT1;GHR;PDGFRB;TEK;INSR;LYN;PTK2;KDR;PDGFRA;EPHB2;BMX;ABI2;PKDCC;ERBB4;JAK2;FGFR2;KIT;ABL2;IGF1R;FGFR4;FLT4
prerank,muscle cell development (GO:0055001),0.5201393683780954,1.2898104263469004,0.16933333333333334,0.8964315845358563,1.0,3/30,1.62%,CXADR;ANK2;NEBL
prerank,positive regulation of gene expression (GO:0010628),0.4036558034844033,1.2892698462163912,0.02108433734939759,0.8967964268043482,1.0,88/442,15.05%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;SMO;VIM;SCAMP5;HPN;OCLN;GSN;SAMD4A;DDX5;YTHDF1;ZC3H12A;IL15;WNT11;CELF1;EP300;NGF;WNT6;NFE2L2;OLFM1;POLR2H;TAF1C;RPS4X;RBMS3;OVOL2;POLR2A;MOV10;HOXA5;KRAS;HCFC1;SOX9;FOXD1;ZBTB7B;DDRGK1;MSN;EIF4A3;ANK3;BMP4;UPF3A;RBM20;EIF6;NFAM1;FGF22;MAPK9;MAZ;POU3F1;TENT4A;TLR6;MAP2K2;TXK;ACTB;POLR1C;EZR;MYO1C;POLR1E;TWIST1;MUSK;SRPK2;HABP4;ACTG1;TLR4;CALCOCO1;EIF2AK3;POLDIP3;POLR1F;SP1;WNT3;PLXNB2;CPEB3;FXR1;GSK3A;UBR5;MYC;GSK3B;MEF2C;GAPDH;UPF3B;ZPR1;PYM1;TLR3
prerank,actin filament polymerization (GO:0030041),0.5178268090333329,1.2892007080399113,0.16502115655853314,0.8952326922360685,1.0,6/29,7.96%,COBL;GSN;DIAPH1;CORO7;ANG;MSRB2
prerank,negative regulation of cell activation (GO:0050866),0.5948296459553278,1.2891959825521544,0.19500780031201248,0.8934407031869182,1.0,3/14,6.15%,LDLR;CD200;THBD
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5832600626722529,1.289194000759761,0.18081761006289307,0.8916418270806551,1.0,9/13,19.87%,NFKBIA;LATS1;PKD1;YWHAB;GET4;FLNA;KEAP1;SUFU;DBN1
prerank,positive regulation of angiogenesis (GO:0045766),0.4354237900030017,1.2887575411808798,0.12694877505567928,0.8916367408850521,1.0,23/108,11.66%,ADAM12;PRKCB;ITGB8;KLF4;ANXA3;TJP1;NINJ1;ZC3H12A;GAB1;FOXC2;HSPB1;MTDH;PKM;MYDGF;AGGF1;VEGFB;JMJD8;EMC10;TWIST1;JAK1;AQP1;S100A1;RAPGEF3
prerank,anion transmembrane transport (GO:0098656),-0.3313150341721263,-1.2883833785260088,0.07453416149068323,0.6475837248846368,1.0,10/67,5.84%,SLC1A3;SLC6A13;SLC13A3;SLC16A12;LRRC8C;SLC6A9;SLC1A2;SLC7A5;SLC1A1;SLC39A8
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4485680608737066,1.2881372807017268,0.1403301886792453,0.8924196268605888,1.0,19/74,13.07%,PHLDB2;DAG1;HPN;CRB2;PPP2CA;BMP5;GCNT2;OLFM1;OVOL2;SPRED3;TGFB2;TGFB1I1;TWIST1;LDLRAD4;EPHA3;TGFBR2;PDPN;SFRP1;GATA3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.37048872523049753,-1.287313886491245,0.11904761904761904,0.6481281865511644,1.0,11/40,8.71%,LEF1;JAG1;COL1A1;DAB2;NOTCH1;RGCC;TGFB1;EZH2;GLIPR2;AXIN2;TIAM1
prerank,central nervous system neuron differentiation (GO:0021953),-0.38952171334441366,-1.2869606623418033,0.124,0.6465007535976636,1.0,14/33,22.09%,MAP2;GRID2;NTRK2;LRP6;RYK;KNDC1;GBA2;TOX;MDGA2;FAIM2;NR4A2;SPOCK1;CHD5;SIN3A
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5574569239105298,1.2867070673778072,0.17289719626168223,0.8965594933695324,1.0,3/17,7.45%,RAET1E;LAMP1;PVR
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.4013717450404659,-1.2864943167299945,0.13636363636363635,0.645167492608808,1.0,12/28,31.65%,CD47;SH3KBP1;NCKAP1L;CYRIB;HSPD1;TYROBP;NOD2;PYCARD;TNIP2;CCR2;PRKDC;CCL2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5813743453484013,1.2864376780972213,0.2052469135802469,0.8958198498623058,1.0,7/14,15.88%,MSN;PATJ;CDC42;OPHN1;EZR;RHOA;FSCN1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.49549823864213,-1.2861747891058866,0.18604651162790697,0.6435197527926817,1.0,4/13,7.59%,ERRFI1;CBLB;ZFYVE28;SOCS5
prerank,atrial septum morphogenesis (GO:0060413),0.6226422011183205,1.286073317020593,0.2106969205834684,0.895546705659855,1.0,2/10,7.30%,NOTCH2;TGFB2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5429425711424853,1.2849966743411012,0.18887262079062958,0.897894810330438,1.0,10/20,18.80%,MCU;MCUB;PMPCA;MICU1;AFG3L2;MCUR1;LETM1;SLC8B1;SPG7;STOML2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5288865040176496,1.2848239733009628,0.16405135520684735,0.8968285670847473,1.0,4/26,5.18%,SORBS1;OCLN;CREBL2;RHOQ
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4958917509123773,1.2842517627694774,0.16170763260025872,0.8974567376818506,1.0,18/44,18.58%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;SFRP1;ARHGEF10L;ITGB1BP1;CCDC88A;TESK1;ABL1;PFN2;FHOD1;ROCK2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.4504247001866958,-1.2837589058282246,0.16766467065868262,0.6481329751027333,1.0,12/18,27.67%,ST18;IL6R;JAK2;STAT3;IL6ST;SMAD4;SOCS3;YAP1;SPI1;CBL;FER;CEBPA
prerank,respiratory tube development (GO:0030323),-0.40713633740629185,-1.283706549692092,0.14444444444444443,0.6456182800588279,1.0,10/28,15.91%,PCSK5;GLI2;FGF2;FGFR2;LOXL3;NPHP3;RBP4;ZIC3;ABCA3;FGF9
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6053608887161558,1.2836154877911086,0.18883415435139572,0.8983262215981235,1.0,4/11,17.73%,UQCRC2;UQCRC1;UQCR11;UQCRH
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.587123449500699,1.2835429946596826,0.1974921630094044,0.8968243111145243,1.0,5/13,17.94%,DCTPP1;UPP2;MBD4;NEIL1;NT5M
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5543669514083935,1.283529185158101,0.18376722817764166,0.8950914176220282,1.0,6/20,12.19%,CNOT6;CELF1;MOV10;EIF6;MOV10L1;AJUBA
prerank,neuron apoptotic process (GO:0051402),-0.4523297784245435,-1.2834083947099075,0.1458966565349544,0.643847227749546,1.0,7/19,11.91%,FAS;FAM162A;BCL2;CIT;TNFRSF21;TRPC5;BID
prerank,DNA catabolic process (GO:0006308),0.6151683856288868,1.283139891252496,0.21112929623567922,0.8949436778842468,1.0,4/11,14.04%,XRN2;DNASE1L2;DNASE1L1;REXO4
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5285936076616047,-1.282194674349018,0.1732283464566929,0.644857304649879,1.0,3/11,11.72%,PID1;TFRC;ZDHHC6
prerank,response to organophosphorus (GO:0046683),-0.469481021711724,-1.2811833505444246,0.17101449275362318,0.6451050337677663,1.0,6/16,21.58%,TRPC3;ABCC9;RFC3;TYMS;DGKQ;VGF
prerank,actin filament capping (GO:0051693),0.5722400809944349,1.2809033937649141,0.16224188790560473,0.9004025900032937,1.0,6/18,6.37%,VILL;GSN;CAPZB;AVIL;TWF1;ADD1
prerank,barbed-end actin filament capping (GO:0051016),0.5722400809944349,1.2809033937649141,0.16224188790560473,0.9004025900032937,1.0,6/18,6.37%,VILL;GSN;CAPZB;AVIL;TWF1;ADD1
prerank,plasma membrane invagination (GO:0099024),0.5074779412851183,1.2804213622547602,0.16391184573002754,0.9005841851883877,1.0,9/29,15.90%,GSN;GULP1;CDC42;SNX33;SNX18;RHOA;DOCK1;VAMP7;ITGB2
prerank,positive regulation of lipid localization (GO:1905954),0.6116090886626169,1.2803021726978114,0.2028301886792453,0.8993105420645234,1.0,2/11,2.62%,ZC3H12A;IKBKE
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6201180198462884,1.2799363021933932,0.17944535073409462,0.8990506402636275,1.0,4/11,5.26%,MMP9;GSN;PRR7;PIH1D1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4086178441647615,-1.2798507742137955,0.125,0.646398679338127,1.0,5/24,5.04%,DMD;PDE4D;CAMK2D;JPH1;PKD2
prerank,in utero embryonic development (GO:0001701),0.5184783842279028,1.2797006414140621,0.18497913769123783,0.8982601147204506,1.0,4/25,8.43%,MBNL1;ADAM10;FUT8;PKD1
prerank,mitochondrial transport (GO:0006839),0.46009683395962625,1.279645819850486,0.15679012345679014,0.8967204921060656,1.0,25/53,25.69%,STARD3;PMAIP1;TIMM10;TIMM44;BCL2L1;TOMM5;BAD;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;SLC25A4;TMEM14C;SPG7;TIMM9;TOMM40;TSPO;FLVCR1;TIMM23;AIP;MAIP1;MTX2;ABCB10;FBXO7
prerank,positive regulation of ERAD pathway (GO:1904294),0.5841137674761205,1.2792248279665719,0.20483870967741935,0.8966863338148028,1.0,4/13,10.68%,CAV1;NFE2L2;TMEM259;BCAP31
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5938051593147537,1.2789391651043471,0.19516129032258064,0.8943556652220832,1.0,6/12,14.32%,HOMER2;HOMER3;RCAN1;CHP1;GSK3B;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5938051593147537,1.2789391651043471,0.19516129032258064,0.8943556652220832,1.0,6/12,14.32%,HOMER2;HOMER3;RCAN1;CHP1;GSK3B;ATP2B4
prerank,negative regulation of cell migration (GO:0030336),0.42191560724164884,1.278667651738506,0.10895361380798274,0.8937438355460602,1.0,16/137,5.17%,CDH1;PHLDB2;SRGAP3;SRGAP2;ADTRP;KANK1;EPHA4;DAG1;MAGI2;WNT11;FOXO3;DUSP10;TIMP1;PTPRU;DLC1;TMEFF2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5320394733330445,1.278423033785232,0.1774436090225564,0.8930053969610751,1.0,5/23,10.00%,UACA;ZC3H12A;PPM1B;PPM1A;NMI
prerank,cellular response to ketone (GO:1901655),0.49132670902624137,1.278387608317475,0.16688567674113008,0.8914379304193322,1.0,8/35,12.95%,CFTR;PTGFR;MSN;GOLPH3;ADCY6;ADAM15;AQP1;SFRP1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5873208832707885,1.2780744852917783,0.19365079365079366,0.8909579431163371,1.0,1/14,0.18%,AGTR1
prerank,defense response to bacterium (GO:0042742),0.43549038987942673,1.2780732102663948,0.14609286523216308,0.8892511271333557,1.0,25/105,17.39%,ANXA3;GALP;SLPI;MAVS;PGLYRP3;EPX;CFP;SHC1;ANG;LBP;ROMO1;STAB2;TLR6;RNASE3;PPP1R11;AQP1;ANKRD17;TLR4;FCER1G;PLA2G6;TLR3;MR1;OAS2;COLEC12;RNASE7
prerank,positive regulation of protein polymerization (GO:0032273),0.45868503841755814,1.2778493984792616,0.14303030303030304,0.8883798447198684,1.0,8/65,6.16%,BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;PSRC1
prerank,eye photoreceptor cell development (GO:0042462),0.5839214017942405,1.2777417965182578,0.1850079744816587,0.8871019885903092,1.0,2/15,3.12%,RP1;CRB2
prerank,regulation of endocytosis (GO:0030100),0.4486071995443361,1.2774063373357398,0.15042117930204574,0.8866833920608875,1.0,13/61,12.26%,RAB17;CDH13;SCAMP5;TSC2;STON1;CBLL1;GPC3;RUBCN;LGALS3;OPHN1;SNX33;EPHA3;SNX12
prerank,positive regulation of GTPase activity (GO:0043547),0.4122287387963764,1.2773234008854344,0.10564853556485355,0.8853585413861695,1.0,45/188,17.58%,ARHGAP42;MAPRE2;RTN4R;NTRK3;SRGAP2;ARAP1;CCL5;NGEF;PLXNB1;PKP4;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;GRTP1;TBC1D16;TIAM2;DOCK7;CAV2;ARHGAP29;CCDC125;DVL3;BCR;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;TBC1D1;ASAP3;SFRP1;RGS6;GSK3B;FLCN;HRAS;ARHGAP27;RAPGEF1;USP6NL;PRTN3;TBC1D22A;RAP1GAP;TBC1D10A;F2R;SLC27A4
prerank,positive regulation of chromatin organization (GO:1905269),0.5934124254860198,1.276929249350285,0.20903010033444816,0.8853182857462948,1.0,6/12,23.37%,DAXX;ATRX;UBE2N;H3-3A;TERF2;TINF2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.522964838106823,1.2767706764710371,0.19940915805022155,0.8842734962000365,1.0,2/24,2.09%,PRKCB;NIBAN2
prerank,carboxylic acid catabolic process (GO:0046395),0.5885438392246684,1.276684768548499,0.20100502512562815,0.8829210561751824,1.0,3/12,10.86%,ACOT8;NAGK;PON3
prerank,cholesterol metabolic process (GO:0008203),0.4571283687734828,1.276538691680594,0.14145141451414514,0.8818564584321882,1.0,19/68,18.49%,FDFT1;SOAT1;STARD3;SULT2B1;DHCR7;HMGCR;FDPS;INSIG1;PMVK;CYP51A1;MSMO1;FDX1;SOAT2;ACAT2;OSBPL5;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,rRNA transcription (GO:0009303),0.546647339208986,1.275849003460939,0.208398133748056,0.8830384696319648,1.0,10/17,24.77%,ANG;POLR1E;GTF3C3;SPIN1;GTF3C2;GTF3C5;GTF3C4;SIRT7;POLR1G;TCOF1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5325515141004052,1.2743375679066298,0.17620481927710843,0.8872130677673382,1.0,6/22,11.85%,SMARCB1;PIH1D1;UBTF;SMARCA4;WDR43;EIF2AK3
prerank,positive regulation of exosomal secretion (GO:1903543),0.5611667879076351,1.2733563007241921,0.2188976377952756,0.8894508279163424,1.0,8/15,18.11%,SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,positive regulation of phosphorylation (GO:0042327),-0.276925163646969,-1.2729569154853262,0.04,0.6643597443775199,1.0,67/240,13.47%,FLT1;IGF1;ROR1;PDGFRB;EPHA7;LEPR;IL34;ENG;TEK;INSR;PECAM1;LIMCH1;DAB2;PDE8A;MERTK;PELI2;ZBTB20;TNIK;LYN;HIF1A;VEGFC;AR;PTK2;GAS6;AXL;TIE1;GLMN;KDR;SLCO3A1;PDGFRA;FAS;THBS1;PRKAA1;FGF2;TFRC;EPHB2;FNIP1;EPHB4;LRRK2;IGF2;CRKL;TGFB1;NTRK2;BRAT1;ERBB4;ACVR2A;AXIN2;ROR2;FGFR2;KIT;ARRB1;RYK;IRGM;NCKAP1L;IGF1R;BTBD10;KNDC1;RIPK1;RACK1;CCN1;FGFR4;PIK3R3;FLT4;TBX1;ITGA6;EPHA5;RET
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3799571950110644,-1.2725352639565954,0.14444444444444443,0.6629984743545371,1.0,11/35,11.76%,FLT1;PTPRM;SULF1;NR2F2;XDH;THBS1;RGCC;ATOH8;PPARG;NF1;ATP5F1A
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.6029267065459111,1.2702067585483152,0.19778481012658228,0.9003139748299152,1.0,4/12,10.88%,CELSR1;LAMA5;ACTB;ACTG1
prerank,regulation of stem cell population maintenance (GO:2000036),0.5539544760996137,1.2701102962289776,0.2044776119402985,0.8989952701818911,1.0,5/18,13.67%,NCOA3;ESRRB;WDR43;PTN;MYC
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.522546558230747,1.2699005521348947,0.18301610541727673,0.898093391396774,1.0,14/23,24.63%,NABP2;ZFYVE19;PLK3;ZW10;VPS4A;PLK2;INTS3;ZWINT;WEE1;CDK5RAP3;NABP1;CHFR;PLK5;PABIR1
prerank,aerobic electron transport chain (GO:0019646),0.446495896259691,1.2698638606968224,0.14727722772277227,0.8965697925592493,1.0,25/68,21.62%,NDUFV1;NDUFB11;UQCRC2;NDUFB8;COX5A;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;NDUFAB1;AFG1L;COX5B;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.46354808950738385,1.2694744877456836,0.17970660146699266,0.8963795384940497,1.0,21/52,22.37%,SREBF2;BBC3;PMAIP1;PPP1R13B;BAD;FZD5;YWHAB;YWHAQ;SAE1;YWHAZ;VPS11;NPEPPS;RHOU;GSK3A;RNF31;E2F1;UBE2D3;YWHAH;FBXW7;ARIH2;MICALL2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5209963754463163,1.269112863471665,0.19781718963165076,0.8961418006497137,1.0,5/26,11.12%,CFTR;EFNA5;KLF7;CDK16;TRPM4
prerank,regulation of platelet activation (GO:0010543),-0.43390784583306713,-1.2688051640970475,0.17421602787456447,0.6718899875507663,1.0,4/21,3.96%,PLA2G4A;LYN;NOS3;PDGFRA
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5277893300922424,1.2684179037477776,0.19969742813918306,0.8972998575519557,1.0,3/21,7.63%,PRKCB;CD81;NFAM1
prerank,inner mitochondrial membrane organization (GO:0007007),0.46926239608055276,1.268338306129445,0.16881443298969073,0.8959330253030627,1.0,25/47,26.87%,TIMM10;CHCHD3;MICOS13;AGK;MICOS10;ROMO1;AFG3L2;LETM1;ATP5PF;OPA1;APOO;IMMT;MTX1;ATP5F1B;SPG7;TIMM9;ATP5PD;MTX3;MAIP1;ATP5ME;MTX2;ATP5MC3;ATP5F1C;ATP5F1D;NDUFA13
prerank,dendritic cell chemotaxis (GO:0002407),0.5847269473115737,1.2682455719397006,0.2081377151799687,0.8946412780208294,1.0,4/14,13.39%,CCL5;CXCR4;TRPM4;TRPM2
prerank,axon development (GO:0061564),-0.31722936485162917,-1.2675769854747898,0.06134969325153374,0.6728918825328419,1.0,28/78,18.19%,MAP1B;SEMA5A;DCC;PAK3;GRM7;NREP;ZDHHC17;BRSK1;NRCAM;CTNNA2;EPHB2;SLITRK1;S100B;DSCAML1;FGFR2;NTNG1;RYK;PLP1;MAPK8IP3;DRD2;DHFR;CAMSAP2;MAP1A;MTR;SLITRK3;EPHB3;ATL1;ARHGAP35
prerank,neurotransmitter transport (GO:0006836),-0.32490468059663774,-1.2672741259230382,0.09333333333333334,0.6711043703821473,1.0,14/73,10.07%,SLC1A3;UNC13B;NRXN1;LIN7A;SLC1A2;BRSK1;SLC1A1;SYT1;PPFIA2;SNAPIN;SLC29A1;APBA1;SNAP25;SLC17A6
prerank,regulation of protein localization to membrane (GO:1905475),0.5053309118197876,1.2663806140835434,0.18758620689655173,0.9001780985285617,1.0,8/28,13.39%,GPC6;GPC1;GSN;GPC4;GPC3;ACTB;VTI1B;VPS4A
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5677832803287864,1.266177583114632,0.18571428571428572,0.8992817991025391,1.0,6/16,14.15%,EP300;NAA40;AANAT;NAA15;NAA20;NAA10
prerank,regulation of cellular component organization (GO:0051128),0.41259382792821825,1.2661371994601573,0.11027837259100642,0.8978260436559857,1.0,36/135,18.88%,AGTR1;RAB17;CDH13;TJP1;RAP1B;MLLT3;RAP1A;SGK3;LTBP4;TSC2;ROS1;STON1;HCFC1;EGLN2;SSRP1;LATS1;DCUN1D5;OPHN1;SOCS2;BCAR1;SNX12;MARK4;OGFR;CHPT1;RAB5C;NEDD4;RAPGEF1;RAB33B;HSP90AA1;ABL1;PACSIN1;PTPN11;PRKCQ;PARK7;ROCK2;STK38L
prerank,inositol lipid-mediated signaling (GO:0048017),0.4666970333003673,1.2658216021107387,0.18773466833541927,0.8974825824937105,1.0,13/50,11.74%,PITPNM2;FGFR1;PLCB3;PLCL2;OGT;PLCD3;NGF;PIK3C2B;PLCL1;PI4KA;EZR;RHOA;IRS2
prerank,glycolipid biosynthetic process (GO:0009247),0.48714416879997485,1.2653821798815448,0.15064935064935064,0.8975586099184756,1.0,10/38,14.92%,ST3GAL4;PIGU;SCCPDH;A4GALT;LARGE1;PIGZ;PGAP2;PIGA;DPM2;PIGN
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6163017289043705,1.2650909630812068,0.21833333333333332,0.8970892794904555,1.0,5/10,22.03%,OGT;ZNF692;PDK2;SDHAF3;SIRT7
prerank,intestinal lipid absorption (GO:0098856),0.5966691961005859,1.2649368419116485,0.21359223300970873,0.896072112235099,1.0,2/11,9.05%,LDLR;SOAT2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.44683728012407026,1.2647859524550629,0.1354292623941959,0.8950477454767195,1.0,20/65,20.76%,FBXL7;FHL1;NABP2;PSMD11;AVEN;PSMD4;PSMF1;ZFYVE19;RBX1;PSMD7;PSMB5;PINX1;VPS4A;INTS3;PSMD1;PSMC4;CDK5RAP3;PSMD8;NABP1;CHFR
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.39859848002595477,1.2646242968079349,0.05236656596173213,0.8940978072685111,1.0,42/348,8.60%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;ANKRD31;SMO;HPN;OCLN;GSN;MAGI2;ZC3H12A;WNT11;CELF1;NGF;WNT6;NFE2L2;OLFM1;RBMS3;OVOL2;MOV10;HOXA5;KRAS;HCFC1;SOX9;FOXD1;ZBTB7B;DDRGK1;MSN;ANXA2;ANK3;MAPK7;BMP4;FGF22;MAPK9;MAZ;POU3F1
prerank,positive regulation of phagocytosis (GO:0050766),-0.3492919848741351,-1.2643326644646269,0.1308411214953271,0.6777906642796006,1.0,10/47,13.49%,PTPRJ;CD47;MERTK;GAS6;IL15RA;APPL2;GATA2;NCKAP1L;LMAN2;CAMK1D
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5501655593700274,1.2640945922980775,0.20574886535552195,0.8946353477501354,1.0,2/18,3.93%,AGTR1;GDNF
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5532997629850465,1.2637824393426365,0.2175925925925926,0.8942387754977997,1.0,8/16,25.91%,ST3GAL4;ALOX5;RHOA;IRAK1;ITGB2;NFAT5;IL6;RELA
prerank,regulation of ossification (GO:0030278),0.48694040367350927,1.2637616708402921,0.18085106382978725,0.8927165927260967,1.0,11/36,14.13%,ANKH;SMAD6;SGMS2;ZBTB16;SOX9;BMP4;TGFB2;TWIST1;PTN;SFRP1;MEF2C
prerank,positive regulation of wound healing (GO:0090303),0.4910230411754771,1.263521691062533,0.1842456608811749,0.8919901033623228,1.0,9/36,14.62%,KANK1;ST3GAL4;OCLN;FOXC2;DMTN;ACTG1;RREB1;ARFGEF1;HRAS
prerank,Golgi ribbon formation (GO:0090161),0.591665629739219,1.2631492739757568,0.22098569157392686,0.891918458746249,1.0,7/13,19.80%,GOLPH3;GCC2;STX16;FHDC1;TMED5;VTI1A;MYO18A
prerank,reverse cholesterol transport (GO:0043691),0.584072661822719,1.2628432996920589,0.21786833855799373,0.8915403734583418,1.0,1/13,0.41%,CLU
prerank,positive regulation of hemostasis (GO:1900048),0.6125720337949625,1.2627124430915122,0.23089430894308943,0.8888653004519177,1.0,2/10,6.32%,ST3GAL4;DMTN
prerank,positive regulation of coagulation (GO:0050820),0.6125720337949625,1.2627124430915122,0.23089430894308943,0.8888653004519177,1.0,2/10,6.32%,ST3GAL4;DMTN
prerank,phospholipid homeostasis (GO:0055091),-0.5089274464314373,-1.262292539708711,0.21173469387755103,0.6814237739545704,1.0,2/11,6.66%,ABCA1;RCN3
prerank,regulation of TORC1 signaling (GO:1903432),0.4901542571068954,1.2622735627570996,0.19215155615696888,0.8890584198710814,1.0,8/33,16.23%,RNF152;SESN2;PIH1D1;SIK3;SMCR8;KPTN;FLCN;SESN1
prerank,response to estrogen (GO:0043627),0.5038935015960007,1.2621785558753325,0.19099590723055934,0.8878689757419307,1.0,9/31,18.50%,KRT19;CAV1;EP300;TRIM25;BCAS3;SFRP1;GATA3;SFR1;RARA
prerank,regulation of dendritic spine development (GO:0060998),-0.44066669782492335,-1.2619419186754568,0.15339233038348082,0.6797714243131557,1.0,9/19,23.73%,SHANK3;TANC2;PPFIA2;NLGN1;KIF1A;DLG5;ARF6;FMR1;GRIN3A
prerank,protein import into mitochondrial matrix (GO:0030150),0.5420929825489299,1.2619112412147269,0.19089574155653452,0.8873023686880797,1.0,9/18,22.46%,TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4055776237826634,-1.2615606357069935,0.16300940438871472,0.6782157361812049,1.0,6/26,8.09%,POR;HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5553434954263767,1.260939202595519,0.20820668693009117,0.8896372107881838,1.0,3/16,10.09%,NUPR1;ABCD1;COX7A2L
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3765442964486255,-1.2607256213018099,0.12598425196850394,0.6781385572360232,1.0,11/35,9.70%,PDE7B;IRAG1;KSR1;PDE3A;RAPGEF2;PDE4D;GUCY1B1;CAP2;ADCY1;PDE9A;PDE2A
prerank,regulation of glucose metabolic process (GO:0010906),0.48827620315213116,1.2604067282670512,0.1865771812080537,0.8900454611755085,1.0,8/34,12.73%,OGT;RORC;PMAIP1;ZNF692;RUBCNL;PDK2;IRS2;FOXK1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.47252408049622463,-1.2602784583149294,0.17079889807162535,0.6768581107954478,1.0,7/13,27.87%,DDIT3;TMSB4X;SOX11;HEY2;HEY1;SIN3A;TAF1
prerank,spliceosomal complex assembly (GO:0000245),0.46499280147679733,1.2601282431937535,0.17571059431524547,0.8896070861216662,1.0,18/46,22.16%,CELF2;CELF1;DDX39B;LUC7L3;USP39;SRPK2;KHDC4;SF3A2;SRPK1;SRSF9;LUC7L2;PRPF19;PRPF6;SRSF1;SRSF5;SF3A3;PUF60;DDX23
prerank,lipid oxidation (GO:0034440),0.5917528731993029,1.2597950141517034,0.2190923317683881,0.8893326433789555,1.0,2/12,5.15%,PPARGC1A;ALOX5
prerank,connective tissue development (GO:0061448),0.4983245607404373,1.2589439459199199,0.1864864864864865,0.8910289983155005,1.0,8/35,8.43%,CD44;ITGB8;RORC;ZBTB16;SOX9;DDRGK1;DYRK1B;PKD1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.48566482821815843,1.2586998844299784,0.20565552699228792,0.8904153249667005,1.0,9/35,14.43%,NR3C2;DAXX;DDX5;RBFOX2;EGLN2;KDM3A;CALCOCO1;UBR5;NEDD4
prerank,eosinophil migration (GO:0072677),0.5708827435229961,1.2581973395137112,0.21087314662273476,0.8892084591842888,1.0,2/14,8.46%,CCL5;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),0.5708827435229961,1.2581973395137112,0.21087314662273476,0.8892084591842888,1.0,2/14,8.46%,CCL5;LGALS3
prerank,neuromuscular synaptic transmission (GO:0007274),0.548292159891772,1.2579740700362458,0.2,0.8885469613926077,1.0,4/18,6.87%,FCHSD2;STAC3;FCHSD1;KIF1B
prerank,cardiac muscle cell contraction (GO:0086003),-0.43816081676277374,-1.25795524046945,0.15454545454545454,0.6814930496780847,1.0,7/19,15.51%,CACNA1C;CAMK2D;KCNJ2;CACNA1G;FGF12;SCN1A;SCN1B
prerank,regulation of viral release from host cell (GO:1902186),0.5187434824203467,1.2579331563525593,0.19658119658119658,0.8871367723622658,1.0,10/21,18.11%,TRIM25;VPS37B;TRIM21;PML;TRIM11;TRIM26;VPS4A;CHMP2A;DDB1;TSG101
prerank,DNA alkylation (GO:0006305),0.5365691843936298,1.2572108440691314,0.2055393586005831,0.8868982778776361,1.0,9/19,25.56%,FOS;BEND3;ATRX;DNMT3A;PPM1D;KMT2E;BAZ2A;TEX15;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),0.5365691843936298,1.2572108440691314,0.2055393586005831,0.8868982778776361,1.0,9/19,25.56%,FOS;BEND3;ATRX;DNMT3A;PPM1D;KMT2E;BAZ2A;TEX15;EHMT1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.39022055410918727,-1.2570345665184153,0.152,0.6814431361162983,1.0,11/33,20.05%,LEF1;IL34;RUNX1;ID2;HSF1;TRAF6;RIPK1;CD74;CTNNBIP1;CSF1;FES
prerank,negative regulation of cellular process (GO:0048523),0.3895283641900364,1.2559428975018323,0.036072144288577156,0.8902987747968231,1.0,117/521,15.86%,WNT16;CDH13;CLU;ZBTB7C;ANGPT1;PTPN14;IGFBP6;SRGAP2;WNT1;KLF4;COL4A3;PLXNB1;PODXL;CDKN1A;ADAM10;SMAD6;NIBAN2;CD200;PLXNA2;CCN2;MAGI2;NUPR1;WNT11;CDK10;CELF1;CDK6;FHL1;SULT2B1;NGF;PTK2B;KANK2;TNFRSF8;SESN2;PPP2CA;BMP5;EPO;PPP1R13B;PTPRU;DLC1;RIPOR2;ALOX5;FBLN1;S100A11;CRYAB;CD9;DUSP1;RARG;TSC2;SH3BP4;PSRC1;FOXM1;ZBTB17;TES;MUL1;CGREF1;BMP4;CBLL1;OSGIN2;TGFB2;TGFB1I1;ERBB3;SLURP1;NLRP2B;CHMP4B;FBXO5;ADAMTS1;PTPN6;NDUFS3;PML;FOXP3;BRD7;DACT2;CASK;APBB1;ABI1;NMI;RAF1;SOD2;ADAM15;SMARCA4;GSDME;VPS4B;EIF2AK3;WDR6;CDKN2AIP;PTPN2;PDPN;RASA1;LPCAT3;PPM1D;EEF1E1;PLXNB2;SFRP1;MYBL1;GATA3;PINX1;CHMP1A;CAPRIN2;MYC;ING4;BTG2;PRDM11;DUS2;ITGB1BP1;BNIP3L;TGFBR3;FLCN;HRAS;P3H3;LMNA;SYT11;ARHGDIB;CHMP2A;IP6K2;FRZB;PRTN3;PLXNA3
prerank,cellular response to drug (GO:0035690),-0.4086046208729412,-1.2559116191363369,0.13993174061433447,0.6824156877496825,1.0,6/25,10.14%,ACER2;GAS6;AIM2;TFRC;PDE4B;TP53
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.493928311711469,1.2551916462781452,0.20080321285140562,0.8915229423446287,1.0,8/33,9.14%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PLK3;BRD7
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3689702983531444,-1.2551483094313627,0.10683760683760683,0.681997307016707,1.0,12/41,13.79%,ITPR1;SLC8A1;SLC8A3;GRIN2A;PKD2;FGF2;GRIN2B;SLC24A2;CHERP;DRD2;RYR2;HTR2A
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6002106485391491,1.2548220661845089,0.21428571428571427,0.8914096988253838,1.0,2/10,4.73%,SMOX;DMGDH
prerank,regulation of calcium ion import (GO:0090279),-0.43518547491357373,-1.2547819295167695,0.1588785046728972,0.6804208773152017,1.0,5/21,17.53%,PDGFRB;CXCL12;PKD2;SLC30A1;EGF
prerank,positive regulation of hydrolase activity (GO:0051345),0.4165439422255182,1.2546190829936024,0.12140575079872204,0.8906193177462308,1.0,30/137,15.99%,MAPRE2;RTN4R;SRGAP2;ARAP1;CCL5;PLXNB1;PKP4;CD200;WNT11;NDEL1;RAP1A;S100A10;CAV2;DVL3;BCAS3;SNX18;SGSM2;RAPGEF3;RHOA;ASAP3;SFRP1;RGS6;GSK3B;FLCN;HRAS;ARHGAP27;RAPGEF1;USP6NL;PRTN3;CTSH
prerank,microtubule-based transport (GO:0099111),0.5754927950742833,1.2545787856073778,0.219435736677116,0.8892312254651753,1.0,3/12,15.38%,DYNC1I1;SPAG17;ADCY10
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5099558284520039,1.2544605298781135,0.20256776034236804,0.8881028395522353,1.0,5/25,8.10%,ATP6V1B1;CAV1;SELENON;ANK3;JPH2
prerank,import into cell (GO:0098657),-0.35438233127291346,-1.2541897446640444,0.11297071129707113,0.679562230076909,1.0,9/41,10.94%,SLC1A3;SLC6A13;LRRC8C;SLC47A1;SLC7A5;SLC6A6;SLC29A1;SNAP25;LRRC8A
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5162739945912436,-1.2541024621062107,0.2164705882352941,0.6771890195741738,1.0,5/10,34.05%,LYN;KIT;CD40;FGR;LILRB1
prerank,gland development (GO:0048732),0.44734207344291854,1.2533550204858845,0.17493796526054592,0.8908316629682266,1.0,12/59,9.98%,COBL;IGSF3;WNT10A;WNT11;CAV1;STRA6;NKX2-8;SOX9;MSN;LSR;SIX1;EZR
prerank,protein oxidation (GO:0018158),-0.5205075508879765,-1.253285902398144,0.2236842105263158,0.676930906753199,1.0,4/11,12.28%,LOXL1;TMX3;LOXL3;LOX
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.43613851105964563,1.2523008571536645,0.15186915887850466,0.8933176633027226,1.0,9/86,6.16%,CLU;BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;PSRC1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5431226414164232,1.252098814496864,0.22503725782414308,0.8925153660128633,1.0,12/18,24.24%,CTNNA1;OTUD7B;LATS1;CHP1;GSK3B;FLCN;UFM1;SUFU;ILRUN;RAB23;LATS2;APOD
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.44010970719643006,1.2516323684046573,0.16666666666666666,0.8928174645458293,1.0,25/69,21.62%,NDUFV1;NDUFB11;UQCRC2;NDUFB8;COX5A;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;NDUFAB1;AFG1L;COX5B;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,negative regulation of type I interferon production (GO:0032480),0.4643658910237684,1.2514659917412003,0.1934640522875817,0.8919948572569933,1.0,6/40,5.66%,IKBKE;MAVS;RELB;PPM1B;TRIM25;IRF3
prerank,regulation of synapse organization (GO:0050807),0.5101241020219316,1.2511488092813254,0.21212121212121213,0.8916711530082426,1.0,3/26,1.68%,RAB17;PDLIM5;EPHA4
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5471628156058559,1.2508143692749987,0.23318385650224216,0.8914898086482997,1.0,6/17,17.73%,CD44;YJU2;TWIST1;MDM2;KDM1A;ARMC10
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4873289323424972,-1.2502376598183342,0.21842105263157896,0.6836889450758559,1.0,11/12,38.56%,EPHB2;B4GALT5;ARHGAP35;HSP90AB1;MYCBP2;PTEN;EPHB6;EPHB1;CHRNB2;B4GALT6;SPTBN4
prerank,chondrocyte differentiation (GO:0002062),-0.38144776560880106,-1.2500644478347305,0.17073170731707318,0.6816574642525173,1.0,10/32,14.85%,SOX5;SULF1;BMPR1B;RUNX2;RUNX1;TGFB1;HMGA2;CCN3;BMPR2;SOX6
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.4562427960522767,-1.2495221057722392,0.19658119658119658,0.6806363202637559,1.0,4/17,15.04%,PDE3B;PRKAA1;MFSD2A;SORL1
prerank,negative regulation of translation (GO:0017148),0.426700837643411,1.2492416598856713,0.16342857142857142,0.8959779246729815,1.0,26/87,19.26%,SAMD4A;CPEB2;YTHDF1;CELF1;SAMD4B;EPRS1;DAPK3;DAPK1;UNK;EIF4A3;EIF4EBP1;SHMT1;EIF2AK3;SYNCRIP;CPEB3;FXR1;BTG2;GAPDH;MEX3D;IGF2BP1;IGF2BP2;EIF2AK4;YTHDF3;ROCK2;IGF2BP3;EIF4EBP2
prerank,fatty acid catabolic process (GO:0009062),0.4443357411934653,1.2491181364666015,0.16132858837485173,0.8948960328495195,1.0,21/67,18.84%,ADTRP;ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;PECR;MTLN;HADHA;ACAT2;PCCA;CPT2;SLC25A17;ECI2;ACADM;AUH;HADHB;ILVBL;SLC27A4;ECHS1;PEX2
prerank,positive regulation of cell population proliferation (GO:0008284),0.39106155972043416,1.2470688328545811,0.044221105527638194,0.9014492304075867,1.0,58/423,9.00%,FN1;DPP4;CDH13;FGFR1;CRLF1;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;PDGFC;EFNB2;CDKN1A;GRK5;ADAM10;EMP2;S100A6;IL15;CDK6;PDF;CD81;PTGFR;TNFSF13;PTK2B;NOP2;GDNF;BMP5;HDAC4;GCNT2;CLCF1;TIMP1;EPO;CIAO1;DOT1L;NACC1;CDK4;RPS4X;FOXM1;KRAS;SOX9;DDRGK1;SHC1;MAPK15;BMP4;TGFB2;CCND2;ERBB3;BAD;ROMO1;LAMC1;FGF22;FBXO5;TCF7L2;MAZ;PTPN6;SSR1;IL7R
prerank,collagen fibril organization (GO:0030199),0.4304577142379668,1.2469497243547056,0.16040955631399317,0.9003634324726323,1.0,10/88,4.66%,ITGB4;ADAMTS14;COL23A1;COL25A1;LAMC2;COL4A3;COL4A4;COL5A2;COL6A1;COL6A3
prerank,cellular component assembly (GO:0022607),0.39706094772697803,1.2465612750719612,0.09763617677286741,0.900437252071189,1.0,45/253,12.23%,REPS2;BAIAP2L1;RP1;PAWR;PPARGC1A;CALD1;PARVA;OCLN;GSN;YTHDF1;LIMS2;EPRS1;PTK2B;BSN;RHOQ;ESPN;ELOB;RTN3;SYCP2;DMTN;ADD1;SOX9;ANK3;ZFYVE27;ILK;MICAL1;AFG3L2;LAMC1;CDC42;GPAA1;CFAP206;PARD6B;OPHN1;PML;KMT2A;GRHL2;PCLO;TLCD2;ACTB;EZR;ACTG1;ZW10;RHOA;YWHAZ;WASF1
prerank,regulation of cytoskeleton organization (GO:0051493),0.42085378208357077,1.2460109792019642,0.16017797552836485,0.9011223584518645,1.0,19/108,11.68%,PHLDB2;PRKAA2;CELSR1;TJP1;PLXNB1;ARHGAP18;CDK10;DIAPH1;MAP6;DLC1;RHOQ;EFNA5;DMTN;CAPN2;IQGAP1;ARHGEF5;EZR;EPHA3;RHOA
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4815554861811361,1.2459106420555066,0.2018716577540107,0.8999971850800076,1.0,8/33,13.07%,KLF5;KLF4;FOXO3;FOS;TGFB2;JUN;SMARCA4;GATA3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.47694728193893965,-1.2450598260725576,0.18133333333333335,0.6917479384649096,1.0,6/13,23.65%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4605430904779184,-1.2450465882115498,0.20294117647058824,0.6891909167602824,1.0,6/14,22.90%,ENTPD1;NUDT1;ENTPD3;ENTPD5;ENTPD6;NUDT16
prerank,nerve growth factor signaling pathway (GO:0038180),0.5954454006862722,1.24501484543508,0.22644628099173553,0.902057515350769,1.0,3/10,3.27%,MAGI2;RAP1A;NGF
prerank,signal transduction in response to DNA damage (GO:0042770),0.45898110909648143,1.2449686573617726,0.185785536159601,0.9007317294892817,1.0,17/49,18.10%,WNT1;NDRG1;SESN2;DOT1L;USP10;ATRX;DONSON;USP28;E2F1;CDC5L;ATR;PRPF19;ABL1;HINFP;NBN;CHEK2;TRIAP1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.583985756111207,1.2449284648585617,0.2448,0.8994137318892923,1.0,2/12,3.62%,NOTCH2;PTK2B
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.6053031131305733,1.2445667547956676,0.23076923076923078,0.8992979521913546,1.0,2/11,1.32%,TJP2;TJP1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5222735022509881,-1.2444226679482528,0.21608040201005024,0.6885608558718682,1.0,4/10,4.73%,RAPGEF2;CD34;KDR;TMEM100
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5300053917907253,1.2443693470261759,0.22953216374269006,0.8985838200713545,1.0,9/22,15.12%,NTRK3;MAGI2;RAP1A;NGF;EHD1;RAB35;WASF1;SH3GL2;RAPGEF1
prerank,chemical synaptic transmission (GO:0007268),-0.260722409619556,-1.2441641409886173,0.0,0.6867838267088524,1.0,82/284,21.10%,PDE7B;SLC1A3;UNC13B;GRIK2;KCND2;NRXN1;NOVA1;GRID2;LIN7A;CACNA1E;GRM3;GRM7;GABRG3;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;SHISA6;PTCHD1;BRSK1;DLGAP1;SLC1A1;SYT1;RIT2;CDH8;GRIN2B;GABRB1;GRM5;GRIK3;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;SLC6A1;LRP6;CHRM3;TBC1D24;SNAPIN;PLP1;PRKAR2B;APBA1;SNAP25;SLC17A6;DTNA;HCRTR2;MBP;GRIK4;GRIK1;GABRA3;DRD2;NLGN3;GLRA3;HTR2A;AMPH;GLRA2;GABRB2;KCNMB4;CHRM2;MPZ;GRM1;KCNQ3;GABRA1;NPTX1;PRKAR1B;RPS6KA1;GABRE;OPRK1;RPS6KA3;CACNA1B;GLRB;KCNK3;HRH1;GRIA4;RIMS1;GRIK5;GABARAP;KCNIP2;SYT10
prerank,positive regulation of B cell proliferation (GO:0030890),0.4966954685462349,1.2441379537417552,0.20028011204481794,0.8979603142923634,1.0,4/29,4.27%,NFATC2;SASH3;CD81;CLCF1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5581565331839038,1.244097509790811,0.22518518518518518,0.8966058326653018,1.0,1/17,0.66%,ANK2
prerank,reticulophagy (GO:0061709),0.5820501233100989,1.2439792759059458,0.24469820554649266,0.8955744721691445,1.0,5/12,16.39%,DDRGK1;TEX264;ULK1;RB1CC1;UFM1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6009496828406987,1.2435416881596766,0.21794871794871795,0.8957228130989415,1.0,1/10,1.08%,ACTN2
prerank,positive regulation of cell differentiation (GO:0045597),-0.27388670944624655,-1.2431669524804696,0.04,0.6875338158828638,1.0,51/237,10.45%,TCF4;PLCB1;BMP6;SOX5;IGF1;ZEB1;LEF1;PRKD1;PRKCH;RAPGEF2;COL1A1;CDH2;DAB2;KITLG;WNT4;BOC;ZHX3;MEDAG;VWC2;AR;ACVRL1;CD34;KDR;SLC6A6;TMEM100;BMPR1B;RUNX2;IL18;BRINP3;NRCAM;CTNNA2;RGCC;PPARD;PKDCC;TGFB1;IL6R;FBN2;EZH2;ID2;GLIPR2;ACVR2A;NUDT21;AXIN2;TIAM1;LRP5;HEYL;PPARG;IMPACT;BTG1;CCN4;BEND6
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5871418612787314,1.2430190196695827,0.23348694316436253,0.8960741036515797,1.0,3/13,9.00%,BMP5;ERLIN2;ERLIN1
prerank,cGMP metabolic process (GO:0046068),-0.5051721739437784,-1.2426591406757916,0.1908831908831909,0.686550591551345,1.0,5/12,10.08%,GUCY1B1;GUCY1A1;PDE9A;PDE2A;NPR1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.4682458142875912,1.242234614967693,0.20546163849154747,0.8975256210130494,1.0,5/39,6.93%,FGF13;UTRN;SLMAP;STK39;ANK3
prerank,regulation of protein kinase A signaling (GO:0010738),-0.42361913389912315,-1.242064714423803,0.19148936170212766,0.6858031241333857,1.0,7/20,19.62%,ADGRV1;LRRK2;PRKAR2B;TCIM;PRKAR1B;AKAP7;MIF
prerank,regulation of protein autophosphorylation (GO:0031952),-0.36206190902018665,-1.242009875721365,0.12350597609561753,0.6834562838129238,1.0,5/36,2.15%,ERRFI1;EPHA7;PDGFD;ENG;ENPP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.5496075228018917,-1.24130658503782,0.21980676328502416,0.683025605095769,1.0,4/10,16.42%,ESR1;PSMC6;TP53;HMGB1
prerank,morphogenesis of an epithelium (GO:0002009),0.5048572549124406,1.2397707997773886,0.2053072625698324,0.9054774538811444,1.0,6/25,10.88%,DAG1;WNT10A;LAMA5;SOX9;ACTB;ACTG1
prerank,regulation of neurogenesis (GO:0050767),-0.3298140730389714,-1.2396730035026444,0.12698412698412698,0.6855547330279468,1.0,19/55,23.32%,TGM2;NOTCH1;APPL2;B2M;SERPINF1;HEYL;PRUNE1;MME;BHLHE40;SORL1;SOX11;OPRM1;NUMB;HEY2;CX3CR1;CX3CL1;HEY1;YAP1;YTHDF2
prerank,positive regulation of autophagy (GO:0010508),0.4305090898168167,1.2391524707314356,0.1674364896073903,0.9063474739417188,1.0,23/81,16.23%,RNF152;PRKAA2;TPCN1;ZC3H12A;FOXO3;SESN2;DAPK1;MTDH;ORMDL3;TSC2;SH3BP4;TRIM21;BAD;PLK3;TFEB;GSK3A;GSK3B;ULK1;BNIP3L;FLCN;PLK2;IKBKG;SESN1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5412882848196696,1.2383568398740892,0.22767857142857142,0.9078291548131875,1.0,3/16,4.00%,IGFBP6;WNT1;BMP5
prerank,detection of calcium ion (GO:0005513),-0.47673439550868246,-1.2377554924640202,0.2116991643454039,0.688813830051545,1.0,6/13,21.89%,STIM1;SYT1;RYR2;KCNMB4;KCNIP2;CASQ2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3998093237586755,1.236919918398449,0.11490683229813664,0.9117616647503911,1.0,20/198,8.56%,PLPPR2;PLB1;NUDT4;PLCB3;LIMK2;PLCD3;DUSP10;HKDC1;PTPRD;PFKP;DUSP12;INPP4A;IP6K1;SLC20A1;AGK;PFKFB2;NADK;PPIP5K2;PPM1A;PI4KA
prerank,chordate embryonic development (GO:0043009),0.44896790894386046,1.2362142233045113,0.20248447204968945,0.9129954177357635,1.0,9/55,9.05%,MBNL1;KIAA1217;FGFR1;ADAM10;WNT11;BMP5;FUT8;PKD1;GRHL2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.5208088197389089,-1.2360326023905706,0.21,0.6913074204048811,1.0,6/10,30.86%,SACS;DNAJB2;SORL1;DNAJB1;HSPA1B;HSPA2
prerank,neuromuscular process controlling balance (GO:0050885),-0.4826276701535878,-1.235428681467019,0.23306233062330622,0.6906022509488888,1.0,4/12,15.24%,NRXN1;PCDH15;TPP1;CLN3
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4313554193589967,1.235222657208115,0.1839080459770115,0.915332055167017,1.0,11/74,10.54%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;RBX1;PSMD7
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4384551411777425,1.2349852573471005,0.18842364532019704,0.9147472767911405,1.0,11/54,10.20%,GPC6;GPC1;HEXA;GPC4;GCNT2;NAGLU;SDC4;GLB1;GPC3;EXT1;GUSB
prerank,dendrite morphogenesis (GO:0048813),-0.3635934954904375,-1.2347482721457792,0.1259259259259259,0.690297415549626,1.0,9/35,8.57%,FARP1;MAP2;SHANK3;DOCK10;PAK3;DCDC2;CTNNA2;EPHB2;SDC2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4715595178302361,-1.234070446767662,0.2193877551020408,0.6898515330487794,1.0,13/14,52.89%,IL18;IL17D;PAEP;CD84;CD80;RASGRP1;ISL1;CARD9;IL23A;IL12B;IL23R;IL17F;IL1B
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5842493785832701,1.233954735229414,0.23697478991596638,0.9173260372997125,1.0,3/12,5.98%,B4GALNT2;GFUS;FUT8
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.43596770828469444,1.2333499480243395,0.19588875453446192,0.9181391813062684,1.0,6/63,4.27%,NFATC2;CCL5;SASH3;IL15;CD81;CLCF1
prerank,protein tetramerization (GO:0051262),-0.3212282017781771,-1.2330610063961134,0.11875,0.6904399385302293,1.0,21/67,15.29%,ALDH1A2;PKD2;OXA1L;APPL2;GBP5;KCNJ2;GRIN2B;HPRT1;UPB1;B2M;MCOLN1;SAMHD1;NUDT21;AQP4;ALDH9A1;CPSF6;KCNJ12;GOLGA2;CBY1;KCNC1;ACACB
prerank,cellular response to interleukin-15 (GO:0071350),-0.47611496162027583,-1.232910126097755,0.21951219512195122,0.6859608243970076,1.0,6/13,12.63%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.47611496162027583,-1.232910126097755,0.21951219512195122,0.6859608243970076,1.0,6/13,12.63%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5090652440977084,1.2328267293762245,0.2239884393063584,0.918589062627571,1.0,8/23,17.42%,NUPR1;EP300;HDAC4;TIGAR;NCOR1;GSK3A;PGP;GIT1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5865509995785608,1.2326390223318024,0.2545454545454545,0.9178308865655129,1.0,6/11,27.68%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,positive regulation by host of viral transcription (GO:0043923),0.5610935479348971,1.2326169312104869,0.23630672926447574,0.9164420838675625,1.0,6/15,12.43%,HPN;EP300;SMARCB1;JUN;SMARCA4;SP1
prerank,regulation of primary metabolic process (GO:0080090),0.40330522509304545,1.2325606560995142,0.15151515151515152,0.9151806312994818,1.0,39/126,20.69%,LDLR;FDFT1;SREBF2;DHCR7;HMGCR;FDPS;PSMD11;PMVK;RUBCNL;PSMD4;PSMF1;AZIN1;CYP51A1;ELOVL6;HDAC3;PSMD7;NFYC;FASN;CERS2;NCOR1;GPAM;ACACA;IRS2;SP1;PSMB5;NCOR2;SQLE;PSMD1;TM7SF2;HMGCS1;PSMC4;ROCK2;PSAP;PRKAB1;PSMD8;SREBF1;OPA3;PRKAB2;ABCA7
prerank,regulation of macromolecule metabolic process (GO:0060255),0.4024906520061743,1.2323694956096722,0.14210526315789473,0.9144332500188612,1.0,41/170,19.65%,CDH1;PRDM6;TRIM60;LDLR;ZC3H12A;CDK6;AFF3;TBC1D16;CGGBP1;GDNF;YBX3;TRIM44;CDK4;TRIM21;TOB2;NKAP;TRIM11;TRIM26;TXK;MTMR3;KDM6A;RASA1;TFEB;TCF19;CDK2;CIAO3;MYC;PRDM11;FOXP1;ADNP;IGF2BP1;HMG20B;HINFP;IGF2BP2;CAVIN4;ZNF462;ROCK2;IGF2BP3;FLOT1;APP;PCBP2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.581478879335218,1.2323285796089658,0.24960505529225907,0.9131210996635938,1.0,6/12,22.86%,PTPN14;BMP4;NEDD4;AAAS;SIRT7;TPR
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5066902432131427,1.2322006848321254,0.21807747489239598,0.9121847877236055,1.0,1/25,0.15%,CD55
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5092450490668737,1.23213234265758,0.20784883720930233,0.9109623838039973,1.0,4/21,8.63%,WNT1;CAV1;DVL3;FZD5
prerank,motor neuron axon guidance (GO:0008045),0.5657140596202286,1.2314706768877461,0.23952095808383234,0.9121059298457388,1.0,2/15,1.68%,LAMC2;EPHA4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5908701551799088,1.2313528028278262,0.2521440823327616,0.9110748846738861,1.0,4/10,14.18%,EMC9;EMC10;EMC6;EMC2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.48022606226255465,-1.2311929983790824,0.2204724409448819,0.6888972241888236,1.0,3/12,3.65%,PDE4D;GJD3;CAMK2D
prerank,linoleic acid metabolic process (GO:0043651),0.5451497134697958,1.23103226748543,0.21766561514195584,0.91084474858673,1.0,6/17,19.51%,ABCD1;ELOVL1;ALOX5;FADS1;GSTM2;FADS2
prerank,regulation of lymphocyte activation (GO:0051249),0.574980988868681,1.2309795735412732,0.23567921440261866,0.9095844203044193,1.0,1/12,1.40%,CCL5
prerank,positive regulation of T cell proliferation (GO:0042102),-0.32840139740771945,-1.2309788572918303,0.12626262626262627,0.6871308329600712,1.0,11/55,12.46%,IGF1;IGFBP2;NCK2;VCAM1;IL18;TFRC;IGF2;CD46;NCKAP1L;PNP;IL6ST
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4433685450398026,1.2308033225348927,0.1791767554479419,0.9088013275638155,1.0,10/62,8.99%,PRKCB;CDK6;EP300;PTK2B;ZBTB16;MOV10;HOXA5;EIF6;LGALS3;KMT2A
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42355410356962064,1.2306647808072944,0.1674259681093394,0.9078218811783619,1.0,25/87,20.36%,FBXL7;KLF4;CDKN1A;CDK6;FHL1;KANK2;PSMD11;CDK4;AVEN;PSMD4;PSMF1;FBXO5;RBX1;BRD7;PSMD7;PSMB5;PINX1;CDKN2D;PSMD1;WEE1;GPNMB;PSMC4;PSMD8;PRMT2;RB1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4171991599212289,1.2305470040562259,0.175,0.9068582551018677,1.0,20/98,14.85%,AGTR1;ANGPT1;KLF4;CCL5;CDKN1A;HPN;MAGI2;ZC3H12A;DHRS4;NFKBIA;ANXA2;ROMO1;FASN;ACACA;STARD4;TGFBR2;GATA3;EIF4G1;RAB1B;DCXR
prerank,calcium ion import across plasma membrane (GO:0098703),-0.474761520193341,-1.2301251749866997,0.21683673469387754,0.687392453563702,1.0,3/14,7.99%,SLC8A1;SLC8A3;SLC24A2
prerank,ureteric bud morphogenesis (GO:0060675),0.5502379745887959,1.2300318094566682,0.24566929133858267,0.9072582448983199,1.0,7/16,13.67%,WNT11;GDNF;BMP4;SIX1;NPNT;GATA3;MYC
prerank,bone development (GO:0060348),-0.35198082711857887,-1.2299475785315266,0.14814814814814814,0.6855143634091088,1.0,13/39,11.33%,SULF1;GNAS;TGM2;SH3PXD2B;CYP26B1;LRP6;FGFR2;LRP5;NOTUM;TP53;DYM;MYOC;SFRP4
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5488508110227928,1.2297895835481176,0.2589147286821705,0.9066769553118026,1.0,3/15,4.23%,NAGK;MGAT3;LARGE1
prerank,regulated exocytosis (GO:0045055),0.3975859549250222,1.2297292727685707,0.13522012578616352,0.9054778660140635,1.0,21/173,9.55%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;OTOF;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;DNAJC5;SYNGR3;VEGFB;PCLO;STEAP2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.34604960792101236,-1.2290818700826327,0.14864864864864866,0.685529137074226,1.0,5/45,3.06%,BMP6;RBPMS;ENG;DAB2;ACVRL1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5407367154058853,1.2288045708590665,0.2473444613050076,0.9076867754058191,1.0,1/17,0.66%,ANK2
prerank,cellular respiration (GO:0045333),0.46122301076481687,1.2281753939492945,0.1969309462915601,0.9086533475544927,1.0,21/41,28.91%,PPARGC1A;SDHB;UQCRC2;ME3;UQCRC1;MTFR1L;MTLN;MDH2;SLC25A14;UQCRH;MTFR2;COX10;UQCRFS1;SURF1;MTFR1;ATP5F1D;NDUFS4;ETFDH;ETFB;ETFA;LYRM7
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5215918198987802,1.2280989054230151,0.24256651017214398,0.9060802565958291,1.0,4/19,8.22%,DAXX;POLR2H;POLR2A;ATRX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5215918198987802,1.2280989054230151,0.24256651017214398,0.9060802565958291,1.0,4/19,8.22%,DAXX;POLR2H;POLR2A;ATRX
prerank,respiratory electron transport chain (GO:0022904),0.5608791121342537,1.227915319108405,0.23183925811437403,0.905322799871069,1.0,2/14,3.93%,PPARGC1A;SDHB
prerank,regulation of MAPK cascade (GO:0043408),0.40391385628883,1.2272119348727053,0.1430084745762712,0.9066189767978019,1.0,20/157,9.94%,FN1;ADRA1B;FGFR1;LPAR1;NTRK3;JCAD;DAG1;LBH;GDF15;CAV1;DUSP1;ROS1;CAV2;SHC1;MYDGF;IQGAP1;PTPN6;ARHGEF5;MAP2K2;PRDM15
prerank,retina homeostasis (GO:0001895),0.5048449120724923,1.2265984859833812,0.21242774566473988,0.907537445132053,1.0,9/23,21.25%,CRB2;HSPB1;POTEF;ACTB;ACTG1;CNGB1;CDH3;JCHAIN;TULP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5926461691012009,1.2265888114689385,0.23688663282571912,0.9061568807563681,1.0,5/10,11.68%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,modulation by symbiont of entry into host (GO:0052372),0.5441153070669174,1.2262972986674274,0.22585669781931464,0.9058341822480155,1.0,5/16,10.73%,CAV1;TRIM25;TRIM21;EXOC7;EXOC2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.43879869397925503,1.2262885659318217,0.20048019207683074,0.9044559034814409,1.0,10/57,10.68%,CYFIP2;NLRP2;MAP3K5;UACA;PMAIP1;DAPK1;PERP;BAD;ARL6IP5;BCAP31
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4051627420063958,-1.2258184808674342,0.174496644295302,0.6927664860895756,1.0,8/22,15.31%,MAP2;MAP1B;AEBP1;PRUNE1;GBA2;GPX1;CAMSAP2;MAP1A
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.515927886212384,1.2256660077240988,0.2445095168374817,0.9053906662516581,1.0,1/20,0.14%,NT5E
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4687725163491027,1.2252065540836086,0.2098273572377158,0.9057345992242617,1.0,14/36,19.96%,NECTIN3;AMN;KIF13A;ANK3;GOLPH3;GCC2;RAB7A;GOLGA7;GGA1;NSF;ARFRP1;RILPL1;GORASP2;RAB10
prerank,dephosphorylation (GO:0016311),0.39742901140573467,1.2250490448818265,0.14668094218415417,0.904926667946854,1.0,17/147,8.64%,PLPPR2;PTPN14;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;DUSP12;DUSP1;UBLCP1;PTPRF;PTPN9;PTPRA;PP2D1;PPM1A;PTPN6
prerank,mitochondrial membrane organization (GO:0007006),0.48743034755325626,1.2245514794431134,0.20930232558139536,0.9053614952443776,1.0,16/32,25.19%,PMAIP1;CHCHD3;MICOS13;BCL2L1;BAD;MICOS10;OPA1;APOO;IMMT;MTX1;SLC25A4;SPG7;TIMM50;MTX3;MAIP1;MTX2
prerank,negative regulation of neuron death (GO:1901215),0.4203476351115542,1.2241686093277686,0.18244803695150116,0.9054290349515672,1.0,26/93,18.32%,CRLF1;PPARGC1A;NRBP2;CD200;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;CHMP4A;CHMP4B;SIX1;SOD2;CD200R1;RASA1;GSK3B;MEF2C;SET;EIF4G1;NENF;IKBKG;POU4F1;F2R;GPNMB;PARK7
prerank,protein targeting to lysosome (GO:0006622),0.5159749531887258,1.2240104379528522,0.23547400611620795,0.9045698150801228,1.0,10/20,23.22%,CLU;GCC2;RAB7A;VPS4A;NEDD4;SNX16;AP3M1;M6PR;AP4M1;NCOA4
prerank,regulation of blood coagulation (GO:0030193),0.49327324746952,1.2239789657877502,0.21940928270042195,0.9033191804624161,1.0,5/27,6.32%,ADTRP;ST3GAL4;CAV1;THBD;DMTN
prerank,negative regulation of glycolytic process (GO:0045820),0.5895698783658732,1.2239156358664234,0.2626427406199021,0.9007834004771393,1.0,5/10,17.42%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5895698783658732,1.2239156358664234,0.2626427406199021,0.9007834004771393,1.0,5/10,17.42%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,regulation of kinase activity (GO:0043549),-0.3004368491166015,-1.2238803698694036,0.102803738317757,0.6960127792896548,1.0,27/89,13.47%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;PLCE1;AXL;TIE1;KDR;PDGFRA;RBL1;EPHB2;EPHB4;NTRK2;ERBB4;ROR2;FGFR2;KIT;RYK;NLRC5;IGF1R;FGFR4;FLT4;EPHA5;RET
prerank,embryonic digestive tract development (GO:0048566),-0.4302458721664647,-1.2237872452755683,0.2443820224719101,0.6938793775088614,1.0,8/18,9.01%,PCSK5;GLI2;RARB;PDGFRA;SALL1;PKDCC;ID2;FGFR2
prerank,protein polyglutamylation (GO:0018095),-0.4974192865658775,-1.2235971092863178,0.23095238095238096,0.6921485694983431,1.0,7/11,29.04%,TTLL4;TTLL11;CFAP20;TTLL5;CEP41;TTLL7;TTLL6
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2786792933427173,-1.2234010459464224,0.04411764705882353,0.6903885149289457,1.0,45/151,14.85%,FLT1;BMP6;SOX5;ADAMTS12;PDE3A;PRKD1;SEMA6A;RAPGEF2;PDE8A;WNT4;WWOX;STAT5B;WNT5A;ACVRL1;STMN2;NDNF;KDR;NOTCH1;TMEM100;CLEC3B;BMPR1B;DAB2IP;RUNX2;APPL2;ACVR1B;MTSS2;CRKL;TGFB1;NTRK2;PTPN12;ACVR2A;RAMP2;PDE2A;RPS6KB1;GAREM1;RACK1;ACAP2;FLT4;HYAL1;TBX1;VSTM2A;SMAD3;BMPR2;DUSP22;SOX6
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5713836378458564,1.223310324416675,0.23613312202852615,0.9016358137665117,1.0,3/13,4.23%,NAGK;MGAT3;LARGE1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5494843313733846,1.223208166224337,0.251088534107402,0.9006344641719268,1.0,6/14,20.51%,ACOT8;ABCD1;EHHADH;ECI2;DECR2;CRAT
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5811848769285081,1.2229861858458795,0.2638888888888889,0.9000425020562595,1.0,1/10,0.10%,PRKCB
prerank,regulation of phagocytosis (GO:0050764),-0.32972483778109685,-1.2229658724459003,0.12980769230769232,0.6893190448284867,1.0,21/53,28.36%,CD47;MERTK;TGM2;GAS6;IL15RA;DYSF;GATA2;PLSCR1;LMAN2;RACK1;CAMK1D;ITGAV;SPHK1;PIP4P2;DOCK2;LYAR;HCK;PYCARD;SLC11A1;FGR;FCGR2B
prerank,regulation of bone mineralization (GO:0030500),-0.3233646057718903,-1.2226978496746013,0.14689265536723164,0.6877810287377016,1.0,14/55,10.03%,BMP6;ADGRV1;WNT4;SLC8A1;ENPP1;KL;BMPR1B;ECM1;PKDCC;TGFB1;FBN2;ACVR2A;NOTUM;BCOR
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.458502238343536,-1.2223184864686327,0.21715817694369974,0.6865650147024511,1.0,6/15,19.61%,RUVBL1;DKC1;CCT7;CCT2;CCT4;NOP10
prerank,carboxylic acid transport (GO:0046942),-0.3209559185737492,-1.2216533611768101,0.10112359550561797,0.6860829565476598,1.0,13/55,7.75%,SLC6A13;SLC13A3;SLC16A12;SLC6A12;SLC1A5;SLC6A9;SLC7A5;SLC16A9;SLC6A6;SLC1A1;SLC16A6;SLC16A1;SLC16A4
prerank,establishment of vesicle localization (GO:0051650),0.5193173411342499,1.2212829117571389,0.24461538461538462,0.9051017119843174,1.0,7/18,19.85%,LIMK2;TOR1A;TMEM230;SYT11;IKBKG;TESK1;RAB27A
prerank,postreplication repair (GO:0006301),0.4488594834794789,1.2207576305295953,0.21528662420382166,0.90573371008854,1.0,18/45,22.88%,TRIM25;USP10;REV1;POLK;WDR33;UBE2B;PCLAF;RPA3;POLH;POLD2;PCNA;UBE2N;UBC;RPS27A;RFC1;POLN;UBE2V1;NSMCE1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4790378332425709,1.2200805394574799,0.2217741935483871,0.9067941037622285,1.0,9/30,11.79%,CHST12;HEXA;DSE;CHST11;CHPF;ARSB;CHST13;HEXB;CHPF2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.42705064937126647,1.21930887843987,0.19506462984723855,0.9083264874113995,1.0,9/72,6.48%,FGF13;CLU;KANK1;LDLR;SSH3;PFDN1;CRYAB;TWF1;EML2
prerank,clathrin coat assembly (GO:0048268),-0.4446489953364995,-1.2189299875622388,0.2231404958677686,0.6921443986461304,1.0,7/15,20.42%,HIP1;CLTA;SGIP1;EPS15;FCHO2;CALY;HIP1R
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3625785520915377,-1.2186830468090648,0.17857142857142858,0.6905806247769305,1.0,15/32,20.62%,SNCAIP;MCTP2;LRRK2;PREPL;DTNBP1;SNAPIN;SLC30A1;CAMK2A;MCTP1;KCNMB4;BAIAP3;CPLX2;FMR1;STX1B;RIMS1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.47902558779244686,1.2184166077566245,0.21587743732590528,0.9102786860643074,1.0,7/31,11.72%,FDFT1;MOCS3;ALOX5;CYP51A1;NFS1;PYCR3;NOXRED1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5382008492588619,1.2178286469806332,0.24960753532182103,0.9110821618460567,1.0,10/16,29.24%,DDX5;SRSF9;DHX9;SRSF1;PUF60;SFPQ;CELF4;CDK13;HNRNPM;DDX17
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5179811303938214,1.2176116093169864,0.24420401854714066,0.9105622762624567,1.0,4/19,15.41%,EP300;PHLDA3;PML;USP28
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4536502482851065,1.217131307390095,0.21855146124523506,0.9109222452181192,1.0,4/47,5.36%,AGTR1;KLF4;FOXO3;NFKBIA
prerank,regulation of sensory perception of pain (GO:0051930),-0.5084026845786269,-1.2168765182584158,0.23177083333333334,0.6936424467846283,1.0,4/11,13.22%,TMEM100;MGLL;ZFHX2;CCN3
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.29992589378833845,-1.21664555220623,0.0967741935483871,0.6920274628968968,1.0,15/86,8.88%,BMP6;RBPMS;ZEB2;SULF1;ENG;DAB2;ACVRL1;NOTCH1;BMPR1B;THBS1;ACVR1B;TGFB1;ING2;ACVR2A;JAK2
prerank,dendritic cell migration (GO:0036336),0.5429940963290908,1.2164681542192122,0.25148809523809523,0.9119426146835038,1.0,5/16,13.39%,CCL5;CXCR4;ALOX5;TRPM4;TRPM2
prerank,regulation of protein catabolic process (GO:0042176),0.40666957593313957,1.2163598538579272,0.17062146892655367,0.9109588812888809,1.0,26/99,19.72%,FZR1;EEF1A1;WWP2;HMGCR;EGLN2;GPC3;AZIN1;CYP51A1;RAB7A;BANP;SF3B3;SNX12;WDR91;GSK3A;GSK3B;NEDD4;MDM2;PLK2;FLNA;CENATAC;DDB1;NSF;CHEK2;ASB5;RNF41;IDE
prerank,acylglycerol catabolic process (GO:0046464),-0.37152030549245035,-1.2161622814377655,0.1821561338289963,0.6911834023102783,1.0,8/30,26.25%,MGLL;LIPE;ABHD12;ABHD2;LPL;PNPLA3;FABP7;PNPLA2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.41183132306541526,-1.216062097023749,0.2119205298013245,0.6892033712953124,1.0,5/21,5.88%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PLAAT3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5170919420781379,1.2151175282405953,0.246875,0.9144263308354401,1.0,4/18,9.98%,HOMER2;HOMER3;FOXP3;EZR
prerank,neutrophil degranulation (GO:0043312),0.3784569945875912,1.214702367426766,0.08844221105527639,0.9145113332067062,1.0,92/425,16.91%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;SLPI;NBEAL2;EEF1A1;CYB5R3;RAP1A;DIAPH1;RAB9B;TMC6;MGAM;DGAT1;AP2A2;UNC13D;EPX;IMPDH2;HP;ORMDL3;LAMP1;ALOX5;MOSPD2;PSMD11;S100A11;TIMP2;RAB44;DPP7;PLEKHO2;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;GLB1;ANXA2;NFAM1;ARSB;GLIPR1;RAB7A;IQGAP1;LGALS3;DNAJC5;PTPN6;MANBA;NAPRT;GOLGA7;DERA;ILF2;RNASE3;GUSB;TOM1;PSMD7;STOM;HEXB;MVP;PTGES2;TRAPPC1;SPTAN1;RHOA;COMMD3;FCER1G;ANO6;HVCN1;TRPM2;AP1M1;DNASE1L1;RAB5C;LTA4H;VAMP7;ATP6V1D;ALDOA;DNAJC3;COMMD9;VNN1;HSP90AA1;RAP2C;PRTN3;ARL8A;ITGB2;CTSH;DYNC1H1;EEF2;CAND1;ARMC8;VCL
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.35994619156391605,-1.2143893271964294,0.16334661354581673,0.691533572852185,1.0,11/36,14.33%,HIF1A;NPR3;NOS3;NOSTRIN;NOS1AP;NOSIP;PIK3CB;GCH1;CYGB;SPR;DHFR
prerank,establishment of epithelial cell polarity (GO:0090162),0.5185585775827992,1.2141984527558112,0.25075075075075076,0.9151352766059548,1.0,8/19,20.17%,MSN;GOLPH3;CDC42;OPHN1;EZR;RHOA;MYO18A;PARD3
prerank,monocarboxylic acid transport (GO:0015718),-0.3321418060227341,-1.214074566325355,0.1317365269461078,0.6901866431533061,1.0,12/51,7.75%,SLC6A13;SLC16A12;ABCC4;SLCO2B1;SLCO1C1;SLC6A12;NCOA1;SLCO3A1;SLC16A9;SLC16A6;SLC16A1;SLC16A4
prerank,iron ion transmembrane transport (GO:0034755),-0.5169253483614135,-1.2140587011496857,0.2557544757033248,0.6879933824179685,1.0,3/10,5.84%,SCARA5;SLC40A1;SLC39A8
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5142675993563051,-1.2140497712298515,0.24607329842931938,0.6857719558592335,1.0,4/10,16.42%,SH3RF1;RUNX1;NCKAP1L;HMGB1
prerank,DNA modification (GO:0006304),0.495223712263028,1.2139285356083984,0.23897581792318634,0.9147673148610883,1.0,13/22,30.14%,PARP3;EXOSC3;MUTYH;MBD4;NEIL1;PARP2;TERF2;TINF2;EXOSC4;PARP1;TERF1;TERF2IP;TDG
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.30531189692353683,-1.2133294924284241,0.1346153846153846,0.6856579848700862,1.0,14/67,7.58%,FLT1;SULF1;PRKD1;PIK3R1;VAV3;VEGFC;PTK2;AXL;KDR;NCK2;CLEC14A;DAB2IP;PIK3CB;ROCK1
prerank,neutrophil activation involved in immune response (GO:0002283),0.37790795705772445,1.2128915469020058,0.08442211055276382,0.9172511414373606,1.0,92/428,16.91%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;SLPI;NBEAL2;EEF1A1;CYB5R3;RAP1A;DIAPH1;RAB9B;TMC6;MGAM;DGAT1;AP2A2;UNC13D;EPX;IMPDH2;HP;ORMDL3;LAMP1;ALOX5;MOSPD2;PSMD11;S100A11;TIMP2;RAB44;DPP7;PLEKHO2;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;GLB1;ANXA2;NFAM1;ARSB;GLIPR1;RAB7A;IQGAP1;LGALS3;DNAJC5;PTPN6;MANBA;NAPRT;GOLGA7;DERA;ILF2;RNASE3;GUSB;TOM1;PSMD7;STOM;HEXB;MVP;PTGES2;TRAPPC1;SPTAN1;RHOA;COMMD3;FCER1G;ANO6;HVCN1;TRPM2;AP1M1;DNASE1L1;RAB5C;LTA4H;VAMP7;ATP6V1D;ALDOA;DNAJC3;COMMD9;VNN1;HSP90AA1;RAP2C;PRTN3;ARL8A;ITGB2;CTSH;DYNC1H1;EEF2;CAND1;ARMC8;VCL
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4305574870130159,-1.2121841830393305,0.18452380952380953,0.6866089698283916,1.0,7/18,19.61%,RUVBL1;DKC1;PARN;CCT7;CCT2;CCT4;NOP10
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4518334989278711,-1.2121734536701014,0.2553763440860215,0.6844329114024051,1.0,7/15,24.31%,KCNN2;ATP1B1;KCNJ2;KCNJ8;KCNIP2;YWHAE;KCNJ3
prerank,muscle organ development (GO:0007517),0.4450594016626322,1.2106492141897172,0.2157829839704069,0.9242230994860289,1.0,14/54,14.13%,UTRN;SGCG;MRAS;SGCA;SGCD;FHL1;LARGE1;COL6A3;MEF2D;EVC;MEF2B;ZBTB42;FXR1;MEF2C
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.43444353252983237,-1.2105940046577028,0.2111111111111111,0.6868549518925151,1.0,4/17,16.76%,N4BP2L2;KAT7;HMGA2;SOX11
prerank,negative regulation of response to external stimulus (GO:0032102),0.4078348397679292,1.2102580846358508,0.19021134593993325,0.9243792208004193,1.0,28/105,20.36%,CD109;RTN4R;KLF4;EPHA4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;CASK;NMI;CARD16;CERS2;PTPN2;LPCAT3;GATA3;CRK;DUSP3;CDH5;OTULIN;FNDC4;ILRUN;GPER1;PCBP2;RTN4RL1;RB1
prerank,protein-containing complex assembly (GO:0065003),0.3850156108978316,1.2102544910575646,0.12830957230142567,0.923022982573845,1.0,55/259,15.87%,FN1;REPS2;FBXL7;F5;PPARGC1A;ADAM10;OCLN;ZC3H12A;CAND2;EP300;PEF1;EPRS1;MCU;PTK2B;PPP6R3;PYGO2;TFG;ELOB;CTSZ;DMTN;SOX9;BAD;TRAPPC9;AFG3L2;LAMC1;GPAA1;TCF7L2;PARD6B;RBX1;TNFRSF1A;PML;KMT2A;SMARCA4;ZW10;TLE2;TLE4;TRAPPC1;MCFD2;ANO6;WASF1;OPA1;NAPA;MYC;PREB;SEC23A;GSK3B;ITGB1BP1;RAB1B;CNIH1;DNM1L;MDM2;ANKRD28;DHX9;IKBKG;SLC9A1
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4463562233148153,-1.210173808444747,0.21066666666666667,0.6858713609932385,1.0,6/15,34.34%,PLTP;ABCG1;LCAT;ABCA5;APOC1;LIPC
prerank,neuron remodeling (GO:0016322),-0.5061207155261288,-1.2101236185566977,0.23429951690821257,0.6838178121519988,1.0,7/10,30.26%,ADGRB3;ANKS1A;C1QA;EPHA8;CX3CL1;C3;RND1
prerank,sterol homeostasis (GO:0055092),0.4333908937654365,1.2095761039154302,0.20425029515938606,0.9242877955378375,1.0,13/65,9.64%,LDLR;SOAT1;ABCD1;CAV1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,protein stabilization (GO:0050821),0.38862214680154145,1.2091101501123926,0.14952279957582185,0.9246624931859816,1.0,30/168,12.14%,CLU;ANK2;PPARGC1A;EPHA4;PARVA;CDKN1A;EP300;CREBL2;FLOT2;BAG1;TRIM44;LAMP1;CRYAB;FKBPL;CREB1;HCFC1;MUL1;DNLZ;IFT46;DVL3;USP19;CHP1;BAG3;GOLGA7;UBE2B;GNAQ;COA8;RABL3;HYPK;NAA15
prerank,protein homotetramerization (GO:0051289),-0.33740318240373846,-1.2087277471474511,0.17475728155339806,0.6855449685506385,1.0,18/49,18.13%,ALDH1A2;PKD2;APPL2;GBP5;KCNJ2;HPRT1;UPB1;B2M;MCOLN1;SAMHD1;AQP4;ALDH9A1;KCNJ12;GOLGA2;CBY1;ACACB;HCN1;CBR4
prerank,endoplasmic reticulum organization (GO:0007029),0.42019720629021406,1.2086511303851164,0.20862470862470864,0.9250627208907541,1.0,29/72,23.64%,SPTSSB;OTOF;REEP3;CAV2;RTN3;MAPK15;GET4;TMEM33;EIF2AK3;LPCAT3;ATL2;DNM1L;REEP4;CCDC47;SHTN1;RNF112;TLE6;SMPD4;SEC31B;APP;RAB10;MIA3;TMCC1;SEC31A;SEC16A;VAMP2;SGTA;VAPA;TOR1AIP2
prerank,plasma membrane organization (GO:0007009),0.444539433162564,1.208584151698452,0.20908004778972522,0.9239130031216037,1.0,20/61,18.54%,ANK2;AHNAK2;SYTL4;ABCD1;CXCR4;OTOF;A4GALT;CAVIN2;ANK3;CHMP4A;TLCD2;SNX33;PLSCR3;ANO6;FER1L6;SYT11;NSF;PACSIN1;STX4;OSBPL2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4816457691122275,1.2084782805970413,0.2272108843537415,0.9229275269283114,1.0,7/31,9.14%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;BRD7
prerank,neuron projection development (GO:0031175),-0.26700959132294116,-1.2081487822412489,0.05,0.6851000603510858,1.0,50/168,16.48%,PTPRM;CNTNAP2;MAP2;RAPGEF2;ADGRV1;SHANK3;DCLK1;TNIK;LYN;NRK;DOCK10;PAK3;GRM7;FRY;STMN2;NYAP2;SGK1;LGI1;DAB2IP;EPB41L3;LAMB1;EPHB2;LRP12;LRRK2;NLGN1;ROCK1;DTNBP1;TBC1D24;RYK;SNAPIN;PLP1;NCKAP1L;MYOC;ALS2;MAPK8IP3;MANF;TBC1D23;MAP4K4;TMEM108;BDNF;PPP1R9A;CNTNAP1;STMN3;ATXN10;NCDN;CAMSAP2;MYO16;RASGRF1;HMGB1;ATCAY
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.48069988632892713,-1.2075977264477906,0.21875,0.6844961606036393,1.0,3/12,4.91%,DMD;ATP1B1;WNK2
prerank,diol metabolic process (GO:0034311),-0.4325800140571131,-1.2073625110097552,0.22096317280453256,0.6829219636427267,1.0,9/19,27.45%,NOS3;DEGS2;GCH1;SPR;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2
prerank,cell projection assembly (GO:0030031),0.5029711911566132,1.2070264694694508,0.24746743849493488,0.9270740941615416,1.0,5/22,13.46%,PARVA;GSN;RHOQ;CDC42;RHOU
prerank,chromatin assembly (GO:0031497),0.46192515568635245,1.206578160194801,0.22070844686648503,0.9274286874229044,1.0,6/38,8.22%,DAXX;GRWD1;ASF1A;SOX9;KAT6B;ATRX
prerank,Golgi to plasma membrane transport (GO:0006893),0.43798698366534006,1.2064120240572762,0.21491782553729458,0.9266818574151375,1.0,17/47,17.46%,STXBP6;AMN;KIF13A;ARL3;ANK3;GOLPH3;GCC2;EXOC4;GOLGA7;STEAP2;GGA1;EXOC2;EXOC8;OSBPL5;CCDC22;NSF;ARFRP1
prerank,protein homooligomerization (GO:0051260),-0.28785138980774955,-1.206395033195679,0.10752688172043011,0.6837096117094419,1.0,39/114,20.07%,ALDH1A2;SLC1A5;SCARA5;SLC1A2;EHD4;IKZF4;PKD2;APPL2;GBP5;KCNJ2;HPRT1;EHD3;UPB1;B2M;MCOLN1;GSDMD;SAMHD1;AQP11;JMJD6;AQP4;ALDH9A1;TRMT61B;ALS2;KCNJ12;G3BP2;GLRA3;GOLGA2;CBY1;ACACB;MPP2;BLM;TIFA;DISP1;HCN1;CBR4;ATL1;MIF;RNF135;CRYZ
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4552004780813429,1.205636306418169,0.21501272264631044,0.9280760707629705,1.0,6/42,8.76%,CCL5;PTK2B;ACKR3;GPR75;STK39;OXSR1
prerank,calcium ion import into cytosol (GO:1902656),-0.4586816711580948,-1.2053301393628986,0.23138297872340424,0.6847280358418164,1.0,3/15,7.99%,SLC8A1;SLC8A3;SLC24A2
prerank,spinal cord development (GO:0021510),-0.48217836401225517,-1.205324625386711,0.2198952879581152,0.6826039259092023,1.0,7/12,18.46%,GLI2;PKD2;VIT;LOXL3;NF1;SOX11;SOX12
prerank,response to organic cyclic compound (GO:0014070),-0.3244386742505012,-1.2052997939995707,0.18592964824120603,0.6805711321974338,1.0,15/52,14.33%,STAT5B;ESR1;IGFBP5;GGT5;CYP1B1;ALPL;SLC1A1;IL18;LRRK2;TGFB1;PAQR8;STAT3;FGFR4;DRD2;DHFR
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5312375918400528,1.2049521411495128,0.24311926605504589,0.9292625849262278,1.0,3/17,6.00%,CLU;RTN1;RTN3
prerank,fatty acid elongation (GO:0030497),0.5553027169752998,1.2049169918469724,0.27346278317152106,0.9280205018236148,1.0,4/13,9.43%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,sulfur compound biosynthetic process (GO:0044272),0.40759625032470836,1.204887596838907,0.19910514541387025,0.9268010375788202,1.0,15/104,9.16%,UST;ANGPT1;ST3GAL4;CHST12;B4GAT1;HAGH;DSE;CHST11;PRELP;CHPF;MGST3;GSTO1;HPGDS;MAT2B;CHST13
prerank,prostanoid biosynthetic process (GO:0046457),-0.4624907835525299,-1.2038321776980272,0.24260355029585798,0.682707588531088,1.0,8/15,19.62%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.4621719799109546,-1.203735992586863,0.24484536082474226,0.6809012324570722,1.0,10/14,36.16%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1;ERN1;NCBP2;CPSF4L;CPSF2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4754517226822039,1.2035321599690842,0.24413793103448275,0.930460595249786,1.0,7/31,11.12%,RANBP3L;SMAD6;CRIM1;CDK6;SOX9;TWIST1;TRPM4
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.48370530016803037,1.2027048158102973,0.2430167597765363,0.9322221407796341,1.0,8/29,13.07%,HPN;PPP2CA;BMP5;OVOL2;SPRED3;LDLRAD4;SFRP1;GATA3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.47681694641889194,-1.202612017903705,0.2749326145552561,0.6820240048360775,1.0,7/11,42.22%,JAK2;TMEM106A;HDAC2;XBP1;TAF7;PF4;IL4
prerank,regulation of mitochondrion organization (GO:0010821),0.4504842165629244,1.2025499249598888,0.22081218274111675,0.9314105056741913,1.0,22/47,22.03%,PPARGC1A;SREBF2;EP300;HAX1;MUL1;GOLPH3;FZD5;MIEF2;PLSCR3;GSK3A;VDAC1;GSK3B;FLCN;DNM1L;HDAC6;PISD;RHOT2;SREBF1;MAPT;FBXW7;INF2;SIRT7
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.523322052748425,1.202515422734004,0.26331360946745563,0.9301801355592927,1.0,4/17,12.18%,CCL5;MOSPD2;CREB3;ANO6
prerank,acylglycerol homeostasis (GO:0055090),-0.4116914063791022,-1.2023640780317217,0.22121212121212122,0.6806349815616332,1.0,4/20,8.90%,IL18;NR1H3;PNPLA8;RORA
prerank,negative regulation of reproductive process (GO:2000242),-0.4296851418157136,-1.201556613214665,0.24709302325581395,0.6807029804164026,1.0,2/17,0.65%,IGF1;SULF1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4248475757338181,1.201452882177446,0.22105263157894736,0.9328014835855916,1.0,14/69,11.74%,PITPNM2;FGFR1;PLCB3;PLCL2;OGT;PLCD3;NGF;PIK3C2B;PLCL1;ERBB3;PI4KA;EZR;RHOA;IRS2
prerank,steroid biosynthetic process (GO:0006694),0.4369391185009919,1.2012341298990885,0.22794117647058823,0.932228535761872,1.0,11/56,11.27%,FDFT1;OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;OSBPL7
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.455278817817431,1.200941541042539,0.2378449408672799,0.9319839847541402,1.0,10/40,14.86%,CLU;MMP9;BBC3;PMAIP1;BCL2L1;BAD;PLSCR3;HRK;OPA1;DNM1L
prerank,cellular response to reactive oxygen species (GO:0034614),0.4322279702974069,1.2002334641996883,0.21608643457382953,0.933279078212446,1.0,17/59,18.32%,MMP9;MAP3K5;FOS;NFE2L2;PXN;MAPK7;ROMO1;MAPK9;JUN;AGAP3;AQP1;PDK2;TRPM2;CHUK;ABL1;HDAC6;PARK7
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4135308078944252,1.2001307346800447,0.21245828698553948,0.9323489697973071,1.0,13/86,10.54%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;PSMD4;PSMF1;MAPK7;EGLN2;RBX1;BAG3;PSMD7
prerank,autophagosome maturation (GO:0097352),-0.36630923618439615,-1.2000980723906833,0.18672199170124482,0.6827603764989775,1.0,13/32,16.89%,ATP2A2;LAMP2;VMP1;UBQLN1;SNX14;CHMP3;VPS16;VPS33B;LIX1;MAP1LC3A;CLN3;VPS33A;TECPR1
prerank,skeletal muscle tissue development (GO:0007519),0.46121297024952174,1.1999535391742173,0.24481327800829875,0.9315914023330443,1.0,6/32,8.24%,CAV1;CSRP3;SELENON;LMOD3;CAV2;SIX1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4776064571188002,1.1995486151297936,0.23233695652173914,0.9317387176569101,1.0,11/31,15.79%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;ZNF205;YWHAZ;GSK3A;GSK3B;E2F1
prerank,hyaluronan catabolic process (GO:0030214),0.518884223507317,1.1991417678790113,0.2552870090634441,0.93188560966088,1.0,6/18,11.13%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,negative regulation of heart contraction (GO:0045822),0.5766868004488911,1.1990405419390697,0.27419354838709675,0.9309614049645595,1.0,3/11,10.78%,ZC3H12A;ATP1A2;GRK2
prerank,regulation of actin filament polymerization (GO:0030833),0.4215964319148424,1.1989419099367362,0.2375296912114014,0.9300040672517681,1.0,12/69,7.61%,BAIAP2L1;KANK1;ARHGAP18;SSH3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;TWF1;HAX1;LATS1
prerank,regulation of neuron projection development (GO:0010975),0.3875595536030232,1.198785954880077,0.19423692636072573,0.929208109806694,1.0,24/163,7.78%,RAB17;LPAR1;RTN4R;NTRK3;TBR1;KANK1;PDLIM5;PRAG1;EPHA4;EFNB2;PTK7;MAGI2;SIPA1L1;NDEL1;ITM2C;EP300;RAP1A;PTK2B;AVIL;TWF1;PTPN9;ARSB;ADCY6;SRCIN1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4756668621759922,1.198686111834395,0.23214285714285715,0.9282360318479673,1.0,10/30,17.93%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;ALG5;DPM2;UBE2J1;RPN2
prerank,RNA splicing (GO:0008380),0.4036247351718614,1.1985221628994605,0.21099887766554434,0.9274933216167927,1.0,32/95,23.15%,MBNL1;PPARGC1A;SRSF2;YJU2;PPP2CA;SNRPB;LSM4;DDX39B;RBM8A;DBR1;LUC7L3;SF3B3;USP39;SRPK2;SRSF7;DDX47;SYNCRIP;SRPK1;RNPS1;MAGOHB;MAGOH;PRPF6;PTBP1;ZMAT5;WBP4;SF3A3;PRPF8;DDX23;SFPQ;U2AF1;NRDE2;SRRM1
prerank,glutamate metabolic process (GO:0006536),0.5054299511647252,1.1984005386666952,0.2575976845151954,0.9266488416935743,1.0,6/19,21.34%,GLUL;GLUD1;ALDH18A1;PRODH;DGLUCY;GAD1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.44550935393418317,-1.198027939328634,0.21148036253776434,0.6866728225289813,1.0,7/15,20.77%,SMARCD3;LRRK2;TAFA1;NF1;DRD2;CX3CR1;CX3CL1
prerank,positive regulation of DNA replication (GO:0045740),-0.44445201457272304,-1.19765972979887,0.24702380952380953,0.6857345144007964,1.0,7/16,19.08%,GLI2;KAT7;GLI1;BCAR3;EGF;STN1;CTC1
prerank,protein targeting to mitochondrion (GO:0006626),0.42648368232083467,1.1976367452133172,0.21348314606741572,0.9280975244945566,1.0,18/52,20.66%,TIMM10;TIMM44;PMPCA;AGK;DNLZ;TOMM5;ROMO1;HSPA4;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;TOMM40L;TIMM9;TOMM40;TIMM50;TSPO
prerank,ventricular septum morphogenesis (GO:0060412),-0.3765523513207273,-1.1976257769340029,0.2,0.6837537500765322,1.0,13/27,21.98%,ZFPM2;ROBO1;NOTCH1;ROBO2;SLIT2;HEYL;SLIT3;BMPR2;SOX11;HEY2;SMAD4;APLNR;HEY1
prerank,negative regulation of cartilage development (GO:0061037),0.560655098664157,1.1972550650725113,0.263681592039801,0.9281329764861528,1.0,4/13,6.73%,ADAMTS7;WNT11;SOX9;EFEMP1
prerank,mitochondrion organization (GO:0007005),0.38284376438934786,1.1971189882956672,0.1761006289308176,0.9272798464967441,1.0,69/165,26.94%,CXADR;PPARGC1A;GABPB1;TIMM10;TIMM44;CHCHD3;AGTPBP1;CAV2;BCL2L1;HCFC1;HAX1;NRF1;MUL1;SLIRP;TOMM5;AFG3L2;MTFR1L;PITRM1;MIEF2;THG1L;COX7A2L;AFG1L;BCAP31;NIPSNAP2;WASF1;TOMM20;OPA1;BNIP3L;TIMM17B;DNM1L;VPS13D;MTX1;ATP5F1B;SLC25A4;CLUH;MTFR2;SPG7;PARK7;PISD;STOML2;RHOT2;TIMM9;HSD17B10;TOMM40;TIMM50;TSPO;TWNK;MIEF1;GABPA;SIRT4;LONP1;TIMM23;TFAM;MTX3;AIP;IFIT2;AIFM2;ADCK1;MTX2;RAB32;FBXO7;MTFR1;DNAJA3;FANCG;ATP5F1D;RHOT1;PARP1;ESRRA;COX7A2
prerank,N-glycan processing (GO:0006491),-0.42308478841649577,-1.1968938131953948,0.2175141242937853,0.6839839477579819,1.0,7/18,16.77%,MAN1C1;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;ST8SIA2;ST8SIA5
prerank,negative regulation of phagocytosis (GO:0050765),-0.4304373330381501,-1.1967302371921895,0.21301775147928995,0.6824310804720136,1.0,6/17,16.42%,CD47;DYSF;PLSCR1;RACK1;CD300A;HMGB1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.39733193734261163,1.1967142460920581,0.19175027870680045,0.9273970128724228,1.0,15/114,8.88%,TNFRSF11B;EDA2R;EDA;FOXO3;TNFSF13;PTK2B;TNFRSF8;PSMD11;NFKBIA;PSMD4;COMMD7;PSMF1;ILK;PYDC1;TNFRSF1A
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5042106360301569,1.1964818383048048,0.2453900709219858,0.9257113500528265,1.0,7/23,11.72%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5042106360301569,1.1964818383048048,0.2453900709219858,0.9257113500528265,1.0,7/23,11.72%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,neutrophil mediated immunity (GO:0002446),0.372232566373008,1.1963976925773299,0.10531594784353059,0.9246889095722307,1.0,92/432,16.91%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;SLPI;NBEAL2;EEF1A1;CYB5R3;RAP1A;DIAPH1;RAB9B;TMC6;MGAM;DGAT1;AP2A2;UNC13D;EPX;IMPDH2;HP;ORMDL3;LAMP1;ALOX5;MOSPD2;PSMD11;S100A11;TIMP2;RAB44;DPP7;PLEKHO2;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;GLB1;ANXA2;NFAM1;ARSB;GLIPR1;RAB7A;IQGAP1;LGALS3;DNAJC5;PTPN6;MANBA;NAPRT;GOLGA7;DERA;ILF2;RNASE3;GUSB;TOM1;PSMD7;STOM;HEXB;MVP;PTGES2;TRAPPC1;SPTAN1;RHOA;COMMD3;FCER1G;ANO6;HVCN1;TRPM2;AP1M1;DNASE1L1;RAB5C;LTA4H;VAMP7;ATP6V1D;ALDOA;DNAJC3;COMMD9;VNN1;HSP90AA1;RAP2C;PRTN3;ARL8A;ITGB2;CTSH;DYNC1H1;EEF2;CAND1;ARMC8;VCL
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5199414899925188,1.1963114182952344,0.278816199376947,0.9236974903379347,1.0,5/17,12.71%,SREBF2;ERLIN2;ERLIN1;ABCA2;LPCAT3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5550844454229409,1.1961166637728475,0.275808936825886,0.923106496875532,1.0,4/12,11.12%,DSG2;CAV1;DSC2;TRPM4
prerank,positive regulation of epithelial cell migration (GO:0010634),0.41413709004528754,1.19603218195303,0.21621621621621623,0.9221130694954316,1.0,22/92,14.90%,ANGPT1;MAPRE2;DOCK5;ANXA3;MMP9;ZC3H12A;GFUS;PTK2B;FOXC2;SOX9;BMP4;TGFB2;EMC10;BCAS3;NRP2;BCAR1;DOCK1;GATA3;RREB1;FOXP1;ITGB1BP1;AAMP
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.42123140925995844,1.195430978494653,0.22798552472858866,0.9229425048065122,1.0,19/69,19.17%,CRLF1;PPARGC1A;NRBP2;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;SOD2;RASA1;MEF2C;SET;ZPR1;POU4F1;F2R;PARK7;TOX3
prerank,ameboidal-type cell migration (GO:0001667),0.4349595722798657,1.195211587250259,0.22151088348271447,0.9224599899583766,1.0,6/51,3.93%,SEMA3D;SRGAP2;FAT2;SEMA3B;ITGB7;GDNF
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5650587862035206,1.1951651893591362,0.29015544041450775,0.921347282692474,1.0,3/11,10.85%,SMARCB1;PIH1D1;SMARCA4
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.34004063610163915,-1.1951013345167951,0.16591928251121077,0.6849098685411671,1.0,9/41,7.85%,TGFA;IL34;DOCK3;GAS6;NOX4;GRM5;ACE;LRP8;NTRK2
prerank,regulation of T cell migration (GO:2000404),0.5223886723156275,1.1949635029632384,0.26308139534883723,0.9207929992706644,1.0,5/18,12.13%,CCL5;CD200;RIPOR2;RHOA;CD200R1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.41159458836171725,1.1948133752327228,0.2290950744558992,0.9200479838542301,1.0,17/73,12.75%,TFAP2C;HDAC5;EP300;CGGBP1;HDAC4;POLR2H;TAF1C;PHF1;ZFP57;DNMT3A;ACTB;POLR1C;MYO1C;POLR1E;AEBP2;POLR1F;PPM1D
prerank,bicarbonate transport (GO:0015701),0.4932708176971066,1.1945542580677089,0.25312934631432543,0.9197099350084719,1.0,3/25,6.98%,CFTR;SLC4A2;CYB5RL
prerank,regulation of tube diameter (GO:0035296),0.5620903106873287,1.1945244162165827,0.27899686520376177,0.9172800614634508,1.0,1/13,0.18%,AGTR1
prerank,vascular process in circulatory system (GO:0003018),0.5620903106873287,1.1945244162165827,0.27899686520376177,0.9172800614634508,1.0,1/13,0.18%,AGTR1
prerank,mammary gland development (GO:0030879),-0.40094684773452816,-1.1940382885413963,0.23460410557184752,0.6859149820117312,1.0,6/21,9.61%,GLI2;WNT4;TBX3;ERBB4;JAK2;NOTCH4
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.47348086165705444,-1.1936353226885121,0.2541436464088398,0.6850496111251738,1.0,3/12,5.48%,JAG1;NOTCH1;N4BP2L2
prerank,engulfment of apoptotic cell (GO:0043652),-0.4463353778691135,-1.1931643546786768,0.23314606741573032,0.6842610035044447,1.0,4/15,10.09%,RHOBTB1;MEGF10;THBS1;XKR6
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4799160824020392,1.1928393804227655,0.26768377253814146,0.9221362917457859,1.0,4/26,8.99%,OGT;EEF2KMT;BEND3;KMT2A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4080416605157331,1.1927203583963955,0.21997621878715815,0.9213101712915085,1.0,21/72,18.10%,CNOT6;CDKN1A;NDRG1;EP300;SESN2;USP10;FOXM1;PLK3;ATRX;PML;ING4;BTG2;MDM2;PLK2;E2F1;PCNA;NBN;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3872414707555927,-1.192560163233372,0.22377622377622378,0.6840006742098473,1.0,9/25,14.09%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3;STAT6
prerank,proteasome assembly (GO:0043248),0.5631301958389705,1.192251733904656,0.26677577741407527,0.9217713699558934,1.0,3/11,6.79%,PSMD11;POMP;PSMD4
prerank,regulation of exosomal secretion (GO:1903541),0.5037852039222097,1.1922306051724822,0.28313253012048195,0.9205616781037393,1.0,9/19,18.11%,SDC4;RAB7A;ATP9A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,brain morphogenesis (GO:0048854),-0.4785500314626066,-1.1921695591672237,0.24932249322493225,0.6830982225696913,1.0,7/12,25.26%,SHANK3;CTNNA2;SPEF2;BBS4;VPS51;PAX2;PTEN
prerank,histone H3-K9 demethylation (GO:0033169),0.5624527339419031,1.192079773036389,0.26825396825396824,0.9198679189087691,1.0,5/11,16.74%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,negative regulation of chemokine production (GO:0032682),0.5492472699744151,1.1920699617777837,0.2630769230769231,0.918633908338225,1.0,2/14,6.74%,KLF4;MUL1
prerank,steroid catabolic process (GO:0006706),0.5927523124197343,1.1918843185809995,0.2632450331125828,0.9179886823130124,1.0,3/10,19.60%,HSD17B14;HSD17B11;YWHAH
prerank,inner ear morphogenesis (GO:0042472),0.491805008711811,1.1916755807231219,0.26676176890156916,0.9174563824936953,1.0,5/22,9.28%,ATP6V1B1;HPN;SOX9;SIX1;ZIC1
prerank,regulation of exocytosis (GO:0017157),0.44083457846957846,1.1908945464768468,0.2420785804816223,0.9190153791735416,1.0,14/46,20.61%,CFTR;STXBP6;SYTL4;UNC13D;RAB3B;CPLANE2;RAB8B;NSF;RAB2B;STX4;RAB9A;RAB27A;RAB10;ATP6AP1
prerank,response to thyroid hormone (GO:0097066),0.5422986392685061,1.1907995889773786,0.26291079812206575,0.9180985807758981,1.0,2/13,2.01%,THRB;HPN
prerank,regulation of programmed necrotic cell death (GO:0062098),0.509142100569456,1.1906993074326575,0.2761627906976744,0.9172334895791243,1.0,8/20,19.38%,OGT;NUPR1;FLOT2;PELI1;HSP90AA1;STUB1;PDCD6IP;FLOT1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.41081265087300645,1.190399443948601,0.20396270396270397,0.9170749823212991,1.0,17/84,14.29%,CLU;RTN1;SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;ORMDL3;RTN3;EIF4A3;SHMT1;EIF2AK3;SYNCRIP;CPEB3;FXR1;BTG2;GAPDH
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5021957825371991,1.1902055208383884,0.2655786350148368,0.916509398618779,1.0,8/21,24.93%,ANK2;KCNA5;FLNA;SCN4B;SNTA1;CACNA2D1;GJA5;KCNH2
prerank,regulation of embryonic development (GO:0045995),0.46104254488207663,1.1899583383436605,0.24497991967871485,0.9161304587228027,1.0,5/34,4.37%,PHLDB2;DAG1;NIBAN2;CRB2;RBM19
prerank,response to nutrient levels (GO:0031667),0.5259073489636141,1.1899203995187893,0.2775193798449612,0.9150362528495805,1.0,4/17,14.31%,PRKAA2;KCNB1;EIF4G1;ULK1
prerank,sulfur compound transport (GO:0072348),-0.3751830778002039,-1.1898928986963262,0.2119205298013245,0.6875244835229616,1.0,4/27,4.68%,SLC6A13;SLC26A7;SLC35F3;SLC6A6
prerank,positive regulation of cartilage development (GO:0061036),-0.4303618360006609,-1.189589741228234,0.25936599423631124,0.6863840258444651,1.0,6/17,14.85%,SOX5;ACVRL1;BMPR1B;PKDCC;BMPR2;SOX6
prerank,regulation of necroptotic process (GO:0060544),0.4930434818058084,1.18928140747479,0.2443820224719101,0.9161547874792686,1.0,10/23,19.38%,OGT;YBX3;FLOT2;PELI1;HSP90AA1;ZBP1;STUB1;SLC25A4;PDCD6IP;FLOT1
prerank,negative regulation of ion transport (GO:0043271),0.49415644928066754,1.1882934345986356,0.25673758865248225,0.9183940037682133,1.0,6/24,15.29%,ACTN2;PTK2B;HTR1B;NEDD4;WNK1;SYT11
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5041847448949599,-1.1881968948110582,0.2795969773299748,0.6883226535414961,1.0,5/10,13.12%,CSGALNACT1;XYLT1;XYLT2;PXYLP1;B3GAT3
prerank,cellular response to alkaloid (GO:0071312),-0.42993993238862893,-1.1881094640365106,0.2188449848024316,0.6865591913261387,1.0,8/17,24.06%,SLC8A1;TGM2;CASP7;RYR2;BLM;SPIDR;CASQ2;RAD51
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3931416243381184,-1.1880679503805103,0.2305194805194805,0.6846978625790958,1.0,6/20,4.30%,CACNA1C;DMD;SLC8A1;CAMK2D;ATP2A2;ATP1B1
prerank,sprouting angiogenesis (GO:0002040),0.4344468166436102,1.1877230792997902,0.25061425061425063,0.9191922590275007,1.0,7/51,3.62%,CDH13;ANGPT1;ADTRP;PARVA;EFNB2;RSPO3;PTK2B
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.47115375205253784,-1.1875998697804122,0.24585635359116023,0.6840364519185727,1.0,3/13,5.68%,GAS6;AXL;IL18
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.47244448007797424,1.1874021580445477,0.24789915966386555,0.9190434173487294,1.0,13/29,23.37%,PPP6R3;MRE11;GAR1;PINX1;CDK2;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,glycine transport (GO:0015816),0.5687002122297209,1.186750503334701,0.2757475083056478,0.9201761410199014,1.0,2/10,10.60%,SLC36A3;SLC25A38
prerank,limb morphogenesis (GO:0035108),0.5053805383989294,1.1865994841125376,0.27514792899408286,0.9194817037707561,1.0,3/20,7.30%,MBNL1;GLI3;TGFB2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4887968787753361,1.1857859920336988,0.2605042016806723,0.9211924175641977,1.0,2/24,3.08%,FGF13;KIF2A
prerank,secretory granule organization (GO:0033363),-0.5018707524938406,-1.1856975930154448,0.25245098039215685,0.687467623562859,1.0,4/10,10.83%,ABCA1;LYST;DTNBP1;VPS33B
prerank,negative regulation of anoikis (GO:2000811),-0.4547862824883643,-1.1855687479780042,0.2289855072463768,0.68585451401804,1.0,4/14,6.74%,PTK2;TLE1;NOTCH1;BCL2
prerank,metal ion homeostasis (GO:0055065),0.45101600364807903,1.1855576417662046,0.2516382699868938,0.9207579824223202,1.0,8/40,11.96%,ATP6V1B1;SLC12A8;CAV1;SELENON;ANK3;JPH2;SLC12A4;LETM1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.459482982167327,-1.1855493632787097,0.23138297872340424,0.6839184376108833,1.0,6/13,16.56%,IRAK2;PIK3AP1;TRAF6;UNC93B1;PIK3C3;TLR7
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.43616766361185305,1.185008474573605,0.25692695214105793,0.9214365167861144,1.0,5/52,3.40%,MBNL1;CELF2;DDX5;CELF1;RBFOX2
prerank,lipid biosynthetic process (GO:0008610),0.4087963569949972,1.1846923489672554,0.2183507549361208,0.9213113395181215,1.0,14/77,12.09%,PRKAA2;FDFT1;OLAH;HMGCR;ALOX5;CYP51A1;PDSS2;ACSM3;NDUFAB1;FADS1;ACSF3;GPAM;ACACA;SCD5
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5588098104634331,1.1844797342565967,0.2659235668789809,0.9208155517010157,1.0,5/13,9.74%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.573249051664141,1.1844693886976607,0.30405405405405406,0.918401558737966,1.0,1/10,0.33%,NFATC2
prerank,calcineurin-mediated signaling (GO:0097720),0.573249051664141,1.1844693886976607,0.30405405405405406,0.918401558737966,1.0,1/10,0.33%,NFATC2
prerank,telomere maintenance via telomerase (GO:0007004),0.4742593447951425,1.1843067115538983,0.25140449438202245,0.9177649244892425,1.0,13/28,23.37%,PPP6R3;MRE11;GAR1;PINX1;CDK2;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4140869917182952,1.1841199919338017,0.21830985915492956,0.9172512011689119,1.0,14/80,11.19%,CD44;NLRP2;KLF4;MAP3K5;UACA;PMAIP1;NGF;DAPK1;BAD;RAF1;CARD16;ARL6IP5;BCAP31;AQP1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.4032759069246177,1.1839497690165974,0.2120866590649943,0.9166377477177916,1.0,25/98,15.90%,SORBS1;BBC3;PMAIP1;CD81;STAC3;PPP1R13B;ANK3;PTPN9;BAD;LGALS3;CHP1;YWHAB;MIEF2;YWHAQ;MYO1C;KCNB1;AKAP5;CNPY4;EPHA3;YWHAZ;ATP2B4;ITGB1BP1;HRAS;E2F1;ITGB2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4549582388705358,1.1836601686274633,0.26783310901749663,0.9164616642813667,1.0,7/38,13.49%,DSG2;ANK2;CAV1;DSC2;TRPM4;KCNA5;CACNB2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.39732209011200403,-1.183197779637417,0.1962025316455696,0.6885879884248165,1.0,5/21,3.65%,CACNA1C;DMD;SLC8A1;PDE4D;CAMK2D
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.49132535199222355,1.1829193556514344,0.25677603423680456,0.917943105282054,1.0,6/23,8.31%,PMAIP1;TIMM10;AGK;BAD;ROMO1;HSPA4
prerank,negative regulation of apoptotic process (GO:0043066),0.36959705653904085,1.1828139573890086,0.12462311557788945,0.91716953142295,1.0,98/444,17.71%,ANGPT1;CD44;CRLF1;NOTCH2;PRKAA2;WNT1;KLF4;PPARGC1A;TJP1;NRBP2;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;ZC3H12A;TNFAIP8;WNT11;CAV1;NGF;QARS1;PTK2B;GDNF;CLCF1;ANXA4;SH3RF2;HSPB1;BAG1;MTDH;SON;NFKBIA;CRYAB;ANXA5;AVEN;BCL2L1;MRE11;HAX1;SOX9;DDRGK1;SHC1;DDAH2;MYDGF;BMP4;GOLPH3;ARHGAP10;CCND2;ERBB3;PLK3;UNC5B;SIX1;MAZ;BAG3;RAF1;HDAC3;CARD16;SOD2;PTMA;AQP1;YWHAZ;SOCS2;HYPK;NAA15;PDPN;COPS5;RASA1;OPA1;SFRP1;ERCC5;ARF4;CBX4;VDAC1;MYC;ZFAND6;IRAK1;GSK3B;MEF2C;SET;BNIP3L;DNAJC3;PLK2;DSTYK;BFAR;IGBP1;FLNA;MAEA;CTSH;UFM1;POU4F1;UBC;RPS27A;LRP2;XIAP;CDKN2D;CIAPIN1;F2R;PIDD1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.43083656249808794,1.182504460930398,0.2379778051787916,0.9170146143835228,1.0,10/55,13.25%,FBXL7;FHL1;PSMD11;AVEN;PSMD4;PSMF1;RBX1;PSMD7;PSMB5;PINX1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4286125841362237,-1.1820265327081043,0.25076452599388377,0.6898180148229445,1.0,7/16,32.87%,PDS5B;NIPBL;BOD1;NAA50;RAD21;SGO1;DSCC1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.44912307649493766,-1.1818646737687786,0.26595744680851063,0.688308289090448,1.0,4/13,11.16%,HIF1A;SYBU;NEFL;LRPPRC
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.40355985152081186,1.1818524223996607,0.23885714285714285,0.9180824410808489,1.0,22/85,17.09%,CLU;TRIB2;NUPR1;ZYG11B;SH3RF2;TMEM259;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;OSBPL7;CSNK1E;PIAS1;GSK3A;DDA1;GSK3B;MDM2;STUB1;KEAP1
prerank,response to purine-containing compound (GO:0014074),-0.429563152979645,-1.1816726914520126,0.21994134897360704,0.6869642638790988,1.0,6/17,21.58%,TRPC3;ABCC9;RYR2;P2RY1;DGKQ;VGF
prerank,positive regulation of kinase activity (GO:0033674),-0.28546515776246906,-1.181566241525184,0.12962962962962962,0.6853686876610654,1.0,32/107,13.47%,FLT1;PRKAG2;ROR1;PDGFRB;EPHA7;TEK;RAPGEF2;INSR;MERTK;PTK2;GAS6;AXL;TIE1;KDR;PDGFRA;EPHB2;EPHB4;NTRK2;ERBB4;ROR2;FGFR2;KIT;RYK;IGF1R;ALS2;CCN1;FGFR4;SPDYA;FLT4;MMD;EPHA5;RET
prerank,ribonucleoprotein complex assembly (GO:0022618),0.38634522617043826,1.1813680588666942,0.20304017372421282,0.9185219104649687,1.0,56/132,28.47%,CELF2;NLE1;CELF1;NOP2;PPAN;TARBP2;SNRPB;MRPS7;EIF6;RPSA;LSM4;DDX39B;EIF4B;LUC7L3;USP39;SRPK2;KHDC4;PWP2;SF3A2;SRPK1;SRSF9;GEMIN6;HSP90AA1;DHX9;ISY1;LUC7L2;PRPF19;CLP1;PRPF6;SRSF1;SNUPN;RPL6;SRSF5;DDX20;RPS28;PUF60;PTGES3;DDX23;GEMIN5;SHQ1;EIF2S2;CELF4;CPSF7;CLNS1A;GEMIN2;GEMIN8;RPS27;RRS1;MDN1;NOP53;XRCC5;SNRPD2;SNRPD1;SF1;RSL24D1;RPL24
prerank,regulation of monocyte chemotaxis (GO:0090025),0.48012227937573276,1.1812230724383812,0.266016713091922,0.9178439120728088,1.0,6/24,12.18%,CCL5;NBL1;MOSPD2;DUSP1;CREB3;ANO6
prerank,response to nitric oxide (GO:0071731),-0.46179754851653343,-1.1810645396160537,0.24725274725274726,0.6849664923496445,1.0,5/13,15.32%,GUCY1B1;FOXO1;EGLN1;TXN;MTR
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3082238312652756,-1.1808310233169808,0.1678832116788321,0.6836857791286644,1.0,16/72,10.00%,GRIK2;NRXN1;SHANK3;SLC8A3;GRIN2A;LGI1;SYT1;GRIN2B;EPHB2;NLGN1;CLSTN2;ADCY1;SLC24A2;DTNBP1;NFATC4;CACNG8
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.47487952366394287,-1.1806310954411308,0.26139088729016785,0.6824151053384533,1.0,10/12,50.09%,IL18;IL17D;PAEP;CD80;RASGRP1;ISL1;CARD9;IL23A;IL12B;IL23R
prerank,regulation of synapse maturation (GO:0090128),-0.49081639282956,-1.180108133686783,0.25495049504950495,0.6819992499846935,1.0,3/10,7.13%,NRXN1;DAB2IP;ARHGEF15
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5237331272798129,1.1801028054756204,0.2818991097922849,0.920651731842007,1.0,4/18,7.28%,KANK1;DLC1;RIPOR2;CCDC125
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.48027157407110416,1.1800965825011622,0.2714486638537271,0.9194666377263088,1.0,2/27,1.20%,UTRN;SLMAP
prerank,cellular response to estradiol stimulus (GO:0071392),0.5042122858802381,1.1797407432638387,0.2692307692307692,0.9194989609813574,1.0,6/18,19.60%,NCOA3;FAM210B;LCOR;SFRP1;POU4F1;GPER1
prerank,peptidyl-asparagine modification (GO:0018196),0.4648353506487135,1.1793486969295646,0.25068493150684934,0.9197212997637656,1.0,10/31,17.93%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;ALG5;DPM2;UBE2J1;RPN2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.41116584026299896,1.179172394893282,0.2372093023255814,0.9191365154032657,1.0,12/75,10.46%,AGTR1;CDH13;FGFR1;JCAD;NRAS;MYDGF;AGGF1;BMP4;ANG;VEGFB;EMC10;NRP2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4116679383472426,1.1789125820822433,0.23255813953488372,0.9188200133053553,1.0,18/63,18.10%,CNOT6;CDKN1A;EP300;PLK3;FBXO31;PML;SDE2;CCND1;CDK2;BTG2;MDM2;PLK2;E2F1;PCNA;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,hyaluronan metabolic process (GO:0030212),0.4869021491598628,1.1786052471864945,0.2613138686131387,0.9186231751708345,1.0,6/23,11.13%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,sodium ion export across plasma membrane (GO:0036376),0.5472007837301027,1.1784633128460595,0.2845528455284553,0.917915608158512,1.0,7/13,21.40%,ATP1A2;SLC9A1;SLC4A4;ATP1B3;ATP1A1;ATP1A3;ATP1A4
prerank,amino sugar biosynthetic process (GO:0046349),0.5436112169561514,1.1783420037595207,0.2934609250398724,0.917126526780489,1.0,6/12,27.68%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,negative regulation of interferon-beta production (GO:0032688),0.5663019050335214,1.1780065289687132,0.2879858657243816,0.9170497341128041,1.0,2/10,4.62%,RELB;PPM1B
prerank,purine ribonucleotide transport (GO:0015868),-0.42840848627927874,-1.1779925698175615,0.24788732394366197,0.686042533709743,1.0,2/16,1.27%,ABCC4;LRRC8C
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.48465326564876443,1.1775039808499663,0.26991150442477874,0.9176213935555582,1.0,3/21,2.90%,CNOT6;SAMD4A;SAMD4B
prerank,positive regulation of response to wounding (GO:1903036),0.4905298589323175,1.1772763690003816,0.2735166425470333,0.9171951528046925,1.0,7/24,14.62%,KANK1;OCLN;DMTN;ACTG1;PTN;ARFGEF1;HRAS
prerank,muscle cell differentiation (GO:0042692),-0.35233210555095806,-1.1771931710499826,0.2379182156133829,0.6864590127879705,1.0,13/32,15.65%,DMD;SYNE1;MRTFB;GLMN;MEGF10;TBX18;SPEG;RORA;SGCZ;TMEM204;TBX1;GATA6;MYOCD
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.44818963680818547,1.1771896355424873,0.257516339869281,0.9163255812943195,1.0,16/38,22.37%,SREBF2;HAX1;FZD5;ATP5IF1;SIAH3;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;SREBF1;FBXW7;ARIH2;MICALL2
prerank,mesonephros development (GO:0001823),0.559697587611425,1.1764841680345426,0.2879746835443038,0.9176038051819821,1.0,3/11,13.07%,ZBTB16;BMP4;GATA3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4449172856716128,1.1763829189685948,0.2563451776649746,0.9167824805767631,1.0,18/51,18.58%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;SFRP1;ARHGEF10L;ITGB1BP1;CCDC88A;TESK1;ABL1;PFN2;FHOD1;ROCK2
prerank,negative regulation of axon extension (GO:0030517),0.45737049840275934,1.1761793350084297,0.2493112947658402,0.9163440379572093,1.0,3/30,2.82%,SEMA3D;RTN4R;SEMA3B
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.34291015066378483,-1.176010516512394,0.21875,0.6878198895651387,1.0,8/35,11.92%,PAM;ACSS3;GGT5;HMGCLL1;FAR2;HMGCS2;BDH1;HPGD
prerank,negative regulation of cilium assembly (GO:1902018),0.5504486800091248,1.1759973351676665,0.29411764705882354,0.9157894236698386,1.0,3/12,6.92%,LIMK2;CDK10;MAP4
prerank,cristae formation (GO:0042407),0.47281254720366417,1.1757895845789341,0.2627840909090909,0.9153392295425462,1.0,14/27,26.36%,CHCHD3;MICOS13;AFG3L2;LETM1;ATP5PF;APOO;IMMT;ATP5F1B;SPG7;ATP5PD;ATP5ME;ATP5MC3;ATP5F1C;ATP5F1D
prerank,photoreceptor cell development (GO:0042461),0.5318089902633318,1.1754315450460546,0.2809667673716012,0.915452057093144,1.0,2/14,4.91%,RP1;ARL3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37450756987406775,1.1749390910335427,0.17010309278350516,0.9160486907987939,1.0,60/234,19.55%,PRKCB;CLU;WNT1;ANXA3;PPARGC1A;SMO;EDA2R;EDA;TSSK4;CD200;IKBKE;CAV1;MAVS;HDAC5;EP300;HDAC4;FLOT2;TRIM25;MTDH;SMARCB1;NFKBIA;ZIC2;DDRGK1;TRIM21;TRIM41;LPAR5;NFAM1;TAB3;RAB7B;ARHGEF5;TRIM26;TLR6;CARD16;SMARCA4;TLR4;COPS5;MAP3K13;IRAK1;CHUK;DHX9;RNF31;IKBKG;UBE2N;KDM1A;UBC;RPS27A;PRKCZ;RELN;PIDD1;TAB2;PRKCQ;ATF2;PARK7;TRIM37;NFKB2;FZD2;ZBTB7A;FLOT1;PRKD2;APP
prerank,negative regulation of programmed cell death (GO:0043069),0.36876521981993243,1.1747879673719586,0.14646464646464646,0.9153998390652668,1.0,81/355,17.71%,ANGPT1;CD44;NOTCH2;PRKAA2;WNT1;TJP1;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;TNFAIP8;WNT11;NGF;PTK2B;KANK2;GDNF;ANXA4;SH3RF2;HSPB1;BAG1;MTDH;SON;NFKBIA;CRYAB;ANXA5;AVEN;BCL2L1;MRE11;HAX1;SOX9;DDRGK1;SHC1;DDAH2;MYDGF;BMP4;GOLPH3;ARHGAP10;CCND2;PLK3;RAB7A;BAG3;RAF1;HDAC3;TIGAR;PTMA;AQP1;YWHAZ;SOCS2;HYPK;NAA15;PDPN;COPS5;RASA1;OPA1;SFRP1;ERCC5;ARF4;CBX4;VDAC1;MYC;ZFAND6;IRAK1;GSK3B;BNIP3L;DNAJC3;PLK2;DSTYK;BFAR;FLNA;CTSH;UFM1;POU4F1;UBC;RPS27A;LRP2;XIAP;CIAPIN1;PIDD1
prerank,neurogenesis (GO:0022008),0.44310979625121716,1.1746926654463095,0.271523178807947,0.914533637280488,1.0,5/43,8.24%,LPAR1;CXCR4;CDK6;TGFB2;SIX1
prerank,carbohydrate derivative transport (GO:1901264),-0.405772092588944,-1.174232540048667,0.2349570200573066,0.6907661806023252,1.0,7/18,21.35%,PLTP;SLC29A1;MFSD2A;CLN3;SLC10A7;SLC15A2;ABCG1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.38885574556536223,1.1737335218920109,0.2229806598407281,0.9167370370994967,1.0,13/104,8.14%,CD109;WNT1;VEPH1;SMAD6;MAGI2;NBL1;TRIM33;CRIM1;CAV1;IGSF1;SPRED3;TGFB1I1;PPM1A
prerank,oligodendrocyte differentiation (GO:0048709),-0.40397921338866294,-1.173724917236589,0.2535612535612536,0.6902163091801466,1.0,7/19,15.86%,SLC8A3;SOX13;EIF2B3;PTPRZ1;TPPP;SOX6;MYRF
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5389002697273777,1.1736871137792637,0.28802588996763756,0.915705264828926,1.0,1/13,0.14%,SORBS1
prerank,positive regulation of actin nucleation (GO:0051127),0.5581340351779351,1.173684062426759,0.30708661417322836,0.9145498163580735,1.0,3/11,12.23%,GSN;FCHSD2;WASF1
prerank,peptidyl-lysine methylation (GO:0018022),0.48083283887453904,1.1734555362590495,0.27926657263751764,0.9141669610697065,1.0,13/26,27.26%,EEF2KMT;SMYD3;EEF1AKMT3;TRMT112;SETD7;ANTKMT;SMYD1;KMT5A;ATPSCKMT;N6AMT1;EHMT1;SMYD2;EEF1AKMT2
prerank,sensory perception of smell (GO:0007608),-0.4704835344676481,-1.1733799275650822,0.2689295039164491,0.6891986548603597,1.0,6/11,28.94%,UBR3;DRD2;BBS4;SYT10;ADCY3;SLC24A4
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4753406554655434,-1.173307347491749,0.2978723404255319,0.6874933693199001,1.0,5/11,26.94%,HIF1A;NONO;RACK1;NR4A3;ATF4
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.418489007058785,-1.1731106969977283,0.26282051282051283,0.6861086913300989,1.0,10/19,31.02%,ZMIZ1;GAS6;AXL;NCKAP1L;CD27;RHOH;BTK;IL7;XBP1;PRKDC
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.38344247769868867,1.173097009317311,0.2091295116772824,0.9142406807629861,1.0,19/152,11.62%,ADRA1B;GPR4;LPAR1;GRK5;ADCY9;PTGFR;ADGRL2;ADGRD1;CRHR2;RAMP1;ADCY6;LGR4;ADGRG2;HTR1B;AKAP5;ADGRG6;GNAO1;GNAQ;GNA13
prerank,regulation of gene expression (GO:0010468),0.3657280573429033,1.1730876245826418,0.047,0.9131042157926862,1.0,190/903,18.32%,FN1;CDH1;WNT16;MBNL1;BNC2;NFATC2;CLU;ANGPT1;ANK2;ITGB8;NOTCH2;PRDM6;NTRK3;PRKAA2;FOXN3;DAXX;TRIM60;ADTRP;TFAP2C;KLF4;PPARGC1A;AHNAK;SMO;AHNAK2;ADAM10;HPN;OCLN;GSN;ZC3H12A;WNT11;CELF1;HDAC5;CDK6;EP300;NGF;AFF3;CGGBP1;DAPK3;GDNF;ZNF219;PPP2CA;CREBL2;WNT6;HDAC4;GCNT2;YBX3;NFE2L2;OLFM1;WWP2;FLOT2;TRIM44;SON;SNRNP70;IGSF1;PRRX2;MLF2;ESRRB;CDK4;PHF1;PATZ1;RBMS3;OVOL2;POLR2A;MOV10;HOXA5;KRAS;HCFC1;SOX9;FOXD1;ZBTB7B;DDRGK1;KAT6B;EFEMP1;MSN;ANK3;BMP4;TRIM21;RBM20;TGFB2;TOB2;NKAP;ZFHX3;FGF22;ATRX;SIX1;MAPK9;MAZ;POU3F1;PML;HNRNPH2;FOXP3;TRIM11;TRIM26;TLR6;MAP2K2;MYCBP;TXK;SMCR8;APBB1;EZR;GON4L;TWIST1;MUSK;FADS1;ZNF205;SRPK2;NFYC;ACTG1;SRRM4;MYT1;TLR4;CALCOCO1;EIF2AK3;SBNO2;SFMBT2;AJUBA;SNX12;KDM6A;TAF5;ZNF148;SP1;WNT3;SPIN1;TFEB;SFRP1;MYBL1;SH3GL2;CHD3;GATA3;GPBP1;RREB1;TCF19;CDK2;NFIA;CIAO3;GSK3A;UBR5;MYC;TLE5;PRDM11;REXO4;GSK3B;MEF2C;FOXP1;SRRT;ATP2B4;IRF2;PTP4A3;SETDB1;FLCN;HRAS;GRSF1;ZPR1;TLR3;UTP4;MBNL2;PABPN1;E2F1;ADNP;NAB2;CTSH;IGF2BP1;HMG20B;ABL1;PAK6;SPTY2D1;HINFP;LRP3;LIN54;POU4F1;TMEM119;PRKAG1;IGF2BP2;CAVIN4;MLLT6;SUFU;CHEK2;TRRAP;HDAC6;BMPR1A;CDH3;BRDT;CDH5;WTIP;PRKCQ;CAMK2N1;ATF2;APBB3;ZNF462;PARK7
prerank,myelination (GO:0042552),-0.32495843833379817,-1.1717462831789174,0.1917808219178082,0.6881403436525263,1.0,20/46,16.95%,SLC8A3;MAL;EPB41L3;NFASC;TNFRSF21;CMTM8;GAL3ST1;PLP1;NF1;PLLP;MBP;MYOC;TPPP;CNTNAP1;ABCD2;MYRF;SIRT2;B4GALT5;MPZ;ACSBG1
prerank,pore complex assembly (GO:0046931),0.5020619671459278,1.170764870861838,0.29121725731895226,0.9199525653582368,1.0,5/19,12.18%,ADAM10;NUP93;BAD;NDC1;ANO6
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4712297174051942,-1.1702860773280246,0.29310344827586204,0.6904704311463031,1.0,5/11,24.31%,ATP1B1;KCNJ2;KCNIP2;YWHAE;KCNJ3
prerank,positive regulation of type I interferon production (GO:0032481),0.4052754932006289,1.1701121201082503,0.2447058823529412,0.9209720323912421,1.0,23/73,19.38%,MAVS;EP300;POLR2H;IRF3;MRE11;POLR3B;POLR1C;TLR4;POLR3C;IRAK1;CHUK;GAPDH;TLR3;HSP90AA1;DHX9;OAS2;ZBP1;POLR3G;PTPN11;NFKB2;POLR3H;POLR2E;FLOT1
prerank,nucleosome organization (GO:0034728),0.42347529566360653,1.169900887205497,0.2575,0.920501162397801,1.0,17/55,18.54%,DAXX;GRWD1;SMARCB1;ASF1A;SOX9;KAT6B;ATRX;SMARCA4;SRCAP;SMARCD2;SET;SMARCC1;SPTY2D1;LIN54;BRDT;ZNHIT1;H3-3A
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3791057937371976,-1.1698126355192549,0.2147887323943662,0.6898839146636647,1.0,5/23,5.23%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5004373507754877,1.1696513573713583,0.2857142857142857,0.9201680580260166,1.0,4/20,9.14%,PRKAA2;PPARGC1A;FOXP3;BRD7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4675431483508733,1.1688160401612777,0.260748959778086,0.9219361169462479,1.0,7/27,13.49%,ANK2;AHNAK;CACNB3;SELENON;JPH2;JPH3;CACNB2
prerank,regulation of apoptotic process (GO:0042981),0.36332449516973175,1.1686120896131766,0.079,0.9214784270378837,1.0,144/676,17.31%,EGLN3;CLU;ANGPT1;CD44;NOTCH2;PRKAA2;PAWR;DAXX;WNT1;ACTN2;TJP1;MMP9;NGEF;MAP3K5;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NDRG1;ARHGEF17;NUPR1;AKAP13;TNFAIP8;WNT11;ARHGEF12;PMAIP1;NGF;PRR7;PHLDA3;FOXO3;PTK2B;TNFRSF8;DAPK3;TIAM2;GDNF;DAPK1;ANXA4;SH3RF2;OLFM1;HSPB1;PPP1R13B;BAG1;MTDH;UTP11;SON;NFKBIA;CRYAB;ANXA5;RARG;IRF3;AVEN;PERP;BCL2L1;ARHGEF18;MRE11;HOXA5;HAX1;SOX9;DDRGK1;SHC1;DDAH2;MYDGF;BMP4;PNMA2;GOLPH3;EGLN2;ARHGAP10;CCND2;BAD;LATS1;TNFRSF10B;PLK3;NLRP2B;PIP5KL1;PTPN6;JUN;BAG3;ARHGEF5;ADAMTSL4;TRIO;APBB1;RAF1;HDAC3;USP42;IER3IP1;ARL6IP5;PTMA;AQP1;GNA13;YWHAZ;SOCS2;PLSCR3;HYPK;ANKRD13C;GADD45B;NAA15;ANO6;BCAR1;PDPN;COPS5;HRK;RASA1;EEF1E1;OPA1;SFRP1;SOS2;ERCC5;LGALS1;RNPS1;ARF4;CBX4;VDAC1;MYC;ING4;ZFAND6;IRAK1;GSK3B;MEF2C;BNIP3L;FLCN;DNAJC3;DNM1L;PLK2;DSTYK;HSP90AA1;BFAR;IP6K2;ACTN4;FRZB;FLNA;E2F1;CTSH;ZBP1;ARHGEF1;UFM1;ABL1;UBC;RPS27A;PLEKHG2;LRP2;SIGMAR1;SIAH1;XIAP
prerank,post-translational protein modification (GO:0043687),0.36721678284367687,1.168439487255501,0.15454545454545454,0.9208732367218764,1.0,67/332,17.09%,FN1;MSLN;FBXL7;F5;FAM20C;FBXW8;PRSS23;ADAM10;PENK;ASB14;FBXL20;SPSB4;SERPINC1;TIMP1;ZBTB16;PSMD11;NUB1;ANO8;ELOB;KLHL21;PSMD4;PSMF1;BMP4;WSB2;GPC3;FEM1C;FEM1A;SUMF1;LAMC1;FBXL18;FBXO31;RBX1;LAMB2;COP1;PSMD7;DCUN1D1;FBXW9;FEM1B;CALU;SUMF2;KLHL13;SOCS2;CP;DCAF6;COPS5;PSMB5;UBXN7;LGALS1;CHML;DDA1;ASB7;TULP4;SOCS6;DCAF17;RAB1B;DNAJC3;ASB6;PRKCSH;DDB1;CCDC22;ASB3;FBXL15;CAND1;ASB8;CUL9;UBE2F;KEAP1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.46471771150275387,-1.1683128318796399,0.28501228501228504,0.6922074981898477,1.0,6/12,25.39%,DKC1;CCT7;GNL3L;CCT2;CCT4;WRAP53
prerank,toxin transport (GO:1901998),0.5629141548119048,1.1682531152122717,0.3076923076923077,0.9203513537652448,1.0,2/10,5.04%,ADAM10;ANTXR1
prerank,regulation of interleukin-12 production (GO:0032655),-0.33321199194801443,-1.1682379981895064,0.16228070175438597,0.6905190698267112,1.0,5/47,5.86%,PLCB1;CD47;LGALS9;THBS1;IRAK3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.3897349321245691,-1.1682220131151924,0.21806853582554517,0.6886826082495892,1.0,4/21,3.98%,DMD;PDE4D;GPD1L;NCK2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5489877055798589,1.1680394559355605,0.30333333333333334,0.9199627284645235,1.0,1/12,0.14%,SORBS1
prerank,early endosome to late endosome transport (GO:0045022),0.503693084045268,1.1675781342964588,0.2912912912912913,0.9205188681357539,1.0,7/20,19.02%,EMP2;RAB7A;LMTK2;HOOK1;WDR91;SNX16;HOOK3
prerank,neuron differentiation (GO:0030182),0.3806550850337791,1.1673378603570848,0.21525600835945663,0.9201974414254922,1.0,15/165,8.89%,WNT16;WNT1;PBX3;PBX1;NRBP2;WNT10A;WNT11;ITM2C;WNT6;PTPRD;TGFB2;WNT5B;FZD5;ACSL3;OPHN1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2725373604630821,-1.1672600147844032,0.05263157894736842,0.6896691920496315,1.0,34/124,16.48%,PTPRM;CNTNAP2;MAP2;RAPGEF2;LYN;FRY;STMN2;LIMA1;LGI1;PKD2;LAMB1;CEP78;LRP12;NLGN1;ROCK1;DTNBP1;ARMC2;TBC1D24;RYK;SNAPIN;PLP1;FAM161A;MYOC;MANF;TBC1D23;TMEM108;PPP1R9A;KIFAP3;STMN3;ATXN10;NCDN;RASGRF1;HMGB1;ATCAY
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.31283260152966813,-1.1672072853079036,0.16336633663366337,0.6879446066707089,1.0,9/56,8.61%,BMP6;RBPMS;ENG;DAB2;ACVRL1;SNX25;BMPER;TGFB1;ACVR2A
prerank,regulation of interferon-beta production (GO:0032648),0.4285553947715359,1.1671387903707768,0.26527958387516254,0.9197553867258194,1.0,18/46,23.47%,MAVS;RELB;PPM1B;IRF3;POLR3B;TLR4;POLR3C;TLR3;HSP90AA1;DHX9;OAS2;POLR3G;PTPN11;FLOT1;YY1;POLR3F;SIRPA;POLR3D
prerank,leukocyte tethering or rolling (GO:0050901),0.5047396672565989,1.1668837534998113,0.2728613569321534,0.9195582520480943,1.0,3/17,7.19%,PODXL2;ITGB7;GOLPH3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5501042702920265,1.1668131123643275,0.3209076175040519,0.9186498154427165,1.0,6/13,19.16%,PMAIP1;VDAC2;BAD;BLOC1S2;BNIP3L;RHOT2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5391632141140883,1.1665315761889894,0.2993527508090615,0.9184807445037501,1.0,4/12,20.78%,ADTRP;WNK1;ASS1;MIA3
prerank,positive regulation of response to external stimulus (GO:0032103),0.3843465613928594,1.1665281757600292,0.22535211267605634,0.9173492088025625,1.0,23/128,16.22%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;THBD;FEM1A;TNFRSF1A;POLR3B;NMI;ANKRD17;TLR4;PTN;POLR3C;TNIP1;TLR3;DHX9;ZBP1;POLR3G
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5086215394100484,1.166200625079833,0.28865979381443296,0.91726802136548,1.0,3/19,7.04%,KLF4;HPN;MAPK7
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5630571668494123,1.1658087779113637,0.2901134521880065,0.9174367884360898,1.0,3/10,13.71%,KLF4;MAPK7;TLE5
prerank,plasma membrane repair (GO:0001778),0.5361897572883758,1.1657134458891538,0.313953488372093,0.9166160540656881,1.0,2/13,2.31%,AHNAK2;SYTL4
prerank,regulation of GTPase activity (GO:0043087),0.3794054523061653,1.1656516623635362,0.22350472193074503,0.9156820858498179,1.0,47/177,17.54%,MAPRE2;RTN4R;SRGAP2;ARAP1;CCL5;NGEF;PLXNB1;EPHA4;PKP4;PLXNA2;CPEB2;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;ADAP1;SH3BP4;CAV2;EFNA5;DVL3;ARHGEF5;BCAS3;SNX18;SGSM2;EPHA3;RAPGEF3;ASAP3;PLXNB2;SFRP1;RGS6;ARFGEF1;OCRL;GSK3B;ITGB1BP1;WNK1;FLCN;HRAS;ARHGAP27;RAPGEF1;USP6NL;PRTN3;PLXNA3;CRK;RAP1GAP;FICD;F2R
prerank,positive regulation of receptor internalization (GO:0002092),0.47878227776071497,1.1654222414981632,0.2733918128654971,0.9153124529068383,1.0,2/22,2.30%,ANGPT1;MAGI2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.39661357399149405,-1.16494800330175,0.2347266881028939,0.6904581117720071,1.0,5/20,5.23%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.39661357399149405,-1.16494800330175,0.2347266881028939,0.6904581117720071,1.0,5/20,5.23%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,regulation of membrane repolarization (GO:0060306),0.5399101194921297,1.1648844965711038,0.30016583747927034,0.9160379477967415,1.0,2/13,3.49%,CAV1;CACNB3
prerank,Rap protein signal transduction (GO:0032486),0.563001478463574,1.1648290099625611,0.2928452579034942,0.9151242109077674,1.0,6/10,15.63%,RAP1B;RAP1A;RAPGEF3;RAPGEF1;PLK2;RAP2C
prerank,regulation of mitotic nuclear division (GO:0007088),-0.3113216528163788,-1.1644561925630865,0.15625,0.689980387354844,1.0,14/55,17.91%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;RCC1;ANAPC15;TOM1L1;EDN1;BORA;EGF;EDN3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.477537177944232,1.163828813349983,0.29781021897810217,0.9174601299678384,1.0,5/25,11.47%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,DNA damage checkpoint signaling (GO:0000077),0.4697532706083263,1.1634188449794376,0.2755798090040928,0.9176616945814561,1.0,13/28,25.30%,DOT1L;DONSON;USP28;E2F1;CDC5L;ATR;PRPF19;HINFP;NBN;CHEK2;TIPRL;RAD9A;STK33
prerank,regulation of lamellipodium assembly (GO:0010591),0.4587112133559335,1.1612788362200959,0.2774108322324967,0.9239909274893233,1.0,7/34,8.25%,WNT1;OCLN;CAPZB;AVIL;TWF1;DMTN;CDC42
prerank,cardiac conduction system development (GO:0003161),0.4689687251004911,1.1610288960746793,0.27209944751381215,0.9237231652270627,1.0,3/24,7.10%,NOTCH2;GJB6;BMP4
prerank,organic substance transport (GO:0071702),0.3799804056949866,1.160823433507042,0.2239297475301866,0.9232965137745068,1.0,14/121,10.53%,CUBN;SLCO2A1;SCAMP5;ABCD1;AMN;RAMP1;SLC48A1;RAB7A;SLC22A18;ARRDC3;NDC1;ABCA2;TOM1;ARL6IP5
prerank,prostaglandin metabolic process (GO:0006693),-0.3823734204913187,-1.1606539496148816,0.24603174603174602,0.6988083207733722,1.0,10/26,19.62%,PLA2G4A;PTGIS;PTGS2;PNPLA8;ACOX1;PTGES;HPGD;EDN1;CD74;MIF
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.40897191465066995,1.1605564342112118,0.26460071513706795,0.9230351637564445,1.0,18/67,17.28%,RAB17;PODXL;RABEP2;CAV1;TBC1D16;CAPZB;TWF1;DMTN;MAPK15;CDC42;TBC1D1;ODAD3;FXR1;TRPM2;USP6NL;FSCN1;TBC1D22A;TBC1D10A
prerank,keratan sulfate catabolic process (GO:0042340),0.5493935915768338,1.1605370247465852,0.3016393442622951,0.9219798983990537,1.0,4/11,11.13%,HEXA;PRELP;GLB1;HEXB
prerank,response to exogenous dsRNA (GO:0043330),0.49863335114969837,1.160279888538692,0.29402985074626864,0.9217440324802906,1.0,7/18,19.38%,CAV1;MAVS;MUL1;TLR3;DHX9;COLEC12;FLOT1
prerank,regulation of B cell activation (GO:0050864),-0.3743055087835955,-1.1601796476652588,0.22916666666666666,0.6982524761101876,1.0,12/25,38.03%,SH3KBP1;TNFAIP3;NOD2;AHR;TNIP2;FCGR2B;BANK1;SAMSN1;FOXJ1;IL4I1;IKZF3;THEMIS2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5091915357011818,1.1599477793831974,0.2942097026604069,0.9217175827904771,1.0,1/15,0.37%,CDH13
prerank,endomembrane system organization (GO:0010256),0.37325526956314126,1.1598495184323223,0.2280334728033473,0.920903211626962,1.0,58/178,21.02%,SPTSSB;FBXW8;ANXA8;ANXA8L1;SYP;OTOF;TJAP1;A4GALT;REEP3;TMED1;CAV2;NUP93;ATP8B2;MAPK15;ANK3;NSFL1C;GOLPH3;ARHGAP21;SRGN;CDC42;TLCD2;HOOK1;TOR1A;BCAS3;SNX33;ZW10;EIF2AK3;VPS11;PHETA2;GOLGB1;EXOC8;VPS4A;ARFGEF1;VPS18;NPLOC4;FER1L6;PLEKHJ1;PHETA1;ATL2;DNM1L;REEP4;USP6NL;PI4K2A;WASHC4;SEC23IP;SUN2;TMED5;OSBPL2;RNF112;HOOK3;SMPD4;GORASP2;SEC31B;MYO18A;MIA3;TMCC1;SEC31A;SEC16A
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5359553079244974,1.159038570377563,0.3188180404354588,0.9225786057825818,1.0,3/13,7.57%,CYFIP2;PERP;BAD
prerank,positive regulation of cell migration (GO:0030335),0.36678674748524975,1.1590231379448195,0.1985743380855397,0.921515721378192,1.0,30/253,8.86%,FN1;SEMA3D;CDH13;DOCK5;NTRK3;LAMC2;TJP1;SMO;CCL5;MMP9;PODXL;PDGFC;ADAM10;GAB1;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2;S100A11;DMTN;SOX9;DDRGK1;CBLL1;TGFB2;WNT5B;FBXO5;MAZ;ELP5
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5290125824570103,1.1583798995894201,0.3051643192488263,0.9226612667472538,1.0,6/14,15.76%,EMP2;LIMS2;TIMP1;DMTN;ITGB1BP1;FLNA
prerank,positive regulation of translation (GO:0045727),0.3949481895021184,1.1581275995890523,0.25316455696202533,0.9224250786133861,1.0,25/94,18.71%,CCL5;VIM;SAMD4A;YTHDF1;YBX3;RPS4X;PKM;EIF4A3;UPF3A;EIF6;MRPS27;HABP4;POLDIP3;PLXNB2;CPEB3;FXR1;BOLL;UPF3B;PYM1;DHX9;JMJD4;EEF2;YTHDF3;USP16;TRUB2
prerank,regulation of anoikis (GO:2000209),-0.3922234743018588,-1.1580010671013283,0.23974763406940064,0.702595728387071,1.0,5/19,6.74%,PTK2;TLE1;NOTCH1;SIK1;BCL2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.46749594550749307,1.15748223252885,0.2742155525238745,0.9235255186491677,1.0,4/25,5.62%,LIMK2;KANK1;CDK10;CAPZB
prerank,response to interleukin-4 (GO:0070670),-0.48514570050335837,-1.1572556366686793,0.28391959798994976,0.7028978392806573,1.0,1/10,0.45%,LEF1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.42334023330067,1.1568683980055874,0.2723833543505675,0.9245530575074765,1.0,14/50,19.31%,CD44;KLF4;MMP9;NGF;PIH1D1;RAF1;CARD16;AQP1;IGBP1;XIAP;CDKN2D;TRIAP1;PARK7;BEX3
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.39738460205237647,-1.1568647891436932,0.25360230547550433,0.7021482984078086,1.0,6/18,7.57%,RDX;RIC1;DAB2IP;DACT1;VPS35;AMER1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.44878719649388377,-1.1566686002766393,0.2798913043478261,0.7008632507846456,1.0,4/12,16.69%,KAT7;TIPIN;WRNIP1;BLM
prerank,negative regulation of secretion by cell (GO:1903531),0.43470770366330364,1.156359002288004,0.26702269692923897,0.9251826164485097,1.0,10/38,15.29%,ADTRP;STXBP6;HMGCR;CYP51A1;TNFRSF1A;HTR1B;SERGEF;RHBDF2;PNKD;SYT11
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.39064537544523653,1.1560784390179086,0.2665929203539823,0.9250121695163184,1.0,14/110,11.62%,ADRA1B;GPR4;LPAR1;ADCY9;PTGFR;ADGRL2;ADGRD1;RAMP1;ADCY6;LGR4;ADGRG2;ADGRG6;GNAQ;GNA13
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5147722848058609,1.155711104383801,0.2912912912912913,0.9251389416686386,1.0,4/16,10.68%,ANK2;PPP1R15A;DDRGK1;BCAP31
prerank,regulation of osteoblast differentiation (GO:0045667),-0.29508911153736217,-1.155702065958324,0.1417910447761194,0.7016556874384337,1.0,19/82,10.28%,BMP6;IGF1;SMOC1;PRKD1;WNT4;ZHX3;PTK2;NOTCH1;RORB;BMPR1B;RUNX2;IL6R;FBN2;ACVR2A;FGFR2;LRP5;PPARG;TWIST2;CCN4
prerank,positive regulation of cellular process (GO:0048522),0.36028810348448,1.1554994741191043,0.12112112112112113,0.9247170971945525,1.0,86/565,12.21%,FN1;DPP4;FGFR1;CRLF1;NTRK3;PRKAA2;CNOT6;WNT1;LAMC2;TJP1;CCL5;EPHA4;PDGFC;EFNB2;GRK5;ADAM10;HPN;EMP2;CCN2;NUPR1;ZC3H12A;IL15;CAV1;CELF1;PDF;PRR7;CD81;PTGFR;TNFSF13;PTK2B;NOP2;GDNF;BMP5;PPP1R13L;HDAC4;GCNT2;CLCF1;TIMP1;EPO;HP;HPR;CIAO1;DOT1L;NACC1;CDK4;RPS4X;NSMCE4A;FOXM1;KRAS;HCFC1;SOX9;DDRGK1;SHC1;MAPK15;BMP4;TRIM21;TGFB2;CCND2;ERBB3;ZFHX3;LBP;ROMO1;FGF22;CDC42;FBXO5;MAZ;PTPN6;SSR1;IL7R;CAPNS1;MTLN;CCND1;SRPK2;FASN;KDM4C;TBRG4;TRPM4;ANKRD17;TLR4;ACACA;IRS2;PTN;FCER1G;EIF4G2;CDKN2AIP;TGFBR2
prerank,secretion (GO:0046903),-0.448109472694486,-1.1554632888904268,0.2727272727272727,0.7004990497221742,1.0,7/14,30.70%,FBLN5;NPR1;RIMS1;SLC22A6;SLC22A2;GUCA1B;PRKCI
prerank,outer dynein arm assembly (GO:0036158),0.5170659263754684,1.1553641100606171,0.30077519379844964,0.9240338785834936,1.0,6/14,23.62%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DNAAF4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5202689983051476,1.1552070439402071,0.31296572280178836,0.9234893526313007,1.0,7/16,16.89%,IMPDH2;NUDT2;PAICS;GMPS;GART;AMPD2;ADSS2
prerank,response to UV (GO:0009411),0.38948151627292893,1.1551432906227523,0.2536312849162011,0.922584714879873,1.0,28/95,21.08%,SCARA3;FEN1;EP300;MAP3K4;REV1;SDE2;POLK;UBE2B;CCND1;PCLAF;AQP1;ERCC5;MYC;POLH;NEDD4;USP28;ATR;PCNA;ERCC2;KDM1A;EIF2AK4;CDKN2D;USF1;TRIAP1;COPS9;ERCC4;RHBDD1;YY1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.451151995498664,1.1549559743540907,0.29403973509933773,0.9220900083913481,1.0,7/32,17.39%,GALP;PGLYRP3;ANG;ROMO1;RNASE3;GAPDH;RNASE7
prerank,positive regulation of intracellular transport (GO:0032388),0.44231899221096366,1.1545136759905688,0.29649595687331537,0.9225080551064317,1.0,13/38,24.28%,ACTN2;EHD1;PLK3;BCAS3;NEDD4;RIPOR1;DYNC1H1;NUMA1;KIF20B;VAMP2;TPR;PCM1;ICE1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4269929712966394,-1.1542594543859777,0.29329608938547486,0.7021864444937652,1.0,5/16,7.80%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,regulation of actin filament-based movement (GO:1903115),0.5624296681765544,1.154111776461966,0.3279742765273312,0.9227827266039061,1.0,1/10,0.66%,ANK2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.45511695184437123,1.153873944217082,0.30327868852459017,0.922524971211398,1.0,12/30,22.37%,SREBF2;FZD5;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;FBXW7;ARIH2;MICALL2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4796778768088149,-1.153840117354807,0.2776349614395887,0.7015344203950095,1.0,5/10,23.65%,KDR;IL33;JAK2;NOD2;NAMPT
prerank,positive regulation of isotype switching (GO:0045830),0.5133786214231145,1.1535102305435816,0.32868217054263565,0.9226975135264068,1.0,4/15,9.45%,TNFSF13;CLCF1;SHLD2;RIF1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4043071800697908,1.1534724806958725,0.26762246117084826,0.9217156561350358,1.0,17/76,15.60%,NR3C2;UACA;ZC3H12A;EP300;PPM1B;TRIM44;NFKBIA;ILK;PPM1A;EZR;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4390443220315708,-1.153458676947736,0.275,0.7007688945645185,1.0,6/14,16.64%,WNT5A;SEMA7A;CAMK4;KIT;GPRC5B;CD74
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5335576720309989,1.153405779206828,0.31121642969984203,0.9208444943844037,1.0,4/12,5.50%,ADTRP;NBL1;BMP5;DUSP1
prerank,neuron projection extension (GO:1990138),0.44992416861922613,1.1530525778760221,0.266754270696452,0.9209803635132502,1.0,11/32,17.65%,ALCAM;FLRT1;IQGAP1;SLC9A6;NRP2;SH3GL2;FLRT3;ULK1;HSP90AA1;EIF2AK4;SEMA3A
prerank,carnitine metabolic process (GO:0009437),0.5415873202358286,1.152940025699176,0.32554517133956384,0.9202915182378321,1.0,5/12,13.36%,ACADL;CPT1B;SHMT1;CPT2;ACADM
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.44061350129309845,1.1521867817562368,0.2864721485411141,0.9218479294593055,1.0,4/35,2.82%,SEMA3D;PLXNB1;PLXNA2;SEMA3B
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.43600294148191554,1.152182735759031,0.27359781121751026,0.9207745430344719,1.0,14/38,21.62%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.42822103585995425,1.151934811501224,0.2855263157894737,0.9205642219947483,1.0,14/42,20.19%,TRIM25;USP10;REV1;POLK;PCLAF;RPA3;POLH;POLD2;PCNA;UBC;RPS27A;CDKN2D;RFC1;POLN
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4425003904440254,-1.1519098272479056,0.28851540616246496,0.7032093361816749,1.0,8/13,25.52%,AZIN2;ACSL1;ACSL5;CA2;SLC26A6;C2CD5;NR4A3;C3
prerank,positive regulation of potassium ion transport (GO:0043268),0.42873468961215977,1.1516096057782217,0.2979865771812081,0.920601491218876,1.0,3/38,3.17%,ANK2;ACTN2;FHL1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.497448249598338,1.1513003293866273,0.30077519379844964,0.9205477458762102,1.0,9/19,27.68%,NAGK;NANS;UAP1L1;GFPT1;GNPDA2;PMM1;UAP1;PMM2;PGM3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.45880968369103703,-1.1510672786449994,0.2914572864321608,0.7036837341830876,1.0,5/11,36.62%,NOS1AP;KCNIP2;TREM2;RNF207;ALG10B
prerank,neural tube development (GO:0021915),-0.4266090136961865,-1.15102823947278,0.27848101265822783,0.702008798406305,1.0,4/15,7.36%,ALDH1A2;PKD2;DACT1;TGFB1
prerank,regulation of organelle organization (GO:0033043),0.3982706760308075,1.1509502732196828,0.25608342989571264,0.9206745861895161,1.0,23/80,15.29%,TJP1;PLXNB1;MAVS;EP300;DIAPH1;MUL1;MAPK15;MSN;CAPN2;GOLPH3;MYO5A;ARHGEF5;MIEF2;EZR;TMEM33;VPS11;ARMH3;CPLANE2;PREB;DNM1L;USP6NL;RAB33B;SYT11
prerank,actin filament organization (GO:0007015),0.37714825748529873,1.1492869285210028,0.25078698845750264,0.9253002074654085,1.0,22/151,9.99%,BAIAP2L1;POF1B;COBL;NEBL;MYO1H;TMOD3;VILL;EMP2;GSN;MPRIP;TMOD2;MCU;CORO7;LMOD3;ENAH;AVIL;DMTN;CDC42;MYO5A;GAS2L1;ABI1;MYO1C
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.547674853681726,1.1492838162146224,0.3275039745627981,0.9242256337611414,1.0,1/11,0.58%,SCARA3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5186030395397264,1.1487136060893353,0.32445141065830724,0.9250258511027083,1.0,6/15,18.83%,CD44;MDM2;KDM1A;ARMC10;TRIAP1;TAF9B
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5120725309470673,1.1485063195248069,0.3213213213213213,0.9246760891188286,1.0,5/16,11.17%,ERLIN2;SOX9;ACADL;ERLIN1;NCOR1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5316564919412392,1.148379538500093,0.33068362480127184,0.9240269760949259,1.0,5/13,16.05%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4865183276560382,-1.1483138433923066,0.2950391644908616,0.7077589103074318,1.0,3/10,9.93%,SLC2A1;ACSL1;RPS6KB1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.397559943004964,-1.1481354730143063,0.28343949044585987,0.7063590446467172,1.0,12/19,47.35%,LRP6;RYK;MANF;NR4A2;LMX1A;WNT2;SHH;VEGFA;FOXA1;EN1;FOXA2;CDNF
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4739938778098038,1.1481038322370993,0.28674351585014407,0.9238806468808167,1.0,5/23,9.77%,DYNC1I1;MAP6;KIF1C;KIF1B;HOOK1
prerank,translesion synthesis (GO:0019985),0.4218746317823142,1.1479970208111214,0.29562982005141386,0.9231439107693573,1.0,14/42,20.19%,TRIM25;USP10;REV1;POLK;PCLAF;NPLOC4;RPA3;POLH;POLD2;PCNA;UBC;RPS27A;RFC1;POLN
prerank,xenobiotic transport (GO:0042908),-0.43010374712767496,-1.1477681615376405,0.27507163323782235,0.7055826980121626,1.0,9/17,31.78%,SLC47A1;SLC7A5;ABCA3;SLC15A2;ABCC3;SLC22A2;ABCG2;SLC22A3;ABCC1
prerank,defense response to protozoan (GO:0042832),-0.4604220266764204,-1.147548027571058,0.3103448275862069,0.7042720259597135,1.0,6/12,26.58%,LYST;GBP6;CD40;GBP2;GBP4;SLC11A1
prerank,insulin receptor signaling pathway (GO:0008286),0.3973711087680891,1.1475187982470405,0.2828638497652582,0.9236427632412311,1.0,17/69,15.78%,SORBS1;ATP6V1B1;GAB1;FOXC2;RHOQ;CAV2;AP3S1;SHC1;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1D;ATP6V1E1;ATP6V0D1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.5029736557438814,1.146894448033662,0.3157894736842105,0.9246994757349936,1.0,4/16,9.45%,KDM4D;SHLD2;PARP3;RIF1
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4268398285375435,1.146831780761839,0.26587301587301587,0.9238139870730687,1.0,8/47,8.55%,ANXA8;ANXA8L1;CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,positive regulation of catabolic process (GO:0009896),0.39675058252675327,1.1468105514775866,0.27898550724637683,0.9228036486046244,1.0,14/65,19.72%,FZR1;WWP2;EGLN2;GPC3;RAB7A;GSK3A;GSK3B;NEDD4;PLK2;DDB1;NSF;ASB5;RNF41;IDE
prerank,macrophage migration (GO:1905517),0.5277661244960612,1.1467838061474567,0.32339089481946626,0.921809618400771,1.0,2/13,8.46%,CCL5;LGALS3
prerank,diol biosynthetic process (GO:0034312),-0.42661503929166367,-1.1466772089124047,0.2972972972972973,0.704988417612998,1.0,9/15,32.97%,ACER2;GCH1;SPR;DHFR;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,negative regulation of organelle assembly (GO:1902116),0.4448684114873126,1.1466762841399027,0.2859007832898172,0.9210653291644352,1.0,12/35,19.68%,LIMK2;NUPR1;CDK10;TMEM39A;CHMP4A;CHMP4B;SMCR8;TESK1;FEZ1;TRIM37;NBDY;PHF23
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5027319162781448,1.1465343620340351,0.3157099697885196,0.9204689654369441,1.0,2/16,3.19%,LDLR;ABHD5
prerank,positive regulation of T cell migration (GO:2000406),0.4864638778145771,1.146329250579513,0.3055141579731744,0.9200466681208166,1.0,8/20,19.66%,CCL5;ADAM10;STK39;OXSR1;RHOA;WNK1;APP;ADAM17
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.303846692799315,-1.146185880268679,0.18823529411764706,0.7045361685242351,1.0,15/66,10.70%,FLT1;PDGFRB;SASH1;PDGFD;IL34;ROBO1;DAB2IP;FGF2;LRRK2;TGFB1;TPD52L1;EZH2;PIK3R6;KIT;TRAF6
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5051768541182956,1.1460654883678192,0.31045241809672386,0.9198915978494339,1.0,4/15,11.47%,NLRP2B;PYDC1;TLR6;TLR4
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.564670982702155,1.1459943588771235,0.3145299145299145,0.919072036001763,1.0,5/11,12.95%,RSPO3;MLLT3;WNT5B;CSNK1E;SFRP1
prerank,regulation of interferon-gamma production (GO:0032649),-0.29570193411901,-1.1457563727397133,0.20238095238095238,0.7039874654213722,1.0,9/71,7.79%,IL1R1;CD47;PDE4D;GAS6;AXL;SLC7A5;LGALS9;IL18;PDE4B
prerank,regulation of ruffle assembly (GO:1900027),0.4727141071434388,1.1457340381336798,0.3132867132867133,0.9189103665411231,1.0,4/23,2.82%,KANK1;EPS8L2;CAV1;NDEL1
prerank,cellular response to sterol (GO:0036315),0.5324479686729033,1.1455278283791683,0.3279742765273312,0.9185552670874864,1.0,4/13,11.27%,SMO;RORC;INSIG1;OSBPL7
prerank,central nervous system myelination (GO:0022010),0.5523902805136489,1.1452841135941005,0.32387312186978295,0.9182897108679516,1.0,1/11,0.41%,CLU
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2927060608339966,-1.1450807341946139,0.21232876712328766,0.7040854956532038,1.0,17/75,9.52%,FARP1;MAP2;MAP1B;DCC;PAK3;DCDC2;ZDHHC17;BRSK1;NRCAM;CTNNA2;SLITRK1;S100B;DSCAML1;SDC2;FGFR2;NTNG1;RYK
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5608760738202362,1.145003487183995,0.28865979381443296,0.9181893500060282,1.0,2/10,9.13%,ZC3H12A;FOXP3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.37226027949635915,1.1449154861094624,0.23753976670201485,0.9174006043507495,1.0,40/158,17.82%,PRKCB;LPAR1;EDA2R;AKAP13;IKBKE;MAVS;TRIM25;MTDH;TFG;SLC20A1;MUL1;CC2D1A;WLS;TRIM21;TNFRSF10B;TAB3;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;CHUK;GAPDH;PLK2;GPR89A;RNF31;IKBKG;FLNA;UBE2N;CCDC22;F2R;MAP3K3;TAB2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.40387332681644555,1.1448382164414639,0.2761904761904762,0.9165941510149949,1.0,17/65,15.28%,EGLN3;NDRG1;CPEB2;PMAIP1;EGLN2;BAD;TWIST1;CARD16;TIGAR;AQP1;HYOU1;SFRP1;NPEPPS;MYC;BNIP3L;MDM2;LMNA
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.39876585769175926,1.1447450507402563,0.2605140186915888,0.9158618085276817,1.0,20/80,16.80%,WNT1;ARAP1;OCLN;EPS8L2;NDEL1;CDC42EP4;PALM;CDC42EP5;RIPOR2;RHOQ;AVIL;CDC42;BCAS3;PLEKHM1;MARK4;HRAS;CCDC88A;WASHC1;FSCN1;ARPC2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4769081765010085,-1.1446569700510494,0.2916666666666667,0.7034449592910367,1.0,6/10,27.62%,ADGRV1;PLS1;SOD1;TSKU;WHRN;IFT88
prerank,regulation of lipid metabolic process (GO:0019216),0.3866953113440882,1.1443105467379482,0.27815315315315314,0.9162779452728743,1.0,21/88,12.43%,FDFT1;SREBF2;RORC;CAV1;DHCR7;HMGCR;FDPS;PMVK;RUBCNL;CYP51A1;ELOVL6;HDAC3;NFYC;FASN;CERS2;NCOR1;GPAM;ACACA;MBOAT7;IRS2;SP1
prerank,negative regulation of TOR signaling (GO:0032007),0.4363035608982035,1.144172766479323,0.2951885565669701,0.9156689429590411,1.0,5/36,5.67%,RNF152;PRKAA2;SESN2;TSC2;SH3BP4
prerank,glycoprotein catabolic process (GO:0006516),-0.4148541855242117,-1.1439567615900048,0.26170798898071623,0.7036041628592389,1.0,2/17,1.29%,ADAMTS12;ADAMTS9
prerank,negative regulation of ossification (GO:0030279),0.4802790518543125,1.1434100208637195,0.3146551724137931,0.9170833583117972,1.0,7/23,14.13%,SMAD6;PTK2B;SOX9;SRGN;TRPM4;SFRP1;MEF2C
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.37321606131767626,-1.1431467884541824,0.27208480565371024,0.7042237532908834,1.0,12/25,20.46%,SULF1;ENG;ACVRL1;NOTCH1;BMPR1B;ACVR2A;ZNF423;CCN1;BMPR2;SOX11;UBE2O;SMAD4
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3519686288376984,-1.1429454928735077,0.2556390977443609,0.7029926217640249,1.0,4/29,9.01%,ENG;NOTCH1;TGFB1;FGFR2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.45986810102794,1.1426158462960199,0.3016759776536313,0.9187034765617932,1.0,6/27,16.90%,MAP3K8;MAP3K5;CHUK;IKBKG;UBC;RPS27A
prerank,protein localization to lysosome (GO:0061462),0.45093326304420295,1.142455382615533,0.30536451169188444,0.9181941481895843,1.0,13/28,23.22%,CD81;SH3BP4;GCC2;RAB7A;VPS4A;KPTN;NEDD4;SNX16;AP3M1;M6PR;SZT2;AP4M1;NCOA4
prerank,acyl-CoA biosynthetic process (GO:0071616),0.49585059743745136,1.1423859619250414,0.3281733746130031,0.9173943660507589,1.0,8/16,23.03%,SLC25A1;FASN;ACACA;SCD5;PPT2;ACLY;MLYCD;GCDH
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3652343860416999,1.1422290041048102,0.24375,0.9168763106458618,1.0,48/166,20.99%,SORBS1;CLU;KLF4;PPARGC1A;LDLR;CCL5;VIM;SAMD4A;YTHDF1;RPS4X;DDAH2;EIF4A3;UPF3A;EIF6;NNMT;CHP1;TLR6;ZNF205;TLR4;IRS2;STARD4;POLDIP3;PTPN2;SP1;PLXNB2;CPEB3;FXR1;MYC;UPF3B;PYM1;HSP90AA1;DHX9;DDB1;PCNA;EEF2;ASS1;PRMT1;CDH3;YTHDF3;PARK7;GPLD1;PRKD2;SREBF1;KLF2;SOX4;ARNT;PAOX;ZCCHC4
prerank,kidney development (GO:0001822),0.40298259275819104,1.1421526271899447,0.2841726618705036,0.9160662091435262,1.0,11/65,8.43%,AGTR1;STRA6;KANK2;GDNF;ZBTB16;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,modified amino acid transport (GO:0072337),-0.43295047086038396,-1.142099770469951,0.2801047120418848,0.7036031690259898,1.0,2/15,1.14%,SLC6A13;SLC16A12
prerank,positive regulation of neuron differentiation (GO:0045666),-0.32651765316205317,-1.1419282897396783,0.21810699588477367,0.7023796872443389,1.0,14/40,17.69%,TCF4;ZEB1;VWC2;BRINP3;NRCAM;HEYL;IMPACT;BEND6;ARHGEF2;MMD;GPRC5B;BRINP2;SOX11;HOXD3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5118679546773787,1.141822482193376,0.3110773899848255,0.915068392240338,1.0,4/16,10.36%,PHLDB2;DLC1;DMTN;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5118679546773787,1.141822482193376,0.3110773899848255,0.915068392240338,1.0,4/16,10.36%,PHLDB2;DLC1;DMTN;BCAS3
prerank,positive regulation of JNK cascade (GO:0046330),0.40286863283107793,1.1415081785579084,0.283175355450237,0.9150933391464704,1.0,6/70,4.47%,WNT16;EDA2R;MAP3K5;CCN2;PTK2B;SH3RF2
prerank,nervous system development (GO:0007399),0.35863392350636664,1.1413277599955227,0.16164658634538154,0.9146883044352409,1.0,49/429,9.81%,FN1;CDH1;MBNL1;FGF13;SDK1;LPAR1;NOTCH2;CHRM1;CELSR1;ZIC4;SMO;PDGFC;PCDHA8;SREBF2;GSN;NBL1;NINJ1;CRIM1;CXCR4;EP300;TMOD2;NGF;RBFOX2;GDNF;GLIS2;HDAC4;ZBTB16;UTP11;HMGCR;PCDHB12;NAGLU;GFRA3;EFNA5;UNC119;AVIL;EIF2B2;ZIC2;LRCH4;ERBB3;CYP51A1;PKD1;POU3F1;FZD5;OPHN1;GRHL2;ZIC1;DPF2;PCDHA4;ADGRA2
prerank,homologous chromosome segregation (GO:0045143),0.48461240601139355,1.1404221496306475,0.3028485757121439,0.9165647319910839,1.0,1/20,1.17%,ANKRD31
prerank,supramolecular fiber organization (GO:0097435),0.36096771123372334,1.1403738064670013,0.20362903225806453,0.9156927452638153,1.0,40/333,10.71%,ITGB4;FGF13;PGM5;ADAMTS14;COL23A1;TNXB;COL25A1;POF1B;TSPAN5;LAMC2;COL4A3;COL4A4;VIM;MYO1H;TMOD3;ADAM10;EMP2;GSN;COL5A2;MPRIP;TMOD2;KIF2A;CORO7;COL6A1;COL6A3;LMOD3;AVIL;PXDN;CLIP4;TGFB2;PLK3;CDC42;CHP1;MYO5A;HOOK1;HDGFL3;MYO1C;KLHL24;GGA1;PLEC
prerank,negative regulation of DNA recombination (GO:0045910),0.42291870586101776,1.1403357105097602,0.30522088353413657,0.9147742422104121,1.0,8/43,9.45%,DAXX;POLR2H;SHLD2;POLR2A;PARP3;KLHL15;ATRX;RIF1
prerank,regulation of defense response to virus by host (GO:0050691),0.44690345711712637,1.1402550468847374,0.2944369063772049,0.9140278784418326,1.0,8/30,17.21%,ZC3H12A;MAVS;TRIM44;TARBP2;MUL1;HSP90AA1;DHX9;EIF2AK4
prerank,regulation of cell division (GO:0051302),0.39679706296441025,1.140254048061469,0.2795321637426901,0.9129985677679116,1.0,21/72,20.09%,NCOA3;MLLT3;KIF13A;ESRRB;RAB11FIP3;BCL2L1;KLHL21;PLK3;AURKC;PRDM15;INSC;KLHL13;MYC;FLCN;PLK2;GIT1;ZFYVE26;TLE6;UVRAG;CSPP1;PIK3R4
prerank,response to axon injury (GO:0048678),-0.405065005628582,-1.1399382329265262,0.2861271676300578,0.7062446048605964,1.0,8/18,21.59%,NREP;MAPK8IP3;DHFR;MTR;SARM1;SOD1;P2RY12;TYROBP
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5234240773099952,1.1394714775746841,0.30095541401273884,0.9145134862095563,1.0,4/13,12.21%,GLI3;ZBTB7B;NKAP;TGFBR2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3898836025329281,1.139339902139487,0.2777129521586931,0.9139315688628525,1.0,10/84,13.26%,FZR1;PSMD11;PSMD4;PSMF1;FBXO5;FBXO31;PSMD7;PSMB5;ANAPC4;CDK2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.35744723829300906,1.1389831480196575,0.1715145436308927,0.9140707832560505,1.0,64/509,10.09%,FN1;ADRA1B;WNT16;PRKCB;CDH13;FGFR1;ANGPT1;NR3C2;LPAR1;NTRK3;CCL5;EDA2R;PLXNB1;JCAD;PDGFC;BBC3;NUPR1;AKAP13;GDF15;GAB1;IKBKE;WNT11;CAV1;MAVS;EP300;PMAIP1;GCNT2;EPO;TRIM25;MTDH;TRIM44;TFG;CAV2;SLC20A1;BCL2L1;RHEB;HAX1;SOX9;SHC1;MUL1;MYDGF;CC2D1A;WLS;TRIM21;GOLPH3;TGFB2;ERBB3;ILK;BAD;TNFRSF10B;UNC5B;TAB3;PPM1A;FGF22;TCF7L2;MAZ;IQGAP1;PTPN6;TNFRSF1A;TLR6;SMCR8;JMJD8;NMI;HDAC3
prerank,regulation of chemokine production (GO:0032642),-0.33896232119710684,-1.1388062957207734,0.24596774193548387,0.7077164462162115,1.0,17/36,33.15%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;TLR7;CD74;LPL;SIGIRR;PYCARD;ACKR1;IL7;HMOX1;AIF1;SNAI2;TREM2
prerank,polarized epithelial cell differentiation (GO:0030859),0.5267001150901147,1.1387753626386061,0.3268608414239482,0.9137034606120442,1.0,5/13,11.68%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3871755568372986,-1.1387614932038663,0.27759197324414714,0.7061041798178851,1.0,6/20,9.27%,TGM2;CAMK2D;ATP2A2;BCL2;SELENOK;FIS1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4459482962015637,1.138380653248454,0.3086092715231788,0.9139757454338397,1.0,12/31,22.46%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,glycolipid metabolic process (GO:0006664),0.41440334278069835,1.1380669783255328,0.2860727728983689,0.9139848177661458,1.0,13/47,15.11%,ST3GAL4;HEXA;SCCPDH;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ST3GAL6;ESYT2;SMPD2;NAGA;ST6GALNAC4
prerank,renal water homeostasis (GO:0003091),-0.37543113115672877,-1.1378972093117248,0.267515923566879,0.7067316045611521,1.0,12/23,22.18%,ADCY5;ADCY7;RAB11FIP2;ADCY1;ADCY4;AQP4;PRKAR2B;MYO5B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,regulation of cellular respiration (GO:0043457),-0.40412762788958495,-1.1375054238475946,0.2727272727272727,0.7061027393416193,1.0,12/17,42.22%,PRDM16;CBFA2T3;NOA1;SHMT2;PNPT1;TRAP1;IL10RB;IFNLR1;IFNAR1;NOS2;VCP;IL4
prerank,cellular response to calcium ion (GO:0071277),-0.28847138956195617,-1.1372815356603616,0.16774193548387098,0.7050063044547937,1.0,13/67,7.75%,CPNE8;ADGRV1;WNT5A;CAMK2D;RASGRP2;CPNE4;SYT9;PKD2;PRKAA1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,triglyceride homeostasis (GO:0070328),-0.36275558068534575,-1.137053702434044,0.2833333333333333,0.7038907650678784,1.0,9/26,27.25%,IL18;NR1H3;PNPLA8;RORA;LPL;DGAT2;FITM2;NR1H4;ANGPTL4
prerank,regulation of Ras protein signal transduction (GO:0046578),0.39524701363687537,1.1369669013011783,0.2789351851851852,0.916642642108993,1.0,22/85,12.68%,NOTCH2;KANK1;OGT;AKAP13;EPS8L2;NGF;KANK2;EPO;DLC1;DENND3;RASAL3;ARHGEF18;FOXM1;SHC1;TGFB2;OPHN1;BCR;RAF1;IRS2;RABL3;MAPKAP1;SYNGAP1
prerank,cholesterol homeostasis (GO:0042632),0.40775887878270556,1.1368589944631247,0.2977461447212337,0.9159540934667647,1.0,12/64,9.64%,LDLR;SOAT1;CAV1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,embryonic hemopoiesis (GO:0035162),-0.44537270123666395,-1.1367516516270493,0.2773109243697479,0.7029782411766783,1.0,8/12,26.94%,KITLG;KDR;SH2B3;KIT;FLT3LG;TAL1;THOC5;ATF4
prerank,response to cytokine (GO:0034097),-0.2613449494277363,-1.136751346621929,0.13432835820895522,0.7012719833097446,1.0,35/141,14.43%,PID1;LEF1;ALDH1A2;OSMR;IL1R1;SP100;IL1RAPL1;TIMP3;LIFR;IRAK2;GGT5;LGALS9;XAF1;ADAR;PTPN4;IRAK3;IFNAR2;BCL2;IL6R;IFITM3;PTPN12;GCH1;CXCL16;JAK2;TBK1;PLSCR1;TRAF6;STAT3;RIPK1;IL6ST;KLHL20;MME;YTHDC2;ADAM9;SMAD3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.4501249535187208,-1.1365958612638831,0.30256410256410254,0.6999915240153886,1.0,9/13,36.16%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1;NCBP2;CPSF4L;CPSF2
prerank,response to X-ray (GO:0010165),-0.4313510009699748,-1.1363069457014303,0.27887323943661974,0.6991579944991483,1.0,4/14,16.69%,BRCC3;IKBIP;NIPBL;BLM
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4564917787145969,1.1355177635915792,0.2947067238912732,0.9193176932956512,1.0,5/28,11.27%,CLU;NUPR1;DDRGK1;ATP5IF1;OSBPL7
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.39937799570366006,1.1353641406233332,0.2770114942528736,0.9188145965008108,1.0,20/73,19.55%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;HAX1;LATS1;RAF1;RAPGEF3;CAPRIN2;EIF4G1;ATP2B4;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,embryonic limb morphogenesis (GO:0030326),0.4411418371606482,1.1351859091794416,0.3184885290148448,0.9183704037368485,1.0,6/34,10.26%,MBNL1;GLI3;AFF3;RARG;TGFB2;TWIST1
prerank,cellular response to hypoxia (GO:0071456),0.3779118836950795,1.1350667064158884,0.267027027027027,0.917722955983489,1.0,30/126,16.96%,EGLN3;NDRG1;CPEB2;EP300;PMAIP1;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;BAD;PLK3;RBX1;TWIST1;CARD16;PSMD7;TIGAR;AQP1;HYOU1;PSMB5;SFRP1;NPEPPS;MYC;BNIP3L;MDM2;LMNA;UBC;RPS27A;STUB1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.31297198199009135,-1.1347769487177959,0.26732673267326734,0.7017952050656553,1.0,15/47,11.86%,LEF1;ENG;WNT4;HIF1A;WNT5A;TBX3;NOTCH1;TGFB1;ROCK1;TASOR;HEYL;NOTCH4;LOXL3;DLG5;HMGA2
prerank,excitatory postsynaptic potential (GO:0060079),-0.39171138013059337,-1.133870077487537,0.3081395348837209,0.7025712455670211,1.0,6/19,15.47%,GRID2;GRIN2A;GRIN2B;LRRK2;DRD2;MPP2
prerank,embryonic organ morphogenesis (GO:0048562),-0.32903638835391763,-1.1338465597604372,0.2669683257918552,0.7009489328882208,1.0,16/42,17.69%,FBN1;MFAP5;PDGFRA;DSCAML1;FBN2;SOX17;ID2;FGFR2;MEGF8;RBP4;TBX1;RYR2;NIPBL;SOX11;HOXC4;HOXD3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3637778349837345,1.133488650743044,0.24688796680497926,0.9219455955378709,1.0,48/199,16.18%,PLCL2;LAMA4;HPN;SMAD6;IL15;GDF15;WNT11;TWSG1;FOXC2;PPP2CA;BMP5;DUSP10;TIMP1;HMGCR;PROCR;RAB11FIP3;IP6K1;DOCK7;OVOL2;PARP3;RHEB;SPRED3;SOX9;PLCL1;BMP4;KLF7;CYP51A1;LGR4;SRGN;ARRDC3;GRHL2;FOXP3;PPP1R11;NFIB;RAB11FIP5;LDLRAD4;TLR4;SFRP1;GATA3;GSK3A;GSK3B;MEF2C;ATP2B4;FLCN;SYT11;ARHGDIB;RAB11FIP1;ABHD6
prerank,positive regulation of immune response (GO:0050778),0.40192199861824135,1.1330623147784484,0.29484029484029484,0.9222968450356259,1.0,13/64,17.92%,CCL5;SASH3;IL15;CD81;TGFB2;POLR3B;NMI;POLR3C;DHX9;ITGB2;POLR3G;EIF2AK4;STX4
prerank,positive regulation of histone acetylation (GO:0035066),0.47431847809338246,1.1330042486435996,0.3224852071005917,0.9214856768098492,1.0,5/23,9.14%,PPARGC1A;SMARCB1;PIH1D1;FOXP3;BRD7
prerank,calcium ion transport into cytosol (GO:0060402),-0.39173767140433025,-1.1329774823932404,0.27102803738317754,0.7016393374789115,1.0,5/21,6.04%,CACNA1C;SLC8A1;GRIN2A;JPH1;GRIN2B
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4614646175619215,1.1326714383530203,0.3045977011494253,0.9215769595197415,1.0,10/27,18.12%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;GSK3A;PIP4K2C;PRKCZ;SLC27A4;PRKCQ
prerank,organelle fusion (GO:0048284),0.46813460205576557,1.1325866961004847,0.29243937232524964,0.9208456508913765,1.0,10/22,21.21%,CHCHD3;AFG3L2;MIEF2;THG1L;VPS11;OPA1;VPS18;STX4;SPG7;MIEF1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4550364611334364,1.1324860023460388,0.31136044880785413,0.9201137513103245,1.0,7/28,12.76%,DAXX;NGF;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3453772055956674,-1.1322018503097893,0.23574144486692014,0.7020201717623091,1.0,9/31,15.65%,CDH2;BOC;MEGF10;CTNNA2;IGF2;ID2;FGFR2;MAPK12;MYOCD
prerank,regulation of cell-matrix adhesion (GO:0001952),0.40859429955180543,1.1320975889110478,0.29064039408866993,0.9203791714822622,1.0,21/64,18.58%,CDH13;UTRN;EMP2;CDK6;PTK2B;DAPK3;EFNA5;PTPRA;CASK;ADAM15;ACTG1;EPHA3;RHOA;RASA1;SFRP1;GSK3B;SLC9A1;PEAK1;VCL;DUSP3;ROCK2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.46293110941392845,1.1311043489566444,0.31420373027259685,0.9226882371421229,1.0,7/23,18.97%,NDEL1;NSFL1C;PAFAH1B1;INSC;ZW10;NUMA1;MISP
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4905723557269669,1.1310891445394418,0.32872503840245776,0.9217237335468031,1.0,5/20,12.71%,SREBF2;TTC39B;ACADL;ABCA2;LPCAT3
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4641143690811257,1.1309527241876853,0.33090379008746357,0.9211477800570141,1.0,5/26,11.47%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3818011891249122,-1.1308518471104274,0.3064516129032258,0.7040796933173563,1.0,11/22,36.26%,WNT5A;SLC7A5;TNFRSF1B;TRIL;NOD2;BTK;TRIM6;CCR2;TNFRSF14;LILRB1;LACC1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3352288775407632,-1.1306894477071463,0.25,0.7028526177202996,1.0,15/37,26.51%,PRKAG2;CEMIP;TGFB1;IRGM;SIRT2;S1PR2;EGF;SPRED1;SPHK1;DGKQ;BMP7;STOX1;TRIM6;CADM4;RIPK2
prerank,regulation of nuclear division (GO:0051783),0.47246055087907746,1.1305962604891155,0.3180473372781065,0.9213100118124563,1.0,9/20,27.05%,DAPK3;CAV2;FBXO5;PKMYT1;CUL9;KIF20B;CCDC8;CDK13;CUL7
prerank,recombinational repair (GO:0000725),0.39741859182907424,1.1304456689613167,0.29036004645760743,0.920814644246785,1.0,29/77,22.88%,FEN1;KDM4D;RECQL4;NABP2;RNF138;MRE11;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;LIG3;FAN1;UBE2N;SFR1;NBN;SMC6;ZFYVE26;RAD50;NUCKS1;ERCC4;POLN;NABP1;YY1;SWI5;SFPQ;NSMCE1
prerank,ribosomal large subunit assembly (GO:0000027),0.4684329982546124,1.1304036909981032,0.32956152758132956,0.9199275418234137,1.0,3/24,4.63%,NLE1;NOP2;PPAN
prerank,response to zinc ion (GO:0010043),-0.3616082066404111,-1.1297618341972824,0.2757352941176471,0.7037600402232795,1.0,14/25,36.28%,PAM;GLRA1;CRIP1;GLRA2;D2HGDH;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;SLC30A3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4498496852244064,-1.1296724289872824,0.31733333333333336,0.7023617611822732,1.0,3/12,2.94%,PRKG1;DOCK4;IGFBP5
prerank,regulation of telomerase activity (GO:0051972),0.4104777303868881,1.1295273439272817,0.30275229357798167,0.9218317394262499,1.0,15/45,22.43%,KLF4;NEK7;NABP2;MAPK15;MAP3K4;GRHL2;PINX1;MYC;HSP90AA1;HMBOX1;PRKCQ;PNKP;ERCC4;PTGES3;MEN1
prerank,cell proliferation in forebrain (GO:0021846),0.5392961325244602,1.128877281228748,0.3469721767594108,0.9229281994343879,1.0,6/10,25.33%,DOCK7;AKNA;HOOK3;CEP120;PCM1;NUMBL
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.38758861518151283,1.1287417099491603,0.28319623971797886,0.9223623380040092,1.0,24/72,19.88%,ZC3H12A;FEN1;MRE11;RBX1;XRN2;POLK;DNASE1L2;ERCC5;DNASE1L1;RPA3;REXO4;DCP1A;POLD2;FAN1;DDB1;PCNA;ERCC2;UBC;RPS27A;RNASE4;RAD50;RFC1;DXO;ERCC4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4419756521235545,1.128487434187417,0.32,0.9221594025363262,1.0,4/31,2.47%,PDLIM5;NGEF;EPHA4;SIPA1L1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41520658116487524,1.1284840162046814,0.3141809290953545,0.9211722835391507,1.0,8/55,8.02%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ALOX5;FOXM1;EIF6;ROMO1
prerank,lytic vacuole organization (GO:0080171),-0.3401946278782751,-1.1281273397451335,0.25190839694656486,0.7048030220678358,1.0,10/32,17.66%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;TMEM106B;CLN3;CLVS1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.47503833654363276,1.1280157098398198,0.3260553129548763,0.921761378906705,1.0,5/20,14.11%,CCL5;MTDH;LBP;TLR4;IRAK1
prerank,embryonic eye morphogenesis (GO:0048048),-0.45616728757140185,-1.1279610521672614,0.3248730964467005,0.7036329733019762,1.0,5/11,9.74%,FBN1;MFAP5;FBN2;LRP6;TBX2
prerank,peptide hormone secretion (GO:0030072),0.4675923360467524,1.1278988876498788,0.31754874651810583,0.9211416943522871,1.0,3/26,7.42%,GAL;LTBP4;CDK16
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5026660284688111,1.1277520242192547,0.33172302737520126,0.9196018873284515,1.0,8/15,24.28%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5026660284688111,1.1277520242192547,0.33172302737520126,0.9196018873284515,1.0,8/15,24.28%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,oligosaccharide metabolic process (GO:0009311),0.4097025307516027,1.1275757106482855,0.2922885572139303,0.9191781327305432,1.0,8/46,15.11%,B3GALT1;B4GALNT2;ST3GAL4;FUT8;MANBA;ST3GAL6;NAGA;ST6GALNAC4
prerank,cardiac muscle cell action potential (GO:0086001),-0.34877406646107756,-1.1271751357329856,0.2786259541984733,0.7040758269283449,1.0,10/30,15.51%,CACNA1C;DMD;SLC8A1;ATP1B1;KCNJ2;CACNA1G;FGF12;HCN2;SCN1A;SCN1B
prerank,adenine nucleotide transport (GO:0051503),-0.40374208069172846,-1.1269854801672174,0.29190751445086704,0.7029599203692586,1.0,2/17,1.27%,ABCC4;LRRC8C
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4915800348961106,1.126809512239263,0.328149300155521,0.9206105999993038,1.0,7/17,22.51%,EMC9;EMC10;GET4;EMC6;EMC2;SGTA;MMGT1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5185499832712869,1.1266400689171798,0.32781456953642385,0.9201261905101227,1.0,5/12,13.26%,PLK3;FBXO31;SDE2;CCND1;CDK2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.4909469124065785,1.1265315413856338,0.3323170731707317,0.9195166024314128,1.0,3/17,7.10%,ADTRP;ATP1A2;BMP4
prerank,positive regulation of interferon-beta production (GO:0032728),0.43733653677178635,1.1261463612849258,0.3190348525469169,0.9197726296202412,1.0,14/33,23.47%,MAVS;IRF3;POLR3B;TLR4;POLR3C;TLR3;HSP90AA1;DHX9;OAS2;POLR3G;PTPN11;FLOT1;POLR3F;POLR3D
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4520842890638205,1.1256864374674687,0.32968536251709984,0.9202983114477677,1.0,14/30,20.29%,DDX5;EP300;SMARCA4;KDM4C;NCOR1;SFRP1;NCOR2;FOXP1;KDM1A;HDAC6;PARK7;H3-3A;ZBTB7A;PRMT2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4437113388549929,-1.1254679624953048,0.2957393483709273,0.7055924741836235,1.0,3/12,12.35%,CYP26B1;EZH2;DHRS3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4555880250134947,1.1251450796951306,0.3393854748603352,0.9211304147524518,1.0,4/25,8.90%,EPHA4;PSMF1;OPHN1;PML
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3392391921131014,-1.1247489720444037,0.2536231884057971,0.7059458684542871,1.0,10/32,8.63%,SLC6A9;DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;GRIN2B;EPHB2;NLGN1;NEFL
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43417101564446703,1.1246465214927561,0.3100671140939597,0.9217254777996731,1.0,12/35,19.38%,FEN1;MUTYH;POLG;MBD4;RPA3;POLD2;LIG3;PCNA;NEIL1;PARG;RFC1;PNKP
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5146847410716267,1.124256089597051,0.34181240063593005,0.9219715940912978,1.0,2/13,3.25%,SULT1A1;SULT2B1
prerank,mammary gland epithelium development (GO:0061180),-0.428920073734,-1.1242089996056652,0.3018867924528302,0.7057706861127209,1.0,4/14,8.88%,WNT4;ID2;ERBB4;JAK2
prerank,regulation of response to biotic stimulus (GO:0002831),0.45862542577686266,1.1239126632167753,0.3008356545961003,0.9221014171064142,1.0,1/28,0.15%,CD55
prerank,tryptophan metabolic process (GO:0006568),0.5258703187517347,1.1238881131460627,0.3470394736842105,0.9212008998705415,1.0,4/11,24.59%,TDO2;HAAO;KYAT1;KMO
prerank,negative regulation of locomotion (GO:0040013),0.5290878518022487,1.1233611024756749,0.3555926544240401,0.92189602099214,1.0,7/12,17.90%,SPINT2;FBLN1;CCDC125;PTPN2;GATA3;CRK;DUSP3
prerank,cell cycle checkpoint signaling (GO:0000075),0.526962440739958,1.1228469168110689,0.3466003316749585,0.9224528923305548,1.0,7/12,20.76%,NABP2;ZW10;PLK2;ZWINT;WEE1;NABP1;CHFR
prerank,regulation of microglial cell activation (GO:1903978),0.5082162687922992,1.122729924169545,0.32701421800947866,0.9218387926037701,1.0,1/15,1.19%,LDLR
prerank,regulation of protein kinase C signaling (GO:0090036),-0.425585556194318,-1.1226678891270074,0.3116531165311653,0.7085505296310559,1.0,5/14,13.03%,ADGRV1;WNT5A;GPD1L;DGKG;FLT4
prerank,indolalkylamine catabolic process (GO:0046218),0.5327708629912499,1.1224997482984647,0.346218487394958,0.9215543869428237,1.0,4/10,24.59%,TDO2;HAAO;KYAT1;KMO
prerank,regulation of coagulation (GO:0050818),0.5290328148864184,1.1223869182600013,0.3531409168081494,0.9209212536349407,1.0,2/11,5.31%,CAV1;PROCR
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5316789481734101,1.122166449177775,0.3525535420098847,0.9206809872265115,1.0,3/11,8.02%,TIMM10;AGK;ROMO1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.38822053620312336,-1.1221596971598151,0.29152542372881357,0.7083097890603208,1.0,3/20,7.36%,PID1;DAB2;TGFB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5139004750510092,1.1221072807041252,0.350076103500761,0.9198758347635836,1.0,6/14,16.89%,IMPDH2;ADK;PAICS;GMPS;GART;ADSS2
prerank,negative regulation of cell growth (GO:0030308),0.36872411388911286,1.1219714779752676,0.28291621327529926,0.9193123258810231,1.0,27/121,15.69%,FGF13;RTN4R;OSTN;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;PSRC1;MUL1;OSGIN2;TGFB2;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;SFRP1;CAPRIN2;GSK3A;PRDM11;ULK1;FLCN;IP6K2;FRZB
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.25356551212239586,-1.121874943887999,0.1774193548387097,0.7074588928548149,1.0,42/161,16.12%,BICC1;MCC;FZD6;DAB2;IGFBP2;SOX13;WNT5A;DKK3;STK3;ANKRD6;TLE1;TMEM131L;ZNRF3;SHISA6;DAB2IP;HECW1;CHD8;PSMC6;JADE1;TBX18;DACT1;APC;GLI1;PSMA6;AMER1;SOX17;FZD4;LRP6;AXIN2;NOTUM;IGFBP4;INVS;SFRP4;NPHP3;DDIT3;CCDC88C;TMEM64;PSME1;NKD2;APC2;PSMB10;PSMD5
prerank,positive regulation of vasculature development (GO:1904018),0.3839349030934688,1.1218191941843196,0.2909090909090909,0.9188740942921434,1.0,17/94,12.43%,ADAM12;PRKCB;ITGB8;ANXA3;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;MYDGF;AGGF1;VEGFB;EMC10;TWIST1;AQP1;RAPGEF3;SP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4468082265731773,1.1210535760337341,0.3244005641748942,0.9203309917519016,1.0,14/29,25.30%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;UBC;RPS27A;UBE2D3;BIRC3;IKBKB;LY96;CASP8
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.3975490900519085,-1.120841701069307,0.26813880126182965,0.7087348744914667,1.0,9/18,11.28%,UNC13B;GRIK2;GRID2;GRIA2;CDH8;GRIK3;SLC17A6;GRIK4;GRIK1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.39069533121533173,-1.1204213414987332,0.31313131313131315,0.7083501704116411,1.0,4/20,7.36%,PID1;DAB2;PKDCC;TGFB1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.37150244196413834,-1.1203998404498687,0.30689655172413793,0.7067830009543351,1.0,5/24,13.05%,PLA2G4A;PNPLA8;SERAC1;CDS2;ABCA3
prerank,positive regulation of filopodium assembly (GO:0051491),0.45023901896667856,1.1200408757750135,0.3328611898016997,0.9226843350499213,1.0,6/24,10.36%,ARAP1;PALM;RIPOR2;RHOQ;CDC42;BCAS3
prerank,regulation of proteolysis (GO:0030162),0.4120061429869341,1.119756666263667,0.31086142322097376,0.9226615020989779,1.0,6/48,7.57%,CYFIP2;OGT;CAV1;LTBP4;PERP;BAD
prerank,cellular response to light stimulus (GO:0071482),0.3939066727208223,1.119406655778688,0.3181818181818182,0.9228826617707404,1.0,26/66,27.68%,OPN1SW;EP300;SDE2;POLK;AQP1;CNGB1;MYC;PDE6B;NEDD4;USP28;ATR;PCNA;KDM1A;EIF2AK4;TRIAP1;COPS9;ERCC4;RHBDD1;YY1;CDC25A;RPL26;EIF2S1;PTPRK;PARP1;POLD1;USP47
prerank,regulation of neuroinflammatory response (GO:0150077),0.4772203735049303,1.1189069306953914,0.3338323353293413,0.923484180852491,1.0,3/19,2.38%,MMP9;CD200;NUPR1
prerank,regulation of cell motility (GO:2000145),0.37208175392661286,1.1188455360009915,0.2779587404994571,0.9226955116684918,1.0,30/121,17.15%,PRAG1;PLXNB1;PLXNA2;ARHGAP18;CDK6;KIF2A;SPINT2;DIAPH1;SGK3;LMO4;DAPK3;MGAT3;FBLN1;CCDC125;ERBB3;SRCIN1;FGF22;PARD6B;RAF1;TWIST1;RHOA;PLXNB2;GATA3;MEMO1;LMNA;FLNA;PLXNA3;ABL1;CRK;TBCCD1
prerank,negative regulation of viral release from host cell (GO:1902187),0.5101059578345393,1.1188124570978066,0.32423756019261635,0.9218211306743084,1.0,4/13,9.30%,TRIM21;PML;TRIM11;TRIM26
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5093832773048315,1.1187139103323553,0.35202492211838005,0.9211799402117195,1.0,3/15,7.10%,NCOA3;SULT2B1;BMP4
prerank,negative regulation of cell population proliferation (GO:0008285),0.351009345474562,1.1184096389588272,0.23380566801619435,0.921200852581877,1.0,67/351,14.65%,CDH13;ZBTB7C;PTPN14;IGFBP6;KLF4;COL4A3;PLXNB1;CDKN1A;HPN;SMAD6;NIBAN2;CD200;MAGI2;NUPR1;CDK10;CELF1;CDK6;SULT2B1;NGF;PTK2B;KANK2;TNFRSF8;BMP5;DUSP10;PTPRU;DLC1;FBLN1;S100A11;RARG;TSC2;SH3BP4;SLC16A2;ZBTB17;SOX9;TES;CGREF1;BMP4;TGFB2;TGFB1I1;SLURP1;ANG;ADAMTS1;PTPN6;PML;FOXP3;BRD7;ABI1;NMI;RAF1;SOD2;GSDME;WDR6;PTPN2;PDPN;PPM1D;EEF1E1;SFRP1;GATA3;PINX1;MYC;ING4;BTG2;ITGB1BP1;TGFBR3;FLCN;HRAS;P3H3
prerank,cellular response to lipid (GO:0071396),0.3636779209813298,1.1183584905409099,0.2858638743455497,0.9204000561202325,1.0,32/191,14.13%,CFTR;ADTRP;NCOA3;VIM;RORC;PTK7;ZC3H12A;WNT11;ATP1A2;PTK2B;FAM210B;WNT6;INSIG1;LCOR;CREB1;SOX9;MSN;TRIM41;ADCY6;LBP;WNT5B;CARD16;ADAM15;AQP1;EPHA3;TLR4;RHOA;SBNO2;WNT3;SFRP1;IRAK1;MEF2C
prerank,regulation of myoblast fusion (GO:1901739),0.5355557376431783,1.1183007808139536,0.36156351791530944,0.9196229541045802,1.0,2/11,5.14%,EHD1;RIPOR2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.48126797437695235,1.1179225929014132,0.31221719457013575,0.9199051335371057,1.0,6/18,13.94%,DDX5;ZC3H12A;BMP4;MAP2K2;NCOR1;NCOR2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3634848145912637,1.1178257817832267,0.2834051724137931,0.9192421081890354,1.0,21/138,12.33%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;RARG;POLR2A;RXRB;MAZ;NR2C1;HDAC3;NCOR1;GTF2E1;DR1;TAF5
prerank,regulation of sprouting angiogenesis (GO:1903670),0.43590446114365555,1.1176591562233535,0.33288590604026846,0.9187936478311255,1.0,9/33,11.30%,KLF4;TJP1;GLUL;ALOX5;PKM;JMJD8;SYNJ2BP;JAK1;S100A1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3870593523449954,1.1175980134226302,0.3074245939675174,0.9180329553541385,1.0,16/84,14.03%,MBNL1;CELF2;DDX5;CELF1;RBFOX2;SON;LARP7;RBM8A;SRPK2;SRRM4;SRSF7;SRPK1;FXR1;RNPS1;DAZAP1;SRSF9
prerank,regulation of axon extension (GO:0030516),0.42400897604062526,1.1175062699287543,0.29733163913595934,0.9173885598567627,1.0,11/37,20.05%,ISLR2;RTN4R;OLFM1;ZFYVE27;MAP3K13;GSK3B;ABL1;SEMA3A;SHTN1;DBN1;MAPT
prerank,negative regulation by host of viral process (GO:0044793),0.5436507514006383,1.1168299645559083,0.3532110091743119,0.9185883122498628,1.0,3/10,23.17%,ZC3H12A;EIF2AK4;VAPA
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.41986758693227694,1.1160260562243263,0.32496863237139273,0.9202143070344114,1.0,10/46,8.57%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,response to chemokine (GO:1990868),0.5181623008347075,1.1153775732411377,0.3578125,0.921342090744389,1.0,7/13,14.48%,ZC3H12A;RIPOR2;DUSP1;STK39;OXSR1;RHOA;WNK1
prerank,regulation of acute inflammatory response (GO:0002673),-0.3940389395405105,-1.1148773931141323,0.2966360856269113,0.7205758834194673,1.0,3/18,12.46%,OSMR;PTGES;IL6ST
prerank,retrograde axonal transport (GO:0008090),-0.4077987414329117,-1.1146130667437848,0.29110512129380056,0.7196998289313704,1.0,7/16,18.59%,DLG2;ACTR10;KIF1A;NEFL;TMEM108;MAP1A;SOD1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.45799750348288226,-1.114567250715664,0.32608695652173914,0.718192879767292,1.0,5/10,12.24%,PDE8A;LRRK2;GPR37;RIPK1;TXN
prerank,blood vessel endothelial cell migration (GO:0043534),0.46749884662001834,1.1144612868549735,0.34008683068017365,0.9232951920826964,1.0,3/22,2.03%,ADTRP;EFNB2;EMP2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.477898921904738,1.114412297395957,0.33081570996978854,0.9224785453586165,1.0,6/19,15.36%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,skeletal muscle organ development (GO:0060538),0.4512983846961071,1.1141960021445436,0.3244047619047619,0.9221921149137805,1.0,7/26,14.13%,CAV1;STRA6;CSRP3;LARGE1;SIX1;FXR1;MEF2C
prerank,actin crosslink formation (GO:0051764),0.5146707808763508,1.1141606759265645,0.357032457496136,0.9213462112514149,1.0,1/12,0.44%,BAIAP2L1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.44052515400952913,-1.1141399657578304,0.32577903682719545,0.7176794018523569,1.0,6/12,35.36%,MAOA;HNMT;DDC;SMS;SLC22A3;SLC29A4
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4652169559948091,1.1136177916816066,0.34609720176730485,0.9221784518275083,1.0,8/24,18.32%,CLU;ALOX5;BCL2L1;CREB3;LPCAT3;OPA1;USP25;PARK7
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4324441659252142,-1.113400839637048,0.32228915662650603,0.7181071687843692,1.0,8/14,31.65%,THBS1;RGCC;ITGA4;PDCD4;CD40;PRKCI;PLCG1;CCL2
prerank,T cell proliferation (GO:0042098),-0.42727375795276495,-1.112729950080192,0.3316708229426434,0.7181882244064636,1.0,4/13,8.44%,CADM1;DOCK8;PPP3CB;CTPS1
prerank,histone H4-K16 acetylation (GO:0043984),0.4704026971693381,1.1126286200734867,0.3438395415472779,0.9243840306550574,1.0,7/19,15.95%,OGT;HCFC1;KMT2A;JADE2;ING4;MSL2;MEAF6
prerank,peptide metabolic process (GO:0006518),-0.28278200123318803,-1.1125732001669197,0.2236842105263158,0.7170128708113406,1.0,19/75,15.93%,DMD;PCSK5;AEBP1;CPD;GSTZ1;ACE;GSTT1;CPXM2;TPP1;SPCS2;CPXM1;NLN;BACE2;CPQ;ETHE1;ENPEP;MME;GPX1;CPM
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.39160932216286004,1.112457228929387,0.33775633293124246,0.9239482022436102,1.0,22/76,20.29%,NLRP2;KLF4;CD200;ZC3H12A;ANXA4;NFKBIA;COMMD7;TRIM21;NLRP2B;CHP1;PYDC1;FOXP3;COMMD6;IRAK1;CHUK;MTURN;CCDC22;OTULIN;TRIM37;CDK5RAP3;CMKLR1;PRMT2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.36744681721949346,-1.1124305166467814,0.30916030534351147,0.7158270052946475,1.0,6/25,12.88%,SHANK3;SHISA6;NLGN1;CACNG8;SHISA9;NLGN3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4307913326942772,-1.112303868459148,0.31932773109243695,0.7145450858776984,1.0,5/13,15.24%,GRIK2;SLC4A10;SHISA6;SHISA9;CLN3
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3478114439221809,-1.1122821939217227,0.29508196721311475,0.7129969168859216,1.0,11/30,28.47%,CD34;LGALS9;CD46;STAT3;HMGB1;HSPD1;NOD2;PYCARD;PIBF1;PLCG2;ISG15
prerank,regulation of mRNA catabolic process (GO:0061013),0.36499162975926563,1.1122669263411695,0.30184581976112923,0.9236039987589261,1.0,31/121,18.60%,VIM;SAMD4A;YTHDF1;ZC3H12A;SAMD4B;TNFSF13;HSPB1;PSMD11;MOV10;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;YWHAZ;CARHSP1;PSMB5;FXR1;TNPO1;DCP1A;SET;EIF4G1;IGF2BP1;UBC;RPS27A;IGF2BP2;MAPKAPK2;PSMD1;YTHDF3;PSMC4;IGF2BP3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3846761322605744,1.1122556734222668,0.308411214953271,0.9226847867254205,1.0,8/87,6.08%,FGFR1;CD44;CCL5;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.43049698305083045,1.1120642150731377,0.3257978723404255,0.922315843341048,1.0,14/33,23.62%,DDX5;EP300;DDRGK1;LATS1;KDM4C;GPAM;UFM1;KDM1A;HDAC6;PARK7;H3-3A;PRMT2;RNF14;DNAAF4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.388153257896716,-1.1095223819379474,0.33226837060702874,0.7190411261646074,1.0,6/19,9.27%,PTPRJ;KDR;VCAM1;STIMATE;GRM5;FIS1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.42962637415846217,-1.1095092017054609,0.33153638814016173,0.71746745400963,1.0,2/13,0.20%,PLCB1;IGF1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4395887931422415,1.1090797341880316,0.33707865168539325,0.930988084696433,1.0,14/30,25.30%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;UBC;RPS27A;UBE2D3;BIRC3;IKBKB;LY96;CASP8
prerank,positive regulation of mitochondrion organization (GO:0010822),0.39919748133902616,1.108951031570428,0.34525277435265106,0.9304378482655503,1.0,14/57,15.39%,PPARGC1A;MMP9;BBC3;PMAIP1;MCU;MUL1;BAD;MIEF2;ZNF205;HRK;GSK3A;GSK3B;DNM1L;DDHD1
prerank,mitochondrion morphogenesis (GO:0070584),-0.45635172285271286,-1.108483087881684,0.3436619718309859,0.7185088171200804,1.0,3/11,9.27%,PID1;MTM1;FIS1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.35207285637173746,1.107532915355103,0.2823164426059979,0.9340786355736661,1.0,49/208,17.82%,PRKCB;LPAR1;EDA2R;ZC3H12A;AKAP13;IKBKE;MAVS;TRIM59;PPM1B;HSPB1;TRIM25;MTDH;TFG;USP10;SLC20A1;OTUD7B;MUL1;CC2D1A;WLS;TRIM21;TNFRSF10B;TAB3;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;TNIP1;ZFAND6;IRAK1;CHUK;GAPDH;PLK2;GPR89A;RNF31;IKBKG;FLNA;UBE2N;CCDC22;F2R;MAP3K3;PIDD1;TAB2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3555217424692387,1.1073773455284601,0.288117770767613,0.9336114019819807,1.0,28/175,14.21%,TNFRSF11B;CCL5;EDA2R;ADAMTS7;EDA;ZC3H12A;FOXO3;TNFSF13;PTK2B;TNFRSF8;YBX3;NFE2L2;PSMD11;NFKBIA;PSMD4;COMMD7;PSMF1;ILK;PYDC1;TNFRSF1A;PSMD7;GSDME;NPNT;PSMB5;SFRP1;GATA3;ZFAND6;CHUK
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38352479514507837,1.1071391810531426,0.3329479768786127,0.9333918076570131,1.0,20/76,17.09%,CLU;TRIB2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;GSK3A;DDA1;GSK3B;MDM2;CCDC22;STUB1;KEAP1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.4352082692648389,1.1070078536811154,0.34065934065934067,0.932852611487046,1.0,15/33,26.93%,MAP3K5;NFE2L2;MAPK7;AQP1;TRPM2;ABL1;SIGMAR1;HDAC6;PARK7;RNF112;SIRPA;IL6;RHOB;RELA;RPS3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.49762298476778954,1.106542508051955,0.35760517799352753,0.9333972897543477,1.0,6/16,13.67%,GDNF;FOXD1;BMP4;SIX1;NPNT;MYC
prerank,smooth muscle tissue development (GO:0048745),0.538137181931418,1.1061613045845458,0.3615257048092869,0.933713297306483,1.0,3/10,7.10%,SMO;STRA6;BMP4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5246081083492441,1.106134834599108,0.35714285714285715,0.9328390222939861,1.0,1/11,0.58%,CD44
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.40745408566226776,1.1055447635543656,0.3374384236453202,0.9337262540786123,1.0,11/49,11.85%,MMP9;BBC3;NUPR1;CAV1;PMAIP1;BCL2L1;BAD;NDUFS3;BCAP31;GSDME;EIF2AK3
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4727461678178697,1.1053821334451897,0.33236994219653176,0.9333278185206882,1.0,3/18,7.19%,PODXL2;ITGB7;GOLPH3
prerank,proteolysis (GO:0006508),0.3512135958093055,1.1052562742728873,0.26331967213114754,0.9328133206012429,1.0,49/252,18.61%,DPP4;CPB1;TMPRSS6;CPA4;CPA3;MMP9;OGT;ADAMTS7;ADAM10;HPN;TINAGL1;ADAM33;DPP7;CTSZ;NAALAD2;KLKB1;CAPN2;CPE;DESI2;DESI1;SRGN;AFG3L2;SDE2;PITRM1;MMP12;SPCS3;RNF123;NAPSA;PSMB5;NPEPPS;PGPEP1L;PGPEP1;TASP1;MDM2;TRABD2B;SPPL2B;PRTN3;CTSH;HM13;ATG4B;BACE1;SUFU;SPPL3;USP25;CAPN15;FBXL2;SPG7;PSMC4;SPPL2A
prerank,response to insulin (GO:0032868),0.37986148918625945,1.1050995076546148,0.31627906976744186,0.9323810887503797,1.0,11/80,9.12%,SORBS1;OGT;CPEB2;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ZBTB7B;EIF6;MYO5A
prerank,cartilage development (GO:0051216),0.4125250858634462,1.1050741556840815,0.3454317897371715,0.9315075330603606,1.0,9/49,10.57%,CD44;ITGB8;ZBTB16;SOX9;DDRGK1;BMP4;WNT5B;PKD1;NFIB
prerank,regulation of cholesterol efflux (GO:0010874),0.43360512266524603,1.1049891798420828,0.33738191632928477,0.9308394014684046,1.0,5/30,9.64%,SREBF2;CAV1;TTC39B;NFKBIA;ABCA2
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.30654383397587737,-1.1048166624930957,0.27631578947368424,0.7269489853534425,1.0,6/48,7.79%,IL1R1;PDE4D;SLC7A5;LGALS9;IL18;PDE4B
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.467077632802639,-1.1047769071037103,0.3634085213032581,0.7254304909340428,1.0,3/10,2.15%,ERRFI1;ENG;ENPP1
prerank,regulation of metal ion transport (GO:0010959),0.4965168004492113,1.1044116046018806,0.3496932515337423,0.9317769106294073,1.0,2/16,2.72%,ANK2;IL16
prerank,activation of GTPase activity (GO:0090630),0.37697922548929513,1.1040239062096653,0.33061699650756693,0.9321159470842243,1.0,15/89,11.82%,ARHGAP42;NTRK3;NGEF;SIPA1L1;GRTP1;TBC1D16;TIAM2;DOCK7;ARHGAP29;CCDC125;BCR;ARHGEF5;BCAS3;SGSM2;TBC1D1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3803531635862467,1.1040113615582532,0.315606936416185,0.9312088180748825,1.0,24/87,16.76%,NOTCH2;CELSR1;ARHGAP18;CDK10;PTK2B;DAPK3;DLC1;RHOQ;EFNA5;TWF1;DMTN;IQGAP1;ARHGEF5;EZR;EPHA3;RAPGEF3;RHOA;TRPM2;CCDC88A;ARHGDIB;FSCN1;TESK1;ABL1;CRK
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5079955785179804,1.1039438918790838,0.35093167701863354,0.930477087057114,1.0,6/13,17.65%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3;SEMA3A
prerank,lung development (GO:0030324),-0.3316539299125274,-1.1038414528009195,0.29218106995884774,0.7264384526901126,1.0,12/33,16.76%,ERRFI1;GLI2;FGF2;RCN3;FGFR2;LOXL3;NPHP3;RBP4;ZIC3;ABCA3;FGF9;SOX11
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4623870491618224,1.1031217726568239,0.3502235469448584,0.9320966741300821,1.0,4/22,8.10%,ANK2;STAC3;GSTO1;JPH2
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3822977852029144,-1.1029771058447748,0.2990353697749196,0.7271564637959229,1.0,4/18,7.36%,CLASP2;RUNX1;RGCC;TGFB1
prerank,cellular response to retinoic acid (GO:0071300),0.4154138997282542,1.1029152576534158,0.3484276729559748,0.9318166892550535,1.0,10/42,12.63%,PTK7;WNT11;PTK2B;WNT6;CREB1;SOX9;WNT5B;AQP1;EPHA3;WNT3
prerank,generation of neurons (GO:0048699),0.35702633957875307,1.1028289829502638,0.2962962962962963,0.9311298170089695,1.0,19/190,8.89%,WNT16;FGF13;FGFR1;CELSR1;WNT1;NRBP2;WNT10A;WNT11;ITM2C;CDK6;WNT6;PTPRD;DOCK7;TGFB2;WNT5B;SIX1;FZD5;ACSL3;OPHN1
prerank,positive regulation of B cell activation (GO:0050871),0.40534779898267526,1.1027606455306969,0.33290816326530615,0.9304192007886429,1.0,5/50,4.80%,NFATC2;SASH3;CD81;CLCF1;SHLD2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.33438540553210117,-1.1024001865884803,0.2781954887218045,0.7271536120084443,1.0,11/33,12.90%,GRIK2;NRG3;GRID2;LRRC4C;GRIK3;NLGN1;LRP8;GRIK4;GRIK1;NLGN3;BDNF
prerank,apical protein localization (GO:0045176),0.5380209382190992,1.102307992602328,0.3724247226624406,0.9308937647221085,1.0,3/10,10.64%,CELSR1;ACTB;INSC
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4416007709648364,1.102193853517328,0.3472222222222222,0.9302981539604439,1.0,2/27,1.39%,NAPEPLD;ETNK2
prerank,response to ethanol (GO:0045471),-0.4134323314242032,-1.1021513515661487,0.32951289398280803,0.7262451532426429,1.0,8/14,25.46%,GRIN2A;ADCY7;GRIN2B;GLRA1;GLRA2;SOD1;GRIN3A;GOT2
prerank,regulation of inflammatory response (GO:0050727),0.35545613489357236,1.1021187359451292,0.29485834207764955,0.929594518234091,1.0,27/190,14.22%,AGTR1;GPR4;NAPEPLD;KLF4;CCL5;MMP9;CD200;IL17RA;NINJ1;IL15;IL16;CELF1;ALOX5;NFKBIA;AKNA;MAPK7;FEM1A;TNFRSF1A;NMI;TLR4;SBNO2;CD200R1;PTPN2;LPCAT3;GATA3;TNIP1;FOXP1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4777412808479745,1.1019937206251988,0.37367624810892586,0.9290094110291158,1.0,5/17,10.61%,COX5A;COX8A;COX7A2L;AFG1L;COX5B
prerank,cellular response to radiation (GO:0071478),0.413966995196797,1.1018681738803986,0.35271317829457366,0.9284784757508429,1.0,3/40,4.33%,OPN1SW;CDKN1A;KDM4D
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4075583430356441,-1.1017307883142968,0.31129476584022037,0.7257342322238586,1.0,8/16,20.62%,SNCAIP;MCTP2;CAMK2A;MCTP1;KCNMB4;CPLX2;FMR1;RIMS1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.39429519498160437,-1.1016914151228103,0.3364485981308411,0.7242536890517526,1.0,6/18,9.74%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5179640736613453,1.1010850432107329,0.3777429467084639,0.9299875821522944,1.0,5/12,16.89%,IMPDH2;PAICS;GMPS;GART;ADSS2
prerank,keratan sulfate metabolic process (GO:0042339),0.4351203043728106,1.101040361003358,0.34392265193370164,0.9292182055780084,1.0,7/31,13.08%,ST3GAL4;HEXA;B4GAT1;PRELP;GLB1;HEXB;ST3GAL6
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.390965228606028,1.1009498013503096,0.32063882063882065,0.9285749917059133,1.0,14/54,18.10%,CNOT6;CDKN1A;EP300;PLK3;PML;BTG2;MDM2;PLK2;E2F1;PCNA;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.499687259389404,1.100812744197046,0.3674074074074074,0.9280794756668129,1.0,3/15,6.96%,SMOX;TPH2;AANAT
prerank,negative regulation of hippo signaling (GO:0035331),-0.438654421353887,-1.100594788805671,0.35597826086956524,0.72568663062458,1.0,6/12,21.92%,WWC2;CIT;DLG5;LIMD1;MAPK14;WWC1
prerank,positive regulation of axonogenesis (GO:0050772),0.41303967560195354,1.1005003932672905,0.3160493827160494,0.9281043524107488,1.0,10/43,13.33%,ISLR2;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;ZFYVE27;RHOA;PLXNB2;MAP3K13
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4034723856120617,1.100367661353894,0.3350582147477361,0.9276271894509499,1.0,17/46,23.39%,TIMM10;TIMM44;DNLZ;TOMM5;ROMO1;PITRM1;HK1;BCAP31;TOMM20;TIMM17B;TOMM40L;TIMM9;TOMM40;TIMM50;TSPO;TIMM23;AIP
prerank,regulation of establishment of protein localization (GO:0070201),-0.4284335776245937,-1.100225323919234,0.3368146214099217,0.725132212248696,1.0,9/13,34.69%,CORO2B;DNAJA1;SPIDR;CTSD;CEP135;SCFD1;GAPVD1;TREM2;CEP295
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4438348934498777,1.099993571974508,0.3356940509915014,0.9278232712509166,1.0,10/28,18.12%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;GSK3A;PIP4K2C;PRKCZ;SLC27A4;PRKCQ
prerank,regulation of vacuole organization (GO:0044088),-0.38213669950777784,-1.0998894025819275,0.34285714285714286,0.7244080236331354,1.0,6/20,10.12%,TBC1D12;SCARB2;MTM1;LAPTM4B;TBC1D14;NPRL3
prerank,negative regulation of actin filament polymerization (GO:0030837),0.4608598295942701,1.0997083494748852,0.35774647887323946,0.9278145980718477,1.0,4/22,6.13%,KANK1;GSN;SSH3;TWF1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.354328033424684,-1.099490230464127,0.31875,0.7239175030310726,1.0,7/23,9.40%,GHR;NOTCH1;CYP1B1;ERBB4;JAK2;OCIAD1;KIT
prerank,myotube cell development (GO:0014904),0.5343612460728027,1.0992022792898022,0.38487394957983195,0.9284749221431472,1.0,4/10,8.24%,SELENON;LMOD3;CAV2;SIX1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4219198517012188,1.0991363832330856,0.3328964613368283,0.9277596795151403,1.0,12/36,18.67%,QARS1;DUSP10;SH3RF2;DUSP1;FOXM1;EZR;HDAC3;NCOR1;MYC;IGBP1;DUSP3;TAOK3
prerank,myotube differentiation (GO:0014902),0.4889966946309338,1.0987530077328622,0.3601147776183644,0.9280755260939145,1.0,1/17,0.09%,ADAM12
prerank,histone lysine demethylation (GO:0070076),0.4399593030227046,1.098312925416077,0.336986301369863,0.9284925263393425,1.0,7/25,12.31%,KDM4D;KDM4B;KDM5C;KDM3A;KDM4C;RIOX2;KDM6A
prerank,regulation of mast cell degranulation (GO:0043304),-0.4071027838742295,-1.0983046109640406,0.3147632311977716,0.7255687930816505,1.0,8/14,27.39%,LYN;LGALS9;GAB2;CD300A;CD84;FES;FER;FGR
prerank,cell differentiation in spinal cord (GO:0021515),-0.47204829841191376,-1.0982852377277126,0.3838383838383838,0.7240363359555494,1.0,3/10,14.85%,SOX13;MDGA2;SOX6
prerank,telomere organization (GO:0032200),0.4116182195379373,1.0981801925211834,0.3363286264441592,0.9279560889966079,1.0,24/43,28.08%,RECQL4;DOT1L;PARP3;MRE11;RIF1;HUS1B;RPA3;POLD2;ATR;PCNA;NBN;RAD50;H3-3A;ERCC4;TERF2;PTGES3;TINF2;APEX1;PARP1;RPA2;POLD1;TERT;XRCC5;TERF1
prerank,cellular response to UV (GO:0034644),0.3827235716708463,1.0979261805096938,0.31939605110336816,0.9278595651896245,1.0,22/76,21.08%,OPN1SW;MMP9;CDKN1A;EP300;TIMP1;SDE2;POLK;CARD16;AQP1;MYC;NEDD4;USP28;DDB1;ATR;PCNA;KDM1A;EIF2AK4;TRIAP1;COPS9;ERCC4;RHBDD1;YY1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.33758095556129397,-1.0974882965546398,0.2951388888888889,0.7245199486389939,1.0,7/30,13.03%,FLT1;KDR;ACE;TGFB1;KIT;TP53;FLT4
prerank,retinol metabolic process (GO:0042572),-0.4152923696331672,-1.097201331545535,0.336,0.7238113318968327,1.0,6/14,16.74%,CYP1B1;DHRS3;RBP4;RDH10;ADH1A;RDH11
prerank,chromatin remodeling (GO:0006338),0.36691932737280064,1.0968968935342125,0.32075471698113206,0.9301464720638143,1.0,32/100,19.58%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;HCFC1;SOX9;KDM5C;ATRX;FOXP3;ACTB;SMARCA4;KDM4C;SRCAP;DR1;MPND;BAZ2B;ACTL6B;KDM6A;MYSM1;SMARCD2;CHD3;MYC;GATAD2B;SMARCC1;GATAD1;BRDT;ARID1B;ZBTB7A;PBRM1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.45944629958477257,-1.0968631496521073,0.3622448979591837,0.7232197827984052,1.0,2/10,7.94%,PTPRJ;PTPN12
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.44948950663152926,-1.096841966784046,0.33915211970074816,0.7217419778221231,1.0,4/11,14.33%,NOS3;GCH1;SPR;DHFR
prerank,triglyceride biosynthetic process (GO:0019432),0.47914580566465576,1.09680582471511,0.3805970149253731,0.9295351880131386,1.0,4/18,11.41%,DGAT1;MOGAT3;MOGAT1;GPAM
prerank,positive regulation of translational initiation (GO:0045948),0.4703715871651811,1.0965994782223174,0.3677811550151976,0.9292397561580196,1.0,4/18,13.65%,CCL5;YTHDF1;HABP4;BOLL
prerank,cytoskeleton organization (GO:0007010),-0.2558627967059489,-1.0962840721731424,0.2087912087912088,0.721710078070667,1.0,26/114,13.46%,MAST4;MARK1;RHOBTB1;SEMA6A;FGD5;TNIK;PLCE1;RND3;FMNL3;PALLD;MICAL3;LRCH3;EPB41L3;SH3KBP1;RANBP9;BIN1;ABI2;RHOBTB3;FGD3;ARAP3;ZMYM3;CNN2;KLHL20;DES;CECR2;CNTNAP1
prerank,regulation of interferon-alpha production (GO:0032647),0.45272175323147545,1.0961298405912179,0.35074626865671643,0.9297297717070051,1.0,6/23,15.36%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5081813072089786,1.0954410978143407,0.37886178861788616,0.9308979159634955,1.0,1/12,0.58%,CD44
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.31198268122303774,-1.0953433564370572,0.30042918454935624,0.7227471538843032,1.0,9/39,12.16%,ABCA1;STEAP3;MTTP;RCN3;SEL1L;PPY;TMEM167A;TANGO2;TVP23B
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4224945870996884,-1.095268821323205,0.3463541666666667,0.7214312395867393,1.0,3/14,9.75%,RAPGEF2;PKIG;PRKAR2B
prerank,regulation of translational initiation (GO:0006446),0.38991266391817125,1.0949925943521457,0.33093525179856115,0.9313559310249728,1.0,21/63,19.26%,CCL5;YTHDF1;HSPB1;EIF2B2;EIF4EBP1;EIF4B;HABP4;EIF2AK3;EIF4G2;BOLL;EIF4G1;PAIP1;DNAJC3;EIF5B;EIF3B;CTIF;EIF1;EIF2AK4;EIF4A2;YTHDF3;EIF4EBP2
prerank,positive regulation of telomerase activity (GO:0051973),0.4214340842111861,1.0948051585938037,0.33746556473829203,0.9310432225140536,1.0,10/33,19.38%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PRKCQ;PNKP
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.48406768546193774,1.0947395860303624,0.36085626911314983,0.9303407200256489,1.0,1/17,0.15%,CD55
prerank,negative regulation of response to stimulus (GO:0048585),0.3877074787444939,1.0943824760890788,0.3402948402948403,0.9304822016796732,1.0,14/60,13.71%,CLU;KLF4;CDK6;ALOX5;MAPK7;KLF7;ERBB3;FBXO5;FOXP3;CASK;TWIST1;LPCAT3;BRAP;TLE5
prerank,sensory perception of light stimulus (GO:0050953),-0.2634131312480926,-1.0939614197658822,0.2571428571428571,0.7233095586378143,1.0,11/87,5.12%,COL1A1;ADGRV1;PCDH15;SLC4A10;COL18A1;RP2;EYA4;ATXN7;GRM8;MYO9A;COL11A1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.48572101614615415,1.0937805697005143,0.3790446841294299,0.9314573800528694,1.0,4/15,10.51%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,regulation of pseudopodium assembly (GO:0031272),0.5253662296194486,1.093217596006157,0.3716216216216216,0.9314235009287679,1.0,4/10,14.72%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5253662296194486,1.093217596006157,0.3716216216216216,0.9314235009287679,1.0,4/10,14.72%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4775810705669094,1.093140482610198,0.35901386748844377,0.9307386567122552,1.0,5/16,22.85%,RAET1E;ULBP1;VAMP7;VAMP2;ARL8B
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.44053975359991404,-1.0930013934643514,0.3361581920903955,0.724323909585149,1.0,3/12,10.86%,INSR;IRGM;IGF1R
prerank,positive chemotaxis (GO:0050918),0.4766676228805117,1.0929066029818186,0.38427947598253276,0.9305638923601226,1.0,3/17,8.46%,ANGPT1;TSC2;LGALS3
prerank,negative regulation of endocytosis (GO:0045806),0.4497978656665671,1.0928399049356554,0.35511363636363635,0.9298724705222494,1.0,7/24,11.45%,SCAMP5;CAV1;UNC119;RUBCN;LGALS3;SNX33;EPHA3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.36119630112613627,-1.0920309151032617,0.3173076923076923,0.7252067954357441,1.0,8/22,14.58%,GHR;NOTCH1;CYP1B1;ERBB4;OCIAD1;KIT;MGAT5;CRLF3
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3852732180108118,1.0915112323852458,0.34545454545454546,0.933120182014723,1.0,27/69,24.49%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;TAF5;SP1;ELL;SRRT;INTS3;POLR2C;INTS13;INTS6;POLR2E;TAF8;TBP;SNAPC3;NABP1;TAF6;GTF2E2;INTS1;CDK9;ICE1;POLR2K;ELL2
prerank,"wound healing, spreading of cells (GO:0044319)",0.44082579241172215,1.0911953511792827,0.3732193732193732,0.9331172289176991,1.0,7/24,12.50%,CD44;TMEFF2;TOR1A;MMP12;RHOA;DDR1;PDPN
prerank,positive regulation of protein catabolic process (GO:0045732),0.37264744619786916,1.0909205243936155,0.3392018779342723,0.9331016849124809,1.0,21/84,19.72%,FZR1;WWP2;MSN;EGLN2;GPC3;PLK3;RAB7A;EZR;SNX33;VPS11;GSK3A;GSK3B;NEDD4;PLK2;HSP90AA1;DDB1;NSF;ASB5;GPLD1;RNF41;IDE
prerank,glycerolipid metabolic process (GO:0046486),-0.45602931249881173,-1.0907548303684742,0.3790523690773067,0.7270652610838609,1.0,8/11,26.30%,DGKB;GAL3ST1;DGKG;PNPLA3;DGKZ;DGKQ;PIP5K1A;PLA2G15
prerank,negative regulation of cell aging (GO:0090344),0.47956069498804377,1.090534415552842,0.3665594855305466,0.9334356309931278,1.0,9/16,21.28%,WNT1;CDK6;FOXM1;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4422099499409066,-1.090183978333514,0.3224932249322493,0.7270162924914687,1.0,4/12,11.29%,SDK2;PROM1;RORB;STAT3
prerank,regulation of axonogenesis (GO:0050770),0.40271268808017213,1.089929017636932,0.3600493218249075,0.9344178519518671,1.0,8/51,4.80%,RTN4R;PLXNB1;EPHA4;PLXNA2;SIPA1L1;NGF;TIAM2;MAP6
prerank,organelle transport along microtubule (GO:0072384),0.4242906065603344,1.0897058886010296,0.3592896174863388,0.9341827428642324,1.0,9/31,20.05%,DYNC1I1;NDEL1;ARHGAP21;CDC42;PAFAH1B1;COPG1;TMEM201;RHOT2;MAPT
prerank,negative regulation of coagulation (GO:0050819),0.4894671657422529,1.0895095665287808,0.3742138364779874,0.9338805221867285,1.0,3/14,6.15%,ADTRP;PROCR;THBD
prerank,ion transport (GO:0006811),0.3613592703528619,1.0890270902386976,0.3285077951002227,0.9345287160690661,1.0,18/111,14.75%,SLC9A2;SLC9A4;TRPM3;SLC4A2;SLC20A1;CTNS;VDAC2;CNGB3;SLC9A7;SLC9A6;SLC12A4;PKD2L1;ANO6;CNGB1;VDAC1;SLC26A4;WNK1;SLC9A8
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3997672884141316,1.088528018670998,0.3445692883895131,0.935168916258893,1.0,7/50,8.73%,NXN;OGT;CAV1;PRR7;SH3RF2;FBXO5;CHP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.43473199992181,1.087752960130146,0.35488308115543327,0.9365682086010557,1.0,2/29,6.22%,ANKRD31;SYCP2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.45801496881974385,1.0877491529626921,0.33781763826606875,0.935678333638347,1.0,5/22,13.52%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,glycolytic process (GO:0006096),0.43692571244835837,1.08770321050173,0.3746556473829201,0.934902558620646,1.0,8/28,16.30%,HKDC1;PKM;PFKFB2;ENO2;HK1;GAPDH;ALDOA;TPI1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.36266897978918583,1.0875019781445705,0.34972677595628415,0.9346215413268264,1.0,30/107,21.02%,CFTR;MAP3K5;SCAMP5;BBC3;TMEM117;RNF5;TMEM259;PPP1R15A;DDRGK1;TNFRSF10B;USP19;JUN;TMEM33;BCAP31;HYOU1;EIF2AK3;GSK3B;DNAJC10;CREB3L2;CCDC47;UFM1;FICD;THBS4;CDK5RAP3;ERP27;GORASP2;FLOT1;RHBDD1;TMX1;SEC16A
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.32010107492871037,-1.0873003468176732,0.3125,0.7331009081217744,1.0,13/36,15.60%,PLCB1;LEF1;FZD6;WNT5A;NFATC1;FZD4;PPP3CB;PPP3R1;TNRC6A;PPP3CA;CAMK2A;AGO1;GNB1
prerank,myoblast differentiation (GO:0045445),0.5039475319635087,1.0871862850014071,0.3575757575757576,0.9347159319226973,1.0,2/14,2.34%,MBNL1;DDX5
prerank,regulation of lipid kinase activity (GO:0043550),-0.4396861605692776,-1.0869889587578998,0.37894736842105264,0.7324677945551705,1.0,4/11,17.97%,PIK3R1;RBL1;PIK3R3;PIK3R2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.40627414623056674,1.0869547039110985,0.3450064850843061,0.9344854392611458,1.0,6/40,8.90%,CLU;PTK2B;NUB1;DESI1;LATS1;PML
prerank,regulation of cell migration (GO:0030334),0.34106021731167463,1.0868246884346404,0.29518072289156627,0.9339740576990426,1.0,48/382,8.86%,CDH1;SEMA3D;CDH13;PHACTR1;NTRK3;SRGAP3;SRGAP2;KANK1;LAMC2;TJP1;SMO;CCL5;MMP9;PLXNB1;EPHA4;PODXL;PDGFC;DAG1;ADAM10;PLXNA2;MAGI2;WNT11;CAV1;SEMA3B;KIF2A;FOXO3;PTK2B;SGK3;LMO4;MGAT3;GCNT2;DUSP10;SH3RF2;PTPRU;DLC1;TMEFF2;DDRGK1;MAPK15;CBLL1;SLURP1;ARSB;SRCIN1;WNT5B;FGF22;MAZ;PARD6B;PIP5KL1;ELP5
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4068232254388399,1.0863441751313987,0.340153452685422,0.9345553961431314,1.0,3/40,2.30%,CLU;ANGPT1;MAGI2
prerank,cellular glucan metabolic process (GO:0006073),-0.4498885796316805,-1.0862817001266691,0.36585365853658536,0.7329405781144368,1.0,4/11,17.46%,PRKAG2;PHKA1;UGP2;GBE1
prerank,Rac protein signal transduction (GO:0016601),0.47408289153985705,1.085778926075062,0.3818443804034582,0.9354326518854378,1.0,1/18,0.37%,CDH13
prerank,oligodendrocyte development (GO:0014003),-0.40655381974119964,-1.0854507902428878,0.3324022346368715,0.7336479024048934,1.0,6/15,16.49%,EIF2B3;PLP1;TPPP;CNTNAP1;MYRF;B4GALT5
prerank,cAMP metabolic process (GO:0046058),-0.4215004968768781,-1.0853565688567475,0.34877384196185285,0.732334604405192,1.0,9/13,22.18%,ADCY5;PDE4D;ADCY7;ADCY1;ADCY4;PTHLH;ADCY2;ADCY3;ADCY8
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2566538614252572,-1.0844218820782976,0.23404255319148937,0.7333320562059925,1.0,20/109,8.38%,PLCB1;PDGFRB;PLA2G4A;PIK3R1;INPP4B;PIP5K1B;INPP5D;PIP4K2A;SYNJ2;FGF2;ARF3;PLAAT3;MTMR14;BMX;MTM1;PLEKHA8;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3790236220007717,1.0843796167419308,0.3565525383707202,0.9387814261716267,1.0,8/73,7.62%,EGLN3;COL4A3;BBC3;NGF;DLC1;MUL1;BAD;TNFRSF10B
prerank,negative regulation of phosphatase activity (GO:0010923),0.44265110288748877,1.083659846765147,0.38872832369942195,0.9400781265758733,1.0,8/25,15.21%,SH3RF2;PPP1R15A;TGFB2;CHP1;CRY2;PPP1R11;GSK3B;PPP1R1B
prerank,regulation of isotype switching (GO:0045191),0.49095398176515187,1.0829383341227132,0.3856920684292379,0.9413428320164673,1.0,3/14,9.45%,SHLD2;PARP3;RIF1
prerank,intracellular pH reduction (GO:0051452),0.42402602267977585,1.082799086116344,0.35647530040053405,0.940890636711055,1.0,10/33,20.02%,ATP6V1B1;RAB7A;DMXL2;ATP6V1D;ATP6V1E1;GPR89B;GPR89A;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,positive regulation of protein processing (GO:0010954),0.45690172955699443,1.0826239026002629,0.35650887573964496,0.9404925317591754,1.0,5/19,14.23%,HPN;GSN;KLKB1;LPCAT3;PLGRKT
prerank,myelination in peripheral nervous system (GO:0022011),-0.4248234633555434,-1.0823959702221106,0.35054347826086957,0.7372228423833529,1.0,8/13,26.10%,NF1;MYOC;CNTNAP1;SIRT2;SOD1;PRX;DICER1;NCMAP
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.45373866195211354,-1.0822202924121396,0.37701149425287356,0.7360971145437244,1.0,6/10,32.30%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3484089640201461,1.0817974362256912,0.31601272534464475,0.942133088489432,1.0,25/166,12.33%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;RARG;TAF1C;POLR2A;RXRB;MAZ;UBTF;NR2C1;POLR1C;POLR1E;HDAC3;NCOR1;GTF2E1;POLR1F;TAF5
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.43954379741473926,-1.0816619540337258,0.36578947368421055,0.7360552528142336,1.0,4/11,9.32%,NOVA1;NOVA2;ZNF445;PCBP3
prerank,lymphocyte chemotaxis (GO:0048247),-0.3144090934122026,-1.0810184823580538,0.35361216730038025,0.7363319059951361,1.0,15/34,32.38%,CYP7B1;GAS6;SLC12A2;CXCL16;PIK3CD;CCL13;CX3CL1;GPR183;CCL19;ADAM8;HSD3B7;PIK3CG;CXCL10;CCL2;CCL14
prerank,membrane assembly (GO:0071709),0.41810553215629964,1.0808433702259506,0.35733695652173914,0.944162353764144,1.0,14/34,19.38%,EMP2;S100A10;FLOT2;PTPRD;ANXA2;ANK3;NSFL1C;CHMP4B;TLCD2;VPS4A;CHMP2A;NLGN2;STX4;FLOT1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4970541608687539,1.0806785812291677,0.3763440860215054,0.9437670169799878,1.0,4/13,16.10%,CRLF1;JAK1;OAS2;CANX
prerank,Ras protein signal transduction (GO:0007265),0.3591054588771094,1.0805324464029353,0.3351063829787234,0.9433336055565423,1.0,34/137,16.37%,AGTR1;CDH13;CELSR1;CDKN1A;MRAS;RAP1B;EPS8L2;RAP1A;CDC42EP4;CDC42EP5;NRAS;KRAS;SHC1;ARHGAP29;RALGDS;JUN;GNA13;RAPGEF3;RHOA;WASF1;PDPN;RREB1;CDK2;BRAP;SHC2;SETDB1;HRAS;RAPGEF1;PLK2;USP28;ARHGDIB;RAP2C;RIPOR1;ARHGEF1
prerank,cell part morphogenesis (GO:0032990),-0.4239409199989076,-1.080526716037523,0.3982808022922636,0.7361226381793128,1.0,3/13,9.27%,PID1;MTM1;FIS1
prerank,regulation of B cell proliferation (GO:0030888),0.40051485997918407,1.0800663216991624,0.3548812664907652,0.9439142156693726,1.0,4/44,4.27%,NFATC2;SASH3;CD81;CLCF1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37505010048873355,1.0799534113234592,0.34606741573033706,0.943334988771796,1.0,16/94,11.37%,MAP3K5;CDKN1A;FHIT;DDX5;BBC3;IKBKE;PMAIP1;TMEM117;PPP1R13B;PPP1R15A;BCL2L1;BAD;TNFRSF10B;PML;ARL6IP5;PDK2
prerank,positive regulation of developmental process (GO:0051094),0.3519681003355688,1.0799105095095487,0.3544973544973545,0.9425500673760759,1.0,29/164,13.33%,PHLDB2;FGFR1;NCOA3;COBL;DAG1;NIBAN2;CCN2;MCU;GDNF;BMP5;PPP1R13L;RBM19;ZBTB16;SHLD2;ESRRB;SOX9;FOXD1;MUL1;BMP4;DVL3;FBXO5;MIEF2;RIF1;TRPM4;RAPGEF3;PTN;CPEB3;RREB1;MAP3K13
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4139314515795981,-1.0790497624208155,0.32189973614775724,0.7386172613085638,1.0,3/14,4.91%,DMD;ATP1B1;WNK2
prerank,cell projection organization (GO:0030030),0.4191791845077102,1.0789552543976841,0.3804347826086957,0.944554234715686,1.0,4/30,8.25%,PARVA;GSN;RHOQ;CDC42
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.3632715282605242,-1.0786090996563034,0.3591331269349845,0.738289118856223,1.0,5/21,8.88%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,cellular response to chemical stress (GO:0062197),0.36897206252577475,1.0783192654993696,0.3439273552780931,0.9455838842853707,1.0,10/96,5.31%,PRKAA2;PPARGC1A;CPEB2;ZC3H12A;CAV1;FOXO3;SESN2;MGAT3;NFE2L2;NUDT2
prerank,cellular response to copper ion (GO:0071280),0.47902182025241724,1.0782758331250637,0.37059724349157736,0.9448122447100197,1.0,2/16,11.19%,DAXX;AQP1
prerank,regulation of mRNA metabolic process (GO:1903311),0.5124771530245901,1.0780799600072763,0.3929712460063898,0.9445142834749035,1.0,5/11,19.65%,SLTM;SRPK2;SRPK1;DHX9;CDK11B
prerank,positive regulation of fat cell differentiation (GO:0045600),0.39845203310696425,1.07793722907383,0.3604060913705584,0.9440815512654762,1.0,12/47,13.24%,NAPEPLD;ZC3H12A;CREBL2;ZBTB16;CREB1;WDFY2;ZBTB7B;AAMDC;SIX1;TRPM4;SFRP1;RREB1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3832728488054166,1.0778665114834376,0.3694581280788177,0.9434111469458448,1.0,6/58,4.05%,SPTSSB;ST3GAL4;SGMS2;PPM1L;SCCPDH;ELOVL1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.47238916122362085,1.077726142530605,0.3929663608562691,0.9429596263576808,1.0,5/16,14.60%,NAPEPLD;ZBTB7B;SIX1;RREB1;FLCN
prerank,negative regulation of metabolic process (GO:0009892),0.39637622949711976,1.0775807189440132,0.3669950738916256,0.942512701531204,1.0,10/54,8.57%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,phosphate ion transmembrane transport (GO:0035435),0.5018591915683374,1.0775421808025112,0.3892307692307692,0.9417417254505459,1.0,4/12,14.27%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.44233083566339654,1.0773412025479292,0.3855932203389831,0.941508178952496,1.0,1/23,0.33%,DSG2
prerank,carbohydrate catabolic process (GO:0016052),0.4149039917846048,1.0773302441113233,0.3776595744680851,0.9406564120087265,1.0,11/38,16.30%,HKDC1;PKM;PFKFB2;MANBA;ENO2;DERA;HK1;GAPDH;ALDOA;NAGA;TPI1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4463243910710165,1.0772081397099496,0.38142857142857145,0.9401488883132405,1.0,6/25,14.86%,MMP9;BBC3;PMAIP1;BAD;HRK;DNM1L
prerank,positive regulation of phospholipase C activity (GO:0010863),0.40712277228569627,1.077192019311118,0.3656998738965952,0.9393186368021864,1.0,3/40,0.83%,FGFR1;LPAR1;NTRK3
prerank,pulmonary valve morphogenesis (GO:0003184),0.4732332558987728,1.077189039912804,0.3803030303030303,0.9384517258555013,1.0,5/17,7.30%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2
prerank,cochlea morphogenesis (GO:0090103),0.5201491844145335,1.0770989991799278,0.41029900332225916,0.9378703991879809,1.0,2/10,6.49%,HPN;SOX9
prerank,metanephric mesenchyme development (GO:0072075),-0.462069499988554,-1.0766601871109924,0.3769633507853403,0.742235036222725,1.0,3/10,10.74%,WNT4;PKD2;BASP1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.41791333378377077,-1.0759859808919912,0.37158469945355194,0.7425433140867931,1.0,5/13,12.28%,PDE8A;LRRK2;GPR37;TXN;RACK1
prerank,O-glycan processing (GO:0016266),-0.29615097506168153,-1.075983557970923,0.3128205128205128,0.741041215397014,1.0,15/54,17.97%,ST3GAL1;GALNT7;ST3GAL3;GALNT13;GALNT15;C1GALT1;GXYLT2;POMGNT1;GALNT2;GALNT14;GCNT1;B4GALT5;C1GALT1C1;POFUT1;GALNT9
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.42537803032653904,1.075912022678591,0.3832658569500675,0.9406601866656209,1.0,10/30,18.40%,CAV1;PPP2CA;DMTN;SRCIN1;PTPN6;MVP;PTPN2;SFRP1;PRKCZ;SH3BP5L
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3420357226407483,1.0758383871649422,0.3415384615384615,0.9399988956501014,1.0,17/214,6.64%,FN1;ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;GCNT2;DUSP10;ACKR3;FBLN1;ROS1;SPRED3;SHC1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.3398781243135004,-1.0757582585485692,0.34782608695652173,0.7401728488485827,1.0,5/26,12.55%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,regulation of vasculogenesis (GO:2001212),-0.40647585074200643,-1.0756799702200437,0.3546666666666667,0.7388524756497287,1.0,5/14,4.73%,RAPGEF2;XDH;CD34;KDR;TMEM100
prerank,activation of protein kinase A activity (GO:0034199),-0.38720654987470277,-1.0755349660445304,0.3756906077348066,0.7377343092931005,1.0,10/16,22.18%,ADCY5;ADCY7;ADCY1;ADCY4;PRRC1;PRKAR2B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.41519935002400193,1.0751973276756248,0.3663101604278075,0.9411214542233687,1.0,14/33,23.37%,PPP6R3;MRE11;GAR1;PINX1;CDK2;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;ZBTB48;SHQ1;TINF2
prerank,tryptophan catabolic process (GO:0006569),0.5000654963945884,1.0742669777933975,0.39327731092436974,0.9431222073727307,1.0,4/11,24.59%,TDO2;HAAO;KYAT1;KMO
prerank,ganglioside metabolic process (GO:0001573),-0.37112564017357147,-1.0739942117083932,0.3547400611620795,0.740474991140821,1.0,9/20,19.65%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;NEU1;ST8SIA2;GM2A;NEU3
prerank,positive regulation of innate immune response (GO:0045089),0.42379989274259344,1.0739830940348192,0.3602150537634409,0.9430739651529532,1.0,9/30,16.22%,CCL5;MAVS;LBP;POLR3B;NMI;POLR3C;DHX9;ZBP1;POLR3G
prerank,response to reactive oxygen species (GO:0000302),0.39621815743519506,1.0735398637904685,0.3686131386861314,0.9434915233157649,1.0,14/54,14.77%,MMP9;FOS;HP;PXN;PLK3;ROMO1;MAPK9;JUN;SOD2;AGAP3;PDK2;COA8;CHUK;APTX
prerank,cellular response to metal ion (GO:0071248),0.3542227182573643,1.07325539870333,0.33659066232356133,0.9434929789840037,1.0,22/123,15.30%,CDH1;PRKAA2;DAXX;MMP9;FOS;DMTN;ADD1;ANK3;MAPK9;IQGAP1;JUN;TIGAR;AQP1;SLC41A1;CPNE2;HVCN1;TRPM2;SYT6;MEF2C;CHUK;SYT11;SYT12
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3793294137718566,1.0732118074216808,0.3609112709832134,0.942760653887559,1.0,14/64,15.68%,ADTRP;ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;SLC27A3;ACADL;ELOVL6;ACSL3;FADS1;CPT2;LTA4H;GSTM2
prerank,maintenance of blood-brain barrier (GO:0035633),0.41827872903198937,1.0729928529684563,0.38376891334250346,0.9425264176408483,1.0,8/30,10.88%,TJP2;TJP1;OCLN;GJB6;LSR;LAMC1;ACTB;ACTG1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4433554088356917,-1.0729787167978488,0.35989717223650386,0.7417937450500964,1.0,6/11,14.06%,CD34;LGALS9;THBS1;PTGS2;CD46;GATA6
prerank,positive regulation of dendrite development (GO:1900006),0.5345100464029447,1.0728294437257755,0.4142614601018676,0.9421883774425157,1.0,3/10,11.84%,COBL;BMP5;PTN
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.3198161035342126,-1.0727757225395427,0.35802469135802467,0.7408619968140442,1.0,8/32,11.39%,ADGRB3;IL1RAPL1;RAPGEF2;TNIK;HECW1;SDC2;KNDC1;CDKL5
prerank,regulation of lipid storage (GO:0010883),0.4496492418789882,1.0727674157469582,0.4120956399437412,0.9415247159076179,1.0,8/22,24.07%,ZC3H12A;IKBKE;NFKBIA;PTPN2;HILPDA;FBXW7;FTO;IL6
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5129175344422684,1.072425598606117,0.38461538461538464,0.9417277796325448,1.0,6/11,25.30%,NUPR1;YBX3;PELI1;SLC25A4;BIRC3;CASP8
prerank,protein deacylation (GO:0035601),0.44909534743935925,1.072184862849414,0.3895184135977337,0.9415827476103475,1.0,7/23,18.51%,HDAC5;HDAC4;ABHD10;HDAC3;LYPLAL1;HDAC6;ABHD17C
prerank,protein-DNA complex disassembly (GO:0032986),0.46722403876006496,1.0721374569550544,0.40998487140695916,0.9408626554976391,1.0,7/16,15.63%,GRWD1;SMARCB1;SMARCA4;SMARCD2;MYC;SET;SMARCC1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.41473842606880484,1.0721204912635731,0.363758389261745,0.9400465570462307,1.0,8/37,10.99%,BBC3;NUPR1;CAV1;PMAIP1;BCL2L1;BAD;BCAP31;GSDME
prerank,positive regulation of cell adhesion (GO:0045785),-0.2740793269591206,-1.071920919435871,0.2925170068027211,0.741633127747628,1.0,17/74,14.70%,FRMD5;PTPRJ;CD47;TGM2;CXCL12;NDNF;MEGF10;JAK2;VIT;NCKAP1L;RSU1;PPP3CA;HYAL1;RET;ADAM9;ITGAV;TFE3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.38549005864819647,1.0718370346740886,0.3655514250309789,0.9400410730938122,1.0,9/54,13.25%,NXN;OGT;CAV1;PRR7;SH3RF2;TRIM21;CHP1;PIAS3;PINX1
prerank,microglial cell activation (GO:0001774),0.45403265517361063,1.0718052895001235,0.38266068759342303,0.9392785511105314,1.0,1/21,0.41%,CLU
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.49021823024251376,1.0714089884949922,0.39464882943143814,0.9396464641548493,1.0,3/13,7.69%,CD81;INSIG1;GCC2
prerank,membrane depolarization (GO:0051899),0.4362614176260558,1.0710308777798923,0.3871829105473965,0.9399615572291705,1.0,4/32,3.49%,SCN3A;CACNA1A;CAV1;CACNB3
prerank,axon guidance (GO:0007411),0.3422514015069006,1.0709948675702892,0.3607399794450154,0.9391929748525265,1.0,35/201,11.74%,ALCAM;SEMA3D;NOTCH2;LAMC2;SMO;GPC1;PLXNB1;EPHA4;EFNB2;DAG1;NIBAN2;PLXNA2;GAB1;SEMA3B;CXCR4;DOK6;LAMA5;GDNF;SPTBN2;ENAH;GFRA3;EFNA5;SHC1;MAPK7;PTPRA;KLF7;UNC5B;OPHN1;EZR;NRP2;NFIB;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5053977506836366,1.070828541211639,0.3937908496732026,0.9388102429851062,1.0,4/11,19.60%,EFNB2;TGFB2;MEF2C;GPER1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3676796317970851,1.0699400334034523,0.3615819209039548,0.9405986624592445,1.0,40/95,27.22%,FEN1;KDM4D;RECQL4;NABP2;RNF138;MRE11;RAD54L;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;LIG3;FAN1;UBE2N;MCM7;SFR1;MCM6;NBN;SMC6;ZFYVE26;RAD50;NUCKS1;ERCC4;POLN;NABP1;YY1;MCM4;SWI5;SFPQ;NSMCE1;FANCM;FBH1;MCM2;PARP1;RPA2;ZSWIM7;PALB2
prerank,sphingosine metabolic process (GO:0006670),-0.39169769042328806,-1.0696654122311096,0.353887399463807,0.7463511790617298,1.0,9/17,32.97%,ACER2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC2;ACER3;SPTLC3
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4884639767587864,1.0696323973919948,0.3953488372093023,0.9406802143289329,1.0,2/14,2.16%,LDLR;CD200
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3695512779585238,1.0695694230662414,0.35273573923166474,0.9391623880660828,1.0,18/78,16.52%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;AP2A1;FCER1G;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;CANX;DYNC1H1;AP1B1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3695512779585238,1.0695694230662414,0.35273573923166474,0.9391623880660828,1.0,18/78,16.52%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;AP2A1;FCER1G;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;CANX;DYNC1H1;AP1B1
prerank,regulation of type I interferon production (GO:0032479),0.3655690488417445,1.06949086890061,0.3811188811188811,0.9385596250416134,1.0,22/84,19.65%,IKBKE;MAVS;EP300;POLR2H;TRIM25;IRF3;MRE11;TRIM21;POLR3B;POLR1C;POLR3C;NPLOC4;IRAK1;GAPDH;DHX9;ZBP1;POLR3G;NFKB2;ILRUN;POLR3H;POLR2E;PCBP2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.484159442071787,1.069455626379516,0.39969604863221886,0.937804473656232,1.0,5/14,18.34%,KLF4;HDAC5;RHOA;ITGB1BP1;MEOX2
prerank,anion transport (GO:0006820),-0.32368959436476197,-1.0693051079337026,0.35074626865671643,0.7458329761831874,1.0,4/33,1.71%,SLC13A3;LRRC8C;SLC26A7;SLCO2B1
prerank,mitotic recombination (GO:0006312),-0.3913745281895832,-1.0692365340399395,0.36538461538461536,0.7445323948319611,1.0,10/15,29.14%,MSH3;RAD51D;RAD54B;SMC5;ERCC1;RAD51;TEP1;TPRKB;GEN1;RAD52
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.39539927901148114,1.069200560432619,0.37957124842370743,0.9377448291758329,1.0,8/47,12.21%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ROMO1;TLR6;TLR4;TGFBR2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36665466699346816,1.0690890969610363,0.3565714285714286,0.937248339300419,1.0,15/85,12.90%,CELSR1;WNT1;MAGI2;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;CDC42;FZD5;PSMD7;RHOA;AP2A1;PSMB5
prerank,cell-cell junction assembly (GO:0007043),0.37558078540253415,1.0689766482818546,0.3871763255240444,0.9367337295389161,1.0,11/63,11.68%,CLDN11;TJP1;PKP4;CTNNA1;GJB6;CD9;PATJ;PARD6B;ACTB;ACTG1;RHOA
prerank,activation of protein kinase B activity (GO:0032148),-0.33344393243710857,-1.068928502208963,0.3412698412698413,0.7438541157722627,1.0,5/29,5.68%,IGF1;INSR;GAS6;WNT5A;IL18
prerank,endocytic recycling (GO:0032456),0.3923014081980872,1.0685811791118496,0.36855345911949683,0.9370706585485754,1.0,11/50,16.35%,RAB17;EHD1;RAB11FIP3;RAB7A;LMTK2;RAB35;SNX12;VPS52;WASHC1;CCDC22;VPS50
prerank,protein K48-linked ubiquitination (GO:0070936),0.3861571329398992,1.0685168447227187,0.36246786632390743,0.9364197205975228,1.0,12/54,17.01%,RNF152;RNF5;UBE2G2;RBX1;RNF146;UBE2B;RNF126;PELI1;UBR5;UBE2H;BFAR;UBE2D3
prerank,protein kinase A signaling (GO:0010737),0.5030645668100509,1.0684727573498551,0.38871951219512196,0.9357085377844475,1.0,2/12,9.98%,GAL;EZR
prerank,protein ADP-ribosylation (GO:0006471),-0.34392328757660573,-1.0682794899885177,0.36042402826855124,0.7442050233345534,1.0,6/28,9.16%,ZC3HAV1;PARP12;ART3;PARP14;TNKS;PARP8
prerank,protein depolymerization (GO:0051261),0.4458622233379276,1.0681955162908603,0.3921015514809591,0.9356953298915255,1.0,6/27,11.67%,GSN;MICAL2;KIF2A;TWF1;MICAL1;VPS4B
prerank,snRNA transcription (GO:0009301),0.3757832241081779,1.0679708618934376,0.3802647412755716,0.935507228891965,1.0,27/70,24.49%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;TAF5;SP1;ELL;SRRT;INTS3;POLR2C;INTS13;INTS6;POLR2E;TAF8;TBP;SNAPC3;NABP1;TAF6;GTF2E2;INTS1;CDK9;ICE1;POLR2K;ELL2
prerank,cellular protein modification process (GO:0006464),0.32990223215594217,1.0678233362991587,0.237,0.9350726422372301,1.0,215/982,18.67%,FN1;EGLN3;PRKCB;UST;MSLN;FGFR1;PTPN14;FBXL7;B3GALT1;PRKAA2;F5;LIMK2;FAM20C;PRAG1;FBXW8;ST3GAL4;NRBP2;MAP3K5;TRIB2;PRSS23;GRK5;ADAM10;TSSK6;TSSK4;PENK;PIGU;IKBKE;WNT11;NEK7;CDK10;CDK6;PDF;ASB14;FBXL20;PPM1L;MKNK2;PTK2B;SGK3;DAPK3;PPP2CA;ATE1;SPSB4;GCNT2;DUSP10;DAPK1;LARGE1;SERPINC1;TIMP1;ZBTB16;WWP2;PPM1B;PTPRU;PTPRD;CDKL2;PSMD11;DUSP12;DUSP1;CDK4;NUB1;UBLCP1;ANO8;MGAT1;ROS1;ELOB;CREB1;PHKA2;RNASEL;PARP3;MACROD1;STK39;SIK3;KLHL21;NPC1;DDOST;CSK;PSMD4;PTPRF;PTPN9;PSMF1;PTPRA;BMP4;WSB2;TGM5;CPE;TGFB2;CDK16;GPC3;ILK;PP2D1;FEM1C;FEM1A;LATS1;SUMF1;DYRK1B;LAMC1;PPM1A;FBXL18;FBXO31;GPAA1;MAPK9;PTPN6;RBX1;AURKC;OXSR1;MANBA;BCR;LMTK2;TXK;MTMR3;LAMB2;COP1;PIGT;SRPK2;PSMD7;CDKL4;GRK2;JAK1;DCUN1D1;FBXW9;FEM1B;CALU;PDK2;SUMF2;PARP6;PTPRE;CSNK1E;ALG1;KLHL13;YWHAZ;SOCS2;EIF2AK3;CP;PPP1CB;TGFBR2;MARK4;DCAF6;COPS5;CDK18;ALG5;PPM1D;SRPK1;PSMB5;UBXN7;ST3GAL6;CDK2;MAP3K13;LGALS1;CHML;ARF4;GSK3A;DDA1;ASB7;IRAK1;GSK3B;CHUK;ULK1;TULP4;WNK1;SOCS6;DCAF17;RAB1B;NUS1;SERP2;DNAJC3;NTAQ1;CDC42BPA;PPP2CB;PIGS;PLK2;ASB6;TNKS2;DUSP11;PRKCSH;JMJD4;DDB1;AAK1;CCDC22;ASB3;FBXL15;CAND1;PTPN13;ATG4B;ASB8;MAP3K6;ABL1;PAK6;CUL9;PEAK1;PRKAG1;UBE2F;UBE2D3;MAPK6;KEAP1;PRKCZ;EIF2AK4;MAPKAPK2;CDC25B;CHEK2;PTP4A2;BMPR1A;USP25;PDP1;PSMD1;RPN2;FBXL2;YES1;PARP2;PARK7;RARA;PSMC4;STK24;ROCK2;PPP2R5E;RSKR;TAOK3
prerank,mitochondrial gene expression (GO:0140053),0.4031814753918529,1.067754513222392,0.3626943005181347,0.9344210363986936,1.0,11/42,17.38%,MRPS16;FOXO3;MRPL2;HARS1;MRPS7;LARS2;MRPS34;MRPL57;MRPS15;MRPS28;GATB
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.45533767119475266,1.0676736258316992,0.4057971014492754,0.933825454712819,1.0,6/21,11.39%,HKDC1;PGM2;PGD;DERA;HK1;RPIA
prerank,regulation of Notch signaling pathway (GO:0008593),0.3669450570770672,1.0675083518709592,0.3741258741258741,0.9334618305661838,1.0,8/76,4.54%,TSPAN5;WNT1;PRAG1;ELF3;SREBF2;NIBAN2;EP300;WWP2
prerank,negative regulation of calcium ion transport (GO:0051926),0.471699589359846,1.0674709807896856,0.3878504672897196,0.9327470071847133,1.0,2/15,4.49%,ATP1A2;EPO
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4466978011774097,1.0672787620010016,0.40459110473457677,0.932453159044079,1.0,6/20,12.09%,DGAT1;SLC25A1;ACSL3;FASN;ACACA;SCD5
prerank,membrane repolarization during action potential (GO:0086011),-0.4019844972285384,-1.0671161756166214,0.3875338753387534,0.7457460866548297,1.0,4/13,24.05%,ATP1B1;KCNJ2;KCNIP2;YWHAE
prerank,positive regulation of programmed cell death (GO:0043068),0.33718959898401196,1.0670267091413415,0.3367451381780962,0.9323515762650002,1.0,61/272,17.71%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;AKAP13;TNFAIP8;ARHGEF12;PMAIP1;NGF;PRR7;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;ARHGEF18;HOXA5;BMP4;PNMA2;BAD;LATS1;TNFRSF10B;NLRP2B;PIP5KL1;JUN;ARHGEF5;ADAMTSL4;TRIO;APBB1;ARL6IP5;GNA13;GADD45B;ANO6;MARK4;HRK;EEF1E1;SFRP1;SOS2;RNPS1;ING4;BNIP3L;FLCN;DNM1L;IP6K2;FRZB;E2F1;ZBP1;ARHGEF1;ABL1;UBC;RPS27A;PLEKHG2;SIAH1;SLC27A4;HDAC6;PIDD1
prerank,endocardial cushion development (GO:0003197),-0.36918741964963075,-1.0667657128067287,0.32525951557093424,0.7451706834186755,1.0,6/21,9.74%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,ribosome assembly (GO:0042255),0.3964701800294794,1.0665604015995105,0.38471502590673573,0.9329403519324685,1.0,19/47,28.47%,NLE1;NOP2;PPAN;MRPS7;EIF6;RPSA;PWP2;RPL6;RPS28;EFL1;C1QBP;EIF2A;RPS27;RRS1;MDN1;NOP53;DDX3X;RSL24D1;RPL24
prerank,apoptotic mitochondrial changes (GO:0008637),0.410841746382286,1.0664362592477978,0.3997233748271093,0.9324968659107399,1.0,5/32,10.75%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.48870948641696016,1.0658829994681318,0.3990306946688207,0.9333185734478502,1.0,4/13,13.24%,NAPEPLD;ZBTB7B;SIX1;RREB1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.33567151244290405,-1.0656041704838803,0.3498233215547703,0.746699784427318,1.0,9/30,15.51%,CACNA1C;GJC1;GPD1L;KCNJ2;CACNA1G;FGF12;RYR2;SCN1A;SCN1B
prerank,phosphate ion transport (GO:0006817),0.47155040564870676,1.0653736409808228,0.40667678300455234,0.9339897196643749,1.0,4/16,14.27%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4683408756038677,1.064900737565154,0.37709923664122136,0.9344937603551766,1.0,4/18,7.57%,PMAIP1;BCL2L1;MUL1;BAD
prerank,RNA processing (GO:0006396),0.34209617241596113,1.0647833904243236,0.35355648535564854,0.9340059121799115,1.0,52/176,22.29%,MBNL1;CELF2;PPARGC1A;SRSF2;CELF1;YJU2;PPP2CA;SON;SNRPB;RNASEL;LSM4;DDX39B;XRN2;TENT4A;RBM8A;LUC7L3;SF3B3;USP39;SRPK2;SRRM4;SRSF7;SF3A2;DDX47;ZCCHC8;SYNCRIP;HNRNPUL1;SRPK1;TUT7;RNPS1;SRSF9;PABPN1;DUSP11;MAGOHB;MAGOH;TSEN2;CLP1;PRPF6;RBMS2;SRSF1;PTBP1;SRSF5;ZMAT5;CSTF3;DDX20;WBP4;SF3A3;THOC1;PRPF8;TUT1;DDX23;SFPQ;U2AF1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.32071362136998033,-1.064385712132395,0.3805668016194332,0.7484680583385894,1.0,10/33,14.46%,DNAJC6;DNM3;SYNJ2;SYT1;NLGN1;ITSN2;NLGN3;AMPH;STON2;FCHO2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3507084842239978,1.0643741158189612,0.3807982740021575,0.9343541132558045,1.0,31/132,15.33%,RNF152;PRKAA2;TPCN1;ZC3H12A;ABCD1;ABHD5;FOXO3;DAPK1;MTDH;ORMDL3;SH3BP4;MOV10;PFKFB2;MSN;TRIM21;BAD;MTLN;EZR;TWIST1;SNX33;IRS2;VPS11;ZSWIM8;TFEB;GSK3A;GSK3B;ULK1;FLCN;GRSF1;PLK2;HSP90AA1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.4914610252228564,1.0631422959570203,0.3983739837398374,0.937180093497076,1.0,3/12,8.44%,PODXL;MAGI2;IQGAP1
prerank,organic hydroxy compound transport (GO:0015850),-0.3159306721977357,-1.0630072459142712,0.3783783783783784,0.7508293345774533,1.0,5/36,6.95%,ABCC4;SLCO2B1;SLCO1C1;NCOA1;SLC16A1
prerank,carnitine shuttle (GO:0006853),0.4991206926490813,1.0629325808550913,0.41223832528180354,0.9369755731456255,1.0,4/11,12.43%,PRKAA2;CPT1B;ACACA;CPT2
prerank,protein kinase B signaling (GO:0043491),0.4408126619987377,1.0628508091387598,0.3903133903133903,0.936372700316744,1.0,4/23,7.64%,ADTRP;CCL5;TSC2;PLK3
prerank,cytoplasmic microtubule organization (GO:0031122),0.3833985509510888,1.0628402626793207,0.37163814180929094,0.9355774842578646,1.0,20/54,24.80%,LIMK2;CLIP4;PLK3;CHP1;HOOK1;EZR;VPS4B;RHOA;CCDC88A;DYNC1H1;CAMSAP1;NUMA1;KATNAL2;HOOK3;TUBGCP5;MAPT;TRPV4;PCM1;CEP126;SLK
prerank,translation (GO:0006412),0.33983169111522243,1.0628254564299562,0.359504132231405,0.934788998006697,1.0,61/208,21.07%,MRPS16;EEF1A1;MRPL24;EPRS1;QARS1;MRPL37;MRPL2;VARS1;FARS2;HARS1;TMA7;RPS4X;MRPS7;RPSA;ABCF1;RPL31;LARS2;MRPS34;RPL22;GSPT2;AARS1;MRPS33;RPL28;MRPL57;SRBD1;RPS26;MRPL9;COPS5;EEF1E1;TARS1;EEF1D;YARS1;TNIP1;HARS2;RPL10A;EIF4G1;SARS1;SARS2;RRBP1;MRPS15;RPL14;MRPS18C;MRPS28;EEF2;RPS27A;GATB;FARSA;HBS1L;IGF2BP3;FARSB;RPL6;DARS2;EIF4EBP2;TRMT112;RPS28;NARS1;ETF1;RPL41;EEF2K;RPLP2;YARS2
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.37932833731384086,-1.0626185845837486,0.37267080745341613,0.7503646780650789,1.0,4/19,3.87%,PARD3B;DLG2;ERBIN;LRRC7
prerank,pharyngeal system development (GO:0060037),0.475032120292573,1.0624420249464408,0.4105754276827372,0.9351036550674064,1.0,5/15,17.63%,BMP5;BMP4;TGFB2;GATA3;BMPR1A
prerank,granulocyte differentiation (GO:0030851),0.4676751692504429,1.0619526282707499,0.4160475482912333,0.9357230324145215,1.0,7/18,18.50%,CDKN1A;EP300;CDK4;PML;CDK2;E2F1;RARA
prerank,regulation of protein transport (GO:0051223),0.4215594919436098,1.061819180186516,0.3635077793493635,0.9352901426136432,1.0,6/27,14.15%,NDEL1;WWP2;CHP1;LLGL2;SNX12;RHBDF2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.4322385810240665,-1.061779032271215,0.3726027397260274,0.7510774079422989,1.0,4/12,14.37%,PRKD1;SAP30BP;ING2;NIPBL
prerank,establishment of endothelial barrier (GO:0061028),0.42353327778469835,1.0617033470662887,0.39381153305203936,0.9348032538273324,1.0,10/29,15.63%,TJP2;TJP1;RAP1B;RAP1A;MSN;EZR;RAPGEF3;RAB1B;RAPGEF1;RAP2C
prerank,negative regulation of catabolic process (GO:0009895),0.39705956759493083,1.0616456995229515,0.36610608020698576,0.9341521944323646,1.0,10/47,12.26%,NUPR1;HDAC4;HMGCR;AZIN1;CYP51A1;BANP;SF3B3;TIGAR;NCOR1;SNX12
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5097525960082422,1.0610789218791277,0.41086587436332767,0.9350127030725333,1.0,5/11,22.54%,MAP3K5;ARL6IP5;PRODH;STK24;DIABLO
prerank,pulmonary valve development (GO:0003177),0.4633469749480282,1.059795974320107,0.4084720121028744,0.9380177159623841,1.0,6/18,8.88%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2;TNFRSF1A
prerank,mitochondrial fusion (GO:0008053),0.44956765321988573,1.059168478368108,0.3961424332344214,0.9390634225439041,1.0,8/18,21.21%,CHCHD3;AFG3L2;MIEF2;THG1L;OPA1;SPG7;STOML2;MIEF1
prerank,positive regulation of developmental growth (GO:0048639),-0.299577365275224,-1.0587768766811227,0.33175355450236965,0.7578479026829454,1.0,9/49,12.90%,PLCB1;GHR;INSR;SEMA7A;SYT1;ITSN2;CDKL5;MACF1;BDNF
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.4458325230370058,-1.0587120900313682,0.3631713554987212,0.7565655038878345,1.0,2/10,4.03%,LYN;FAS
prerank,phagosome acidification (GO:0090383),0.4290587764155804,1.0582453583839375,0.3796940194714882,0.9409620749854024,1.0,7/26,20.02%,ATP6V1B1;RAB7A;ATP6V1D;ATP6V1E1;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,copper ion homeostasis (GO:0055070),0.45959742239831464,1.0581040543497067,0.4243827160493827,0.9405439366179025,1.0,6/17,19.55%,COX19;SLC31A2;CCDC22;XIAP;ABCB6;APP
prerank,regulation of protein phosphorylation (GO:0001932),0.33354445413577005,1.0578586768088418,0.3609406952965235,0.9403846253806607,1.0,34/256,10.43%,FN1;ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;OCLN;ZC3H12A;MAVS;SESN2;PPP2CA;KDM4D;HSPB1;FBLN1;EFNA5;TWF1;KRAS;WDFY2;SOX9;MYDGF;BMP4;CCND2;ILK;DVL3;FGF22;PIP5KL1;CHP1;VEGFB;PML;FKBP8;CCND1;HDAC3;MUSK
prerank,negative regulation of viral process (GO:0048525),0.38387082925771066,1.0577464828353729,0.3845208845208845,0.9399221193188408,1.0,14/57,16.94%,CCL5;SLPI;MAVS;RNASEL;TRIM21;LARP7;PML;TRIM11;TRIM26;SRPK2;SRPK1;TNIP1;OAS2;HEXIM1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.433774844954955,1.057591465785074,0.3854014598540146,0.9395682126133189,1.0,2/25,2.20%,B3GALT1;B4GAT1
prerank,positive regulation of apoptotic process (GO:0043065),0.33413994792512186,1.057318148872609,0.3709349593495935,0.9395388822318754,1.0,67/293,17.71%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;NUPR1;ZC3H12A;AKAP13;TNFAIP8;ARHGEF12;PMAIP1;NGF;PRR7;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;DLC1;RARG;ARHGEF18;HOXA5;BMP4;PNMA2;TGFB2;BAD;LATS1;TNFRSF10B;NLRP2B;PIP5KL1;JUN;ARHGEF5;ADAMTSL4;TRIO;APBB1;SRPK2;ARL6IP5;GNA13;GADD45B;ANO6;HRK;EEF1E1;SFRP1;SOS2;RNPS1;TLE5;ING4;PRDM11;BNIP3L;FLCN;DNM1L;IP6K2;FRZB;E2F1;ZBP1;ARHGEF1;ABL1;BACE1;UBC;RPS27A;PLEKHG2;SIAH1;SLC27A4;PIDD1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4278918539134584,1.057277945115051,0.3900709219858156,0.9388272670064867,1.0,4/27,7.73%,CPA4;EP300;KAT6B;MORF4L2
prerank,activation of phospholipase C activity (GO:0007202),0.42140878032560425,1.0572148046274736,0.3873994638069705,0.9381973072215561,1.0,4/29,11.46%,LPAR1;ANG;TXK;GNAQ
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3798835524128533,1.057027066958776,0.38246041412911086,0.9379430775882613,1.0,15/53,16.20%,DDX5;EYA2;PMAIP1;NSMCE4A;SPRED3;EYA1;TIGAR;ABRAXAS1;EEF1E1;FXR1;MYC;DHX9;ATR;PCNA;UBE2N
prerank,potassium ion transport (GO:0006813),0.3474729566806312,1.0568511167706343,0.3864894795127353,0.937638687140926,1.0,18/120,14.75%,SLC9A2;SLC9A4;HPN;NALCN;ATP1A2;KCNJ13;ABCC8;CHP1;KCNA4;SLC9A7;SLC9A6;KCNB1;AQP1;PKD2L1;KCNA5;KCNQ5;TMEM175;SLC9A8
prerank,regulation of fatty acid oxidation (GO:0046320),0.4724329726899019,1.0566123043118407,0.4110236220472441,0.9375196360848265,1.0,4/16,7.53%,PPARGC1A;ABCD1;SOX9;ACADL
prerank,cellular response to oxygen-containing compound (GO:1901701),0.337414889503107,1.0561233176378761,0.37714863498483314,0.9381263161490635,1.0,52/291,14.32%,CFTR;NCOA3;MMP9;VIM;RORC;PTK7;RAP1B;ZC3H12A;WNT11;RAP1A;PTK2B;FAM210B;FOS;SESN2;WNT6;DAPK1;SH3BP4;INSIG1;LCOR;CREB1;DMTN;SOX9;PXN;AANAT;CAPN2;TRIM41;ADCY6;LBP;ROMO1;WNT5B;MAPK9;JUN;SHMT1;ACTB;EZR;CARD16;AGAP3;AQP1;PDK2;EPHA3;TLR4;RAPGEF3;RHOA;SBNO2;WNT3;SFRP1;CPEB3;CDK2;IRAK1;MEF2C;CHUK;ATP2B4
prerank,response to interferon-beta (GO:0035456),-0.34625113400541163,-1.0559770974096576,0.3448275862068966,0.7625582136835588,1.0,9/22,20.11%,XAF1;AIM2;IFNAR2;IFITM3;PLSCR1;IRGM;SHFL;HTRA2;BST2
prerank,carboxylic acid metabolic process (GO:0019752),-0.3135682280344487,-1.0559407747944873,0.34074074074074073,0.7611604606319687,1.0,5/33,4.84%,PLA2G4A;ST3GAL1;SLC2A1;PTGIS;CSGALNACT1
prerank,protein import (GO:0017038),0.3655805532653661,1.0557427829248385,0.3886966551326413,0.9384499886667023,1.0,23/84,18.84%,CLU;PEX26;ABCD1;IPO7;TSC2;NUP93;HSPA4;TNPO2;SNX33;MMP12;SLC25A17;NXT2;TNPO1;HEATR3;PXMP4;RANBP6;HSP90AA1;IPO4;RAB8B;CSE1L;PPP1R10;PEX3;PEX2
prerank,gliogenesis (GO:0042063),0.48320897847149696,1.0556711264192116,0.4069400630914827,0.9378262552243619,1.0,4/15,10.57%,CDK6;CD9;TGFB2;NFIB
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3585298514664903,-1.0555682233817685,0.33630952380952384,0.7607570800434406,1.0,5/19,9.61%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,myelin assembly (GO:0032288),0.5109301286847459,1.0554576359498236,0.4169381107491857,0.9376188472953862,1.0,3/10,9.64%,GPC1;CD9;ABCA2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.41082893956373384,1.0552811033000338,0.4062927496580027,0.937308513738769,1.0,10/38,16.97%,CLU;KLF4;ZC3H12A;CAV1;DDAH2;TLR6;TLR4;ATP2B4;HSP90AA1;ASS1
prerank,protein destabilization (GO:0031648),0.4144495074511324,1.0551378429623106,0.3853459972862958,0.9369397496038655,1.0,8/32,18.84%,GSN;EP300;MUL1;TRIM21;SERF2;MDM2;CTSH;PEX2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.36080640375405115,1.05497732186107,0.38497652582159625,0.9365586284657842,1.0,15/76,13.72%,ANGPT1;ZC3H12A;CAV1;HDAC4;MUL1;CENPS;DCUN1D5;HDAC3;HSPBP1;SAE1;DCUN1D1;PIAS1;PIAS3;GSK3A;TNIP1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3716587551942375,1.054532662225505,0.38044758539458184,0.9370248160049547,1.0,9/76,8.25%,BAIAP2L1;NTRK3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;HAX1;CDC42
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4881464224223679,1.0541892664357804,0.4305993690851735,0.9372004400890636,1.0,3/13,11.59%,NR3C2;BMP4;CALCOCO1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.39252474486853484,-1.0533012952106218,0.3858695652173913,0.7655527023095393,1.0,6/14,32.49%,FANCB;WDR48;MRNIP;ERCC6;WRAP53;RAD51AP1
prerank,mononuclear cell differentiation (GO:1903131),-0.3485349875596596,-1.0529908372028332,0.38652482269503546,0.764979492930085,1.0,4/24,2.84%,IL31RA;LYN;GAS6;AXL
prerank,ethanol metabolic process (GO:0006067),0.48702497558298596,1.0529641712355677,0.400990099009901,0.9399752609033806,1.0,2/12,3.00%,SULT1A1;ADH7
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.2607919278607042,-1.0528434818466785,0.3442622950819672,0.7638878563119363,1.0,33/94,27.37%,CEP250;IQCB1;CCP110;CEP78;ALMS1;TMEM67;NDE1;AHI1;PRKAR2B;TCTN1;CEP162;C2CD3;SCLT1;NEDD1;CSNK1D;SDCCAG8;TCTN2;TCTN3;B9D1;NPHP4;CKAP5;CEP41;MAPRE1;RPGRIP1L;HAUS4;HAUS7;CEP72;SSNA1;YWHAE;TUBB4B;B9D2;HAUS6;CEP131
prerank,regulation of mRNA stability (GO:0043488),0.3441463064491704,1.0524838922584454,0.3732470334412082,0.9405400370494812,1.0,36/145,18.60%,VIM;SAMD4A;YTHDF1;CELF1;SAMD4B;TNFSF13;GDNF;HSPB1;PSMD11;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;TBRG4;YWHAZ;CARHSP1;PSMB5;FXR1;TNPO1;DCP1A;SET;EIF4G1;PAIP1;E2F1;MEX3D;IGF2BP1;UBC;RPS27A;IGF2BP2;MAPKAPK2;PSMD1;YTHDF3;PSMC4;ROCK2;IGF2BP3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.475991912136546,1.0523065083571164,0.4258064516129032,0.9402575260158312,1.0,3/14,6.47%,MMP9;CAV1;SPRED3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.31724405746530426,-1.052292177262202,0.3686274509803922,0.7639150386105555,1.0,5/31,9.01%,ENG;ZFPM2;NOTCH1;TGFB1;FGFR2
prerank,regulation of response to external stimulus (GO:0032101),0.3487383301082465,1.0517641028581368,0.36830601092896176,0.941067604231414,1.0,7/121,2.89%,CD55;AGTR1;EFNB2;GUCY2F;CAV1;CXCR4;CELF1
prerank,glycoprotein biosynthetic process (GO:0009101),0.364279439690175,1.0513832898756248,0.3911525029103609,0.9413612787802854,1.0,17/79,14.67%,B3GALT1;ST3GAL4;CHST12;GCNT2;LARGE1;CHST11;MGAT1;NPC1;DDOST;GOLPH3;CHST13;ALG1;ALG5;ST3GAL6;TNIP1;NUS1;SERP2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.35384042182592207,1.0513597923022957,0.37767756482525366,0.9406141344871694,1.0,20/100,14.97%,CLU;OGT;TRIB2;FHIT;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;DESI1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;GSK3A;DDA1;GSK3B;MDM2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4319202764333374,-1.0513305050671633,0.39841688654353563,0.7650372329027123,1.0,8/11,41.95%,TP53;DDIT3;ATF3;ATF4;HSPA5;ATF6;ATF6B;CREB3L1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.34332967821381427,1.0512731665636188,0.38692390139335475,0.9400625759021308,1.0,27/129,13.66%,SCEL;KANK1;PTK7;TMEM198;CAV1;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;LGR4;PPM1A;RNF146;ADGRA2;UBE2B;PRDM15;PSMD7;TRPM4;CSNK1E;PSMB5;SFRP1;CAPRIN2;UBR5
prerank,regulation of protein export from nucleus (GO:0046825),0.43689117378726966,1.0511694639439906,0.4084919472913616,0.9395523385521415,1.0,9/23,22.86%,PTPN14;TCF7L2;BAG3;RAPGEF3;GSK3B;PARK7;XPO4;SIRT7;TPR
prerank,ceramide metabolic process (GO:0006672),0.3805913302171249,1.0510978765942371,0.39397741530740277,0.9389631600737255,1.0,7/49,11.15%,SPTSSB;SGMS2;PPP2CA;ORMDL3;AGK;ABCA2;CERS2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.42524238382320706,1.0506291831845167,0.4158273381294964,0.939443462334059,1.0,1/24,0.14%,SORBS1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.466928769938354,1.0504404412664459,0.41809672386895474,0.9391912471745454,1.0,2/15,6.02%,CLU;BCL2L1
prerank,translational termination (GO:0006415),0.3566856394427541,1.0502742920390482,0.39265212399540755,0.9388547153234784,1.0,43/95,28.74%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;GSPT2;MRPS23;MRPS33;MRPS27;MRPL57;MRPL9;MRPL50;MRPS15;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MTRF1L;TRMT112;ETF1;MRPL19;MRPL14;MRPL32;AURKAIP1;N6AMT1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;MRPL44;PTCD3;MRPS6;MRPL18;MRPS24
prerank,pentose-phosphate shunt (GO:0006098),0.5081849671082891,1.0500449483053378,0.4228295819935691,0.938692389066079,1.0,6/11,22.18%,PGM2;PGD;DERA;RPIA;RBKS;RPE
prerank,regulation of interleukin-4 production (GO:0032673),-0.3557770013064741,-1.049741015912461,0.39820359281437123,0.7678100358035431,1.0,3/21,4.61%,LEF1;SLC7A5;LGALS9
prerank,positive regulation of cellular component organization (GO:0051130),-0.2512316690497976,-1.0495614323263047,0.34285714285714286,0.7668250560121681,1.0,29/107,15.49%,FRMPD4;INSR;NRXN1;DAB2;SHANK3;ASAP1;AR;SLF1;DAB2IP;RUNX1;TFRC;FNIP1;TGFB1;SH3GLB1;IGF1R;TIRAP;TPPP;BCL2L11;BID;RACK1;HYAL1;BMF;FNIP2;SURF4;SLF2;CDC42EP2;GPX1;BAX;GNL3L
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.44273709486368756,1.0495113202445827,0.4124031007751938,0.9394148362945093,1.0,5/20,15.93%,CLU;HSPA4;MKKS;HSP90AA1;PTGES3L
prerank,histone H4-K8 acetylation (GO:0043982),0.4685807471356861,1.0493196416874493,0.42168674698795183,0.9383418676175272,1.0,5/15,15.95%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,histone H4-K5 acetylation (GO:0043981),0.4685807471356861,1.0493196416874493,0.42168674698795183,0.9383418676175272,1.0,5/15,15.95%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,mitotic cytokinetic process (GO:1902410),0.4445922354464888,1.0493035981061019,0.397341211225997,0.9375915260935693,1.0,12/20,26.87%,CHMP4A;CHMP4B;VPS4B;RHOA;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;CHMP5;KLHDC8B;CHMP1B
prerank,regulation of synapse assembly (GO:0051963),0.3914397106181492,1.0487456339517691,0.40253164556962023,0.9384001703588306,1.0,5/46,4.87%,RAB17;GPC6;PDLIM5;GPC4;PTPRD
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3990190502079186,1.0487169760817967,0.4077791718946048,0.9376936047208059,1.0,8/43,9.51%,CDH13;CCL5;MMP9;BMP4;MEF2D;ADAMTS1;JUN;HTR1B
prerank,positive regulation of protein acetylation (GO:1901985),0.49024595477085986,1.04841286121317,0.4140127388535032,0.9377738463610679,1.0,1/12,0.83%,PRKAA2
prerank,androgen receptor signaling pathway (GO:0030521),0.5093317190876159,1.0483650731778356,0.42995169082125606,0.9371038443908086,1.0,2/11,2.34%,DAXX;DDX5
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3882823384604142,1.048315513486107,0.40433673469387754,0.9364689319802465,1.0,11/44,19.31%,CD44;KLF4;NGF;RAF1;CARD16;AQP1;IGBP1;XIAP;CDKN2D;TRIAP1;BEX3
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.34118787185594923,1.0478222596719016,0.4017094017094017,0.9370656270557625,1.0,37/140,17.21%,SRGAP3;SRGAP2;ARAP1;NGEF;ARHGEF17;AKAP13;ARHGAP18;ARHGEF12;ARAP2;TIAM2;DLC1;RHOQ;ARHGEF18;FOXM1;ARHGAP29;ARHGAP10;ARHGAP21;CDC42;OPHN1;BCR;ARHGEF5;TRIO;GNA13;RHOA;RABL3;SOS2;INPP5B;RHOU;OCRL;ARHGAP31;FLCN;ARHGDIB;ARHGEF1;TAGAP;PLEKHG2;ARHGAP33;RELN
prerank,sensory perception of sound (GO:0007605),0.3621651774333187,1.0474926713058128,0.4126984126984127,0.9372173053945254,1.0,17/88,14.24%,ATP6V1B1;USP53;COL4A3;HPN;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1;TMC2;PDZD7;GSDME;MKKS;SLC26A4;PAX3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3927019406799146,1.0473967223689788,0.3851010101010101,0.9366871985094615,1.0,13/44,18.54%,OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;MSMO1;OSBPL7;SQLE;TM7SF2;PARK7;OSBPL2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33352373408731706,1.0472746200780974,0.4010204081632653,0.93623919593646,1.0,56/259,18.72%,RAB17;CDH13;CYS1;SRGAP2;ABLIM2;ACTN2;ABLIM1;PARVA;EMP2;GSN;RAP1B;RAP1A;EHD1;CNGA2;INPP5E;ARL3;CCDC28B;RAB11FIP3;AVIL;DMTN;GOLPH3;EXOC7;IFT46;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;OPHN1;EZR;EXOC2;ARFIP2;ANO6;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;ATP6V1D;CCDC88A;RAP2C;FLNA;ATP6V0D1;FSCN1;TMEM138;RAB8B;VCL;PTPDC1;HDAC6;WDR35;RILPL1;SHTN1;GALNT11;FHDC1;ARHGEF6
prerank,macromolecule catabolic process (GO:0009057),-0.3407328313337199,-1.0471811023666904,0.35294117647058826,0.7719800404089879,1.0,16/26,35.52%,SNX25;TGFB1;SH3GLB1;TPP1;MVB12A;CLPX;USE1;SMURF1;CLN6;CLN8;TRIM24;PPT1;UCHL3;CAPN3;BECN1;LGMN
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.48999604045371986,1.0470966025897415,0.41836734693877553,0.9359500012413927,1.0,2/11,9.13%,ZC3H12A;FOXP3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4239711508840218,-1.0470822188505124,0.3783068783068783,0.7707612655360313,1.0,3/11,11.70%,LYN;MFHAS1;TIRAP
prerank,regulation of myoblast differentiation (GO:0045661),-0.3230543122198688,-1.0469936618324451,0.33941605839416056,0.7695433142950439,1.0,8/32,10.94%,PLCB1;BOC;TBX3;NOTCH1;TGFB1;BTG1;SRA1;LRRC8A
prerank,negative regulation of viral genome replication (GO:0045071),0.40030570918564484,1.0469223481985743,0.3958602846054334,0.9356705846541373,1.0,9/40,15.61%,CCL5;SLPI;MAVS;RNASEL;SRPK2;SRPK1;TNIP1;SETDB1;OAS2
prerank,acylglycerol metabolic process (GO:0006639),-0.3224048874037404,-1.0468325398736342,0.40408163265306124,0.7685282211082604,1.0,18/37,27.44%,DGKH;DGKB;MGLL;PLAAT3;SEL1L;DGKI;ABHD12;DGKG;ABHD2;LPL;PNPLA3;DGKZ;DGAT2;DGKQ;DGKK;GK5;PNPLA2;AWAT2
prerank,protein autoprocessing (GO:0016540),-0.370165745304369,-1.0467356486402357,0.37168141592920356,0.7673400558885278,1.0,7/17,22.05%,FAM111A;CTSL;FXN;CASP4;MYRF;HTRA2;SPRTN
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3406175483555325,1.0467297125035324,0.3893048128342246,0.9354296091918612,1.0,31/152,13.66%,SCEL;KANK1;RSPO3;PTK7;TMEM198;CAV1;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;LGR4;WNT5B;PPM1A;RNF146;ADGRA2;UBE2B;PRDM15;PSMD7;SMARCA4;TRPM4;CSNK1E;PSMB5;SPIN1;SFRP1;CAPRIN2;UBR5
prerank,error-prone translesion synthesis (GO:0042276),0.4370873649569917,1.0462939323624638,0.411144578313253,0.9359073161241455,1.0,8/21,18.48%,REV1;POLK;RPA3;POLH;PCNA;UBC;RPS27A;RFC1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3163689383481168,-1.046184316172658,0.3612167300380228,0.7673811235015928,1.0,10/31,6.93%,SEMA6A;SEMA5A;ROBO1;SEMA3C;SEMA7A;NOTCH1;THBS1;SEMA3E;ROBO2;SLIT2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4193339168721643,1.0461753849670938,0.4092178770949721,0.9354416437792692,1.0,3/27,8.37%,AGTR1;NFKBIA;MAPK9
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3990852368829218,1.045879203001507,0.4026666666666667,0.9354699489569677,1.0,5/36,8.89%,OGT;FHIT;DDRGK1;PSMF1;OPHN1
prerank,regulation of amyloid-beta formation (GO:1902003),0.4086331630395403,1.0457330163531255,0.39667128987517336,0.9351424983071549,1.0,7/34,13.52%,CLU;RTN1;EPHA4;RTN3;ABCA2;SP1;GSK3A
prerank,nucleic acid-templated transcription (GO:0097659),0.3854295387474956,1.0456352872844996,0.4127604166666667,0.9346265511117536,1.0,5/42,6.08%,THRB;CREBL2;POLR2H;NKX2-8;POLR2A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.28836290995436453,-1.0450057531249584,0.3793103448275862,0.7690784582965333,1.0,8/51,7.51%,IL34;VEGFC;PTK2;GAS6;CXCL12;LGALS9;THBS1;IL6R
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.26326134099355425,-1.0449999068730322,0.3620689655172414,0.7676387167316082,1.0,26/72,22.16%,LIFR;GAS6;AXL;IRAK2;RUNX1;IFNGR1;IRAK3;IFNGR2;IFNAR2;JAK2;CFLAR;RIPK1;RBCK1;RACK1;CD74;CDC37;VRK2;HSP90AB1;TRADD;AGPAT2;TRAF1;SPHK1;TNFAIP3;CYLD;SOCS3;SIGIRR
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.45263175822223695,1.044029571128004,0.4356287425149701,0.9385079554193909,1.0,6/18,20.78%,ADTRP;WNK1;ASS1;DUSP3;GPNMB;MIA3
prerank,"base-excision repair, AP site formation (GO:0006285)",0.44311186196118124,1.042634427313975,0.40441176470588236,0.941760452612224,1.0,9/17,30.14%,MUTYH;ERCC5;MBD4;NEIL1;TERF2;TINF2;TERF1;TERF2IP;TDG
prerank,histone H4 acetylation (GO:0043967),0.39283569430445564,1.0424563763718278,0.4027431421446384,0.9414883283238455,1.0,16/47,18.35%,OGT;EP300;NAA40;BEND3;HCFC1;MORF4L2;KMT2A;APBB1;ACTL6B;JADE2;ING4;MSL2;MEAF6;TRRAP;ATF2;TRIM16
prerank,modification-dependent protein catabolic process (GO:0019941),0.3347775052001937,1.0419929882868584,0.4109014675052411,0.9419786881314854,1.0,34/193,17.22%,FZR1;FBXL7;PCYOX1;RNF43;SPSB4;RNF5;TRIM25;PSMD11;NUB1;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RBX1;RNF146;UBE2B;PPP1R11;RNF126;WDR91;ANAPC4;NPLOC4;UBE4A;NEDD4;MDM2;UBE2H;BFAR;DDB1;UBA6;UBC;RPS27A;STUB1;KEAP1;SIAH1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3590316917206591,1.0419503700964314,0.3962920046349942,0.9413002045952077,1.0,18/79,16.52%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;AP2A1;FCER1G;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;CANX;DYNC1H1;AP1B1
prerank,positive regulation of immune effector process (GO:0002699),-0.33874844203909227,-1.0419201776212403,0.3916349809885932,0.7745818172468181,1.0,5/27,9.38%,PTPRJ;LGALS9;APPL2;DDX60;CD46
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.38564985031813276,1.0418410133425773,0.4316185696361355,0.9408326905368896,1.0,5/48,4.69%,FGFR1;ANGPT1;JCAD;FOXC2;HSPB1
prerank,activation of protein kinase activity (GO:0032147),-0.2483111230056283,-1.0418315524781456,0.39622641509433965,0.7733727101918759,1.0,24/106,12.66%,IGF1;GHR;INSR;ADCY5;TNIK;NRK;PAK3;GAS6;WNT5A;STK3;ADCY7;CARD10;IL18;ADCY1;ADCY4;JAK2;PRRC1;STRADA;PRKAR2B;TRAF6;TIRAP;MAP4K4;TXN;TOM1L1
prerank,regulation of cell aging (GO:0090342),0.49917654070451833,1.0416180902763619,0.4304,0.9407017459825329,1.0,2/11,6.18%,WNT1;FOXM1
prerank,regulation of nervous system development (GO:0051960),-0.3008596776199614,-1.0415537303266023,0.3541666666666667,0.772617698442902,1.0,15/37,25.20%,PTPRZ1;HEYL;TENM4;PRUNE1;NPHP3;TNFRSF1B;BHLHE40;SIRT2;HEY2;CX3CR1;CX3CL1;HEY1;YAP1;YTHDF2;BHLHE41
prerank,mitochondrial translational termination (GO:0070126),0.35652720495921053,1.0411355099465425,0.4050925925925926,0.9413062983967726,1.0,39/88,28.74%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL57;MRPL9;MRPL50;MRPS15;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;MRPL44;PTCD3;MRPS6;MRPL18;MRPS24
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3975107985827631,-1.040277624610282,0.4273972602739726,0.7747023787002304,1.0,2/13,2.44%,PID1;NOS3
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.45970261456727435,1.0400153962865564,0.4405144694533762,0.9437402483689908,1.0,3/16,13.52%,PLCB3;KLK1;GSK3A
prerank,zinc ion homeostasis (GO:0055069),-0.32448549672398797,-1.0399460339222157,0.40636042402826855,0.7741744538749884,1.0,5/28,12.55%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.390211806090118,-1.0398104164576383,0.3983739837398374,0.7731247675477995,1.0,8/15,27.56%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4440465798748009,1.0396505535030998,0.43582089552238806,0.944041305138842,1.0,11/21,18.58%,DAPK3;EFNA5;PTPRA;ACTG1;EPHA3;RHOA;SLC9A1;PEAK1;VCL;DUSP3;ROCK2
prerank,fatty acid transmembrane transport (GO:1902001),0.4452211152441171,1.0392104400166622,0.41654571843251087,0.9445974402557781,1.0,5/19,12.43%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2
prerank,lysosome organization (GO:0007040),-0.3021128014948229,-1.0389176192651894,0.3360655737704918,0.7740822666429972,1.0,11/36,17.66%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;TMEM106B;CLN3;VPS33A;CLVS1
prerank,natural killer cell mediated immunity (GO:0002228),0.4566712076151625,1.0377374832841113,0.4439102564102564,0.9479458850867075,1.0,2/15,13.68%,RAET1E;ULBP1
prerank,positive regulation of MAPK cascade (GO:0043410),0.3319047881729991,1.0376664160598574,0.41260162601626016,0.9473783233786677,1.0,20/245,7.30%,ADRA1B;FGFR1;ANGPT1;CD44;LPAR1;NOTCH2;NTRK3;CCL5;JCAD;PDGFC;CCN2;GDF15;RAP1A;PTK2B;GCNT2;ACKR3;CAV2;SHC1;MYDGF;TGFB2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.43467733280432636,1.0374351048993429,0.41897810218978104,0.9465082270323969,1.0,8/24,16.30%,PFKP;PKM;ENO2;HK1;FOXK1;GAPDH;ALDOA;TPI1
prerank,canonical glycolysis (GO:0061621),0.43467733280432636,1.0374351048993429,0.41897810218978104,0.9465082270323969,1.0,8/24,16.30%,PFKP;PKM;ENO2;HK1;FOXK1;GAPDH;ALDOA;TPI1
prerank,positive regulation of viral process (GO:0048524),0.3666148469736431,1.037422462007857,0.41919805589307413,0.9457559051907296,1.0,16/60,19.18%,CCL5;GTF2F1;POLR2H;TARBP2;POLR2A;TMEM39A;RAB7A;SRPK2;SRPK1;VPS4A;DHX9;DDB1;NELFB;POLR2C;POLR2E;NELFA
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.35541599973678895,1.037219880084748,0.4061433447098976,0.9455623217448372,1.0,12/93,10.53%,WNT16;EDA2R;MAP3K5;CCN2;ZC3H12A;PTK2B;SH3RF2;TGFB2;MAP3K4;RELL1;EMC10;ARL6IP5
prerank,response to cholesterol (GO:0070723),0.4585148526920353,1.0370261958869393,0.4265842349304482,0.9453152598434185,1.0,5/17,12.21%,SMO;PMVK;ABCA2;OSBPL7;TGFBR2
prerank,negative regulation of vascular permeability (GO:0043116),-0.41082292151101607,-1.0366393735269444,0.4230769230769231,0.7788526865467476,1.0,6/12,9.70%,PTPRJ;PDE3A;CLDN5;SLIT2;RAMP2;PDE2A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.45106038666320686,1.0366097721224072,0.42946708463949845,0.9456706594868519,1.0,5/17,15.12%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4325008606332798,1.0362152236794053,0.413589364844904,0.9460296027627839,1.0,2/20,2.82%,SEMA3D;SEMA3B
prerank,cellular glucose homeostasis (GO:0001678),-0.29058304282758685,-1.0355609566862816,0.38596491228070173,0.7802647405511021,1.0,12/41,12.28%,PIK3R1;UNC13B;ZBTB20;HIF1A;GAS6;FOXO1;FOXK2;PRKAA1;HK2;IGF1R;LRRC8A;RACK1
prerank,determination of bilateral symmetry (GO:0009855),-0.3354155476878094,-1.0355099035841417,0.3856655290102389,0.778964621726974,1.0,8/24,18.40%,NOTCH1;PKD2;NPHP3;ZIC3;TBX1;BBS7;KIF3B;DNAH11
prerank,translational elongation (GO:0006414),0.35098003756247087,1.0355051145369605,0.41485714285714287,0.9472466061352829,1.0,23/101,16.40%,MRPS16;MRPL38;EEF1A1;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;LTN1;MRPS33;MRPS27;MRPL57;MRPL9;EEF1D;MRPL50;MRPS15;MRPS18C;MRPS28;MRPS35;EEF2
prerank,regulation of protein targeting to membrane (GO:0090313),0.4126139830503951,1.0353027066493274,0.4103967168262654,0.9470162933480857,1.0,9/28,15.90%,DMTN;ANK3;CHP1;MIEF2;MYO1C;KCNB1;ITGB1BP1;HRAS;ITGB2
prerank,cytosolic calcium ion transport (GO:0060401),0.4127561607923862,1.0352593240667418,0.4136947218259629,0.946354445315916,1.0,9/28,12.10%,MCU;CACNB3;MCUB;MICU1;AFG3L2;JPH2;ITPR3;MCUR1;JPH3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.49312183739331505,1.034811041787519,0.453525641025641,0.9468458857913088,1.0,3/12,9.00%,ERLIN2;ACADL;ERLIN1
prerank,RNA interference (GO:0016246),0.4572263725360715,1.0345520094535512,0.44832826747720367,0.9467868141648937,1.0,5/17,16.96%,CELF1;TARBP2;TSNAX;DHX9;CLP1
prerank,regulation of muscle contraction (GO:0006937),0.41906489140578135,1.034405985912518,0.4160887656033287,0.9464367701384948,1.0,3/26,3.81%,CAV1;ATP1A2;DAPK3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.44486754088975766,1.0341939822680097,0.4002911208151383,0.9462951551150012,1.0,8/19,19.97%,FBXW8;PTPRD;CAPRIN2;SS18L2;RELN;SS18L1;DBN1;CAMK2B
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3536587264871423,-1.0334518520045979,0.419672131147541,0.783069481707707,1.0,7/21,18.96%,IGF1;KDR;LGALS9;ITGAV;EGF;MAP2K1;PTGER4
prerank,cellular response to insulin stimulus (GO:0032869),0.33911746872413356,1.0332240163453748,0.41073384446878425,0.9482035086111439,1.0,32/124,20.02%,SORBS1;ATP6V1B1;CPEB2;GAB1;HDAC5;EPRS1;FOXC2;RHOQ;INSIG1;CAV2;PKM;AP3S1;SHC1;MYO5A;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1D;ATP6V1E1;ATP6V0D1;RAB8B;SLC27A4;USF1;ATP6V1B2;PCK2;GPLD1;IDE;RAB10;ATP6V0B
prerank,response to copper ion (GO:0046688),0.4337491387940444,1.0332225268792554,0.4128166915052161,0.9474282972254059,1.0,1/20,0.93%,DAXX
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.47053411754270774,1.0329051252154118,0.4218009478672986,0.9475501068130352,1.0,3/15,11.66%,EHD1;RIPOR2;RAPGEF3
prerank,negative regulation of B cell activation (GO:0050869),-0.3560471730363277,-1.0324032889957087,0.4093567251461988,0.7844899867675589,1.0,11/21,32.15%,LYN;TNFRSF21;ID2;CD300A;RC3H1;TNFAIP3;TYROBP;FCGR2B;BANK1;SAMSN1;FOXJ1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.503966497964178,1.0322745200179884,0.4246353322528363,0.9485429846210877,1.0,2/11,12.20%,HPN;BCAR1
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4094469594467927,1.0318349099626916,0.4133148404993065,0.9490277763794456,1.0,10/28,20.63%,EPHA4;YTHDF1;AKAP5;PTN;GSK3B;ABL1;EIF2AK4;RELN;APP;AGER
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4626700602144238,1.0318221731054937,0.4283513097072419,0.9482969390591288,1.0,6/16,23.82%,SHOC1;CENPS;RMI1;ERCC4;TOP2B;FANCM
prerank,response to fatty acid (GO:0070542),-0.3728922735751979,-1.0317981153911084,0.4045584045584046,0.7847088208700617,1.0,2/17,4.01%,PID1;FOXO1
prerank,positive regulation of behavior (GO:0048520),-0.4375530157021764,-1.0317160480147036,0.4264705882352941,0.7834580094971927,1.0,5/10,9.33%,NLGN1;NPAS2;AGRP;SGIP1;CFAP20
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3415072146010775,1.031689609717714,0.4370208105147864,0.9479356972194699,1.0,16/121,8.88%,ANGPT1;CD44;CRLF1;CCL5;EPHA4;IL15;CD81;PTK2B;CLCF1;EPO;EFNA5;UNC119;HAX1;ERBB3;SRCIN1;TNFRSF1A
prerank,positive regulation of cytokine production (GO:0001819),-0.2174735442189712,-1.0313764069126452,0.375,0.7829715350865614,1.0,49/292,13.24%,PLCB1;SULF1;IL1R1;AFAP1L2;CCBE1;PDE4D;NOD1;CADM1;PLA2R1;HIF1A;WNT5A;SLC7A5;TMED10;CD34;GLMN;LGALS9;CYP1B1;RUNX1;SPTBN1;IL18;GBP5;PTGS2;RFTN1;RGCC;TGFB1;LRRFIP1;IL6R;PDE4B;IL33;RORA;TBK1;CRCP;CD46;PIK3CD;TRAF6;MBP;STAT3;ARHGEF2;PNP;TIRAP;POLR3A;RIPK1;IL6ST;DDIT3;DRD2;IL17D;POLR2F;FLT4;POU2F2
prerank,histone H3-K4 methylation (GO:0051568),0.41733228150721186,1.0311813865985573,0.43478260869565216,0.9485307980454134,1.0,10/26,23.89%,OGT;BEND3;KMT2A;KDM6A;DYDC2;KMT2B;MEN1;KMT2C;CTR9;CXXC1
prerank,sensory organ development (GO:0007423),0.3690945602751818,1.0309042898034462,0.42016806722689076,0.948504317679125,1.0,4/51,3.06%,PBX3;PBX1;WNT10A;STRA6
prerank,organic anion transport (GO:0015711),0.3583183069878821,1.0306422904948545,0.4337899543378995,0.9484917330176141,1.0,7/76,8.05%,CFTR;SLCO2A1;SLC4A2;SLC35A2;SLC16A2;CYB5RL;SLC2A8
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48545656901672607,1.0303275465396637,0.4271523178807947,0.9486411925274502,1.0,3/11,9.36%,DDX5;BMP4;MAP2K2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.29683283726809434,-1.0301890393058304,0.3893805309734513,0.7848518830503158,1.0,8/40,10.60%,SLC7A11;SLC13A3;SLC7A5;SLC16A1;SLC7A7;SLC38A11;SLC16A7;SLC38A9
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3380220473058986,-1.0297459511663443,0.38801261829652994,0.784690887248268,1.0,7/21,10.08%,ADCY5;GUCY1B1;ADCY7;GUCY1A1;ADCY1;ADCY4;NPR1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4211480046280301,1.0295937001928415,0.43175487465181056,0.9498943636955719,1.0,9/26,14.22%,KANK2;CRY2;SMARCA4;NCOR1;VPS11;SFRP1;VPS18;NCOR2;FOXP1
prerank,multivesicular body organization (GO:0036257),0.403078539989448,1.0294968536529872,0.43112947658402206,0.9494116560276504,1.0,13/31,20.08%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;VPS37A;RAB27A;IST1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4799141454203175,1.0291240620543267,0.42857142857142855,0.9496785847952216,1.0,3/12,14.22%,KLF4;TLR4;FOXP1
prerank,protein localization to cilium (GO:0061512),-0.3113561921973119,-1.02894805207279,0.41796875,0.7853610765630104,1.0,13/32,18.71%,IFT122;TTC21B;TULP3;RAB29;TCTN1;ZNF423;INVS;WDR19;BBS1;CSNK1D;TCTN2;NPHP4;BBS4
prerank,ESCRT III complex disassembly (GO:1904903),0.4946010161792676,1.0287426005683518,0.4360655737704918,0.9491651008328827,1.0,7/10,26.87%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.4946010161792676,1.0287426005683518,0.4360655737704918,0.9491651008328827,1.0,7/10,26.87%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,cation transport (GO:0006812),0.3313104632494794,1.0286969262064172,0.4205020920502092,0.9485281767219673,1.0,24/167,13.39%,FGF13;TRPM3;SLC36A3;SCN3A;ATP1A2;TRPM8;SLC66A1;KCNJ13;ABCC8;SLC36A4;CNGB3;SLC22A18;CHP1;KCNA4;TRPM6;SLC7A6;TRPM4;AQP1;SLC41A1;PKD2L1;ANO6;KCNA5;CNGB1;TRPM2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4098383013858316,1.0285096964329865,0.43175487465181056,0.9482598299830235,1.0,4/26,7.19%,ST3GAL4;SCCPDH;LARGE1;GOLPH3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.43719878737712076,1.0284010914840305,0.4467153284671533,0.9477929246897203,1.0,4/20,6.30%,CDK6;PTK2B;ZBTB16;HOXA5
prerank,cellular response to interleukin-4 (GO:0071353),-0.4379233110024292,-1.0283269833413624,0.4409448818897638,0.7855138423143909,1.0,1/10,0.45%,LEF1
prerank,ventricular septum development (GO:0003281),-0.30131897945147645,-1.028238338663398,0.41767068273092367,0.7843572410568675,1.0,15/37,21.98%,ZFPM2;ROBO1;NOTCH1;ROBO2;SLIT2;SALL1;HEYL;PDE2A;SLIT3;BMPR2;SOX11;HEY2;SMAD4;APLNR;HEY1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.3699982821238792,-1.0281769221658992,0.4,0.7830865673061442,1.0,10/17,22.18%,ADCY5;ADCY7;ADCY1;ADCY4;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3383136484067646,-1.02788326812296,0.4197952218430034,0.7824707159063584,1.0,8/26,12.88%,NRXN1;SHANK3;SLC8A3;LRRK2;NLGN1;MTMR2;TMEM108;NLGN3
prerank,renal system development (GO:0072001),0.36935174851937685,1.0273562058002945,0.41277641277641275,0.9499083595058448,1.0,8/52,8.43%,AGTR1;STRA6;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,hippo signaling (GO:0035329),0.41404773952125845,1.0273376811861912,0.41292134831460675,0.9491945562104509,1.0,4/26,9.18%,TJP2;TJP1;LATS1;YWHAB
prerank,regulation of cell cycle (GO:0051726),0.3283708250322883,1.0272694432976637,0.424923391215526,0.9486408761905973,1.0,71/271,20.64%,NOTCH2;CDKN1A;GRK5;ADAM10;MAGI2;NUPR1;NEK7;CDK10;CDK6;EP300;DAPK3;PES1;PPP1R13B;SON;PPP1R15A;DUSP1;CDK4;TSC2;JUND;FOXM1;ZBTB17;HCFC1;SOX9;BMP4;TRIM21;TGFB2;NLRP2B;FBXO5;TCF7L2;PKD1;IQGAP1;JUN;PML;GAS2L1;APBB1;CCND1;PCLAF;SRPK2;TBRG4;ANKRD17;WDR6;GADD45B;EIF4G2;SFRP1;GATA3;CHMP1A;MYC;ING4;PRDM11;HRAS;MDM2;MAEA;ABL1;LIN54;POU4F1;NBN;XIAP;CDKN2D;INTS13;GADD45GIP1;CAMK2N1;RARA;KIF20B;CDK5RAP3;RNF112;GPER1;CDK11B;RASSF1;CENPF;RB1;IRF6
prerank,microtubule polymerization (GO:0046785),0.40881381614487045,1.0269677691744152,0.4206896551724138,0.948687173519696,1.0,2/28,2.82%,FGF13;NDEL1
prerank,negative regulation of binding (GO:0051100),0.3575987012399689,1.0267930575986468,0.42160278745644597,0.9483917991410672,1.0,23/81,18.92%,CFHR1;SMO;CDKN1A;GTF2F1;CAV1;SLPI;NFKBIA;CTSZ;JUN;SUMO3;ACTB;CARD16;HABP4;CSNK1E;TLE5;GSK3B;ITGB1BP1;E2F1;KDM1A;PARK7;ILRUN;WAPL;BTAF1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3951698843201607,1.0267121522102034,0.40808344198174706,0.9478513745119203,1.0,11/36,17.44%,DOT1L;HUS1B;DONSON;USP28;E2F1;CDC5L;ATR;PRPF19;HINFP;NBN;CHEK2
prerank,negative regulation of protein catabolic process (GO:0042177),0.38952819246163833,1.026681926864177,0.42118863049095606,0.9471662316894234,1.0,10/40,12.26%,TIMP4;TIMP1;HMGCR;SNRNP70;TIMP2;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.46834949542141074,1.0265539736911675,0.4359375,0.9467867969520172,1.0,3/12,12.71%,SREBF2;ABCA2;LPCAT3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4276714594007581,1.0263489973139808,0.4499252615844544,0.9466095410157076,1.0,1/21,0.23%,FGF13
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.35540539902245327,-1.0262804760188118,0.41904761904761906,0.7854558339327661,1.0,9/20,21.98%,ENG;ACVRL1;TBX3;NOTCH1;HEYL;PDCD4;SPRY1;HEY2;HEY1
prerank,pyruvate metabolic process (GO:0006090),0.375702691011376,1.0262028689484246,0.4326328800988875,0.946250420980986,1.0,13/52,16.30%,HAGH;HKDC1;ME3;PKM;LDHB;PFKFB2;LDHAL6B;ENO2;HK1;VDAC1;GAPDH;ALDOA;TPI1
prerank,regulation of presynapse assembly (GO:1905606),0.44851451693223815,1.0257712521976394,0.44169096209912534,0.9458583668372976,1.0,6/18,15.45%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1
prerank,regulation of presynapse organization (GO:0099174),0.44851451693223815,1.0257712521976394,0.44169096209912534,0.9458583668372976,1.0,6/18,15.45%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1
prerank,cardiac atrium morphogenesis (GO:0003209),0.4524985244346189,1.0257521007002677,0.45537065052950076,0.9451589031974255,1.0,2/16,7.30%,NOTCH2;TGFB2
prerank,amino acid transmembrane transport (GO:0003333),-0.2882622904772034,-1.0252965209311644,0.3867924528301887,0.7865191365800364,1.0,8/45,10.60%,SLC7A11;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC7A7;SLC38A11;SLC38A9
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.3158964602994098,-1.025193484818982,0.42704626334519574,0.7853855952934505,1.0,8/29,11.29%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.37279858919401865,1.0250634851936131,0.42534504391468003,0.9462610175219398,1.0,8/52,11.45%,SORBS1;STAC3;PTPN9;LGALS3;ACSL3;AKAP5;CNPY4;EPHA3
prerank,regulation of cell cycle phase transition (GO:1901987),0.3506238857224033,1.0241228824254351,0.4376443418013857,0.9480574787678113,1.0,14/91,18.53%,FZR1;CDKN1A;PSMD11;PSMD4;PSMF1;FBXO5;PSMD7;PSMB5;ANAPC4;ATP2B4;DDB1;ERCC2;PSMD1;PSMC4
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.44852099743243873,1.024106017304232,0.45068285280728376,0.9473491503532293,1.0,8/20,16.89%,IMPDH2;PAICS;NT5C2;GMPS;AK3;GART;AMPD2;ADSS2
prerank,cellular protein metabolic process (GO:0044267),0.3227784010698978,1.0239288980816477,0.44176706827309237,0.947051292295803,1.0,90/396,19.72%,FN1;MSLN;IGFBP6;F5;FAM20C;PRSS23;ADAM10;PENK;MRPS16;EEF1A1;MRPL24;MRPL37;SFTPC;SERPINC1;TIMP1;WWP2;RNF5;DENND3;HARS1;DUSP12;RPS4X;ANO8;MRPS7;PHKA2;BMP4;TGM5;CPE;GPC3;RPSA;MSRB2;AFG3L2;LAMC1;UBE2G2;ABCF1;MANBA;FDX1;RPL31;RPL22;GSPT2;LAMB2;MRPS33;SPCS3;RPL28;CALU;SRBD1;CP;RPS26;MRPL9;COPS5;NAPSA;ST3GAL6;LGALS1;TNIP1;HARS2;RPL10A;LTA4H;EIF4G1;SARS1;RRBP1;MRPS15;DNAJC3;NTAQ1;RPL14;MRPS18C;PRKCSH;CTSH;HM13;ABL1;RPS27A;UBE2D3;SEC11A;SPPL3;CHEK2;USP25;RPN2;FBXL2;YES1;SPG7;GALNT11;HBS1L;IGF2BP3;STOML2;FARSB;RPL6;EIF4EBP2;SFTPA1;SFTPA2;APP;ADAM17;IDE
prerank,regulation of actomyosin structure organization (GO:0110020),0.47797904248669315,1.0238391271043399,0.43851132686084143,0.9465569778918544,1.0,7/13,18.58%,AKAP13;CDC42;ACTG1;ASAP3;SLC9A1;FHOD1;ROCK2
prerank,cellular response to osmotic stress (GO:0071470),0.4320808295154466,1.0234933982980807,0.43490701001430615,0.9467605283602634,1.0,5/21,11.19%,YBX3;EPO;STK39;OXSR1;AQP1
prerank,COPII-coated vesicle budding (GO:0090114),0.3619262742602726,1.0231980293686613,0.42266824085005905,0.9468244502349171,1.0,21/68,21.02%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;SEC23A;RAB1B;CNIH1;ANKRD28;NSF;SEC23IP;SEC31B;SEC24B;MIA3;SEC31A;SEC16A
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3541593395359617,1.0228063225012713,0.43146603098927294,0.9471714292639304,1.0,27/71,20.76%,ADAMTS7;PMAIP1;ATE1;ZYG11B;CTSZ;OTUD7B;CAPN2;CHMP4B;VPS4B;RNF123;VPS4A;SOCS6;MDM2;DDB1;CTSH;HM13;PRPF19;UBC;RPS27A;STUB1;PDCD6IP;HDAC6;RNF41;IDE;RHBDD1;CTSK;CHFR
prerank,amyloid precursor protein catabolic process (GO:0042987),0.459680697792932,1.0226903178664521,0.42242703533026116,0.9467199196736793,1.0,6/14,23.70%,ADAM10;BACE1;ADAM17;ABCA7;APH1A;PSEN1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4902838868350053,1.0223997870016204,0.42673107890499196,0.946772603631262,1.0,2/10,8.15%,TARBP2;TSNAX
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4902365846611094,1.0222558214408304,0.43449419568822556,0.9464236954308815,1.0,3/10,14.07%,PFKP;HK1;GFPT1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.28966897414226067,-1.0220849592487176,0.38495575221238937,0.7922135918278173,1.0,5/41,5.86%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.41739400821107975,1.0220817050081121,0.4314868804664723,0.9461252915628198,1.0,3/23,7.45%,RAET1E;LAMP1;PVR
prerank,positive regulation of myelination (GO:0031643),-0.42010179214519205,-1.0220201993423774,0.41114058355437666,0.7909820998801756,1.0,6/11,26.10%,TENM4;TPPP;TNFRSF1B;MYRF;DICER1;NCMAP
prerank,cellular copper ion homeostasis (GO:0006878),0.4695223441665213,1.0217951311695175,0.45307443365695793,0.9461735683158543,1.0,6/14,23.86%,COX19;SLC31A2;CCDC22;ABCB6;APP;MT2A
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.43397020814139725,1.0217571431599402,0.4583941605839416,0.9455441515023927,1.0,7/21,11.96%,MCU;MCUB;MICU1;AFG3L2;BCAP31;MCUR1;LETM1
prerank,regulation of chromatin binding (GO:0035561),0.4890031720862745,1.0213779475657656,0.4431438127090301,0.9458767744523914,1.0,4/10,18.92%,KDM4D;HMBOX1;WAPL;BTAF1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.36501936707250704,1.0212686790250374,0.4522673031026253,0.9454501291795643,1.0,14/66,11.44%,KLF4;LSM10;CDKN1A;CDK6;FHL1;KANK2;CDK4;CCND2;ADAMTS1;PKD1;PTPN6;BRD7;CCND1;ANKRD17
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.3648688421378435,-1.020840949244819,0.43283582089552236,0.7928615560949565,1.0,8/17,11.33%,TMEM100;FGF2;VEZF1;ATOH8;AHI1;BTG1;RFX3;SFRP4
prerank,error-free translesion synthesis (GO:0070987),0.4240341846749426,1.020784049575443,0.4395770392749245,0.9460500195072092,1.0,11/22,27.28%,REV1;NPLOC4;RPA3;POLH;PCNA;UBC;RPS27A;RFC1;RCHY1;RPA2;POLD1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.44824541333047224,1.0205924442438041,0.4601226993865031,0.9458164536445015,1.0,3/16,13.04%,ZC3H12A;MOV10;CPEB3
prerank,regulation of ATP metabolic process (GO:1903578),0.36456225981555873,1.0201954017921522,0.4536702767749699,0.9461738315609657,1.0,10/54,10.09%,OGT;ABCD1;EP300;BEND3;NUP93;EIF6;NDC1;ATP5IF1;JMJD8;COX7A2L
prerank,response to retinoic acid (GO:0032526),0.3674794865905313,1.020069847775023,0.44806763285024154,0.9457735095138808,1.0,16/59,18.50%,PTK7;WNT11;PTK2B;WNT6;RARG;CREB1;RXRB;SOX9;WNT5B;AQP1;EPHA3;WNT3;CTSH;CDKN2D;TRIM16;RARA
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.44526837261226215,1.0200311388354388,0.43846153846153846,0.9451234754115567,1.0,2/17,1.74%,ADTRP;EFNB2
prerank,positive regulation of protein maturation (GO:1903319),-0.4077925070624123,-1.019857199047616,0.42091152815013405,0.7941442235267406,1.0,4/11,25.44%,CCBE1;NKD2;BAG2;ADAM8
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3966946352072498,-1.019772474105161,0.4243243243243243,0.7929606389561886,1.0,3/13,12.95%,NOS3;GCH1;SPR
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.32965740740103827,-1.019579601071156,0.41767068273092367,0.79210295462758,1.0,8/24,12.13%,PTPRJ;TEK;PIK3R1;KDR;TSC1;ROCK1;MYOC;MAP4K4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.36104891099786407,-1.0192672587119496,0.4194528875379939,0.7914891537840231,1.0,2/17,8.87%,PLA2G4A;SERAC1
prerank,peptide catabolic process (GO:0043171),-0.3429333984544699,-1.0191822657314866,0.4212121212121212,0.7903326188880426,1.0,9/23,23.77%,ECE1;GGT5;ACE;TPP1;CPQ;ENPEP;ANPEP;TRHDE;CHAC2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.31525893563633894,-1.0189443823146276,0.392,0.789608588950795,1.0,13/30,21.32%,NOS3;FAS;TNFSF10;RFFL;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,cytosolic transport (GO:0016482),0.34236456177636676,1.0188884364247404,0.4443231441048035,0.9475006005931542,1.0,35/108,20.16%,EMP2;RAB9B;CORO7;VPS13A;LAMP1;GCC2;MAGEL2;RAB7A;MON2;LMTK2;HOOK1;VPS54;GGA1;AP2A1;VTI1B;RNF126;WDR91;PHETA2;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;WASHC1;SNX16;VPS50;TBC1D10A;ARFRP1;TMEM87B;YKT6;RAB9A;HOOK3;VTI1A;BET1L;TBC1D17
prerank,negative regulation of developmental process (GO:0051093),0.36383678147856413,1.0187306541669028,0.4221411192214112,0.947193713959431,1.0,10/69,7.14%,WNT1;KANK1;WNT11;CDK6;FOXM1;PARP3;SOX9;MUL1;BMP4;KLF7
prerank,blood vessel diameter maintenance (GO:0097746),0.40266140186715216,1.0186841770090227,0.45539280958721706,0.9465653018485706,1.0,1/34,0.18%,AGTR1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.40996471107785104,1.0183975709976667,0.4331476323119777,0.9465335162598336,1.0,6/27,15.29%,CD200;ZC3H12A;PTPN6;TLR4;CD200R1;SYT11
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46984280908165205,1.0181300201128296,0.4512987012987013,0.9465213843807251,1.0,8/13,29.79%,DESI2;DESI1;SAE1;UBA6;UBA7;UBA3;UBA2;SENP6
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.313663143909032,-1.0178541244368247,0.43617021276595747,0.7912276383823618,1.0,9/27,14.51%,PDGFRB;DACH1;ACVRL1;FGF2;RGCC;TNKS;FGFR4;TOM1L1;BMPR2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.42977022131111203,-1.0172514955271506,0.46851385390428213,0.791420361971763,1.0,1/10,0.64%,TGFA
prerank,COPII vesicle coating (GO:0048208),0.36382688854200973,1.0170283219206875,0.43130227001194743,0.9472642837608952,1.0,19/61,21.02%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;SEC23A;RAB1B;CNIH1;ANKRD28;NSF;SEC23IP;SEC24B;SEC31A;SEC16A
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.36382688854200973,1.0170283219206875,0.43130227001194743,0.9472642837608952,1.0,19/61,21.02%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;SEC23A;RAB1B;CNIH1;ANKRD28;NSF;SEC23IP;SEC24B;SEC31A;SEC16A
prerank,vesicle coating (GO:0006901),0.36382688854200973,1.0170283219206875,0.43130227001194743,0.9472642837608952,1.0,19/61,21.02%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;SEC23A;RAB1B;CNIH1;ANKRD28;NSF;SEC23IP;SEC24B;SEC31A;SEC16A
prerank,positive regulation of immunoglobulin production (GO:0002639),0.39652415499144905,1.0164381706489172,0.42276422764227645,0.9481638597520928,1.0,4/31,9.45%,SASH3;CLCF1;SHLD2;RIF1
prerank,regulation of cartilage development (GO:0061035),0.44869472856299847,1.0157514827054606,0.4484304932735426,0.9493096336166404,1.0,5/18,7.10%,MBOAT2;WNT11;ZBTB16;SOX9;BMP4
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.38670243668093773,1.0157296040153245,0.4590604026845638,0.9486304236026009,1.0,12/39,15.60%,WNT1;KANK1;GCNT2;FBLN1;EFNA5;DMTN;CASK;ADAM15;RHOA;RASA1;ITGB1BP1;ACTN4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2846432224209443,-1.0151161569739635,0.39555555555555555,0.7959144452899428,1.0,5/43,5.86%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4778261794121158,1.0151144931332676,0.46411483253588515,0.9495697191042913,1.0,2/11,10.33%,RNF5;TOR1A
prerank,sterol metabolic process (GO:0016125),0.366578513879757,1.015064487932405,0.4467312348668281,0.9489716295151226,1.0,12/60,9.05%,SOAT1;STARD3;SULT2B1;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;FDX1;SOAT2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.427289911558476,1.014945088029626,0.45492957746478874,0.9485481115960956,1.0,4/24,8.25%,WNT1;OCLN;AVIL;CDC42
prerank,RNA 3'-end processing (GO:0031123),0.3565525289740136,1.0146513518384441,0.4302741358760429,0.9486177560521751,1.0,26/69,23.15%,SRSF2;EIF4A3;DDX39B;TENT4A;RBM8A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;TUT7;CSTF1;RNPS1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;CSTF3;THOC1;TUT1;U2AF1;SRRM1
prerank,regulation of monooxygenase activity (GO:0032768),-0.3335435414639788,-1.0146286617883802,0.4140127388535032,0.7957699319963126,1.0,7/23,12.95%,POR;NOS3;NOSTRIN;NOS1AP;NOSIP;CYGB;SPR
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.40322858565374053,1.0145479236608361,0.4432284541723666,0.9481788464562562,1.0,6/33,8.39%,ANGPT1;NUPR1;NFE2L2;MAPK7;KRIT1;TCF7L2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3297820233056874,1.0141290079509881,0.445859872611465,0.9485601806982246,1.0,36/149,19.55%,PRKCB;CLU;EDA2R;EDA;CAV1;EP300;FLOT2;TRIM25;MTDH;NFKBIA;DDRGK1;TRIM21;TAB3;RAB7B;TLR6;CARD16;TLR4;MAP3K13;IRAK1;CHUK;DHX9;RNF31;IKBKG;UBE2N;UBC;RPS27A;PRKCZ;PIDD1;TAB2;PRKCQ;TRIM37;NFKB2;ZBTB7A;FLOT1;PRKD2;APP
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.42588680138468193,1.0139445692679185,0.45760233918128657,0.9483292517680121,1.0,7/22,18.81%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR;HEXIM1;CDK5RAP3
prerank,glucan catabolic process (GO:0009251),0.46253678647260316,1.0139112661822605,0.4541284403669725,0.9476806173738598,1.0,4/15,11.03%,MGAM;PHKA2;PGM2;PHKB
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.31864843328202047,1.0139045149581376,0.47575757575757577,0.9469647869917928,1.0,72/306,19.26%,THRB;ST3GAL4;MRPS16;FEN1;GRWD1;EEF1A1;MRPL24;MRPL37;CREBL2;LARGE1;RECQL4;POLR2H;HARS1;RPS4X;NKX2-8;POLR2A;MRPS7;MRE11;GOLPH3;REV1;RPSA;PTMS;ABCF1;RPL31;EXT1;RPL22;GSPT2;PCLAF;MRPS33;RMI1;PTMA;RPL28;SRBD1;EIF4G2;TOPBP1;RPS26;MRPL9;COPS5;EEF1D;CDK2;RNPS1;ING4;TNIP1;HARS2;RPL10A;RPA3;SET;EIF4G1;SARS1;RRBP1;MRPS15;DONSON;POLD2;RPL14;MCM8;MRPS18C;E2F1;ATR;EEF2;MCM7;MCM6;RPS27A;NBN;POLR2C;NT5M;RAD50;HBS1L;IGF2BP3;FARSB;RPL6;POLR2E;EIF4EBP2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4284069337382589,1.0138980096505628,0.4504643962848297,0.9462469687182388,1.0,1/19,0.33%,NFATC2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.46001380947582393,1.0138699655701455,0.47151898734177217,0.9455937162638823,1.0,4/14,11.74%,ABCD1;MTLN;TWIST1;IRS2
prerank,fatty acid biosynthetic process (GO:0006633),0.35745016462169954,1.0138596599223582,0.43452380952380953,0.9448912152353746,1.0,13/63,14.17%,ABCD1;OLAH;ELOVL1;ALOX5;ELOVL6;ACSM3;HACD4;NDUFAB1;FADS1;ACSF3;ACACA;SCD5;LTA4H
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3926600158627137,-1.0138367932723558,0.4550561797752809,0.7965333507577412,1.0,6/13,20.68%,RCL1;UTP20;NOP9;RPS21;TBL3;KRI1
prerank,immunoglobulin mediated immune response (GO:0016064),0.49284710368417717,1.0136545781729411,0.4577702702702703,0.944713643761899,1.0,2/10,11.87%,CD81;FCER1G
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3455842560444134,-1.0134877766234363,0.4351851851851852,0.7961560842809897,1.0,4/20,6.02%,SLC8A1;ATP1B1;SLC12A2;KCNJ2
prerank,neuropeptide signaling pathway (GO:0007218),0.36573937017701214,1.01329740011488,0.44619105199516323,0.9449547884158952,1.0,5/58,9.02%,SORCS2;GAL;PENK;CPE;HCRTR1
prerank,regulation of vasculature development (GO:1901342),-0.3144182825093585,-1.0130316761909406,0.40625,0.7960259536016121,1.0,7/26,13.98%,SP100;BMPER;FGF2;TSPAN12;NF1;EGLN1;RNH1
prerank,calcium ion transmembrane transport (GO:0070588),0.3451789378137938,1.0130103721660488,0.4330254041570439,0.9449417580554884,1.0,20/86,14.32%,TRPM3;CACNA1A;NALCN;TRPM8;MCU;CACNB3;MCUB;PMPCA;CACNA2D4;TMEM165;MICU1;AFG3L2;PKD1;TRPM6;MCUR1;TRPM4;LETM1;ANO6;TRPM2;ATP2B4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4914100374501922,1.012881083795776,0.46790540540540543,0.9445618273923246,1.0,2/10,6.89%,EPHA4;ANXA2
prerank,megakaryocyte differentiation (GO:0030219),-0.4163821890284072,-1.0127096125926218,0.44080604534005036,0.7954353053730083,1.0,3/11,18.94%,SH2B3;KIT;TAL1
prerank,regulation of translation (GO:0006417),0.3255209281261064,1.012400698947532,0.44863731656184486,0.9451314267386246,1.0,43/173,18.60%,VIM;SAMD4A;YTHDF1;SAMD4B;EPRS1;FOXO3;DAPK3;DAPK1;HSPB1;RPS4X;EIF2B2;EIF4A3;UPF3A;EIF6;EIF4B;SHMT1;LTN1;EIF2AK3;SYNCRIP;EIF4G2;POLDIP3;PLXNB2;CPEB3;FXR1;BTG2;EIF4G1;GAPDH;PAIP1;UPF3B;EIF5B;PYM1;DHX9;EIF3B;IGF2BP1;EEF2;CTIF;EIF1;IGF2BP2;EIF2B4;EIF2AK4;EIF4A2;YTHDF3;IGF2BP3
prerank,regulation of tissue remodeling (GO:0034103),-0.3639204703417519,-1.0123908486406488,0.40978593272171254,0.7949289541008904,1.0,6/18,17.39%,LEPR;RUNX1;IL18;TGFB1;FLT4;SUCO
prerank,protein modification by small protein conjugation (GO:0032446),0.3180170474627169,1.012368359573557,0.4686868686868687,0.944503337292312,1.0,104/361,23.63%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;RNF220;SPSB4;NFE2L2;WWP2;TRIM44;MOCS3;NUB1;RNF138;ELOB;NUP93;KLHL21;DDRGK1;MUL1;TRIM21;EYA1;CBLL1;TRIM41;UBE2G2;RBX1;DCUN1D5;NDC1;SDE2;TRIM11;TRIM26;SUMO2;SUMO3;TRIM47;UBE2B;PCNP;RNF182;KLHL24;SAE1;DCUN1D1;TRPM4;KLHL13;VPS11;ZSWIM8;NSMCE2;MIB2;PIAS1;DTX3;PIAS3;BRAP;VPS18;NEDD4;MDM2;UBE2H;MSL2;DDB1;PCNA;UBE2N;CCDC22;PDZRN3;DTX2;UFM1;UBA6;FBXL15;CAND1;CUL9;UBC;RPS27A;STUB1;UBE2F;UBE2D3;KEAP1;RAE1;AAAS;FBXL2;OTULIN;CDK5RAP3;PEX2;UBE2Z;ASB5;RNF41;FBXO9;CHFR;VHL;UBE2E1;SMURF2;FBXW7;ARIH2;TRIM5;RNF168;CUL2;RCHY1;RNF213;POM121;TPR;RNF14;CDC23;DET1;URM1;RNF7;ATG3;RANBP2;CTR9;FBXO4
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41722804796481294,1.0120938567974325,0.4519774011299435,0.9444914636545847,1.0,3/24,4.96%,ZC3H12A;MAVS;TRIM44
prerank,stress granule assembly (GO:0034063),0.4353101762515338,1.0112486015297217,0.4652482269503546,0.9460142416382713,1.0,7/20,20.05%,YTHDF1;PRRC2C;DYNC1H1;ATXN2L;YTHDF3;UBAP2L;MAPT
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.41001622495168033,1.010050156140191,0.43867243867243866,0.9486150840256523,1.0,2/24,2.82%,SEMA3D;SEMA3B
prerank,L-serine metabolic process (GO:0006563),0.48061065973562417,1.0097947990420775,0.456198347107438,0.9485724573212118,1.0,3/10,9.26%,SERINC5;PHGDH;SHMT1
prerank,homocysteine metabolic process (GO:0050667),-0.41141386012942927,-1.009500669291783,0.44412607449856734,0.8014633271688044,1.0,7/11,43.04%,NOX4;MTHFR;CTH;MMUT;CBS;DPEP1;TST
prerank,snRNA metabolic process (GO:0016073),0.45133529151520413,1.0094856195283077,0.47086614173228347,0.94865870165765,1.0,8/17,22.09%,INTS2;MTREX;ZCCHC8;MEPCE;INTS3;INTS6;TUT1;INTS1
prerank,lung epithelium development (GO:0060428),0.48984037653125856,1.0094228396367806,0.4713584288052373,0.9480897878607376,1.0,4/10,9.05%,STRA6;BMP4;PKD1;GRHL2
prerank,membrane organization (GO:0061024),0.3211008931104222,1.0091492721294923,0.45781893004115226,0.9480599100753831,1.0,54/227,18.54%,CFTR;REPS2;ANK2;LDLR;SYP;OTOF;CLTB;A4GALT;AP2A2;REEP3;NUP93;NPC1;ANK3;NSFL1C;SLC2A8;CHMP4A;CHMP4B;CHP1;IL7R;AGFG1;TLCD2;ACTB;TOR1A;TMEM33;ACTG1;VPS4B;AP2A1;VTI1B;LPCAT2;LPCAT3;STX11;OPA1;NAPA;SH3GL2;CHMP1A;VPS4A;OCRL;FER1L6;TOR1AIP1;VAMP7;CCDC88A;DNM1L;REEP4;CHMP2A;AAK1;CERT1;ARPC2;UBC;RPS27A;LRP2;PDCD6IP;STAM;SUN2;OSBPL2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32960820121639217,1.0086086317546932,0.4740740740740741,0.9487582998717727,1.0,11/151,4.61%,ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;GCNT2;ACKR3
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4837670623681918,1.0082000830732272,0.466996699669967,0.9491330637445775,1.0,6/11,21.81%,ASF1A;ATRX;UBN1;IPO4;H3-3A;HAT1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3174587770644649,1.0079866897930738,0.4689092762487258,0.9489542856377632,1.0,39/268,14.91%,SLC9A2;SLC9A4;TRPM3;SLC36A3;ATP6V1B1;ASIC5;SCN3A;HPN;CACNA1A;NALCN;ATP1A2;TRPM8;CACNA2D4;TMEM165;ABCC8;SLC39A3;PKD1;SLC39A6;KCNA4;SLC9A7;SLC9A6;KCNB1;TRPM6;TRPM4;SLC41A1;PKD2L1;ANO6;KCNA5;HVCN1;TRPM2;SLC25A14;SLC39A13;KCNQ5;SLC6A7;ATP2B4;TMEM175;SLC25A27;SLC9A8;SLC30A6
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.30505282524064026,-1.0077825172392845,0.42023346303501946,0.8047562816277528,1.0,18/32,36.80%,ABHD3;SLC44A2;PCYT1A;LPIN2;MFSD2A;SLC44A1;PCTP;STARD10;SLC44A5;LCAT;CHAT;CSNK2B;SLC44A3;PEMT;LPIN3;CSNK2A1;CSNK2A2;ACHE
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4919735329314926,1.007722363548561,0.4461805555555556,0.9489459711137043,1.0,3/10,13.67%,MLLT3;SFRP1;LMBR1L
prerank,fat cell differentiation (GO:0045444),0.36264235976766596,1.0076037469336176,0.4469413233458177,0.94854492863417,1.0,6/57,8.39%,KLF4;PPARGC1A;SMAD6;EP300;WNT5B;TCF7L2
prerank,intracellular lipid transport (GO:0032365),0.4269939974702556,1.0074764638269,0.4579710144927536,0.9481635485038715,1.0,5/21,12.43%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2
prerank,protein-containing complex subunit organization (GO:0043933),0.3374699798475558,1.0065332531764422,0.45865490628445427,0.9499056464113195,1.0,15/109,8.99%,REPS2;PPARGC1A;OCLN;EPRS1;PTK2B;ELOB;DMTN;SOX9;AFG3L2;LAMC1;GPAA1;PARD6B;PML;NDC1;KMT2A
prerank,negative regulation of interleukin-10 production (GO:0032693),0.43886074939258546,1.006346561008384,0.44904458598726116,0.9496721787186605,1.0,2/16,9.13%,TRIB2;FOXP3
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3432822380618981,-1.006225242753545,0.43260188087774293,0.807637469854827,1.0,5/20,12.43%,PLOD2;GATM;PTDSS1;PLSCR1;CNDP2
prerank,neuron projection regeneration (GO:0031102),-0.41860042609012516,-1.006053891405504,0.456575682382134,0.8066738788182393,1.0,4/10,15.32%,NREP;MAPK8IP3;DHFR;MTR
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.38710999958138864,1.0057317199545832,0.45910290237467016,0.9505977357394272,1.0,9/35,14.60%,KANK1;DLC1;RIPOR2;RASAL3;CCDC125;TGFB2;MAPKAP1;SYNGAP1;FLCN
prerank,inflammatory response (GO:0006954),0.3235871829003412,1.0056577818466006,0.463768115942029,0.9500495795487374,1.0,20/195,11.47%,AGTR1;CD44;CCL5;ELF3;CXCR4;HDAC5;PTGFR;FOS;RELB;HDAC4;HP;HPR;CCRL2;NFAM1;ABCF1;TNFRSF1A;TLR6;TAC4;CDO1;TLR4
prerank,exit from mitosis (GO:0010458),-0.3986080176743318,-1.0052953346300655,0.4588859416445623,0.8073735889744519,1.0,5/12,17.12%,CLASP2;EPS8;UBE2S;CTDP1;CHMP7
prerank,organophosphate catabolic process (GO:0046434),-0.4122852002631406,-1.0051013097112227,0.44501278772378516,0.8065419173723223,1.0,2/11,12.79%,ENPP2;ABHD12
prerank,negative regulation of phosphorylation (GO:0042326),0.34171836979110437,1.0050930392553756,0.45617977528089887,0.9507965667439412,1.0,22/85,18.81%,NTRK3;CDKN1A;OCLN;NUPR1;ZC3H12A;HDAC4;FBLN1;BMP4;PIP5KL1;CHP1;FKBP8;TIGAR;NCOR1;IRS2;SH3GL2;DNAJC10;TESK1;PTPN13;CDKN2D;GIT1;PARK7;CDK5RAP3
prerank,nuclear envelope organization (GO:0006998),0.4276930173533026,1.0049976011883774,0.46656534954407297,0.950337083798554,1.0,7/20,18.23%,REEP3;NUP93;TOR1A;VPS4A;TOR1AIP1;REEP4;SUN2
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.333238427790181,-1.0045626476210923,0.42474916387959866,0.8066136993647303,1.0,9/24,18.67%,ERRFI1;PRKCH;RUNX1;ROCK1;HOXA7;CTSL;SGPP1;ZFP36;NME2
prerank,histone H3-K36 demethylation (GO:0070544),0.46808112377152755,1.0043546763712747,0.4624183006535948,0.9513639278252587,1.0,3/10,11.01%,KDM4B;KDM4C;RIOX2
prerank,chromatin disassembly (GO:0031498),0.4486096729312194,1.0033471744510185,0.4582677165354331,0.9525675738691096,1.0,6/14,15.63%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,nucleosome disassembly (GO:0006337),0.4486096729312194,1.0033471744510185,0.4582677165354331,0.9525675738691096,1.0,6/14,15.63%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,positive regulation of ruffle assembly (GO:1900029),0.46012074030861866,1.0029796329686578,0.4572317262830482,0.9528522945248593,1.0,4/13,14.62%,EPS8L2;NDEL1;PLEKHM1;HRAS
prerank,positive regulation of viral genome replication (GO:0045070),0.3980893935126356,1.00260948155749,0.4556786703601108,0.9531358287573812,1.0,13/29,28.75%,CCL5;TARBP2;TMEM39A;SRPK2;SRPK1;DDB1;TOP2B;PABPC1;PPID;PDE12;PPIE;DDX3X;LARP1
prerank,positive regulation of signal transduction (GO:0009967),0.3172586986166009,1.001975409446979,0.4852492370295015,0.9540947575904883,1.0,23/238,7.50%,PRKCB;SORBS1;TSPAN5;NTRK3;WNT1;KANK1;SMO;JCAD;ELF3;RSPO3;EMP2;EP300;LIMS2;PTK2B;SMARCB1;TRIM44;PIH1D1;CAV2;DMTN;ZBTB7B;WLS;TGFB2;ILK
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4252638482369013,1.0018474865529008,0.45481927710843373,0.953696330548132,1.0,6/19,15.36%,KLF4;MAVS;MAPK7;TLE5;IRAK1;DHX9
prerank,regulation of protein neddylation (GO:2000434),-0.4196782099841012,-1.0014688181278129,0.49242424242424243,0.8135272237984132,1.0,5/10,17.47%,HIF1A;EPAS1;RPL11;DCUN1D3;DCUN1D2
prerank,microtubule bundle formation (GO:0001578),0.3747317038439409,1.001306866690633,0.4648786717752235,0.9544166423541693,1.0,6/42,12.29%,RP1;PSRC1;CFAP206;CHP1;GAS2L1;MARK4
prerank,regulation of axon guidance (GO:1902667),0.4815998967024754,1.001219387254968,0.46915584415584416,0.9539417265707664,1.0,4/10,20.46%,YTHDF1;ZSWIM8;TUBB2B;ZSWIM6
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.39238246205742777,1.000829218857872,0.45694444444444443,0.9542715528525032,1.0,11/29,22.64%,FEM1A;FBXO5;ARRDC3;DCUN1D5;DCUN1D1;FEM1B;UBE2N;ABL1;PARK7;FBXW7;TRIB3
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.41704728633391774,-1.0000612779835847,0.4973958333333333,0.8159036961200344,1.0,4/10,20.77%,SMARCD3;DRD2;CX3CR1;CX3CL1
prerank,mitochondrial translational elongation (GO:0070125),0.3458782871859478,0.9999299938701814,0.46650998824911866,0.9558737176872137,1.0,38/88,28.74%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL57;MRPL9;MRPL50;MRPS15;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;MRPL44;PTCD3;MRPS6;MRPL18;MRPS24
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.448468922107893,0.9998563686479403,0.4611801242236025,0.9553431517289008,1.0,6/14,22.36%,SEC23A;SEC31B;SEC24B;MIA3;SEC31A;SEC24D
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3569324210616853,0.9995814642527759,0.44154228855721395,0.954630424843011,1.0,24/56,28.38%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10;TIMMDC1;NDUFA13;NDUFAF7;NDUFB3;NDUFS4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3569324210616853,0.9995814642527759,0.44154228855721395,0.954630424843011,1.0,24/56,28.38%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10;TIMMDC1;NDUFA13;NDUFAF7;NDUFB3;NDUFS4
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.37882973730073133,0.9994425279813379,0.48404255319148937,0.9543059893380881,1.0,4/39,2.96%,TSPAN5;WNT1;ELF3;EP300
prerank,nuclear export (GO:0051168),0.34901638896159953,0.9989751272614128,0.4591121495327103,0.9548041817818187,1.0,29/80,23.15%,RANBP3L;SRSF2;EIF4A3;DESI1;PKD1;CHP1;DDX39B;RBM8A;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;WASHC4;RAE1;RITA1;CSE1L;SRSF1;SRSF5;XPO4;THOC1;RANBP3;U2AF1;POM121;TPR;SRRM1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3710019755743701,-0.9989293315971496,0.4715447154471545,0.8174586088272813,1.0,2/14,5.86%,THBS1;IRAK3
prerank,negative regulation of DNA replication (GO:0008156),0.4586714143183446,0.9988650780424693,0.4935483870967742,0.9543685188368136,1.0,6/13,28.59%,S100A11;ATR;WAPL;GTPBP4;TERF1;CDC6
prerank,protein autophosphorylation (GO:0046777),-0.22845155317061647,-0.9988506086393016,0.4576271186440678,0.816319794197645,1.0,33/157,14.02%,FLT1;PDGFRB;PRKD1;TEK;INSR;TNIK;LYN;PTK2;CAMK4;CAMK2D;KDR;PDGFRA;SIK1;WNK2;CDK12;ACVR1B;EPHB4;LRRK2;BMX;NTRK2;ERBB4;JAK2;DAPK2;FGFR2;KIT;IGF1R;STK17B;CDKL5;RIPK1;FGFR4;FLT4;CAMK2A;NEK6
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.39721111155831385,-0.9988276235580239,0.47075208913649025,0.8149826448577444,1.0,3/13,3.65%,SLC8A1;PDE4D;CAMK2D
prerank,regulation of signal transduction (GO:0009966),0.31425974470620494,0.9987091859823333,0.47253886010362695,0.9540554850961295,1.0,34/190,14.36%,CD55;CLU;IGFBP6;PRAG1;OGT;SREBF2;GRK5;VEPH1;RSPO3;GDNF;PPP2CA;TIMP1;TSC2;FRMPD1;OVOL2;CSK;PXN;ERBB3;ILK;UBTF;FOXP3;ZIC1;LLGL2;USP20;SYNJ2BP;GRK2;SOCS2;CDKN2AIP;PTPN2;GATA3;RGS6;BRAP;IRAK1;ITGB1BP1
prerank,peptidyl-lysine acetylation (GO:0018394),0.4756724541884564,0.997902633712976,0.4599659284497445,0.9554523041807189,1.0,1/10,2.96%,EP300
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.3138343031111549,-0.997870350630368,0.4121863799283154,0.8162813815870171,1.0,11/31,28.68%,PLCB1;LGALS9;TIRAP;HMGB1;CD40;HSPD1;MAPK14;CCL19;RIPK2;PLCG2;MAPK11
prerank,regulation of immune response (GO:0050776),0.3275939666102453,0.9972788402971859,0.4908108108108108,0.9564084257163392,1.0,9/135,7.45%,CXADR;RAET1E;CD200;IL15;ITGB7;CD81;CSK;TGFB2;PVR
prerank,regulation of cell size (GO:0008361),-0.32313141247485344,-0.997162829135018,0.4524590163934426,0.816762705201403,1.0,8/23,18.49%,RDX;VAV3;DEPTOR;PRR16;MTPN;EDN1;AKT1S1;VAV1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.3651706980904297,-0.9969753714134919,0.45161290322580644,0.815857888186806,1.0,3/15,4.60%,SLC8A1;ATP1B1;SLC12A2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32614892694594944,0.99694085236212,0.49688796680497926,0.9566082605921709,1.0,53/182,21.68%,ITGB8;NOTCH2;PRKAA2;KLF4;LDLR;SMO;ADAM10;OCLN;ZC3H12A;CELF1;OLFM1;WWP2;FLOT2;RBMS3;OVOL2;MOV10;DDRGK1;BMP4;TGFB2;MAP2K2;SMCR8;SFMBT2;SNX12;ZNF148;SFRP1;SH3GL2;TLE5;MEF2C;FOXP1;ATP2B4;SETDB1;FLCN;HRAS;TET1;RIN3;HINFP;LRP3;POU4F1;BMPR1A;PARK7;ROCK2;APP;GPER1;MAPT;RB1;TERF2;SLC2A10;YY1;DLG4;VHL;AP1AR;FBXW7;WDR54
prerank,positive regulation of cellular respiration (GO:1901857),0.4814617162671569,0.9968095010710158,0.46915584415584416,0.9562422632066154,1.0,1/11,2.38%,NUPR1
prerank,regulation of immunoglobulin production (GO:0002637),0.4106570073288694,0.9962681837030746,0.48241912798874825,0.9569384468011118,1.0,2/23,4.27%,SASH3;CLCF1
prerank,polyamine metabolic process (GO:0006595),0.453896981552045,0.9960830300220461,0.46885245901639344,0.9567403682094167,1.0,1/13,1.38%,SMOX
prerank,positive regulation of dendrite extension (GO:1903861),-0.3570186595930903,-0.9953932358303804,0.4638888888888889,0.8188200438309766,1.0,10/17,36.78%,SYT1;ITSN2;RIMS1;SMURF1;CPNE9;CPNE5;RNF157;RASAL1;SYT17;SYT4
prerank,glycoprotein metabolic process (GO:0009100),-0.2665682652271315,-0.9951247521674498,0.45933014354066987,0.8182580602648065,1.0,15/53,18.23%,ST6GALNAC3;MAN1C1;ADAMTS9;HIF1A;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;MAN2B1;GCNT1;B4GALT5;ST8SIA2;ST8SIA5;B4GALT7;PCSK6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.39503967286645214,0.9951225000523508,0.46226415094339623,0.9585115728699408,1.0,4/32,3.88%,KLF4;JCAD;HDAC5;FOXC2
prerank,potassium ion transmembrane transport (GO:0071805),0.32465640728942025,0.9949562644966266,0.4809575625680087,0.9582278173376788,1.0,18/135,14.75%,SLC9A2;SLC9A4;HPN;SLC12A8;NALCN;ATP1A2;KCNJ13;ABCC8;KCNA4;SLC9A7;SLC9A6;KCNB1;SLC12A4;PKD2L1;KCNA5;KCNQ5;TMEM175;SLC9A8
prerank,regulation of cell cycle process (GO:0010564),0.33337002532274784,0.994665799469135,0.4816053511705686,0.958280460703828,1.0,28/104,20.09%,KIF13A;DAPK3;RAB11FIP3;CAV2;BCL2L1;SOX9;KLHL21;PLK3;CDC42;FBXO5;USP19;AURKC;PKMYT1;KLHL13;MARK4;SFRP1;FLCN;MAD1L1;PLK2;DYNC1H1;CUL9;GIT1;NUMA1;ZFYVE26;KIF20B;GPER1;UVRAG;PIK3R4
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4482673499526185,0.994655208705462,0.47058823529411764,0.9575895245216478,1.0,4/16,11.03%,MGAM;PHKA2;PGM2;PHKB
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3416444971531963,-0.9944027252078047,0.46808510638297873,0.8187938518998057,1.0,3/20,8.40%,SP100;SYNE1;TOPORS
prerank,membrane depolarization during action potential (GO:0086010),-0.31313016333485044,-0.993796796483415,0.4652777777777778,0.8191093676829035,1.0,8/26,15.51%,CACNA1C;SLC8A1;SCN7A;KCNJ2;CACNA1G;HCN2;SCN1A;SCN1B
prerank,protein deubiquitination (GO:0016579),0.3144736008910082,0.9936306078618026,0.48102564102564105,0.959553746089646,1.0,72/242,24.43%,CFTR;OGT;MINDY2;ZC3H12A;EP300;USP46;USP29;OTUD1;PSMD11;NFKBIA;USP32;USP10;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;USP19;ACTB;USP24;ENY2;USP20;USP42;PSMD7;USP3;RHOA;MYSM1;TOMM20;ABRAXAS1;COPS5;RNF123;FOXK1;PSMB5;GATA3;MYC;TNIP1;MDM2;USP28;IKBKG;OTUD6B;UBC;RPS27A;KEAP1;TRRAP;USP25;STAM;PSMD1;OTULIN;PSMC4;USP21;USP16;TAF9B;PSMD8;USP22;INO80D;YY1;INO80C;SMURF2;USP2;USP11;INO80E;WDR20;BIRC3;MDM4;TADA3;PSMA7;CDC25A;USP13;TFPT;STAM2;USP34;MBD6
prerank,regulation of cholesterol storage (GO:0010885),0.4459494759706951,0.9935077982945909,0.47473200612557426,0.9591654860372157,1.0,3/15,3.63%,SREBF2;TTC39B;EHD1
prerank,ureteric bud development (GO:0001657),0.43695693111323336,0.9930090734473527,0.4946889226100152,0.9597864466051728,1.0,5/17,12.24%,WNT11;BMP4;GPC3;SIX1;NPNT
prerank,vesicle organization (GO:0016050),0.36840075129190575,0.9925867477126791,0.4775,0.9602020930625929,1.0,15/46,17.06%,ANXA8;ANXA8L1;CAV1;CAV2;SRGN;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1;PI4K2A;WASHC4
prerank,negative regulation of gene expression (GO:0010629),0.31482486695581524,0.9924984457991498,0.5182186234817814,0.9596965543524499,1.0,57/302,14.62%,ITGB8;NOTCH2;PRKAA2;KLF4;SMO;ADAM10;OCLN;SAMD4A;ZC3H12A;TWSG1;CELF1;SAMD4B;EPRS1;DAPK3;DAPK1;OLFM1;WWP2;FLOT2;PHF1;RBMS3;OVOL2;MOV10;DDRGK1;EIF4A3;BMP4;TGFB2;LGR4;SRGN;FOXP3;SHMT1;MAP2K2;DNMT3A;SMCR8;PPP1R11;AEBP2;NCOR1;EIF2AK3;SYNCRIP;SFMBT2;SNX12;RPS26;ZNF148;PPM1D;SFRP1;SH3GL2;CPEB3;FXR1;TLE5;BTG2;NCOR2;MEF2C;FOXP1;GAPDH;ATP2B4;SETDB1;FLCN;HRAS
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.45305189322241035,0.9922315801662223,0.4788961038961039,0.9597204777942363,1.0,3/14,6.73%,ADAMTS7;SOX9;EFEMP1
prerank,DNA metabolic process (GO:0006259),0.31324182341944606,0.9920532556576517,0.505091649694501,0.9594946132974221,1.0,74/270,22.49%,NT5E;FEN1;RECQL4;DOT1L;SMARCB1;NABP2;ASF1A;NSMCE4A;PARP3;MRE11;DCTPP1;CENPS;INIP;RAD54L;TCF7L2;POLK;RIF1;UBE2B;DNASE1L2;MUTYH;POLG;SRPK2;USP3;POLE4;CSNK1E;HUS1B;TOPBP1;PWWP3A;CDK2;ERCC5;MBD4;BTG2;DNASE1L1;RPA3;REXO4;ENDOV;POLH;POLD2;PRIM2;MCM8;LIG3;FAN1;DDB1;ATR;PCNA;UBE2N;MCM7;HINFP;NEIL1;MCM6;UBC;RPS27A;NBN;INTS3;TRRAP;PARG;RAD50;PARP2;PARK7;RFC1;PNKP;UVRAG;ERCC4;NABP1;TOP2B;TERF2;ORC2;MCM4;PTGES3;SIRT7;DDX23;LONP1;MEN1;IGHMBP2
prerank,regulation of astrocyte differentiation (GO:0048710),0.4697170745149837,0.9919586943085477,0.49514563106796117,0.9590305902165894,1.0,2/12,4.27%,EPHA4;CLCF1
prerank,positive regulation of nervous system process (GO:0031646),-0.34834232188315595,-0.9916461162895651,0.44171779141104295,0.8236065543134773,1.0,8/18,26.10%,UNC13B;TENM4;TPPP;TNFRSF1B;MYRF;RIMS1;DICER1;NCMAP
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.42583900814953,0.9915521828167905,0.4687975646879756,0.9594393574587486,1.0,4/18,11.94%,COX19;COX16;COA8;COX20
prerank,multivesicular body assembly (GO:0036258),0.3911803405193254,0.9915500488323695,0.463448275862069,0.9587386569011819,1.0,12/30,20.08%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;VPS37A;IST1
prerank,organelle organization (GO:0006996),0.31111888721442904,0.9910490216314237,0.5191532258064516,0.9593614258879896,1.0,102/388,21.37%,CXADR;SPTSSB;PPARGC1A;FMNL2;FBXW8;ANK1;MICAL2;YTHDF1;GABPB1;ABCD1;CAV1;DIAPH1;TJAP1;ZMYM6;NCKIPSD;TMED1;AGTPBP1;CAPZB;CAV2;DMTN;HCFC1;HAX1;NRF1;SYNE3;ATP8B2;MAPK15;NSFL1C;GOLPH3;ARHGAP10;ARHGAP21;MICAL1;CHMP4A;CHMP4B;CDC42;STRIP1;CENPT;RAB7A;PCLO;MIEF2;TOR1A;BCAS3;AFG1L;ZW10;NIPSNAP2;VPS4B;EIF2AK3;VPS11;AJUBA;MARK4;ZMYM4;OPA1;GOLGB1;CHMP1A;VPS4A;RHOU;ARFGEF1;VPS18;MYC;NPLOC4;ATL2;DNM1L;VPS13D;USP6NL;CHMP2A;PEX6;MTX1;ATP5F1B;CAMSAP1;PAK6;PI4K2A;CFAP61;NUMA1;CLUH;PDCD6IP;PACSIN1;SEC23IP;STX4;MTFR2;WTIP;YTHDF3;PARK7;ODF2;TMED5;PEX3;STOML2;PEX2;RNF112;RHOT2;SMPD4;GORASP2;SEC31B;MYO18A;HSD17B10;HILPDA;MNS1;TWNK;MIA3;TMCC1;SEC31A;SEC16A;GABPA;SIRT4
prerank,protein O-linked mannosylation (GO:0035269),0.42328214008239695,0.9907545659640002,0.4735249621785174,0.9593670857578706,1.0,3/18,4.23%,B4GAT1;TMTC1;LARGE1
prerank,nuclear membrane reassembly (GO:0031468),0.35954637784126275,0.9907425749029456,0.4865853658536585,0.9586907914517296,1.0,12/54,15.56%,CC2D1B;PPP2CA;REEP3;NUP93;NSFL1C;CHMP4A;CHMP4B;NDC1;VPS4A;REEP4;LMNA;CHMP2A
prerank,metal ion export (GO:0070839),-0.2997866805567625,-0.9904853583272176,0.44609665427509293,0.8252732971668563,1.0,4/31,5.80%,KCNT2;KCNK5;ATP1B1;SLC40A1
prerank,negative regulation of protein binding (GO:0032091),0.350230008550634,0.9898010504567925,0.47248803827751196,0.9604700141666603,1.0,14/71,14.36%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;CTSZ;PTPRF;ACTB;CARD16;ADAM15;CSNK1E;TLE5;GSK3B;ITGB1BP1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.41297062102777937,-0.9897702972404097,0.46112600536193027,0.8258240264207073,1.0,5/11,25.10%,GRK3;ARRB1;ADM;SAG;ARRB2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.40873568116443315,-0.9896808298514922,0.46462264150943394,0.8246991515098719,1.0,6/11,32.30%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3554549474076644,-0.98955221095326,0.4613003095975232,0.8236737679294244,1.0,2/17,0.77%,PDGFRB;ITGA1
prerank,cellular response to virus (GO:0098586),0.3931275845718516,0.9892335110875397,0.47690217391304346,0.9612659743400307,1.0,7/30,15.33%,CCL5;ZC3H12A;IRF3;LGALS8;GSDME;CHUK;HSP90AA1
prerank,substrate-dependent cell migration (GO:0006929),-0.3819114140334551,-0.9889511231903673,0.45231607629427795,0.8239729279848111,1.0,5/14,19.59%,VEGFC;ITGA11;ANKS1A;EPHA8;P2RY12
prerank,regulation of histone acetylation (GO:0035065),0.39134496043133304,0.9887730759640698,0.4812332439678284,0.9617693562856348,1.0,8/33,14.60%,PPARGC1A;HDAC5;KMT2A;FOXP3;BRD7;RAPGEF3;SET;FLCN
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4041476829692053,-0.9887498967106112,0.49489795918367346,0.8231329445890705,1.0,6/11,27.52%,TMEM67;RBM14;CCNF;KAT2B;BRCA1;NPM1
prerank,neurotrophin signaling pathway (GO:0038179),0.41667076648956514,0.9886647960723483,0.4732272069464544,0.9613544059856037,1.0,6/21,15.12%,MAGI2;RAP1A;NGF;ZFYVE27;BCAR1;RAPGEF1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4271417340437348,0.9883047412579126,0.46534653465346537,0.9616451620015981,1.0,8/20,20.36%,NIBAN2;EP300;DDRGK1;TWIST1;GATA3;POU4F1;PARK7;RB1
prerank,regulation of cell development (GO:0060284),0.38463508408651637,0.9879580868979388,0.4805194805194805,0.9618673773576069,1.0,5/36,12.63%,NOTCH2;DOCK7;RHEB;ADGRA2;WNT3
prerank,mesonephric tubule development (GO:0072164),0.44772992368756,0.9879340773364961,0.48367029548989116,0.96123882767481,1.0,5/15,12.24%,WNT11;BMP4;SIX1;PKD1;NPNT
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3067622090458653,0.9874580652000678,0.5526579739217653,0.9618325357709115,1.0,70/532,11.87%,FN1;TNFRSF11B;CD44;CRLF1;MAP3K8;CCL5;MMP9;EDA2R;IL17RE;VIM;EDA;CDKN1A;RORC;IL17RA;RAP1B;IL15;IL16;LAMA5;FOXO3;TNFSF13;PTK2B;FOS;TNFRSF8;IL3RA;CLCF1;TIMP1;EPO;ACKR3;TRIM25;ALOX5;PSMD11;NFKBIA;IRF3;BCL2L1;RNASEL;GPR75;SHC1;CSK;PSMD4;MSN;ANXA2;COMMD7;GSTO1;PSMF1;TRIM21;MTAP;STAT4;ILK;TAB3;LBP;CDC42;PTPN6;RBX1;NDN;PYDC1;TNFRSF1A;PML;IL7R;TRIM26;CCND1;TWIST1;PSMD7;SOD2;JAK1;SMARCA4;IL1R2;YWHAZ;IRS2;SOCS2;FCER1G
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3831186773348075,0.9874144165084948,0.5006570302233903,0.9612509718842183,1.0,12/33,26.40%,GLUL;DDAH2;GLUD1;PYCR3;ALDH18A1;PRODH;KYAT1;DGLUCY;SIRT4;PYCR2;DDAH1;ALDH5A1
prerank,nuclear pore complex assembly (GO:0051292),0.4796772867636428,0.987347505421613,0.48067226890756304,0.960722107450492,1.0,2/10,8.91%,NUP93;NDC1
prerank,L-amino acid transport (GO:0015807),0.39807115326445813,0.986820642968946,0.47644683714670255,0.961372541186759,1.0,8/28,15.34%,SLC36A3;CTNS;SLC36A4;SFXN1;ARL6IP5;SLC1A4;SLC25A12;SLC7A3
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.30968692006460946,-0.9868097828618825,0.4626865671641791,0.8270312404334783,1.0,14/29,32.71%,UTP6;NGDN;UTP20;RRP36;NOP9;RPS21;DHX37;TBL3;KRI1;WDR46;NOL10;ABT1;MRPS11;HELB
prerank,regulation of calcium-mediated signaling (GO:0050848),0.39563146590591786,0.9867278182491116,0.46219686162624823,0.96090342564749,1.0,1/25,0.37%,CDH13
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4479207078289019,0.9864023526732765,0.49686520376175547,0.9610332346900193,1.0,7/15,20.72%,USP46;ZDHHC12;NPS;STXBP1;NLGN2;SYN3;ZDHHC3
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4555943047436765,0.9863481036984157,0.4968553459119497,0.9604638386262538,1.0,1/12,0.55%,THRB
prerank,polyol metabolic process (GO:0019751),0.3633018758279838,0.9861831104206175,0.46675031367628605,0.9602001410796572,1.0,11/46,15.59%,NUDT4;PLCB3;PLCD3;INPP4A;IP6K1;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,phosphorylation (GO:0016310),0.30863450163337136,0.9860623579345603,0.5210843373493976,0.9598066797558302,1.0,97/384,20.14%,PRKCB;FGFR1;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;GRK5;ADAM10;TSSK6;TSSK4;IKBKE;WNT11;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;AGK;CREB1;RNASEL;STK39;SIK3;CSK;NADK;TGFB2;CDK16;ILK;LATS1;DYRK1B;MAPK9;PI4KA;AURKC;OXSR1;BCR;LMTK2;TXK;HK1;SRPK2;CDKL4;GRK2;DGKA;JAK1;PDK2;CSNK1E;YWHAZ;EIF2AK3;TGFBR2;MARK4;CDK18;SRPK1;CDK2;MAP3K13;GSK3A;IRAK1;GSK3B;CHUK;ULK1;WNK1;CDC42BPA;PLK2;AAK1;MAP3K6;ABL1;PAK6;PEAK1;PRKAG1;MAPK6;PRKCZ;EIF2AK4;MAPKAPK2;CDC25B;CHEK2;BMPR1A;RARA;STK24;ROCK2;RSKR;TAOK3;STK38L;PNKP;PRKD2;APP;CDK11B;PRKAB1;MAP3K1;CAMK2B;PIK3R4;TBCK
prerank,positive regulation of integrin activation (GO:0033625),0.4802303855986222,0.9860329111431264,0.4792703150912106,0.959183473479749,1.0,1/11,2.26%,RAP1B
prerank,regulation of angiogenesis (GO:0045765),0.32038311782281714,0.9860166098686933,0.49844559585492226,0.9585343101072406,1.0,27/192,10.56%,ADAM12;PRKCB;ITGB8;KLF4;ANXA3;COL4A3;EMP2;NIBAN2;GLUL;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;ALOX5;HOXA5;MYDGF;AGGF1;TGFB2;KRIT1;ADAMTS1;VEGFB;PML;ADGRA2;EMC10;TWIST1;SYNJ2BP
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4163364168122545,0.985704964415022,0.49575070821529743,0.9586507640716098,1.0,10/20,26.25%,ADAM10;SPPL2B;HM13;SPPL2A;ADAM17;RHBDD1;APH1A;PSEN1;RELA;MBTPS2
prerank,regulation of programmed cell death (GO:0043067),0.31897208787313674,0.9857003363928171,0.4905263157894737,0.9579674058780344,1.0,22/161,12.29%,CLU;DAXX;ACTN2;NDRG1;PMAIP1;KANK2;DAPK3;DAPK1;PPP1R13B;RARG;IRF3;PERP;HAX1;SOX9;TNFRSF10B;PTPN6;RAF1;USP42;TIGAR;PLSCR3;BCAR1;MARK4
prerank,calcium ion homeostasis (GO:0055074),0.33690223588494317,0.9855899690265171,0.48522727272727273,0.9575327991009012,1.0,11/95,8.29%,ANK2;ATP6V1B1;STIM2;CCL5;CAV1;CSRP3;SELENON;ATP13A3;TMEM165;JPH2;ATP13A4
prerank,Notch signaling pathway (GO:0007219),0.3486776339055432,0.985495290052451,0.4787234042553192,0.9570756567348518,1.0,5/59,2.96%,NOTCH2;PBX1;ADAM10;NLE1;EP300
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4716738930998685,0.985464854085098,0.4698996655518395,0.9564614760357809,1.0,3/11,14.52%,TGFB2;TGFBR2;TGFBR3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.2657706746860752,-0.9853415714142938,0.4298642533936652,0.8296570935825748,1.0,15/54,15.60%,DPP10;KCNN2;KCNIP4;NOS1AP;KCNIP3;KCNJ2;BIN1;KCNIP1;KCNJ12;DPP6;KCNJ6;KCNJ10;KCNMA1;KCNMB4;GNB1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35726114131746295,-0.9853406554015685,0.49584487534626037,0.8282839218564294,1.0,8/16,20.87%,ARHGAP24;AUTS2;PIK3CB;ALS2;STMN3;RASGRF1;ARF6;GABARAP
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.34345442553921907,0.9852899723968805,0.4908675799086758,0.9562305838713387,1.0,28/80,20.16%,RAB9B;SNX8;GCC2;MAGEL2;RAB7A;RAB7B;VPS54;GGA1;SGSM2;VTI1B;SNX12;RNF126;PHETA2;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;WASHC1;VPS50;TBC1D10A;ARFRP1;TMEM87B;YKT6;RAB9A;VTI1A;BET1L;TBC1D17
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4802667875318941,0.9851444052480298,0.49072512647554806,0.9559010636429305,1.0,1/10,0.76%,CHRM1
prerank,glucose import (GO:0046323),-0.38810390105785975,-0.9849144257707515,0.4859550561797753,0.8280858026445662,1.0,2/13,8.39%,SLC2A1;SORT1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4576533783180523,0.9847521714852626,0.4691151919866444,0.9562086720510498,1.0,1/11,1.19%,LDLR
prerank,heart contraction (GO:0060047),0.37912285154512493,0.9847332934269608,0.4883720930232558,0.9555709240887579,1.0,4/41,3.70%,SGCG;SGCD;ATP1A2;CSRP3
prerank,RNA destabilization (GO:0050779),0.42873601836223346,0.9846810472807486,0.4761171032357473,0.9550155452808851,1.0,7/18,22.51%,YTHDF1;CELF1;MEX3D;YTHDF3;ROCK2;DXO;FTO
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.38287199134640554,0.9843443782205805,0.4746922024623803,0.9551718707416841,1.0,14/30,24.37%,AMN;KIF13A;ANK3;GOLPH3;GCC2;GOLGA7;GGA1;NSF;ARFRP1;RAB10;SEC16A;VAMP2;RAB31;GOLPH3L
prerank,phosphatidylserine metabolic process (GO:0006658),-0.30746755167833617,-0.9841197435512421,0.4895397489539749,0.8288925708241917,1.0,6/32,5.88%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PTDSS1;PLAAT3
prerank,regulation of vesicle-mediated transport (GO:0060627),0.33356043326060075,0.9838998906042911,0.49426605504587157,0.9556367428328723,1.0,17/91,17.92%,RAB17;CDH13;TSC2;STON1;RAB3B;OPHN1;MAP2K2;ATP9A;SNX12;CPLANE2;RAB5C;RAB33B;RAB8B;ABL1;NSF;PACSIN1;STX4
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4467339101965371,0.9836365438829602,0.47923875432525953,0.9556499884756746,1.0,10/14,29.16%,NABP2;ATRX;PINX1;TNKS2;ATR;TERF2;TINF2;TERT;XRCC5;TERF2IP
prerank,positive regulation of cell projection organization (GO:0031346),0.33109114409565843,0.983567253582239,0.5111358574610245,0.9551306491931485,1.0,17/115,7.85%,NTRK3;FBXW8;PLXNB1;PTK7;PLXNA2;MAGI2;EP300;RAP1A;NGF;PTK2B;TIAM2;MAP6;PTPRD;AVIL;TWF1;ARSB;DVL3
prerank,heterocycle biosynthetic process (GO:0018130),0.43914425351303027,0.9835507223776173,0.48822605965463106,0.9544834995968606,1.0,5/14,11.72%,MOCS3;ALOX5;NFS1;PYCR3;NOXRED1
prerank,regulation of JUN kinase activity (GO:0043506),0.385585564506108,0.9832786616356929,0.4610027855153203,0.9545384529174327,1.0,6/33,9.31%,MAP3K5;DUSP10;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,response to histamine (GO:0034776),-0.4114021779944165,-0.9829514412702623,0.46190476190476193,0.8306395863366415,1.0,6/10,22.48%,GABRB1;GABRG2;DRD2;GABRB2;HRH1;GABRB3
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.47301481380529725,0.982821421042777,0.4863123993558776,0.9550666559310688,1.0,6/11,20.69%,SOAT1;ITM2C;ABCA2;NECAB3;NECAB2;ABCA7
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.45676167171093746,0.9827334841411935,0.5049833887043189,0.9546173070777063,1.0,4/12,19.85%,TLR6;ZNF205;TLR4;RAB27A
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4247183595119184,-0.9825807471924558,0.5,0.8301771641530773,1.0,7/10,32.28%,NUDT21;HSF1;CPEB1;PAF1;NCBP1;DHX36;NCBP2
prerank,axoneme assembly (GO:0035082),0.39008482476765277,0.9822994306677142,0.4661134163208852,0.9550587599238467,1.0,2/30,8.32%,RP1;CFAP206
prerank,neuron migration (GO:0001764),0.36186168413213127,0.9822495060077586,0.48685857321652065,0.9544941295103349,1.0,3/48,0.88%,FGF13;FGFR1;CELSR1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3215552862415943,-0.9819496791193509,0.4583333333333333,0.8304942082165344,1.0,2/24,1.44%,PID1;DAB2
prerank,regulation of protein ubiquitination (GO:0031396),0.32615496890826934,0.9818949266062768,0.492622020431328,0.9547433887555167,1.0,28/108,22.96%,ANGPT1;DAXX;NXN;OGT;CAV1;PRR7;SH3RF2;CENPS;CHP1;HDAC3;HSPBP1;DCUN1D1;PINX1;GSK3A;WASHC1;HSP90AA1;UBE2N;STUB1;XIAP;PARK7;CDK5RAP3;PHF23;SOX4;FBXW7;SIRT7;SPOPL;RCHY1;BIRC3
prerank,mesenchymal cell development (GO:0014031),-0.34287440702009697,-0.9815762423826772,0.49673202614379086,0.8301687614999662,1.0,8/18,22.42%,CDH2;NOTCH1;HEYL;PDCD6;SOX11;NOLC1;HEY2;KBTBD8
prerank,mitochondrial protein processing (GO:0034982),0.4624826388821248,0.9814980214941811,0.5,0.955060892965137,1.0,4/11,18.80%,PMPCA;AFG3L2;SPG7;STOML2
prerank,long-chain fatty acid transport (GO:0015909),0.3901769639387873,0.9810310021895222,0.4931506849315068,0.9555678908871257,1.0,6/30,12.43%,PRKAA2;ABCD1;CPT1B;ACSL3;ACACA;CPT2
prerank,regulation of viral genome replication (GO:0045069),0.35946527941483053,0.9808251206748901,0.4919053549190536,0.9554048276953336,1.0,11/56,15.98%,CCL5;SLPI;MAVS;TARBP2;RNASEL;TMEM39A;SRPK2;SRPK1;TNIP1;OAS2;DDB1
prerank,positive regulation of cell motility (GO:2000147),0.3139300757149171,0.9806625354487628,0.5220125786163522,0.955135036878308,1.0,17/205,4.47%,SEMA3D;CDH13;NTRK3;LAMC2;TJP1;SMO;CCL5;MMP9;PODXL;PDGFC;ADAM10;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3085906158496645,-0.9805271847453839,0.5376344086021505,0.8315976489718248,1.0,12/28,20.61%,CLASP2;MAP2;MAP1B;STMN2;PRUNE1;GBA2;STMN3;CAMSAP2;MAP1A;FKBP4;MAPRE1;STMN4
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.42536401059583107,0.9805004181405927,0.4764079147640791,0.9548912831145453,1.0,2/16,2.69%,ZC3H12A;ABCD1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21726268172481156,-0.9804679578303551,0.5609756097560976,0.8303543540032098,1.0,50/172,19.61%,PLA2G4A;PIK3R1;INPP4B;ETNK1;PIP5K1B;DGKH;GPD1L;INPP5D;DGKB;PIP4K2A;SYNJ2;FGF2;ABHD3;ARF3;PTDSS1;PLD1;MTMR14;BMX;MTM1;PLEKHA8;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6;CDS2;PIK3CD;SLC44A2;PLSCR1;PCYT1A;MTMR7;LPIN2;MTMR2;PIK3R3;DGKG;MFSD2A;SLC44A1;PI4K2B;PIK3C3;CLN3;AGPAT3;RUFY1;PIK3R5;PCTP;STARD10;PIK3R2;INPPL1;FIG4;PNPLA3;PLA2G4C;AGPAT2
prerank,alpha-amino acid metabolic process (GO:1901605),0.36281835657398454,0.9803226715084149,0.4975186104218362,0.9546941602632842,1.0,15/45,24.73%,GLUL;NAALAD2;DDAH2;GLUD1;PYCR3;THAP4;SLC25A12;ASS1;ALDH18A1;KYAT1;PYCR2;KYAT3;KMO;DDAH1;GPT2
prerank,regulation of neuron migration (GO:2001222),0.40188787121519554,0.9799430770346074,0.48424068767908307,0.9549975348573162,1.0,2/26,0.87%,PHACTR1;SRGAP2
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3661678264104747,0.9796256512356427,0.5083440308087291,0.9551269840158263,1.0,11/45,14.90%,DDX5;BUD23;POLR2A;BMP4;RBM20;MAP2K2;HABP4;WDR43;HRAS;GRSF1;ZPR1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.35915024279849117,-0.9792327243883696,0.4811594202898551,0.8322508310316898,1.0,4/16,10.94%,PLCB1;BOC;BTG1;LRRC8A
prerank,regulation of protein metabolic process (GO:0051246),0.3653395827903043,0.9789382960294387,0.47307692307692306,0.9561884690763828,1.0,12/44,22.07%,KLF4;LDLR;LTBP4;MAPK7;MDM2;CENATAC;CHEK2;ROCK2;APP;KLF2;ABCA7;SPOPL
prerank,negative regulation of myotube differentiation (GO:0010832),0.4493116613435326,0.9789004569091503,0.46771653543307085,0.9556167996241092,1.0,3/12,10.09%,HDAC5;HDAC4;HDAC3
prerank,mRNA destabilization (GO:0061157),0.373277414183959,0.9788201357392893,0.4772117962466488,0.9551566279910217,1.0,9/38,18.58%,YTHDF1;ZC3H12A;CELF1;MOV10;TUT7;CPEB3;MEX3D;YTHDF3;ROCK2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.23415566624418024,-0.9788008060261515,0.47126436781609193,0.8320327615729652,1.0,51/116,33.43%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;CYSLTR2;ADM;PTGDR;ADCY2;PRKAR1B;PTGER4;GLP2R;RXFP1;MC5R;MAPK14;VIPR2;ADCY3;ADCY8;GPR27;ADCYAP1R1;HCK;NPSR1;CALCA;IAPP;GNG2;HRH2;TSHR;FGR;CD247;ADRB1;PLCG2;FCGR2B;LHCGR;PLCG1;PTH2R;GPR20;CD163;HTR6;GIPR;TREM2;CRHR1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4690627825080236,0.9786472246927174,0.515,0.9549020165352141,1.0,3/11,10.84%,CCL5;ANK3;JAK1
prerank,regulation of cytokinesis (GO:0032465),0.33305428249603275,0.9786095294267493,0.49026345933562426,0.9543090946889292,1.0,21/78,20.09%,PKP4;KIF13A;RAB11FIP3;BCL2L1;KLHL21;ZFYVE19;PLK3;CDC42;AURKC;RHOA;KLHL13;VPS4A;FLCN;PLK2;CDC25B;GIT1;ZFYVE26;KIF20B;UVRAG;CSPP1;PIK3R4
prerank,negative regulation of cell communication (GO:0010648),-0.32889506500117766,-0.9785532606018253,0.4749262536873156,0.8313051225168993,1.0,4/21,12.24%,UBASH3B;GLRA1;SOCS5;KIF26A
prerank,regulation of focal adhesion assembly (GO:0051893),0.3610711825932415,0.978509034005012,0.4835566382460414,0.9538671126053334,1.0,19/54,18.58%,PHLDB2;S100A10;DAPK3;DLC1;EFNA5;DMTN;PTPRA;BCAS3;ACTG1;EPHA3;RHOA;SFRP1;ITGB1BP1;SLC9A1;ABL1;PEAK1;VCL;DUSP3;ROCK2
prerank,modulation by host of viral genome replication (GO:0044827),0.44941988766745544,0.9783836664861063,0.5022761760242792,0.9535021681033872,1.0,5/13,23.17%,ZC3H12A;EIF2AK4;FBXL2;NUCKS1;VAPA
prerank,positive regulation of endothelial cell migration (GO:0010595),0.3428144777878004,0.9783060915949869,0.49537037037037035,0.9530253249941568,1.0,21/84,16.59%,FGFR1;ANGPT1;ANXA3;ZC3H12A;GFUS;PTK2B;FOXC2;HSPB1;BMP4;EMC10;BCAS3;NRP2;BCAR1;SP1;GATA3;FOXP1;ITGB1BP1;NUS1;AAMP;ATP5F1B;ABL1
prerank,telomere maintenance (GO:0000723),0.3569209901924607,0.9779516535490869,0.48872180451127817,0.9532584959744423,1.0,25/50,28.08%,RECQL4;PARP3;MRE11;RIF1;HUS1B;NSMCE2;RPA3;POLD2;ATR;PCNA;NBN;SMC6;RAD50;ERCC4;TERF2;PTGES3;ZBTB48;TINF2;APEX1;PARP1;RPA2;POLD1;TERT;XRCC5;TERF1
prerank,response to hydrogen peroxide (GO:0042542),0.3661816919921968,0.9778530875825384,0.4961038961038961,0.9528474523679261,1.0,18/45,27.27%,MAP3K5;NFE2L2;HP;MAPK7;AQP1;TRPM2;APTX;ABL1;HDAC6;PARK7;STK24;SIRPA;IL6;RHOB;FYN;RELA;RPS3;STK25
prerank,icosanoid metabolic process (GO:0006690),-0.2799875499139784,-0.9776648746426077,0.4851063829787234,0.8323204744655761,1.0,7/40,6.54%,PLA2G4A;PTGIS;GGT5;CYP1B1;MGLL;PTGS2;PNPLA8
prerank,cellular response to nitrogen compound (GO:1901699),0.42049633731574143,0.9776008877622491,0.5036818851251841,0.9528264339839877,1.0,7/20,24.23%,DAXX;ATRX;ATP2B4;ROCK2;EPG5;DDI2;RTF2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3703207252109681,0.9770836027653469,0.49670619235836627,0.9534385512333547,1.0,4/37,8.90%,OGT;FHIT;DDRGK1;PML
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3488416201751077,-0.9768904289206735,0.4876543209876543,0.8330341983086762,1.0,9/18,25.46%,MSRA;ASPG;FOLH1;MTHFR;ADI1;ASNS;GOT1;SMS;GOT2
prerank,positive regulation of cell cycle (GO:0045787),0.3402269672133759,0.9768004764902612,0.4935672514619883,0.9534812570142256,1.0,21/62,21.48%,NUPR1;CDK4;PSRC1;HCFC1;TRIM21;TGFB2;CCND2;PKD1;USP19;EIF4EBP1;CCND1;SRPK2;ANKRD17;MDM2;CDC25B;DUSP3;RARA;APP;ADAM17;USP22;USP2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3786618115602596,-0.9765342078918537,0.5013927576601671,0.8325835333771721,1.0,3/13,7.51%,SHANK3;EPHB2;ADCY1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.41659319716411475,0.9764374812366272,0.476831091180867,0.9537498943392951,1.0,3/20,10.67%,FKBP5;NKTR;PPIC
prerank,triglyceride metabolic process (GO:0006641),0.3587944157402381,0.9762063332607478,0.48306148055207027,0.9536635750353368,1.0,4/48,5.82%,CAV1;DGAT1;MOGAT3;MOGAT1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46679846524645563,0.9757504881293364,0.5024711696869851,0.954103246065578,1.0,7/10,31.10%,SETD7;KMT5A;EHMT1;SMYD2;EEF1AKMT2;METTL18;SETD6
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.26304672426506515,-0.9752796390750996,0.5209580838323353,0.8347260659207711,1.0,21/63,21.47%,IGF1;SH3RF1;SP100;WWOX;AR;FAS;THBS1;DEPTOR;TNFSF10;CFLAR;BID;RIPK1;ITGA6;ITGAV;PELI3;ZMYND11;TRADD;TRAF1;TNFSF12;SIAH2;CYLD
prerank,synapse organization (GO:0050808),0.3234899673323711,0.9751266082392073,0.4983853606027987,0.9550277530332887,1.0,12/125,8.63%,CDH1;SDK1;GPC6;UNC13C;GPC4;CACNB3;PTPRD;MYOT;PTPRF;ANK3;CDC42;FZD5
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.23229450941944504,-0.9750955512471952,0.5151515151515151,0.83388152908609,1.0,31/113,17.50%,ABCA1;UNC13B;ASAP1;SLF1;ESR1;CUL4B;DAB2IP;GBP5;PSMC6;TFRC;FNIP1;TGFB1;SH3GLB1;TP53;TIRAP;TPPP;BCL2L11;BID;RACK1;RASIP1;BMF;FNIP2;SLF2;CDC42EP2;TTBK1;ERCC3;BAX;GNL3L;SKAP1;GTF2H3;SPIDR
prerank,regulation of autophagosome maturation (GO:1901096),0.4479972403363105,0.9747687456514953,0.47266881028938906,0.9552896341273753,1.0,5/13,19.73%,TMEM39A;RUBCN;SMCR8;PHF23;UVRAG
prerank,sympathetic nervous system development (GO:0048485),0.43858583417567865,0.9743228399665064,0.5082458770614693,0.9557461788957471,1.0,5/15,20.41%,GDNF;NRP2;GATA3;SEMA3A;SOX4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.45075733911957294,0.9732737187972688,0.49059561128526646,0.9576651946736822,1.0,1/13,0.48%,FGFR1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.46707281261104217,0.9731834159882489,0.5104,0.9572304122413053,1.0,1/10,0.83%,PRKAA2
prerank,calcium ion transport (GO:0006816),0.32559516187445414,0.973145883057085,0.49344978165938863,0.9566618243480415,1.0,20/113,13.49%,TRPM3;ANK2;STIM2;CCL5;CACNA1A;NALCN;CAV1;TRPM8;CACNB3;RAMP1;CACNA2D4;TMEM165;MICU1;PKD1;TRPM6;MCUR1;TRPM4;ANO6;TRPM2;CACNB2
prerank,protein localization to vacuole (GO:0072665),0.4504688132934359,0.9730524572450528,0.5174603174603175,0.9562178596903542,1.0,9/13,31.01%,CD81;SH3BP4;KPTN;SZT2;GLMP;LAMTOR5;RTN4;ATP13A2;RNF128
prerank,regulation of cellular component biogenesis (GO:0044087),0.3654152315201485,0.9728313937454215,0.49286640726329445,0.9561401443409951,1.0,13/39,18.58%,TJP1;RAP1B;RAP1A;HCFC1;MSN;LATS1;EZR;VPS11;RAPGEF1;HSP90AA1;SPTY2D1;PTPN11;ROCK2
prerank,regulation of urine volume (GO:0035809),-0.4202461006648307,-0.9727395586494099,0.5038560411311054,0.8385741098999053,1.0,5/10,27.34%,NPR3;NPR1;ADM;HYAL2;HAS2
prerank,cellular response to hormone stimulus (GO:0032870),0.3402536872045532,0.9727136515221353,0.5160905840286055,0.9557467666296073,1.0,6/69,5.07%,THRB;ADTRP;NCOA3;CAV1;ATP1A2;RAMP1
prerank,regulation of glucose import (GO:0046324),0.382960169547532,0.9726685677643622,0.4909596662030598,0.9551891823139338,1.0,4/30,5.18%,SORBS1;OCLN;CREBL2;RHOQ
prerank,regulation of phospholipase C activity (GO:1900274),0.4361070906640741,0.9725142190706422,0.496274217585693,0.9549128251401964,1.0,2/15,0.83%,FGFR1;NTRK3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.33818531153547254,0.9721927179668439,0.4951338199513382,0.9550704784730848,1.0,10/65,12.42%,CD109;VEPH1;SMAD6;CAV1;SPRED3;TGFB1I1;PPM1A;LDLRAD4;TGFBR2;DAND5
prerank,macrophage activation (GO:0042116),0.3811142104437847,0.9721624537645129,0.502710027100271,0.9544776092904225,1.0,10/34,20.63%,CLU;LBP;NMI;TLR4;SBNO2;FOXP1;ITGB2;APP;MAPT;AGER
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3383035916790034,-0.9717932528383776,0.5269461077844312,0.8396811052430957,1.0,11/18,34.12%,AQP4;SPEF2;RFX3;NPHP3;CFAP53;CCDC39;ROPN1L;SPA17;DNAAF2;ODAD4;NEK10
prerank,receptor clustering (GO:0043113),0.3826415612620369,0.9711800732791965,0.49201741654571846,0.9562957220139938,1.0,8/27,15.90%,MAGI2;ITGB7;MUSK;SYNJ2BP;PTN;ITGB1BP1;FLNA;ITGB2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.47410749744819,0.9709690452541129,0.5041050903119869,0.9561285873261198,1.0,1/10,1.24%,NCOA3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30731709376472616,0.9708278609038159,0.563971340839304,0.9558567092352145,1.0,43/308,12.50%,ADRA1B;PPARGC1A;NCOA3;SMO;OGT;PDGFC;SCAMP5;NIBAN2;IL15;CAV1;TRPM8;CXCR4;CRB2;GDNF;GCNT2;RBM19;OLFM1;ZBTB16;SHLD2;ESRRB;SOX9;FOXD1;ZBTB7B;BMP4;TGFB2;TGFB1I1;ACADL;BAD;NFAM1;LBP;ELOVL6;SIX1;FBXO5;TXK;RIF1;HDAC3;TWIST1;KDM3A;TRPM4;PTN;TGFBR2;CPT2;PDPN
prerank,inositol phosphate metabolic process (GO:0043647),0.3584392798279944,0.9705771817588178,0.49566294919454773,0.9558332250219185,1.0,11/46,15.59%,NUDT4;PLCB3;PLCD3;INPP4A;IP6K1;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.32822320776910735,0.9703500989516922,0.5330243337195828,0.9557597882265135,1.0,11/95,8.14%,CD109;VEPH1;SMAD6;TRIM33;CAV1;EP300;LTBP4;SPRED3;TGFB1I1;LATS1;PPM1A
prerank,electron transport chain (GO:0022900),0.43049240394413496,0.9701669776497774,0.5023847376788553,0.9555712897513345,1.0,3/15,9.34%,PPARGC1A;SDHB;CYB561
prerank,transition metal ion homeostasis (GO:0055076),0.39388364536081666,0.9700459698312894,0.5078459343794579,0.9552242927766161,1.0,4/28,11.89%,TMPRSS6;HEPH;NEO1;CP
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.40011444955395986,0.9699737194127468,0.49279538904899134,0.9547322901520217,1.0,3/23,5.16%,EFNB2;NIBAN2;LMOD3
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4128520775048865,0.969651018581511,0.484304932735426,0.9548585142077473,1.0,5/18,23.70%,ADAM10;BACE1;ADAM17;APH1A;PSEN1
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.2913113001916638,-0.9696280412402508,0.5296610169491526,0.8439601522973011,1.0,9/34,9.31%,RUNX1T1;ZFPM2;ENPP1;WNT5A;FOXO1;TGFB1;BBS12;RORA;GATA2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.33511493265848324,0.96929167193661,0.5152542372881356,0.9550931815824438,1.0,10/85,7.15%,ATP6V1B1;USP53;COL4A3;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3802274859710215,0.9691968511192058,0.4891008174386921,0.9546797230830896,1.0,8/31,11.68%,ANK1;CRB2;MSN;CDC42;OPHN1;EZR;SYNJ2BP;RHOA
prerank,regulation of execution phase of apoptosis (GO:1900117),0.46762735116301823,0.9691240639289519,0.5130718954248366,0.9541956759716016,1.0,3/11,6.02%,ZC3H12A;DLC1;BCL2L1
prerank,digestive tract development (GO:0048565),0.3791173140043027,0.9689848998680718,0.50472334682861,0.9538807557308416,1.0,6/32,8.43%,COBL;SMO;GLI3;STRA6;TGFB2;PKD1
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.28101322576581667,-0.9689577035469109,0.49783549783549785,0.8443634447490858,1.0,9/36,17.53%,TGFA;SHANK3;HIF1A;EPHB2;JAK2;NLGN3;EDN1;HDAC2;EGF
prerank,"DNA-templated transcription, termination (GO:0006353)",0.340733676430729,0.9683901529323752,0.5138721351025332,0.954721893444549,1.0,18/68,19.82%,LSM10;POLR2H;SNRPB;TAF1C;POLR2A;MAZ;UBTF;WDR33;POLR1C;POLR1E;POLR1F;CSTF1;PABPN1;ERCC2;CLP1;POLR2E;TBP;CSTF3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.37970324464441013,0.9683680259672058,0.5049088359046283,0.9541291971611335,1.0,8/29,12.09%,ELOVL1;ELOVL6;SLC25A1;ACSL3;ACSF3;FASN;ACACA;SCD5
prerank,positive regulation of JUN kinase activity (GO:0043507),0.40558225249307966,0.9682788273831185,0.48148148148148145,0.9536999159113196,1.0,5/23,9.31%,MAP3K5;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3279959392980548,-0.9681722440280246,0.5141065830721003,0.8451709770537134,1.0,3/21,6.04%,EPHA7;AIM2;GRIN2B
prerank,B cell activation (GO:0042113),0.33936688628180095,0.9681626949775496,0.5139056831922612,0.9533118477311392,1.0,11/68,16.60%,PRKCB;HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;MEF2C;KLF6;TPD52
prerank,organic cation transport (GO:0015695),-0.3329255889598491,-0.9680684920979421,0.49216300940438873,0.844102526327068,1.0,10/20,36.72%,SLC47A1;SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;PDZK1
prerank,regulation of viral transcription (GO:0046782),0.36438976457764694,0.9679093282276368,0.5013227513227513,0.953283462373583,1.0,14/39,20.39%,GTF2F1;POLR2H;TARBP2;POLR2A;TRIM21;LARP7;TRIM11;DHX9;HEXIM1;NELFB;POLR2C;POLR2E;NELFA;UBP1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.35038000604843406,0.9678303328482571,0.4987562189054726,0.9528178342674583,1.0,14/56,13.53%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;JTB;RHOA;EFHC2;RASA1;VPS4A;SEPTIN9
prerank,response to steroid hormone (GO:0048545),0.37892329625458976,0.9676759411667484,0.5041551246537396,0.9525383574742754,1.0,5/31,9.64%,ADTRP;CAV1;ATP1A2;TGFB2;ABCA2
prerank,protein neddylation (GO:0045116),0.4402948733379805,0.9676361767669149,0.49390243902439024,0.9519736371843414,1.0,8/13,29.63%,RBX1;DCUN1D5;DCUN1D1;UBE2F;RNF7;UBE2M;UBA3;NEDD8
prerank,peptidyl-proline modification (GO:0018208),0.3966056075933616,0.9675803248442871,0.4848920863309353,0.9514645832791778,1.0,4/25,10.67%,FKBP5;NTMT1;NKTR;PPIC
prerank,regulation of protein sumoylation (GO:0033233),0.423089380750327,0.9675396296377468,0.5254730713245997,0.9509048034599046,1.0,6/17,18.32%,HDAC4;MUL1;SAE1;PIAS1;PIAS3;PARK7
prerank,cellular response to glucose starvation (GO:0042149),0.36522796277985914,0.9674172114491907,0.5190355329949239,0.9505547751284837,1.0,5/41,3.92%,PRKAA2;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.34168741022652993,0.9672775309940171,0.5316606929510155,0.9502291919057048,1.0,7/72,8.17%,FGFR1;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,ncRNA transcription (GO:0098781),0.4432254166119074,0.9671398142404721,0.4911717495987159,0.9499211610263055,1.0,5/13,22.33%,ANG;SPIN1;SNAPC3;SIRT7;POLR1G
prerank,acute inflammatory response (GO:0002526),0.40437402987748433,0.9668303119424596,0.4909596662030598,0.9500204040196824,1.0,5/23,15.12%,HP;HPR;LBP;ANO6;VNN1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3302655929524545,0.9666426226081313,0.5217391304347826,0.9498086017839394,1.0,7/79,2.48%,WNT1;GPC1;SMAD6;NIBAN2;NBL1;TRIM33;CRIM1
prerank,regulation of JNK cascade (GO:0046328),0.3261538072365201,0.9662885543681988,0.5289532293986637,0.9500081650589328,1.0,7/101,4.47%,WNT16;EDA2R;MAP3K5;CCN2;PTK2B;DUSP10;SH3RF2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.41301897302674917,0.9662797843883396,0.4985207100591716,0.9493776767462428,1.0,2/18,1.50%,FGFR1;COL4A3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4510427239704719,0.96623274427426,0.5159235668789809,0.9488598837568969,1.0,3/13,9.00%,PIGU;DOT1L;IL7R
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3804241009754019,0.96609122501215,0.4916897506925208,0.9485649508696905,1.0,3/29,7.45%,RAET1E;LAMP1;PVR
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4087682388303269,0.9660602104132503,0.49556213017751477,0.9479973436657483,1.0,4/20,9.73%,FMNL2;RHOQ;STRIP1;LLGL2
prerank,leukotriene biosynthetic process (GO:0019370),-0.3576891284234467,-0.96597264260795,0.49279538904899134,0.8482572828016897,1.0,2/14,3.97%,PLA2G4A;GGT5
prerank,positive regulation of embryonic development (GO:0040019),0.4202724720487018,0.965923487257193,0.5059171597633136,0.9476836649407991,1.0,3/19,4.37%,WNT1;NIBAN2;RBM19
prerank,regulation of establishment of planar polarity (GO:0090175),0.32893043749515827,0.9655178825555564,0.5254813137032842,0.9480205519778784,1.0,14/88,12.90%,CELSR1;WNT1;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;CDC42;FZD5;PSMD7;RHOA;AP2A1;PSMB5
prerank,cellular response to fatty acid (GO:0071398),-0.3917992463121015,-0.9647182559973804,0.512396694214876,0.8502030376573507,1.0,1/12,0.08%,PID1
prerank,mismatch repair (GO:0006298),0.3880266912143033,0.9642969488817268,0.5078014184397163,0.9503420886797191,1.0,7/27,16.59%,MLH1;MUTYH;MLH3;RPA3;POLD2;PCNA;ABL1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.34444445363376675,0.9642214250872374,0.5104039167686658,0.9498746499256446,1.0,24/64,25.45%,GTF2F1;MLLT3;POLR2H;ELOB;POLR2A;SSRP1;ELP4;POLR1E;ELL;TCEA2;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CDK9;CTR9;LEO1;POLR2K;MNAT1;CDK13
prerank,protein transport (GO:0015031),0.30245156263409534,0.9641090562292546,0.574468085106383,0.949494716730362,1.0,89/332,22.32%,PRKCB;RAB17;CLU;ATP6V1B1;SCAMP5;AMN;GRTP1;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;RAMP1;TMED1;SIL1;UNC119;ANK3;WLS;GOLPH3;GCC2;RAB3B;STXBP1;RAB7A;ARRDC3;NDC1;LMTK2;GOLGA7;MON1A;TOM1;SNX33;ARL6IP5;GGA1;SGSM2;SCAMP2;ARFIP2;AP2A1;TBC1D1;RABL3;STX11;NAPA;VIPAS39;CHMP1A;ARF4;VPS26B;NAPB;RAB5C;PREB;RAB1B;ATP6V1D;STX16;ATP6V1E1;USP6NL;NECAB3;CHMP2A;ATP6V0D1;CANX;TBC1D22A;RAB8B;COPG1;LRP2;NSF;TBC1D10A;ARFRP1;HDAC6;SEC23IP;STX4;ATP6V1B2;TMED5;SEC31B;YWHAH;RAB10;ATP6V0B;TBCK;TBC1D17;CENPF;REP15;ATP6AP1;MIA3;HIKESHI;SEC31A;ARFIP1;RAB3GAP2;RABGAP1;VAMP2;AP4M1;VPS26A;AP3D1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3283924479122776,0.9641037089663116,0.5159010600706714,0.9488670728323031,1.0,24/80,23.82%,ANGPT1;CAV1;PEF1;SPSB4;CENPS;ARRDC3;RBX1;DCUN1D5;HDAC3;HSPBP1;DCUN1D1;GSK3A;UBE2N;KDM1A;STUB1;XIAP;CDK5RAP3;PHF23;FBXW7;RCHY1;TRIB3;BIRC3;FBXO4;FANCM
prerank,organic acid transport (GO:0015849),0.33610299231489804,0.9639124539060436,0.530933633295838,0.948695731606715,1.0,11/94,13.44%,SLC7A14;SLC10A5;SLC27A3;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;PDPN;SLC25A17;SLC25A14
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3454038450732622,0.9638055345561323,0.511742892459827,0.9483390438651025,1.0,6/57,4.49%,CRLF1;CCL5;IL15;PPP2CA;CLCF1;EPO
prerank,amide transport (GO:0042886),-0.3092775925749566,-0.9636713475403901,0.5033333333333333,0.8515893327966559,1.0,11/26,30.32%,PLTP;TAP2;PLEKHA8;AQP11;DISP1;SLC5A6;SLC14A1;ABCG2;PLEKHA3;ABCA13;SLC38A5
prerank,negative regulation of leukocyte activation (GO:0002695),0.43538967168111736,0.9633698309901364,0.5351681957186545,0.9487645852233354,1.0,2/15,2.49%,CD200;ZC3H12A
prerank,gluconeogenesis (GO:0006094),0.3679018352786019,0.9633024800881738,0.5195954487989887,0.9482845566936905,1.0,9/39,18.39%,PPARGC1A;SLC25A1;ENO2;MDH2;GAPDH;ALDOA;SLC25A12;TPI1;PCK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.34805780112164453,-0.9632796139762911,0.5060240963855421,0.8512773780447618,1.0,2/17,5.88%,PLA2G4A;PLAAT3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4282494784514602,0.9632072583934496,0.5159332321699545,0.9478714179179197,1.0,2/15,4.11%,EDA;WNT6
prerank,negative regulation of viral entry into host cell (GO:0046597),0.45878846796650385,0.9630375605247271,0.5477308294209703,0.9476689068962904,1.0,3/12,9.30%,GSN;TRIM11;TRIM26
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3254485137336902,0.9621937923390541,0.5280373831775701,0.9490428106237894,1.0,35/87,29.23%,COX19;NDUFV1;NDUFB11;COX16;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;COA8;COX20;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;SMIM20;NDUFB5;SDHAF3;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10;UQCRFS1;SURF1;TIMMDC1;NDUFA13;NDUFAF7;COX14;NDUFB3;NDUFS4;LYRM7;OMA1
prerank,epithelial tube morphogenesis (GO:0060562),-0.28779781342026417,-0.9621172942739145,0.5099601593625498,0.8529396798954821,1.0,9/32,13.77%,GLI2;ACVRL1;COL4A1;PKD2;SLIT2;SOX17;MEGF8;RASIP1;RYR2
prerank,regulation of store-operated calcium entry (GO:2001256),0.46209669654242824,0.9621171429896204,0.5415384615384615,0.948577381751558,1.0,2/10,3.48%,HOMER2;HOMER3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3709764031180763,-0.9619968550803663,0.47540983606557374,0.8518738477656006,1.0,5/13,17.51%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,negative regulation of hemostasis (GO:1900047),0.4489802167206903,0.9618009338487354,0.496,0.9486741029135093,1.0,2/12,6.15%,ADTRP;THBD
prerank,mRNA metabolic process (GO:0016071),0.3274593951503605,0.961406058118112,0.5308498253783469,0.9489572923032762,1.0,24/90,22.29%,PPARGC1A;LSM10;DDX5;SRSF2;CELF1;SON;SNRPB;USP39;SRRM4;TBRG4;SRSF7;SF3A2;SRSF9;RNASE4;SRSF1;PTBP1;SRSF5;DXO;PCBP2;CSTF3;SF3A3;PRPF8;SFPQ;U2AF1
prerank,ear morphogenesis (GO:0042471),0.41238611668538094,0.9612400124836483,0.5103550295857988,0.9487278043765927,1.0,4/20,10.26%,ATP6V1B1;SIX1;ZIC1;TWIST1
prerank,peroxisomal membrane transport (GO:0015919),0.3886933683776235,0.9609480525265831,0.5101214574898786,0.9488053922916837,1.0,8/27,18.84%,PEX26;ABCD1;SLC25A17;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.35827038142493295,0.9607572820421812,0.5194630872483221,0.948636820780523,1.0,2/41,1.08%,ANK2;ACTN2
prerank,midbody abscission (GO:0061952),0.41710495987372814,0.9606909563875681,0.4831288343558282,0.9481547317049297,1.0,10/17,26.87%,CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;CHMP5;CHMP1B
prerank,neural crest cell development (GO:0014032),0.3588587247356226,0.9603381959178333,0.525096525096525,0.9483641383748995,1.0,4/44,3.93%,SEMA3D;SEMA3B;PEF1;GDNF
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.37457979856155044,-0.960337717492149,0.5127551020408163,0.8549392555280002,1.0,5/13,18.59%,GLI2;CAMK4;TOX;CLPTM1;SOD1
prerank,sodium ion homeostasis (GO:0055078),-0.32368800803653686,-0.9601146204101577,0.5016077170418006,0.8542115243697818,1.0,3/21,4.60%,SLC8A1;ATP1B1;SLC12A2
prerank,mitotic cytokinesis (GO:0000281),0.35011515418567163,0.9596209728606695,0.5,0.9494689512220029,1.0,11/47,12.69%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;JTB;EFHC2;RASA1
prerank,skeletal system development (GO:0001501),0.31693349301201,0.9594430323767849,0.5498938428874734,0.9493003869102477,1.0,15/148,7.30%,TNFRSF11B;KIAA1217;FGFR1;CD44;ITGB8;WNT1;ANKH;AKAP13;WNT11;BMP5;ZBTB16;PRELP;SOX9;DDRGK1;TGFB2
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.38141589468538983,-0.959090028291861,0.5311653116531165,0.855500738529435,1.0,2/12,3.27%,MAP2;STMN2
prerank,response to glucagon (GO:0033762),-0.33523201604178543,-0.9589268083245276,0.49707602339181284,0.8546004696999224,1.0,11/19,22.18%,ADCY5;ADCY7;ADCY1;ADCY4;CRY1;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,regulation of T cell differentiation (GO:0045580),0.37202120193166877,0.9587692481724901,0.505420054200542,0.9503709285543886,1.0,1/33,0.33%,NFATC2
prerank,gonad development (GO:0008406),-0.2760542082785396,-0.9585402894517927,0.5296610169491526,0.8542730021968952,1.0,8/41,10.74%,NR2F2;KITLG;WNT4;AR;WNT5A;SALL1;KIT;BASP1
prerank,mesoderm development (GO:0007498),-0.34480882269226604,-0.9579588541617823,0.5258358662613982,0.8545203632380638,1.0,6/18,13.67%,TBX3;TIE1;BMX;JAK2;TBX1;MEST
prerank,histone H3 deacetylation (GO:0070932),0.4290839237762829,0.9578946418592574,0.5383435582822086,0.9518859740235729,1.0,7/15,25.36%,HDAC4;HDAC3;SIRT7;SFPQ;PER1;HDAC8;PER2
prerank,ribosomal small subunit assembly (GO:0000028),0.4179457968841165,0.9578020450257838,0.5176110260336907,0.9514718972863314,1.0,8/16,31.33%,MRPS7;RPSA;PWP2;RPS28;RPS27;XRCC5;RPS15;ERAL1
prerank,myeloid leukocyte differentiation (GO:0002573),0.34140855512083623,0.9577810709614529,0.5136417556346382,0.9508885297618064,1.0,17/65,19.03%,MMP9;CDKN1A;IL15;EP300;CDK4;BMP4;CDC42;PML;SBNO2;TGFBR2;CDK2;FOXP1;PRTN3;E2F1;PDE1B;RARA;BATF2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.29371720753590763,-0.9577393600189714,0.4921875,0.853770671736709,1.0,6/33,7.68%,PLCB1;RDX;UBE2E2;RGCC;GLI1;EZH2
prerank,positive regulation of catalytic activity (GO:0043085),-0.2743858893606749,-0.9576605121910565,0.5327868852459017,0.8526430446312608,1.0,13/37,23.08%,AZIN2;MSH3;IGF2;ABL2;NHEJ1;FGFR4;B3GAT3;FXN;SLC5A3;SOD1;CIB1;MAPK14;NOD2
prerank,actin-myosin filament sliding (GO:0033275),0.36472712604754853,0.9575118992271429,0.504424778761062,0.9502603678358805,1.0,2/38,1.67%,ACTN2;VIM
prerank,muscle filament sliding (GO:0030049),0.36472712604754853,0.9575118992271429,0.504424778761062,0.9502603678358805,1.0,2/38,1.67%,ACTN2;VIM
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.3441930936662125,-0.9568785529968391,0.5604395604395604,0.8532840375107781,1.0,8/17,22.64%,SULF1;ZDHHC17;SLIT2;SFRP4;TMEM204;PCSK6;FSTL3;DOK5
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3465383032650885,-0.9566427504240989,0.51875,0.8525946200751546,1.0,8/18,19.62%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.4076108576600322,0.9565778901832277,0.5296671490593343,0.9518485058409729,1.0,5/21,11.79%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4220632588074276,0.9559528778206815,0.4970326409495549,0.9527796316377448,1.0,6/18,14.12%,RAP1B;RAP1A;SYN1;RIMS4;VPS18;GSK3B
prerank,endocrine system development (GO:0035270),-0.3232144486793257,-0.9559364483172982,0.5412844036697247,0.8531445363000341,1.0,6/21,13.14%,GLI2;WNT4;DKK3;SALL1;NF1;TBX1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3981175873700176,0.9552378588941507,0.5116279069767442,0.9539414400872628,1.0,8/25,16.30%,PFKP;PKM;ENO2;HK1;FOXK1;GAPDH;ALDOA;TPI1
prerank,melanosome organization (GO:0032438),0.3885286651254531,0.955182512429278,0.4954954954954955,0.953459326697323,1.0,6/26,14.47%,KIF13A;BLOC1S6;AP3B1;BLOC1S2;AP1M1;PMEL
prerank,mitotic chromosome condensation (GO:0007076),0.39322211752124847,0.9551171520303542,0.5220994475138122,0.9529825146385951,1.0,10/26,22.15%,TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;RB1;PHF13;NCAPH;KMT5A;SMC4
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.4000498971080104,-0.9549874364036304,0.5086848635235732,0.8542908466756809,1.0,6/10,26.36%,DNAJC19;MTMR2;ABCA3;MFSD2A;MTMR4;PHB2
prerank,peptidyl-methionine modification (GO:0018206),0.45555132231881235,0.9549806531078197,0.5310015898251192,0.9526905757145488,1.0,3/12,13.29%,PDF;NAA15;NAA20
prerank,tRNA processing (GO:0008033),0.3419200606524314,0.9546365224951685,0.5351418002466092,0.9529201323801092,1.0,26/61,26.88%,FARS2;LCMT2;TRPT1;POP1;ELP5;TRIT1;AARS1;THG1L;ANKRD16;RPP21;SARS1;TRNT1;CTU1;TSEN2;CLP1;TRMT10B;CTU2;TYW5;RPP40;URM1;NSUN6;FAM98B;KARS1;FTSJ1;WDR4;PUS3
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.35091357545105795,0.9545423045270729,0.513375796178344,0.9525203527633952,1.0,11/50,15.60%,NR3C2;EP300;TRIM44;ILK;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,sodium-independent organic anion transport (GO:0043252),0.4741155586254356,0.9543583180503192,0.5211038961038961,0.9523726823980808,1.0,2/10,6.02%,SLCO2A1;SLC16A2
prerank,regulation of phosphate metabolic process (GO:0019220),0.42249969847117014,0.9539132650950829,0.5384615384615384,0.9528096224730264,1.0,6/16,24.17%,SMG7;TIGAR;IGBP1;MCM7;PSEN1;IKBKB
prerank,cardiac ventricle development (GO:0003231),-0.3231308096313813,-0.9538747970069078,0.5392156862745098,0.8558717293148174,1.0,5/20,9.70%,ENG;NOTCH1;SALL1;HEYL;PDE2A
prerank,positive regulation of ATP metabolic process (GO:1903580),0.37258563598729144,0.9538742240747495,0.5027472527472527,0.9522695115206125,1.0,5/32,6.67%,PRKAA2;PPARGC1A;NUPR1;BEND3;PFKFB2
prerank,regulation of defense response (GO:0031347),-0.24876059221389413,-0.9537957401253537,0.5748031496062992,0.8547513455401993,1.0,16/76,10.21%,ADAMTS12;IL1R1;WNT5A;SEMA7A;NR1D2;APPL2;MGLL;PTGS2;PSMA6;ELMOD2;LRP8;BRD4;SAMHD1;JAK2;PIK3AP1;PTGES
prerank,negative regulation of cell junction assembly (GO:1901889),0.39076310063284647,0.9536079309807148,0.5170454545454546,0.9522998441955849,1.0,4/25,10.36%,PHLDB2;DLC1;DMTN;BCAS3
prerank,heart looping (GO:0001947),0.35878481723662503,0.9532957695761548,0.5051413881748072,0.9524016364038723,1.0,3/39,2.25%,TBR1;SMO;MICAL2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.34999939782608835,0.9530110018539265,0.5297927461139896,0.9524669059994622,1.0,5/49,4.49%,CRLF1;CCL5;IL15;CLCF1;EPO
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.32821731007027255,0.9528544176099318,0.542528735632184,0.952231262174683,1.0,10/77,8.84%,CLU;MMP9;QARS1;PIH1D1;BCL2L1;BMP4;TCF7L2;MAZ;LGALS3;NDUFS3
prerank,regulation of neuron projection arborization (GO:0150011),-0.35218361857988895,-0.9528111882508367,0.5400516795865633,0.8560483792502647,1.0,6/15,13.45%,WNT5A;MYO9A;FZD4;NTNG1;MACF1;MFSD2A
prerank,protein heterooligomerization (GO:0051291),-0.34142235785785924,-0.9520172117134852,0.5436046511627907,0.8566197321459204,1.0,5/17,11.82%,PKD2;GRIN2B;MAT2A;NUDT21;CPSF6
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3632481436029819,-0.9519943053930909,0.5251396648044693,0.8553453311493946,1.0,5/15,6.78%,GRM3;GRM7;GRM8;GRM5;GRIK3
prerank,gastrulation (GO:0007369),-0.35433014247170685,-0.9515572042330984,0.5070422535211268,0.855148605168057,1.0,4/15,12.37%,TASOR;LRP5;MEGF8;NPHP3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.31948907794067,-0.9508395574752373,0.5255972696245734,0.8556878075025021,1.0,5/22,6.22%,LYN;MFHAS1;DAB2IP;APPL2;NR1H3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.28023827027641907,-0.9508038775335926,0.52734375,0.8544669946168446,1.0,18/37,28.65%,IFT81;IFT122;TTC21B;IFT74;WDR19;KIFAP3;IFT43;KIF3B;CLUAP1;DYNLL2;DYNC2LI1;DYNC2I2;IFT27;KIF3C;CEP131;IFT88;IFT140;IFT22
prerank,epithelial cell morphogenesis (GO:0003382),0.41091321919037715,0.9505311365798353,0.5241581259150805,0.9571713578668262,1.0,3/17,9.48%,POF1B;GRHL2;DACT2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.39153182138149595,0.9504939186002106,0.515850144092219,0.9566324868092617,1.0,1/25,0.66%,ANK2
prerank,protein mannosylation (GO:0035268),0.3880749238073599,0.9503286493942258,0.5235294117647059,0.9564018168700938,1.0,3/22,4.23%,B4GAT1;TMTC1;LARGE1
prerank,regulation of fat cell differentiation (GO:0045598),0.33254360084915946,0.9500338576696642,0.5413271245634459,0.956482694226101,1.0,22/74,19.97%,WNT1;TRIB2;RORC;ZC3H12A;CREBL2;ZBTB16;ALOX5;CREB1;WDFY2;AAMDC;TRIO;TRPM4;SFRP1;GATA3;FRZB;E2F1;CCDC85B;LRP3;CDS1;TAF8;GPER1;CMKLR1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.34547962875265753,0.9499197963528608,0.5208333333333334,0.9561094292473697,1.0,5/51,2.48%,WNT1;SMAD6;NBL1;TRIM33;CRIM1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.46011146491097,0.9498009049464149,0.5332197614991482,0.9557346807481185,1.0,1/11,1.04%,WNT1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3727614888680609,0.9496280361614141,0.5400271370420624,0.9554887573378892,1.0,9/32,14.36%,PHLDB2;DLC1;DMTN;CASK;BCAS3;ADAM15;MMP12;RASA1;ITGB1BP1
prerank,protein complex oligomerization (GO:0051259),-0.2360651389664515,-0.9495611431026011,0.5310344827586206,0.8563746904267678,1.0,26/85,18.17%,LRRC8C;EHD4;IKZF4;PKD2;OXA1L;EHD3;MAT2A;UPB1;GSDMD;NUDT21;AQP11;JMJD6;WDCP;TRMT61B;LRRC8A;ALS2;CPSF6;G3BP2;CLDN1;GLRA3;KCNC1;MPP2;BLM;TIFA;BOK;ATL1
prerank,regulation of steroid metabolic process (GO:0019218),0.4012228965010253,0.9494534977805521,0.5423242467718795,0.9552517075151273,1.0,4/23,9.64%,RORC;TTC39B;ACADL;ABCA2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.29622283452200754,0.948716342031217,0.6091370558375635,0.9563294566994673,1.0,58/314,17.22%,FZR1;FBXL7;FBXL20;SPSB4;NFE2L2;WWP2;RNF5;TRIM25;ERLIN2;PSMD11;PSMD4;PSMF1;NSFL1C;FEM1C;FEM1A;KLHL15;FBXL18;FBXO5;FBXO31;UBE2G2;USP19;RMND5B;RBX1;PML;ERLIN1;RNF121;UBE2B;PCNP;LTN1;COP1;PSMD7;SIAH3;AGAP3;FEM1B;ZSWIM8;RNF126;PSMB5;ANAPC4;CDK2;PELI1;GSK3A;RHBDD2;NPLOC4;UBE4A;DNAJC10;NEDD4;MDM2;BFAR;MAEA;DDB1;FBXL15;UBE2J1;ARMC8;UBC;RPS27A;STUB1;UBE2D3;SIAH1
prerank,protein localization to organelle (GO:0033365),0.30656060883547204,0.9486768379795788,0.5503791982665223,0.9558044824418744,1.0,45/133,24.62%,ANK2;LAMP5;OTOF;EHD1;CSRP3;ARL3;LAMP1;PPP1R15A;DDRGK1;BMP4;GCC2;SIX1;BANP;GET4;TOR1A;RAB35;TOR1AIP1;DCP1A;ATP6V1D;MDM2;RAB33B;LMNA;DHX9;CCDC47;FAM83H;RIPOR1;ARFRP1;WDR35;ZBTB7A;APP;CROCC;ABCA7;TULP1;YBX1;VAMP2;TULP2;SGTA;VAPA;MTCH2;ARL6;ARL1;GABARAPL2;SNX10;SIX4;TIA1
prerank,secondary alcohol metabolic process (GO:1902652),0.36320410866521496,0.9480387750240938,0.525065963060686,0.9566809127216483,1.0,9/42,16.19%,SOAT1;STARD3;SULT2B1;IDH3G;FDX1;SOAT2;OSBPL5;SQLE;IDH3A
prerank,sodium ion transport (GO:0006814),0.3251543152383358,0.948005478102932,0.5426267281105991,0.9561406543194718,1.0,5/85,2.83%,FGF13;ASIC5;SCN3A;NALCN;ATP1A2
prerank,transcription by RNA polymerase III (GO:0006383),0.3712361636508105,0.9479627151093785,0.5279770444763271,0.955614215287844,1.0,13/27,28.11%,GTF3C3;ELL;POLR3G;GTF3C2;GTF3C5;POLR3H;TBP;SNAPC3;GTF3C4;ICE1;POLR2K;ZC3H8;BRF1
prerank,anterior/posterior pattern specification (GO:0009952),-0.2565761793904787,-0.9478856214454453,0.5347593582887701,0.8593052465575547,1.0,21/53,27.96%,PCSK5;LRP5;HEYL;HOXA7;BASP1;DDIT3;TBX1;BMPR2;BHLHE40;HOXB7;HHEX;HOXC4;HOXB6;HOXD3;HEY2;HEY1;BHLHE41;HOXC5;HOXB9;HOXC9;SMAD2
prerank,regulation of keratinocyte proliferation (GO:0010837),0.39101043762745824,0.9478628865142377,0.5306122448979592,0.9552247251078506,1.0,1/22,0.72%,NOTCH2
prerank,positive regulation of cellular protein localization (GO:1903829),0.3343567327740589,0.9475598318978251,0.5308788598574822,0.9553228119697101,1.0,27/69,25.94%,PRKAA2;LIMK2;SESN2;ORMDL3;DDRGK1;SNX33;EIF2AK3;MARK4;GSK3B;CCDC88A;SYT11;TESK1;NUMA1;STX4;PARK7;CDK5RAP3;NECAB2;MAPT;CROCC;ABCA7;TM9SF4;WWTR1;GAS8;FYN;STX3;NUP62;RIC3
prerank,isotype switching (GO:0045190),0.4611387638561295,0.9469635825122571,0.5227655986509275,0.9560638790860077,1.0,5/10,30.38%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,glucose homeostasis (GO:0042593),0.3276135016643612,0.9466557689830544,0.5526905829596412,0.9561684802047058,1.0,15/83,12.73%,PRKAA2;PPARGC1A;MCU;HKDC1;ALOX5;HECTD4;KLF7;BAD;TCF7L2;CRY2;HK1;KCNB1;PDK2;PTPN2;FOXK1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.32279068644282516,-0.9466297429236419,0.5348101265822784,0.8612442148474012,1.0,4/20,7.35%,GLI2;ACVRL1;BMPR1B;DSCAML1
prerank,endosome organization (GO:0007032),0.3589511884154508,0.9465096396260785,0.5305343511450382,0.9558737324471885,1.0,15/41,20.91%,ANXA8;ANXA8L1;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1;PI4K2A;WASHC4;HOOK3;RAB27A;TMCC1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.38307237792420445,0.9464587924161334,0.5370121130551817,0.9553730384633401,1.0,5/28,7.62%,MAP3K5;BBC3;TMEM117;PPP1R15A;TNFRSF10B
prerank,mitochondrial translation (GO:0032543),0.31749683808740287,0.9463298178729277,0.5484234234234234,0.9550537469694603,1.0,23/104,18.01%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;HARS1;MRPL49;MRPL33;MRPS7;LARS2;MRPS34;MRPS23;MRPS33;MRPS27;MRPL57;MRPL9;MRPL50;MRPS15;MRPS18C;MRPS28;MRPS35;GATB;GADD45GIP1
prerank,catecholamine biosynthetic process (GO:0042423),-0.3879215324145644,-0.9462877608213115,0.532258064516129,0.8607306112407088,1.0,2/11,8.09%,MOXD1;GCH1
prerank,bile acid metabolic process (GO:0008206),0.3879017739243872,0.9462148903509917,0.516914749661705,0.9546898777206806,1.0,5/27,11.27%,OSBPL9;ACOT8;NPC1;CYP39A1;OSBPL7
prerank,negative regulation of proteolysis (GO:0045861),0.3672565041890783,0.945927188333138,0.5233644859813084,0.954770270495178,1.0,5/34,7.11%,EPHA4;TIMP4;TIMP1;TIMP2;TRIM21
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31695017626074123,-0.9459218482764686,0.5173501577287066,0.8603777628114859,1.0,2/21,0.77%,PDGFRB;ITGA1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.31070296032795036,-0.945793462207185,0.5324675324675324,0.8593795149316137,1.0,2/24,0.85%,PID1;LEPR
prerank,icosanoid biosynthetic process (GO:0046456),0.45284858746240714,0.9456482561435602,0.5318471337579618,0.9548186474384287,1.0,4/10,14.17%,ALOX5;MGST3;FADS1;LTA4H
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.28128060608994143,-0.9456238695402299,0.5565217391304348,0.8585094365452058,1.0,10/39,9.56%,TEK;SEMA5A;GAS6;NDNF;KDR;THBS1;RGCC;RAMP2;GATA2;ITGA4
prerank,receptor catabolic process (GO:0032801),-0.31055688924808456,-0.9453920148957,0.5238095238095238,0.8578476975307046,1.0,7/24,9.02%,SNX25;ZNRF3;CLTA;MYLIP;AP2B1;TGFB1;SH3GLB1
prerank,regulation of receptor internalization (GO:0002090),0.36509727084776505,0.9450693237417379,0.5495978552278821,0.9555815627796306,1.0,2/35,2.30%,ANGPT1;MAGI2
prerank,Notch signaling involved in heart development (GO:0061314),0.45273022791158013,0.9446132668969236,0.5416666666666666,0.9560657651102898,1.0,1/11,0.72%,NOTCH2
prerank,toll-like receptor signaling pathway (GO:0002224),0.3215120287385023,0.9445869596306538,0.5498839907192575,0.9555028790743025,1.0,33/84,25.30%,SCARA3;TAB3;LBP;TLR6;NMI;CNPY3;S100A1;TLR4;TNIP1;IRAK1;CHUK;TLR3;IKBKG;ITGB2;UBC;RPS27A;COLEC12;UBE2D3;MAPKAPK2;TAB2;IRAK4;SFTPA1;SFTPA2;MAP3K1;PIK3R4;CTSK;BIRC3;TLR1;EPG5;TLR5;IKBKB;LY96;CASP8
prerank,cGMP biosynthetic process (GO:0006182),-0.40329199420709594,-0.9444778166162207,0.519893899204244,0.8588979673519088,1.0,3/10,10.08%,GUCY1B1;GUCY1A1;NPR1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.43025202241690363,0.9444186949174839,0.5365853658536586,0.9552655007560388,1.0,2/15,4.69%,FGFR1;HSPB1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3792413272248517,-0.9443271151245821,0.5196850393700787,0.8579718115768598,1.0,2/11,1.37%,JAG1;ZFPM2
prerank,regulation of BMP signaling pathway (GO:0030510),0.3247111278191139,0.9442736949175085,0.5600475624256838,0.9550011674854828,1.0,19/73,17.97%,WNT1;SMAD6;NBL1;TRIM33;CRIM1;TWSG1;CRB2;FOXD1;BMP4;DAND5;RBPMS2;FBXL15;SMAD5;UBE2D3;LRP2;XIAP;NUMA1;BMPR1A;CDH5
prerank,photoperiodism (GO:0009648),-0.289709723841069,-0.9440269787907927,0.5525423728813559,0.857474664724239,1.0,7/28,14.53%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,DNA strand elongation (GO:0022616),0.4076525966634328,0.9436142902071368,0.5335365853658537,0.9559210694574366,1.0,7/18,21.77%,MRE11;POLD2;MCM7;NBN;RAD50;GINS3;MCM4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.46211988816120136,0.9432508342336794,0.5609756097560976,0.9561461104863609,1.0,2/10,7.87%,NINJ1;LBP
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3021093633389267,-0.9429887723776202,0.5121107266435986,0.8588539193629268,1.0,7/29,12.65%,DPP10;KCNN2;KCNIP4;KCNIP3;FGF12;KCNIP1;DPP6
prerank,positive regulation of proteolysis (GO:0045862),0.3445122148814292,0.942893366268132,0.5487053020961775,0.9563974221611737,1.0,14/55,20.22%,CYFIP2;OGT;ZC3H12A;PERP;BAD;ATP5IF1;SNX33;TNIP1;CTSH;STUB1;TBC1D10A;GPLD1;IST1;RHBDD1
prerank,development of primary male sexual characteristics (GO:0046546),-0.2834753323241434,-0.9427717583531496,0.5867768595041323,0.8581376764638007,1.0,5/34,2.99%,KITLG;WNT4;AR;WNT5A;LHFPL2
prerank,histone monoubiquitination (GO:0010390),-0.3077568534277018,-0.9427452038369352,0.5566666666666666,0.8569147556982353,1.0,8/24,23.13%,CUL4B;WAC;BCOR;DTX3L;KDM2B;PAF1;RYBP;RNF2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2837470880579031,-0.942717922112792,0.5675675675675675,0.8557030510212961,1.0,7/34,10.43%,PTPRB;PTPRJ;UBASH3B;TNS2;PTPN12;PTPRZ1;PTPRT
prerank,negative regulation of viral life cycle (GO:1903901),0.429269530334243,0.9424027852057288,0.5696594427244582,0.9569604773816234,1.0,3/15,9.30%,GSN;TRIM11;TRIM26
prerank,cellular response to ATP (GO:0071318),-0.35542332870500065,-0.9421405635209872,0.5094850948509485,0.8559085205636666,1.0,5/14,27.87%,SSH1;P2RY1;P2RY12;CIB2;TAF1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.36280768997988916,0.9420889805642265,0.5450762829403606,0.9570983533282791,1.0,15/32,29.80%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;CCT8;CTNNB1;NAF1;CCT6A
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.34623867186885315,-0.9418418453895301,0.5539358600583091,0.8554039081298144,1.0,14/16,52.47%,CYRIB;STX7;CEACAM1;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL12B;IL23R;RIPK3;KLRC1;XCL1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.41366861058974747,0.9417719834215064,0.5219435736677116,0.9572198855812244,1.0,3/17,10.26%,SCAMP5;UNC13D;KCNB1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3768337779295003,0.9416142370398636,0.5256588072122053,0.9569593621484708,1.0,5/28,7.41%,PRKAA2;CCL5;CTNS;AVIL;EIF6
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.26246139469730256,-0.9414540289662497,0.5852534562211982,0.8550734048953462,1.0,7/46,6.49%,TIMP3;SEMA6A;LYN;WNK2;DAB2IP;EPHB2;RANBP9
prerank,protein-containing complex disassembly (GO:0032984),0.3379254623210213,0.9412515378090974,0.5691554467564259,0.957174464152568,1.0,16/54,19.73%,WNT1;CAV1;RUBCNL;DVL3;FZD5;VTI1B;VIPAS39;VPS4A;MYC;GSK3B;VAMP7;PYM1;MAP1LC3B;TSG101;FZD2;UVRAG
prerank,regulation of actin filament-based process (GO:0032970),0.3313661290372586,0.9412464251804125,0.539568345323741,0.9565690415038336,1.0,19/70,18.58%,CELSR1;ARHGAP18;CDK10;DLC1;RHOQ;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;EPHA3;RHOA;CCDC88A;FSCN1;TESK1;ABL1;CRK;ARHGAP44;ROCK2
prerank,response to peptide hormone (GO:0043434),0.35551067851172474,0.9410589845800346,0.5532734274711169,0.9563694221140521,1.0,7/43,7.50%,OGT;CAV1;CREB1;EIF2B2;ZBTB7B;EIF6;STAT4
prerank,cellular response to BMP stimulus (GO:0071773),0.32750252650141154,0.9409744439248505,0.5603345280764636,0.9559418992594616,1.0,9/66,7.30%,ADAMTS7;SMAD6;DDX5;HIVEP1;GDF15;BMP5;SOX9;BMP4;TGFB2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.43473499082714345,0.940970178947242,0.5327102803738317,0.9553365100099874,1.0,2/12,8.86%,STARD3;FDX1
prerank,protein sumoylation (GO:0016925),0.34746579407690104,0.9403346680922849,0.5516372795969773,0.956227197733979,1.0,19/49,25.85%,NUP93;EYA1;NDC1;SUMO2;SUMO3;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;RAE1;AAAS;POM121;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.4532188291207079,0.9401734062316661,0.5336617405582923,0.9559884293997052,1.0,3/10,14.43%,ATP1A2;STK39;NEDD4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3159235157851861,-0.9401500845214766,0.5737179487179487,0.8556872771999916,1.0,4/23,8.58%,ZEB2;DAB2;THBS1;ING2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3159235157851861,-0.9401500845214766,0.5737179487179487,0.8556872771999916,1.0,4/23,8.58%,ZEB2;DAB2;THBS1;ING2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4003247973740248,0.9400685746293922,0.5223880597014925,0.9556188241650267,1.0,2/19,2.07%,TJP1;OCLN
prerank,protein localization to synapse (GO:0035418),0.4298934287126202,0.939853273328951,0.5312,0.9555073168717598,1.0,6/12,21.29%,ZDHHC12;BSN;PCLO;NLGN2;SHANK1;DLG4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.31346359819754227,-0.9396641800890748,0.5326460481099656,0.8556581525174226,1.0,5/23,7.59%,ERRFI1;CBLB;SH3BP5;ZFYVE28;SOCS5
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.40026579170555987,0.9393857072764435,0.5243161094224924,0.9559647980411318,1.0,5/18,16.92%,HDAC5;HDAC4;HDAC3;GSK3A;TMEM119
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.373450999339201,0.9392374496523473,0.5313751668891856,0.9557056380155131,1.0,5/29,12.18%,CCL5;MOSPD2;LGALS3;CREB3;ANO6
prerank,striated muscle cell differentiation (GO:0051146),-0.3446832805027575,-0.9388323595031418,0.5163934426229508,0.8565227757016909,1.0,6/16,15.65%,MYEF2;KDM6B;SIK1;SORT1;CBY1;MYOCD
prerank,regulation of receptor binding (GO:1900120),0.4600236796311422,0.9384220688334611,0.5458937198067633,0.9570498437209521,1.0,3/10,10.76%,MMP9;PTPRF;ADAM15
prerank,negative regulation of protein processing (GO:0010955),-0.37661144395645896,-0.938269712392625,0.5353260869565217,0.856632528389229,1.0,3/12,6.83%,THBS1;SERPINE2;LRRK2
prerank,microtubule depolymerization (GO:0007019),-0.3369058891013102,-0.9382323245970021,0.5030120481927711,0.8554403974695057,1.0,11/17,34.42%,STMN2;NCKAP5;KIF18A;STMN3;CKAP5;STMN4;KIF18B;KIF14;CCSAP;NCKAP5L;KIF19
prerank,regulation of protein binding (GO:0043393),0.31509264008748805,0.9381958566450969,0.5661846496106785,0.9569447534397241,1.0,21/114,14.36%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;HDAC5;PPP2CA;HDAC4;CTSZ;ADD1;BMP4;TRIM21;TCF7L2;PKD1;ACTB;CARD16;CSNK1E;CAPRIN2;TLE5;GSK3B;ITGB1BP1
prerank,regulation of interleukin-1 production (GO:0032652),-0.35270899400741773,-0.9379083043244664,0.5222551928783383,0.8550256354438073,1.0,2/15,3.10%,GAS6;TMED10
prerank,DNA double-strand break processing (GO:0000729),0.40100367508949986,0.9372039525928908,0.5236051502145923,0.9586693954080597,1.0,5/18,18.15%,RNF138;MRE11;UBE2N;NBN;RAD50
prerank,clathrin-dependent endocytosis (GO:0072583),0.37323016945064,0.9371630705328234,0.5301369863013699,0.9581550944439995,1.0,4/26,4.42%,CLTB;AP2A2;FCHSD2;GPR107
prerank,regulation of striated muscle contraction (GO:0006942),0.38414146437822716,0.9371453274480122,0.5406896551724137,0.9575902863008621,1.0,2/27,2.83%,ANK2;ATP1A2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3816936326280599,0.9370264037425364,0.5330520393811533,0.9572633299804022,1.0,8/24,15.90%,ANK3;CHP1;MIEF2;MYO1C;KCNB1;ITGB1BP1;HRAS;ITGB2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3279454349567374,-0.9369743070870771,0.5497076023391813,0.8561233732158041,1.0,6/18,17.91%,LYN;SLIT2;IL6R;MTUS1;CAMK1D;EDN3
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.34337286233181596,0.9366577871339099,0.5611246943765281,0.9568902660318683,1.0,11/51,15.56%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;REEP4;LMNA;CHMP2A
prerank,mitotic nuclear membrane organization (GO:0101024),0.34337286233181596,0.9366577871339099,0.5611246943765281,0.9568902660318683,1.0,11/51,15.56%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;REEP4;LMNA;CHMP2A
prerank,protein localization to mitochondrion (GO:0070585),-0.38320396108851085,-0.9365512342834367,0.5445783132530121,0.8559131923019078,1.0,3/11,7.92%,LRRK2;HK2;DNAJA1
prerank,mRNA processing (GO:0006397),0.2933095131997348,0.935591870142574,0.6208291203235592,0.9586899909763417,1.0,91/287,25.17%,PPARGC1A;GTF2F1;DDX5;SRSF2;CELF1;RBM19;POLR2H;SON;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;HNRNPH2;RBM8A;WDR33;PHF5A;DBR1;RPRD2;MTREX;SF3B3;USP39;SRRM4;TBRG4;SRSF7;SF3A2;ZCCHC8;SYNCRIP;POLDIP3;THOC7;HNRNPUL1;GPATCH1;RBM10;FRG1;CSTF1;RNPS1;PNN;SRSF9;SRRT;UPF3B;PLRG1;GEMIN6;DHX9;ISY1;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;ERCC2;CLP1;PRPF40B;PRPF6;POLR2C;SRSF1;HNRNPA3;PPIL1;PTBP1;POLR2E;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;THOC1;PUF60;PRPF8;YBX1;DDX23;GEMIN5;SFPQ;U2AF1;RBM15;SPEN;SRRM1;PABPC1;AURKAIP1;SNRPB2;POLR2K;DDX46;PRKACA;CMTR2;MNAT1;CPSF7;CWF19L1;GEMIN2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.25566635280773337,-0.9353508719341812,0.5795454545454546,0.8575949129899165,1.0,13/57,11.36%,DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;SHISA6;DLGAP1;GRIN2B;NLGN1;NEFL;NETO1;CACNG8;SHISA9
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4288200536592237,0.9353422491644601,0.5443234836702955,0.9586557939413796,1.0,6/12,27.11%,LARP7;HEXIM1;NELFB;NELFA;RNF168;RNF8
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3954873351957581,0.935328232761423,0.527536231884058,0.9580743511386057,1.0,2/19,3.25%,SULT1A1;SULT2B1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.3812391405965029,0.9349143312631538,0.5280898876404494,0.9584264410459165,1.0,2/25,1.46%,ARAP1;MMP9
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2901291844895469,0.9346613870864393,0.69,0.9583886593484459,1.0,108/572,17.01%,THRB;PRDM6;TMPRSS6;TFAP2C;KLF4;SREBF2;RORC;FOXP2;GLI3;DDX5;HIVEP1;TRIM33;FOXP4;KLF12;CAV1;ZNF436;HDAC5;EP300;ZMYM5;ZNF692;MXD4;FOXO3;KANK2;CGGBP1;FOXC2;GLIS2;ZNF219;HDAC4;NR6A1;EPO;ZBTB16;WWP2;MTDH;BEND3;RARG;PHF21A;LCOR;FOXM1;OTUD7B;HCFC1;SOX9;ZBTB7B;CC2D1A;BMP4;KLF7;NKAP;PLK3;ZFHX3;PPM1A;ATRX;LARP7;TCF7L2;MAZ;JUN;CRY2;ZFP57;BAG3;FOXP3;DPF2;NR2C1;DNMT3A;RIF1;APBB1;CCND1;EZR;HDAC3;TWIST1;SAP130;ZNF205;NFIB;NFIC;SMARCA4;SP2;NCOR1;MIER2;DR1;MAFK;ZNF148;CPEB3;CHD3;GATA3;RREB1;ZNF177;CBX4;MYC;TLE5;NCOR2;MEF2C;PCGF2;FOXP1;SARS1;NEDD4;IRF2;GATAD2B;FLCN;MDM2;IGBP1;ZGPAT;E2F1;HMBOX1;TCF25;IRF2BP2;KDM1A;POU4F1;UBC;RPS27A;HEXIM1;UBE2D3
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.2674428850635679,-0.9345415014440873,0.5611814345991561,0.8583887085129115,1.0,5/38,10.17%,BMP6;SASH1;GBP5;DDX60;PLSCR1
prerank,mRNA modification (GO:0016556),-0.3114002066673222,-0.9343452329831577,0.54,0.8576645171630153,1.0,6/22,16.05%,METTL8;PUS7;METTL16;TRMT61B;DKC1;TRMT6
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.310331058285856,0.9334426196992589,0.5954198473282443,0.9605969499451608,1.0,14/118,8.31%,PHLDB2;PDLIM5;FMNL2;EPHA4;DAG1;EMP2;SIPA1L1;CRB2;GDNF;ZMYM6;CAPZB;EFNA5;SRCIN1;STRIP1
prerank,hepaticobiliary system development (GO:0061008),0.3937914401488283,0.9333409008433772,0.5310245310245311,0.9602064026092314,1.0,7/20,21.33%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;CDK5RAP3;PHF2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4574565251269893,0.9330636515011644,0.544839255499154,0.9602494891245761,1.0,1/10,1.04%,WNT1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.43587266065234614,0.9329719472879365,0.5342465753424658,0.959872987385597,1.0,6/13,24.87%,PPP1R15A;DDRGK1;BFAR;ABCA7;PPP1R15B;NCK1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3979476938868339,0.932933063166309,0.5390505359877489,0.9593383906971478,1.0,7/18,15.33%,CD81;MSN;ABCA2;ATP5IF1;EZR;VPS11;HSP90AA1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.35272365638864484,0.9328772111836771,0.5401554404145078,0.9588437735934081,1.0,7/41,12.09%,ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;FADS1;SCD5
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2897731657341007,-0.9321726835309292,0.5566666666666666,0.8619508934507608,1.0,7/27,14.53%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,chromatin organization (GO:0006325),0.3078728330810462,0.9316591528341217,0.5980707395498392,0.9609781244894445,1.0,27/132,14.55%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;PHF1;HCFC1;SOX9;KDM5C;ATRX;FOXP3;HDAC3;SMARCA4;KDM4C;DR1;MPND;BAZ2B;ACTL6B;KDM6A;MYSM1;SMARCD2;HMGN1;PWWP3A;MYC;SETDB1
prerank,establishment of protein localization to membrane (GO:0090150),0.32528984467170907,0.9312491557445839,0.566350710900474,0.9612902801992492,1.0,8/66,9.99%,NECTIN3;ZDHHC12;VPS37B;FRMPD1;NPC1;SYNE3;GOLGA7;MYO1C
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.40200812291127996,0.9312383062049561,0.5584218512898331,0.9607023619321527,1.0,6/18,18.32%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.44101750741932766,0.9308233114105181,0.5377503852080123,0.961075628680001,1.0,1/12,0.85%,UNC13C
prerank,mRNA 3'-end processing (GO:0031124),0.3243107549431008,0.9303442947064781,0.5675029868578255,0.9616152408789154,1.0,28/78,23.16%,SRSF2;AHCYL1;EIF4A3;DDX39B;RBM8A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;CSTF1;RNPS1;SRSF9;UPF3B;GRSF1;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;APP;CSTF3;THOC1;TUT1;U2AF1;SRRM1;PABPC1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3671254020581448,0.9301008800027919,0.5362116991643454,0.9615649948370781,1.0,3/30,6.61%,OGT;FHIT;DDRGK1
prerank,regulation of nervous system process (GO:0031644),-0.32457158725488977,-0.9298293971613888,0.5545454545454546,0.8665848610292425,1.0,3/18,5.25%,SLC8A3;NOS3;DLGAP1
prerank,GTP metabolic process (GO:0046039),0.40685294697111524,0.9297089312459813,0.5444617784711389,0.9618530747313824,1.0,7/15,23.05%,IMPDH2;RHOQ;AK3;OPA1;RAB23;GNAI3;EFL1
prerank,sphingolipid biosynthetic process (GO:0030148),0.3207510123055685,0.9294285479157596,0.5782556750298686,0.9619017600398838,1.0,10/71,11.15%,SPTSSB;SGMS2;PPM1L;A4GALT;ELOVL1;LARGE1;AGK;ELOVL6;HACD4;CERS2
prerank,cellular response to glucose stimulus (GO:0071333),-0.2924358161720243,-0.929183371791468,0.5692883895131086,0.8669791928403714,1.0,8/30,12.28%,UNC13B;ZBTB20;GAS6;PRKAA1;RAB11FIP2;IGF1R;RAB11B;RACK1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3553536273489323,0.929120015116578,0.5579896907216495,0.9620266490474689,1.0,6/37,11.47%,IL17RA;ZC3H12A;ABCD1;ALOX5;TLR6;TLR4
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3824090174210236,0.929089765204946,0.556047197640118,0.9614906228765087,1.0,8/24,18.48%,POLK;RPA3;POLD2;LIG3;PCNA;UBC;RPS27A;RFC1
prerank,cellular amino acid catabolic process (GO:0009063),0.31706262188770745,0.9289280931330633,0.5671296296296297,0.9612750562088209,1.0,26/87,23.03%,GLUL;CARNMT1;TDO2;PIPOX;GLUD1;ABAT;SHMT1;CARNS1;AMT;SLC25A21;SLC25A44;AUH;OGDH;BCAT2;DLST;IVD;ECHS1;HAAO;PRODH;KYAT1;MCCC2;HSD17B10;GAD1;SARDH;BLMH;GCDH
prerank,intracellular protein transmembrane transport (GO:0065002),0.3438044054398118,0.9280384332539778,0.561314791403287,0.96275015171295,1.0,12/42,22.46%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,regulation of protein kinase activity (GO:0045859),0.3128842625181926,0.9279148285007162,0.5812641083521445,0.9624133526015547,1.0,16/106,11.46%,DAXX;TRIB2;CDKN1A;RAP1A;QARS1;PTK2B;HSPB1;TARBP2;TSC2;CAMKK1;IQGAP1;CHP1;PYDC1;SMCR8;JTB;GNAQ
prerank,negative regulation of cellular component movement (GO:0051271),0.4130981001774775,0.9278412656334254,0.5657051282051282,0.961975191192386,1.0,7/15,16.76%,SPINT2;FBLN1;CD9;CCDC125;GATA3;TGFBR3;CRK
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.3104165014193633,-0.9278254471765711,0.5736677115987461,0.8691224744830094,1.0,11/23,19.16%,ENPP1;MOSMO;IFT122;TULP3;MEGF8;RACK1;KCTD21;BTRC;KIF7;ULK3;PTCH2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.39693668143689115,0.92752255539423,0.5417910447761194,0.9621033305431359,1.0,6/17,17.90%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.30036291290463046,-0.9274608307939114,0.5801282051282052,0.8687669739424149,1.0,12/24,29.04%,TTLL4;TTLL11;CFAP20;AGBL4;TTLL5;CEP41;GGCX;VKORC1;TTLL7;TTLL8;AGBL5;TTLL6
prerank,positive regulation of secretion by cell (GO:1903532),0.3260534176094916,0.9272847618112127,0.5727699530516432,0.9620443082626153,1.0,11/70,10.78%,CFTR;SYTL4;UNC13D;GOLPH3;TGFB2;ANG;APBB1;EZR;KCNB1;IER3IP1;GRK2
prerank,regulation of interleukin-2 production (GO:0032663),-0.25937573533922426,-0.9272075433668152,0.5859030837004405,0.8681538288667402,1.0,8/43,11.67%,PDE4D;CD34;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,base-excision repair (GO:0006284),0.3417308391540468,0.9267612512157912,0.5482625482625483,0.962629417504641,1.0,14/48,20.42%,FEN1;MUTYH;POLG;ERCC5;MBD4;RPA3;POLD2;LIG3;PCNA;NEIL1;PARG;RFC1;PNKP;APEX2
prerank,insulin secretion (GO:0030073),0.3951703024006587,0.9267234564066782,0.5370919881305638,0.9621038509155209,1.0,7/19,28.05%,GAL;RAB11FIP5;PARK7;ADCYAP1;CYB5R4;PTPRN;PTPRN2
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.343992214281949,-0.9263675563302631,0.547550432276657,0.8689449013797714,1.0,7/15,21.18%,ENTPD1;CMPK2;NME2;AK4;ENTPD3;ENTPD5;ENTPD6
prerank,glutathione derivative metabolic process (GO:1901685),0.39359472615328295,0.9260454942113778,0.5672082717872969,0.9625287969416119,1.0,5/20,15.68%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.39359472615328295,0.9260454942113778,0.5672082717872969,0.9625287969416119,1.0,5/20,15.68%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,regulation of response to stress (GO:0080134),-0.38007040803914105,-0.9259947572492836,0.5166240409207161,0.8686465836749397,1.0,4/10,22.18%,CORO2B;OPRM1;STOX1;ADCY8
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2917143518664644,0.9259532464808541,0.6599394550958627,0.9621469070243271,1.0,77/336,18.67%,NFATC2;WNT1;SUSD6;CDKN1A;ZC3H12A;IKBKE;FEN1;RECQL4;DOT1L;PPP1R15A;NABP2;IRF3;USP10;ASF1A;PHF1;BCL2L1;NSMCE4A;PARP3;MRE11;MACROD1;MAPK15;CENPS;PLK3;INIP;RAD54L;FBXO31;DCUN1D5;PML;POLK;RIF1;UBE2B;APBB1;CCND1;MUTYH;PCLAF;MTREX;TIGAR;USP3;CSNK1E;CDKN2AIP;TOPBP1;PAXX;PWWP3A;MBD4;UBR5;MYC;BTG2;REXO4;ENDOV;FOXP1;POLH;APTX;USP28;MCM8;IKBKG;E2F1;FAN1;DDB1;ATR;UBA6;MCM7;ABL1;HINFP;NBN;XIAP;SMC6;MAPKAPK2;CHEK2;INTS3;TRRAP;PIDD1;RAD50;ATF2;PARP2;PARK7;USP16;TAOK3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3321118695337084,0.9259076378355078,0.562137049941928,0.9616410876645611,1.0,10/59,11.51%,OSBPL9;ACOT8;ALOX5;GAMT;CYP39A1;ACSM3;NDUFAB1;ACSF3;OSBPL7;ACACA
prerank,cognition (GO:0050890),-0.2616407441354791,-0.9257649706822709,0.6267942583732058,0.8679533417212892,1.0,13/42,16.19%,SOBP;RP9;TUSC3;SETD5;PTCHD1;GRM5;TTC8;CHD7;NF1;CHMP2B;MFSD2A;NIPBL;DOP1B
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3126772333535795,0.9252899066726351,0.5895765472312704,0.9624841586367339,1.0,27/110,18.32%,CLU;GSN;EP300;PIH1D1;CRYAB;HCFC1;MAPK15;LATS1;STXBP1;CDC42;LGALS3;MTLN;RAF1;AJUBA;HRK;NAPA;NAPB;PREB;GSK3B;ULK1;TRABD2B;HSP90AA1;PRKCZ;HDAC6;CDH5;PTPN11;PARK7
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.36645819691534165,-0.925073253559961,0.5672823218997362,0.8684579299311345,1.0,4/13,10.76%,TBX3;NOTCH1;TGFB1;SRA1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2785842249538462,-0.9246073782361792,0.5823293172690763,0.8684198722092117,1.0,13/36,19.61%,HIF1A;GAS6;AXL;WNT5A;PARP14;NLRC5;IRGM;RIPK1;CASP4;EDN1;CD74;CSF1;AGPAT2
prerank,heme biosynthetic process (GO:0006783),0.38562977560287814,0.9244744207736578,0.5663189269746647,0.9637663646376167,1.0,10/22,21.50%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;COX10
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.28573960384274816,0.9243293635633305,0.827,0.9635044621966115,1.0,296/1646,16.94%,CDH1;PRKCB;BNC2;NFATC2;ZBTB7C;KLF5;NR3C2;FOXN3;DAXX;TMPRSS6;TBR1;WNT1;TFAP2C;KLF4;PBX3;PPARGC1A;PBX1;ZIC4;KLF3;TFAP2D;DMRT2;OGT;MAP3K5;ELF3;LBH;SREBF2;CDKN1A;RORC;SMAD6;NIBAN2;FOXP2;GLI3;DDX5;MLLT3;HOXA4;HIVEP1;TRIM33;CAND2;FOXP4;WNT11;KLF12;ZNF436;HDAC5;ZFHX4;EP300;TOX4;ZNF692;MXD4;QARS1;RBFOX2;CC2D1B;FOXO3;FOS;RELB;NOP2;DAPK3;PCGF6;MGA;FOXC2;SP5;GLIS2;ZNF219;PPP2CA;KLF16;CREBL2;PPP1R13L;HDAC4;NFE2L2;ZBTB8A;NR6A1;ANXA4;EPO;ZBTB16;WWP2;MTDH;CIAO1;SMARCB1;TRIM44;NFE2L1;IGSF1;NACC1;POU2F3;FOXD2;PRRX2;MLF2;CRYAB;ESRRB;RFX7;IRF3;SLTM;BICRA;NKX2-8;PHF1;PATZ1;JUND;LCOR;OVOL2;ZBTB46;POLR2A;CREB1;PSRC1;ZIK1;FOXM1;PCGF3;ZBTB17;RXRB;HOXA5;HCFC1;ZIC2;SOX9;NRF1;FOXD1;ZBTB7B;KAT6B;SHC1;KDM5C;EFEMP1;CC2D1A;PHF10;COMMD7;BMP4;MEF2D;KLF7;TGFB1I1;CDK16;STAT4;ILK;NKAP;ZNF418;MED30;ZFHX3;ZNF471;DVL3;DYRK1B;CIC;L3MBTL3;PPM1A;MAGEL2;ATRX;SIX1;FBXO5;TCF7L2;MAZ;POU3F1;JUN;ELP4;POU5F2;CRY2;PML;KMT2A;ZFP57;GRHL2;FOXP3;BRD7;ZIC1;SCML2;DPF2;MAP2K2;NR2C1;MYCBP;PHF5A;ABCA2;YWHAQ;HDGFL3;APBB1;ILF2;PRDM15;MED29;HDAC3;NFE2L3;ZNF467;ENY2;GON4L;TWIST1;FADS1;ZNF205;ARID4A;KDM3A;NFIB;NFYC;NFIC;BCL7A;SOD2;SMARCA4;MAMLD1;CREB3L4;CREB3;KDM4C;SP2;TLE2;AEBP2;NCOR1;MYT1;ARID3B;CALCOCO1;SRCAP;SBNO2;MAFG;SFMBT2;HOXB5;NAA15;MEF2B;AJUBA;BAZ2B;ACTL6B;TAF5;MAFK;ZNF148;SP1;ZBTB42;MED8;CCNL2;CDK18;TSC22D4;FOXK1;PIAS1;MED12;SPIN1;ZSCAN20;TFEB;SFRP1;SMARCD2;PIAS3;MYBL1;CHD3;GATA3;ZFP30;MED21;MED24;GPBP1;RREB1;CHMP1A;ZNF177;NFIA;CBX4;BEND5;TCEA2;POLR3C;MYC;TLE5;ING4;PRDM11;ZFP1;NCOR2;REXO4;MEF2C;ZFP92;CHUK;FOXP1;SET;PAX3;SRRT;ATP2B4;ZXDC;IRF2;PTP4A3;ATMIN;TASP1;MDM2;UTP4;RFXAP;ZFP3;DHX9;KLF6;CREB3L2;ELP2;RCOR2;MED6;SMARCC1;ZGPAT;ZMIZ2;E2F1;HMBOX1;NAB2;CDC5L;IFRD1;PCNA;IRF2BP2;POLR3G;CAMTA2;SFR1;CCDC85B;ABL1;PAK6;SPTY2D1;MED27;HINFP;KDM1A;RNF10;LIN54;CRK;HSF2;POU4F1;RGMB;SMAD5;HEXIM1
prerank,negative regulation of cell differentiation (GO:0045596),0.2957089858536465,0.9242487522021211,0.6205450733752621,0.9631007054986093,1.0,21/181,7.10%,WNT1;RANBP3L;TRIB2;ADAMTS7;HPN;SMAD6;COL5A2;CRIM1;CAV1;CDK6;PTK2B;PPP2CA;BMP5;ZBTB16;NFKBIA;ESRRB;OVOL2;SPRED3;SOX9;EFEMP1;BMP4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4025276879517644,0.9241031085894468,0.5422222222222223,0.9628214719087266,1.0,3/17,5.24%,MCU;RIPOR2;MOSPD2
prerank,ephrin receptor signaling pathway (GO:0048013),0.3192365552296857,0.9239489854162899,0.5793103448275863,0.9625855613678926,1.0,22/82,18.58%,MMP9;NGEF;EPHA4;EFNB2;SIPA1L1;AP2A2;EFNA5;CDC42;ACTB;ACTG1;EPHA3;RHOA;AP2A1;RASA1;EFNA4;HRAS;CRK;ARPC2;GIT1;PTPN11;YES1;ROCK2
prerank,chromosome organization (GO:0051276),0.30895230299657495,0.9239204899706084,0.5843307943416758,0.9620654914262514,1.0,26/99,20.73%,HDAC5;DOT1L;PHF1;LATS1;CENPT;TCF7L2;RBX1;HDAC3;SMARCA4;ACTL6B;COPS5;HMGN1;PWWP3A;CENPH;MYC;DDB1;ABL1;UBC;RPS27A;RAE1;GATAD1;H3-3A;NUCKS1;ZBTB7A;SETD7;TOP2B
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.33078232788375234,0.9239115458307339,0.5733333333333334,0.9614819981282832,1.0,6/57,10.49%,LPAR1;CHRM1;ADCY9;ADCY6;HTR1B;AKAP5
prerank,protein N-linked glycosylation (GO:0006487),0.3275145357701704,0.9237345306069206,0.5843230403800475,0.9612740929662997,1.0,15/66,14.07%,B4GALNT2;MGAT3;ASGR1;TMEM165;MGAT1;FUT8;DDOST;SRD5A3;ALG1;MCFD2;MGAT4C;ALG5;DPM2;ALG12;GFPT1
prerank,cellular response to nutrient levels (GO:0031669),0.33018617835664854,0.9236372492519379,0.5762304921968787,0.9608701234936959,1.0,17/62,20.21%,PRKAA2;SREBF2;GAS2L1;KCNB1;FADS1;PDK2;TFEB;SFRP1;EIF4G1;ULK1;FLCN;MAP1LC3B;RIPOR1;ZFYVE1;STK24;SREBF1;KLF10
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.37402501398276905,0.9233854026331082,0.5366197183098591,0.9608516072592534,1.0,5/26,9.00%,PRKAA2;ERLIN2;EIF6;ACADL;ERLIN1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.31501728036408777,0.9233181087321762,0.5952941176470589,0.9604124128383943,1.0,26/88,16.52%,STXBP6;CORO7;BLOC1S6;VPS13A;ARL3;EXOC4;MON2;MYO5A;GOLGA7;STEAP2;EXOC2;SCAMP2;AP1S3;AP2A1;NAPA;GOLGB1;SH3GL2;EXOC8;AP1M1;AP1S2;VAMP7;OSBPL5;CHMP2A;AP4E1;CCDC22;AP1B1
prerank,negative regulation of transport (GO:0051051),0.33820106122852095,0.9230509450770514,0.5658720200752823,0.9604276900823411,1.0,13/51,15.72%,SCAMP5;WWP2;CRYAB;ERBB3;RAB7A;RUBCN;LGALS3;SNX33;ARL6IP5;EPHA3;SNX12;SYT11;PRTN3
prerank,positive regulation of growth (GO:0045927),-0.244315350281229,-0.9228646164952053,0.6242424242424243,0.8713737020939556,1.0,14/64,14.50%,PLCB1;INSR;LGI1;RFTN1;BCL2;SLC25A33;BRAT1;CXCL16;HYAL1;EXOSC2;FXN;MFSD2A;MTPN;KLHL22
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3369122184084991,0.9227649387967071,0.5675340768277571,0.9604956257085061,1.0,7/45,8.44%,REPS2;GAB1;PTK2B;SOX9;SHC1;EFEMP1;IQGAP1
prerank,protein targeting to peroxisome (GO:0006625),0.36583881914810007,0.9226471655039498,0.5425531914893617,0.9601646162403115,1.0,9/29,18.84%,PEX26;ABCD1;SLC25A17;ZFAND6;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3952844574265105,0.9224459366076446,0.5579710144927537,0.9600159927798216,1.0,5/20,9.64%,BMP5;ERLIN2;ACADL;ERLIN1;ABCA2
prerank,regulation of glycolytic process (GO:0006110),0.3255318435663091,0.9223490267330762,0.5873959571938169,0.959658472601571,1.0,12/68,11.17%,PRKAA2;OGT;NUPR1;EP300;HDAC4;NUP93;PFKFB2;EIF6;NDC1;JMJD8;TIGAR;NCOR1
prerank,lymphocyte migration (GO:0072676),0.3620730060122064,0.9221441039277366,0.5506849315068493,0.9595795846190908,1.0,3/32,13.07%,CCL5;MSN;GATA3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2893910771172548,-0.9221364958893239,0.6070287539936102,0.8719275921259636,1.0,7/27,9.03%,MARK1;IL1RAPL1;MBOAT1;BRSK1;CTNNA2;VPS35;NTNG1
prerank,transcription by RNA polymerase II (GO:0006366),0.28889938626521616,0.9211912759926489,0.670061099796334,0.9611534548611793,1.0,65/305,20.30%,NR3C2;THRB;NOTCH2;PPARGC1A;LSM10;RORC;CCN2;GTF2F1;DDX5;MLLT3;HDAC5;NR6A1;POLR2H;NABP2;SNRPB;ESRRB;RARG;TAF1C;NKX2-8;ELOB;POLR2A;RXRB;ZBTB7B;SSRP1;MAZ;ELP4;NR2C1;INTS2;WDR33;RPRD2;HDAC3;NFE2L3;NFIC;NCOR1;GTF2E1;TAF5;SP1;ELL;RREB1;CSTF1;RPAP1;NCOR2;SRRT;ELP2;PABPN1;TBPL1;ERCC2;MED27;CLP1;NELFB;INTS3;POLR2C;INTS13;RARA;INTS6;TAF9B;POLR2E;NELFA;TEAD1;TAF8;TBP;CSTF3;MED7;SNAPC3;MNT
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3626536656590855,0.9205627962380619,0.5644736842105263,0.961989396862471,1.0,7/32,16.80%,WNT1;OCLN;AVIL;CDC42;RREB1;FSCN1;ARPC2
prerank,negative regulation of dephosphorylation (GO:0035305),0.40687962591411586,0.9202703230003202,0.5744,0.9620622446849255,1.0,4/18,9.18%,SH3RF2;PPP1R15A;CHP1;YWHAB
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3009247640659314,0.9202545224049722,0.6108108108108108,0.96150352946052,1.0,18/136,9.13%,NLRP2;KLF4;CD200;NUPR1;ZC3H12A;GLIS2;HDAC4;ANXA4;WWP2;NFKBIA;COMMD7;TRIM21;NLRP2B;TCF7L2;PKD1;CHP1;PYDC1;FOXP3
prerank,pre-miRNA processing (GO:0031054),-0.3465122236018584,-0.9196594160952093,0.5611111111111111,0.8769972361078003,1.0,6/14,22.72%,TUT4;ADAR;DROSHA;AGO1;AGO4;DICER1
prerank,regulation of mitochondrial fission (GO:0090140),-0.2995590861283986,-0.9193115532107448,0.5909090909090909,0.876609554210547,1.0,7/24,14.80%,DCN;KDR;LRRK2;VPS35;FIS1;CYRIB;SPIRE1
prerank,regulation of macroautophagy (GO:0016241),0.310307354090994,0.9193045787886743,0.611672278338945,0.9629891296210461,1.0,37/105,24.58%,PRKAA2;ATP6V1B1;NRBP2;SESN2;TSC2;RHEB;EXOC7;EXOC4;CAPNS1;SMCR8;EXOC8;VPS26B;GAPDH;ULK1;BNIP3L;NEDD4;ATP6V1D;ATP6V1E1;RB1CC1;IKBKG;ATP6V0D1;SESN1;PRKAG1;HDAC6;LZTS1;ATP6V1B2;PRKAB1;ATP6V0B;PRKAB2;CDK5R1;VPS26A;GNAI3;UBQLN2;ATP6V0E1;CASP3;SCOC;PRKACA
prerank,protein maturation (GO:0051604),0.31223548980742566,0.9191415284812684,0.597752808988764,0.9627384881594642,1.0,20/95,16.97%,TSPAN5;OGT;ADAM10;NAA40;CIAO1;AANAT;CPE;SRGN;AFG3L2;SDE2;PITRM1;NDUFAB1;ISCA1;NAA15;DNAJB11;NAA10;TASP1;BACE1;STUB1;LMF2
prerank,protein modification by small protein removal (GO:0070646),0.29114925473563236,0.9191412293288805,0.6578140960163432,0.9621465346981157,1.0,72/252,24.43%,CFTR;OGT;ZC3H12A;EP300;USP46;USP29;OTUD1;PSMD11;NFKBIA;USP32;USP10;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;DESI1;USP19;ACTB;USP24;USP20;TOR1A;USP42;PSMD7;USP3;RHOA;MYSM1;TOMM20;ABRAXAS1;COPS5;RNF123;FOXK1;PSMB5;GATA3;MYC;TNIP1;SENP3;MDM2;USP28;IKBKG;OTUD6B;UBC;RPS27A;KEAP1;TRRAP;USP25;STAM;PSMD1;PSMC4;USP21;USP16;TAF9B;PSMD8;USP22;INO80D;YY1;INO80C;SMURF2;USP2;USP11;INO80E;WDR20;BIRC3;MDM4;TADA3;PSMA7;CDC25A;USP13;TFPT;STAM2;USP34;MBD6
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3931272602895029,0.9188184925258918,0.5736196319018405,0.9622541252571467,1.0,9/19,24.73%,SMAD6;OLFM1;TGFB2;TGFBR2;BMPR1A;SOX4;EFNA1;MDM4;ZFPM1
prerank,positive regulation of viral transcription (GO:0050434),0.37072264540597444,0.9186413375790777,0.5783475783475783,0.9620757127872173,1.0,8/25,19.18%,GTF2F1;POLR2H;POLR2A;DHX9;NELFB;POLR2C;POLR2E;NELFA
prerank,sphingolipid metabolic process (GO:0006665),0.3030170152607832,0.9185138332534485,0.6111731843575419,0.9617568227589565,1.0,16/108,11.48%,SPTSSB;HEXA;SGMS2;PPM1L;PPP2CA;ELOVL1;ORMDL3;AGK;GLB1;SUMF1;ELOVL6;HACD4;ABCA2;HEXB;CERS2;SUMF2
prerank,regulation of microtubule depolymerization (GO:0031114),0.36995030835881243,0.9183794569022437,0.5683139534883721,0.961454903262556,1.0,1/25,0.23%,FGF13
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.284424446536445,-0.9183603227633451,0.6428571428571429,0.8776980340379923,1.0,14/31,34.28%,LYN;GLMN;TNFRSF21;DLG5;CD300A;RC3H1;SOX11;TYROBP;CD86;FCGR2B;LST1;CD80;LILRB1;IL4I1
prerank,cellular protein localization (GO:0034613),0.290449282888664,0.9182949420204662,0.6802860061287027,0.9610478081429088,1.0,56/285,17.92%,RAB17;ANGPT1;ANK2;CELSR1;EMP2;OCLN;PIGU;WNT11;GRTP1;KIF13A;TBC1D16;EHD1;ARL4A;CSRP3;COPA;AP3B1;SNX8;PTPRU;TMED1;SIL1;ARMCX3;WLS;CPE;UNC50;STXBP1;GGA1;SGSM2;TM9SF1;ARFIP2;AP2A1;TBC1D1;RABL3;CPLANE2;MESD;STX11;NAPA;VIPAS39;ARF4;VPS26B;SEPTIN9;NAPB;RAB5C;RAB1B;STX16;USP6NL;FLNA;PRPF19;TBC1D22A;VCL;NSF;TBC1D10A;ARFRP1;HDAC6;PACSIN1;SEC23IP;STX4
prerank,synaptic vesicle transport (GO:0048489),0.4348055454713589,0.9182402816906583,0.5756013745704467,0.9605688474536863,1.0,7/11,31.11%,TOR1A;TMEM230;RAB27A;KIF5A;SYNJ1;KIF5C;DNM2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4089414884127204,0.9180198884847681,0.5876923076923077,0.9604796593997814,1.0,3/16,7.20%,DDX5;RBFOX2;EGLN2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.35946819776891387,0.9173434527891563,0.5593451568894953,0.9614355294511853,1.0,14/30,26.74%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;POLR2K;MNAT1;POLR1B;TTF1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3964621995251312,0.916629089103009,0.5632352941176471,0.9624740910814438,1.0,4/18,15.68%,NUP93;ENY2;POLDIP3;PABPN1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.30817468356506983,0.9164672725800083,0.5991041433370661,0.9622260651157668,1.0,11/102,9.12%,SORBS1;CPEB2;ADCY9;CAV1;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ADCY6;MYO5A
prerank,response to calcium ion (GO:0051592),-0.22376717574611593,-0.9164525512681868,0.6976744186046512,0.8812862232160448,1.0,16/102,7.75%,CPNE8;STIM1;ADGRV1;TRPC3;WNT5A;CAMK2D;RASGRP2;CPNE4;SYT9;PKD2;THBS1;PRKAA1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3403152615457945,0.9160599930055696,0.5615183246073299,0.9625646651167284,1.0,9/46,10.84%,RAP1B;MSN;ANXA2;GSTO1;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.39506581466386026,0.9159587114331663,0.5424739195230999,0.962203849298889,1.0,3/19,5.24%,MCU;RIPOR2;MOSPD2
prerank,regulation of cell growth (GO:0001558),0.2925430465441394,0.9158668034514247,0.6295525494276795,0.9618294298118183,1.0,38/204,15.69%,AGTR1;CDKN1A;ADAM10;HPN;WNT11;FHL1;SGK3;SESN2;PPP2CA;LTBP4;SH3BP4;ROS1;PSRC1;MUL1;EGLN2;OSGIN2;TGFB2;CDC42;NDUFS3;DCUN1D5;PML;APBB1;ADAM15;SMARCA4;SOCS2;EIF4G2;CDKN2AIP;BCAR1;OGFR;CHPT1;SFRP1;CAPRIN2;PRDM11;EIF4G1;FLCN;RAB33B;IP6K2;FRZB
prerank,positive regulation of protein kinase activity (GO:0045860),0.29965461324123405,0.9158386187281231,0.615553121577218,0.9613114443093648,1.0,17/148,9.36%,CLU;DAXX;CCL5;EPHA4;CDKN1A;EMP2;RAP1A;PTK2B;PPP2CA;PIH1D1;UNC119;CAMKK1;TGFB2;ERBB3;SRCIN1;IQGAP1;MAP2K2
prerank,spermatid development (GO:0007286),-0.2791501824503657,-0.9156304905500897,0.5631399317406144,0.8820934141630047,1.0,7/32,19.68%,ING2;YTHDC2;ZMYND15;BBS4;RFX2;CIB1;NME5
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3477017287761945,0.9155915217315906,0.5508586525759577,0.9612844479206154,1.0,7/40,10.18%,PGLYRP3;ANG;LBP;ROMO1;STAB2;RNASE3;PPP1R11
prerank,odontogenesis (GO:0042476),0.3553719020005166,0.9155821511525998,0.5932203389830508,0.9607143983949045,1.0,5/35,7.30%,EDA;WNT10A;WNT6;BMP4;TGFB2
prerank,regulation of dendrite extension (GO:1903859),0.3960525092590155,0.915533748669405,0.5494672754946728,0.9602358077827253,1.0,1/18,0.95%,OSTN
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.33094450146836235,0.9154850471982304,0.594272076372315,0.9597492775230667,1.0,15/59,16.70%,CDKN1A;CDK4;MOV10;SOX9;MED30;TCF7L2;JUN;CCND1;TWIST1;MED8;PPM1D;MED12;MED24;MED6;MED27
prerank,motile cilium assembly (GO:0044458),-0.3582180805390355,-0.9152681770052186,0.5589887640449438,0.8817063972664065,1.0,8/12,45.79%,BBOF1;DNAAF3;CCDC39;RSPH9;CCDC40;E2F4;RSPH6A;DNAAF1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2938577913809899,-0.9150854290290338,0.5862068965517241,0.8809309154997333,1.0,11/25,24.22%,TMEM50A;LYST;CHMP3;LAPTM4B;SORT1;CHMP2B;MVB12A;CHMP7;UBXN6;CHMP4C;DENND10
prerank,phospholipid biosynthetic process (GO:0008654),0.3533657684863541,0.9150610699829483,0.5676392572944297,0.9600834773511999,1.0,8/36,14.58%,SGMS2;FDPS;AGK;SRD5A3;FADS1;GPAM;DOLK;NUS1
prerank,cardiocyte differentiation (GO:0035051),-0.37934059893284633,-0.9145886936272605,0.5619266055045872,0.8808412827080607,1.0,6/10,15.65%,KDM6B;SIK1;EEF1AKMT4-ECE2;CBY1;GATA6;MYOCD
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2881562175199798,0.9142828990193188,0.6717479674796748,0.9612138031419303,1.0,101/264,28.33%,GTF2F1;DDX5;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;HNRNPH2;RBM8A;WDR33;PHF5A;DBR1;MTREX;SF3B3;USP39;SRPK2;SRSF7;SF3A2;ZCCHC8;SYNCRIP;HNRNPUL1;SRPK1;GPATCH1;RBM10;FRG1;CSTF1;RNPS1;PNN;SRSF9;SRRT;UPF3B;PLRG1;GEMIN6;DHX9;ISY1;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;SRSF1;HNRNPA3;PPIL1;PTBP1;SNUPN;POLR2E;SRSF5;ZMAT5;PCBP2;CSTF3;DDX20;WBP4;SF3A3;PUF60;PRPF8;YBX1;DDX23;GEMIN5;SFPQ;U2AF1;RBM15;SPEN;SRRM1;PABPC1;DCPS;CELF4;SNRPB2;POLR2K;DDX46;CPSF7;CLNS1A;CWF19L1;GEMIN2;GEMIN8;CDK13;RBM15B;LSM5;PPIL3;PRPF40A;DDX42;RBM6;GPKOW;HNRNPM;SNRPD2;SNRPD1;PPIE;SF1;SF3B2;HNRNPR;HNRNPH1
prerank,nuclear transport (GO:0051169),-0.3447147570257225,-0.9142551893559647,0.5654761904761905,0.8803934359902339,1.0,8/16,28.71%,XPO1;NUTF2;NUP205;NXT1;BANF1;NPM1;RSRC1;PSIP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4126031921440046,0.9140154350744017,0.5521172638436482,0.9612137021717362,1.0,6/13,25.91%,RHOA;IRAK1;ITGB2;NFAT5;IL6;RELA
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4368062248678811,0.913971137005269,0.6015625,0.9607186509842455,1.0,3/12,12.02%,INSIG1;GPAA1;ANKRD13C
prerank,nitric oxide biosynthetic process (GO:0006809),0.41784450548526375,0.9139024536157228,0.5567651632970451,0.9602891430490641,1.0,3/13,7.72%,CYB5R3;DDAH2;CYB5B
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.32326361927869285,-0.9138237236570567,0.5755627009646302,0.8801408174585501,1.0,5/18,12.88%,NRXN1;SHANK3;NLGN1;CACNG8;NLGN3
prerank,positive regulation of neuron projection development (GO:0010976),0.3145821895464719,0.9136443108965436,0.5863267670915412,0.9602732264672871,1.0,11/85,7.67%,NTRK3;COBL;PTK7;MAGI2;EP300;RAP1A;PTK2B;BMP5;AVIL;TWF1;ARSB
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.33500479173186765,0.913627146969199,0.5698254364089775,0.9597311515016539,1.0,18/48,22.33%,EP300;POLR2H;TAF1C;ASF1A;ACTB;POLR1C;MYO1C;POLR1E;POLR1F;SERTAD1;CDCA4;ZMIZ2;ARID1B;POLR2E;TBP;ELOF1;PHF2;POLR1G
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4038617589445073,0.913141639148708,0.5635276532137519,0.9602020724042659,1.0,5/17,8.42%,DOCK5;CCL5;S100A11;DOCK7;ADAMTS1
prerank,regulation of hydrolase activity (GO:0051336),0.3220617541779918,0.913114933974524,0.6011834319526628,0.9596800723660583,1.0,19/71,16.84%,NGEF;PLXNB1;EPHA4;PLXNA2;SIPA1L1;CAV1;ADAP1;EFNA5;ARHGEF5;ATP5IF1;PAFAH1B1;EPHA3;PLXNB2;OCRL;ITGB1BP1;ARHGAP27;PLXNA3;CRK;RAP1GAP
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.34609354413935256,-0.9130118403833518,0.5706666666666667,0.8808003452122862,1.0,3/14,5.17%,IL34;PTK2;THBS1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.4274164362904819,0.9129978857859128,0.5586776859504132,0.9593638315382544,1.0,2/11,5.50%,NBL1;DUSP1
prerank,myeloid cell development (GO:0061515),-0.3206277965690867,-0.9129888925595323,0.557632398753894,0.8796092885959895,1.0,5/18,11.22%,ALAS1;SH2B3;KIT;NCKAP1L;NRROS
prerank,histone modification (GO:0016570),0.3026382084309257,0.9129314514742204,0.5977777777777777,0.9589258185688945,1.0,31/109,22.03%,CPA4;HDAC5;EYA2;EP300;HDAC4;NTMT1;KAT6B;EYA1;MORF4L2;AURKC;UBE2B;ENY2;USP3;MIER2;CDK2;RCOR2;UBE2N;PRMT1;TRRAP;HDAC6;SGF29;PARP2;PARK7;USP21;USP16;MRGBP;PRMT2;USP22;RCOR3;TAF6;SIRT7
prerank,amyloid fibril formation (GO:1990000),0.33232192506502223,0.9128710833526776,0.5707196029776674,0.958482291941932,1.0,13/51,21.32%,TSPAN5;ADAM10;GSN;GGA1;MDM2;BACE1;UBC;RPS27A;SIAH1;H3-3A;APP;MAPT;APH1A
prerank,embryonic digit morphogenesis (GO:0042733),-0.32696501900211367,-0.9128704958713141,0.5969696969696969,0.8786445575260917,1.0,7/18,17.76%,ECE1;TBX3;SALL1;TBX2;INTU;HDAC2;WDPCP
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.345217984092588,0.912443343489864,0.5877659574468085,0.9588498649133463,1.0,6/38,8.14%,ZC3H12A;TRIM59;PPM1B;USP10;OTUD7B;PPM1A
prerank,gene expression (GO:0010467),0.2860117328371789,0.9124057202943858,0.7194752774974773,0.9583568187460072,1.0,78/348,19.26%,THRB;TSPAN5;CELF2;MRPS16;SRSF2;EEF1A1;MRPL24;MRPL37;CREBL2;POLR2H;HARS1;RPS4X;NKX2-8;POLR2A;MRPS7;RNASEL;NUP93;EIF4A3;SMG7;GOLPH3;RPSA;ABCF1;DDX39B;NDC1;XRN2;RBM8A;RPL31;RPL22;GSPT2;AGFG1;WDR33;MRPS33;PTMA;RPL28;SRSF7;SRBD1;SYNCRIP;POLDIP3;RPS26;MRPL9;THOC7;HNRNPUL1;COPS5;DNAJB11;RNPS1;TNIP1;HARS2;RPL10A;SRSF9;EIF4G1;SARS1;RRBP1;UPF3B;MRPS15;TASP1;RPL14;PABPN1;MRPS18C;E2F1;DUSP11;MAGOHB;MAGOH;RPS27A;CLP1;STUB1;LMF2;RAE1;AAAS;POLR2C;RBMS2;SRSF1;HBS1L;IGF2BP3;FARSB;RPL6;POLR2E;SRSF5;EIF4EBP2
prerank,mitochondrion distribution (GO:0048311),-0.35205893722554643,-0.9121480873834543,0.5826771653543307,0.8791786134076056,1.0,5/12,17.19%,LRRK2;MTM1;TRAK2;ATCAY;MSTO1
prerank,negative regulation of cellular component organization (GO:0051129),0.3195456342812844,0.9115940661434299,0.6011834319526628,0.9595432601792836,1.0,17/74,17.58%,CLU;SCAMP5;EP300;TMEFF2;CRYAB;CDC42;RUBCN;LGALS3;RAF1;SNX33;EPHA3;RAPGEF3;GSK3B;ULK1;SYT11;PRKCZ;HDAC6
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3256038973035107,0.911514516112422,0.6177184466019418,0.9591329883594778,1.0,16/66,13.07%,HPN;NUPR1;CAV1;CDK6;DUSP10;ALOX5;CAV2;SOX9;TGFB2;KRIT1;CASK;ATP5IF1;SYNJ2BP;NFIB;SFRP1;GATA3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.4151417031756043,0.911434609981488,0.568,0.9587430952369539,1.0,3/13,9.43%,ELOVL1;ELOVL6;HACD4
prerank,gene silencing by miRNA (GO:0035195),0.35708019310081995,0.9109923525352425,0.573170731707317,0.9591244575915734,1.0,4/32,7.41%,CNOT6;TARBP2;MOV10;EIF6
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3285400707059214,0.9107223168349184,0.5907928388746803,0.959146077891092,1.0,14/52,15.78%,ZBTB17;ADD1;SHC1;MYDGF;FKBP14;SSR1;HYOU1;DNAJB11;GSK3A;PREB;GFPT1;DNAJC3;LMNA;ATP6V0D1
prerank,neurotransmitter uptake (GO:0001504),0.42965105853288954,0.9103123099737436,0.5736677115987461,0.9594918542741842,1.0,2/12,2.83%,GLUL;ATP1A2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3034546064728798,-0.909984808668304,0.5913312693498453,0.8833617669817545,1.0,10/22,27.34%,ESR1;PSMC6;TP53;MED4;MED16;PAXIP1;SRF;SUB1;MED14;DHX36
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3670911350748622,0.909589635204256,0.5746478873239437,0.9605531117584576,1.0,5/26,10.37%,PPM1B;MUL1;TRIM21;NMI;CARD16
prerank,regulation of histone deacetylation (GO:0031063),-0.3569019657083323,-0.9094475125336635,0.5857519788918206,0.8834210218619067,1.0,6/13,22.94%,CAMK2D;SAP30BP;ING2;NIPBL;APLNR;PRMT6
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.44512961322417177,0.9091023507338584,0.5786802030456852,0.961061024152712,1.0,3/10,9.42%,PCGF3;ZFP57;DNMT3A
prerank,cellular macromolecule catabolic process (GO:0044265),0.3347134283018505,0.9090092699825641,0.5755305867665418,0.960686387387058,1.0,9/49,10.22%,RNF5;DENND3;SIDT2;UBE2G2;MANBA;XRN2;DNASE1L2;RNASE3;MTREX
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.3671878405356839,0.9084743781385457,0.5961272475795297,0.9612632103412341,1.0,8/25,23.52%,ZYG11B;RNF5;KLHL15;TOR1A;STUB1;HDAC6;LONP1;NGLY1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.40207323574669535,0.9084519132352746,0.5814696485623003,0.9607335936516237,1.0,1/15,1.14%,PPARGC1A
prerank,positive regulation of DNA binding (GO:0043388),0.3652605188488545,0.9084365581817194,0.5967523680649527,0.9601824387833348,1.0,9/31,20.36%,MMP9;NIBAN2;NGF;TWIST1;GATA3;PINX1;POU4F1;PARK7;RB1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.3040816227331777,-0.908208450885541,0.5809859154929577,0.8851731847646215,1.0,4/23,6.54%,PLA2G4A;MBOAT1;PLAAT3;PNPLA8
prerank,negative regulation of transferase activity (GO:0051348),0.36135903161934185,0.9081432824613956,0.5750708215297451,0.9602524331190941,1.0,11/28,22.43%,FBXO5;IRS2;PINX1;GSK3A;GSK3B;ABL1;EIF4A2;PARK7;ERCC4;MAPT;MEN1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.37817924905120404,-0.9080722709684215,0.577023498694517,0.8829782211790151,1.0,5/11,21.48%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.37817924905120404,-0.9080722709684215,0.577023498694517,0.8829782211790151,1.0,5/11,21.48%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,double-strand break repair (GO:0006302),0.2981344832592767,0.9079980276525323,0.6382070437566703,0.9599877439988928,1.0,43/158,22.27%,FEN1;KDM4D;RECQL4;NABP2;KDM4B;RNF138;PARP3;MRE11;EYA1;TENT4A;RIF1;APBB1;RMI1;MDC1;HUS1B;NSMCE2;MMS22L;ABRAXAS1;PAXX;ERCC5;RPA3;APTX;DCLRE1C;MCM8;LIG3;FAN1;UBE2N;PRPF19;SFR1;NBN;SMC6;CHEK2;ZFYVE26;RAD50;PARP2;NUCKS1;ERCC4;POLN;NABP1;YY1;SWI5;RNF168;SFPQ
prerank,nitric oxide metabolic process (GO:0046209),0.4132428915412909,0.9079131225816354,0.5526315789473685,0.9595959532059868,1.0,3/14,7.72%,CYB5R3;DDAH2;CYB5B
prerank,ruffle organization (GO:0031529),-0.34044257923118076,-0.9076576934329973,0.5805471124620061,0.8827044284929306,1.0,5/16,22.43%,LIMA1;AIF1L;ARF6;PIP5K1A;CORO1B
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.25319962301121046,-0.9074684242646066,0.6428571428571429,0.8819090545665399,1.0,11/49,16.64%,AFAP1L2;NOD1;LGALS9;STAT3;TIRAP;RIPK1;DDIT3;IL17D;HMGB1;TLR7;CD74
prerank,sulfur amino acid catabolic process (GO:0000098),0.43114880678525364,0.9074430733766835,0.5925324675324676,0.9600165139553766,1.0,3/10,22.50%,ADO;TXN2;BLMH
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.36911953907167955,0.9072244280966195,0.5746971736204576,0.9598809020950876,1.0,4/29,6.13%,KANK1;TJP1;SSH3;TWF1
prerank,wound healing (GO:0042060),-0.23792815776044476,-0.9069317746817593,0.659217877094972,0.8819894747388165,1.0,22/62,24.72%,IGF1;WNT5A;PDGFRA;DYSF;FGF2;MYOF;CFLAR;NF1;PPP3CA;MACF1;CLDN1;SMAD3;ANXA6;DCBLD2;PRCP;TSKU;EPB41L4B;SRF;CORO1B;JAML;DSP;PAK1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3490281160669896,0.9067911718798697,0.5963060686015831,0.9602315218683418,1.0,5/38,6.74%,DAG1;MAGI2;PHLDA3;TSC2;MUL1
prerank,regulation of chromatin organization (GO:1902275),0.4116839635113916,0.9066746419676733,0.5789473684210527,0.9598954254143219,1.0,2/14,7.21%,MLLT3;SSRP1
prerank,RNA stabilization (GO:0043489),-0.27652566588096844,-0.906660034509481,0.6088709677419355,0.8814213593858546,1.0,14/33,28.73%,TENT5A;ZCCHC17;EIF4ENIF1;AXIN2;DKC1;PARN;TENT5D;NOCT;TENT2;PHAX;SLC11A1;RBM24;DHX36;ELAVL1
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.28982032801204205,-0.9065806807353218,0.6514084507042254,0.880378013008719,1.0,8/26,17.45%,LYN;AIM2;GRIN2B;MBP;STAT3;PSME1;TTBK1;APH1B
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2690693616132476,-0.9062584830373535,0.648,0.8799701145057762,1.0,3/33,3.64%,FBN1;UBASH3B;CAMK4
prerank,somite development (GO:0061053),0.43651932230834506,0.9062444497150995,0.562396006655574,0.9602020789146553,1.0,1/11,1.37%,SMO
prerank,anterograde axonal transport (GO:0008089),0.34730472457914213,0.9060125024483229,0.5970149253731343,0.9601411885083807,1.0,6/37,6.87%,BLOC1S6;AP3B1;HSPB1;KIF1C;AP3S1;KIF1B
prerank,secondary palate development (GO:0062009),-0.3421139505719276,-0.9059977164196252,0.5982404692082112,0.8793555854692161,1.0,4/14,8.86%,LEF1;WNT5A;CHD7;LRRC32
prerank,cellular response to cytokine stimulus (GO:0071345),0.2833287446254049,0.905740459987825,0.7323943661971831,0.9601292191616471,1.0,80/416,16.90%,FN1;PTPN14;CRLF1;CCL5;MMP9;VIM;ADAMTS7;CDKN1A;RORC;ZC3H12A;IL16;CXCR4;LAMA5;EPRS1;FOXO3;FOS;DAPK3;YBX3;DAPK1;NFE2L2;IL3RA;CLCF1;TIMP1;RIPOR2;ALOX5;DUSP1;USP10;BCL2L1;STK39;HAX1;SOX9;SHC1;CSK;PTPN9;STAT4;LBP;UBE2G2;PTPN6;NDN;OXSR1;TNFRSF1A;SHMT1;CCND1;TWIST1;JAK1;GSDME;TLR4;IL1R2;RHOA;YWHAZ;SOCS2;SBNO2;SYNCRIP;NPNT;PTPN2;SFRP1;GATA3;ST3GAL6;RHOU;GSK3A;MYC;ZFAND6;IRAK1;GSK3B;CHUK;GAPDH;WNK1;SOCS6;RAPGEF1;HSP90AA1;DHX9;PRTN3;FSCN1;ITGB2;PTPN13;PDE1B;CRK;POU4F1;UBC;RPS27A
prerank,negative regulation of mitochondrion organization (GO:0010823),0.35454940312383365,0.9056268427288796,0.6055776892430279,0.9598130363040401,1.0,3/33,6.74%,CLU;BCL2L1;MUL1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2838576099409783,-0.9054432015255102,0.58,0.879464057939958,1.0,17/31,32.51%,ITGB3BP;RUVBL1;CENPP;NASP;HJURP;HELLS;KNL1;MIS18BP1;CENPU;CENPX;CENPI;NPM1;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.33640364151040164,0.9054344388011046,0.5833333333333334,0.9596739459978332,1.0,13/39,19.88%,RBX1;POLK;ERCC5;RPA3;POLD2;FAN1;DDB1;PCNA;ERCC2;UBC;RPS27A;RFC1;ERCC4
prerank,regulation of superoxide anion generation (GO:0032928),-0.3406600759676038,-0.9049978201777902,0.5797872340425532,0.8792690941724052,1.0,5/14,26.22%,AATF;TGFB1;SOD1;TYROBP;ITGAM
prerank,regulation of protein acetylation (GO:1901983),0.4253121187853107,0.9048274532767806,0.5825396825396826,0.96044899667449,1.0,7/12,29.16%,RAPGEF3;GSK3B;PARK7;KAT5;DDX3X;TAOK1;TERF2IP
prerank,positive regulation of chemokine production (GO:0032722),-0.25456484465405643,-0.9048133363412536,0.6778242677824268,0.8785039545721974,1.0,12/44,17.95%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;MBP;TIRAP;HMGB1;TLR7;CD74;LPL
prerank,eye development (GO:0001654),0.3271342602096138,0.9047111083877746,0.5875,0.9601254620254003,1.0,6/54,7.30%,PBX3;PBX1;COL5A2;STRA6;EFEMP1;TGFB2
prerank,negative regulation of telomere maintenance (GO:0032205),0.40241144294317477,0.9043129655856263,0.5955414012738853,0.9603950660472272,1.0,9/15,29.16%,PINX1;TNKS2;NBN;RAD50;ERCC4;TERF2;PARP1;TERF1;TERF2IP
prerank,chromosome condensation (GO:0030261),0.3498636773888752,0.9041656479789084,0.5860709592641261,0.960148520890208,1.0,12/36,22.15%,ACIN1;TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;GPER1;RB1;PHF13;NCAPH;KMT5A;SMC4
prerank,regulation of DNA binding (GO:0051101),0.3468225905684985,0.9035819707388238,0.6132315521628499,0.9608686507325387,1.0,8/44,10.72%,SMO;MMP9;NGF;DOT1L;NFKBIA;JUN;SUMO3;HABP4
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.38439336728574586,0.9032969863429644,0.5800604229607251,0.9609067016583114,1.0,7/18,23.79%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2;CDC25A
prerank,positive regulation of neutrophil migration (GO:1902624),0.38741013406457736,0.9031531654196859,0.5762463343108505,0.9606496261432492,1.0,3/18,5.24%,MCU;RIPOR2;MOSPD2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.35214683946203773,-0.9031518402250569,0.5706521739130435,0.8810800631124743,1.0,7/13,25.98%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1;SPI1;CHEK1
prerank,regulation of cellular catabolic process (GO:0031329),0.3241212086443798,0.9030038637422491,0.6051032806804374,0.9604129895716843,1.0,19/62,20.05%,NUPR1;ABCD1;EP300;DAPK3;DAPK1;HSPB1;USP10;MAPK15;SMCR8;MTMR3;OSBPL7;WDR91;PIP4K2C;ABL1;KEAP1;HDAC6;FBXL2;PSAP;MAPT
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.284681373659378,0.9028162096580223,0.6785714285714286,0.9602612651630991,1.0,71/241,23.16%,GTF2F1;DDX5;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;HNRNPH2;RBM8A;WDR33;PHF5A;DBR1;MTREX;SF3B3;USP39;SRSF7;SF3A2;ZCCHC8;SYNCRIP;HNRNPUL1;GPATCH1;RBM10;FRG1;CSTF1;RNPS1;PNN;SRSF9;SRRT;UPF3B;PLRG1;GEMIN6;DHX9;ISY1;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;SRSF1;HNRNPA3;PPIL1;PTBP1;POLR2E;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;PUF60;PRPF8;YBX1;DDX23;GEMIN5;SFPQ;U2AF1;RBM15;SPEN;SRRM1;PABPC1
prerank,protein import into peroxisome membrane (GO:0045046),0.37954757720613513,0.9027668179426296,0.5700280112044818,0.9597974188276662,1.0,7/22,18.84%,PEX26;ABCD1;SLC25A17;PXMP4;RAB8B;PEX3;PEX2
prerank,mitochondrial genome maintenance (GO:0000002),-0.36644625233948047,-0.902739532042103,0.569620253164557,0.8807715090081328,1.0,4/11,20.50%,AKT3;SLC25A33;TOP3A;MPV17
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.36939416991258806,0.9023483801578314,0.5970802919708029,0.9600860391558083,1.0,11/24,21.50%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;SUCLA2;TSPO;FLVCR1;COX10
prerank,nuclear pore organization (GO:0006999),0.41325014501777185,0.9021609311384698,0.5732484076433121,0.9599465928829731,1.0,8/14,29.03%,NUP93;NDC1;TPR;SEH1L;NUP133;NUP35;TMEM170A;RTN4
prerank,determination of heart left/right asymmetry (GO:0061371),0.3373459542839654,0.9020429076321782,0.5672215108834827,0.9596343149938511,1.0,3/42,2.25%,TBR1;SMO;MICAL2
prerank,cortical cytoskeleton organization (GO:0030865),-0.2605195850599224,-0.9020288608587655,0.6341463414634146,0.881317028989332,1.0,8/41,7.77%,RHOBTB1;RND3;FHOD3;FMNL3;EPB41L3;NLGN1;ROCK1;RHOBTB3
prerank,erythrocyte development (GO:0048821),-0.382850619690057,-0.9018540863908951,0.5596816976127321,0.880528427043291,1.0,3/10,10.57%,ALAS1;SH2B3;NCKAP1L
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.38906912116447256,0.9017598660359476,0.5794947994056464,0.9596758656120694,1.0,4/19,10.37%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2788603204369775,0.901502753551802,0.896,0.9596737268231396,1.0,281/1668,16.01%,PRKCB;NFATC2;CDH13;ZBTB7C;KLF5;NR3C2;THRB;PRDM6;TMPRSS6;TBR1;TFAP2C;KLF4;PBX3;PPARGC1A;NCOA3;PBX1;ZIC4;KLF3;GAL;TFAP2D;DMRT2;OGT;ELF3;SREBF2;CDKN1A;RORC;SMAD6;FOXP2;GLI3;GTF2F1;DDX5;HOXA4;HIVEP1;TRIM33;ZC3H12A;GABPB1;GABPB2;FOXP4;KLF12;CAV1;ZNF436;MAVS;HDAC5;ZFHX4;EP300;TOX4;ZMYM5;ZNF692;MXD4;CD81;CC2D1B;FOXO3;KANK2;CSRP3;FOS;RELB;NOP2;CGGBP1;PCGF6;MGA;FOXC2;GDNF;SP5;GLIS2;ZNF219;BMP5;KLF16;PPP1R13L;HDAC4;NFE2L2;ZBTB8A;NR6A1;ANXA4;EPO;ZBTB16;SSBP3;WWP2;MTDH;CIAO1;DOT1L;SMARCB1;NFE2L1;RHOQ;NACC1;POU2F3;FOXD2;NFKBIA;PRRX2;BEND3;ESRRB;CDK4;RARG;PHF21A;RFX7;IRF3;SLTM;NKX2-8;PATZ1;JUND;LCOR;OVOL2;ZBTB46;CREB1;MOV10;RNASEL;ZIK1;FOXM1;PCGF3;ZBTB17;RXRB;HOXA5;OTUD7B;HCFC1;HAX1;ZIC2;SOX9;NRF1;FOXD1;ZBTB7B;AKNA;DDRGK1;KAT6B;MYDGF;CC2D1A;PHF10;MAPK7;BMP4;MEF2D;KLF7;STAT4;NKAP;ZNF418;MED30;PLK3;ZFHX3;ZNF471;DVL3;FIZ1;CIC;PPM1A;ATRX;SIX1;LARP7;TCF7L2;MAZ;PKD1;POU3F1;FZD5;JUN;ELP4;POU5F2;CRY2;TNFRSF1A;KMT2A;ZFP57;GRHL2;FOXP3;BRD7;ZIC1;DPF2;NR2C1;TXK;DNMT3A;RIF1;ABCA2;HDGFL3;APBB1;CCND1;PRDM15;EZR;MED29;HDAC3;NFE2L3;ZNF467;ENY2;TWIST1;SAP130;BCAS3;ZNF205;ARID4A;KDM3A;NFIB;NFYC;NFIC;SOD2;SMARCA4;MAMLD1;CREB3L4;CREB3;KDM4C;SP2;MMP12;AEBP2;NCOR1;MIER2;MYT1;ARID3B;TLR4;CALCOCO1;SRCAP;SBNO2;MAFG;HOXB5;DR1;MEF2B;MPND;BAZ2B;ACTL6B;MAFK;ZNF148;SP1;ZBTB42;MED8;MYSM1;DCAF6;CCNL2;COPS5;FOXK1;PPM1D;PIAS1;MED12;ZSCAN20;TFEB;SMARCD2;PIAS3;MYBL1;CPEB3;CHD3;GATA3;ZFP30;MED21;MED24;RREB1;ZNF177;NFIA;CAPRIN2;ARF4;CBX4;MYC;TLE5;TNIP1;ZFP1;NCOR2;MEF2C;PCGF2;ZFP92;CHUK;FOXP1;PAX3;SARS1;ATP2B4;ZXDC;ITGB1BP1;IRF2;GATAD2B;FLCN;ATMIN;HRAS;SS18L2;MDM2;TLR3;RFXAP;ZFP3;DHX9;KLF6;CREB3L2;TET1;ELP2;IGBP1;RCOR2;MED6;SMARCC1;ZGPAT;ZMIZ2;IKBKG;E2F1;HMBOX1;SLC9A1;CDC5L;TCF25;IFRD1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.4275505469968868,0.9012411102621939,0.5945485519591142,0.959656855894203,1.0,1/11,1.74%,EFNB2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.43617954842020534,0.900901467922113,0.6062602965403624,0.9592305161725264,1.0,3/11,10.84%,PTK2B;SHC1;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.43617954842020534,0.900901467922113,0.6062602965403624,0.9592305161725264,1.0,3/11,10.84%,PTK2B;SHC1;JAK1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3228924908397372,0.9003152884061659,0.597799511002445,0.9599993769482599,1.0,22/62,25.45%,GTF2F1;MLLT3;POLR2H;ELOB;POLR2A;SSRP1;ELP4;ELL;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CDK9;CTR9;LEO1;POLR2K;MNAT1;CDK13
prerank,visual system development (GO:0150063),0.33976556295285953,0.900303518491174,0.5896103896103896,0.959466090999827,1.0,2/37,1.29%,PBX3;PBX1
prerank,positive regulation of cell cycle process (GO:0090068),-0.2215167204841494,-0.9002362912247167,0.7226890756302521,0.8832130707942191,1.0,12/91,10.90%,IGF1;SVIL;PDGFRB;TGFA;INSR;CDC14A;RGCC;CIT;IGF2;LRP5;PLSCR1;GPSM2
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4293570326752931,0.8999377202948187,0.5719237435008665,0.9596962061136018,1.0,3/10,13.49%,CACNB3;NIPSNAP2;CACNB2
prerank,positive regulation of axon extension (GO:0045773),0.37916663132247064,0.8999016407716477,0.5895196506550219,0.9591989638773772,1.0,6/22,20.05%,ISLR2;ZFYVE27;MAP3K13;SHTN1;DBN1;MAPT
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.28479796347984915,0.899900049054746,0.6896907216494845,0.9586389139932975,1.0,48/248,14.48%,SCEL;IGFBP6;KANK1;PTK7;GLI3;AMER3;MLLT3;WNT11;TMEM198;CAV1;RNF220;DAPK3;PPM1B;PTPRU;PSMD11;AMER2;RBMS3;SOX9;PSMD4;WLS;PSMF1;GPC3;ILK;LATS1;DVL3;LGR4;PPM1A;TCF7L2;RBX1;RNF146;ADGRA2;UBE2B;PRDM15;PSMD7;TLE2;TRPM4;TLE4;GNAQ;CSNK1E;PSMB5;SFRP1;CAPRIN2;GSK3A;UBR5;LMBR1L;TLE5;GSK3B;WNK1
prerank,embryonic skeletal system development (GO:0048706),0.3521680674101699,0.8998553807289047,0.5915875169606513,0.9581663412722905,1.0,3/35,2.63%,KIAA1217;HOXA4;WNT11
prerank,positive regulation of organelle organization (GO:0010638),0.3540166005548341,0.8989783798560517,0.5868983957219251,0.9593734107728611,1.0,4/32,14.12%,PPARGC1A;ANXA2;SMCR8;GSK3B
prerank,regulation of glycogen metabolic process (GO:0070873),0.42313833500098275,0.8989254052695917,0.5879478827361564,0.9589279143671966,1.0,5/12,28.26%,RUBCNL;PPP1R3F;PPP1R3C;PPP1R3B;AKT1
prerank,positive regulation of chemotaxis (GO:0050921),0.3389987483176391,0.8987396189452262,0.5754119138149556,0.958772219854513,1.0,3/43,4.69%,CDH13;NTRK3;HSPB1
prerank,negative regulation of growth (GO:0045926),0.29744356669740085,0.8985010524474565,0.6553610503282276,0.9586986418130689,1.0,24/121,15.69%,NOTCH2;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;PSRC1;MUL1;OSGIN2;TGFB2;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;SFRP1;CAPRIN2;ING4;PRDM11;FLCN;IP6K2;FRZB
prerank,axon extension (GO:0048675),0.36681389120931485,0.8981555223561116,0.5907230559345157,0.9588649591675664,1.0,1/23,0.20%,ALCAM
prerank,long-term synaptic potentiation (GO:0060291),-0.30583002278104054,-0.8976437715692006,0.5874125874125874,0.8882067199622149,1.0,5/21,8.76%,SLC8A3;GRIN2A;GRIN2B;SLC24A2;NFATC4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2917915224562864,0.8975895644818683,0.6479481641468683,0.9595045741368718,1.0,40/148,22.57%,PRKAA2;DAXX;EP300;NOP2;PPP1R13L;PPP1R13B;MRE11;SSRP1;PLK3;BANP;PML;BRD7;RMI1;MAPKAP1;TOPBP1;TAF5;CHD3;CDK2;RPA3;MDM2;PAK1IP1;MEAF6;ATR;POU4F1;PRKAG1;HEXIM1;NBN;CCNG1;CHEK2;RAD50;CDK5RAP3;TAF9B;TBP;PRKAB1;PRKAB2;USP2;TAF6;CDK5R1;KMT5A;PIP4P1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3251029371328559,0.8973425537919127,0.6109660574412533,0.9594628288092281,1.0,2/44,1.08%,ANK2;ACTN2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3896377540413138,0.8972395279688997,0.573394495412844,0.9591210205067917,1.0,3/16,12.36%,CAV1;PPP2CA;PTPN2
prerank,zinc ion transmembrane transport (GO:0071577),-0.29635080609879516,-0.8971721553260517,0.6037735849056604,0.8880761675912257,1.0,5/22,12.55%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,positive regulation of sodium ion transport (GO:0010765),0.4193600842414291,0.8971367819391345,0.5810593900481541,0.9587755267751706,1.0,2/12,6.93%,AHCYL1;ANK3
prerank,arachidonic acid metabolic process (GO:0019369),-0.2654739188513857,-0.8969535820723121,0.658008658008658,0.8873760178779158,1.0,6/35,6.54%,PLA2G4A;PTGIS;CYP1B1;MGLL;PTGS2;PNPLA8
prerank,microtubule anchoring (GO:0034453),0.4126358805287639,0.896875231006212,0.5726210350584308,0.9587646062073135,1.0,2/12,7.69%,DAG1;GCC2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3306389458401547,0.8967505100221436,0.6118836915297092,0.9584552776003672,1.0,6/48,8.10%,ANK2;DIAPH1;PTK2B;SELENON;GSTO1;JPH2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.34003517394961374,0.8967247979244152,0.5632333767926988,0.9579529153329446,1.0,8/42,17.39%,GALP;LBP;ROMO1;RNASE3;AQP1;TLR4;MR1;RNASE7
prerank,lipoprotein biosynthetic process (GO:0042158),-0.37068792530536654,-0.8963630476774189,0.5861182519280206,0.8875720062016398,1.0,3/11,17.85%,PIK3C3;UGCG;ATG10
prerank,protein localization to phagophore assembly site (GO:0034497),0.4313602410394828,0.8962555295716063,0.5763239875389408,0.958383198780936,1.0,11/11,56.89%,PACS2;WIPI2;TRAPPC8;WIPI1;WDR45;ATG13;STX17;WDR45B;MFN2;ATG9A;ATG9B
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.2608737039318488,-0.8962151629563673,0.6383928571428571,0.8866772310341562,1.0,14/38,19.18%,SP100;NOS3;FAS;THBS1;TNFSF10;RFFL;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD
prerank,cellular response to interferon-gamma (GO:0071346),0.3050408151747739,0.8960473397647778,0.6381278538812786,0.958272456580363,1.0,16/88,15.61%,CD44;CCL5;EPRS1;DAPK3;DAPK1;TRIM25;IRF3;TRIM21;PML;TRIM26;JAK1;TLR4;SYNCRIP;GAPDH;IRF2;OAS2
prerank,regulation of small molecule metabolic process (GO:0062012),0.365477719808691,0.8959152514433811,0.6062322946175638,0.9579885574799759,1.0,6/28,13.94%,RORC;TTC39B;ACADL;PDK2;FOXK1;NCOR2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.40405490264812804,0.895633056914921,0.584251968503937,0.9580304370344597,1.0,1/14,1.39%,ETNK2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3545429079667219,0.8955420251226426,0.5964187327823691,0.9576662747948645,1.0,7/29,16.39%,KANK2;DDRGK1;LATS1;GPAM;VPS11;VPS18;UFM1
prerank,intracellular cholesterol transport (GO:0032367),0.404066082104053,0.8951980811377137,0.5798192771084337,0.9578447063072427,1.0,6/15,18.54%,LDLR;NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,organelle fission (GO:0048285),0.37112634624259366,0.8951587122049122,0.6041958041958042,0.957371427417382,1.0,9/24,21.21%,ACOT8;MUL1;PEX11G;MTFR1L;OPA1;DNM1L;MTFR2;TMCC1;MIEF1
prerank,neuromuscular junction development (GO:0007528),0.37571991983870223,0.8951441456841714,0.5858585858585859,0.9568389776091439,1.0,8/24,17.54%,UNC13C;CACNB3;ANK3;MUSK;CACNB2;NEDD4;PDZRN3;F2R
prerank,detection of mechanical stimulus (GO:0050982),-0.30462806964731465,-0.8951015949880718,0.6085626911314985,0.8879856305779216,1.0,3/19,5.04%,CDH2;PTK2;PKD2
prerank,microtubule anchoring at centrosome (GO:0034454),-0.378691910924587,-0.8950340173229182,0.6108374384236454,0.8869452126393282,1.0,4/10,21.61%,NIN;BBS4;CCDC68;CEP19
prerank,presynapse assembly (GO:0099054),-0.33428265225831005,-0.8947112770255206,0.615606936416185,0.8865078046157544,1.0,6/16,15.61%,IL1RAPL1;WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,negative regulation of protein depolymerization (GO:1901880),0.3663700710472802,0.894704710516206,0.5855072463768116,0.9572609568505185,1.0,1/24,0.23%,FGF13
prerank,organelle assembly (GO:0070925),0.28059360084383794,0.8946554388134218,0.7447447447447447,0.9568120049136719,1.0,80/384,19.41%,RAB17;PGM5;MAPRE2;CYS1;ABLIM1;PARVA;TMOD3;GSN;YTHDF1;NEK7;TMOD2;EHD1;CNGA2;INPP5E;ARL3;VPS37B;LMOD3;CCDC28B;RAB11FIP3;AVIL;NSFL1C;PRRC2C;EXOC7;IFT46;CFAP54;EXOC4;CHMP4A;CHMP4B;LSM4;CENPT;RAB7A;PKD1;CC2D2A;IFT80;HDAC3;EXOC2;EMC6;NCOR1;VPS4B;CPLANE2;CNGB1;CHMP1A;EXOC8;VPS4A;ARF4;OCRL;MKKS;ULK1;RAB1B;ATP6V1D;MAP1LC3B;SQLE;RB1CC1;CHMP2A;FLNA;ATP6V0D1;TMEM138;DYNC1H1;TMEM41B;ATXN2L;RAB8B;ATG16L2;PTPDC1;CDS1;PDCD6IP;PATL1;HDAC6;ZFYVE1;STAM;WDR35;RILPL1;TSG101;YTHDF3;GALNT11;FHDC1;UBAP2L;VPS37A;TUBGCP5;GORASP2;ABCB6
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.32407185119655496,0.8946401527216581,0.6127023661270237,0.9562889078949277,1.0,11/52,17.92%,SORBS1;STAC3;PTPN9;LGALS3;AKAP5;CNPY4;EPHA3;ATP2B4;NUMA1;EPB41L2;STX4
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.27942003012802025,0.8945336916558659,0.7893681043129388,0.9559474764148357,1.0,87/497,14.29%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;CDKN1A;NIBAN2;SAMD4A;FOXP2;GLI3;TRIM33;WNT11;HDAC5;SAMD4B;EPRS1;QARS1;RBFOX2;DAPK3;PCGF6;GLIS2;ZNF219;HDAC4;DAPK1;ZBTB16;WWP2;NACC1;S100A11;CRYAB;PATZ1;FOXM1;ZIC2;SOX9;FOXD1;KAT6B;SHC1;KDM5C;PHF10;EIF4A3;COMMD7;BMP4;NKAP;CIC;L3MBTL3;MAGEL2;TCF7L2;JUN;CRY2;PML;FOXP3;BRD7;SHMT1;SCML2;DPF2;YWHAQ;HDAC3;TWIST1;ARID4A;BCL7A;SMARCA4;TLE2;NCOR1;EIF2AK3;SBNO2;SYNCRIP;SFMBT2;ZNF148;TSC22D4;FOXK1;SFRP1;CPEB3;GATA3;CHMP1A;FXR1;CBX4;BEND5;GSK3A;TLE5;ING4;BTG2;PRDM11;NCOR2;GSK3B;FOXP1;SET;GAPDH
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33422801339676417,0.8943169378882077,0.5895806861499364,0.9558509894808594,1.0,3/43,2.25%,TBR1;SMO;MICAL2
prerank,regulation of viral entry into host cell (GO:0046596),0.35502218026242627,0.8942446774926407,0.6191780821917808,0.9554576267419916,1.0,6/30,13.37%,GSN;TRIM25;TRIM21;TRIM11;TRIM26;LGALS1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3642812632260215,-0.8941005243560108,0.5873417721518988,0.8868235138117282,1.0,4/11,15.04%,DAB2;RDX;MTMR2;SORL1
prerank,regulation of lipase activity (GO:0060191),-0.353467803040599,-0.8938710096079968,0.5630252100840336,0.886137155126501,1.0,1/13,0.55%,PCSK5
prerank,carbohydrate homeostasis (GO:0033500),0.31901443987079325,0.8936631861398274,0.6404230317273796,0.956126094907716,1.0,11/67,12.36%,PRKAA2;MCU;ALOX5;HECTD4;KLF7;BAD;TCF7L2;CRY2;KCNB1;PDK2;PTPN2
prerank,negative regulation of intracellular protein transport (GO:0090317),0.37222307780006414,0.8936263568226631,0.5929078014184397,0.9556516525515606,1.0,11/22,25.00%,INSIG1;DMTN;CHP1;SIAH3;ITGB1BP1;UFM1;SUFU;PARK7;RAB23;APOD;RANGAP1
prerank,heme catabolic process (GO:0042167),-0.3354338277624491,-0.893607829401862,0.5983379501385041,0.8843684391007289,1.0,6/14,35.79%,SLCO2B1;ABCG2;SLCO1B1;HMOX1;ABCC1;BLVRB
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3354338277624491,-0.893607829401862,0.5983379501385041,0.8843684391007289,1.0,6/14,35.79%,SLCO2B1;ABCG2;SLCO1B1;HMOX1;ABCC1;BLVRB
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.30709647730973333,0.8933228889460653,0.6229143492769744,0.9557245603975513,1.0,22/93,19.55%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;DMTN;HAX1;LATS1;NLRP2B;RAF1;RAPGEF3;CAPRIN2;EIF4G1;ATP2B4;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,protein polyubiquitination (GO:0000209),0.28068350271844766,0.8933066521778329,0.7119675456389453,0.9552116978024596,1.0,76/297,23.82%,FZR1;RNF152;FBXL7;FBXW8;FBXL20;LONRF1;WWP2;RNF5;PSMD11;MUL1;PSMD4;PSMF1;TRIM21;MAGEL2;FBXL18;FBXO31;UBE2G2;RBX1;RNF146;UBE2B;PSMD7;UBE2Q1;FBXW9;RNF126;MIB2;PSMB5;NPEPPS;ANAPC4;PELI1;UBR5;DDA1;UBE4A;NEDD4;MDM2;UBE2H;BFAR;RNF31;TNKS2;TPP2;UBE2N;PRPF19;FBXL15;UBE2J1;UBC;RPS27A;STUB1;UBE2D3;SIAH1;PSMD1;PSMC4;RNF41;FBXO9;PSMD8;UBE3C;THOP1;RMND5A;CHFR;ZFP91;UBE2E1;SMURF2;FBXW7;ARIH2;TRAF3IP2;TRIM5;RNF168;FBXW2;RNF213;BLMH;UBE2V1;RNF14;CDC23;TRIM3;HECTD2;FBXO4;PSMA7;UBE3D
prerank,genitalia development (GO:0048806),-0.3509710906954077,-0.893204462848818,0.5721518987341773,0.8841312088277588,1.0,4/12,8.41%,WNT5A;TBX3;DNAJC19;CHD7
prerank,positive regulation of macroautophagy (GO:0016239),0.3299206097250005,0.892869277355491,0.6102756892230576,0.9555762972851388,1.0,13/48,17.04%,PRKAA2;SESN2;TSC2;HSPB8;BAG3;SMCR8;PIP4K2C;VDAC1;BNIP3L;VPS13D;IKBKG;SESN1;SLC25A4
prerank,ATP transport (GO:0015867),-0.37008391570946253,-0.8923493616518076,0.5862944162436549,0.8848633653847185,1.0,1/10,0.98%,CD47
prerank,lymphocyte proliferation (GO:0046651),-0.30067203438500395,-0.891470581350189,0.5988538681948424,0.8857151541791188,1.0,8/22,21.06%,ELF4;BCL2;PPP3CB;CTPS1;HELLS;CD40;HSPD1;FLT3
prerank,innate immune response (GO:0045087),0.2861514886573195,0.8914213310925231,0.7073422957600828,0.9580576871367881,1.0,41/217,19.63%,TRIM60;PPP1R14B;SERINC5;SLPI;MAVS;PGLYRP3;PTK2B;RELB;TRIM59;TRIM25;NUB1;CFP;TRIM21;ANG;STYK1;LBP;PYDC1;PML;TRIM11;TRIM26;RNASE3;SRPK2;CR2;ADAM15;ANKRD17;TLR4;FCER1G;SRPK1;IRAK1;CHUK;TLR3;VNN1;IKBKG;COLEC12;RNASE7;YES1;OTULIN;IRAK4;APP;ANKHD1;JCHAIN
prerank,regulation of p38MAPK cascade (GO:1900744),0.34375516958209146,0.8911998193757793,0.587696335078534,0.9579535236834589,1.0,8/35,12.09%,ZC3H12A;DUSP10;DUSP1;MAP3K4;RELL1;EMC10;EZR;GADD45B
prerank,C4-dicarboxylate transport (GO:0015740),-0.33746732777384136,-0.8909960268984282,0.6187845303867403,0.885606607402678,1.0,2/14,5.43%,SLC1A2;SLC1A1
prerank,protein autoubiquitination (GO:0051865),0.31450297794277654,0.8909949349189628,0.6157517899761337,0.9578178477178383,1.0,16/61,19.29%,RNF220;SH3RF2;WWP2;TRIM21;RNF146;UBE2B;KLHL24;RNF141;MDM2;BFAR;RNF10;STUB1;UBE2D3;TRIM37;RNF112;RNF41
prerank,negative regulation of RNA splicing (GO:0033119),-0.31145516080216257,-0.8906313028751727,0.599388379204893,0.8851776373480961,1.0,6/19,19.14%,SRSF4;SAP18;SRSF10;TMBIM6;SRSF12;PTBP2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.333108713327432,0.8900825390107714,0.6237373737373737,0.9591750951295702,1.0,9/47,14.33%,ZC3H12A;CAV1;EP300;ERLIN2;ACADL;ERLIN1;ABCA2;ATP2B4;PGP
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.30504679782042476,0.8899450552449604,0.6351039260969977,0.9589147863739791,1.0,19/88,18.81%,SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;EIF4A3;SHMT1;EIF2AK3;SYNCRIP;CPEB3;FXR1;BTG2;GAPDH;IGF2BP1;IGF2BP2;HDAC6;CAMK2N1;IGF2BP3;CDK5RAP3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3859661424215373,0.8898416820289692,0.5915080527086384,0.9585721001180134,1.0,3/20,10.78%,CCL5;YWHAB;GRK2
prerank,protein heterotetramerization (GO:0051290),-0.34760335002327064,-0.8894546347035286,0.6037234042553191,0.8866325001017004,1.0,5/13,18.13%,PKD2;GRIN2B;NUDT21;CPSF6;CBR4
prerank,potassium ion homeostasis (GO:0055075),0.3694478307787972,0.8892177066670147,0.6138328530259366,0.9593234970356705,1.0,8/23,21.40%,SLC12A8;ATP1A2;SLC12A4;SLC12A6;ATP1B3;ATP1A1;ATP1A3;ATP1A4
prerank,positive regulation of histone methylation (GO:0031062),0.3659539209958694,0.8891635423569831,0.6039603960396039,0.9588960938755171,1.0,4/24,9.45%,OGT;PHF1;KMT2A;RIF1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3070804587001963,0.8891078012756071,0.6346153846153846,0.9584640227374867,1.0,12/85,8.39%,ANGPT1;HPN;NUPR1;CDK6;BMP5;DUSP10;SOX9;BMP4;TGFB2;BAD;LAMC1;TCF7L2
prerank,protein acetylation (GO:0006473),0.35811659663085005,0.8886880986049248,0.5858156028368794,0.9587547818740524,1.0,9/30,21.81%,EP300;NAA40;AANAT;NAA15;ING4;NAA10;MAPT;NAA35;HAT1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3719242477309865,0.8885647022560673,0.5781710914454278,0.958467556594797,1.0,4/20,10.93%,EP300;SESN2;NFE2L2;CREB3
prerank,magnesium ion transport (GO:0015693),0.42105251219315465,0.8883062254085008,0.6105769230769231,0.9584793334762794,1.0,5/12,22.51%,NIPAL3;SLC41A1;NIPA2;CNNM4;MMGT1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3426255450999455,0.8879340266377558,0.6140350877192983,0.9587324147359929,1.0,7/33,16.96%,LSM10;SNRPB;MAZ;WDR33;CSTF1;PABPN1;CLP1
prerank,response to tumor necrosis factor (GO:0034612),0.3001231104775884,0.8878237590879209,0.6309794988610479,0.9584342648795432,1.0,16/91,15.58%,CCL5;ADAMTS7;ADAM10;ZC3H12A;AFF3;YBX3;NFE2L2;NUB1;GSDME;NPNT;SFRP1;GATA3;ZFAND6;CHUK;DHX9;IGBP1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.2691017278117683,-0.8872321558417787,0.6356275303643725,0.8903305127089368,1.0,9/33,9.55%,ACVRL1;NOTCH1;THBS1;FGF2;CARD10;RGCC;TGFB1;MECP2;PPARG
prerank,metanephros development (GO:0001656),0.36321237635437675,0.8871597350561491,0.6056338028169014,0.9592794058756136,1.0,5/26,8.43%,GDNF;FOXD1;BMP4;SIX1;PKD1
prerank,cellular response to unfolded protein (GO:0034620),0.35454886767538707,0.8871176832675028,0.6030640668523677,0.9588225842901373,1.0,4/26,9.06%,DAXX;HSPB8;HSPA14;BAG3
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.40767513965455776,0.8870035210911124,0.5911251980982567,0.9585054955035708,1.0,2/13,10.26%,SCAMP5;KCNB1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2789471704794596,0.8866968876466802,0.7794561933534743,0.958572520894627,1.0,70/390,15.33%,SORBS1;FGFR1;ANGPT1;CYFIP2;NTRK3;ATP6V1B1;MMP9;NGEF;EPHA4;PDGFC;EFNB2;HPN;FLRT1;GTF2F1;SIPA1L1;GDF15;GAB1;SHB;NGF;RBFOX2;PTK2B;FOXC2;AP2A2;POLR2H;RHOQ;TSC2;ROS1;CAV2;EFNA5;POLR2A;AP3S1;SHC1;PXN;ZFYVE27;ERBB3;STYK1;FGF22;CDC42;VEGFB;LMTK2;ACTB;ABI1;MUSK;NRP2;ACTG1;MVP;PDK2;EPHA3;RHOA;IRS2;SOCS2;AP2A1;EIF2AK3;BCAR1;PTPN2;DDR1;DOCK1;RASA1;EFNA4;GSK3A;SHC2;FLRT3;GSK3B;ATP6V1D;NUS1;HRAS;ATP6V1E1;AAMP;RAPGEF1;HSP90AA1
prerank,UV-damage excision repair (GO:0070914),-0.3552965674113514,-0.8865804595547541,0.617948717948718,0.8906512189290644,1.0,6/12,34.63%,CUL4B;ACTR5;ERCC1;POLA1;DDB2;POLD3
prerank,response to ketone (GO:1901654),-0.287606528712028,-0.8860285962628616,0.5728476821192053,0.8907391894825312,1.0,10/24,23.26%,THBS1;NR1H3;SLIT2;TGFB1;UBE3A;SLIT3;CATSPER3;ABHD2;CCL19;YAP1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3003774659275148,-0.8859276410440428,0.597972972972973,0.8897601034118269,1.0,4/20,11.13%,SHANK3;NLGN1;LRP8;DLG5
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.296584154805657,0.8858743523562606,0.6681175190424374,0.9597507475581238,1.0,28/119,18.81%,PITPNM2;TTC7A;PIGU;PITPNM3;MTMR12;PIK3C2B;INPP5E;INPP4A;IP6K1;PI4KA;MTMR3;PIGZ;PGAP2;MBOAT7;SOCS2;PIGA;DPM2;EFR3A;PIP4K2C;OCRL;SOCS6;PIGN;IP6K2;PTPN13;PI4K2A;CDS1;PIGP;CDIPT
prerank,monosaccharide transmembrane transport (GO:0015749),0.3930752400352281,0.8857922589211632,0.5718954248366013,0.9593772853928401,1.0,3/16,12.91%,SLC2A12;SLC2A8;SLC2A9
prerank,hexose biosynthetic process (GO:0019319),0.33328420604231745,0.8857026802908355,0.6209068010075567,0.9590144950838816,1.0,10/42,18.39%,PPARGC1A;SLC25A1;ENO2;MDH2;GAPDH;ALDOA;SLC25A12;TPI1;CHST15;PCK2
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.22925300972130552,-0.8855732604839015,0.6962962962962963,0.8893477417906488,1.0,22/73,25.43%,KITLG;TCF12;LMO2;RUNX1;PSMC6;PUS7;PSMA6;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMB9;PSMA4;PSMB7;PSMA8;YAP1;YTHDF2;PSMA3;PSMD10;SPI1
prerank,negative regulation of immune response (GO:0050777),-0.19724039740196603,-0.885454908017812,0.8548387096774194,0.8884305201587173,1.0,69/154,34.16%,ADCY5;CALCRL;LYN;GGT5;ADCY7;IRAK3;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;RAMP2;PRKAR2B;GPR45;MAPKBP1;CYSLTR1;PTHLH;CD300A;GNB1;SIRT2;CYSLTR2;RC3H1;ADM;PTGDR;ADCY2;PRKAR1B;PTGER4;GLP2R;RXFP1;MC5R;MAPK14;TNFAIP3;VIPR2;ADCY3;ADCY8;LYAR;GPR27;ADCYAP1R1;HCK;NPSR1;CALCA;SPI1;IAPP;GNG2;FER;HRH2;TSHR;FGR;CD247;ADRB1;PLCG2;FCGR2B;CCR2;TRIM27;LHCGR;PLCG1;SAMSN1;PTH2R;DHX58;GPR20;RNF26;CD163;HTR6;GIPR;TYRO3;TREM2;CRHR1;LILRB1;GLP1R
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2870352178992159,0.8853529749913744,0.6909282700421941,0.9592124967016082,1.0,48/168,24.19%,CNOT6;SAMD4A;DDX5;ZC3H12A;SAMD4B;PPP2CA;RPS4X;EIF4A3;SMG7;UPF3A;RPSA;XRN2;RBM8A;RPL31;RPL22;GSPT2;RPL28;RPS26;TUT7;RNPS1;RPL10A;DCP1A;EIF4G1;UPF3B;PYM1;RPL14;MAGOHB;MAGOH;CTIF;RPS27A;PATL1;PELO;RPL6;DXO;NBDY;RPS28;ETF1;SMG9;RPL41;RPLP2;TUT1;RPLP1;RPL7;PABPC1;DCPS;PAN3;RPL21;RPL26
prerank,purine-containing compound biosynthetic process (GO:0072522),0.366719726285777,0.8850217112051806,0.6019283746556474,0.9593482967743415,1.0,10/25,23.00%,ADK;PAICS;GMPS;SHMT1;GART;AMPD2;DGUOK;PRPS1L1;PRPS1;APRT
prerank,endoderm development (GO:0007492),0.4098273880392614,0.8846310582068198,0.6006051437216339,0.9596589680302895,1.0,2/13,8.12%,DUSP1;LAMC1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.34394027497824253,0.8845703596970466,0.6110363391655451,0.9592269856943513,1.0,4/35,4.94%,CCL5;PIGU;CAV1;DOT1L
prerank,synaptic vesicle exocytosis (GO:0016079),0.3379265481643955,0.8844326249913658,0.6116015132408575,0.9589845115173896,1.0,5/40,9.13%,UNC13C;OTOF;BLOC1S6;DNAJC5;PCLO
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3260529426690377,-0.8841559931564896,0.6056338028169014,0.8901861510797225,1.0,6/14,21.94%,IFNGR1;IFNGR2;JAK2;CDC37;HSP90AB1;SOCS3
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.27481378522850797,0.8840709607144751,0.892,0.9591887755416038,1.0,196/1082,16.93%,CDH1;NFATC2;CDH13;KLF5;THRB;TMPRSS6;WNT1;TFAP2C;KLF4;PPARGC1A;NCOA3;PBX1;GAL;OGT;MAP3K5;ELF3;LBH;SREBF2;RORC;NIBAN2;GLI3;GTF2F1;MLLT3;HIVEP1;ZC3H12A;GABPB1;GABPB2;CAND2;WNT11;MAVS;HDAC5;EP300;CD81;FOXO3;CSRP3;FOS;FOXC2;GDNF;GLIS2;BMP5;CREBL2;HDAC4;NFE2L2;EPO;ZBTB16;SSBP3;DOT1L;SMARCB1;TRIM44;RHOQ;POU2F3;FOXD2;NFKBIA;ESRRB;RARG;IRF3;BICRA;ASF1A;NKX2-8;JUND;CREB1;PSRC1;RNASEL;FOXM1;ZBTB17;RXRB;HOXA5;HCFC1;HAX1;ZIC2;SOX9;NRF1;AKNA;DDRGK1;KAT6B;SHC1;MYDGF;PHF10;MAPK7;BMP4;MEF2D;KLF7;TGFB1I1;ILK;MED30;ZFHX3;DVL3;FIZ1;DYRK1B;PPM1A;ATRX;SIX1;TCF7L2;MAZ;PKD1;POU3F1;FZD5;JUN;UBTF;DDX39B;TNFRSF1A;PML;KMT2A;GRHL2;FOXP3;BRD7;ZIC1;DPF2;MAP2K2;TXK;PHF5A;APBB1;ILF2;PRDM15;HDAC3;ENY2;TWIST1;BCAS3;KDM3A;NFIB;NFIC;SMARCA4;WDR43;CREB3L4;CREB3;MMP12;TLR4;CALCOCO1;EIF2AK3;SBNO2;DR1;NAA15;MEF2B;MPND;SP1;MYSM1;DCAF6;COPS5;ELL;FOXK1;MED12;SPIN1;TFEB;SFRP1;SMARCD2;HMGN1;MYBL1;GATA3;MED21;MED24;RREB1;NFIA;CAPRIN2;ARF4;SERTAD1;MYC;TNIP1;PRDM11;MEF2C;CHUK;PAX3;ZXDC;ITGB1BP1;IRF2;FLCN;ATMIN;HRAS;SS18L2;TASP1;ZPR1;TLR3;CDCA4;RFXAP;DHX9;KLF6;CREB3L2;TET1;MED6;SMARCC1;ZMIZ2;IKBKG;E2F1;SLC9A1;CDC5L;CAMTA2;SFR1;ABL1;HINFP;KDM1A;RNF10;HSF2;POU4F1;UBC;RPS27A;RGMB;SMAD5
prerank,regulation of dephosphorylation (GO:0035303),0.39466895412514086,0.8838343061924329,0.617363344051447,0.9591365349480835,1.0,5/15,18.81%,SMG7;PPP1R16A;MTMR3;IGBP1;CDK5RAP3
prerank,glucose transmembrane transport (GO:1904659),-0.30425222849325967,-0.8838041134160243,0.6325966850828729,0.8898614098881114,1.0,3/18,8.39%,SLC2A1;PPARD;SORT1
prerank,DNA duplex unwinding (GO:0032508),0.3192285908963191,0.8833438265529489,0.6225930680359435,0.9595575093259142,1.0,14/50,21.77%,RECQL4;MRE11;RBX1;DHX9;DDB1;MCM7;ERCC2;MCM6;UBC;RPS27A;NBN;RAD50;TWNK;MCM4
prerank,bile acid biosynthetic process (GO:0006699),0.3684467051365041,0.8825908458373853,0.6033519553072626,0.9606043699438527,1.0,4/24,11.27%,OSBPL9;ACOT8;CYP39A1;OSBPL7
prerank,DNA replication (GO:0006260),0.2950840042944824,0.8822378164540418,0.6492204899777283,0.960776122650628,1.0,25/105,19.38%,FEN1;GRWD1;RECQL4;MRE11;REV1;PTMS;PCLAF;POLG;RMI1;TOPBP1;CDK2;ING4;RPA3;SET;DONSON;POLD2;MCM8;ATR;MCM7;MCM6;NBN;NT5M;RAD50;RFC1;PNKP
prerank,cardiolipin metabolic process (GO:0032048),-0.3379286047194505,-0.882128944943703,0.6328767123287671,0.8924056291301999,1.0,2/13,6.54%,PLA2G4A;PNPLA8
prerank,regulation of endothelial cell proliferation (GO:0001936),0.30467691306653866,0.8821176370890177,0.6486175115207373,0.9604549640404387,1.0,16/88,10.56%,CDH13;ANGPT1;CAV1;ALOX5;CAV2;NRAS;MYDGF;AGGF1;BMP4;ANG;KRIT1;VEGFB;ATP5IF1;EMC10;NRP2;SYNJ2BP
prerank,Golgi to endosome transport (GO:0006895),0.3956798090805095,0.8821029233699693,0.5935085007727975,0.9599459004625608,1.0,4/16,11.81%,CORO7;VPS13A;MON2;AP2A1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3793095857936515,-0.8820479387357474,0.6491228070175439,0.8913962631214666,1.0,2/10,5.68%,LGALS9;IL18
prerank,protein alkylation (GO:0008213),0.36935805824521306,0.881911962280617,0.6191860465116279,0.9597849191230505,1.0,9/22,27.26%,EEF2KMT;SNRPB;PRMT1;ETF1;PRMT2;FAM98B;FAM98A;CAMKMT;EEF1AKMT2
prerank,regulation of mitotic spindle organization (GO:0060236),0.3369276628836856,0.8817505524541418,0.608,0.9595619993104854,1.0,14/35,25.32%,PSRC1;PARP3;CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;RAE1;NUMA1;PDCD6IP;CEP97;TPR;CHMP5;NUP62
prerank,cellular response to leucine starvation (GO:1990253),0.4255935451208676,0.8815913892025664,0.5960912052117264,0.9593365093220148,1.0,4/10,19.83%,SESN2;SESN1;EIF2AK4;GCN1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2256931380993087,-0.8813286035018173,0.7890625,0.8917860062417858,1.0,27/75,23.82%,PLCB1;PLCE1;RGS5;KCTD8;RGS3;NMT2;MGLL;TULP3;GIT2;ROCK1;CRY1;RIC8B;RGS12;CAMK2A;FNTB;EDN1;MRAP2;RGS4;SAG;RGS16;DGKQ;RPGRIP1L;METAP2;PDE6H;RGS20;PDE6A;GNG7
prerank,regulation of telomere maintenance (GO:0032204),0.35918649775339784,0.8812240325406853,0.6173913043478261,0.9595512671779964,1.0,11/26,25.20%,MRE11;ATRX;PML;MYC;NBN;RAD50;PPP1R10;ERCC4;TERF2;TINF2;HDAC8
prerank,regulation of interleukin-10 production (GO:0032653),-0.246102107804892,-0.8809172904770844,0.6928838951310862,0.8915880100591382,1.0,17/44,28.99%,CD47;CD34;LGALS9;TNFRSF21;CD46;STAT3;HMGB1;HSPD1;TYROBP;NOD2;JAK3;PYCARD;PIBF1;PLCG2;FCGR2B;ISG15;VSIR
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.373717396558359,-0.8807684787620329,0.6072289156626506,0.8907212735373793,1.0,3/10,13.04%,SP100;TP53;RPS6KA6
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.41834531841423395,0.8806371324121268,0.596989966555184,0.9602359714151281,1.0,4/10,22.34%,ATP1A2;VDAC1;SESTD1;CBARP
prerank,phagosome maturation (GO:0090382),0.33757570170649454,0.8805613867095988,0.6128608923884514,0.9598453897800455,1.0,12/35,27.31%,ATP6V1B1;RAB7A;ATP6V1D;ATP6V1E1;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6V0E1;RAB31;RAB32;ATP6V0E2;ATP6V0D2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2733169058462084,0.8805268356865765,0.89,0.9593730300585576,1.0,131/807,14.60%,THRB;PRDM6;FOXN3;DAXX;TMPRSS6;TBR1;TFAP2C;KLF4;ELF3;LBH;SREBF2;RORC;NIBAN2;FOXP2;GLI3;DDX5;HIVEP1;TRIM33;FOXP4;WNT11;KLF12;CAV1;ZNF436;HDAC5;EP300;ZMYM5;ZNF692;MXD4;QARS1;RBFOX2;FOXO3;KANK2;CGGBP1;PCGF6;FOXC2;GLIS2;ZNF219;HDAC4;NR6A1;EPO;ZBTB16;WWP2;MTDH;NACC1;CRYAB;BEND3;RARG;PHF21A;PATZ1;LCOR;CREB1;FOXM1;OTUD7B;HCFC1;ZIC2;SOX9;FOXD1;ZBTB7B;KAT6B;SHC1;KDM5C;PHF10;COMMD7;BMP4;KLF7;NKAP;PLK3;ZFHX3;CIC;L3MBTL3;PPM1A;MAGEL2;LARP7;TCF7L2;MAZ;JUN;CRY2;PML;ZFP57;FOXP3;BRD7;SCML2;DPF2;NR2C1;DNMT3A;RIF1;YWHAQ;APBB1;CCND1;EZR;HDAC3;TWIST1;SAP130;ZNF205;ARID4A;NFIC;BCL7A;SMARCA4;SP2;TLE2;NCOR1;MIER2;SBNO2;SFMBT2;DR1;MAFK;ZNF148;TSC22D4;FOXK1;SFRP1;CPEB3;CHD3;GATA3;RREB1;CHMP1A;ZNF177;CBX4;BEND5;MYC;TLE5;ING4;PRDM11;NCOR2;MEF2C;PCGF2;FOXP1;SET;SARS1;IRF2;GATAD2B;FLCN
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3359166647972418,-0.8805215226247248,0.6418732782369146,0.8900681666730795,1.0,6/14,24.53%,AUTS2;WDR5;PAXIP1;PRDM9;SMAD4;BRCA1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.27575072086502445,0.8800387118212145,0.8054162487462387,0.9597927136436799,1.0,77/476,14.35%,CDH1;NFATC2;WNT1;KLF4;PPARGC1A;MAP3K5;LBH;RORC;NIBAN2;GLI3;MLLT3;CAND2;WNT11;EP300;FOXO3;FOS;FOXC2;GLIS2;CREBL2;HDAC4;EPO;ZBTB16;TRIM44;ESRRB;BICRA;CREB1;PSRC1;FOXM1;RXRB;HCFC1;ZIC2;SOX9;KAT6B;SHC1;BMP4;TGFB1I1;ILK;MED30;ZFHX3;DVL3;DYRK1B;PPM1A;SIX1;MAZ;POU3F1;JUN;PML;KMT2A;FOXP3;BRD7;ZIC1;MAP2K2;PHF5A;APBB1;ILF2;ENY2;KDM3A;NFIB;SMARCA4;CALCOCO1;NAA15;SP1;FOXK1;MED12;SPIN1;TFEB;SFRP1;MYBL1;GATA3;MED24;RREB1;MYC;PRDM11;MEF2C;CHUK;PAX3;ZXDC
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4098780555798843,0.8797525663374328,0.6044303797468354,0.959856420983997,1.0,4/12,19.55%,CCL5;RHOA;JAM2;APP
prerank,protein secretion (GO:0009306),-0.23575224416107254,-0.8797265048552148,0.7135135135135136,0.8906422902293387,1.0,10/56,12.16%,ABCA1;PCSK5;STEAP3;MTTP;RCN3;SEL1L;PPY;TMEM167A;TANGO2;TVP23B
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3895172255214373,0.8796729795069995,0.6290076335877862,0.9594759271598885,1.0,2/17,2.96%,PBX1;EP300
prerank,regulation of cardiac conduction (GO:1903779),0.31920269136534907,0.8795602900299418,0.6327044025157232,0.9591627242249373,1.0,4/54,4.85%,ITPR2;ANK2;ATP1A2;AHCYL1
prerank,T cell migration (GO:0072678),-0.3407006604890384,-0.8794483409618786,0.625,0.8901069382761679,1.0,7/13,31.04%,SLC12A2;CXCL16;PIK3CD;GPR183;S1PR1;PIK3CG;CXCL10
prerank,embryonic organ development (GO:0048568),0.3143066995311213,0.8793084174530832,0.6203931203931204,0.9591452524697176,1.0,6/61,3.93%,PBX3;COBL;PBX1;GLI3;STRA6;GDNF
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.27505360645887095,0.8791811373784475,0.7608915906788247,0.9588836602136188,1.0,80/341,23.12%,FZR1;FBXL7;RNF43;ATE1;SPSB4;NFE2L2;WWP2;RNF5;TRIM25;VPS37B;PSMD11;NUB1;OTUD7B;PSMD4;PSMF1;NSFL1C;TGFB1I1;FEM1C;FEM1A;KLHL15;UBE2G2;RMND5B;RBX1;RNF146;PML;UBE2B;PCNP;PPP1R11;COP1;PSMD7;SIAH3;AGAP3;FEM1B;VPS4B;ZSWIM8;RNF126;WDR91;PSMB5;ANAPC4;PELI1;VPS4A;GSK3A;NPLOC4;UBE4A;NEDD4;MDM2;UBE2H;BFAR;MAEA;DDB1;UBA6;ARMC8;STUB1;UBE2D3;KEAP1;SIAH1;PSMD1;TSG101;PSMC4;VPS37A;PCBP2;PSMD8;RNF130;UBE3C;RMND5A;CHFR;UBE2E1;SMURF2;FBXW7;ARIH2;SPOPL;RNF168;RCHY1;RNF213;RNF150;RNF14;CDC23;UBQLN2;UBR4;TRIM3
prerank,positive regulation of transferase activity (GO:0051347),0.2859226099647001,0.8785531793682336,0.6884368308351178,0.9596286639571683,1.0,29/142,16.20%,FGFR1;NTRK3;KLF4;EPHA4;SERINC5;CD200;NEK7;LMO4;ROS1;MRE11;MAPK15;MAP3K4;ERBB3;ARRDC3;DCUN1D5;GRHL2;LMTK2;MUSK;DCUN1D1;EPHA3;DDR1;GSK3A;MYC;DSTYK;HSP90AA1;PABPN1;HMBOX1;PCNA;UBE2N
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3637885455740632,0.8785268264832298,0.6262341325811002,0.9591456523664862,1.0,4/24,7.78%,ANGPT1;NFE2L2;MAPK7;KRIT1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.358019778187474,0.8774688723822912,0.6057553956834533,0.9607424460808852,1.0,8/22,19.10%,VPS37B;VPS4B;RNF126;VPS4A;NEDD4;STAM;TSG101;VPS37A
prerank,ether lipid metabolic process (GO:0046485),0.403452763500863,0.8771748974612635,0.6185064935064936,0.9608098152431785,1.0,4/14,15.03%,DHRS7B;PAFAH1B1;TMEM86B;PLA2G6
prerank,leukotriene metabolic process (GO:0006691),0.3759359291471909,0.8769752125543142,0.6061046511627907,0.9606873809350938,1.0,5/19,17.33%,ABCC10;ALOX5;MGST3;LTA4H;MAPKAPK2
prerank,organophosphate ester transport (GO:0015748),0.35950195280011604,0.8769306053384858,0.6198224852071006,0.9602423351968689,1.0,3/24,6.46%,LDLR;PRELID3B;PITPNC1
prerank,positive regulation of cell killing (GO:0031343),-0.34330409839054715,-0.8767454927869415,0.6470588235294118,0.8947621540725642,1.0,1/13,2.91%,WNT5A
prerank,cardiac myofibril assembly (GO:0055003),0.39283147791809425,0.8766846621961858,0.5967016491754122,0.9602053300428914,1.0,2/15,3.70%,NEBL;CSRP3
prerank,negative regulation of peptidase activity (GO:0010466),0.32493545316909833,0.8766097431422197,0.6204663212435233,0.9598236295419558,1.0,10/47,18.32%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8;GAPDH;SERPINA2;SERPING1;PARK7
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.33596624716441803,-0.8763516620858168,0.6317280453257791,0.8944882310567923,1.0,6/15,25.44%,TNFRSF1B;ADAM9;PACSIN3;SNX9;SH3D19;ADAM8
prerank,regulation of hormone secretion (GO:0046883),-0.32791693002078914,-0.8758927410990694,0.6588541666666666,0.8943055714941932,1.0,12/15,51.94%,EDN1;SOX11;EDN3;NMB;IL11;LIF;VAMP3;FGF23;OSM;SNX6;FFAR2;SCG5
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3688688112524219,0.87563981805318,0.6002949852507374,0.9612594486482878,1.0,7/22,19.95%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3598077046691214,0.8755263810590862,0.6047197640117994,0.9609440003795698,1.0,3/22,4.72%,AHNAK;CACNB3;STAC3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.30143821205831517,0.8733873234913446,0.6682464454976303,0.9646985740446603,1.0,22/72,19.88%,EP300;POLR2H;POLR2A;RBX1;POLK;COPS5;HMGN1;ERCC5;RPA3;POLD2;ISY1;LIG3;DDB1;PCNA;PRPF19;ERCC2;UBC;RPS27A;POLR2C;RFC1;POLR2E;ERCC4
prerank,sphingolipid catabolic process (GO:0030149),-0.32025952409958997,-0.8733689151650273,0.6483516483516484,0.8987574976520128,1.0,2/15,4.65%,ACER2;ENPP2
prerank,glutathione biosynthetic process (GO:0006750),0.42248783350249225,0.8732819237273304,0.6262295081967213,0.9643642766995352,1.0,1/11,3.33%,HAGH
prerank,negative regulation of MAPK cascade (GO:0043409),0.3007169710775144,0.8728860811291669,0.6566125290023201,0.9646499280059265,1.0,25/87,20.82%,DAG1;CAV1;QARS1;DUSP10;FBLN1;DUSP1;FOXM1;SPRED3;BMP4;PRDM15;EZR;SYNJ2BP;TLR4;PTPN2;MYC;TNIP1;ITGB1BP1;FLCN;IGBP1;DUSP3;CAMK2N1;CDK5RAP3;GPER1;ABCA7;RGS2
prerank,chemical homeostasis (GO:0048878),-0.23206951165393508,-0.8728199121702845,0.7375,0.8988027150817859,1.0,11/61,10.10%,ZBTB20;SLC4A10;KLHL3;NR1D2;WNK2;NR1H3;PNPLA8;AQP11;AQP4;PPARG;ACOX1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.31682610842035025,0.8728146715423092,0.6237980769230769,0.964243081555511,1.0,9/55,10.99%,BBC3;NUPR1;CAV1;PMAIP1;BCL2L1;BAD;PML;BCAP31;GSDME
prerank,regulation of ERAD pathway (GO:1904292),0.4096089707697656,0.8726223330239574,0.6320132013201321,0.9640982676871681,1.0,3/11,17.63%,TMEM259;USP19;USP25
prerank,monocyte differentiation (GO:0030224),-0.35914078933056304,-0.8724369021321436,0.6218274111675127,0.8985158026666483,1.0,3/10,14.31%,IL31RA;PPARG;PIR
prerank,dicarboxylic acid metabolic process (GO:0043648),0.32097858782648225,0.8720472197198484,0.6426829268292683,0.964715666288577,1.0,19/52,26.40%,ACOT8;ME3;SHMT1;ALDH1L2;MDH2;ALDH1L1;OGDH;DLST;ASS1;ALDH18A1;HAAO;SDHAF3;SLC19A1;DGLUCY;ACLY;IDH1;GPT2;IDH2;ALDH5A1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2672530518137236,-0.8719947667030825,0.6384615384615384,0.898351042559542,1.0,3/32,2.38%,PDGFRB;ITGA1;PPP1R16B
prerank,maturation of SSU-rRNA (GO:0030490),-0.2637411856990367,-0.8719585260253129,0.6693548387096774,0.8972740971253599,1.0,17/34,36.04%,UTP6;NGDN;NAT10;RRP36;LSM6;DHX37;TSR3;NOB1;WDR3;SNU13;RIOK2;WDR46;NOL10;MRPS11;HELB;NOL11;RIOK1
prerank,lymphocyte differentiation (GO:0030098),0.3051794638816396,0.8717374707319342,0.6821983273596177,0.9648025743426372,1.0,20/68,20.52%,PBX1;HDAC5;RELB;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;GATA3;LMBR1L;KLF6;GPR89B;GPR89A;TPD52;ZBTB7A;ADAM17;DCAF1;SOX4;IKZF1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.35120111138797044,0.8716339312748034,0.6357142857142857,0.9644837809179,1.0,4/27,10.51%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,positive regulation of secretion (GO:0051047),0.4207731915606224,0.8712063709474214,0.6122778675282714,0.9647872937777063,1.0,3/11,19.24%,ACSL3;AQP1;GPLD1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2866099825097688,-0.8710910091227234,0.6230529595015576,0.8979577041460957,1.0,6/21,20.77%,SMARCD3;NES;DRD2;TOX;CX3CR1;CX3CL1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.29742500598124094,-0.8707280445256651,0.6126984126984127,0.8976265635691922,1.0,7/20,18.03%,DCC;FAS;BCL2;CASP9;ITGAV;BAX;BOK
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3023684438745154,-0.8705478575448395,0.6194690265486725,0.8968742138599213,1.0,7/20,19.50%,PLA2R1;THBS1;RGCC;ITGA4;SFRP4;PDCD4;CD40
prerank,lysosome localization (GO:0032418),0.33309252315597054,0.8699736035112376,0.6373477672530447,0.9667482713199913,1.0,13/37,24.74%,SYTL4;NDEL1;MAP6;PLEKHM1;BLOC1S2;TFEB;FLCN;HDAC6;BORCS6;PIP4P1;ARL8B;KLC2;FAM98A
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.30120510482803164,-0.8694890990078192,0.6158357771260997,0.8981172807946262,1.0,8/21,18.80%,ERRFI1;RUNX1;ROCK1;SFRP4;CTSL;SGPP1;ZFP36;MAFF
prerank,regulation of chondrocyte differentiation (GO:0032330),0.36208830686424914,0.8694595283326503,0.6116642958748222,0.9673053506283495,1.0,5/24,6.73%,MBOAT2;ADAMTS7;ZBTB16;SOX9;EFEMP1
prerank,histone acetylation (GO:0016573),0.3092563114741582,0.8694173532204806,0.6424314660309892,0.9668456153711668,1.0,19/69,19.00%,CPA4;EP300;NAA40;BEND3;KAT6B;MORF4L2;APBB1;DR1;ACTL6B;TAF5;JADE2;BRD1;ING4;MEAF6;TRRAP;SGF29;ATF2;TRIM16;MRGBP
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.35227695030711387,0.8693834739218659,0.6099290780141844,0.9663825115056341,1.0,5/26,11.81%,ABCD1;ALOX5;TLR6;TLR4;COA8
prerank,keratan sulfate biosynthetic process (GO:0018146),0.3542325177113862,0.8693190841794526,0.6107954545454546,0.9659636692882066,1.0,3/26,6.30%,ST3GAL4;B4GAT1;PRELP
prerank,glycosphingolipid metabolic process (GO:0006687),0.3203812265214235,0.868842261390874,0.642023346303502,0.9663627637706674,1.0,10/42,14.20%,HEXA;A4GALT;LARGE1;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ESYT2;SMPD2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.421573250922642,0.8685779764113086,0.6159052453468697,0.9663631397981014,1.0,2/10,8.04%,DLGAP4;NPTX2
prerank,visual perception (GO:0007601),0.2923871503823256,0.8674775447834395,0.6635404454865181,0.9681127507490237,1.0,9/84,6.73%,ABLIM1;GUCY2F;CRYBB3;CACNA2D4;CRYBG3;UNC119;ZIC2;EML2;EFEMP1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.2891614848419795,0.8674375031461636,0.6781354051054383,0.9676485690922099,1.0,18/108,12.95%,KANK1;NXN;RSPO3;PTK7;AMER3;RNF43;PPP2CA;AMER2;TSC2;WLS;GPC3;CXXC4;FOXP3;SMARCA4;HMGXB4;GNAQ;SPIN1;SFRP1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.37141980719258516,0.866953158000525,0.6187150837988827,0.9681005219116681,1.0,5/21,9.51%,MMP9;MEF2D;ADAMTS1;JUN;HTR1B
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.22157623896921086,-0.8663843896864594,0.7549668874172185,0.9036744105361428,1.0,21/70,25.22%,TCF12;LMO2;N4BP2L2;RUNX1;PSMC6;PUS7;PSMA6;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMB9;PSMA4;PSMB7;PSMA8;YAP1;YTHDF2;PSMA3;PSMD10
prerank,response to light stimulus (GO:0009416),0.3115320820134841,0.8663292501899315,0.6495215311004785,0.9687821340382619,1.0,12/55,19.88%,OPN1SW;AANAT;REV1;CPT1B;CRY2;UBE2B;PCLAF;ERCC5;ERCC2;CDKN2D;USF1;ERCC4
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4236437193717032,0.8661570184262778,0.6267361111111112,0.9685820330193086,1.0,3/10,19.24%,PMAIP1;IRS2;GPLD1
prerank,thyroid hormone generation (GO:0006590),-0.361390989491561,-0.8659618059877132,0.6119402985074627,0.9033919355826222,1.0,5/10,32.82%,CPQ;SLC5A5;FOXE1;DIO2;TG
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3879052138761606,0.8656489011606392,0.632258064516129,0.9690828934576474,1.0,2/14,9.45%,SHLD2;RIF1
prerank,negative regulation of mRNA processing (GO:0050686),-0.3254470421505239,-0.8651009697419207,0.65625,0.9040998404028023,1.0,3/15,9.81%,SRSF4;SAP18;SRSF10
prerank,mitotic cell cycle phase transition (GO:0044772),-0.1895613404173655,-0.8650453014197367,0.925,0.9030652938232684,1.0,42/203,17.12%,PLCB1;CDK14;CLASP2;CEP250;EPS8;USP37;CUL4B;BRSK1;CCP110;ACVR1B;CCDC57;CEP78;CCNH;ALMS1;TPD52L1;GSPT1;CCNY;TAF2;NES;NDE1;PRKAR2B;RPS6KB1;UBE2S;RCC1;CTDP1;ANAPC7;SPDYA;NASP;NEDD1;CAMK2A;BTRC;PPME1;CSNK1D;CRLF3;CCNJ;CUL5;SDCCAG8;BORA;DBF4;MASTL;CUL1;CHMP7
prerank,microvillus assembly (GO:0030033),0.39098648539890046,0.8648839707213096,0.6377952755905512,0.9700592878662567,1.0,4/14,9.98%,RAP1B;RAP1A;ESPN;EZR
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.3545609527778,-0.8645217705271442,0.6280788177339901,0.9030514420550317,1.0,3/11,13.04%,SP100;TP53;RPS6KA6
prerank,regulation of cell projection organization (GO:0031344),-0.33536418498660825,-0.864484320022164,0.6175710594315246,0.9019771394564365,1.0,4/13,13.45%,MYO9A;NTNG1;MACF1;MFSD2A
prerank,ion homeostasis (GO:0050801),-0.26857728853473706,-0.8643380435472454,0.7026022304832714,0.9011395248254674,1.0,5/30,7.72%,SLC4A10;CAMK2D;KLHL3;WNK2;UNC80
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3187268430721183,-0.8640659189060867,0.647887323943662,0.9005941718897343,1.0,9/16,38.01%,CECR2;DNASE2;HMGB1;EXOG;DICER1;FOXL2;KPNB1;ENDOG;DFFB
prerank,regulation of intracellular signal transduction (GO:1902531),0.26780228712403503,0.8638401021198563,0.8130653266331658,0.9715710092548396,1.0,102/420,20.74%,NTRK3;PRKAA2;SRGAP3;SRGAP2;MOB3B;DAXX;ARAP1;NGEF;LBH;ARHGEF17;AKAP13;ARHGAP18;EP300;ARHGEF12;NOP2;ARAP2;TIAM2;PPP1R13L;HSPB1;PPP1R13B;DLC1;RHOQ;NFKBIA;ROS1;ARHGEF18;MRE11;GRM2;ARHGAP29;SSRP1;ARHGAP10;ARHGAP21;PLK3;CDC42;BANP;OPHN1;PML;BCR;BRD7;ARHGEF5;TRIO;EZR;RMI1;AKAP5;GNA13;RHOA;MAPKAP1;TOPBP1;TAF5;SOS2;CHD3;INPP5B;CDK2;RHOU;PIP4K2C;OCRL;ARHGAP31;PRDM11;RPA3;ZFAND6;PRKAR2A;FLCN;MDM2;PAK1IP1;ARHGDIB;IKBKG;MEAF6;ATR;ARHGEF1;PTPN13;PAK6;TAGAP;CRK;POU4F1;PRKAG1;PLEKHG2;NBN;ARHGAP33;CCNG1;XIAP;CHEK2;PIDD1;FBXL2;RAD50;TMEM127;ARHGAP44;TAOK3;ARHGEF6;TAF9B;ATP6AP2;RHOT2;RNF41;PRKD2;TBP;PRKAB1;FBXO9;CMKLR1;MAPT;TBCK;TRAF4;AGER;PRKAB2;CASTOR2
prerank,ncRNA processing (GO:0034470),0.2769926713678323,0.8637252958181936,0.7523413111342352,0.9712778927131306,1.0,56/200,22.09%,DGCR8;PES1;FARS2;UTP11;PIH1D1;TARBP2;TRPT1;KRR1;POP4;EXOSC3;WDR55;POP1;XRN2;RPL31;RPL22;INTS2;AARS1;THG1L;MPHOSPH6;BMS1;RRP12;MTREX;WDR36;WDR43;RPL28;PWP2;DDX47;ZCCHC8;RPP21;TUT7;NOC4L;NOL6;RPL10A;SENP3;RRP9;SRRT;SARS1;RPF1;UTP14A;UTP4;RPL14;IMP4;INTS3;PDCD11;IMP3;INTS6;RPL6;RPS28;RPL41;RPLP2;BYSL;DDX52;TUT1;WDR74;RPLP1;INTS1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.34566144552913125,-0.8635702834764929,0.6432160804020101,0.9005514994590682,1.0,3/11,9.16%,PARP12;PARP14;PARP8
prerank,cell cycle G1/S phase transition (GO:0044843),0.3042883488712611,0.8632648073988658,0.66507747318236,0.9716474383457361,1.0,14/61,17.33%,CDKN1A;CDK6;USP29;CDK4;LATS1;PLK3;EIF4EBP1;CCND1;CDK2;MYC;PLK2;E2F1;HINFP;CDKN2D
prerank,regulation of mononuclear cell migration (GO:0071675),0.3598465910303659,0.8629618209023483,0.6334269662921348,0.9716938369909627,1.0,4/23,8.46%,CCL5;BMP5;MSN;LGALS3
prerank,cAMP biosynthetic process (GO:0006171),-0.3534366371735962,-0.8623790904661732,0.6320987654320988,0.9019494122915481,1.0,4/10,7.55%,ADCY5;ADCY7;ADCY1;ADCY4
prerank,response to prostaglandin E (GO:0034695),0.4182713287296469,0.8622925348240179,0.6281833616298812,0.9725078508429702,1.0,3/10,14.52%,ADCY6;SFRP1;TGFBR3
prerank,extracellular transport (GO:0006858),0.40167920390821754,0.8620864945116684,0.630718954248366,0.972360953287848,1.0,5/12,23.62%,WWP2;SPAG17;ADCY10;TSG101;DNAAF4
prerank,regulation of microtubule-based movement (GO:0060632),-0.34522874887775523,-0.8619439043873096,0.6326530612244898,0.9017209743139282,1.0,2/11,5.49%,MAP2;TTC21B
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.28836095226654385,0.8618622429122756,0.7170837867247007,0.9722647165750903,1.0,23/122,16.40%,SORBS1;KLF4;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;TGFB2;EIF6;TLR4;IRS2;POLDIP3;PLXNB2;CPEB3;FXR1;MYC;UPF3B;PYM1;HSPH1;DHX9;PCNA;EEF2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3393497757494223,0.8617601719376135,0.6535326086956522,0.9719420115826253,1.0,14/27,25.96%,TAB3;TLR6;TLR4;TNIP1;IRAK1;UBC;RPS27A;TAB2;IRAK4;MAP3K1;TLR1;TLR5;LY96;TAB1
prerank,protein glycosylation (GO:0006486),0.28392935930701013,0.8615992205627518,0.7145969498910676,0.971766606339007,1.0,13/125,6.66%,B3GALT1;ST3GAL4;OGT;B4GAT1;GALNT1;MGAT3;GCNT2;LARGE1;TMEM165;MGAT1;FUT8;NPC1;DDOST
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3657038948277411,-0.8613462709128331,0.6343283582089553,0.9018813753250912,1.0,3/10,14.21%,APPL2;NCKAP1L;CD300A
prerank,negative regulation of histone acetylation (GO:0035067),-0.35436373136402194,-0.8612553757497403,0.6311688311688312,0.9009227229127125,1.0,5/11,25.43%,THAP7;NOC2L;SIN3A;BRCA1;SPI1
prerank,regulation of ion transmembrane transport (GO:0034765),0.32643421070959794,0.8611363252229174,0.6437246963562753,0.9721426849501533,1.0,6/33,14.48%,WWP2;KCNJ13;AHCYL1;ANO6;NEDD4;WNK1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.27118709626806425,0.8609338465481042,0.7961460446247465,0.9719870793250441,1.0,67/327,18.22%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;PRRX2;MLF2;ESRRB;PHF1;PATZ1;POLR2A;HCFC1;KAT6B;EFEMP1;ZFHX3;RALY;ATRX;SIX1;PML;FOXP3;MYCBP;APBB1;GON4L;FADS1;ZNF205;NFYC;MYT1;SBNO2;AJUBA;TAF5;SP1;SPIN1;TFEB;MYBL1;CHD3;GPBP1;RREB1;NFIA;REXO4;MEF2C;SRRT;IRF2;PTP4A3;UTP4;ACTN4;E2F1;NAB2;ABL1;PAK6;SPTY2D1;HINFP;LIN54;MLLT6;SUFU;CHEK2;TRRAP;BRDT;WTIP;PRKCQ;ATF2;APBB3
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.38286547008706984,0.8606891136855238,0.6387596899224807,0.9719575468814321,1.0,2/17,2.83%,ANK2;ATP1A2
prerank,heart trabecula morphogenesis (GO:0061384),-0.30370659770066016,-0.8602785142945116,0.6722689075630253,0.9018340668104291,1.0,3/18,4.22%,ENG;TEK;NOTCH1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3045581597628121,-0.8602587495377275,0.6738461538461539,0.9007265040009622,1.0,3/18,8.43%,ADAMTS9;BPGM;SAMHD1
prerank,protein localization to centrosome (GO:0071539),-0.3105677589869832,-0.8601917069948664,0.6413043478260869,0.8997005312516271,1.0,8/17,27.56%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2806415164736351,0.8597917057433363,0.7355110642781876,0.9731623112976798,1.0,30/150,14.73%,NTRK3;TRIB2;SMAD6;OCLN;ZC3H12A;CAV1;QARS1;HSPB1;TARBP2;FBLN1;TSC2;DMTN;SPRED3;NLRP2B;PIP5KL1;PTPN6;CHP1;PYDC1;FKBP8;SMCR8;TWIST1;LDLRAD4;MVP;GNAQ;SFRP1;SH3GL2;EIF4G1;DNAJC10;ITGB1BP1;DNAJC3
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2694385350587991,0.8597806384957144,0.7991927346115035,0.9726504339447154,1.0,43/348,10.43%,ANGPT1;CD44;NTRK3;LIMK2;DAXX;ADTRP;MMP9;PDGFC;CDKN1A;IL15;GDF15;TWSG1;CAV1;MAVS;RAP1A;NGF;CD81;PTK2B;BMP5;CREBL2;DOCK7;EFNA5;MRE11;CAMKK1;KRAS;WDFY2;HAX1;SOX9;DDRGK1;MYDGF;BMP4;TGFB2;CCND2;ILK;LATS1;DVL3;FGF22;IQGAP1;VEGFB;CCND1;RAF1;HDAC3;MUSK
prerank,negative regulation of signaling (GO:0023057),-0.2772682848745194,-0.8597012702714196,0.6891025641025641,0.8996276951919195,1.0,6/25,21.56%,UBASH3B;GLRA1;SOCS5;KIF26A;OPRM1;OPTN
prerank,inorganic anion transmembrane transport (GO:0098661),0.3073652665750075,0.8596312670479813,0.6650660264105642,0.9724069038294632,1.0,5/63,6.43%,CFTR;SLC12A8;SLC25A3;SLC20A1;ANO7
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4155805236473187,0.8595702747559301,0.6169154228855721,0.9719839383429077,1.0,2/10,11.85%,NFE2L2;EIF2AK3
prerank,response to estradiol (GO:0032355),0.3375154337805631,0.859513151020121,0.6377410468319559,0.9715658023714,1.0,5/31,12.95%,NCOA3;FAM210B;LCOR;SOCS2;SFRP1
prerank,membrane fusion (GO:0061025),0.3392311120406803,0.8594173136381478,0.649645390070922,0.9712245083984304,1.0,13/33,24.02%,OTOF;NSFL1C;CHP1;VTI1B;STX11;OPA1;NAPA;DNM1L;NSF;VAMP2;SNAP23;VAPA;UBXN2A
prerank,"phagocytosis, engulfment (GO:0006911)",0.32941626850186345,0.8593526440039143,0.650730411686587,0.97082851058168,1.0,7/36,15.90%,GSN;GULP1;XKR4;CDC42;DOCK1;VAMP7;ITGB2
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3758719324858384,0.8593224872987253,0.6521739130434783,0.9703659081504057,1.0,4/17,11.17%,PRKAA2;CAV1;EIF6;NCOR1
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3510411588407537,-0.8591392661867622,0.6408268733850129,0.8996653134823644,1.0,5/11,20.05%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1
prerank,regulation of heart contraction (GO:0008016),0.293266218721312,0.8590702199128057,0.6832946635730859,0.9703314127029855,1.0,5/90,4.85%,ITPR2;ANK2;CELF2;ATP1A2;AHCYL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.28518568212659456,0.8590017233949749,0.7147435897435898,0.9699262050199842,1.0,19/124,12.95%,PLCB3;CELSR1;WNT1;WNT11;AP2A2;PSMD11;MOV10;PSMD4;PSMF1;DVL3;CDC42;TCF7L2;FZD5;PSMD7;GNAO1;RHOA;AP2A1;PSMB5;SFRP1
prerank,neuron development (GO:0048666),0.2835439402633174,0.8587828551650557,0.7398720682302772,0.9698250594854014,1.0,28/141,14.48%,RP1;PBX3;PBX1;EHD1;GDNF;BLOC1S6;ARL3;UNK;DOCK7;MAP4;TGFB2;ZFYVE27;CDK16;OPHN1;HDGFL3;TOR1A;RAB35;SRRM4;ACTL6B;BLOC1S2;SH3GL2;BTG2;FLRT3;GSK3B;MEF2C;ULK1;NEDD4;WNK1
prerank,regulation of protein localization to cell surface (GO:2000008),0.3349400501368661,0.8586796401111444,0.6530324400564175,0.9694945290779482,1.0,5/33,10.97%,ACTN2;ABCA2;TOR1A;SNX33;RAB11FIP5
prerank,negative regulation of kinase activity (GO:0033673),0.3071383999217247,0.85866012085788,0.6611177170035671,0.9690002119358655,1.0,10/62,11.74%,TRIB2;QARS1;HSPB1;TARBP2;TSC2;CHP1;PYDC1;SMCR8;GNAQ;IRS2
prerank,cholesterol efflux (GO:0033344),0.37402419848258545,0.858364531496511,0.6268221574344023,0.969004579396081,1.0,3/20,9.05%,SOAT1;NPC1;SOAT2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.40250764706606595,0.8581250647606281,0.6564019448946515,0.9689356451653599,1.0,3/12,10.57%,EPHA4;PAFAH1B1;NFIB
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3976120760862482,0.8579163493073771,0.6444444444444445,0.9688222888990194,1.0,2/13,7.28%,GLUL;GLUD1
prerank,cellular response to mechanical stimulus (GO:0071260),0.32572036137909555,0.8577468437055884,0.6599749058971142,0.9686244489855687,1.0,10/46,15.87%,TNFRSF8;SOX9;BAD;TNFRSF10B;TNFRSF1A;HABP4;AQP1;TLR4;TLR3;SLC9A1
prerank,negative chemotaxis (GO:0050919),0.33535122066725076,0.8577440961282945,0.6303116147308782,0.9681048421831626,1.0,2/33,2.82%,SEMA3D;SEMA3B
prerank,response to muramyl dipeptide (GO:0032495),0.40113552600422075,0.8576610041596026,0.6307448494453248,0.9677385759928808,1.0,2/12,7.31%,VIM;TRIM41
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.33305391834272513,-0.8575422940640386,0.664756446991404,0.9019940670557901,1.0,3/14,9.81%,SRSF4;SAP18;SRSF10
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.20513075066535377,-0.8570966594247237,0.8160919540229885,0.9017808081473315,1.0,50/117,33.43%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;CYSLTR2;ADM;PTGDR;ADCY2;PRKAR1B;PTGER4;GLP2R;RXFP1;MC5R;MAPK14;VIPR2;ADCY3;ADCY8;GPR27;ADCYAP1R1;HCK;NPSR1;CALCA;IAPP;GNG2;HRH2;TSHR;FGR;CD247;ADRB1;PLCG2;LHCGR;PLCG1;PTH2R;GPR20;CD163;HTR6;GIPR;TREM2;CRHR1
prerank,phagosome-lysosome fusion (GO:0090385),0.4090874634212185,0.856928196092263,0.624390243902439,0.9686516564770316,1.0,2/10,8.40%,RAB7A;RAB7B
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3719521006024048,0.8568580990204128,0.6035767511177347,0.968264385043228,1.0,2/17,7.10%,NOTCH2;BMP4
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3795419000805678,0.8568141024792908,0.6203703703703703,0.9678402120606283,1.0,5/15,12.95%,RSPO3;GPC3;WNT5B;CSNK1E;SFRP1
prerank,relaxation of muscle (GO:0090075),0.39508043041658514,0.8567339951593337,0.6661341853035144,0.9674727194926956,1.0,2/13,2.83%,GSN;ATP1A2
prerank,cellular protein catabolic process (GO:0044257),0.3030494199279825,0.8566316980266911,0.678743961352657,0.9671353407949049,1.0,18/59,20.59%,ADAMTS7;AP2A2;RNF5;DENND3;CTSZ;CAPN2;RAB7A;UBE2G2;AFG1L;AP2A1;RNF123;BNIP3L;MDM2;CTSH;CHEK2;PISD;IDE;CTSK
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.32667769648880024,0.8565490192966931,0.657608695652174,0.9667686265277299,1.0,9/33,19.46%,CD81;UBASH3A;LGALS3;EZR;PTPN2;IKBKG;SH2D1A;DUSP3;PRKD2
prerank,protein-DNA complex assembly (GO:0065004),0.2828586662561678,0.8565243919766268,0.7144444444444444,0.9662911274567979,1.0,25/116,18.54%,DAXX;GRWD1;PSMD11;ASF1A;SOX9;KAT6B;PSMD4;PSMF1;ATRX;RBX1;PSMD7;PSMB5;ERCC5;RPA3;MCM8;DDB1;MCM7;SPTY2D1;ERCC2;MCM6;UBC;RPS27A;PSMD1;PSMC4;H3-3A
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.34879432143792,-0.8564462206695733,0.6574307304785895,0.9020277035674865,1.0,6/10,25.69%,NOTCH1;LRP6;SOX11;BMP7;LIN7C;DLL4
prerank,positive regulation of signaling (GO:0023056),-0.25441518319464207,-0.8563527820207608,0.731404958677686,0.9010620644164091,1.0,11/37,20.62%,GRIK2;ECE1;LGI1;SYT1;CLSTN2;RAB29;EDN1;SOX11;EDN3;KCTD13;RIMS1
prerank,neuron fate commitment (GO:0048663),-0.3200869829903649,-0.8560418885071922,0.6720430107526881,0.9005749469966622,1.0,8/14,43.33%,ID2;MYT1L;DLL4;SHH;POU3F2;PAX6;ASCL1;ISL1
prerank,androgen metabolic process (GO:0008209),0.37034486769847486,0.855844673024144,0.6207906295754027,0.9671044423091689,1.0,3/18,20.23%,SRD5A3;HSD17B11;HSD17B10
prerank,MAPK cascade (GO:0000165),0.26991308650114443,0.8556458454174768,0.7829614604462475,0.9669739387795833,1.0,45/295,14.21%,FGF13;FGFR1;ANGPT1;MAP3K8;ACTN2;CCL5;MAP3K5;MRAS;GDNF;IL3RA;SPTBN2;PSMD11;GFRA3;RASAL3;BCL2L1;NRAS;KRAS;SOX9;SHC1;PSMD4;PSMF1;PTPRA;ERBB3;FGF22;RALGDS;RBX1;YWHAB;RASA2;MAP2K2;GOLGA7;RAF1;PSMD7;JAK1;SPTAN1;IRS2;PPP1CB;RASA3;SYNGAP1;RASA1;PSMB5;BRAP;MYC;SHC2;MEF2C;CHUK
prerank,protein insertion into membrane (GO:0051205),-0.2663267816229058,-0.8555789231751607,0.6929133858267716,0.9004563679800599,1.0,6/32,8.69%,ALDH3A2;OXA1L;TRAM1;STX5;REEP1;SERP1
prerank,axonogenesis (GO:0007409),0.27047580054478365,0.8554763339095467,0.7697031729785057,0.9667918473472384,1.0,38/237,11.74%,SEMA3D;NOTCH2;GPC1;EPHA4;EFNB2;DAG1;NIBAN2;S100A6;GAB1;SEMA3B;CXCR4;DOK6;LAMA5;GDNF;SPTBN2;ENAH;GFRA3;DOCK7;EFNA5;SHC1;ANK3;MAPK7;PTPRA;KLF7;UNC5B;AFG3L2;PARD6B;OPHN1;LMTK2;ACTB;APBB1;EZR;SLC9A6;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,relaxation of cardiac muscle (GO:0055119),0.3940717485950632,0.8553495914111918,0.6530612244897959,0.9665264769944355,1.0,2/13,2.83%,GSN;ATP1A2
prerank,cellular response to purine-containing compound (GO:0071415),-0.36540434383036324,-0.8552177206021031,0.625615763546798,0.900089327816572,1.0,4/10,21.89%,SLC8A1;RYR2;P2RY1;CASQ2
prerank,neuron projection morphogenesis (GO:0048812),0.28050229416408434,0.8551521022709822,0.7124183006535948,0.9663846540961004,1.0,20/137,10.21%,ALCAM;SRGAP2;PLXNB1;FLRT1;S100A6;NBL1;NGF;MAP6;DOCK7;ANK3;KLF7;AFG3L2;CDC42;IQGAP1;PARD6B;TRIO;LMTK2;ACTB;APBB1;SLC9A6
prerank,positive regulation of macrophage migration (GO:1905523),-0.29457814459858095,-0.8550554250753716,0.6529411764705882,0.8992903063256303,1.0,7/19,20.77%,IL34;PTK2;THBS1;CSF1;RARRES2;P2RY12;CX3CL1
prerank,negative regulation of defense response (GO:0031348),0.29524322888118587,0.8550169859342094,0.6781609195402298,0.9661477632608673,1.0,19/77,20.36%,KLF4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;PTPN2;LPCAT3;GATA3;CDH5;OTULIN;FNDC4;ILRUN;GPER1;PCBP2;RB1
prerank,protein phosphorylation (GO:0006468),0.2666651993921445,0.8548248996216214,0.85,0.9659896287605233,1.0,111/478,20.14%,PRKCB;FGFR1;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;EPHA4;GRK5;ADAM10;TSSK6;TSSK4;IKBKE;WNT11;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;CREB1;RNASEL;STK39;SIK3;CSK;EFEMP1;MAPK15;BMP4;TGFB2;CDK16;ILK;LATS1;DYRK1B;STK16;MAPK9;PKD1;PTPN6;AURKC;OXSR1;BCR;LMTK2;TXK;ABI1;MUSK;SRPK2;CDKL4;GRK2;JAK1;PDK2;EPHA3;TLR4;CSNK1E;YWHAZ;EIF2AK3;TGFBR2;MARK4;DDR1;CDK18;SRPK1;CDK2;MAP3K13;GSK3A;IRAK1;GSK3B;CHUK;ULK1;WNK1;TGFBR3;CDC42BPA;TLR3;PLK2;ATR;AAK1;MAP3K6;ABL1;PAK6;TTK;PEAK1;PRKAG1;MAPK6;PRKCZ;EIF2AK4;RELN;MAPKAPK2;CDC25B;CHEK2;BMPR1A;MAP3K3;PRKCQ;RARA;STK24;ROCK2;RSKR;TAOK3;STK38L;CAB39;PRKD2;APP;CDK11B;PRKAB1;MAP3K1;CAMK2B;PIK3R4;TBCK
prerank,acylglycerol biosynthetic process (GO:0046463),0.3496678134097041,0.8544348620395694,0.6363636363636364,0.9662341703793219,1.0,5/23,11.41%,DGAT1;MOGAT3;MOGAT1;ANG;GPAM
prerank,regulation of organelle assembly (GO:1902115),0.30125719318158284,0.8541909795363991,0.6810747663551402,0.9661739120711698,1.0,20/72,18.11%,GSN;RABEP2;TBC1D16;MAPK15;MSN;CEP76;EZR;MTMR3;TBC1D1;VPS11;ODAD3;RAB1B;PLK2;USP6NL;ATXN2L;TBC1D22A;TBC1D10A;PDCD6IP;STAM;TSG101
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.28760548191730817,0.8541610932207756,0.7141280353200883,0.9657132555420169,1.0,21/113,13.67%,CDH13;NOTCH2;HPN;BMP5;NRAS;SOX9;MYDGF;AGGF1;BMP4;BAD;ANG;LAMC1;TCF7L2;VEGFB;EMC10;NRP2;MMP12;PTN;SFRP1;RREB1;MYC
prerank,prostanoid metabolic process (GO:0006692),-0.32457496532596897,-0.8540014023639162,0.6582633053221288,0.9004808803495988,1.0,5/13,25.49%,ACOX1;PTGES;HPGD;CYP2S1;PTGR1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.38799848551272154,0.8539741356125642,0.6351791530944625,0.9655401348709152,1.0,1/13,0.66%,ANK2
prerank,retinoic acid metabolic process (GO:0042573),-0.3236290645793525,-0.8539323477019083,0.696969696969697,0.8994993725699363,1.0,2/14,4.96%,ALDH1A2;CYP26B1
prerank,chloride transmembrane transport (GO:1902476),0.31487465859388314,0.8539167334351251,0.6578616352201258,0.9651269657154999,1.0,2/48,2.30%,CFTR;SLC12A8
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.32434461935186565,0.8537932837019145,0.6375838926174496,0.9648401880484276,1.0,6/39,10.51%,DYNC1I1;MYO1H;NDEL1;MYO5A;MYO1C;PAFAH1B1
prerank,lipid homeostasis (GO:0055088),0.3057249246407026,0.8537212028970338,0.6654366543665436,0.9644578343654444,1.0,8/57,11.74%,PRKAA2;ABCD1;ABHD5;ORMDL3;THADA;TLCD2;ABCA2;IRS2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2901671339747649,0.8535309863419784,0.699546485260771,0.9643200216023692,1.0,21/88,23.73%,FBXL7;FBXL20;PSMD11;PSMD4;PSMF1;FBXL18;FBXO31;RBX1;PSMD7;PSMB5;FBXL15;PSMD1;FBXL2;PSMC4;FBXO9;PSMD8;DMAC2;FBXW7;CUL2;FBXO4;PSMA7
prerank,negative regulation of catalytic activity (GO:0043086),-0.2788112876265215,-0.8531608113204208,0.6804123711340206,0.9000454211773572,1.0,7/24,15.24%,NOTCH1;OXA1L;NOSIP;NES;TP53;CAMK2A;CLN3
prerank,regulation of stem cell differentiation (GO:2000736),-0.20812439522715737,-0.8531015280313339,0.8099173553719008,0.8990581605637771,1.0,12/89,9.31%,JAG1;TCF12;LMO2;PDGFRA;NOTCH1;RUNX1;PSMC6;PUS7;PSMA6;NUDT21;OCIAD1;GATA2
prerank,rRNA processing (GO:0006364),0.2765696858642385,0.8523005833731259,0.7410901467505241,0.9662285348239773,1.0,33/172,15.66%,NSA2;NOP2;PES1;UTP11;PIH1D1;MAK16;EIF6;KRR1;POP4;EXOSC3;WDR55;XRN2;RPL31;RPL22;MPHOSPH6;BMS1;RRP12;MTREX;WDR36;WDR43;RPL28;PWP2;DDX47;NOC4L;NOL6;RPL10A;SENP3;RRP9;RPF1;UTP14A;UTP4;RPL14;IMP4
prerank,signal peptide processing (GO:0006465),-0.34740032241205604,-0.8521303004167946,0.6336088154269972,0.8998764881129161,1.0,2/11,9.60%,PCSK5;SPCS2
prerank,cellular response to hexose stimulus (GO:0071331),-0.27669423621862244,-0.8519787873727034,0.6459627329192547,0.8990625141418148,1.0,6/23,12.28%,UNC13B;ZBTB20;GAS6;PRKAA1;IGF1R;RACK1
prerank,regulation of mitochondrial translation (GO:0070129),-0.28837045725148963,-0.851934979093481,0.6822742474916388,0.898041587241589,1.0,10/21,31.92%,RPUSD4;FASTKD2;TSFM;TRMT10C;FASTKD3;ALKBH1;RMND1;MPV17L2;SHMT2;COA3
prerank,protein dephosphorylation (GO:0006470),0.27710233117777316,0.8519302533666425,0.7393675027262814,0.9664097333146607,1.0,25/135,12.75%,PTPN14;EYA2;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;PPP1R15A;DUSP12;DUSP1;UBLCP1;PTPRF;PTPN9;PTPRA;EYA1;PP2D1;PPP2R2D;PPM1A;PTPN6;MTMR3;PTPRE;PPP1CB;PTPN2;PPM1D
prerank,negative regulation of insulin secretion (GO:0046676),0.3745588439845793,0.851584306124841,0.6439169139465876,0.9665260614839714,1.0,10/17,33.21%,KLF7;KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PSMD9;PRKN;REST;MIDN
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3609637391973745,0.8515160073157954,0.6459259259259259,0.966132609769369,1.0,4/20,20.66%,STARD3;FDX1;HSD17B10;TSPO
prerank,regulation of cardiac muscle contraction (GO:0055117),0.33654516722085115,0.8515080906542212,0.6675392670157068,0.96562905211834,1.0,2/34,2.49%,ANK2;ZC3H12A
prerank,response to unfolded protein (GO:0006986),0.31121722385686945,0.8514445739461495,0.6855670103092784,0.9652359662705108,1.0,7/48,9.06%,DAXX;HSPB1;HSPB2;HSPB8;HSPA4;HSPA14;BAG3
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2891583059958721,-0.8513089071473888,0.6785714285714286,0.898259322643031,1.0,5/19,18.59%,MAOB;ACOX1;GPX1;PRDX4;SOD1
prerank,regulation of endothelial cell migration (GO:0010594),0.2988521515356812,0.8511933316831989,0.7009345794392523,0.9651670584047476,1.0,20/85,14.90%,ANGPT1;ANXA3;EMP2;GLUL;ZC3H12A;GFUS;PTK2B;FOXC2;BMP4;KRIT1;EMC10;BCAS3;NRP2;SYNJ2BP;PTN;BCAR1;GATA3;FOXP1;ITGB1BP1;AAMP
prerank,glycine metabolic process (GO:0006544),0.3839399146358078,0.8509450389592969,0.6360759493670886,0.9651280771060514,1.0,2/12,11.07%,SHMT1;AMT
prerank,positive regulation of rRNA processing (GO:2000234),0.4058172199618785,0.8508259157387132,0.6460481099656358,0.9648445796915306,1.0,4/10,22.03%,BUD23;WDR43;TRMT112;SIRT7
prerank,regulation of sodium ion transport (GO:0002028),0.33668722244275257,0.8507104387903217,0.6588720770288858,0.9645459413916992,1.0,15/34,25.02%,SLMAP;AHCYL1;ANK3;ATP2B4;NEDD4;WNK1;YWHAH;SCN4B;ATP1A1;WNK4;NKAIN4;SNTA1;NKAIN1;PER1;P2RX4
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.30805154990920536,-0.8503509413238622,0.6657142857142857,0.8991229791717309,1.0,1/17,0.03%,PRKG1
prerank,positive regulation of transporter activity (GO:0032411),0.3927687492476429,0.8498372870104638,0.6331168831168831,0.9657032914570765,1.0,3/13,8.99%,STK39;SYNGR3;KMT2A
prerank,synaptic vesicle membrane organization (GO:0048499),0.3813646750308915,0.8497485396324085,0.6569678407350689,0.9653507865625064,1.0,7/17,25.15%,SYP;TOR1A;STX11;STX4;AP3D1;SNAP23;STX3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3562727982782318,-0.8495000067056093,0.655440414507772,0.899683357353147,1.0,2/10,5.28%,CAMK2D;HECW1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2977307051333023,0.84909265521002,0.680622009569378,0.9660503025176629,1.0,14/70,15.05%,DAXX;NGF;BCL2L1;TGFB2;ERBB3;BAD;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2;GSK3A;GSK3B;TLR3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.31895853927499623,0.848967856730779,0.6734417344173442,0.96576547437499,1.0,12/37,19.88%,RBX1;POLK;ERCC5;RPA3;POLD2;DDB1;PCNA;ERCC2;UBC;RPS27A;RFC1;ERCC4
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3686387537345389,0.8488922783664079,0.6320474777448071,0.9653949099242908,1.0,3/16,7.00%,ANK2;ATP1A2;GSTO1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.30123277601808945,0.8482900018726964,0.6853146853146853,0.966024811115124,1.0,8/70,12.97%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;CHPT1;LPCAT3;TMEM86B
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37696516859578577,0.8481425788528126,0.6440944881889764,0.9657998709797454,1.0,6/15,22.86%,TCF7L2;BAG3;RAPGEF3;GSK3B;XPO4;TPR
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3753475711543125,0.8475979513343453,0.6293375394321766,0.9663461679487384,1.0,4/15,15.03%,ORMDL3;TNFRSF1A;SMPD2;PLA2G6
prerank,response to UV-B (GO:0010224),0.3944450072549451,0.8473021757950051,0.641914191419142,0.966367206197542,1.0,1/12,1.91%,CDKN1A
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.3475633379212219,-0.8470812345740348,0.6666666666666666,0.9034889506437395,1.0,5/11,16.85%,WNT5A;FGFR2;LRP5;TBX1;CTNNBIP1
prerank,regulation of postsynapse organization (GO:0099175),0.3407405094872568,0.8469888638973727,0.6532033426183844,0.9664560234646578,1.0,3/28,2.47%,PDLIM5;EPHA4;SIPA1L1
prerank,response to amino acid (GO:0043200),-0.25743389969620956,-0.8465753199232443,0.6923076923076923,0.9034491795788682,1.0,11/31,19.90%,GLRA1;IPO5;CPEB1;SLC38A9;TMBIM6;LAMTOR1;GLRA3;RRAGD;GLRA2;RRAGA;GLRB
prerank,regulation of plasminogen activation (GO:0010755),0.3905404315650659,0.8464609917249543,0.6452145214521452,0.9669010443497317,1.0,2/12,6.11%,HPN;CTSZ
prerank,regulation of mitotic cell cycle (GO:0007346),0.27238654222602665,0.8461363854190488,0.7552966101694916,0.9669990092391109,1.0,35/171,21.48%,FZR1;NEK7;CDK10;DAPK3;PSMD11;CAV2;PSMD4;PSMF1;FBXO5;IQGAP1;EIF4EBP1;PSMD7;PKMYT1;PSMB5;ANAPC4;BTG2;MDM2;MAEA;DDB1;ERCC2;CUL9;CDC25B;INTS13;DUSP3;PSMD1;PSMC4;KIF20B;CDK5RAP3;APP;CDK11B;PSMD8;RB1;USP22;UBE2E1;USP2
prerank,telomere capping (GO:0016233),0.36422177692263585,0.8460401977244962,0.649624060150376,0.9666626791044849,1.0,8/16,29.16%,MRE11;DCLRE1C;NBN;RAD50;TERF2;TINF2;TERF1;TERF2IP
prerank,respiratory chain complex IV assembly (GO:0008535),0.3572895010736936,0.845441217681801,0.6292974588938715,0.967286600385432,1.0,4/21,11.94%,COX19;COX16;COA8;COX20
prerank,small GTPase mediated signal transduction (GO:0007264),0.2869875524704964,0.8454286990023511,0.7216035634743875,0.9668025506391521,1.0,26/103,15.41%,CDKN1A;MRAS;ARHGAP18;TIAM2;ARL3;ARHGEF18;NRAS;KRAS;RHEB;SHC1;KRIT1;RALGDS;JUN;CHP1;BCR;ARFIP2;RREB1;CDK2;BRAP;ARHGAP31;SHC2;SETDB1;HRAS;CCDC88A;PLK2;USP28
prerank,regulation of phosphatase activity (GO:0010921),0.3499350184928826,0.8451632196980332,0.6466380543633763,0.9667878926228736,1.0,3/24,8.73%,PPP6R3;SH3RF2;CHP1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.37209904886454886,0.8449253082917525,0.6571879936808847,0.9667109768743999,1.0,11/16,32.00%,PIH1D1;SIK3;FLCN;PIP4P1;SEH1L;GPR137;LAMTOR5;LARS1;RRAGB;TELO2;CLEC16A
prerank,regulation of dendrite development (GO:0050773),0.3261155474897872,0.8448359343869478,0.6631299734748011,0.9663709395545986,1.0,3/37,4.00%,RAB17;COBL;BMP5
prerank,negative regulation of cell cycle (GO:0045786),0.29422947308984204,0.8444645557749223,0.6834112149532711,0.9665710956463582,1.0,13/73,13.81%,NUPR1;CDK6;PPP1R13B;IPO7;DUSP1;ZBTB17;BMP4;LATS1;NLRP2B;CDK5RAP1;GATA3;CHMP1A;BTG2
prerank,regulation of cilium assembly (GO:1902017),0.30283737609462125,0.84437085604384,0.6864406779661016,0.9662246410392813,1.0,20/62,23.55%,LIMK2;RABEP2;CDK10;TBC1D16;MAPK15;TBC1D1;MARK4;ODAD3;CCDC88A;USP6NL;TESK1;TBC1D22A;TBC1D10A;TBC1D17;CROCC;RABGAP1;CEP97;CEP120;ATG3;TAPT1
prerank,neutral amino acid transport (GO:0015804),0.3428529713644711,0.8441427861779577,0.6501416430594901,0.9661655630615149,1.0,6/28,14.01%,SLC36A3;CTNS;SLC36A4;LLGL2;SLC1A4;SLC6A7
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30746785683626365,0.8440511557445437,0.6845386533665836,0.9658217925864615,1.0,8/53,11.27%,NUPR1;DDRGK1;PSMF1;DESI1;PKD1;USP19;OPHN1;OSBPL7
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.3368965634174115,-0.8438627432733751,0.6822916666666666,0.9077605679245289,1.0,4/12,21.61%,NIN;BBS4;CCDC68;CEP19
prerank,cyclooxygenase pathway (GO:0019371),0.4045058327714477,0.8438266256657346,0.6550580431177446,0.9657182728697717,1.0,3/10,11.45%,PTGDS;HPGDS;PTGES2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.362147925990664,-0.8436433635471331,0.6506024096385542,0.9070645240218398,1.0,7/10,43.34%,DRD2;FMR1;CALM3;CRHR1;GPR35;DRD3;GNB5
prerank,"transcription, DNA-templated (GO:0006351)",0.2673831098942135,0.8435407997632755,0.7688284518828452,0.965736320729193,1.0,55/207,24.78%,THRB;GTF2F1;DDX5;MLLT3;FOXO3;CREBL2;POLR2H;TAF1C;NKX2-8;ELOB;POLR2A;ZBTB7B;SSRP1;UBTF;POLR1C;NFE2L3;NFIC;PTMA;GTF3C3;GTF2E1;TAF5;ELL;RREB1;RPAP1;RNPS1;TCEA2;E2F1;POLR3G;TBPL1;GTF3C2;ERCC2;NELFB;POLR2C;GTF3C5;POLR3H;TAF9B;POLR2E;NELFA;TBP;SNAPC3;MNT;TWNK;TAF6;GTF2E2;GTF3C4;AFF4;CDK9;TFAM;CTR9;LEO1;MBD1;GMEB2;POLR2K;BAZ2A;MNAT1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.36412175389336054,-0.843504452187619,0.6831168831168831,0.9062593408740779,1.0,6/10,29.85%,MTHFD2L;DHFR;MTHFR;TYMS;MTHFS;SHMT2
prerank,establishment of mitotic spindle localization (GO:0040001),0.33292963901234807,0.8434992521364202,0.6555090655509066,0.9653113377150804,1.0,5/28,10.95%,NDEL1;NSFL1C;PAFAH1B1;INSC;ZW10
prerank,positive regulation of metabolic process (GO:0009893),0.2834360877150622,0.8434260681080756,0.7215332581736189,0.9649382752925525,1.0,16/103,12.43%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;BEND3;ZBTB7B;ACADL;ELOVL6;HDAC3;KDM3A;FASN;ACACA;PIGA;CPT2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3669064122075981,0.8433302099200766,0.6534351145038167,0.9646034024963653,1.0,4/17,9.90%,PSRC1;CCND2;PKD1;CCND1
prerank,positive regulation of protein modification process (GO:0031401),0.26866769020102504,0.8431150319172949,0.7658031088082902,0.9644976463970601,1.0,25/203,10.43%,ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;MAVS;DLC1;RAMP1;EFNA5;KRAS;WDFY2;SOX9;MYDGF;BMP4;CCND2;ILK;DVL3;NNMT;FGF22;CHP1;VEGFB;CCND1;HDAC3;MUSK
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3251989554273221,-0.842798218559526,0.6920980926430518,0.9065152919735309,1.0,8/14,37.15%,IL18;SOCS5;CCL19;CD86;MALT1;CD80;NFKBID;NLRP3
prerank,cellular response to gamma radiation (GO:0071480),0.3751241094074822,0.8426085475553453,0.6369137670196672,0.9649421124538475,1.0,5/17,16.74%,CRYAB;HRAS;MDM2;ATR;KDM1A
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.3427019951612499,-0.8423836769574133,0.6524064171122995,0.9062484430954774,1.0,5/11,24.48%,WNT4;FGFR4;DGKQ;STAR;NR1H4
prerank,substantia nigra development (GO:0021762),0.32601387579836005,0.8423554570772431,0.6792698826597132,0.964911241590748,1.0,11/37,12.53%,GLUD1;CDC42;SYNGR3;NDUFS3;ACTB;YWHAQ;S100A1;RHOA;MAPKAP1;ZNF148;ATP5PF
prerank,positive regulation of neurogenesis (GO:0050769),0.29703232916117256,0.8423510195700312,0.7017751479289941,0.9644146872865685,1.0,7/68,4.87%,FBXW8;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;PTPRD
prerank,mesenchymal cell differentiation (GO:0048762),0.31178865046136905,0.8420266588035591,0.7142857142857143,0.9645239238076996,1.0,6/51,7.30%,FGFR1;RANBP3L;DDX5;SOX9;AKNA;TGFB2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.33582082087765375,-0.8418963518244269,0.6873315363881402,0.906091462711389,1.0,3/12,10.21%,ALDH6A1;CTPS1;DPYSL5
prerank,negative regulation of inflammatory response (GO:0050728),-0.18556070307585443,-0.8416417963701973,0.9787234042553191,0.9054678982521025,1.0,60/182,28.35%,IGF1;TEK;ADCY5;CALCRL;LYN;PTGIS;MFHAS1;GGT5;ADCY7;NR1H3;VPS35;PPARD;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;RORA;RAMP2;PPARG;PRKAR2B;GPR45;CCN3;CYSLTR1;TNFRSF1B;PTHLH;GNB1;MVK;CYSLTR2;ADM;PPARA;PTGDR;ADCY2;PRKAR1B;PTGER4;GLP2R;RXFP1;LRFN5;MC5R;MAPK14;TNFAIP3;VIPR2;ADCY3;ADCY8;GPS2;GPR27;NR1H4;ADCYAP1R1;HCK;NPSR1;CALCA;IAPP;GNG2;SMPDL3B;HRH2;TSHR;FGR;CD247;ADRB1;PLCG2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3202191889677693,0.8415649000565807,0.6706989247311828,0.964882667605021,1.0,14/38,23.05%,EPHA4;CAV1;UNC119;SHC1;ERBB3;SRCIN1;MVP;RAP2C;RELN;SH3BP5L;APP;DLG4;FCGR1A;EFNA1
prerank,negative regulation of nuclear division (GO:0051784),0.3985888714666421,0.8415224373294492,0.64,0.9644580418995307,1.0,4/11,23.38%,BMP4;FBXO5;TOM1L2;AURKAIP1
prerank,protein ubiquitination (GO:0016567),0.2617494618263413,0.8408930989399508,0.856,0.9650935119124291,1.0,126/471,23.82%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;FBXL20;RNF220;SPSB4;LONRF1;NFE2L2;SH3RF2;WWP2;TRIM25;TRIM44;PSMD11;NUB1;RNF138;ELOB;KLHL21;MUL1;PSMD4;PSMF1;TRIM21;CBLL1;TRIM41;FBXL18;FBXO31;UBE2G2;RBX1;RNF146;SDE2;TRIM11;TRIM26;TRIM47;UBE2B;PCNP;RNF182;KLHL24;PSMD7;UBE2Q1;FBXW9;KLHL13;VPS11;ZSWIM8;RNF141;RNF126;MIB2;DTX3;PSMB5;NPEPPS;PELI1;BRAP;VPS18;UBR5;DDA1;UBE4A;NEDD4;MDM2;UBE2H;BFAR;RNF31;TNKS2;MSL2;DDB1;PCNA;TPP2;UBE2N;CCDC22;PDZRN3;DTX2;PRPF19;UBA6;FBXL15;CAND1;CUL9;RNF10;UBE2J1;UBC;RPS27A;STUB1;UBE2D3;KEAP1;SIAH1;PSMD1;FBXL2;OTULIN;TRIM37;PSMC4;PEX2;RNF112;UBE2Z;ASB5;RNF41;FBXO9;PSMD8;UBE3C;THOP1;RMND5A;CHFR;USP22;VHL;UBE2E1;SMURF2;FBXW7;ARIH2;TRIM5;RNF168;CUL2;FBXW2;RCHY1;RNF213;BLMH;UBE2V1;RNF14;CDC23;DET1;TRIM3;HECTD2;RNF7;ATG3;CTR9;FBXO4;PSMA7;UBE3D
prerank,T cell homeostasis (GO:0043029),0.397890023166132,0.8402520859724794,0.6388888888888888,0.9658265462437075,1.0,2/10,9.13%,PMAIP1;FOXP3
prerank,inorganic ion transmembrane transport (GO:0098660),0.38090151041549836,0.8396305379046742,0.6191275167785235,0.966460636515691,1.0,3/12,11.60%,ABCC8;TRPM4;PKD2L1
prerank,cellular lipid catabolic process (GO:0044242),-0.2726932065762224,-0.8393209635816591,0.6912280701754386,0.9090348670493164,1.0,7/27,16.36%,ENPP2;CYP1B1;PPARD;ACOX1;LPIN2;ABHD12;SIRT2
prerank,cellular calcium ion homeostasis (GO:0006874),0.2746316409563566,0.839136821863461,0.7379162191192267,0.9668680603324877,1.0,15/133,9.02%,ANK2;STIM2;CCL5;CAV1;MCU;CSRP3;ATP13A3;MCUB;TMEM165;CAV2;MICU1;AFG3L2;ATP13A4;PML;HCRTR1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3379454859104465,0.8389361398127511,0.6732954545454546,0.9667184299841086,1.0,8/27,18.09%,DDX5;BMP4;MAP2K2;AJUBA;FXR1;EIF4G1;DHX9;WTIP
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.23978044326017547,-0.8384219548839514,0.7554585152838428,0.9096905692201782,1.0,12/42,17.32%,SMARCA2;MBD2;ARID1A;CHD8;ACTR6;SMARCC2;SMARCE1;NASP;CECR2;ACTR5;MBD3;HDAC2
prerank,positive regulation of protein secretion (GO:0050714),0.29706477154339056,0.8382309895955736,0.7212336892052195,0.9675278179083594,1.0,22/69,20.41%,SYTL4;MCU;WLS;GOLPH3;GLUD1;TGFB2;BAD;ANG;TCF7L2;APBB1;EZR;IER3IP1;TLR4;IRS2;AACS;DNM1L;NLGN2;APBB3;GPER1;MYO18A;FRMD4A;SOX4
prerank,acetyl-CoA metabolic process (GO:0006084),0.3759139659389519,0.8372723457151197,0.6579754601226994,0.968805380271926,1.0,6/15,22.54%,TDO2;PMVK;ACACA;HMGCS1;ACLY;MLYCD
prerank,protein import into peroxisome matrix (GO:0016558),0.395777148225688,0.8368803229002226,0.6482649842271293,0.9690435357301184,1.0,3/12,18.84%,PEX26;PEX6;PEX2
prerank,response to peptide (GO:1901652),0.3259749639938797,0.8367166850005644,0.6793692509855453,0.968872780654469,1.0,5/33,11.14%,MMP9;CACNA1A;EIF2B2;STAT4;MMP12
prerank,BMP signaling pathway (GO:0030509),0.2923953180476482,0.8366682347769961,0.6991676575505351,0.968458694713519,1.0,7/62,7.30%,SMAD6;DDX5;HIVEP1;GDF15;BMP5;BMP4;TGFB2
prerank,plasma membrane tubulation (GO:0097320),0.39785560523301344,0.8363972417332103,0.6559633027522935,0.9684449559939529,1.0,4/13,17.78%,CAVIN2;CHMP4A;SNX33;PACSIN1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3319797096888355,0.8362460453922675,0.6779661016949152,0.9682202023618143,1.0,8/29,18.31%,MAVS;RNASEL;MUL1;PTPN6;PTPN2;ZBP1;PTPN11;YTHDF3
prerank,negative regulation of lyase activity (GO:0051350),0.3674283990121535,0.8359171581520958,0.6846038863976084,0.9683276468691642,1.0,4/16,11.61%,PALM;GRM2;AKAP5;GABBR2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.37652930954904906,0.8354987185894477,0.6463223787167449,0.9686161930757038,1.0,5/14,17.46%,PPP2CA;DUSP1;PPP2R2D;PPP2CB;PPP2R2C
prerank,positive regulation of heart contraction (GO:0045823),0.36720215314388693,0.8353767392718899,0.6403785488958991,0.9683569300101685,1.0,4/19,13.52%,ATP1A2;TGFB2;TRPM4;GSK3A
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3212537819068677,0.8351460812552901,0.7014341590612777,0.9682820735622657,1.0,8/40,10.53%,ABCD1;PMAIP1;BCL2L1;BAD;PIP5KL1;MTLN;ATP5IF1;ARL6IP5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.30999428350146935,0.8347318870205283,0.6628930817610063,0.9685515308054666,1.0,5/46,8.39%,CDH13;CCL5;BMP4;ANG;TCF7L2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.28095067315797057,0.8346243440076359,0.7628979143798024,0.9682165353502619,1.0,34/110,24.19%,PPP2CA;RPS4X;EIF4A3;SMG7;UPF3A;RPSA;RBM8A;RPL31;RPL22;GSPT2;RPL28;RPS26;RNPS1;RPL10A;DCP1A;EIF4G1;UPF3B;PYM1;RPL14;MAGOHB;MAGOH;CTIF;RPS27A;RPL6;RPS28;ETF1;SMG9;RPL41;RPLP2;RPLP1;RPL7;PABPC1;RPL21;RPL26
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29155758855924496,0.8345297073135903,0.6947743467933492,0.9678855124519671,1.0,8/68,9.97%,SULT1A1;ACOT8;SULT2B1;RHOQ;NT5C2;BAD;ACSM3;AK3
prerank,monocyte chemotaxis (GO:0002548),-0.25449511954950754,-0.834379573809106,0.7803030303030303,0.9164785553678679,1.0,1/32,0.05%,FLT1
prerank,centromere complex assembly (GO:0034508),-0.25043539166355167,-0.834341699959617,0.7100840336134454,0.9154367983526551,1.0,18/36,32.51%,ITGB3BP;RUVBL1;CENPP;NASP;HJURP;HELLS;KNL1;MIS18BP1;CENPE;CENPU;CENPX;CENPI;NPM1;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,positive regulation of T cell differentiation (GO:0045582),-0.24605426076490994,-0.8341267288243034,0.7796610169491526,0.9147423210982782,1.0,6/36,11.67%,LEF1;GLI2;ZMIZ1;CD46;NCKAP1L;PNP
prerank,oxoacid metabolic process (GO:0043436),0.33309421217401913,0.8337607224755275,0.6890756302521008,0.9688178299282832,1.0,2/27,3.25%,SULT1A1;SULT2B1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.37286972081126174,0.83374359630613,0.672782874617737,0.9683466356101117,1.0,5/15,15.84%,HPN;TMC2;PDZD7;MKKS;TMEM120A
prerank,regulation of epithelial cell migration (GO:0010632),0.3047127885902641,0.8335993270376792,0.7042424242424242,0.9681194765873603,1.0,10/51,13.24%,DOCK5;EMP2;GLUL;DUSP10;SOX9;TGFB2;ARSB;PTN;DOCK1;RREB1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3133842246316952,-0.833553192727199,0.698005698005698,0.9146846536346988,1.0,6/17,21.89%,NUDT21;HSF1;CPEB1;CPSF6;NELFE;NCBP1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3365399881629727,0.8334342275947622,0.6884057971014492,0.9679189103416498,1.0,7/26,14.25%,LSM10;CDK10;CCND2;ADAMTS1;CCND1;ANKRD17;EIF4G1
prerank,positive regulation of transport (GO:0051050),0.28329108310165496,0.8333521063437141,0.7257876312718786,0.9675666854273729,1.0,22/85,21.25%,CHRM1;IL15;ANXA2;CBLL1;GPC3;SYNGR3;CHP1;ACSL3;KMT2A;ACTB;ZNF205;FCER1G;GSK3A;GSK3B;DYNC1H1;NUMA1;CDH3;GPLD1;FLOT1;RAB27A;ABCA7;TULP1
prerank,protein targeting to membrane (GO:0006612),0.28518910316322493,0.8332939150844618,0.7047289504036909,0.9671693915480406,1.0,24/83,23.97%,PEX26;ABCD1;ZDHHC12;VPS37B;SIL1;CHMP4A;CHMP4B;SSR1;GOLGA7;MYO1C;SLC25A17;PXMP4;RAB8B;PEX3;PEX2;VPS37A;PARD3;ZDHHC3;ARL6IP1;SRP14;SGTA;ATG3;RAB3IP;ARL6
prerank,cellular response to ionizing radiation (GO:0071479),0.31050631976854653,0.8332267609607046,0.69625,0.9667885046438227,1.0,13/47,24.25%,CDKN1A;KDM4D;CRYAB;EEF1D;HRAS;MDM2;ATR;KDM1A;NUCKS1;SWI5;RAD9A;RPL26;RHOB
prerank,cellular defense response (GO:0006968),-0.23970493153605887,-0.8329644440655649,0.78099173553719,0.914650215496049,1.0,5/40,8.68%,DCDC2;LSP1;CCR9;VEZF1;ADORA2A
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.32435348864230945,0.8328163984899043,0.6779431664411367,0.9670666253769602,1.0,1/32,0.23%,FGF13
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2618238851797548,0.8327192615131465,0.8683417085427135,0.9667403105111916,1.0,70/417,14.23%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;NIBAN2;FOXP2;GLI3;TRIM33;WNT11;HDAC5;QARS1;RBFOX2;PCGF6;GLIS2;ZNF219;HDAC4;ZBTB16;WWP2;NACC1;CRYAB;PATZ1;FOXM1;ZIC2;SOX9;FOXD1;KAT6B;SHC1;KDM5C;PHF10;COMMD7;BMP4;NKAP;CIC;L3MBTL3;MAGEL2;TCF7L2;JUN;CRY2;PML;FOXP3;BRD7;SCML2;DPF2;YWHAQ;HDAC3;TWIST1;ARID4A;BCL7A;SMARCA4;TLE2;NCOR1;SBNO2;SFMBT2;ZNF148;TSC22D4;FOXK1;SFRP1;GATA3;CHMP1A;CBX4;BEND5;TLE5;ING4;PRDM11;NCOR2;FOXP1;SET
prerank,regulation of trophoblast cell migration (GO:1901163),0.3721097115425081,0.8323982429659548,0.6738794435857806,0.9667950792783584,1.0,5/14,24.50%,TIMP1;ARHGDIB;YTHDF3;SMURF2;C1QBP
prerank,transcription by RNA polymerase I (GO:0006360),0.3210875876728705,0.8319794599272378,0.6887417218543046,0.9670506235294115,1.0,15/34,26.74%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;POLR2K;TCOF1;MNAT1;POLR1B;TTF1
prerank,synaptic vesicle recycling (GO:0036465),-0.25220530243078554,-0.8313574665228024,0.7222222222222222,0.9166379964417913,1.0,8/31,14.46%,SYNJ2;SYT1;NLGN1;TBC1D24;NLGN3;AMPH;STON2;FCHO2
prerank,axonal transport (GO:0098930),0.31871008719982424,0.831069299004422,0.6818181818181818,0.9681911685264133,1.0,14/36,24.28%,BLOC1S6;AP3B1;AP3S1;KIF1B;PAFAH1B1;BLOC1S2;OPA1;DYNC1H1;AP3S2;AP3M1;MAPT;AP3D1;RAB21;BLOC1S5
prerank,negative regulation of protein polymerization (GO:0032272),0.3381446963720064,0.8310303416946232,0.6926229508196722,0.9677569178085556,1.0,8/27,17.97%,KANK1;SSH3;TWF1;EML2;ARFGEF1;KANK4;PFN2;CDH5
prerank,cellular response to interleukin-12 (GO:0071349),0.30646612604054824,0.8307046008554838,0.6761658031088082,0.9678341877473304,1.0,9/48,10.84%,RAP1B;MSN;ANXA2;GSTO1;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3089439549774665,0.8301499858240184,0.6864728192161821,0.9683836468989941,1.0,20/41,29.02%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;RAE1;AAAS;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133;GCK;NUP35;PGAM1
prerank,T cell receptor signaling pathway (GO:0050852),-0.18885385021794146,-0.8300916021635152,0.9384615384615385,0.9180233066474495,1.0,33/138,22.17%,PTPRJ;PIK3R1;PDE4D;PAK3;INPP5D;PAG1;EIF2B3;PSMC6;RFTN1;PSMA6;PIK3CB;FYB1;PDE4B;TNFRSF21;THEMIS;PIK3CD;TRAF6;RBCK1;BTRC;PSME1;PSMB10;PSMD5;SKAP1;RC3H1;CUL1;PIK3R2;PSMD3;ICOSLG;PSMB9;PSMA4;PRAM1;PSMB7;PSMA8
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.2949939078639433,-0.8298878493717329,0.6960486322188449,0.917300839251082,1.0,6/18,20.62%,NRXN1;SHANK3;NLGN1;NLGN3;STX1B;RIMS1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.30554997525314176,0.8296471624054682,0.7085927770859277,0.9687892383062522,1.0,8/48,10.66%,OGT;EP300;NUP93;RUBCNL;EIF6;NDC1;JMJD8;TIGAR
prerank,regulation of actin nucleation (GO:0051125),0.39469301969610654,0.8295348545305924,0.696923076923077,0.968491614841693,1.0,2/12,11.75%,GSN;ARFIP2
prerank,regulation of membrane depolarization (GO:0003254),0.37032658223680087,0.8294809147478014,0.6646525679758308,0.9680921897428296,1.0,2/18,3.17%,ABCD1;FHL1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.25667671905268175,-0.8294042903958032,0.764,0.9171775458552354,1.0,2/33,2.94%,PRKG1;IGFBP5
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.37128269063758573,0.8288278134893388,0.6456692913385826,0.9687588539851377,1.0,5/15,18.20%,MRE11;MDC1;HUS1B;CHEK2;ATF2
prerank,mRNA export from nucleus (GO:0006406),0.28038740336253326,0.8288196624895967,0.7572706935123042,0.9682771769465962,1.0,33/102,25.85%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;NDC1;RBM8A;AGFG1;WDR33;ENY2;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;RAE1;AAAS;SRSF1;SRSF5;THOC1;U2AF1;POM121;TPR;SRRM1;RANBP2;NUP42;NUP62;RBM15B;SEH1L
prerank,negative regulation of protein kinase activity (GO:0006469),0.2843967720902316,0.8287516423774954,0.7251995438996579,0.967897431894106,1.0,22/88,18.81%,TRIB2;CDKN1A;CAV1;QARS1;DUSP10;HSPB1;TARBP2;TSC2;SRCIN1;CHP1;PYDC1;SMCR8;MVP;GNAQ;ITGB1BP1;TESK1;ABL1;DUSP3;CAMK2N1;PARK7;SH3BP5L;CDK5RAP3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.26650083093444926,0.828439929995235,0.7952182952182952,0.9679640719622981,1.0,24/190,10.26%,PRKAA2;PIK3IP1;MMP9;DAG1;UACA;MAGI2;ZC3H12A;CAV1;PHLDA3;TRIM59;PPM1B;DUSP1;TSC2;SH3BP4;USP10;BCL2L1;OTUD7B;MUL1;PPM1A;NDUFS3;UBE2B;PRDM15;NMI;TWIST1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3076396956686113,-0.8281433831269587,0.7005813953488372,0.9185378721768849,1.0,1/16,0.12%,SOX5
prerank,negative regulation of hydrolase activity (GO:0051346),0.3080754338391747,0.8274812968685938,0.6994949494949495,0.9692307866352473,1.0,12/49,17.26%,CPEB2;SH3RF2;SH3BP4;MAPK7;CHP1;ATP5IF1;BCAS3;ARFGEF1;WNK1;HRAS;NEIL1;FICD
prerank,regulation of cellular response to stress (GO:0080135),0.2789373910943384,0.8271467488866318,0.7505422993492408,0.969312021517054,1.0,39/115,26.62%,NUPR1;ABCD1;EP300;BAG1;ALOX5;CRYAB;HSPB8;NUP93;USP19;CHORDC1;NDC1;BAG3;AJUBA;RPA3;GSK3B;EIF4G1;HSPH1;HSP90AA1;ATR;ABL1;MAPKAPK2;RAE1;AAAS;ROCK2;CAMK2B;MAPT;HIKESHI;PTGES3;POM121;TPR;RANBP2;AIFM2;ARMT1;NUP42;NUP62;SLC38A2;SEH1L;MBTPS2;RPA2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.35586418092274835,0.8270957387820812,0.6754002911208151,0.968897247003021,1.0,2/21,3.62%,CCL5;PTK2B
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.23049791966815752,-0.8270638936401601,0.7729468599033816,0.9195016173246887,1.0,5/46,5.76%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,regulation of biomineral tissue development (GO:0070167),0.34304303490695587,0.8267092076316114,0.6914600550964187,0.9690915009759228,1.0,5/26,10.26%,ANKH;SGMS2;SOX9;FBXO5;TWIST1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2750050237764505,0.8264780248319503,0.7452725250278087,0.9685110319851689,1.0,19/104,18.53%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;TAB2;PSMD1;PSMC4
prerank,cellular response to lectin (GO:1990858),0.2750050237764505,0.8264780248319503,0.7452725250278087,0.9685110319851689,1.0,19/104,18.53%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;TAB2;PSMD1;PSMC4
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.35371091969982726,0.8263562912772517,0.6666666666666666,0.9682373141009497,1.0,5/21,12.83%,PMAIP1;BCL2L1;CREB3;EIF2AK3;OPA1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3739404836009099,0.8262751391564821,0.6845528455284553,0.9678899315701812,1.0,6/13,23.05%,RHOQ;AK3;OPA1;RAB23;GNAI3;EFL1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.342850979948518,0.8260446208338603,0.6882183908045977,0.9677773650878954,1.0,8/22,20.63%,ZC3H12A;MAP3K4;RELL1;EMC10;GADD45B;PRMT1;RELL2;AGER
prerank,actin filament network formation (GO:0051639),0.39415247898780326,0.8253714257005631,0.6747572815533981,0.9685166956887127,1.0,1/11,1.28%,COBL
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3776619386001652,0.8251158690334429,0.6798107255520505,0.9684828473252649,1.0,4/13,11.61%,PALM;GRM2;AKAP5;GABBR2
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.27390548539824067,0.8249323286222592,0.7475083056478405,0.968306026894456,1.0,19/105,18.53%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;TAB2;PSMD1;PSMC4
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.27392884772001364,-0.8249143947033349,0.6775244299674267,0.922489878987915,1.0,2/22,5.23%,PDE3B;PRKAA1
prerank,histone H3 acetylation (GO:0043966),-0.24776746628036742,-0.824913996307833,0.799163179916318,0.9213836517280026,1.0,9/40,14.91%,LEF1;MBIP;JADE1;KAT7;TAF12;BRCA2;TAF5L;KAT6A;WDR5
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.37587975663809636,0.8248525258355113,0.6835637480798771,0.9679625457185927,1.0,4/15,12.21%,EIF4A3;SIX1;TWIST1;TGFBR2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2793705628787028,0.8248190269884397,0.7480136208853575,0.9675212925298062,1.0,11/90,10.55%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;ZBTB7B;ACADL;ELOVL6;HDAC3;KDM3A
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2863045574384991,0.8244797331654264,0.7214611872146118,0.9676577392843312,1.0,13/78,14.32%,SORBS1;STAC3;RHOQ;BCL2L1;PTPN9;LGALS3;ACTB;AKAP5;CNPY4;EPHA3;VTI1B;VPS4A;ATP2B4
prerank,negative regulation of GTPase activity (GO:0034260),0.34822246444266813,0.8243200469790822,0.6852941176470588,0.9674385276604061,1.0,7/22,17.26%,CPEB2;SH3BP4;BCAS3;ARFGEF1;WNK1;HRAS;FICD
prerank,ERBB signaling pathway (GO:0038127),0.28850326222665085,0.824113236441094,0.7223557692307693,0.9673144650861863,1.0,17/64,20.32%,REPS2;GAB1;PTK2B;SOX9;SHC1;EFEMP1;ERBB3;IQGAP1;MVP;BCAR1;AAMP;HSP90AA1;STUB1;PTPN11;PTPN18;ADAM17;HBEGF
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.25847475193329217,0.8238846710963349,0.864321608040201,0.9672290885962798,1.0,71/366,18.22%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;FOXO3;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;PRRX2;MLF2;ESRRB;PHF1;PATZ1;POLR2A;HCFC1;KAT6B;EFEMP1;ZFHX3;ATRX;SIX1;FBXO5;PML;FOXP3;MYCBP;APBB1;GON4L;FADS1;ZNF205;NFYC;MYT1;ANKRD17;RABL3;SBNO2;AJUBA;TAF5;SP1;SPIN1;TFEB;MYBL1;CHD3;GPBP1;RREB1;NFIA;REXO4;MEF2C;SRRT;IRF2;PTP4A3;CCDC88A;UTP4;E2F1;NAB2;ABL1;PAK6;SPTY2D1;HINFP;LIN54;EIF2B4;MLLT6;SUFU;CHEK2;TRRAP;BRDT;WTIP;PRKCQ;ATF2;APBB3
prerank,ceramide biosynthetic process (GO:0046513),0.3115165297073803,0.8236913687265182,0.7180500658761528,0.9670834524818585,1.0,3/40,5.95%,SPTSSB;SGMS2;AGK
prerank,cilium organization (GO:0044782),0.26351747131099434,0.8236818912128354,0.8175257731958763,0.9666105361471874,1.0,40/209,18.45%,RAB17;CYS1;ABLIM1;PARVA;GSN;EHD1;CNGA2;INPP5E;ARL3;CCDC28B;RAB11FIP3;AVIL;EXOC7;IFT46;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;EXOC2;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;ATP6V1D;FLNA;ATP6V0D1;TMEM138;RAB8B;PTPDC1;CFAP61;HDAC6;WDR35;RILPL1;GALNT11;ODF2;FHDC1
prerank,peptidyl-amino acid modification (GO:0018193),0.3964963306414958,0.8236534526535522,0.6682692307692307,0.9661730546685832,1.0,3/10,21.20%,PDF;FKBP10;METAP1D
prerank,negative regulation of cyclase activity (GO:0031280),0.37353370399274594,0.8236217961837349,0.687888198757764,0.965741586405949,1.0,4/14,11.61%,PALM;GRM2;AKAP5;GABBR2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3845902937189061,0.8234999628850351,0.6814580031695721,0.9654618744680371,1.0,1/12,2.38%,NUPR1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3142492200377086,-0.8234288684897064,0.6810810810810811,0.9231435368450479,1.0,5/13,23.65%,PTGIS;PTGS2;NAXE;NAXD;NAMPT
prerank,actin filament-based transport (GO:0099515),-0.28361022862215923,-0.823255442163464,0.7193548387096774,0.9224017830988362,1.0,6/21,12.48%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO6;SYNE2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2786492870225682,0.8228924374879343,0.7497194163860831,0.9661151925172218,1.0,31/96,25.85%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;NDC1;RBM8A;AGFG1;WDR33;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RAE1;AAAS;SRSF1;SRSF5;THOC1;U2AF1;POM121;TPR;SRRM1;RANBP2;NUP42;NUP62;RBM15B;SEH1L
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.3461898169243391,0.822461019266874,0.6637554585152838,0.966407882076858,1.0,4/22,17.33%,CDKN1A;BMP4;TESK1;CDKN2D
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3679929550720298,0.8221965730749271,0.6815286624203821,0.9663905166901076,1.0,5/16,21.77%,RECQL4;MCM7;MCM6;TWNK;MCM4
prerank,mitotic metaphase plate congression (GO:0007080),0.2994471648806109,0.8221651202837932,0.7092731829573935,0.9659468975752018,1.0,21/51,26.87%,PSRC1;CHMP4A;CHMP4B;ZW10;VPS4B;PINX1;CHMP1A;VPS4A;MAD1L1;CHMP2A;PDCD6IP;RMDN1;NUDC;CDC23;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3352795407343199,0.8216598312941242,0.6783707865168539,0.9663563433711373,1.0,2/24,2.09%,CDKN1A;NIBAN2
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3912550551325231,0.8216188565440232,0.6587436332767402,0.9659273170325067,1.0,4/10,18.50%,RARG;RXRB;ACTN4;RARA
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.32551290955863127,0.8214668304061441,0.6983471074380165,0.9656878348009014,1.0,10/27,26.70%,CD44;RHOA;IRAK1;ITGB2;PRKCQ;NFAT5;SIRPA;IL6;RELA;THY1
prerank,cellular response to zinc ion (GO:0071294),-0.3027985062331042,-0.8207936678767135,0.7138643067846607,0.9260078792985815,1.0,10/15,36.13%,GLRA1;GLRA2;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.34046174521949213,0.820738034903059,0.6867977528089888,0.9664677660808579,1.0,3/26,7.87%,NINJ1;CAV1;LBP
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.31717013211618933,0.8205903973599972,0.6912928759894459,0.9662232149705133,1.0,1/35,0.41%,CLU
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4048420755345362,0.8202542399928523,0.6666666666666666,0.9663298731386646,1.0,3/10,16.85%,INSIG1;UBE2G2;UBE2J1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3039672820722092,-0.8201758287070158,0.7323943661971831,0.9261101334743062,1.0,9/15,34.53%,DAB2;PIK3CB;NEU3;HIP1R;TNK2;WASL;BMP2K;SCYL2;DGKD
prerank,muscle tissue morphogenesis (GO:0060415),-0.30635053216155056,-0.8200210667163523,0.7115987460815048,0.9253124613229405,1.0,3/16,13.14%,MYLK;NOTCH1;TBX1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.26814842470327,0.8198902272199698,0.8027571580063627,0.9664948042873449,1.0,30/163,19.83%,PRKCB;NFATC2;ZC3H12A;FYB2;PSMD11;EIF2B2;CSK;PSMD4;PSMF1;NFAM1;TXK;PSMD7;BCAR1;PSMB5;GATA3;MEF2C;CHUK;WNK1;RNF31;IKBKG;UBE2N;EIF2B4;SPPL3;TAB2;PSMD1;PRKCQ;PSMC4;STOML2;PRKD2;PSMD8
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2581962950886891,-0.8197483855382056,0.7306273062730627,0.9235939126308701,1.0,15/29,32.17%,ITGB3BP;RUVBL1;CENPP;NASP;HJURP;KNL1;MIS18BP1;CENPU;CENPX;CENPI;NPM1;MIS18A;CENPN;CENPA;SMARCA5
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2581962950886891,-0.8197483855382056,0.7306273062730627,0.9235939126308701,1.0,15/29,32.17%,ITGB3BP;RUVBL1;CENPP;NASP;HJURP;KNL1;MIS18BP1;CENPU;CENPX;CENPI;NPM1;MIS18A;CENPN;CENPA;SMARCA5
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.2880413675723982,-0.8197068809152714,0.696319018404908,0.9225743832671583,1.0,3/19,5.17%,IL34;PTK2;THBS1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2857273836992598,-0.8192030953510512,0.7083333333333334,0.9223669532690546,1.0,4/21,11.90%,CYP26B1;PPARD;ACOX1;LPIN2
prerank,amino sugar metabolic process (GO:0006040),0.4032720673875729,0.8190285206899611,0.6882067851373183,0.9675413744141448,1.0,1/10,1.03%,B4GALNT2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3429174454955086,0.818969470296821,0.7126099706744868,0.9671575071346674,1.0,5/20,15.33%,DAXX;DCUN1D5;DCUN1D1;WASHC1;HSP90AA1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.30040652070388646,0.8188745234148813,0.6958698372966208,0.9668438763500312,1.0,9/48,17.44%,IKBKE;EP300;PHLDA3;BCL2L1;PML;USP28;E2F1;ABL1;CHEK2
prerank,tyrosine metabolic process (GO:0006570),-0.3314599456835936,-0.8184912574587258,0.6726804123711341,0.9225322631684183,1.0,1/11,3.47%,GSTZ1
prerank,ATP synthesis coupled proton transport (GO:0015986),0.35607927332246375,0.8183060362369399,0.6885758998435054,0.9673618137580775,1.0,9/17,26.36%,ATP5PF;ATP5F1B;STOML2;VPS9D1;ATP5PD;ATP5ME;ATP5MC3;ATP5F1C;ATP5F1D
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.24759397622659512,-0.818021916154791,0.7758007117437722,0.9222766714989541,1.0,17/30,33.36%,DNAJB4;DNAJC18;DNAJB12;SELENOF;ST13;DNAJB5;CCT2;ENTPD5;HSPA9;DNAJB1;GAK;HSPA1B;HSPA2;UGGT1;SDF2L1;HSPA5;CHCHD4
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.34824416639997785,-0.8178226747084183,0.7109375,0.920467276145019,1.0,3/10,7.34%,CLTA;MYLIP;AP2B1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.34824416639997785,-0.8178226747084183,0.7109375,0.920467276145019,1.0,3/10,7.34%,CLTA;MYLIP;AP2B1
prerank,DNA repair (GO:0006281),0.2564657530236837,0.8177960487201905,0.8406091370558376,0.9677748114698946,1.0,66/284,20.61%,FEN1;MLH1;RECQL4;DOT1L;NABP2;KDM4B;ASF1A;NSMCE4A;PARP3;MRE11;EYA1;TEX264;CENPS;INIP;RAD54L;TENT4A;POLK;WDR33;UBE2B;APBB1;MUTYH;USP3;MDC1;CSNK1E;HUS1B;TOPBP1;ABRAXAS1;PWWP3A;ERCC5;MBD4;MLH3;BTG2;RPA3;REXO4;ENDOV;POLH;APTX;POLD2;DCLRE1C;LIG3;FAN1;DDB1;ATR;PCNA;UBE2N;ABL1;ERCC2;HINFP;NEIL1;UBC;RPS27A;NBN;CDKN2D;CHEK2;INTS3;TRRAP;RAD50;PARP2;PARK7;NUCKS1;PNKP;UVRAG;ERCC4;POLN;APEX2;NABP1
prerank,regulation of myelination (GO:0031641),-0.25926075710900354,-0.8177447861965483,0.7465277777777778,0.9195498032355093,1.0,7/25,16.36%,PTPRZ1;TNFRSF21;TENM4;TPPP;TNFRSF1B;MYRF;SIRT2
prerank,negative regulation of protein modification process (GO:0031400),0.27980164432744087,0.8174714391054304,0.7415990730011588,0.9678657642139634,1.0,10/79,9.23%,NTRK3;PRKAA2;OCLN;ZC3H12A;PPP1R15A;FBLN1;PIP5KL1;CHP1;YWHAB;FKBP8
prerank,phagolysosome assembly (GO:0001845),0.37854069028468973,0.8172863203300034,0.6698113207547169,0.9677048670465531,1.0,2/12,8.40%,RAB7A;RAB7B
prerank,neuronal action potential (GO:0019228),0.3451075334059192,0.8172516367847567,0.672463768115942,0.9672754562461807,1.0,6/22,21.61%,SCN3A;ANK3;SCN9A;GPER1;KCNMB2;KCNMB3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2697346467311631,-0.8171552968058967,0.7090301003344481,0.9195129265008103,1.0,6/25,11.29%,STAT5B;HIF1A;ACVR1B;ACVR2A;NCKAP1L;STAT3
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.3658070544142746,0.8170811225588267,0.6898638426626323,0.967105497347871,1.0,4/14,9.97%,CMPK1;DCTPP1;AK5;AK3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.32449376184810425,0.8170393297513036,0.7008310249307479,0.9666973485070565,1.0,4/28,9.45%,KDM4D;SHLD2;PARP3;RIF1
prerank,neuron maturation (GO:0042551),-0.28660987677736743,-0.8167379879965796,0.7052023121387283,0.9192269698732585,1.0,6/18,20.77%,ADGRB3;ANKS1A;C1QA;B4GALT5;EPHA8;CX3CL1
prerank,RNA biosynthetic process (GO:0032774),0.31841686934742275,0.8162168154659598,0.6965986394557823,0.9677045394060072,1.0,11/31,28.11%,POLR2A;TAF5;TCEA2;PRIM2;TBPL1;TBP;TAF6;TTF1;TAF4;TERT;BRF1
prerank,regulation of protein polymerization (GO:0032271),0.3166559634421001,0.8161587492979104,0.7112299465240641,0.9673345187727476,1.0,13/35,20.05%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1;RASA1;HSP90AA1;CAMSAP1;ABL1;PFN2;PLEKHG2;DBN1;MAPT
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.31831942104583155,-0.816119262122208,0.6866485013623979,0.9192518934960258,1.0,3/11,11.65%,FOXO1;NOTCH1;GLRX3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3341826987817189,0.8159263853138266,0.6841359773371105,0.9672323712605586,1.0,7/21,23.79%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2;CDC25A
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3567350508240394,0.8152593955181148,0.6702619414483821,0.9679309334173716,1.0,1/15,1.19%,LDLR
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3265615837347832,0.81475789578543,0.6902404526166902,0.9682911315659236,1.0,8/28,17.03%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1;RASA1;PFN2;PLEKHG2
prerank,histone H4 deacetylation (GO:0070933),0.39685592955645377,0.814537138244247,0.6886035313001605,0.9681856635982473,1.0,2/10,10.09%,HDAC4;HDAC3
prerank,receptor internalization (GO:0031623),0.30584201044786674,0.8143146727514158,0.7215836526181354,0.9680683248469755,1.0,9/44,15.90%,CAV1;CD81;ACKR3;RAMP1;CD9;GRK2;FCER1G;NEDD4;ITGB2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.28578702787272775,-0.8140965662596275,0.7217391304347827,0.9218061603885582,1.0,5/18,17.04%,DAB2IP;TP53;NF1;CD300A;B4GALT7
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.3866074720367823,0.81396898726983,0.6798732171156894,0.9681830252462001,1.0,1/12,3.33%,HAGH
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.25489561449355086,-0.8137536365481854,0.794425087108014,0.9213031780039203,1.0,8/29,15.15%,TUT4;ADAR;HNRNPA2B1;ZC3H7B;DROSHA;SMAD3;SNIP1;AGO1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.30464406628416657,0.8137143796453251,0.7300771208226221,0.9681321064908693,1.0,7/45,10.84%,CD44;TRIM25;IRF3;TRIM21;PML;TRIM26;JAK1
prerank,regulation of monocyte differentiation (GO:0045655),0.36703185393400756,0.8136760349915543,0.6721804511278195,0.9677239865022634,1.0,4/14,14.22%,CDK6;ACIN1;MYC;FOXP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.32560448593840713,0.8132748429999546,0.6991643454038997,0.9679651818301138,1.0,9/26,18.93%,HOMER2;HOMER3;RCAN1;CHP1;GSK3B;ATP2B4;SLC9A1;SPPL3;PTBP1
prerank,regulation of mRNA processing (GO:0050684),0.3150598528112629,0.8132222990912515,0.6951871657754011,0.9675724845971161,1.0,8/32,15.68%,AHCYL1;SON;SLTM;LARP7;SRPK2;SRPK1;DHX9;PABPN1
prerank,glucose metabolic process (GO:0006006),0.2922170172554765,0.8126100277281687,0.7086801426872771,0.9681806812375081,1.0,11/58,16.30%,PPARGC1A;HECTD4;SLC25A1;ENO2;MDH2;IRS2;GAPDH;ALDOA;DCXR;SLC25A12;TPI1
prerank,response to amyloid-beta (GO:1904645),0.3054169474432039,0.8124368446413804,0.7210191082802547,0.9679817046919852,1.0,6/44,11.47%,MMP9;EPHA4;CACNA1A;TLR6;MMP12;TLR4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3240227845503473,-0.8120589713779056,0.7092391304347826,0.9233342489679731,1.0,4/12,17.32%,AR;TGFB1;EDN1;HDAC2
prerank,cellular metal ion homeostasis (GO:0006875),0.275648127389167,0.8119868172090514,0.7720090293453724,0.9682819342108644,1.0,8/102,5.78%,ANK2;STIM2;CCL5;CAV1;ATP1A2;CSRP3;ATP13A3;TMEM165
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2804594889872221,0.8119395710813445,0.7753705815279361,0.967885389610781,1.0,8/86,6.45%,ANGPT1;CD44;IL15;CD81;PTK2B;EFNA5;DMTN;HAX1
prerank,negative regulation of cation channel activity (GO:2001258),0.3337852527767111,0.8115863069627074,0.6940298507462687,0.9680254872077261,1.0,3/26,7.00%,MMP9;EPO;GSTO1
prerank,homeostasis of number of cells (GO:0048872),0.3753343628941628,0.8115482232489293,0.6855345911949685,0.9676145756083064,1.0,1/12,0.89%,NAPEPLD
prerank,regulation of defense response to virus (GO:0050688),0.3629303681730316,0.8113500557980462,0.7001569858712716,0.9674501043664855,1.0,5/14,24.50%,PPM1B;DHX9;ILRUN;PCBP2;C1QBP
prerank,sulfur amino acid metabolic process (GO:0000096),-0.263241147417447,-0.8111191369917743,0.7368421052631579,0.9239494498358304,1.0,10/24,33.11%,NOX4;MSRA;MTR;MTHFR;ADI1;CTH;SMS;AHCY;MMUT;GCLC
prerank,positive regulation of interleukin-1 production (GO:0032732),0.3005171289170748,0.8111045137158044,0.7440633245382586,0.967368096963349,1.0,7/51,11.47%,NLRP2;IL16;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.33585923971654746,0.810783659671542,0.7190201729106628,0.9674209580066424,1.0,4/24,10.52%,NUPR1;FOXO3;TGFB2;SRPK2
prerank,peroxisome organization (GO:0007031),0.33330264806320153,0.8107150773142062,0.7035971223021583,0.9670537563985061,1.0,7/25,18.84%,ACOT8;ABCD1;PEX11G;DNM1L;PEX6;PEX3;PEX2
prerank,regulation of transport (GO:0051049),-0.23454745314977377,-0.8104961240364026,0.7953667953667953,0.9240765833745981,1.0,6/36,11.91%,LEPR;EPB41;LRRK2;DNAJA1;ICA1;MYO6
prerank,positive regulation of tissue remodeling (GO:0034105),0.387861030137732,0.8104930176718107,0.6766666666666666,0.9669676118687182,1.0,1/10,2.50%,IL15
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.2784295309438328,-0.809912984635119,0.7370030581039755,0.9240265643891645,1.0,13/21,36.21%,PAG1;SOX11;TNFAIP3;JAK3;PIBF1;FCGR2B;BANK1;LST1;SAMSN1;FOXJ1;LAX1;IL4I1;PTPN22
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.2643481689687693,-0.8093543548333786,0.7643312101910829,0.9239286978042536,1.0,3/24,6.08%,CDH2;BOC;CTNNA2
prerank,intracellular protein transport (GO:0006886),0.25503590201928883,0.8092022165196565,0.8554095045500506,0.9686890733485854,1.0,79/304,22.61%,RAB17;RANBP3L;GRTP1;HOMER3;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;TMED1;SIL1;IPO7;TSC2;NUP93;WLS;DESI1;STXBP1;RAB7A;PKD1;TNPO2;CHP1;BAG3;MYO1C;GGA1;MMP12;SGSM2;TECPR2;AP1S3;ARFIP2;AP2A1;TBC1D1;RABL3;STX11;NAPA;VIPAS39;ARF4;VPS26B;NAPB;NXT2;TNPO1;RAB5C;PREB;RAB1B;STX16;HEATR3;RANBP6;USP6NL;IPO4;AP4E1;TBC1D22A;NSF;TBC1D10A;ARFRP1;HDAC6;STAM;CSE1L;SEC23IP;STX4;PPP1R10;TMED5;SEC31B;YWHAH;XPO4;TBCK;TBC1D17;HIKESHI;SEC31A;SEC16A;ARFIP1;RAB3GAP2;RANBP3;RABGAP1;AP4M1;VPS26A;AP3D1;POM121;RAB23
prerank,cellular response to peptide (GO:1901653),0.2949028121610482,0.8091771719690433,0.7367788461538461,0.9682540346576216,1.0,9/56,14.97%,VIM;EPHA4;CACNA1A;CAV1;TRIM41;TLR6;TLR4;GSK3B;MDM2
prerank,inorganic anion transport (GO:0015698),-0.22103867759818166,-0.8088529825489078,0.8402061855670103,0.9237597809545707,1.0,13/53,18.83%,SLC26A7;SLC4A10;ENPP1;ANO4;GLRA1;ENPP3;XPR1;TTYH1;CLIC5;SLC5A5;SLC26A6;CLCN1;FXYD1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.36504854832267375,0.8079539866391943,0.6776212832550861,0.9699370710558335,1.0,3/13,11.13%,HEXA;ARSB;HEXB
prerank,glial cell differentiation (GO:0010001),0.3206467118994275,0.8079167126302342,0.7252440725244073,0.9695176557110287,1.0,5/28,10.80%,GPC1;SOX9;ERBB3;NFIB;ADGRG6
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2518033661141906,0.8078398857933122,0.964,0.9691747042321692,1.0,148/834,16.93%,CDH13;KLF5;THRB;TMPRSS6;TFAP2C;KLF4;PPARGC1A;NCOA3;PBX1;GAL;OGT;ELF3;SREBF2;GLI3;MICAL2;GTF2F1;HIVEP1;ZC3H12A;GABPB1;GABPB2;MAVS;HDAC5;EP300;CD81;FOXO3;CSRP3;FOS;FOXC2;GDNF;GLIS2;BMP5;HDAC4;NFE2L2;SSBP3;DOT1L;SMARCB1;RHOQ;POU2F3;FOXD2;NFKBIA;ESRRB;RARG;IRF3;NKX2-8;JUND;CREB1;RNASEL;FOXM1;ZBTB17;RXRB;HOXA5;HCFC1;HAX1;SOX9;NRF1;AKNA;DDRGK1;KAT6B;MYDGF;PHF10;MAPK7;BMP4;MEF2D;KLF7;TGFB2;MED30;ZFHX3;DVL3;FIZ1;ATRX;SIX1;LARP7;TCF7L2;PKD1;FZD5;JUN;TNFRSF1A;KMT2A;GRHL2;FOXP3;DPF2;TXK;APBB1;PRDM15;HDAC3;TWIST1;BCAS3;NFIB;NFIC;SMARCA4;CREB3L4;CREB3;MMP12;TLR4;CALCOCO1;SBNO2;DR1;MEF2B;MPND;SP1;MYSM1;DCAF6;COPS5;ELL;MED12;TFEB;SMARCD2;MYBL1;GATA3;MED21;MED24;RREB1;NFIA;CAPRIN2;ARF4;MYC;TNIP1;MEF2C;CHUK;PAX3;ITGB1BP1;IRF2;FLCN;ATMIN;HRAS;SS18L2;TLR3;RFXAP;DHX9;KLF6;TET1;MED6;ZMIZ2;IKBKG;E2F1;SLC9A1;MEPCE;CDC5L;CAMTA2;ABL1;HINFP;KDM1A;RNF10;HSF2;POU4F1;UBC;RPS27A;SMAD5
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3300892297576841,0.8075404114024579,0.7155555555555555,0.9691973424013747,1.0,5/23,10.78%,DGAT1;ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2837355501428898,0.8073891773474962,0.7389221556886227,0.9689930225625293,1.0,11/69,15.61%,CLU;MAVS;TNFRSF8;HSPB1;LBP;FZD5;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2908223658074531,0.8073607829514137,0.751486325802616,0.9685601084043015,1.0,13/60,16.70%,CDKN1A;CDK4;MOV10;SOX9;MED30;TCF7L2;CCND1;MED8;PPM1D;MED12;MED24;MED6;MED27
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3810064514294964,0.807026170148626,0.6978653530377669,0.9686470869813731,1.0,2/12,8.35%,SERINC5;PHGDH
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.3846699838008763,0.8068905020713366,0.7060702875399361,0.9683990059479197,1.0,6/12,19.36%,SMARCA4;NCOR1;SFRP1;NCOR2;FOXP1;ZBTB7A
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3282705033718156,-0.8060274540914795,0.6825396825396826,0.9277357641781243,1.0,7/11,28.94%,PLEKHA7;KIT;CCN3;KIFC3;DSP;JUP;CAMSAP3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.35547530340527655,0.8060021133998537,0.7038690476190477,0.9689714845758887,1.0,5/17,11.74%,IL7R;JAK1;SMARCA4;IRS2;SOCS2
prerank,cellular response to interleukin-7 (GO:0098761),0.35547530340527655,0.8060021133998537,0.7038690476190477,0.9689714845758887,1.0,5/17,11.74%,IL7R;JAK1;SMARCA4;IRS2;SOCS2
prerank,ncRNA metabolic process (GO:0034660),0.31100761519247794,0.8056640649494287,0.6973333333333334,0.969055138016745,1.0,7/37,15.93%,DGCR8;TARBP2;MOV10L1;ZCCHC8;TUT7;DTD1;MEPCE
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.23992582355255465,-0.8054135495143986,0.8161764705882353,0.9277155306207009,1.0,2/32,2.46%,CEMIP;TRPC3
prerank,calcium ion import (GO:0070509),0.318612000873337,0.804741934194437,0.7121418826739427,0.9700998631236778,1.0,7/28,13.49%,CACNA1A;MCU;MCUB;MICU1;AFG3L2;MCUR1;CACNB2
prerank,transferrin transport (GO:0033572),0.3078228879843698,0.8046287464290078,0.7078947368421052,0.9698084346882639,1.0,9/33,20.61%,ATP6V1B1;LMTK2;ATP6V1D;ATP6V1E1;ATP6V0D1;ATP6V1B2;ATP6V0B;REP15;ATP6AP1
prerank,covalent chromatin modification (GO:0016569),-0.30006555700053034,-0.8046219820105861,0.7506561679790026,0.9280272057034799,1.0,2/14,4.22%,MBD2;SETD5
prerank,positive regulation of protein deacetylation (GO:0090312),-0.30356523758811993,-0.8044697405582719,0.7374301675977654,0.9271913647416168,1.0,6/14,21.65%,SAP30BP;ING2;NIPBL;DYRK1A;APLNR;BRMS1
prerank,positive regulation of immune system process (GO:0002684),0.35664260138519965,0.804083184019458,0.6979655712050078,0.9702368355514674,1.0,2/16,7.30%,IL15;TGFB2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3220830581019963,-0.8040265095157668,0.7127371273712737,0.926855842258658,1.0,3/13,2.91%,GAS6;AXL;WNT5A
prerank,regulation of sister chromatid cohesion (GO:0007063),0.38411358039950383,0.8039233912072065,0.7142857142857143,0.9700374271607786,1.0,6/12,29.76%,FEN1;WAPL;RB1;HDAC8;CTNNB1;DDX11
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.33263380693195144,0.8037274239853591,0.7224669603524229,0.969895132718748,1.0,5/21,13.22%,MED30;JUN;TWIST1;MED12;MED24
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.26650365984709345,-0.8036867018743461,0.7508650519031141,0.9264015769312752,1.0,6/23,16.36%,TGM2;LRRK2;PDE4B;RYR2;GNB1;SIRT2
prerank,negative regulation of histone methylation (GO:0031061),-0.33225438971440235,-0.8036527239536723,0.7,0.9253931807267035,1.0,4/10,14.91%,JARID2;BCOR;MTF2;WDR5
prerank,mRNA methylation (GO:0080009),-0.30159627014312385,-0.803517625751182,0.7147335423197492,0.9245873961371791,1.0,5/15,21.92%,METTL8;METTL16;TRMT61B;TRMT6;TRMT10C
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3172275873845135,0.8033134390600012,0.7250673854447439,0.9701163881754925,1.0,9/31,22.34%,SCAMP5;STXBP1;KCNB1;SYT6;SYT11;SYT12;SYT3;SYT2;CBARP
prerank,regulation of protein kinase B signaling (GO:0051896),0.2598953795722491,0.8029175360498334,0.8130165289256198,0.9703040934829669,1.0,19/193,8.41%,FGFR1;ANGPT1;NTRK3;DAG1;MAGI2;GDF15;GAB1;PHLDA3;GCNT2;MTDH;TSC2;HAX1;GRM2;MUL1;MYDGF;ERBB3;FGF22;TCF7L2;MAZ
prerank,cellular potassium ion homeostasis (GO:0030007),-0.31167322566013045,-0.8028677949510643,0.7331536388140162,0.9246519030718162,1.0,3/13,6.02%,ATP1B1;SLC12A2;KCNJ2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.3132704021502628,0.8025499982310756,0.711864406779661,0.9704460492275165,1.0,2/30,2.09%,CDKN1A;NIBAN2
prerank,regulation of chemotaxis (GO:0050920),0.3276347360711297,0.8025120362861514,0.7164591977869986,0.9700335130833996,1.0,6/30,12.36%,EFNB2;YTHDF1;CXCR4;ADGRA2;ZSWIM8;PTPN2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.352866217908236,0.8024611083732947,0.6967840735068913,0.9696458547354939,1.0,3/16,9.45%,SHLD2;KLHL15;RIF1
prerank,regulation of cellular response to heat (GO:1900034),0.27707179859202513,0.8021268279175913,0.779463243873979,0.9697257919083864,1.0,31/77,28.65%,EP300;BAG1;CRYAB;HSPB8;NUP93;CHORDC1;NDC1;BAG3;RPA3;GSK3B;HSPH1;HSP90AA1;ATR;MAPKAPK2;RAE1;AAAS;CAMK2B;MAPT;HIKESHI;PTGES3;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;RPA2;NUP133;DNAJB6;NUP35;HSPA8
prerank,cellular protein-containing complex assembly (GO:0034622),0.2588326025389501,0.8019021050768591,0.8266384778012685,0.969614944034475,1.0,17/159,10.09%,CLU;ANGPT1;STXBP6;CLTB;PSMD11;NUP93;POMP;PSMD4;PXN;STXBP1;CHMP4A;CHMP4B;HSPA4;CENPT;NDC1;EIF4B;COX7A2L
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3065069663819727,0.8018106917448135,0.7305236270753512,0.9692999060597797,1.0,7/42,12.50%,WNT1;EMP2;GCNT2;DMTN;RHOA;NPNT;PDPN
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3298113248427119,0.8016392923393562,0.7146974063400576,0.9691244025504577,1.0,4/22,9.25%,CDKN1A;IPO7;LATS1;CDK5RAP1
prerank,histone mRNA metabolic process (GO:0008334),0.3173831994047325,0.8014040352218662,0.7072829131652661,0.9690452607300638,1.0,2/27,5.44%,LSM10;SNRPB
prerank,outflow tract septum morphogenesis (GO:0003148),0.32829774562025105,0.8011086915649414,0.7084507042253522,0.969050138468673,1.0,6/24,12.21%,PARVA;SMAD6;BMP4;TGFB2;NRP2;TGFBR2
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.38235863711329576,0.8010562226397951,0.6978998384491115,0.9681847096767415,1.0,3/10,21.25%,CACNA2D4;CNGB1;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.38235863711329576,0.8010562226397951,0.6978998384491115,0.9681847096767415,1.0,3/10,21.25%,CACNA2D4;CNGB1;TULP1
prerank,tRNA methylation (GO:0030488),-0.2374172298594682,-0.8010434154989277,0.8009049773755657,0.9267745360034152,1.0,15/34,25.54%,TARBP1;METTL1;TRMT61B;TRMT10A;TRMT5;THUMPD2;TRMO;TRMT1L;GTPBP3;TRMT44;ALKBH8;TRMT10C;TYW3;BCDIN3D;PRORP
prerank,response to progesterone (GO:0032570),-0.28077649114908104,-0.7998284634970793,0.778125,0.9278597158378868,1.0,6/18,17.14%,THBS1;NR1H3;TGFB1;UBE3A;CATSPER3;ABHD2
prerank,quinone biosynthetic process (GO:1901663),0.36532227744610624,0.7998094949122971,0.6929133858267716,0.9697621009806004,1.0,2/14,8.44%,UBIAD1;PDSS2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3362579094172098,0.7997611388016724,0.7245508982035929,0.9693740296364022,1.0,4/21,12.95%,SMO;PDCL;EVC;SFRP1
prerank,B cell activation involved in immune response (GO:0002312),0.3730374541365678,0.7994984236949609,0.7035256410256411,0.96932859002231,1.0,5/13,30.38%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,smoothened signaling pathway (GO:0007224),0.30843625615151427,0.7991609705270158,0.71,0.9694247981657141,1.0,4/32,11.60%,SMO;GLI3;CC2D2A;PKD2L1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3038544619325185,0.799031198762712,0.7377717391304348,0.9691619693370538,1.0,15/35,29.80%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;CCT8;CTNNB1;NAF1;CCT6A
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3349855567660938,0.7990112618538234,0.6831395348837209,0.9687239010811693,1.0,4/22,10.41%,TIMP4;TIMP1;TIMP2;SNX33
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.24217105081441254,-0.7987131580161935,0.7967479674796748,0.9287292105187228,1.0,12/32,26.31%,CDK14;CDK17;BRD4;ID2;DHFR;NPAT;ORC1;TYMS;TFDP2;CDC45;POLA1;BACH1
prerank,necroptotic process (GO:0070266),-0.28699627765530156,-0.7985279905407157,0.7560240963855421,0.9279898317473102,1.0,6/16,22.07%,ITPK1;PGAM5;RIPK1;IPMK;CYLD;MLKL
prerank,extracellular matrix assembly (GO:0085029),0.324046346934019,0.7983600910489842,0.7204610951008645,0.9693207398500372,1.0,3/23,10.13%,TNXB;PXDN;LAMB2
prerank,positive regulation of histone modification (GO:0031058),0.3149249706829129,0.7982231898701957,0.7417582417582418,0.9690704865195251,1.0,7/33,16.74%,PPARGC1A;ZBTB7B;FOXP3;BRD7;TET1;UBE2N;KDM1A
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.1955932153836407,-0.7981296870702099,0.8740740740740741,0.9275855728004933,1.0,36/82,37.02%,CEP250;CCP110;CEP78;ALMS1;NDE1;PRKAR2B;TP53;NEDD1;CSNK1D;SDCCAG8;KCNH5;CKAP5;CEP41;MAPRE1;HAUS4;HAUS7;CEP72;SSNA1;YWHAE;TUBB4B;HAUS6;CEP131;NPM1;TPX2;CEP135;HMMR;KIF14;TUBA4A;PCNT;ATAD5;NEK10;CETN2;AURKA;HAUS3;CDK1;PLK1
prerank,regulation of cellular component size (GO:0032535),0.31500453358128844,0.797859764673607,0.7286501377410468,0.9692015371298229,1.0,6/30,9.98%,PPP1R15A;RARG;MSN;PEX11G;RAB3B;EZR
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3921301221059047,0.7978491126003359,0.7049180327868853,0.968747318970289,1.0,2/10,18.95%,THAP4;KYAT1
prerank,cellular response to superoxide (GO:0071451),-0.3331931631551169,-0.7978303135272469,0.718421052631579,0.9270444294781527,1.0,3/10,18.59%,NOS3;SOD3;SOD1
prerank,epithelium development (GO:0060429),0.26879396018344687,0.797270990283198,0.7878453038674034,0.9692295076621038,1.0,11/107,9.05%,UPK1B;SMO;DAG1;KANK2;ANXA4;PIH1D1;SOX9;SIX1;PKD1;LGALS3;GRHL2
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3167509719478104,-0.7969158723522844,0.7423469387755102,0.9274933306676085,1.0,6/12,23.23%,LRRK2;CLN3;VPS33A;CCDC115;TMEM9;CLN6
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.31123186728803165,0.7964629894027875,0.7309236947791165,0.9701232413751972,1.0,12/32,24.78%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;POLR2K;MNAT1
prerank,sphingoid biosynthetic process (GO:0046520),-0.33479946653879844,-0.7963245791622747,0.743073047858942,0.9263508697549601,1.0,6/11,32.97%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,sphingosine biosynthetic process (GO:0046512),-0.33479946653879844,-0.7963245791622747,0.743073047858942,0.9263508697549601,1.0,6/11,32.97%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.29497016543724763,0.7961771317372675,0.7419354838709677,0.970121262528323,1.0,12/48,16.89%,ADCY9;GUCY2F;IMPDH2;NUDT2;DCAKD;GMPS;ADCY6;AK5;ADCY10;AMPD2;PPCDC;ADSS2
prerank,regulation of biosynthetic process (GO:0009889),0.38452161615122926,0.7959832848134047,0.714759535655058,0.9699764315001591,1.0,1/11,5.15%,ALOX5
prerank,regulation of cellular senescence (GO:2000772),-0.25189982371433944,-0.7958319985193664,0.7933579335793358,0.9260879663776443,1.0,8/28,14.02%,SLC30A10;AKT3;RBL1;B2M;ING2;RSL1D1;HMGA2;NEK6
prerank,phospholipid transport (GO:0015914),0.2872147596579245,0.7954200252293749,0.759748427672956,0.9704270811903156,1.0,5/52,6.74%,LDLR;ATP10A;PRELID3B;PITPNC1;ATP8B2
prerank,B cell differentiation (GO:0030183),0.2937083584348683,0.7944734797277091,0.7618437900128041,0.9715308841370538,1.0,13/46,20.35%,HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;KLF6;IRF2BP2;TPD52;ZBTB7A;ADAM17;DCAF1
prerank,protein catabolic process (GO:0030163),0.28261257641663906,0.7942617323385279,0.7563025210084033,0.9714344194696009,1.0,14/59,19.72%,PMAIP1;ATE1;RNF5;DENND3;UBE2G2;MANBA;SOCS6;HSP90AA1;DDB1;PRPF19;SIAH1;CHEK2;RNF41;IDE
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3064260427850747,0.7941674263765793,0.7201591511936339,0.971111373838244,1.0,2/33,1.46%,ARAP1;MMP9
prerank,DNA conformation change (GO:0071103),-0.2945975863634063,-0.7939190031475966,0.7538940809968847,0.9281939229757885,1.0,6/17,22.45%,TOP3A;KAT6A;ERCC3;HMGB1;HHEX;TOP2A
prerank,nucleus organization (GO:0006997),0.289404322433955,0.793708476477032,0.7535667963683528,0.9714108481407181,1.0,14/47,18.23%,REEP3;NUP93;CHMP4A;CHMP4B;NDC1;TOR1A;VPS4B;CHMP1A;VPS4A;REEP4;CHMP2A;NUMA1;PDCD6IP;SUN2
prerank,histone H2B ubiquitination (GO:0033523),-0.33014938902718544,-0.7934215984032371,0.7474747474747475,0.9279591761536959,1.0,3/10,18.12%,WAC;DTX3L;PAF1
prerank,histone methylation (GO:0016571),0.31845693709247,0.7933018727591418,0.7337110481586402,0.9715999438674573,1.0,10/26,25.77%,NTMT1;SMYD3;PRMT1;TRMT112;PRMT2;SMYD1;SIRT7;N6AMT1;EHMT1;SMYD2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.33259957829263875,0.7931058942735768,0.7477477477477478,0.9714452359948232,1.0,9/19,26.87%,CHMP4B;VPS4B;CHMP1A;CHMP2A;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,phosphatidic acid metabolic process (GO:0046473),-0.22007753282187567,-0.7930410501997706,0.8663366336633663,0.9274800164057152,1.0,5/48,5.76%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,primary alcohol metabolic process (GO:0034308),0.32619438250026983,0.7929438884571113,0.736231884057971,0.9712622170715884,1.0,3/25,8.84%,NAPEPLD;ADH7;PECR
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.32051788328186737,0.7923949366564562,0.7231404958677686,0.9717008632931136,1.0,7/29,13.67%,EP300;PYGO2;TCF7L2;SMARCA4;TLE2;TLE4;MYC
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.31200942612378585,-0.7922563674770159,0.7303664921465969,0.9277074998333841,1.0,3/12,7.58%,TMED10;RANBP9;ROCK1
prerank,ceramide catabolic process (GO:0046514),0.3599898445973337,0.7921289781167972,0.7315112540192926,0.9716292200407549,1.0,3/14,14.76%,HEXA;HEXB;NAGA
prerank,axonal fasciculation (GO:0007413),-0.30415974780186567,-0.7920524962731932,0.7544757033248082,0.9269989613837738,1.0,6/12,18.19%,SEMA5A;NRCAM;EPHB2;MEGF8;EPHB3;ARHGAP35
prerank,long-term memory (GO:0007616),0.3347597739728077,0.7915455731268238,0.712166172106825,0.9721149529131718,1.0,1/19,1.19%,LDLR
prerank,ERBB2 signaling pathway (GO:0038128),-0.2409310551755151,-0.7914087625879106,0.8168498168498168,0.9270130163286897,1.0,9/31,17.61%,PIK3R1;ERBIN;PTPN12;ERBB4;MYOC;GRB2;CUL5;EGF;CDC37
prerank,DNA geometric change (GO:0032392),0.3262682163655967,0.7913510398424061,0.7450142450142451,0.9719637397883385,1.0,5/24,18.15%,RECQL4;MRE11;DHX9;NBN;RAD50
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3059630129005956,0.7913137165348644,0.7292225201072386,0.9715585888229397,1.0,1/35,0.37%,CDH13
prerank,muscle cell migration (GO:0014812),0.38596501848338444,0.7911856662710836,0.71,0.9712957191813854,1.0,5/10,18.20%,SIX1;DDR1;ITGB1BP1;AAMP;THBS4
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.326593436625809,0.7910747516504183,0.7038081805359662,0.9710076224940744,1.0,5/23,15.68%,ALOX5;ELOVL6;FADS1;LTA4H;GSTM2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.24076644145155843,-0.7905230062428678,0.8097014925373134,0.9273797541024709,1.0,11/33,20.29%,UBR1;GLRA1;IPO5;CPEB1;SLC38A9;LAMTOR1;KLHL22;RRAGD;GLRA2;RRAGA;CASTOR1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.31219882496735907,-0.7900805301722625,0.7378378378378379,0.9270331009868413,1.0,3/12,10.88%,BDP1;TAF1B;TAF12
prerank,B cell proliferation (GO:0042100),-0.28523726013649553,-0.7900646185626018,0.7594594594594595,0.9260173406358272,1.0,4/17,19.85%,BCL2;CTPS1;CD40;HSPD1
prerank,peptide biosynthetic process (GO:0043043),0.2584419969691619,0.7899704220625825,0.8290870488322718,0.9723776120829096,1.0,42/153,22.56%,MRPS16;EEF1A1;MRPL24;MRPL37;HARS1;RPS4X;MRPS7;RPSA;ABCF1;RPL31;RPL22;GSPT2;MRPS33;CARNS1;RPL28;SRBD1;RPS26;MRPL9;COPS5;TNIP1;HARS2;RPL10A;EIF4G1;SARS1;RRBP1;MRPS15;RPL14;MRPS18C;RPS27A;HBS1L;IGF2BP3;FARSB;RPL6;EIF4EBP2;RPS28;RHD;RPL41;RPLP2;YARS2;RPLP1;IGHMBP2;RPL7
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.323827799742589,0.7899675810795734,0.7335164835164835,0.9719168469534168,1.0,6/26,22.35%,OCLN;PSRC1;NUMA1;MAPT;CDK5R1;TRPV4
prerank,intermediate filament organization (GO:0045109),0.3467577563201961,0.7899360490829919,0.7130044843049327,0.9715050109733773,1.0,2/17,10.25%,VIM;KLHL24
prerank,central nervous system development (GO:0007417),0.24936928982543505,0.7898989749666305,0.8780737704918032,0.9710954899370181,1.0,33/250,13.03%,CELSR1;TBR1;PBX3;PBX1;ZIC4;SMO;PDGFC;GSN;CXCR4;QARS1;ADGRL2;GLIS2;ZBTB16;CTNS;EIF2B2;ZIC2;SOX9;LSR;ZFHX3;CIC;PHGDH;PKD1;GRHL2;CDK5RAP1;ZIC1;ADGRA2;IER3IP1;NFIB;JRKL;TGFBR2;IL1RAPL2;PLXNB2;SH3GL2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3550140144321162,0.7895416771188529,0.7253086419753086,0.9712177607099576,1.0,3/15,11.47%,IL17RA;TLR6;TLR4
prerank,autophagy of peroxisome (GO:0030242),0.3617307553856289,0.7895295602321293,0.7097844112769486,0.9707709001759428,1.0,4/12,27.12%,MAP1LC3B;RB1CC1;PIK3R4;TRAPPC8
prerank,liver development (GO:0001889),0.3071701069542415,0.7893724145001045,0.7364864864864865,0.9705673930664961,1.0,7/32,18.81%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;PCK2;CDK5RAP3
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.32647128661976177,-0.7890993819706277,0.7455470737913485,0.926492468854425,1.0,5/10,19.99%,GALNT13;GALNT16;GALNT2;POGLUT3;MGAT5B
prerank,regulation of exit from mitosis (GO:0007096),-0.23115444275382288,-0.7888556927158624,0.7973568281938326,0.9258273438288592,1.0,16/38,34.85%,ANAPC11;CDC14A;RGCC;UBE2S;ANAPC15;ANAPC7;SIRT2;ANLN;BUB3;MAD2L1;PHB2;ANAPC16;KNTC1;MAD2L1BP;BUB1B;UBB
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3584713409307486,0.7886121931699623,0.7088,0.9713726695074324,1.0,5/14,26.93%,CD81;IKBKG;PRKD2;RELA;RPS3
prerank,RNA transport (GO:0050658),0.2768504996918028,0.78848750796569,0.7684210526315789,0.9711058830012781,1.0,24/71,23.15%,SRSF2;EIF4A3;SIDT2;DDX39B;RBM8A;SRSF7;TGFBR2;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RAE1;SRSF1;SRSF5;FLOT1;THOC1;YBX1;U2AF1;POM121;TPR;SRRM1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.26364006520386984,-0.7884864570414842,0.7815699658703071,0.9254355033668302,1.0,8/22,23.87%,CDK12;KAT7;BRD4;SUPT4H1;ALYREF;EAPP;ERCC6;THOC5
prerank,chromatin assembly or disassembly (GO:0006333),-0.32206009469685626,-0.7883361325944529,0.7478991596638656,0.924602961399579,1.0,4/11,25.57%,TP53;NOC2L;SUV39H2;MTA2
prerank,stress-activated MAPK cascade (GO:0051403),0.28363529361428225,0.788302666344796,0.7771010962241169,0.9709307365910851,1.0,13/61,18.72%,MAP3K8;MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;CHUK;IKBKG;UBE2N;UBC;RPS27A;TAB2;ARHGEF6
prerank,glycogen catabolic process (GO:0005980),0.3595813096467074,0.7882568845237894,0.7138364779874213,0.9705362529923098,1.0,4/15,15.42%,PHKA2;PGM2;PHKB;RB1CC1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3636837160266245,0.7881895195396009,0.6934189406099518,0.9701646126693192,1.0,4/14,14.58%,GAB1;VEGFB;MYO1C;NUS1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.2686588361559463,-0.7879876538886432,0.780952380952381,0.9241346092200191,1.0,4/22,7.36%,SLC7A5;IL18;RFTN1;TGFB1
prerank,receptor metabolic process (GO:0043112),0.2869577753789666,0.7879205951857279,0.7755610972568578,0.9701420975129544,1.0,13/53,15.90%,CAV1;CD81;ACKR3;RAMP1;CD9;LMTK2;GRK2;FCER1G;PHETA2;PLEKHJ1;PHETA1;NEDD4;ITGB2
prerank,receptor recycling (GO:0001881),0.37851026125646037,0.7878729853760698,0.7280130293159609,0.9697509442874356,1.0,5/10,20.57%,LMTK2;PHETA2;PLEKHJ1;PHETA1;REP15
prerank,import into nucleus (GO:0051170),0.2761134199062418,0.7878673246336155,0.7684085510688836,0.9692933414102542,1.0,29/73,28.26%,IPO7;SNRPB;TSC2;NUP93;TNPO2;MMP12;NXT2;TNPO1;HEATR3;GEMIN6;RANBP6;IPO4;CSE1L;PPP1R10;SNUPN;DDX20;HIKESHI;GEMIN5;POM121;TPR;IPO9;GEMIN2;NUP62;GEMIN8;NUP133;SNRPD2;SNRPD1;IPO8;AKT1
prerank,Golgi to lysosome transport (GO:0090160),-0.32611871407086435,-0.7873606402342483,0.7383419689119171,0.9241123949450053,1.0,6/11,24.61%,EHD3;SORT1;CLN3;RBSN;CCDC91;GAK
prerank,regulation of innate immune response (GO:0045088),0.2776113737956569,0.7872358462348868,0.7662178702570379,0.9698561774079025,1.0,12/57,18.02%,CCL5;RNASEL;MUL1;TRIM21;PTPN6;POLR3B;NMI;POLR3C;DHX9;POLR3G;XIAP;PTPN11
prerank,rRNA modification (GO:0000154),-0.2660693694610465,-0.7872191944630444,0.8045602605863192,0.9233043401233113,1.0,9/21,24.18%,NAT10;NSUN4;DKC1;THUMPD1;TFB1M;NOP10;TSR3;DIMT1;MRM2
prerank,superoxide anion generation (GO:0042554),-0.3045531902321562,-0.7868288311719445,0.7406417112299465,0.9229399422067373,1.0,3/13,21.42%,NOX4;NCF2;CYBB
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2749187661110426,0.7867912015450856,0.7734282325029656,0.9701352245138245,1.0,11/73,15.61%,CLU;MAVS;TNFRSF8;HSPB1;LBP;FZD5;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,regulation of hippo signaling (GO:0035330),0.34972085954764437,0.786712422474337,0.7208588957055214,0.9698001097752272,1.0,1/17,0.88%,MOB3B
prerank,organelle disassembly (GO:1903008),0.3084373101399228,0.7864680888530594,0.7355836849507735,0.9697397208840921,1.0,8/33,18.32%,DDRGK1;TEX264;PLK3;KLC1;ULK1;RB1CC1;UFM1;PELO
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2817697238139433,0.7859393142242734,0.7723785166240409,0.9701350867760588,1.0,20/51,29.80%,NEK7;MAPK15;MAP3K4;PINX1;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;TERF2;TINF2;FBXO4;CCT5;EXOSC10;XRCC5;CCT8;TERF1;CTNNB1;NAF1;CCT6A
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.36057656838071994,0.785519262769904,0.7026578073089701,0.970333510341891,1.0,3/13,17.92%,LAMP1;ITGB2;STX4
prerank,protein insertion into ER membrane (GO:0045048),0.2984466398637896,0.7853565229601984,0.7513297872340425,0.9701202478761499,1.0,12/37,23.17%,OTOF;EMC9;EMC10;GET4;EMC6;EMC2;CCDC47;APP;VAMP2;SGTA;MMGT1;VAPA
prerank,RNA export from nucleus (GO:0006405),0.26600532294399315,0.785271633821124,0.8024691358024691,0.9697997270671112,1.0,31/100,25.85%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;NDC1;RBM8A;AGFG1;WDR33;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RAE1;AAAS;SRSF1;SRSF5;THOC1;U2AF1;POM121;TPR;SRRM1;RANBP2;NUP42;NUP62;RBM15B;SEH1L
prerank,regulation of histone modification (GO:0031056),0.36860590169000623,0.7851730694886255,0.710236220472441,0.9694980466192739,1.0,7/13,22.55%,NNMT;FLCN;UBE2N;PARG;PARK7;AKAP8;CDK9
prerank,tRNA modification (GO:0006400),0.2795394316038101,0.7851727139975698,0.7965895249695494,0.9690370394644382,1.0,13/62,14.28%,MOCS3;LCMT2;THADA;ELP5;TRIT1;METTL6;AARS1;THG1L;ANKRD16;TYW1;THUMPD3;WDR6;DUS2
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.24636641631175837,-0.7842117619557695,0.8090277777777778,0.9261184044230294,1.0,15/28,28.95%,NOTCH3;TSPAN15;GATA2;ARRB1;BEND6;LFNG;EGFL7;EGF;TCIM;HEY1;YTHDF2;DLL4;HIF1AN;EGFR;ARRDC1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33878792044814693,0.7840864178130943,0.717425431711146,0.9703370835546126,1.0,6/18,24.39%,UBTF;WDR43;EIF2AK3;FLNA;SIRT7;POLR2K
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.3532050357432026,0.7837730256257756,0.7227272727272728,0.9704010114371545,1.0,5/14,17.24%,NFKBIA;PKD1;CCDC22;KEAP1;SUFU
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3525493911301901,0.7837093162946954,0.7171875,0.9700407973583438,1.0,6/15,24.06%,NGF;ZFYVE27;BCAR1;FRS2;CASP3;SOS1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.38621648496039673,0.7836064183486815,0.7166666666666667,0.9697406666743126,1.0,4/10,23.92%,RIF1;DCLRE1C;TERF2;APEX1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3463710456741369,0.7835353304767492,0.6977124183006536,0.9693981685062993,1.0,2/15,5.19%,MAGI2;IGSF1
prerank,positive regulation of protein binding (GO:0032092),0.28622273008577276,0.7833386256076983,0.7761377613776138,0.9692487865762829,1.0,16/56,19.72%,MMP9;CAV1;PPP2CA;ADD1;BMP4;TRIM21;TCF7L2;PKD1;CAPRIN2;GSK3B;PPP2CB;ABL1;SPPL3;FLOT1;APP;IDE
prerank,endodermal cell fate commitment (GO:0001711),-0.3265269278684774,-0.7832012558924741,0.731457800511509,0.9266401186576694,1.0,2/10,18.12%,SOX17;PAF1
prerank,glycogen metabolic process (GO:0005977),-0.2527037040251186,-0.7823095025341059,0.8231292517006803,0.9270108986593883,1.0,11/27,28.79%,PRKAG2;PHKA1;GAA;UGP2;GBE1;PGM1;GYS1;GYG1;PYGL;PHKG2;PGM2L1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3743376593826107,0.7823088132735929,0.7095238095238096,0.9704176715412143,1.0,3/11,15.59%,IP6K1;PPIP5K2;IP6K2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3424425442484925,0.7822621411062333,0.7280966767371602,0.9700280153770285,1.0,6/17,17.42%,NUPR1;HDAC4;TIGAR;NCOR1;FLCN;GIT1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3466295955839265,0.7820130798393485,0.7315541601255887,0.9699949093973106,1.0,10/17,29.64%,FCHSD2;ARFIP2;WASF1;ARFIP1;BRK1;WASF3;NCKAP1;ARF1;WASF2;CYFIP1
prerank,DNA packaging (GO:0006323),-0.2886173476642779,-0.7815730710655923,0.7768595041322314,0.9270983911948388,1.0,5/16,24.12%,TP53;KAT6A;NOC2L;BANF1;AIFM1
prerank,regulation of osteoblast proliferation (GO:0033688),0.3466255236330251,0.7812654421675884,0.740340030911901,0.9707670000929468,1.0,4/17,16.92%,PLXNB1;RHOA;SFRP1;TMEM119
prerank,regulation of integrin activation (GO:0033623),0.35581324950388143,0.7809068345735676,0.7132132132132132,0.9708777093151656,1.0,1/15,2.26%,RAP1B
prerank,positive regulation of double-strand break repair (GO:2000781),0.29421071057933584,0.7805726656995727,0.7382198952879581,0.9709250195848302,1.0,5/39,9.45%,KDM4D;SHLD2;FOXM1;PARP3;RIF1
prerank,cilium assembly (GO:0060271),0.24569669996521945,0.78013461304527,0.9015228426395939,0.9712074019040492,1.0,50/296,18.68%,RAB17;RP1;CYS1;ABLIM1;PARVA;GSN;DYNLRB1;EHD1;CNGA2;INPP5E;ARL3;CCDC28B;RAB11FIP3;AVIL;EXOC7;IFT46;CFAP54;EXOC4;CFAP206;PKD1;CC2D2A;IFT80;CEP76;PAFAH1B1;EXOC2;CSNK1E;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;TNPO1;ATP6V1D;HSP90AA1;FLNA;ATP6V0D1;TMEM138;DYNC1H1;KIF17;RAB8B;PTPDC1;HDAC6;WDR35;RILPL1;GALNT11;ODF2;FHDC1;SFI1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.33575169785439957,0.77987617458567,0.7423312883435583,0.9711412559809572,1.0,1/16,1.14%,PPARGC1A
prerank,regulation of endopeptidase activity (GO:0052548),0.2786997520359446,0.7795815586935141,0.7810945273631841,0.9711520557395105,1.0,6/59,8.55%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2753891972330643,0.7794989902960139,0.7772397094430993,0.9708233987069687,1.0,9/66,11.47%,NLRP2;ZC3H12A;HSPB1;NLRP2B;FZD5;PYDC1;TLR6;CARD16;TLR4
prerank,eye morphogenesis (GO:0048592),0.33581994295633355,0.7794131613077245,0.7151248164464024,0.9705252105265879,1.0,4/19,6.73%,COL5A2;AGTPBP1;RARG;EFEMP1
prerank,regulation of secretion by cell (GO:1903530),-0.21199593847143738,-0.7792598771775107,0.8556701030927835,0.9296792929033239,1.0,15/54,21.74%,SNCAIP;RIC1;MCTP2;SYT1;STXBP5L;CAMK2A;MCTP1;RAB3D;KCNMB4;CPLX2;DISP1;RAB3C;FMR1;RIMS1;DNAJC1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3129465766661918,0.7792291506584759,0.7560975609756098,0.9703398746861897,1.0,6/28,21.65%,OCLN;PSRC1;GIT1;NUMA1;MAPT;CDK5R1
prerank,Golgi organization (GO:0007030),0.25873955235475155,0.7787557106252078,0.8200654307524536,0.9706339747792392,1.0,27/112,19.80%,FBXW8;TJAP1;TMED1;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;PLK3;GCC2;CDC42;BCAS3;ZW10;YWHAZ;VTI1B;GOLGB1;ARFGEF1;NPLOC4;ATL2;STX16;USP6NL;PI4K2A;SEC23IP;FHDC1;TMED5;GORASP2;VTI1A;MYO18A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3693709234568201,0.7785659462508578,0.7133220910623946,0.9704859369665748,1.0,1/11,2.66%,TWSG1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.25478977172680817,0.7785463960336695,0.8301075268817204,0.9700534805603618,1.0,27/128,17.97%,SMAD6;DDX5;HIVEP1;GDF15;TWSG1;FOS;BMP5;GCNT2;ARHGEF18;PXN;BMP4;TGFB2;TGFB1I1;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;UBC;RPS27A;RGMB;SMAD5;STUB1;PRKCZ;ZYX;BMPR1A;CDH5
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.25330107231926113,-0.7783751914804189,0.815068493150685,0.9300276366184344,1.0,6/24,14.63%,JARID2;SUZ12;EZH2;TASOR;CREBZF;MTF2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.2252934333684811,-0.7781528959212192,0.8609865470852018,0.9293247881409346,1.0,6/41,9.16%,JAG1;ENG;NOTCH1;TGFB1;FGFR2;HEYL
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3513840993420429,0.7780124774988322,0.728414442700157,0.9704220496957374,1.0,6/16,23.74%,CWC15;SRSF1;WBP4;SFSWAP;DDX23;DCPS
prerank,negative regulation of JUN kinase activity (GO:0043508),0.37438741390758423,0.777887555297578,0.7047781569965871,0.9701610742449676,1.0,1/10,4.17%,DUSP10
prerank,presynaptic endocytosis (GO:0140238),-0.2536925891131416,-0.7776416960106078,0.813953488372093,0.9291125573448284,1.0,7/24,14.46%,SYNJ2;SYT1;NLGN1;NLGN3;AMPH;STON2;FCHO2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.31208538707390243,0.7774794498319663,0.7361878453038674,0.9703521767251072,1.0,5/27,11.79%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,mRNA transport (GO:0051028),0.2604967063273773,0.7771864625233696,0.8156732891832229,0.9703285565246368,1.0,31/101,25.85%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;NDC1;RBM8A;AGFG1;WDR33;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RAE1;AAAS;SRSF1;SRSF5;THOC1;U2AF1;POM121;TPR;SRRM1;RANBP2;NUP42;NUP62;RBM15B;SEH1L
prerank,iron ion transport (GO:0006826),0.285617514106299,0.777154453095781,0.7667087011349306,0.9699234670669562,1.0,13/47,21.22%,ATP6V1B1;HEPH;LMTK2;CP;ATP6V1D;ATP6V1E1;ATP6V0D1;SLC11A2;ATP6V1B2;ATP6V0B;REP15;ATP6AP1;MELTF
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.35875943614374123,0.777124299899413,0.7411003236245954,0.969512660729638,1.0,2/13,6.14%,ZC3H12A;MOV10
prerank,heterochromatin assembly (GO:0031507),-0.26787883109412125,-0.777081050534255,0.7727272727272727,0.9289685229185299,1.0,5/20,16.36%,MBD2;SMCHD1;HMGA2;HELLS;SIRT2
prerank,amide biosynthetic process (GO:0043604),0.28995068956359116,0.7770313945622236,0.7693282636248415,0.9692016252858613,1.0,4/47,6.96%,SPTSSB;SGMS2;AGK;AANAT
prerank,regulation of interleukin-6 production (GO:0032675),0.2626575118920666,0.7768155836740435,0.839677047289504,0.9690712844932027,1.0,18/96,18.02%,CD200;IL17RA;ZC3H12A;IL16;MAVS;LBP;RAB7B;PTPN6;TLR6;TWIST1;TLR4;CD200R1;TLR3;SYT11;DHX9;MAPKAPK2;F2R;PTPN11
prerank,regulation of neutrophil migration (GO:1902622),-0.32236321752352126,-0.7767514361651637,0.7772151898734178,0.928444406690077,1.0,9/10,50.63%,NCKAP1L;RHOH;JAM3;BST1;RAC2;RHOG;OLFM4;RAC1;SLAMF8
prerank,sister chromatid segregation (GO:0000819),-0.24439297117414832,-0.7767432912120753,0.8191881918819188,0.9274340106613969,1.0,17/31,31.61%,KIF18A;NCAPG2;RAN;KLHL22;WRAP73;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;NDC80;KIFC1;NSL1;CDCA8;TUBG2;SGO1
prerank,negative regulation of ATPase activity (GO:0032780),-0.283436497681951,-0.7760983330939012,0.7896341463414634,0.9274129242940354,1.0,3/16,10.14%,TSC1;OXA1L;TP53
prerank,iron-sulfur cluster assembly (GO:0016226),0.32084180243762145,0.7760222560504008,0.7186588921282799,0.9698763792571068,1.0,7/24,19.95%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,RNA metabolic process (GO:0016070),0.2553888680910605,0.7758214571295998,0.8406417112299466,0.9697280551187042,1.0,30/127,20.40%,CELF2;GTF2F1;ZC3H12A;RBFOX2;POLR2H;POLR2A;RNASEL;SIDT2;DDX39B;XRN2;HNRNPH2;RNASE3;MTREX;TBRG4;SYNCRIP;HNRNPUL1;DHX9;PABPN1;DUSP11;CLP1;RNASE4;POLR2C;RBMS2;WTAP;HNRNPA3;PTBP1;POLR2E;PCBP2;DDX20;THOC1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.35237612772097443,0.7756674130904598,0.7076205287713841,0.9695152969012792,1.0,5/14,17.26%,DDRGK1;TMEM33;COPS5;BFAR;FICD
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2889986434249694,0.775476337755862,0.7519083969465649,0.9693630713765808,1.0,20/41,29.02%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;RAE1;AAAS;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133;GCK;NUP35;PGAM1
prerank,regulation of smooth muscle contraction (GO:0006940),0.3259041868046299,0.7754357165829967,0.7389984825493171,0.9689711697736044,1.0,2/20,3.81%,CAV1;DAPK3
prerank,regulation of aerobic respiration (GO:1903715),0.3440261961830477,0.7750194783119084,0.7167182662538699,0.9691464258742942,1.0,2/15,10.09%,ABCD1;COX7A2L
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.250970531200079,0.7749628368305551,0.8559322033898306,0.9687783442612601,1.0,36/145,24.58%,FBXL7;FHL1;PSMD11;CDK4;AVEN;PSMD4;PSMF1;FBXO5;RBX1;CEP76;CCND1;PAFAH1B1;PSMD7;CSNK1E;VPS4B;PSMB5;PINX1;CDK2;HSP90AA1;DYNC1H1;CDC25B;PSMD1;ODF2;PSMC4;SFI1;PSMD8;CENPF;RCC2;HAUS1;CEP192;PSMA7;TUBG1;CDC25A;PCM1;PLK4;PRKACA
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.35536994485993845,0.7747186023875036,0.7322834645669292,0.9687065750908526,1.0,3/13,10.57%,SOX9;BMP4;NFIB
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3698678764695539,0.7745671477086855,0.7418831168831169,0.9685070220553134,1.0,2/11,14.33%,EP300;PGP
prerank,regulation of autophagosome assembly (GO:2000785),0.3071542039939142,0.7745229822994851,0.7429718875502008,0.9681210988180193,1.0,12/33,23.02%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8;MTMR3;PIP4K2C;RAB1B;FEZ1;PHF23;RAB3GAP2;UBQLN2
prerank,cellular response to misfolded protein (GO:0071218),0.3257575320567587,0.7744247760221282,0.7546897546897547,0.9678208455351187,1.0,5/20,16.96%,RNF5;KLHL15;TOR1A;RNF126;STUB1
prerank,negative regulation of blood coagulation (GO:0030195),0.2997233306354243,0.7743681533060293,0.7596899224806202,0.9674630937644916,1.0,3/38,6.42%,ADTRP;THBD;KLKB1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3228489700761648,0.7741492110730196,0.7407407407407407,0.9673432024615961,1.0,4/23,10.37%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.3569880995485346,0.7739539408862429,0.7608695652173914,0.9671992157497703,1.0,4/14,12.36%,NLRP2B;PYDC1;CARD16;PTPN2
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.37560012848197777,0.7737328509038804,0.7383627608346709,0.96708653861248,1.0,3/10,16.74%,ATRX;RIF1;KDM1A
prerank,protein export from nucleus (GO:0006611),0.3124026686569324,0.7732174378622075,0.7639664804469274,0.9674223117465158,1.0,4/27,8.73%,RANBP3L;DESI1;PKD1;CHP1
prerank,mesenchyme development (GO:0060485),0.3469678861816966,0.7731744063257893,0.7496206373292867,0.9670493072703497,1.0,2/15,7.10%,WNT11;BMP4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.28077925511603724,0.7731125953038058,0.7848258706467661,0.9666910541081439,1.0,14/50,24.78%,CDKN1A;CCND2;ACTB;CCND1;PKMYT1;SERTAD1;CCNG1;CDKN2D;CAMK2N1;CDK5RAP3;CDK5R1;CDC25A;GTPBP4;MNAT1
prerank,negative regulation of DNA binding (GO:0043392),0.3104570139791524,0.7724571145799173,0.766531713900135,0.9672773403387452,1.0,8/28,18.63%,SMO;NFKBIA;JUN;SUMO3;HABP4;E2F1;KDM1A;ILRUN
prerank,adipose tissue development (GO:0060612),0.3711676847598754,0.7724058731811579,0.7212020033388982,0.9669137434734305,1.0,2/11,8.04%,RORC;DYRK1B
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.27229198395729315,-0.7723610322674093,0.7806267806267806,0.9320399694046813,1.0,7/20,20.44%,SULF1;THBS1;FGF2;SPRY1;SPRY4;FGFBP3;SMOC2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.30710618069984386,0.7720783905478332,0.7419786096256684,0.9669940764458771,1.0,4/29,6.64%,NOTCH2;NGF;EPO;SHC1
prerank,acute-phase response (GO:0006953),-0.3021613150606972,-0.7720450202367244,0.7808988764044944,0.9314761340315045,1.0,4/12,22.16%,IL6R;PLSCR1;IL22;SIGIRR
prerank,autophagy of nucleus (GO:0044804),0.34077498698685993,0.771382286795833,0.7341211225997046,0.9676684537055039,1.0,8/16,28.13%,ULK1;RB1CC1;ATG3;WIPI2;ATG2B;ATG12;WIPI1;WDR45
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3346886490263812,0.7712145722039225,0.7437407952871871,0.9674660430188868,1.0,2/18,3.88%,JCAD;FOXC2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.31691000392616253,-0.7706320372392088,0.7196969696969697,0.9324885360023176,1.0,5/11,24.22%,LRRK2;CHMP3;USP7;MAP2K1;DENND10
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.36328840820955804,0.7698661871214042,0.7508090614886731,0.9691459997885767,1.0,2/12,8.14%,CHMP4A;CHMP4B
prerank,cellular response to organic substance (GO:0071310),0.2570427995527095,0.769707651601418,0.8290788013318535,0.9689481864072177,1.0,17/116,12.95%,PTPN14;KLF4;NCOA3;CCL5;CXCR4;RAMP1;HAX1;SHC1;PTPN9;MAPK7;PTPN6;ARL6IP5;RHOA;SOCS2;TGFBR2;PTPN2;SFRP1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23654148227726832,-0.7692923457485158,0.85,0.9335097301828765,1.0,4/28,11.13%,GLMN;LGALS9;TNFRSF21;DLG5
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2609715770016881,0.768988163030317,0.8201603665521191,0.9695940209420311,1.0,20/87,17.97%,SMAD6;GDF15;TWSG1;FOS;GCNT2;ARHGEF18;PXN;TGFB2;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;UBC;RPS27A;SMAD5;PRKCZ;ZYX;BMPR1A;CDH5
prerank,skeletal system morphogenesis (GO:0048705),0.29056161383084717,0.7685903407968931,0.7750325097529259,0.9697811654524401,1.0,2/42,2.43%,FGFR1;HOXA4
prerank,epithelial cell differentiation (GO:0030855),0.2636845340443341,0.7685827712712106,0.8296892980437284,0.9693409802803399,1.0,14/88,16.06%,UPK1B;ANXA4;PIH1D1;OVOL2;BMP4;LATS1;SIX1;LGALS3;GRHL2;PTER;GATA3;VDAC1;GSTK1;PCNA
prerank,negative regulation of signal transduction (GO:0009968),0.2431570799126944,0.7683690156914407,0.8949536560247168,0.9692104749745902,1.0,24/249,9.18%,PRKCB;KANK1;NXN;CCL5;GPC1;NIBAN2;GLI3;GDF15;TMEM25;RNF43;QARS1;KANK2;PALM;GLIS2;BMP5;WWP2;TSC2;GPC3;ERBB3;LGR4;NLRP2B;MAZ;CXXC4;YWHAB
prerank,negative regulation of transposition (GO:0010529),0.3319607985950087,0.7678963134759753,0.7244582043343654,0.9695255324991576,1.0,3/16,13.00%,MOV10;TUT7;MYBL1
prerank,protein processing (GO:0016485),0.2596938325132908,0.7677718699726938,0.8234649122807017,0.9692735925086908,1.0,23/102,19.66%,OGT;ADAM10;HP;HPR;PRSS12;KLKB1;CPE;SRGN;AFG3L2;SDE2;PITRM1;KLK1;SPCS3;CTSH;HM13;BACE1;SEC11A;SPPL3;PIDD1;SPG7;STOML2;MMP14;ADAM17
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.29630177931359836,-0.7674449345970396,0.7789757412398922,0.9352539235046554,1.0,5/13,20.54%,SRSF10;CD2BP2;SRSF12;LSM2;USP4
prerank,regulation of T cell proliferation (GO:0042129),0.2739646166187002,0.7673741327363119,0.7944038929440389,0.969430907099213,1.0,5/61,9.13%,CCL5;IL15;SDC4;LGALS3;FOXP3
prerank,synaptic vesicle cycle (GO:0099504),-0.23217069331540624,-0.7669208584193118,0.8436363636363636,0.9350023406089921,1.0,9/30,21.10%,BRSK1;NLGN1;SNAPIN;SNAP25;SLC17A6;SYNDIG1;CPLX2;RIMS1;SYT10
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3692480696531317,0.7668482604674705,0.7389078498293515,0.9697781882354143,1.0,3/11,17.92%,MAVS;ITGB2;STX4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.24321328595693786,-0.7667646523245826,0.8292682926829268,0.9342297081101437,1.0,7/26,17.51%,PDE8A;STAT5B;DAB2IP;PTPN12;GAREM1;DUSP22;ZFP36
prerank,negative regulation of cellular senescence (GO:2000773),0.35186106694569796,0.7664894484550889,0.7336601307189542,0.9699079124166813,1.0,7/13,21.28%,CDK6;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.28352757803525447,0.7664524030770637,0.7795566502463054,0.9695174967968541,1.0,4/51,3.27%,SRGAP2;PLXNB1;NBL1;NGF
prerank,protein methylation (GO:0006479),0.2893702004132565,0.766388174261112,0.7657894736842106,0.9691606187994075,1.0,14/40,25.56%,EEF2KMT;NTMT1;SNRPB;EEF1AKMT3;PRMT1;TRMT112;ETF1;PRMT2;ATPSCKMT;FAM98B;N6AMT1;FAM98A;CAMKMT;EHMT1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.28672817053272975,0.7662159895875859,0.7904884318766067,0.968950996684111,1.0,9/44,18.58%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;BTG2;MEX3D;YTHDF3;ROCK2
prerank,positive regulation of viral life cycle (GO:1903902),0.31837276209981646,0.7657957099080779,0.7489300998573466,0.9691319643799101,1.0,7/22,18.11%,VPS37B;TRIM11;LGALS1;VPS4A;CHMP2A;DDB1;TSG101
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2915953518945805,0.7655595061913312,0.7878787878787878,0.9690228637391806,1.0,18/40,26.62%,NSMCE4A;FBXO5;FEM1B;FXR1;MYC;POLH;UBE2N;ABL1;PARG;MAPT;SIRT7;KMT5A;CDK9;UBE2V1;NSMCE1;ARMT1;SMYD2;RPA2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.34564719995401927,0.7644629308552479,0.7375,0.970218740136263,1.0,5/13,22.12%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,positive regulation of TOR signaling (GO:0032008),0.285814638032284,0.764411901716104,0.7942708333333334,0.9698402931821943,1.0,6/40,10.09%,PIH1D1;RHEB;SIK3;GOLPH3;SMCR8;HDAC3
prerank,renal absorption (GO:0070293),0.36946768545646475,0.7641164312127642,0.7252931323283082,0.9698743894844911,1.0,1/10,2.11%,GSN
prerank,myeloid dendritic cell activation (GO:0001773),-0.3035047001206226,-0.7637384432922031,0.7295918367346939,0.9376138437023432,1.0,4/12,25.50%,CAMK4;HMGB1;DOCK2;PYCARD
prerank,cellular response to type I interferon (GO:0071357),-0.22477884813929747,-0.7636852834203637,0.8828828828828829,0.9356377950766485,1.0,6/41,8.43%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1
prerank,type I interferon signaling pathway (GO:0060337),-0.22477884813929747,-0.7636852834203637,0.8828828828828829,0.9356377950766485,1.0,6/41,8.43%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1
prerank,proteasomal protein catabolic process (GO:0010498),0.24277285378390798,0.7632277304178602,0.8776150627615062,0.9707512975184088,1.0,45/201,20.54%,PMAIP1;ATE1;SPSB4;NFE2L2;WWP2;RNF5;PSMD11;PSMD4;PSMF1;NSFL1C;FEM1C;RMND5B;RBX1;PML;UBE2B;PCNP;COP1;PSMD7;SIAH3;AGAP3;FEM1B;ZSWIM8;RNF126;PSMB5;PELI1;GSK3A;NEDD4;SOCS6;MDM2;BFAR;CCDC47;MAEA;DDB1;PRPF19;ARMC8;STUB1;UBE2D3;SIAH1;PSMD1;PSMC4;RNF41;PCBP2;PSMD8;RHBDD1;RMND5A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2812766883489097,-0.7620465444605361,0.7642276422764228,0.9369473283711329,1.0,5/15,26.23%,ANAPC7;NEK6;HECW2;CENPE;RIOK2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2521680632153563,-0.761910807961145,0.8208955223880597,0.9361090735878695,1.0,12/22,37.12%,MAN1C1;SEL1L;SYVN1;EDEM2;UGGT2;TRIM13;EDEM1;MAN1B1;UGGT1;OS9;UBB;UBA52
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3337625801579723,0.7617883840692169,0.7693452380952381,0.9724331270032297,1.0,3/18,7.54%,TSSK4;CD200;LPAR5
prerank,regulation of oxidoreductase activity (GO:0051341),0.35820467928322414,0.7617477219956509,0.7484375,0.9720460981554676,1.0,5/13,21.87%,HP;ABL1;HDAC6;SIRT4;SZT2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3232096312803961,0.7615857706269038,0.7671641791044777,0.9718534473473854,1.0,7/18,21.91%,CHRM1;GRK2;GNAQ;GNA11;GNA15;CDK5R1;CHRM5
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.1884864472196107,-0.759343202928935,1.0,0.9389174649719152,1.0,10/91,7.80%,BMP6;SLC30A10;SCARA5;SLC39A12;FBXL5;SLC40A1;SLC39A8;TFRC;ATOX1;SLC39A10
prerank,negative regulation of bone mineralization (GO:0030502),0.35291737192671113,0.7593295046754974,0.749613601236476,0.9748047149480561,1.0,3/13,11.12%,PTK2B;SRGN;TRPM4
prerank,zinc ion transport (GO:0006829),0.3185024043879122,0.7593244065153456,0.7485294117647059,0.9743639724837396,1.0,5/21,14.91%,SLC39A3;SLC39A6;TRPM2;SLC39A13;SLC30A6
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2897973471151339,0.7591895890755566,0.7926988265971316,0.974138460311332,1.0,9/39,20.41%,MCU;GLUD1;BAD;TCF7L2;IRS2;AACS;NLGN2;GPER1;SOX4
prerank,mitochondrial fission (GO:0000266),0.3406177011721033,0.7585440152403492,0.7545731707317073,0.9746438699063313,1.0,6/16,21.21%,MUL1;MTFR1L;OPA1;DNM1L;MTFR2;MIEF1
prerank,ubiquinone metabolic process (GO:0006743),0.340497987923849,0.758395891281644,0.7335423197492164,0.9744074529616966,1.0,2/15,8.44%,UBIAD1;PDSS2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3308908578968885,0.7583308892676068,0.7625570776255708,0.9740719918876891,1.0,4/18,11.90%,LBP;NMI;FCER1G;SBNO2
prerank,spliceosomal snRNP assembly (GO:0000387),0.28896941330885706,0.7581118565479169,0.7784891165172856,0.9739787034981697,1.0,14/38,27.80%,SNRPB;LSM4;GEMIN6;PRPF19;PRPF6;SNUPN;DDX20;PRPF8;GEMIN5;CLNS1A;GEMIN2;GEMIN8;SNRPD2;SNRPD1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2668945617561705,0.7576587735819452,0.8176178660049628,0.9742159141700318,1.0,14/60,19.46%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;TNKS2;ATR;PCNA;PRKCQ;PNKP;PRKD2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3694656239781424,0.7572396813694875,0.7554076539101497,0.974422302663363,1.0,1/10,2.69%,ABCD1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3016123308617395,0.7571937056151342,0.763758389261745,0.9740417894755696,1.0,4/30,9.43%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,ovarian follicle development (GO:0001541),0.34919931133912013,0.7571669930793999,0.7492354740061162,0.9736246573752747,1.0,3/13,17.16%,EIF2B2;ANG;EIF2B4
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3372103060825803,0.7569307718210617,0.7519500780031201,0.9735390849399059,1.0,3/16,12.73%,RORC;PDK2;FOXK1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3590074117648975,0.7567646817522822,0.7774086378737541,0.9733318490735247,1.0,3/12,13.94%,ZC3H12A;NCOR1;NCOR2
prerank,cellular response to pH (GO:0071467),0.33452106515193936,0.75647631878992,0.7561728395061729,0.9733089264328485,1.0,6/17,19.24%,CHP1;RAB11FIP5;PKD2L1;HVCN1;SLC9A1;GPLD1
prerank,monoacylglycerol metabolic process (GO:0046462),0.34164767193616513,0.7563620863756947,0.750402576489533,0.9730341083097865,1.0,2/13,4.07%,DGAT1;MOGAT3
prerank,tRNA 5'-leader removal (GO:0001682),0.3500433237573457,0.7561543229817935,0.7524916943521595,0.9728965972537776,1.0,3/13,12.55%,POP4;POP1;RPP21
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3178989993057312,0.7558955484854157,0.7607090103397341,0.9728365835806205,1.0,6/22,18.29%,PDGFC;MRE11;RAP2C;NBN;RAD50;GPNMB
prerank,lysine catabolic process (GO:0006554),0.357837671639565,0.7558161925840993,0.7544426494345718,0.9720651126620625,1.0,4/12,16.65%,PIPOX;SLC25A21;OGDH;DLST
prerank,lysine metabolic process (GO:0006553),0.357837671639565,0.7558161925840993,0.7544426494345718,0.9720651126620625,1.0,4/12,16.65%,PIPOX;SLC25A21;OGDH;DLST
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.35754702242572445,0.7557226778308496,0.7515625,0.9717587609495124,1.0,3/11,14.52%,NT5C3A;SLC19A2;CTPS2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.34308973511074253,0.7555566427904421,0.7663398692810458,0.971557177335374,1.0,4/13,21.58%,CD81;BCAP31;SEC16A;TM9SF4
prerank,positive regulation of cell growth (GO:0030307),0.2585327299860385,0.7550851664349678,0.8213879408418657,0.9718130511913137,1.0,22/96,21.18%,ISLR2;ADAM10;HPN;NGF;TGFB2;ZFYVE27;CDC42;EIF4G2;CDKN2AIP;SFRP1;MAP3K13;EIF4G1;SHTN1;H3-3A;TAF9B;MMP14;ADAM17;DBN1;MAPT;SYT3;UNC13A;SYT2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3625941157559368,0.7550074278485818,0.7559726962457338,0.9714886221042021,1.0,2/10,11.47%,FOXP3;TLR4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3289822678576096,0.7546509096030845,0.7480438184663537,0.9715709877461588,1.0,8/16,26.36%,ATP5PF;ATP5F1B;STOML2;ATP5PD;ATP5ME;ATP5MC3;ATP5F1C;ATP5F1D
prerank,ribosome biogenesis (GO:0042254),0.24404282881449518,0.754201421643015,0.8898216159496327,0.9717625666091096,1.0,35/187,15.66%,GLUL;PES1;UTP11;PIH1D1;EIF6;KRR1;POP4;EXOSC3;WDR55;XRN2;RPL31;RPL22;SDAD1;MPHOSPH6;NIP7;BMS1;RRP12;MTREX;WDR36;WDR43;RPL28;PWP2;DDX47;NOC4L;NOL6;RPL10A;SENP3;RRP9;RPF1;HEATR3;UTP14A;UTP4;PAK1IP1;RPL14;IMP4
prerank,regulation of spindle organization (GO:0090224),0.32789141586805504,0.7534180704731075,0.7611026033690659,0.9724725141227009,1.0,5/18,17.43%,PSRC1;PARP3;DYNC1H1;RAE1;NUMA1
prerank,regulation of TOR signaling (GO:0032006),0.2633911145032278,0.753416129512904,0.8222996515679443,0.9720332957674445,1.0,9/67,10.09%,PRKAA2;PIH1D1;TSC2;SH3BP4;ROS1;RHEB;GOLPH3;SMCR8;HDAC3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.24294241867748886,0.7533625966245421,0.8846960167714885,0.9716818776861937,1.0,30/186,14.12%,IGFBP6;NXN;GLI3;MLLT3;WNT11;CAV1;RNF43;PTPRU;PSMD11;AMER2;TSC2;RBMS3;SOX9;PSMD4;PSMF1;LATS1;DVL3;TCF7L2;RBX1;CXXC4;PSMD7;TLE2;TLE4;HMGXB4;PSMB5;SFRP1;GSK3A;LMBR1L;TLE5;GSK3B
prerank,macrophage activation involved in immune response (GO:0002281),0.34569133679118985,0.7529040922756477,0.7757475083056479,0.9719151560248114,1.0,3/13,11.90%,LBP;NMI;SBNO2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.2210642118225296,-0.7527771744177169,0.8554216867469879,0.9471761374677565,1.0,14/36,27.04%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;TFDP2;RNF2;RAD51;BRCA1;CHEK1;PHC1
prerank,natural killer cell activation (GO:0030101),0.30896907117033034,0.7524412951094026,0.7704447632711621,0.972156819615711,1.0,3/23,13.68%,PBX1;RABL3;ULBP1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.24553454423585439,0.7524380383857793,0.8807733619763695,0.9717203484803324,1.0,21/151,12.71%,SPTSSB;ST3GAL4;SGMS2;PPM1L;ELOVL1;LARGE1;MOCS3;LCMT2;MGST3;GSTO1;GOLPH3;ELOVL6;HPGDS;HACD4;NFS1;TYW1;CDO1;CERS2;LPCAT2;CHPT1;LPCAT3
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.28065802137465246,-0.7516354656933281,0.8416666666666667,0.947697837415149,1.0,5/15,17.51%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,positive regulation of cell aging (GO:0090343),0.35515822077861925,0.7509884166201766,0.7655502392344498,0.9733962070173502,1.0,3/11,15.28%,YPEL3;EEF1E1;LMNA
prerank,positive regulation of interleukin-6 production (GO:0032755),0.263193668708576,0.750660241940469,0.8243080625752106,0.9734376130152994,1.0,14/68,20.63%,IL17RA;IL16;MAVS;LBP;RAB7B;TLR6;TWIST1;TLR4;TLR3;DHX9;F2R;PTPN11;APP;AGER
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2790839377995723,0.7506264122148675,0.8111979166666666,0.9730481245563884,1.0,6/45,11.47%,NLRP2;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,neuromuscular process (GO:0050905),0.3304041880707443,0.7505687230611388,0.7623318385650224,0.9726910394869053,1.0,3/16,10.51%,STRA6;AGTPBP1;PAFAH1B1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.2930628179645531,0.7497695159572129,0.7838983050847458,0.9729903774289692,1.0,3/31,6.08%,GTF2F1;POLR2H;POLR2A
prerank,7-methylguanosine RNA capping (GO:0009452),0.2930628179645531,0.7497695159572129,0.7838983050847458,0.9729903774289692,1.0,3/31,6.08%,GTF2F1;POLR2H;POLR2A
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.3456060684247583,0.7497210387783316,0.7719568567026194,0.972623883865819,1.0,3/12,13.94%,ZC3H12A;NCOR1;NCOR2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.27182058169638734,0.749689276837518,0.7975903614457831,0.9722306841120467,1.0,2/54,0.52%,FGFR1;ANGPT1
prerank,negative regulation of lipid storage (GO:0010888),0.3184298988954877,0.7494820533426241,0.749266862170088,0.9721022297975487,1.0,3/19,5.36%,TTC39B;ABHD5;NFKBIA
prerank,regulation of fibrinolysis (GO:0051917),0.3493338952028765,0.7493691021956069,0.7599364069952306,0.9718370282136385,1.0,2/13,6.42%,THBD;KLKB1
prerank,negative regulation of cell division (GO:0051782),0.35497802667454875,0.7491420346075801,0.7529021558872305,0.9717381172447439,1.0,3/11,13.67%,ZFYVE19;VPS4A;MYC
prerank,histone H2A ubiquitination (GO:0033522),-0.2653727353803326,-0.7490979738718464,0.7921686746987951,0.9502539955107322,1.0,8/17,30.90%,CUL4B;BCOR;DTX3L;KDM2B;RYBP;RNF2;DDB2;SKP1
prerank,cellular response to inorganic substance (GO:0071241),-0.2513655198566349,-0.7489817796272507,0.8501529051987767,0.9493884855412066,1.0,6/21,20.09%,GUCY1B1;FOXO1;MTR;BLM;SPIDR;FMR1
prerank,positive regulation of cell development (GO:0010720),0.28899326654571056,0.7487496050185861,0.7452054794520548,0.9718880358391501,1.0,4/31,7.57%,NIBAN2;LMOD3;BMP4;BAD
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.33128495044904127,0.7487470221590297,0.75,0.9714524408818787,1.0,5/17,14.58%,SRD5A3;ALG1;ALG12;DOLK;NUS1
prerank,nucleotide-excision repair (GO:0006289),0.2491844700277632,0.7485550899956265,0.8658399098083427,0.9712909207779675,1.0,25/101,19.88%,EP300;POLR2H;POLR2A;RBX1;POLK;HUS1B;COPS5;HMGN1;ERCC5;RPA3;POLD2;ISY1;LIG3;FAN1;DDB1;PCNA;PRPF19;ERCC2;UBC;RPS27A;POLR2C;RFC1;POLR2E;PNKP;ERCC4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.32325938541692234,0.7484826612605261,0.778125,0.9709507662236826,1.0,4/18,10.78%,ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2918334314223837,-0.747949896488133,0.7977839335180056,0.949737917060592,1.0,2/12,6.36%,HPRT1;PRPSAP2
prerank,protein localization to nucleus (GO:0034504),0.25105231766205754,0.7472226847379674,0.8393063583815029,0.9723570525501612,1.0,27/102,20.89%,IPO7;TSC2;NUP93;BMP4;SIX1;TNPO2;BANP;PML;TOR1A;MMP12;PINX1;NXT2;TNPO1;TOR1AIP1;HEATR3;MDM2;RANBP6;LMNA;IPO4;INTS13;CSE1L;PPP1R10;ARL2BP;ZBTB7A;TAF8;ABCA7;HIKESHI
prerank,positive regulation of cellular component movement (GO:0051272),-0.24361223905733548,-0.7470462966431572,0.8448844884488449,0.9498438081747945,1.0,3/24,9.33%,LYN;SPOCK2;CFAP20
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2693044228349345,-0.7468468771003337,0.825,0.9491103853796639,1.0,10/18,34.69%,CORO2B;DKC1;CCT7;CCT2;CCT4;WRAP53;CEP135;CCT3;TREM2;CEP295
prerank,miRNA metabolic process (GO:0010586),0.3197773361327514,0.7458242572970646,0.7849779086892489,0.9739761489802503,1.0,3/20,12.89%,DGCR8;TARBP2;TUT7
prerank,cellular response to interferon-beta (GO:0035458),-0.2784114707752894,-0.745467339868061,0.7947976878612717,0.9498277852708308,1.0,5/14,30.18%,AIM2;IRGM;HTRA2;TRIM6;PNPT1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.26325566053475735,0.7454094437594372,0.8368794326241135,0.9741264530697081,1.0,11/74,8.46%,EYA2;GDNF;BMP5;BCL2L1;MAPK7;BMP4;EYA1;TNFRSF10B;UNC5B;TCF7L2;LGALS3
prerank,cell cycle G2/M phase transition (GO:0044839),-0.17455310517270872,-0.7453493480471451,0.9885057471264368,0.9489457907436182,1.0,30/129,21.63%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CEP78;CCNH;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;BTRC;PPME1;CSNK1D;SDCCAG8;BORA;MASTL;CUL1;CKAP5;CEP41;BRSK2;MAPRE1;HAUS4;OPTN;HAUS7
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2876446741511258,0.7451721569572088,0.7917771883289124,0.9740170051342931,1.0,10/39,17.02%,TTC7A;PIK3C2B;IP6K1;PI4KA;SOCS2;EFR3A;PIP4K2C;SOCS6;IP6K2;PI4K2A
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3103496371430325,0.7451306133023686,0.7743813682678311,0.9736423283339569,1.0,4/20,15.52%,CHRM1;GRK2;GNAQ;GNA11
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.28640979829207064,0.7444817525634901,0.7854356306892067,0.974158137009947,1.0,7/37,10.75%,MMP9;CDKN1A;MEF2D;ADAMTS1;JUN;HTR1B;SOD2
prerank,regulation of multicellular organismal development (GO:2000026),-0.24229158107716453,-0.7441768897482401,0.8609271523178808,0.9494956274343245,1.0,4/25,14.37%,INSR;SOX17;TRIP12;NIPBL
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.17515668373859966,-0.7441547813322915,0.9770114942528736,0.9485005372064867,1.0,30/128,21.63%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CEP78;CCNH;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;BTRC;PPME1;CSNK1D;SDCCAG8;BORA;MASTL;CUL1;CKAP5;CEP41;BRSK2;MAPRE1;HAUS4;OPTN;HAUS7
prerank,establishment of protein localization to organelle (GO:0072594),0.25917333544560445,0.7441457596030149,0.8349282296650717,0.9742001736581136,1.0,15/72,18.43%,LAMP5;LAMP1;IPO7;TSC2;NUP93;TNPO2;HK1;MMP12;NXT2;TNPO1;HEATR3;RANBP6;IPO4;CSE1L;PPP1R10
prerank,peptidyl-serine modification (GO:0018209),0.2396064536428588,0.7439891664459105,0.8848996832101372,0.9739883918232213,1.0,35/166,19.46%,PRKCB;IKBKE;MKNK2;GALNT1;SGK3;NTMT1;STK39;LATS1;DYRK1B;MAPK9;PKD1;LMTK2;SRPK2;GRK2;CSNK1E;EIF2AK3;TGFBR2;CDK2;MAP3K13;GSK3B;NAA10;CHUK;ULK1;WNK1;PLK2;ATR;TTK;PRKCZ;MAPKAPK2;PRKCQ;PARP2;ROCK2;STK38L;CAB39;PRKD2
prerank,tRNA wobble uridine modification (GO:0002098),0.34111077823290237,0.7437931200223457,0.7657512116316639,0.9738434600030225,1.0,5/14,23.15%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,placenta development (GO:0001890),-0.29366404481971964,-0.7434991398234133,0.8061224489795918,0.9483690853946491,1.0,3/12,18.59%,PTK2;PPARG;SOD1
prerank,gas transport (GO:0015669),-0.31480081599799115,-0.7434263148301071,0.7974025974025974,0.9474429582385276,1.0,3/10,14.83%,IPCEF1;CYGB;CA2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.32564723648712274,0.7428961158961458,0.7858220211161387,0.9747160026942706,1.0,9/18,27.42%,ZC3H12A;NCOR1;RPS26;NCOR2;PTBP1;NRDE2;SHQ1;ZC3H10;TERT
prerank,copper ion transport (GO:0006825),-0.3080161076347602,-0.7425914808536501,0.7858942065491183,0.9475041947506113,1.0,2/11,6.52%,STEAP3;ATOX1
prerank,regulation of adaptive immune response (GO:0002819),0.31955905842336463,0.7423538683305456,0.7811550151975684,0.9750281400833973,1.0,1/18,1.95%,SASH3
prerank,brain development (GO:0007420),0.24302962481087206,0.7421844431483917,0.8898582333696837,0.9748230685856463,1.0,17/136,10.57%,TBR1;PBX3;PBX1;CXCR4;QARS1;ADGRL2;CTNS;ZIC2;ZFHX3;CIC;PHGDH;GRHL2;CDK5RAP1;ZIC1;PAFAH1B1;IER3IP1;NFIB
prerank,chloride transport (GO:0006821),0.25861572466811644,0.7417265155098854,0.8422301304863582,0.9750549403665129,1.0,8/74,12.18%,CFTR;SLC12A8;ANO8;ANO7;CLIC1;CLCN4;SLC12A4;ANO6
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.26528056061132754,-0.7412099443576335,0.8333333333333334,0.9483768033897296,1.0,14/16,51.27%,TNFRSF1B;SOX11;AHR;TNFSF8;IL27;LST1;PTPN22;IKZF3;IL12A;CD22;TNFSF9;FGF10;IL12B;TNFSF18
prerank,mRNA catabolic process (GO:0006402),-0.2152341376160876,-0.7411793920275271,0.9302325581395349,0.947394664717047,1.0,18/44,28.21%,TUT4;METTL16;RNH1;AGO1;RC3H1;LSM6;ZFP36;UPF1;LSM2;CNOT10;AGO4;NUDT16;YTHDF2;MRTO4;ERN1;DCP2;EXOSC9;HSPA1B
prerank,positive regulation of protein transport (GO:0051222),0.2625894952079443,0.7408927497610514,0.8444714459295262,0.9757870028022846,1.0,25/67,24.82%,SYTL4;GOLPH3;TGFB2;PLK3;ANG;CHP1;ACSL3;ARHGEF5;APBB1;EZR;BCAS3;IER3IP1;DNM1L;RIPOR1;APBB3;KIF20B;MYO18A;FRMD4A;VAMP2;TPR;PCM1;ATP2C1;ICE1;GOLPH3L;PPID
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2762208008234213,0.7399140111292226,0.8250303766707169,0.976745966120089,1.0,16/49,24.73%,EP300;MOV10;EIF6;RAB7B;KMT2A;MEF2C;MTURN;PRMT1;PITHD1;PRKCQ;H3-3A;KMT2B;RBM15;KMT2E;KMT2C;ZFPM1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24062030828732975,0.7398789689988391,0.8838709677419355,0.9763612072836476,1.0,32/153,19.46%,PRKCB;IKBKE;MKNK2;SGK3;STK39;LATS1;DYRK1B;MAPK9;PKD1;LMTK2;MAP2K2;SRPK2;GRK2;CSNK1E;EIF2AK3;TGFBR2;CDK2;MAP3K13;GSK3B;CHUK;ULK1;WNK1;PLK2;ATR;TTK;PRKCZ;MAPKAPK2;PRKCQ;ROCK2;STK38L;CAB39;PRKD2
prerank,JNK cascade (GO:0007254),0.28048230304825106,0.7397179363903125,0.8395860284605433,0.9761475285108286,1.0,11/40,18.72%,MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;IKBKG;UBE2N;UBC;RPS27A;TAB2;ARHGEF6
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.24559659688322946,0.7395023985242207,0.8722222222222222,0.9759839463033307,1.0,26/112,17.97%,WNT10A;SMAD6;GDF15;TWSG1;FOS;GCNT2;OVOL2;ARHGEF18;SOX9;PXN;MAPK7;TGFB2;JUN;RHOA;TGFBR2;SFRP1;MEF2C;TGFBR3;ZMIZ2;UBC;RPS27A;SMAD5;PRKCZ;ZYX;BMPR1A;CDH5
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3040779939940672,0.7392755183748575,0.8102941176470588,0.9758601496829131,1.0,6/22,17.90%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2669279531829728,0.7386733449079479,0.825065274151436,0.9762577828897053,1.0,5/52,8.52%,CNOT6;SAMD4A;SAMD4B;LSM4;EXOSC3
prerank,regulation of smoothened signaling pathway (GO:0008589),0.26612702928778864,0.738532594365402,0.8061617458279846,0.9760334060699358,1.0,8/50,12.95%,SMO;GLI3;GLIS2;GPC3;ZIC1;PDCL;EVC;SFRP1
prerank,membrane lipid catabolic process (GO:0046466),-0.3068105356918461,-0.7380309288190635,0.7700534759358288,0.9504324084191147,1.0,2/10,4.96%,ENPP2;CYP1B1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2973824115780447,0.737935776051671,0.8008415147265077,0.9764234913310781,1.0,6/26,17.54%,ITPR2;ITPR3;LETM1;TRPM2;SLC8B1;F2R
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.26244517635116116,0.7374250350480109,0.8451380552220888,0.9767251991159204,1.0,16/71,18.07%,CYFIP2;NCKIPSD;CDC42;ACTB;ABI1;MYO1C;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;ABL1;CRK;ARPC2;YES1
prerank,endothelial tube morphogenesis (GO:0061154),0.362386246927764,0.7366065889469677,0.7678275290215588,0.9774514844503178,1.0,4/10,24.25%,BMP4;RHOA;PRKD2;RHOB
prerank,histone lysine methylation (GO:0034968),0.28528943213354696,0.7363878329640782,0.8222222222222222,0.9773451336499973,1.0,12/33,23.89%,DOT1L;SMYD3;KMT2A;KDM6A;SETDB1;TRMT112;DYDC2;SMYD1;KMT2B;MEN1;N6AMT1;CXXC1
prerank,cell differentiation in hindbrain (GO:0021533),0.35695303141753587,0.736231599429875,0.7925445705024311,0.9771252122236919,1.0,3/11,14.02%,AGTPBP1;OPHN1;CEND1
prerank,ncRNA export from nucleus (GO:0097064),-0.2126424936460468,-0.7357078872000636,0.895397489539749,0.9523337690140389,1.0,12/36,22.84%,TSC1;NUP85;NUP54;RAN;NUP210;NUP214;NUP88;XPOT;NUP188;PHAX;NUP205;NUP37
prerank,response to interleukin-1 (GO:0070555),0.25456583284040984,0.7354826412419546,0.8375149342891278,0.9777305239366251,1.0,6/73,6.49%,CCL5;ADAMTS7;ZC3H12A;HDAC4;USP10;SOX9
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.31104285935934184,0.7351699245582984,0.8130563798219584,0.977729326524078,1.0,4/20,14.33%,EP300;NCOR1;GSK3A;PGP
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.30000112632182907,0.735099176545117,0.8048780487804879,0.9774053252821687,1.0,3/25,7.71%,CCL5;ILK;ANG
prerank,cellular amide metabolic process (GO:0043603),0.24902973019274233,0.7341563379113619,0.8668903803131991,0.9782946953391823,1.0,25/102,22.85%,NAPEPLD;ACOT8;PPP2CA;ORMDL3;CPE;NNMT;ACSM3;SHMT1;ABCA2;NIT1;ALDH1L2;PCCA;SMPD2;ALDH1L1;VNN1;ABCB9;GNE;SLC19A1;MCCC2;THOP1;ST6GAL1;SGPL1;ABHD4;MLYCD;AASDHPPT
prerank,microvillus organization (GO:0032528),0.33412007288501894,0.7339853908290195,0.7756714060031595,0.9780965484339524,1.0,3/13,9.98%,RAP1B;RAP1A;EZR
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.29178702023341624,0.7339016051522408,0.7880886426592798,0.9777869856264733,1.0,5/31,12.21%,HOXA4;EIF4A3;SIX1;TWIST1;TGFBR2
prerank,programmed necrotic cell death (GO:0097300),-0.2573595391650583,-0.7336760942846507,0.8471337579617835,0.9538762208105636,1.0,6/18,22.07%,ITPK1;PGAM5;RIPK1;IPMK;CYLD;MLKL
prerank,positive regulation of leukocyte activation (GO:0002696),-0.25836820831220253,-0.7336489455561463,0.8362573099415205,0.952893476928883,1.0,3/18,7.97%,WNT5A;THBS1;IL33
prerank,negative regulation of translational initiation (GO:0045947),0.33592560626983947,0.7335462592418119,0.7670364500792393,0.9778393237739783,1.0,6/13,30.12%,EIF4EBP1;EIF2AK4;EIF4EBP2;TPR;LARP1;PAIP2
prerank,fatty acid metabolic process (GO:0006631),0.2445339006408792,0.7332953290220098,0.8779956427015251,0.9777544618165572,1.0,16/115,13.36%,PPARGC1A;ACOT8;ALOX5;SLC27A3;CPT1B;MSMO1;ACSL3;ACSM3;NDUFAB1;ACSF3;PON3;FASN;GPAM;ACACA;CPT2;ACADM
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.25302697677274233,0.7329031449068051,0.8658823529411764,0.9778691232421018,1.0,15/80,17.23%,KIF2A;ERGIC1;COPA;KIF1C;ERGIC2;GOLPH3;ATP9A;ZW10;KLC1;ERGIC3;NAPA;ARF4;RAB1B;COPG1;NSF
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3049077303087876,0.7326969534065519,0.7942028985507247,0.9777233216906354,1.0,2/21,5.36%,CAV1;NFKBIA
prerank,sulfur compound catabolic process (GO:0044273),0.2759265446587007,0.7321813539420364,0.8154450261780105,0.9780296559344702,1.0,7/38,14.40%,HEXA;PRELP;GLB1;ARSB;HEXB;ADO;TXN2
prerank,purine-containing compound salvage (GO:0043101),-0.2792676836164111,-0.7309751778545422,0.7877094972067039,0.9551370512120742,1.0,4/12,12.75%,HPRT1;AMPD3;PNP;DCK
prerank,regulation of ion transport (GO:0043269),0.24891151818901533,0.7305946286295466,0.878300803673938,0.979782561677958,1.0,12/76,15.30%,CHRM1;GDNF;WWP2;KCNJ13;ANK3;TOR1A;KCNA5;SYT6;NEDD4;WNK1;SYT11;SYT12
prerank,ncRNA catabolic process (GO:0034661),-0.23197902013107255,-0.7299111456907387,0.8666666666666667,0.9554303782338788,1.0,5/28,13.39%,TUT4;DIS3L;EXOSC7;PARN;EXOSC2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2501606693535803,0.7295907998039746,0.8727272727272727,0.9807348866589722,1.0,18/83,17.33%,CDKN1A;CDK6;USP29;CDK4;CDK16;LATS1;PLK3;FBXO5;EIF4EBP1;CCND1;CDK18;CDK2;MYC;PLK2;E2F1;PCNA;HINFP;CDKN2D
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2121899137804943,-0.7295118897980113,0.8806584362139918,0.9548780275380637,1.0,14/38,27.04%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;TFDP2;RNF2;RAD51;BRCA1;CHEK1;PHC1
prerank,rRNA catabolic process (GO:0016075),-0.27556777449844305,-0.7294760786997316,0.84,0.9539154006367607,1.0,3/16,13.39%,DIS3L;EXOSC7;EXOSC2
prerank,ubiquinone biosynthetic process (GO:0006744),0.3303737796945515,0.7291344074659382,0.7619808306709265,0.9809128434762037,1.0,2/15,8.44%,UBIAD1;PDSS2
prerank,positive regulation of T cell activation (GO:0050870),0.2580607244287239,0.729071498809095,0.84375,0.980559160911845,1.0,4/62,4.65%,CCL5;IL15;CD81;FLOT2
prerank,peptidyl-lysine modification (GO:0018205),0.24774824662806916,0.7289109900262201,0.87651598676957,0.9803287930913935,1.0,31/99,25.85%,EP300;HDAC4;NUP93;EYA1;NDC1;SUMO2;SUMO3;NDUFAB1;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;EEF1AKMT3;VIPAS39;SENP3;P3H3;RAE1;HDAC6;AAAS;PARK7;SIRT4;SIRT7;ATPSCKMT;POM121;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2567530973978898,-0.7285961560673129,0.8721311475409836,0.9529956474654326,1.0,6/20,18.02%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2567530973978898,-0.7285961560673129,0.8721311475409836,0.9529956474654326,1.0,6/20,18.02%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2814137509081922,0.7285751092258664,0.7986577181208053,0.9803700842987828,1.0,2/34,4.27%,SASH3;CLCF1
prerank,lipid transport (GO:0006869),0.24773688347589867,0.7284044211998819,0.859375,0.9801558602963625,1.0,8/97,7.87%,SLCO2A1;LDLR;SLC10A5;ABCD1;PRELID3B;PITPNC1;SLC27A3;LBP
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.35184334311934495,0.7282813258755308,0.7860696517412935,0.9798907518802438,1.0,3/10,13.67%,SOX9;TGFBR2;MYC
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3074609909797481,0.7277968983765087,0.7994186046511628,0.980103817600348,1.0,7/22,18.58%,PPP1R15A;LGALS3;CRY2;PPP1R11;GSK3B;PPP1R1B;ROCK2
prerank,peptidyl-arginine modification (GO:0018195),-0.27252486709850554,-0.727646700215247,0.8413597733711048,0.9531688704912517,1.0,3/15,19.89%,ART3;PADI2;KRTCAP2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.24558252261034225,0.7274668442642683,0.8647450110864745,0.980120940709941,1.0,9/107,8.49%,ANK2;STIM2;CCL5;CAV1;CSRP3;ATP13A3;TMEM165;ATP13A4;SLC39A6
prerank,regulation of interleukin-8 production (GO:0032677),0.2536322375609736,0.7272220621626074,0.8512396694214877,0.9800567032859071,1.0,7/69,11.47%,KLF4;MAVS;ANXA4;OTUD7B;LBP;TLR6;TLR4
prerank,superoxide metabolic process (GO:0006801),-0.22658890246995647,-0.726756303663759,0.9021739130434783,0.9531977469833071,1.0,8/29,21.42%,SH3PXD2B;NOS3;NOX4;NRROS;NCF2;SOD3;SOD1;CYBB
prerank,neural crest cell differentiation (GO:0014033),-0.26106706081076847,-0.7250434206045309,0.8584905660377359,0.9542693214999738,1.0,8/18,26.19%,CDH2;LRP6;PDCD6;SOX11;NOLC1;KBTBD8;HTR2B;KLHL12
prerank,histone H2A acetylation (GO:0043968),0.3232531973487761,0.7244823407529225,0.810930576070901,0.9833130336148056,1.0,4/16,17.55%,NAA40;MORF4L2;MEAF6;TRRAP
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.26146384244781334,0.7244109269017869,0.853566958698373,0.9829790253695083,1.0,16/56,20.59%,TAB3;LBP;TLR6;CNPY3;S100A1;TLR4;IRAK1;TLR3;UBC;RPS27A;MAPKAPK2;TAB2;IRAK4;SFTPA1;SFTPA2;CTSK
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2562744188892198,0.72416638600777,0.8595238095238096,0.9828591648084903,1.0,16/73,18.07%,CYFIP2;NCKIPSD;CDC42;ACTB;ABI1;MYO1C;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;ABL1;CRK;ARPC2;YES1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3069730344956931,0.7238188165119782,0.8107302533532041,0.982886451934924,1.0,4/20,9.90%,PSRC1;CCND2;PKD1;CCND1
prerank,integrated stress response signaling (GO:0140467),0.32619104123653153,0.7236402122291867,0.8030534351145038,0.982682938034952,1.0,3/14,17.21%,NFE2L2;EIF2AK3;EIF2AK4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.2968607113141792,0.7235142808132425,0.8113207547169812,0.9824203989600008,1.0,1/24,0.50%,ITPR2
prerank,response to interferon-gamma (GO:0034341),0.25370372421037796,0.7234375418482487,0.859338061465721,0.9820809398691344,1.0,6/67,7.11%,CCL5;EPRS1;DAPK3;DAPK1;NUB1;TRIM21
prerank,neuron projection fasciculation (GO:0106030),0.3493979781825056,0.7234089806889118,0.788235294117647,0.9816927043643543,1.0,1/10,1.68%,EPHA4
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.30522833998044774,-0.7233217183875792,0.8503740648379052,0.9553270167381107,1.0,4/10,21.79%,DKC1;RPUSD4;NOP10;TSR3
prerank,defense response to symbiont (GO:0140546),0.24629856753162244,0.7231655393595947,0.8771526980482205,0.9815903658865468,1.0,15/92,16.79%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;MOV10;RNASEL;NT5C3A;BNIP3L;IRF2;TLR3;OAS2;FLNA;ZBP1;NDUFAF4
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.270859385300938,-0.7230734482621213,0.8338028169014085,0.9546031847051658,1.0,6/15,27.18%,SRPRB;SPCS2;RYR2;SRPRA;RAB3GAP1;EDEM1
prerank,DNA-dependent DNA replication (GO:0006261),0.23832776501453215,0.7230256845696349,0.8836443468715697,0.9813462769151325,1.0,30/128,22.16%,RECQL4;PSMD11;PSMD4;PSMF1;POLG;SRPK2;PSMD7;POLE4;TOPBP1;PSMB5;CDK2;RPA3;POLD2;PRIM2;MCM8;MCM7;MCM6;UBC;RPS27A;PSMD1;RFC1;PSMC4;PNKP;PSMD8;TWNK;ORC2;GINS3;MCM4;SIRT7;DDX23
prerank,regulation of protein dephosphorylation (GO:0035304),0.2757258589947077,0.7228256331733457,0.8326693227091634,0.9811750411502046,1.0,5/37,9.48%,PPP6R3;DLC1;PPP1R15A;YWHAB;PPP1R16A
prerank,NAD biosynthetic process (GO:0009435),-0.24457968787851309,-0.7226242539012974,0.8590163934426229,0.9541296728968202,1.0,6/20,23.65%,PTGIS;PTGS2;NAXE;QPRT;NAXD;NAMPT
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.2906016423195018,0.7218756205982825,0.7912552891396333,0.9820296466200197,1.0,4/26,9.64%,CYB5R3;DDAH2;CYB5B;ABCA2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.2472222541229251,0.7217290190409207,0.8627671541057368,0.9817765045948084,1.0,12/101,14.13%,CCL5;VIM;ZC3H12A;MTDH;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3375207682828371,0.7217161567275425,0.7847896440129449,0.9813632005145989,1.0,1/11,2.71%,CAV1
prerank,ceramide transport (GO:0035627),-0.2881599545593956,-0.7216746108813146,0.8590078328981723,0.9542279476077458,1.0,3/12,13.49%,PLTP;PLEKHA8;SGPP1
prerank,iron ion homeostasis (GO:0055072),-0.19709892047313562,-0.721366975314136,0.9484536082474226,0.9535801365584542,1.0,13/58,18.59%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;B2M;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1
prerank,vasculogenesis (GO:0001570),0.2833834865046193,0.7213585492866127,0.8253968253968254,0.981386642299514,1.0,7/32,15.32%,ITGB8;CAV1;AGGF1;TGFBR2;RASA1;TGFBR3;TNNI3
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22501879241577707,-0.7208579515390603,0.9201520912547528,0.9531638336605766,1.0,12/31,23.72%,USP8;STAMBPL1;OTUD7A;BABAM2;BRCC3;USP7;BABAM1;OTUD5;TNFAIP3;ATXN3;CYLD;YOD1
prerank,rRNA metabolic process (GO:0016072),0.235091512211349,0.7204997474886483,0.9126730564430245,0.9821265739652719,1.0,40/160,22.00%,PES1;UTP11;PIH1D1;KRR1;POP4;EXOSC3;WDR55;XRN2;RPL31;RPL22;MPHOSPH6;BMS1;RRP12;MTREX;WDR36;WDR43;RPL28;PWP2;DDX47;NOC4L;NOL6;RPL10A;SENP3;RRP9;RPF1;UTP14A;UTP4;RPL14;IMP4;PDCD11;IMP3;RPL6;RPS28;MAPT;RPL41;RPLP2;BYSL;DDX52;WDR74;RPLP1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3085281704294076,0.7191236929969262,0.7964071856287425,0.9835013151467247,1.0,4/18,14.12%,MUL1;ZNF205;GSK3A;GSK3B
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.25294753068876197,0.7189506216147747,0.8596908442330559,0.9832842918498242,1.0,3/65,1.46%,CDH13;ARAP1;MMP9
prerank,positive regulation of macrophage activation (GO:0043032),-0.253034687117029,-0.7187617830614758,0.8662790697674418,0.9545404335102896,1.0,3/17,7.97%,WNT5A;THBS1;IL33
prerank,t-circle formation (GO:0090656),-0.3084443963310135,-0.7187457074247029,0.8397129186602871,0.9515638255324627,1.0,5/10,33.39%,BLM;ERCC1;EXO1;SLX4;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3084443963310135,-0.7187457074247029,0.8397129186602871,0.9515638255324627,1.0,5/10,33.39%,BLM;ERCC1;EXO1;SLX4;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3084443963310135,-0.7187457074247029,0.8397129186602871,0.9515638255324627,1.0,5/10,33.39%,BLM;ERCC1;EXO1;SLX4;DNA2
prerank,spindle assembly (GO:0051225),0.25145397801010133,0.7186315456427149,0.8669891172914147,0.9832802545948419,1.0,13/67,19.23%,MAPRE2;NEK7;KIF2A;HDAC3;NCOR1;RHOA;ABRAXAS1;FLNA;NUMA1;CHEK2;AAAS;MISP;TUBGCP5
prerank,negative regulation of receptor internalization (GO:0002091),0.34032905383338413,0.7178161747834921,0.8116883116883117,0.9839261005318805,1.0,7/12,27.95%,RIN3;NECAB2;DLG4;WDR54;UBQLN2;ANKRD13D;ANKRD13B
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.29324830446952116,0.7176241012015041,0.8279266572637518,0.9837292171187577,1.0,10/25,27.95%,UNC119;ABCA2;RIN3;APP;DLG4;WDR54;UBQLN2;PSEN1;ANKRD13D;ANKRD13B
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.25888548882484463,0.7169234344700688,0.857849196538937,0.9842127381050744,1.0,15/58,19.88%,MRE11;RIF1;MDC1;NSMCE2;ABRAXAS1;PAXX;DCLRE1C;LIG3;UBE2N;PRPF19;NBN;RAD50;ZBTB7A;UVRAG;ERCC4
prerank,endochondral bone morphogenesis (GO:0060350),-0.29592161465071154,-0.7165309697005656,0.8235294117647058,0.9530503043187385,1.0,5/11,23.70%,COL13A1;BMPR1B;BMPR2;INPPL1;FGFR3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2804608846064941,0.7162819121848507,0.8262068965517242,0.984645778387921,1.0,4/30,7.61%,TRIM33;TWSG1;LTBP4;LATS1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.21342670832812752,-0.7157231024169673,0.9157509157509157,0.9529828335144594,1.0,7/32,19.07%,TMED10;TSC1;GRM5;ROCK1;MTPN;ATXN2;NOLC1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3135729887977606,0.7151260203333363,0.7925696594427245,0.9857493794900231,1.0,4/17,20.17%,DMTN;SPRED3;EIF4G1;PARD3
prerank,mRNA stabilization (GO:0048255),0.27054992113125853,0.7148837342361442,0.8322496749024707,0.985628156085137,1.0,9/40,17.33%,GDNF;YBX3;SYNCRIP;BOLL;PAIP1;DHX9;E2F1;IGF2BP1;MAPKAPK2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.291996271811354,0.7144698629850822,0.8304597701149425,0.9857204907537223,1.0,3/26,8.30%,ATP1A2;GSTO1;THADA
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2802482333023448,0.7143799952353167,0.8328651685393258,0.9854068836250027,1.0,6/29,18.42%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,positive regulation of endocytosis (GO:0045807),0.26664910175970163,0.7143104316820823,0.8448717948717949,0.985064013244526,1.0,6/45,12.18%,CLU;CBLL1;GPC3;CDC42;TOR1A;ANO6
prerank,regulation of cellular localization (GO:0060341),0.2645427521004155,0.7140003898838204,0.8503067484662576,0.9850114620954289,1.0,12/46,17.43%,GSN;UNC13D;EFNA5;CDK16;DVL3;PARD6B;CSNK1E;MAD1L1;HSP90AA1;DYNC1H1;KDM1A;NUMA1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.303812266260136,0.7131554957759074,0.7952522255192879,0.9856828267189282,1.0,5/18,12.26%,MSN;MAP2K2;EZR;VPS11;SNX12
prerank,peptidyl-lysine dimethylation (GO:0018027),0.30692009540440424,0.7131502655037014,0.8287373004354136,0.9852617678115945,1.0,7/18,28.01%,KMT2A;SETD7;KMT2B;EHMT1;SMYD2;EEF1AKMT2;SETMAR
prerank,diacylglycerol metabolic process (GO:0046339),0.2925494816745172,0.7129709888565354,0.8350668647845468,0.9850747838231969,1.0,5/23,11.41%,DGAT1;MOGAT1;ANG;DGKA;GPAM
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2541901964864791,0.7125655718153816,0.8768292682926829,0.9851631774669759,1.0,11/56,14.25%,LSM10;CDK4;CCND2;FBXO5;ADAMTS1;CCND1;ANKRD17;VPS4B;NSMCE2;ANAPC4;EIF4G1
prerank,response to hydroxyurea (GO:0072710),-0.28243465917774685,-0.7123353189705428,0.8093994778067886,0.9555476444878072,1.0,5/11,27.09%,KAT7;BLM;SPIDR;FMR1;NSMCE3
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2777479972644341,0.7121538587647349,0.8294993234100135,0.9852792206620253,1.0,4/31,9.06%,DAXX;HSPB8;HSPA14;BAG3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.29037717874455204,0.7120900950073935,0.8095890410958904,0.9849313834904293,1.0,8/25,20.36%,NIBAN2;DOT1L;TWIST1;GATA3;POU4F1;PARK7;ZBTB7A;RB1
prerank,rRNA methylation (GO:0031167),0.3007705001142492,0.7109232205366006,0.8359486447931527,0.9860390783603696,1.0,2/22,4.67%,NOP2;BUD23
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.26072359015137647,-0.7107292977565952,0.8578947368421053,0.9562718546294743,1.0,9/15,35.13%,RPL11;DTX3L;BAG5;BAG2;MAD2L1;LIMK1;SMAD7;RPS7;MAD2L2
prerank,regulation of macrophage activation (GO:0043030),0.28900628180953525,0.7096724510146479,0.8540245566166439,0.9872193658433491,1.0,5/30,11.47%,CD200;ZC3H12A;LBP;TLR6;TLR4
prerank,cellular iron ion homeostasis (GO:0006879),-0.19568246983530738,-0.7096464502766063,0.9540816326530612,0.9564667271167528,1.0,12/55,18.59%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1
prerank,tRNA 5'-end processing (GO:0099116),0.32026612665985593,0.7092960491135205,0.8037383177570093,0.9872815563955342,1.0,5/15,21.75%,POP4;POP1;RPP21;HSD17B10;RPP40
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2701616914832848,0.7092738403032843,0.8549019607843137,0.9868811483798398,1.0,9/38,18.54%,ASF1A;CENPS;ATRX;CENPT;UBN1;CENPH;IPO4;CENPO;H3-3A
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3209323726586989,0.7089736347117294,0.7907348242811502,0.9868764562573036,1.0,4/14,15.05%,TNFRSF10B;TLR6;IRAK1;TLR3
prerank,neuron projection organization (GO:0106027),-0.2606901544073817,-0.7085485422264122,0.8662613981762918,0.9567027957806573,1.0,4/15,15.31%,INSR;PLS1;ABCD2;MAP1A
prerank,protein K48-linked deubiquitination (GO:0071108),0.29149716601827064,0.7081897795805531,0.8648255813953488,0.9874764436237645,1.0,3/23,10.22%,MINDY2;OTUD7B;USP20
prerank,regulation of Golgi organization (GO:1903358),0.3081534911669995,0.7080434055434971,0.8076923076923077,0.9872409574841862,1.0,5/17,15.27%,MYO5A;MAP2K2;ARMH3;USP6NL;RAB33B
prerank,positive regulation of RNA splicing (GO:0033120),0.28137470016711513,0.7071005837074371,0.837730870712401,0.9880228095749529,1.0,5/29,14.90%,POLR2A;RBM20;HABP4;DAZAP1;ZPR1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3433390504213975,0.7070294738853047,0.8006644518272426,0.9872454168969537,1.0,3/10,15.03%,TNFRSF1A;SMPD2;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3433390504213975,0.7070294738853047,0.8006644518272426,0.9872454168969537,1.0,3/10,15.03%,TNFRSF1A;SMPD2;PLA2G6
prerank,serine family amino acid catabolic process (GO:0009071),0.3450246096284988,0.7069086344724926,0.8071672354948806,0.9869919046714719,1.0,2/10,11.07%,SHMT1;AMT
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.31540132383261676,0.7063025210444401,0.8102643856920684,0.9873197515569349,1.0,3/14,9.97%,CMPK1;AK5;AK3
prerank,lipid translocation (GO:0034204),0.29823728759753465,0.706119959848025,0.8058823529411765,0.9871081947964364,1.0,3/21,10.93%,ATP10A;ATP8B2;ATP9A
prerank,regulation of intracellular transport (GO:0032386),0.2693917967917993,0.7060135259795556,0.8468834688346883,0.9868279527633094,1.0,9/38,22.22%,NDEL1;LAMP1;CRYAB;ATP9A;DYNC1H1;NUMA1;AAAS;ANTKMT;ATPSCKMT
prerank,T-helper cell differentiation (GO:0042093),0.32444195403140563,0.7056529655181633,0.8003003003003003,0.9868753624282438,1.0,1/14,1.96%,RORC
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.28358547294280934,0.7046827263376749,0.8407557354925776,0.9876469384082959,1.0,8/29,19.35%,COPA;VTI1B;NAPA;COG8;RAB33B;COPG1;NSF;VTI1A
prerank,positive regulation of cytokinesis (GO:0032467),0.2727295757517759,0.7045922165507826,0.849476439790576,0.9873410343143914,1.0,7/32,19.75%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,hexose metabolic process (GO:0019318),0.2665087851535686,0.7045830807340643,0.8404118404118404,0.9869236760946108,1.0,8/39,14.85%,SLC35A2;HECTD4;HK1;IRS2;FUOM;ALDOA;GALK2;DCXR
prerank,response to growth factor (GO:0070848),0.2677801731980009,0.7044412377314258,0.8513341804320204,0.986669885626661,1.0,9/41,17.63%,KLF4;SHC1;MAPK7;TGFBR2;SFRP1;MYC;LRP2;HDAC6;BMPR1A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2867578578394883,0.7035876545122418,0.8459343794579173,0.9873376179179029,1.0,6/26,18.50%,CDK6;TLR4;PTPN2;MYC;TLR3;RARA
prerank,early endosome to Golgi transport (GO:0034498),-0.28803622319248257,-0.7035449150483369,0.8414322250639387,0.9609881406060207,1.0,4/11,18.89%,EHD3;STX5;SURF4;RBSN
prerank,negative regulation of synaptic transmission (GO:0050805),0.28626017075717597,0.7034335096882175,0.8273381294964028,0.9870980288999387,1.0,5/23,15.29%,TMEM25;STXBP1;PLK2;PNKD;SYT11
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.23467299758158378,0.7029562331629463,0.8995633187772926,0.9872657133270738,1.0,37/104,29.31%,TRIB2;CDKN1A;PPP2CA;PIH1D1;CCND2;MAP2K2;ACTB;CCND1;PKMYT1;RHOA;SERTAD1;TESK1;ABL1;CCNG1;CDKN2D;MTCP1;TSG101;CDK5RAP3;CAB39;UVRAG;RB1;CDK5R1;TRIB3;CDC25A;GTPBP4;MNAT1;CALM2;SNCA;THY1;CCNE2;SYAP1;CCNT1;DDX3X;AKT1;CDC6;GADD45A;CALM1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.24995926802268878,0.7024470000539835,0.8871548619447779,0.987475272273656,1.0,15/70,18.07%,CYFIP2;NCKIPSD;CDC42;ACTB;ABI1;MYO1C;ACTG1;DOCK1;WIPF2;PLA2G6;HSP90AA1;ABL1;CRK;ARPC2;YES1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.24664171264986107,-0.7020766278010613,0.8871473354231975,0.9614660503275577,1.0,11/20,30.23%,NR2F2;APC;IPO5;MYOCD;HHEX;INCA1;CDKN1B;PTEN;CEBPA;HEXIM2;CDKN1C
prerank,regulation of centrosome cycle (GO:0046605),0.292940660519656,0.7019065796751941,0.8289085545722714,0.9877090802392235,1.0,6/21,17.51%,CHMP4B;VPS4B;MARK4;CHMP1A;CHMP2A;PDCD6IP
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22477031606068862,0.7017227624416414,0.9428868120456906,0.9874997303325118,1.0,26/184,18.68%,FZR1;PSMD11;PSMD4;PSMF1;FBXO5;PKD1;PTPN6;CEP76;PAFAH1B1;PSMD7;ZW10;CSNK1E;PSMB5;ANAPC4;CDK2;HSP90AA1;E2F1;DDB1;DYNC1H1;ERCC2;UBC;RPS27A;PSMD1;ODF2;PSMC4;SFI1
prerank,negative regulation of receptor binding (GO:1900121),0.3434036444376898,0.7010474105943612,0.815831987075929,0.9879003286548237,1.0,2/10,10.76%,PTPRF;ADAM15
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.28151732434521637,0.7005766406360567,0.8506401137980085,0.9880673101162815,1.0,11/24,26.29%,BCAP31;FCER1G;SEC23A;ABCB9;CANX;SEC24B;IDE;SEC31A;SEC24D;TAPBP;HFE
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2572309857609177,0.7004903943602617,0.8671679197994987,0.9877438420500942,1.0,9/50,19.83%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23537726440728735,0.7002402551539758,0.9005586592178771,0.9876434609907676,1.0,20/109,19.83%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;MAPK9;JUN;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;TAB2;PSMD1;PRKCQ;PSMC4;MAP3K1;PSMD8
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3056132898412514,0.6988708937831934,0.8061674008810573,0.9889333160966649,1.0,9/18,33.21%,KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PSMD9;PRKN;REST;MIDN
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.23945351808738022,0.6985584290884345,0.8835855646100116,0.9889132704586538,1.0,22/78,24.78%,CDKN1A;IPO7;PSRC1;CCND2;LATS1;PKD1;CDK5RAP1;ACTB;CCND1;PKMYT1;SERTAD1;HEXIM1;CCNG1;CDKN2D;CDK5RAP3;ADAM17;CDK5R1;MEN1;LATS2;CDC25A;GTPBP4;MNAT1
prerank,positive regulation of cell communication (GO:0010647),-0.22581089594345968,-0.6985077415599533,0.9309090909090909,0.9639999538432638,1.0,9/28,20.62%,GRIK2;LGI1;SYT1;CLSTN2;EDN1;SOX11;EDN3;KCTD13;RIMS1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.30819907108444966,0.6982208342818592,0.8251192368839427,0.9888923877410726,1.0,8/17,25.73%,ADD1;TNFRSF1A;VCL;CDH5;ROCK2;IKBKB;PPP1R12A;F11R
prerank,response to ionizing radiation (GO:0010212),0.24468369459544312,0.6979636648813954,0.8933649289099526,0.9887963836435826,1.0,11/70,15.41%,CDKN1A;KDM4D;NABP2;EYA1;INIP;COP1;TOPBP1;ABRAXAS1;EEF1D;MYC;USP28
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.31415453568213414,0.6978014326947808,0.8109854604200323,0.9885767054971726,1.0,1/14,1.46%,GPC1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3163783644806994,0.6977918982771028,0.8207109737248841,0.9881661147925541,1.0,4/15,16.59%,PTK2B;TXK;DDR1;ABL1
prerank,cellular response to interleukin-1 (GO:0071347),0.22687237511843972,0.6976785894968572,0.9294245385450597,0.9878940219474215,1.0,27/143,18.53%,MAP3K8;CCL5;ADAMTS7;ZC3H12A;PSMD11;NFKBIA;USP10;SOX9;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;SFRP1;PELI1;IRAK1;CHUK;IKBKG;UBE2N;UBC;RPS27A;MAP3K3;TAB2;PSMD1;PSMC4
prerank,lipid catabolic process (GO:0016042),0.29957912361198924,0.6975354967767423,0.8330849478390462,0.9876532737823089,1.0,2/18,7.53%,HSD17B14;ACADL
prerank,protein import into nucleus (GO:0006606),0.2465492532926428,0.6967686185547597,0.8786057692307693,0.9881919162969561,1.0,15/66,18.43%,KPNA7;IPO7;TSC2;NUP93;TNPO2;MMP12;KPNA4;NXT2;TNPO1;HEATR3;RANBP6;IPO4;KPNA1;CSE1L;PPP1R10
prerank,protein lipidation (GO:0006497),0.2526879616934427,0.6965032048483619,0.8764845605700713,0.9880789970579532,1.0,13/59,21.92%,GLUL;PIGU;ZDHHC12;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;GPLD1;PIGQ;ZDHHC3;ZDHHC13
prerank,cardiac muscle contraction (GO:0060048),0.27351797896068164,0.695751078563027,0.8462532299741602,0.9885374018585495,1.0,5/34,11.59%,GSN;ATP1A2;CSRP3;GRK2;MYL4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.30948736279513767,0.6955396501113942,0.8386605783866058,0.9883806079614428,1.0,5/17,18.50%,FCER1G;GATA3;PRKCZ;PRKCQ;RARA
prerank,T cell differentiation (GO:0030217),0.26244165437909,0.6955277086900071,0.875,0.9879726001700021,1.0,9/40,15.44%,GLI3;RABL3;FCER1G;PTPN2;GATA3;LMBR1L;MR1;GPR89B;GPR89A
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.29918051370190524,0.6952654191442806,0.8262910798122066,0.9878773959995529,1.0,2/18,4.98%,PMAIP1;TMEM259
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.3286810264598049,0.6950706077707542,0.8022690437601296,0.9876879383816021,1.0,6/12,28.59%,HUS1B;TOPBP1;CHEK2;STK33;SETMAR;CDC6
prerank,regulation of DNA repair (GO:0006282),0.26057252105922624,0.6943214196719121,0.8679950186799502,0.9881633744164193,1.0,15/44,22.58%,EYA2;EYA1;PML;TIGAR;ABRAXAS1;UBR5;POLH;DHX9;PCNA;UBE2N;PARG;SIRT7;RNF168;CDK9;UBE2V1
prerank,tRNA wobble base modification (GO:0002097),0.3169970034319284,0.6943080352587548,0.8048387096774193,0.9877642193484918,1.0,5/14,23.15%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2375519954424121,0.6941824801356867,0.9114942528735632,0.9874901735871212,1.0,19/88,18.32%,CLU;PIH1D1;SDC4;RAB7A;LGALS3;MTLN;VPS4B;AJUBA;HRK;VPS4A;GSK3B;TRABD2B;CHMP2A;PFN2;PDCD6IP;STAM;CDH5;TSG101;PARK7
prerank,NIK/NF-kappaB signaling (GO:0038061),0.2432644493211684,0.6936843056093732,0.8985849056603774,0.9876762021966745,1.0,16/72,21.10%,RELB;PSMD11;PSMD4;PSMF1;TNFRSF10B;TLR6;PSMD7;PSMB5;IRAK1;CHUK;TLR3;PSMD1;PSMC4;NFKB2;PSMD8;ZFP91
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.31602689631441705,0.6936187320257087,0.8341307814992025,0.9873320377664623,1.0,5/12,25.66%,UPP2;UMPS;UPP1;UCK2;UCKL1
prerank,macroautophagy (GO:0016236),0.23003945351704883,0.6931678897983262,0.9088913282107574,0.9874654184398046,1.0,31/118,20.64%,PRKAA2;VPS37B;RUBCNL;TOMM5;CHMP4A;CHMP4B;MTMR3;PLEKHM1;VPS4B;VTI1B;TOMM20;VIPAS39;VPS4A;VDAC1;VAMP7;ULK1;MAP1LC3B;RB1CC1;CHMP2A;ATG4B;PRKAG1;ZFYVE1;STAM;TSG101;ILRUN;VPS37A;PRKAB1;UVRAG;PIK3R4;TOMM40;PRKAB2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2865494555289192,0.6930247711048501,0.8408104196816208,0.9872097583494129,1.0,3/24,7.04%,SESN2;NFE2L2;MAPK7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.31720155009250095,0.6928717238837566,0.8223684210526315,0.9869797243429191,1.0,8/13,25.00%,CHP1;UFM1;SUFU;PARK7;RAB23;TPR;APOD;RANGAP1
prerank,female gamete generation (GO:0007292),0.27452271897740643,0.6917504578840853,0.8482758620689655,0.9879144094533912,1.0,4/29,15.62%,DIAPH2;TOB2;PTN;MCM8
prerank,Fc receptor signaling pathway (GO:0038093),0.23230337510506027,0.6915597547395408,0.9193729003359462,0.9877126215714261,1.0,20/110,19.83%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;MAPK9;JUN;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;TAB2;PSMD1;PRKCQ;PSMC4;MAP3K1;PSMD8
prerank,positive regulation of ATPase activity (GO:0032781),-0.19772195188785383,-0.6915335106890762,0.9487179487179487,0.969902979340614,1.0,11/41,24.09%,ATP1B1;MSH3;VMP1;PLSCR1;RYR2;DNAJB2;TNNT3;DYNLL2;DNAL4;DNAJB1;AHSA1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3026305984621588,0.6913995852374688,0.8508124076809453,0.9875021225809334,1.0,5/18,15.39%,MCU;MUL1;MIEF2;DNM1L;DDHD1
prerank,histone H2A monoubiquitination (GO:0035518),0.29939314578339893,0.6912572676840232,0.8138847858197932,0.9872617849421524,1.0,8/17,26.58%,PCGF6;PCGF3;PCGF2;DDB1;TRIM37;RNF168;RING1;BMI1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.27705534304766166,-0.6910413390026504,0.8733850129198967,0.9693872962087999,1.0,6/12,29.25%,STX2;SNAP25;STX1B;SNAP29;STX19;STX1A
prerank,ganglion development (GO:0061548),0.32239280232906165,0.6904582861035224,0.8168789808917197,0.9878148579685031,1.0,2/11,17.65%,NRP2;SEMA3A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.24268076163454136,0.6904464960972095,0.8971631205673759,0.9874128066024429,1.0,13/69,16.96%,RNF5;TRIM25;ERLIN2;UBE2G2;USP19;ERLIN1;RNF121;RHBDD2;NPLOC4;UBE4A;DNAJC10;UBE2J1;STUB1
prerank,kinetochore organization (GO:0051383),0.31723135967042504,0.6902608475084709,0.8112903225806452,0.9871998345517481,1.0,4/13,25.21%,CENPT;CENPH;CENPF;MIS12
prerank,ERAD pathway (GO:0036503),0.23670529673628157,0.6899516543857427,0.9165714285714286,0.9871495346047277,1.0,16/83,16.96%,RNF5;TRIM25;ERLIN2;UBE2G2;USP19;ERLIN1;RNF121;GET4;TOR1A;RHBDD2;NPLOC4;UBE4A;DNAJC10;CCDC47;UBE2J1;STUB1
prerank,striated muscle contraction (GO:0006941),0.2557428058242719,0.6897626792955426,0.8719806763285024,0.9869748227456293,1.0,9/53,15.32%,ATP1A2;CSRP3;STAC3;LMOD3;GRK2;MYL4;CCDC78;ALDOA;TNNI3
prerank,C-terminal protein amino acid modification (GO:0018410),0.32669541958337484,0.6896334301892109,0.8372093023255814,0.9867057973111444,1.0,2/11,7.99%,AGTPBP1;AGBL1
prerank,regulation of gene silencing by RNA (GO:0060966),0.25158162317500077,0.6894172514096789,0.8909313725490197,0.9861427251560834,1.0,22/50,29.14%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;RAE1;AAAS;POLR2C;H3-3A;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;NUP35;PUM2;TRIM71
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.25158162317500077,0.6894172514096789,0.8909313725490197,0.9861427251560834,1.0,22/50,29.14%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;RAE1;AAAS;POLR2C;H3-3A;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;NUP35;PUM2;TRIM71
prerank,peptidyl-threonine modification (GO:0018210),0.24266279863814358,0.6892784111807835,0.8957345971563981,0.9859051360277411,1.0,23/66,25.08%,CDK10;GALNT1;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;GSK3B;ULK1;WNK1;CDC42BPA;GALNT11;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;GALNT3;PRKCA;MAP3K10;PDPK1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2692239756239722,0.6886358135778818,0.8411214953271028,0.9862377681312001,1.0,8/33,17.77%,FOXO3;FAM210B;HOXA5;RAB7B;BRD1;MTURN;PRMT1;PITHD1
prerank,potassium ion import across plasma membrane (GO:1990573),0.2542778690388513,0.6883381392214395,0.8772378516624041,0.9861791846761522,1.0,3/41,4.55%,SLC12A8;ATP1A2;KCNJ13
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.32926290288676485,0.6878971132153625,0.8068181818181818,0.9862922699902431,1.0,4/10,22.09%,NAGK;GNE;ST6GAL1;GNPDA2
prerank,fluid transport (GO:0042044),-0.27608174965690546,-0.6875514353936956,0.8448753462603878,0.9717594620592931,1.0,3/12,17.42%,AQP11;AQP4;SLC26A6
prerank,protein O-linked glycosylation (GO:0006493),0.2331113572936366,0.6875109670538007,0.9250851305334846,0.9863001454055453,1.0,6/96,4.23%,ST3GAL4;OGT;B4GAT1;TMTC1;GALNT1;LARGE1
prerank,axonemal dynein complex assembly (GO:0070286),0.2742438539764552,0.6866157261317064,0.8519021739130435,0.9869586106533754,1.0,8/27,26.26%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DNAAF4;DRC1;SPAG1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3326842737739661,0.6864757791819129,0.8225255972696246,0.9867048937923356,1.0,4/11,18.09%,AJUBA;FXR1;DHX9;WTIP
prerank,response to leucine (GO:0043201),-0.28030993185048914,-0.6862149490493521,0.8337531486146096,0.9710771213773826,1.0,3/10,15.00%,UBR1;KLHL22;RRAGD
prerank,cellular response to leucine (GO:0071233),-0.28030993185048914,-0.6862149490493521,0.8337531486146096,0.9710771213773826,1.0,3/10,15.00%,UBR1;KLHL22;RRAGD
prerank,negative regulation of bone remodeling (GO:0046851),-0.275540274671595,-0.6861757927183495,0.8511166253101737,0.9701254652574134,1.0,4/11,25.08%,UBASH3B;TNFAIP3;GREM1;CALCA
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32121733283007264,0.6855712623188231,0.8114478114478114,0.9873164431930049,1.0,3/13,16.13%,NIBAN2;NEDD4;CNMD
prerank,organophosphate biosynthetic process (GO:0090407),0.2630202846774294,0.6852208970838574,0.8571428571428571,0.9873054059513873,1.0,8/37,16.30%,MOCS3;IP6K1;PPIP5K2;NFS1;FADS1;GPAM;IP6K2;TPI1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3071800719860669,0.684676099793413,0.8287878787878787,0.987506263805632,1.0,2/16,7.10%,VIM;BMP4
prerank,response to hexose (GO:0009746),0.2825981797608058,0.6845230231313352,0.8425655976676385,0.9872619698827092,1.0,6/25,21.80%,EIF2B2;TCF7L2;IRS2;EIF2B4;GPLD1;VAMP2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.32382258664973845,0.6839606983458678,0.8262243285939969,0.9874899269325362,1.0,2/11,8.52%,LARP7;EXOSC3
prerank,male gonad development (GO:0008584),0.26257952179740246,0.6838091276546078,0.8833780160857909,0.9872584162439195,1.0,5/34,13.07%,TFAP2C;SOX9;TGFB2;MAMLD1;GATA3
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2643721808358703,-0.683781283190517,0.8794117647058823,0.9713229543342732,1.0,7/14,31.92%,RPUSD4;FASTKD2;TRMT10C;FASTKD3;RMND1;MPV17L2;COA3
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.34223247144307967,0.683400904621521,0.8319604612850082,0.9873257555724191,1.0,2/10,17.58%,HP;HDAC6
prerank,urogenital system development (GO:0001655),-0.2782904927147263,-0.6829979835622092,0.8802083333333334,0.9710958779378543,1.0,4/11,24.15%,EPHB2;EPHB3;PAX2;PAX8
prerank,response to metal ion (GO:0010038),0.24215406385701702,0.6829717824461905,0.8986175115207373,0.9874085302314214,1.0,13/67,17.66%,NDRG1;CAV1;PEF1;PPP2CA;AHCYL1;ITPR3;HVCN1;NEDD4;SLC25A12;PPP2CB;SNCB;SLC11A2;HAAO
prerank,glycerophospholipid metabolic process (GO:0006650),0.24158486470494162,0.6820758166788615,0.9120095124851367,0.9880269427207619,1.0,18/75,19.78%,PLCB3;SERINC5;AGK;PIGZ;PAFAH1B1;PIGA;DPM2;PIGX;PGP;PIGN;PLA2G6;PLCD1;ABHD6;PIGP;SERINC1;GPLD1;SMPD4;PIGQ
prerank,stem cell development (GO:0048864),-0.24433358166802494,-0.6812709639879249,0.906060606060606,0.9716982373385673,1.0,10/16,36.49%,CDH2;PDCD6;SOX11;NOLC1;KBTBD8;KLHL12;NRG1;SNAI2;WNT7A;SHH
prerank,regulation of receptor recycling (GO:0001919),0.30334543802279545,0.6810883855095313,0.8687782805429864,0.9887289248182817,1.0,2/16,6.89%,TBC1D16;ANXA2
prerank,synaptic vesicle localization (GO:0097479),-0.2597617756067913,-0.6810686819179459,0.8640776699029126,0.970888375137186,1.0,3/13,12.70%,NLGN1;SNAPIN;SYNDIG1
prerank,phospholipid translocation (GO:0045332),0.2714102249532515,0.6808051432240014,0.8267394270122783,0.9886491760620848,1.0,5/28,12.18%,ATP10A;ATP8B2;ATP9A;PLSCR3;ANO6
prerank,synaptonemal complex assembly (GO:0007130),0.3062032502536511,0.6805402993348507,0.8355957767722474,0.9881238674084173,1.0,1/15,6.22%,SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.3062032502536511,0.6805402993348507,0.8355957767722474,0.9881238674084173,1.0,1/15,6.22%,SYCP2
prerank,vasodilation (GO:0042311),-0.2674721944017699,-0.6802430569041081,0.8797814207650273,0.9706050326931676,1.0,3/13,18.59%,NOS3;KCNMA1;SOD1
prerank,stem cell differentiation (GO:0048863),0.2554223205713274,0.679757437425599,0.893979057591623,0.9885911707632932,1.0,6/39,14.13%,MLLT3;PSMD11;TGFB2;SFRP1;LMBR1L;MEF2C
prerank,retinal metabolic process (GO:0042574),0.3215917884031122,0.6796116233355902,0.84,0.9883383620480143,1.0,2/12,9.70%,DHRS13;ALDH8A1
prerank,anterior/posterior axis specification (GO:0009948),0.30533602940878213,0.6791741266687487,0.828393135725429,0.9884258619905565,1.0,2/15,8.63%,WLS;FZD5
prerank,cellular senescence (GO:0090398),0.2709794571801787,0.6777723576640486,0.8694481830417228,0.9896228367223862,1.0,6/27,17.32%,CDKN1A;PML;NSMCE2;OPA1;HRAS;SMC6
prerank,monocarboxylic acid metabolic process (GO:0032787),0.228541871387808,0.6773516052718993,0.9277899343544858,0.9896742868564212,1.0,17/117,11.49%,ADH7;HAGH;ME3;GAMT;LDHB;NPC1;ABAT;CPT1B;MSMO1;ACSL3;LDHAL6B;ALDH8A1;CKMT1A;ACSF3;FASN;GPAM;PCCA
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2811604018241079,0.6772145506687687,0.8309037900874635,0.9894222817035783,1.0,6/21,15.21%,PPP1R15A;CRY2;YWHAB;PPP1R11;GSK3B;PPP1R1B
prerank,positive regulation of vacuole organization (GO:0044090),-0.286123819789516,-0.6770957192897084,0.8823529411764706,0.9725752387100268,1.0,5/10,22.74%,PIP4K2A;SH3GLB1;RALB;PIP4K2B;RAB3GAP1
prerank,regulation of cellular metabolic process (GO:0031323),0.254825896966862,0.6770884238007595,0.8847117794486216,0.9891375752183147,1.0,13/45,19.38%,TBC1D16;FOXM1;EIF6;ABCA2;FASN;PDK2;ACACA;MBOAT7;ARF4;NCOR2;STUB1;RNF41;FLOT1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3030543011196166,0.6741238618407773,0.8571428571428571,0.992087916924879,1.0,4/15,24.59%,TDO2;HAAO;KYAT1;KMO
prerank,tRNA transport (GO:0051031),0.2597491843251396,0.6736868623641912,0.8868421052631579,0.9921653107180698,1.0,15/35,28.49%,NUP93;NDC1;TOMM20;NOL6;RAE1;AAAS;YBX1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133;NUP35
prerank,ether lipid biosynthetic process (GO:0008611),0.33033002397030786,0.6734865582663182,0.8241379310344827,0.9919809251690686,1.0,3/10,12.51%,DHRS7B;LPCAT2;CHPT1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2612563738457526,0.6730797109288359,0.8777472527472527,0.9920308491584546,1.0,3/31,8.52%,CNOT6;LSM4;EXOSC3
prerank,defense response to virus (GO:0051607),0.2269714642892477,0.6723242263186746,0.936026936026936,0.9924440836193156,1.0,8/100,6.54%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;MOV10;RNASEL;NT5C3A
prerank,regulation of B cell differentiation (GO:0045577),-0.24184802419091286,-0.6719396299879887,0.9076923076923077,0.9760207283488918,1.0,8/17,37.59%,ID2;NCKAP1L;CD27;BTK;XBP1;PPP2R3C;IL4I1;IKZF3
prerank,pancreas development (GO:0031016),-0.2614811715255375,-0.6715796574030711,0.8933333333333333,0.9753538626170553,1.0,5/12,29.16%,NPHP3;ZIC3;NKX6-1;CCDC39;FOXF1
prerank,regulation of spindle assembly (GO:0090169),0.2680875739339842,0.6711632013746219,0.8728571428571429,0.9932949762653734,1.0,10/25,24.75%,CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;CEP97;TPR;CHMP5
prerank,skeletal muscle contraction (GO:0003009),0.2926719570734795,0.6710663688122199,0.8599105812220567,0.9929845648483431,1.0,3/19,15.32%,STAC3;CCDC78;TNNI3
prerank,response to lipid (GO:0033993),0.22857599145775803,0.6704696777544076,0.9400921658986175,0.9932170990457972,1.0,22/105,18.50%,SMAD6;SLPI;FOXO3;RARG;RXRB;SOX9;LBP;ABCA2;TLR4;VPS4B;SOCS2;PELI1;IRAK1;FOXP1;CTSH;CDKN2D;MAPKAPK2;F2R;TAB2;TRIM16;PCK2;RARA
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.276854225081995,0.6702241773909703,0.8744650499286734,0.9930779759131998,1.0,3/23,14.16%,GUCY2F;CNGB1;PDE6B
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.30658898107926513,0.6699985761117397,0.8416,0.9929310857758471,1.0,2/13,15.24%,PVR;MR1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3218368621897438,0.6697809939655743,0.8680445151033387,0.9927581915446602,1.0,2/10,9.06%,JUN;BAG3
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2633245474514274,0.6685232669764832,0.8995695839311334,0.9937200013357764,1.0,7/29,16.90%,RBX1;ERCC5;RPA3;DDB1;ERCC2;UBC;RPS27A
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2777009859831748,0.6679053968485258,0.8551829268292683,0.9935616138488846,1.0,6/21,19.88%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2777009859831748,0.6679053968485258,0.8551829268292683,0.9935616138488846,1.0,6/21,19.88%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,regulation of erythrocyte differentiation (GO:0045646),0.25655806018225674,0.66740841358105,0.8825857519788918,0.9936615786180025,1.0,4/35,6.30%,CDK6;FOXO3;FAM210B;HOXA5
prerank,positive regulation of collagen metabolic process (GO:0010714),0.29707758882390045,0.6660650996659988,0.86,0.9946863933695442,1.0,2/17,7.10%,VIM;BMP4
prerank,regulation of cytokine production (GO:0001817),0.2181601770082646,0.6659575900204858,0.9526881720430107,0.9943857918578426,1.0,23/126,19.38%,SCAMP5;IL15;TWSG1;ALOX5;IRF3;TRIM21;NFAM1;LGR4;SRGN;FOXP3;TXK;PPP1R11;GATA3;FOXP1;GAPDH;SYT11;ZBP1;IGF2BP1;IGF2BP2;MAPKAPK2;GPNMB;IGF2BP3;FLOT1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.25923910089507884,-0.6658710608551772,0.8762886597938144,0.9791978848315164,1.0,4/13,26.22%,TGFB1;SOD1;TYROBP;ITGAM
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2729710081653343,0.6654612564817858,0.8742857142857143,0.9944857048628376,1.0,6/26,18.32%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.32517518457931344,0.6653618196224015,0.8440207972270364,0.994172622000481,1.0,4/10,21.29%,SYP;APP;CAMK2B;DLG4
prerank,polyol biosynthetic process (GO:0046173),0.3018281543632569,0.6652804605364749,0.8535502958579881,0.9938333561411052,1.0,3/16,15.59%,IP6K1;PPIP5K2;IP6K2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.23541829453992116,0.6643484270898318,0.9055489964580874,0.9943917867210443,1.0,16/61,19.46%,EYA2;PARP3;MRE11;EYA1;ATRX;PML;TIGAR;ABRAXAS1;MYC;DHX9;PCNA;UBE2N;NBN;RAD50;PPP1R10;PRKD2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.24164045016977928,0.6636979692224594,0.9090909090909091,0.9946735831348681,1.0,1/53,0.76%,CHRM1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3044281956606651,0.6634703240901823,0.8311897106109325,0.9944950491228788,1.0,4/14,18.32%,BCL2L1;CREB3;OPA1;PARK7
prerank,protein deacetylation (GO:0006476),0.2526004179179205,0.6633712796928828,0.9040920716112532,0.9941933330380351,1.0,11/41,22.03%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;RCOR2;FLNA;HDAC6;RCOR3;SIRT4;SIRT7
prerank,protein auto-ADP-ribosylation (GO:0070213),0.30500981571423347,0.6632469439125425,0.8557046979865772,0.9939095950260679,1.0,7/12,28.88%,PARP3;PARP6;TNKS2;PARP2;PARP11;PARP1;TIPARP
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22433768628058703,0.6628946944935852,0.9307958477508651,0.9938779043348598,1.0,23/94,19.83%,MAP3K8;PSMD11;NFKBIA;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;CHUK;IKBKG;UBE2N;UBC;RPS27A;MAP3K3;TAB2;PSMD1;PSMC4;IRAK4;PSMD8
prerank,primary miRNA processing (GO:0031053),0.31922358985776045,0.6627915384957193,0.8453947368421053,0.9935685767403796,1.0,2/10,14.25%,DGCR8;SRRT
prerank,pre-replicative complex assembly (GO:0036388),0.23494527938100526,0.6626637247758485,0.9097472924187726,0.9932932711950444,1.0,15/64,21.77%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;MCM8;MCM7;MCM6;UBC;RPS27A;PSMD1;PSMC4;PSMD8;ORC2;MCM4
prerank,regulation of lipid catabolic process (GO:0050994),0.28934132090896786,0.6622642504038363,0.8700906344410876,0.9933293798725956,1.0,1/19,2.69%,ABCD1
prerank,regulation of centrosome duplication (GO:0010824),0.2592206743306975,0.6618462858387202,0.8913649025069638,0.9933712191619191,1.0,8/29,17.51%,CHMP4B;CEP76;VPS4B;CHMP1A;PLK2;CHMP2A;CENATAC;PDCD6IP
prerank,regulation of interleukin-17 production (GO:0032660),0.2585856222336162,0.6616583460745186,0.8829201101928374,0.99315268087513,1.0,4/31,11.47%,IL15;ZBTB7B;FOXP3;TLR4
prerank,glycerol metabolic process (GO:0006071),0.3160658816423292,0.6615912928832223,0.8166383701188455,0.9928072878254359,1.0,6/10,30.88%,PGP;TPI1;COQ3;ANGPTL3;GK;COQ2
prerank,negative regulation of cell cycle process (GO:0010948),0.23366536517025185,0.6611153621052835,0.9259708737864077,0.9929294247545439,1.0,14/61,20.87%,PCGF6;MGA;BMP4;ZFYVE19;FBXO5;VPS4A;PCGF2;CHMP2A;E2F1;PPP1R10;WAPL;GPER1;TOM1L2;TERF2
prerank,histone deubiquitination (GO:0016578),0.2784029830486754,0.6610056489740377,0.8642745709828393,0.9926349331424631,1.0,6/18,20.79%,ENY2;USP3;TRRAP;USP21;USP16;USP22
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.24401046067341545,-0.6609740521874895,0.8629737609329446,0.9821824612361034,1.0,8/15,35.15%,GLI1;EZH2;PAF1;PHB2;NPM1;PLCG2;ATAD5;FAM83D
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2852800991319935,0.6604038866121418,0.8609077598828697,0.9928564077403561,1.0,2/19,7.10%,VIM;BMP4
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2352213685753216,0.6603765505938407,0.9125151883353585,0.992473943576176,1.0,20/59,25.08%,CDK10;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;GSK3B;ULK1;WNK1;CDC42BPA;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;PDPK1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.2855781731584982,0.6602953308310808,0.8624420401854714,0.9921496417799236,1.0,6/18,21.77%,POLD2;LIG3;PCNA;MCM7;GINS3;MCM4
prerank,positive regulation of cellular senescence (GO:2000774),0.3172436720099632,0.6598527144070074,0.8440065681444991,0.992177064261668,1.0,2/10,12.78%,YPEL3;EEF1E1
prerank,regulation of regulated secretory pathway (GO:1903305),0.2590022349648648,0.6595989908194967,0.8680272108843538,0.9920158944024489,1.0,11/34,21.18%,UNC13D;SYN1;RIMS4;VPS18;SYT6;GSK3B;SYT11;SYT12;RAB27A;SYT3;SYT2
prerank,protein acylation (GO:0043543),0.2509643899035166,0.659152229512163,0.9124668435013262,0.9920904723702084,1.0,3/38,4.67%,GLUL;EP300;ZDHHC12
prerank,folic acid metabolic process (GO:0046655),0.2902416962058743,0.6585378463225321,0.8638360175695461,0.9922792671024739,1.0,4/18,18.47%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.18998062330648846,-0.6584747052694188,0.9613733905579399,0.9831334132503451,1.0,19/42,32.71%,SMCHD1;UBQLN4;SPIDR;PPP4C;FANCB;WDR48;MRNIP;CGAS;ERCC6;RMI2;RAD51;PARPBP;WRAP53;CHEK1;SIRT6;RTEL1;SHLD3;RAD51AP1;HELB
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2111926812130081,-0.6581482864183729,0.9333333333333333,0.9823846788337024,1.0,8/26,20.56%,CCDC57;HSF1;RPS6KB1;MEIS2;TAL1;SMOC2;SPHK1;ASNS
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.23548957662390013,0.6567088366706552,0.9166666666666666,0.9937154415382032,1.0,9/61,13.94%,CAV1;PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PDK2;PSMB5;NCOR2
prerank,regulation of DNA replication (GO:0006275),-0.18116253883866662,-0.6563760926358198,0.9743589743589743,0.982767135476168,1.0,11/49,19.08%,GLI2;ACVRL1;USP37;KAT7;GLI1;ORC5;BCAR3;BLM;EGF;STN1;CTC1
prerank,vesicle transport along actin filament (GO:0030050),0.28053146658905637,0.6563480626037925,0.8770614692653673,0.9936807769894259,1.0,6/19,17.41%,MYO1H;MYO5A;MYO1C;MYO15A;ACTN4;MYO1E
prerank,nuclear body organization (GO:0030575),0.30810248864079404,0.6558831630018588,0.8374384236453202,0.9937316417035368,1.0,4/12,14.90%,PML;SRPK2;HABP4;ZPR1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.2793302406127684,0.6547334460464941,0.8660714285714286,0.9945042220401451,1.0,5/19,15.90%,LBP;NMI;TLR4;IRAK1;ITGB2
prerank,protein localization to Golgi apparatus (GO:0034067),0.2592316117934774,0.6543174261232874,0.895774647887324,0.9945113796121898,1.0,7/27,17.46%,VPS13A;GOLPH3;GCC2;VPS13D;RAB33B;RIPOR1;ARFRP1
prerank,negative regulation of secretion (GO:0051048),-0.27218577381177506,-0.6536393344109727,0.8800959232613909,0.9839451859665146,1.0,7/10,39.93%,NR1H3;CD74;EGF;NRG1;PTGER3;VAMP8;TIFAB
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.30031686444872235,0.6535627198980686,0.847723704866562,0.9948678784529758,1.0,3/13,13.52%,CPE;TGFBR2;GSK3A
prerank,response to alcohol (GO:0097305),0.2631023807399187,0.6533226964356748,0.8948824343015215,0.9946943571705635,1.0,5/27,14.52%,ADH7;PMVK;ABCA2;TGFBR2;TGFBR3
prerank,negative regulation of viral transcription (GO:0032897),0.3008989243724626,0.6532893842922436,0.8792270531400966,0.9943213389763939,1.0,5/13,20.39%,TRIM21;LARP7;TRIM11;HEXIM1;UBP1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.31032906862587495,0.6529246891664043,0.8462783171521036,0.9943008092769827,1.0,3/11,16.10%,STAT4;JAK1;CANX
prerank,negative regulation of JNK cascade (GO:0046329),0.25396825128698414,0.6528900429471405,0.8936170212765957,0.9939307039637667,1.0,10/31,24.93%,DUSP10;SH3RF2;HDAC3;NCOR1;DUSP3;TAOK3;MEN1;SIRPA;PER1;MAPK8IP1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23745255399223317,0.6526588054674342,0.9229813664596274,0.9937737511128837,1.0,9/53,19.83%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,protein deneddylation (GO:0000338),0.3193367915740386,0.6520673725850219,0.8439490445859873,0.993955228440715,1.0,2/10,12.58%,TOR1A;COPS5
prerank,positive regulation of binding (GO:0051099),0.22739596934761536,0.6519894452753437,0.9419953596287703,0.9936223852867067,1.0,9/84,8.43%,MMP9;CAV1;NGF;KDM4D;ADD1;BMP4;TRIM21;TCF7L2;PKD1
prerank,I-kappaB phosphorylation (GO:0007252),0.3174514530120357,0.6517812470419193,0.8569105691056911,0.9934307256687672,1.0,3/10,15.05%,TLR4;CHUK;TLR3
prerank,cellular response to estrogen stimulus (GO:0071391),0.29562702112878936,0.6516019924822766,0.8706624605678234,0.9931928134660439,1.0,5/14,23.22%,BCAS3;SFRP1;SFR1;RARA;NCOA4
prerank,positive regulation of organelle assembly (GO:1902117),0.24432549351414665,0.6511089884751048,0.9252948885976409,0.993246863028955,1.0,16/44,25.43%,CNOT6;SDC4;MARK4;PIP4K2C;CCDC88A;FSCN1;DYNC1H1;NUMA1;PDCD6IP;CROCC;RAB3GAP2;CEP120;TAPT1;PLK4;NUP62;LRSAM1
prerank,RNA polyadenylation (GO:0043631),0.2586529350307246,0.6489780495642969,0.8921568627450981,0.9945591721270665,1.0,9/26,24.10%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.2586529350307246,0.6489780495642969,0.8921568627450981,0.9945591721270665,1.0,9/26,24.10%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.21405411590424445,-0.6487746047159596,0.950920245398773,0.9864998948999456,1.0,7/22,24.13%,PSMA6;PSMB10;PSMB9;PSMA4;PSMB7;PSMA8;PSMA3
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.25265826828378085,0.6486749280510979,0.886968085106383,0.9944540913060785,1.0,6/33,15.79%,CDKN1A;DDRGK1;PKD1;PTPN6;ATP2B4;E2F1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.19408101267219396,-0.6472104745492241,0.9533898305084746,0.9866094077031885,1.0,10/37,24.53%,AATF;MTMR2;EDNRB;ITGAV;EDN1;SIRT2;ATXN2;OPTN;PAX2;BRCA1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.22204074629427897,-0.6468201032345385,0.9161290322580645,0.9858913246219619,1.0,7/19,21.40%,HPRT1;AMPD3;PNP;DCK;TYMS;GMPR2;CDA
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.24265882380669468,0.6466531360126815,0.9207161125319693,0.995977819771671,1.0,9/47,15.58%,QARS1;FOXM1;TGFB2;MAP2K2;ARL6IP5;COPS5;MYC;TGFBR3;IGBP1
prerank,protein targeting (GO:0006605),0.2130777098101879,0.6463929697338019,0.9662542182227222,0.9958206727796095,1.0,30/118,23.97%,TIMM10;HOMER3;TIMM44;ZDHHC12;VPS37B;TOMM5;PITRM1;GOLGA7;MYO1C;BCAP31;SPCS3;AP1S3;TOMM20;ZFAND6;TIMM17B;AP4E1;PEX6;VPS37A;TIMM9;PARD3;TOMM40;TSPO;ZDHHC3;AP4M1;SRP14;TIMM23;AIP;ATG3;RAB3IP;ARL6
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2612378107750105,0.6460292021984265,0.9126074498567335,0.9957598604930886,1.0,11/25,27.11%,LARP7;WDR43;ELL;HEXIM1;NELFB;NELFA;RNF168;LEO1;CDK13;LDB1;RNF8
prerank,phasic smooth muscle contraction (GO:0014821),0.31356269576828694,0.6459079901292415,0.8694214876033057,0.9954730827092639,1.0,1/10,3.93%,GDNF
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.23173196618449698,-0.64414722321042,0.9260450160771704,0.9867124391364563,1.0,11/19,49.56%,CHRNB1;SLC5A7;CHRNA4;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3
prerank,regulation of tumor necrosis factor production (GO:0032680),0.21614707161051364,0.6441332810017815,0.9618834080717489,0.9968024763321536,1.0,19/112,18.63%,CLU;ZC3H12A;MAVS;TNFRSF8;HSPB1;LBP;FZD5;PTPN6;TWIST1;TLR4;FOXP1;TLR3;SYT11;DHX9;OAS2;MAPKAPK2;PTPN11;RARA;ILRUN
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2675024733173606,0.6438427339197503,0.8939393939393939,0.9966732252958156,1.0,8/23,24.21%,MTMR12;MTMR3;INPP5B;OCRL;TPTE;PIP4P1;MTMR9;MTMR10
prerank,nucleotide metabolic process (GO:0009117),0.267511095282346,0.6437023358185481,0.8986111111111111,0.9963993948932515,1.0,5/23,18.32%,FHIT;CMPK1;AK5;CTPS2;PARK7
prerank,atrioventricular valve development (GO:0003171),-0.24230099397024918,-0.6428390026229265,0.9064171122994652,0.986624328430172,1.0,4/14,14.51%,NOTCH1;HEYL;SLIT3;BMPR2
prerank,response to gamma radiation (GO:0010332),0.2697431121732002,0.6427680572780189,0.8961593172119487,0.9968756518924771,1.0,6/24,16.74%,CRYAB;MYC;HRAS;MDM2;ATR;KDM1A
prerank,membrane repolarization (GO:0086009),0.28764432439573245,0.6425722034271178,0.8736176935229067,0.9966582493988684,1.0,1/15,2.83%,ATP1A2
prerank,protein localization to chromatin (GO:0071168),-0.225303359067584,-0.6424001914428533,0.9240506329113924,0.9859548431501993,1.0,5/18,18.74%,ESR1;TASOR;NIPBL;CHMP7;MRNIP
prerank,alcohol catabolic process (GO:0046164),0.31243998630464564,0.6420975956351118,0.8588235294117647,0.9966664885113873,1.0,1/10,8.20%,SRD5A3
prerank,negative regulation of T cell activation (GO:0050868),0.25121220616839396,0.6405190323922119,0.9060402684563759,0.9977048869919531,1.0,4/35,9.13%,RIPOR2;SDC4;LGALS3;FOXP3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2479668700549954,0.640477171706701,0.8836265223274695,0.9973393813569682,1.0,7/35,15.21%,MAGI2;PPP6R3;PPP1R15A;CRY2;PPP1R11;GSK3B;PPP1R1B
prerank,regulation of protein localization to centrosome (GO:1904779),0.3088081423923805,0.6400870751801233,0.8660130718954249,0.9973008410191484,1.0,3/10,14.12%,NSFL1C;MARK4;GSK3B
prerank,aspartate family amino acid catabolic process (GO:0009068),0.2771400786188756,0.6400097978637781,0.8973214285714286,0.9969632754126999,1.0,4/19,16.65%,PIPOX;SLC25A21;OGDH;DLST
prerank,regulation of microtubule polymerization (GO:0031113),0.24646042021108336,0.6398154257596526,0.9169811320754717,0.9967459609826764,1.0,10/40,22.86%,OCLN;PSRC1;EML2;CAMSAP1;ABL1;NUMA1;CDH5;MAPT;CDK5R1;TBCD
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.2931171414921369,0.6389841560083965,0.8791208791208791,0.9971179717362436,1.0,5/14,28.00%,PES1;DDX18;RPL7;ZNHIT6;URB1
prerank,histone deacetylation (GO:0016575),0.24210201814398563,0.6388217260862908,0.9480354879594424,0.9968656536882489,1.0,14/43,25.36%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;RCOR2;HDAC6;RCOR3;SIRT7;SFPQ;BAZ2A;PER1;HDAC8;PER2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.2689043866680781,0.6384139150787795,0.9014285714285715,0.9968213303441383,1.0,4/21,12.68%,RASAL3;TGFB2;MAPKAP1;SYNGAP1
prerank,protein palmitoylation (GO:0018345),0.24963754891153106,0.638357280303803,0.9099462365591398,0.9964753634878752,1.0,3/30,9.43%,GLUL;ZDHHC12;GOLGA7
prerank,regulation of histone methylation (GO:0031060),0.29661972390466373,0.637645513276697,0.865040650406504,0.996710214474768,1.0,3/13,15.49%,PIH1D1;NNMT;TET1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.257357575228792,0.6376427876549083,0.8930555555555556,0.9963105710083294,1.0,4/29,12.95%,CAV1;PMAIP1;PML;SFRP1
prerank,regulation of B cell apoptotic process (GO:0002902),0.3014293610535773,0.6371818221961917,0.8812199036918138,0.9963277726342927,1.0,3/12,14.22%,ORMDL3;IRS2;FOXP1
prerank,protein prenylation (GO:0018342),-0.27183410455107293,-0.6364550995123885,0.902200488997555,0.9891103955515373,1.0,5/10,33.58%,FNTB;CHM;PTAR1;FNTA;RCE1
prerank,negative regulation of neurogenesis (GO:0050768),0.24989954651623483,0.6363099272937728,0.9146341463414634,0.996748832713666,1.0,1/34,0.75%,RTN4R
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.30746684045373995,0.635333138273375,0.8717047451669596,0.9972134262302507,1.0,4/10,20.76%,TUT7;UBC;RPS27A;CHFR
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2252267096094594,0.6352659873123379,0.9451073985680191,0.9968649187472003,1.0,26/62,29.14%,POLR2H;POLR2A;NUP93;NDC1;AJUBA;FXR1;EIF4G1;DHX9;RAE1;AAAS;POLR2C;WTIP;H3-3A;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;NUP35;PUM2;TRIM71
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3052718804434116,0.6350839004720673,0.8784246575342466,0.9966083884539876,1.0,2/10,12.36%,PPP2CA;PTPN2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.22133879452443037,-0.6346071981108302,0.9373040752351097,0.9893365298912365,1.0,2/19,5.92%,AR;CHD8
prerank,serine family amino acid metabolic process (GO:0009069),0.2842706776464792,0.6335551967775034,0.8717948717948718,0.9975665554893132,1.0,3/16,14.26%,SHMT1;CDO1;SARS1
prerank,regulation of DNA recombination (GO:0000018),0.24907720713072207,0.6318372542145193,0.9179206566347469,0.9987108139996476,1.0,7/32,20.40%,SHLD2;MRE11;IL7R;KDM1A;KPNA1;RAD50;THOC1
prerank,interstrand cross-link repair (GO:0036297),-0.17350038590842562,-0.6315982770819446,0.9904761904761905,0.9902829342226557,1.0,16/53,25.81%,ERCC6L2;FANCL;FANCI;FANCC;USP1;FAAP100;FANCB;WDR48;FANCD2;DCLRE1A;NEIL3;ERCC1;EXO5;RAD51;RAD51AP2;CENPX
prerank,lipoprotein catabolic process (GO:0042159),0.30498953330839296,0.6314869117772731,0.8643790849673203,0.9986297924162413,1.0,3/11,18.51%,ABHD10;LYPLAL1;ABHD17C
prerank,regulation of peptidase activity (GO:0052547),0.2730133643499603,0.63142584382875,0.8941717791411042,0.9982878405338174,1.0,1/19,2.71%,CAV1
prerank,mitochondrial transcription (GO:0006390),0.30991312303619595,0.6311513924441265,0.8666666666666667,0.9981344060019314,1.0,1/10,3.60%,FOXO3
prerank,lipid droplet formation (GO:0140042),0.30556275231985247,0.6307585141734843,0.8792270531400966,0.9980605340755826,1.0,3/10,17.66%,SQLE;CDS1;ZFYVE1
prerank,autophagosome assembly (GO:0000045),0.22826041607993777,0.6299772315981211,0.9441069258809235,0.9983436540472322,1.0,22/52,28.13%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;ATG3;UBXN2A;GABARAPL2;PACS2;WIPI2;ATG2B;STX12;TRAPPC8;ATG12;WIPI1;WDR45
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2944072635607363,0.6296497068095191,0.8840579710144928,0.9982436997906647,1.0,2/13,11.23%,CIAO1;ISCA1
prerank,cilium movement (GO:0003341),0.23442156872222353,0.6295725816773305,0.9319640564826701,0.9979122060296732,1.0,12/47,24.48%,CFAP91;CFAP54;CFAP206;ODAD3;SPAG17;ADCY10;DNAAF5;CFAP61;ODAD2;DNAH5;DNAAF4;GAS8
prerank,cellular response to acid chemical (GO:0071229),0.2531922779396911,0.6294327837725905,0.9199438202247191,0.9976258414304405,1.0,3/27,7.03%,SESN2;SH3BP4;CAPN2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.3006711320802042,0.6293832894436092,0.8742331288343558,0.9972720379559158,1.0,3/11,18.32%,ABCD1;COA8;PARK7
prerank,thymus development (GO:0048538),-0.2448228362843458,-0.6286939590851769,0.9178082191780822,0.9911439762254989,1.0,7/13,39.05%,TBX1;EPHB3;SOD1;FOXE1;FADD;SHH;HES1
prerank,erythrocyte differentiation (GO:0030218),0.23566724740312667,0.6282888811080015,0.9282970550576184,0.9978054597219128,1.0,14/44,25.35%,ACIN1;EPO;DMTN;ATP5IF1;SLC25A38;PTPN2;TGFBR3;CDK5RAP3;IKZF1;FLVCR1;KMT2E;CASP3;ZFPM1;ABCB10
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2541344622998254,0.6282490392989859,0.9147727272727273,0.9974350641610618,1.0,3/25,9.04%,BAG1;SDF2;HSPA14
prerank,amyloid-beta metabolic process (GO:0050435),0.2786079786813945,0.6272583071681717,0.8819018404907976,0.9979072051346393,1.0,6/16,23.70%,MGAT3;BACE1;IDE;ABCA7;APH1A;PSEN1
prerank,cytoplasmic translational initiation (GO:0002183),0.27107014304103827,0.6270816239765256,0.8974739970282318,0.997643802278041,1.0,5/17,17.85%,EIF4B;EIF3M;EIF4G1;EIF4A1;EIF4A2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.25669394473022056,0.6260926234121142,0.9077809798270894,0.9981070903579498,1.0,3/23,7.61%,TRIM33;LTBP4;LATS1
prerank,DNA replication initiation (GO:0006270),0.2399814074660486,0.6259404977250046,0.9244264507422402,0.9978382259970539,1.0,13/37,26.62%,POLE4;TOPBP1;CDK2;RPA3;PRIM2;MCM8;MCM7;MCM6;ORC2;MCM4;ORC3;MCM2;RPA2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.2984746720230996,0.6258987655508604,0.8850574712643678,0.9974765432321425,1.0,11/11,70.17%,PRKCQ;NLRP10;CLEC6A;NFKBIZ;IL23R;IL12B;IL23A;CARD9;IL12RB1;NFKBID;MALT1
prerank,positive regulation of peptidase activity (GO:0010952),-0.21189623788426043,-0.6255193675705731,0.9463087248322147,0.9920806454027261,1.0,4/20,17.45%,RCN3;MAPK12;PSME1;APH1B
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.2773665063648441,0.62546374483593,0.8914100486223663,0.9974651822039664,1.0,2/15,9.13%,TGFB2;FOXP3
prerank,cilium-dependent cell motility (GO:0060285),-0.20549812633587977,-0.6216318460738534,0.9617834394904459,0.9934710624418578,1.0,10/22,35.43%,CFAP44;RFX3;DNAH3;DNAH2;CCDC39;RSPH9;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2596120587860684,0.6208311195296026,0.9053084648493543,1.0,1.0,5/23,16.90%,RBX1;COPS5;DDB1;UBC;RPS27A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2803458619144081,0.6202758031670869,0.9039087947882736,1.0,1.0,1/13,5.50%,DUSP1
prerank,response to glucose (GO:0009749),0.2306444538724573,0.6202271270350564,0.9361979166666666,1.0,1.0,11/46,21.80%,PRKAA2;EIF2B2;TCF7L2;KCNB1;IRS2;EIF2B4;PCK2;GPLD1;GPER1;SOX4;VAMP2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.205580246894977,0.6200433174055837,0.9809417040358744,1.0,1.0,26/125,21.58%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;CENPT;AURKC;PAFAH1B1;ZW10;EFHC2;CENPH;MAD1L1;PLK2;DYNC1LI2;CENPO;DYNC1H1;TTK;INTS13;ZWINT;SUN2;TBCE;CENPF;RMDN1;WDR62;RCC2;NUDC
prerank,membrane lipid metabolic process (GO:0006643),0.2556850497874643,0.6199482807428774,0.8977777777777778,1.0,1.0,5/22,19.12%,AGK;ST3GAL6;ST6GALNAC4;TEX2;SERINC1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.27964854410342127,0.6192137896061616,0.9050632911392406,1.0,1.0,1/15,3.19%,ABHD5
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.22099515136566206,-0.6188302312271493,0.9298245614035088,0.9941228111798199,1.0,1/18,1.41%,FBN1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.2870232929177191,0.6180955909245031,0.8950819672131147,1.0,1.0,4/12,26.18%,MCM7;MCM6;MCM4;MCM2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.25473302136087156,0.6173859873533301,0.9074829931972789,1.0,1.0,7/26,23.98%,FLOT2;LGR4;NLRP2B;TLR3;FLOT1;BIRC3;TLR5
prerank,positive regulation of type 2 immune response (GO:0002830),0.28198225423335993,0.61734599752242,0.8938193343898574,1.0,1.0,5/14,26.63%,CD81;PRKCZ;RARA;IL6;DENND1B
prerank,positive regulation of cholesterol transport (GO:0032376),0.2487691477411561,0.6161027267695053,0.9170182841068917,1.0,1.0,2/27,5.36%,CAV1;NFKBIA
prerank,intracellular sterol transport (GO:0032366),0.28597333535155817,0.6160982972292431,0.8935837245696401,1.0,1.0,5/13,18.54%,NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2537516278224831,-0.6154451935355645,0.9441860465116279,0.9951147930622002,1.0,2/10,16.72%,LGALS9;RC3H1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2800628296363689,0.6151123534823658,0.8939157566302652,1.0,1.0,3/14,17.33%,YBX3;BOLL;MAPKAPK2
prerank,regulation of rRNA processing (GO:2000232),0.2677501790596566,0.6140863635560092,0.9173166926677067,1.0,1.0,5/16,23.17%,BUD23;WDR43;TRMT112;SIRT7;SHQ1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.27164785217279513,0.613112373663454,0.8988941548183255,1.0,1.0,8/16,29.33%,PINX1;TNKS2;ERCC4;TERF2;TINF2;PARP1;TERF1;NAF1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.25348645727540436,0.6124739050880695,0.9182209469153515,1.0,1.0,3/23,11.47%,ZC3H12A;FOXP3;TLR4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.2527191156948348,-0.6120766628353821,0.9170854271356784,0.995955709960108,1.0,5/10,27.47%,APC;SIRT2;ECT2;KNSTRN;SPAG5
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.29784191675230515,0.6106419998885894,0.9133986928104575,1.0,1.0,2/10,14.16%,CNGB1;PDE6B
prerank,autophagosome organization (GO:1905037),0.22252702561714185,0.6102530251196314,0.952088452088452,1.0,1.0,21/50,28.13%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;ATG3;UBXN2A;GABARAPL2;PACS2;WIPI2;ATG2B;STX12;ATG12;WIPI1;WDR45
prerank,cellular response to amyloid-beta (GO:1904646),0.23649980127062634,0.6100996358393713,0.9139504563233377,1.0,1.0,11/35,24.80%,EPHA4;CACNA1A;TLR6;TLR4;GSK3B;APP;AGER;ATP1A3;PSEN1;CACNA2D1;FYN
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.21581106839391057,-0.6099076540403008,0.946875,0.9961512251954111,1.0,12/18,51.71%,NCKAP1L;PRDM1;CCR2;PRKDC;IL4I1;IKZF3;CRTAM;ZFP36L2;TBX21;SLAMF8;PRELID1;CD2
prerank,neurotransmitter secretion (GO:0007269),0.2283059219283205,0.6090644273799215,0.9347826086956522,1.0,1.0,5/44,9.13%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,signal release from synapse (GO:0099643),0.2292890651615948,0.6090239329947007,0.9421593830334191,1.0,1.0,5/43,9.13%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.25211245887594186,0.6090016230542986,0.924812030075188,1.0,1.0,7/21,22.86%,FBXO5;ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,activation of adenylate cyclase activity (GO:0007190),0.23549849263558412,0.6087753461452896,0.9292267365661862,1.0,1.0,4/35,10.05%,ADCY9;ADCY6;LGR4;RAF1
prerank,fatty acid transport (GO:0015908),0.2662931840781949,0.6086634069818861,0.9085365853658537,1.0,1.0,4/17,17.58%,SLC27A3;CPT1B;SLC25A17;SLC27A4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2504977346947954,0.6084343703376784,0.9321533923303835,1.0,1.0,5/22,16.90%,RBX1;DDB1;ERCC2;UBC;RPS27A
prerank,regulation of leukocyte activation (GO:0002694),0.28218416807652613,0.6074212699789379,0.8959627329192547,1.0,1.0,1/14,2.16%,CD200
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.21934250977522096,0.6072651755878256,0.9599514563106796,1.0,1.0,13/59,18.58%,RELB;NFKBIA;TAB3;TNFRSF1A;TLR4;CHUK;TLR3;RNF31;IKBKG;UBC;RPS27A;TAB2;ROCK2
prerank,protein localization to kinetochore (GO:0034501),0.2805628364197307,0.6071981567305222,0.9173419773095624,1.0,1.0,5/14,25.21%,CENPT;ZW10;TTK;RCC2;MIS12
prerank,regulation of secretion (GO:0051046),0.279297452052288,0.6070234819932514,0.9020537124802528,1.0,1.0,5/13,23.91%,ERBB3;ACSL3;OAS2;GPLD1;POFUT2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.24809122210069312,0.6070188418091479,0.930576070901034,1.0,1.0,4/26,13.00%,DUSP1;FBXO5;NSMCE2;ANAPC4
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.24018315045109273,-0.6059402048662034,0.9183673469387755,0.9972600490708445,1.0,5/13,23.09%,GPD1L;MAP1A;HSP90AB1;TYROBP;TMEM35A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2873949553542959,0.6058338725995349,0.9085173501577287,1.0,1.0,2/12,9.44%,PCGF3;LRIF1
prerank,regulation of viral life cycle (GO:1903900),0.2525284473420936,0.6058229147801533,0.9237536656891495,1.0,1.0,5/21,21.88%,TRIM25;TRIM21;VPS4A;TSG101;TRIM5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.23528931707068368,-0.6045507183817855,0.9554896142433235,0.9969929937650266,1.0,3/12,18.50%,TASOR;SETDB2;APOBEC1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.294081743101807,0.604496122354403,0.90311986863711,1.0,1.0,3/11,15.78%,FBXO5;DONSON;LIG3
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2874692727042748,0.6039555035082653,0.8918032786885246,1.0,1.0,1/11,6.81%,PXDN
prerank,actin nucleation (GO:0045010),0.2565463932020895,0.6032560994011168,0.9320531757754801,1.0,1.0,4/21,16.80%,LMOD3;MAGEL2;WASHC1;ARPC2
prerank,negative regulation of biosynthetic process (GO:0009890),0.2708798797927606,0.6021635724692956,0.8993993993993994,1.0,1.0,4/16,19.60%,ABCD1;COA8;PARK7;GPER1
prerank,cell junction maintenance (GO:0034331),0.27275286929439485,0.601863912061679,0.9346092503987241,1.0,1.0,3/14,17.54%,PRTN3;NLGN2;F2R
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.24373489207877846,-0.6000773355931787,0.9216589861751152,0.9972659165794134,1.0,4/11,19.09%,DKC1;CCT7;CCT2;CCT4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.24373489207877846,-0.6000773355931787,0.9216589861751152,0.9972659165794134,1.0,4/11,19.09%,DKC1;CCT7;CCT2;CCT4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.22065197580932744,-0.5989258035330808,0.9430199430199431,0.9968574203773838,1.0,6/16,24.53%,AUTS2;BCOR;WDR5;PAXIP1;SMAD4;BRCA1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.20917960313928238,-0.5986277633283609,0.960960960960961,0.9960055817971326,1.0,4/19,19.08%,NAT10;GNL3L;STN1;CTC1
prerank,histone mRNA catabolic process (GO:0071044),-0.22402166107520197,-0.5983872878772111,0.9281914893617021,0.9951385550604286,1.0,4/15,26.30%,TUT4;TENT2;UPF1;DCP2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2838038982999542,0.5978543028191587,0.9173419773095624,1.0,1.0,3/11,20.98%,LPCAT3;ATL2;ARL6IP1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.25977391979096176,0.5976674564599701,0.9175412293853074,1.0,1.0,8/18,31.83%,ANKRD17;NPLOC4;BIRC3;C1QBP;NOP53;PUM2;PUM1;USP15
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.20540850879227693,0.5972846832275559,0.970917225950783,1.0,1.0,12/95,15.68%,VIM;ZC3H12A;TRIM41;LBP;FZD5;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C;PABPN1
prerank,body fluid secretion (GO:0007589),-0.22292405505692237,-0.5970802626105007,0.9672544080604534,0.9948176665992639,1.0,2/15,10.08%,ERBB4;NPR1
prerank,RNA methylation (GO:0001510),0.2160839458681123,0.5967187864178254,0.9633136094674556,1.0,1.0,8/60,12.08%,NOP2;BUD23;LCMT2;CBLL1;THADA;METTL6;THUMPD3;WDR6
prerank,mitotic spindle organization (GO:0007052),0.19548128513270227,0.5961854487986732,0.9868995633187773,1.0,1.0,43/153,26.08%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;CENPT;AURKC;PAFAH1B1;ZW10;RHOA;EFHC2;ABRAXAS1;CENPH;MAD1L1;PLK2;FLNA;DYNC1LI2;CENPO;DYNC1H1;TTK;CHEK2;AAAS;INTS13;ZWINT;SUN2;TBCE;MISP;CENPF;RMDN1;WDR62;RCC2;NUDC;CEP192;RANBP2;TUBG1;SMC3;CEP126;RANGAP1;MIS12;KIFC2;SEH1L;RPS27;DCTN2
prerank,regulation of DNA metabolic process (GO:0051052),0.224590752912929,0.5961075665267397,0.9579617834394905,1.0,1.0,16/44,25.20%,IL7R;GRHL2;MYC;POLH;UBE2N;NBN;KPNA1;PARG;NUCKS1;THOC1;TERF2;SIRT7;CDK9;UBE2V1;WDR18;HDAC8
prerank,negative regulation of histone modification (GO:0031057),0.2699269236424444,0.5950260875875669,0.9113300492610837,1.0,1.0,3/14,14.23%,FOXP3;TWIST1;SET
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.280301971983919,0.5946961934097625,0.9261538461538461,1.0,1.0,6/14,31.83%,ANKRD17;TLR3;TLR5;PUM2;PUM1;USP15
prerank,replication fork processing (GO:0031297),0.2286170449956313,0.5943574568808218,0.9581151832460733,1.0,1.0,11/38,24.46%,MRE11;CENPS;ATRX;MMS22L;ATR;PCNA;NUCKS1;THOC1;CDK9;FANCM;FBH1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.22282243114374728,-0.5934226300242976,0.9698630136986301,0.9956515583281647,1.0,3/15,20.85%,BCL2L11;ZFP36;NR3C1
prerank,regulation of myotube differentiation (GO:0010830),0.24568620524401036,0.5925176382652739,0.93,1.0,1.0,3/24,10.09%,HDAC5;HDAC4;HDAC3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.2322309116552215,0.5923930928987423,0.9486486486486486,1.0,1.0,13/28,25.96%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;UBC;RPS27A;TAB2;OTULIN;UBE2V1;CASP8;RELA;TAB1
prerank,cellular response to heat (GO:0034605),0.22974915804912102,0.5921817177751457,0.9518072289156626,1.0,1.0,9/35,24.58%,DAXX;BAG3;HSP90AA1;STUB1;MAPT;HIKESHI;TRPV4;TPR;PRKACA
prerank,alpha-amino acid catabolic process (GO:1901606),0.23575614591797003,0.5915555609112253,0.9413407821229051,1.0,1.0,8/29,24.59%,TDO2;HAAO;PRODH;KYAT1;HSD17B10;SARDH;BLMH;KMO
prerank,establishment of spindle localization (GO:0051293),0.2678640418422164,0.5902406761654766,0.922824302134647,1.0,1.0,5/14,21.30%,MAP4;LLGL2;DYNC1H1;TLE6;LLGL1
prerank,positive regulation of phospholipid transport (GO:2001140),0.28702124228192083,0.5901830619103244,0.9098497495826378,1.0,1.0,3/10,23.68%,TRIAP1;ABCA7;ABCB4
prerank,negative regulation of double-strand break repair (GO:2000780),0.2349564515054253,0.5895940761014259,0.9347222222222222,1.0,1.0,5/30,13.66%,SHLD2;KLHL15;RIF1;TWIST1;UBR5
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.2738693424782524,0.589579316239324,0.9301587301587302,1.0,1.0,3/13,13.96%,SRD5A3;ALG1;ALG12
prerank,action potential (GO:0001508),0.2219202429326254,0.5895158989482097,0.9615384615384616,1.0,1.0,11/44,21.61%,SCN3A;ANK3;KCNB1;GNAQ;GNA11;SCN9A;GPER1;YWHAH;GNA15;KCNMB2;KCNMB3
prerank,regulation of cholesterol transport (GO:0032374),0.2514274295494727,0.5890015594885886,0.9385065885797951,1.0,1.0,3/20,14.58%,TTC39B;ABCA2;NUS1
prerank,mesenchymal to epithelial transition (GO:0060231),0.2878650075538738,0.5885682405779676,0.9124579124579124,1.0,1.0,2/10,13.07%,BMP4;GATA3
prerank,carbohydrate transport (GO:0008643),-0.2395385138036879,-0.5879559861282406,0.9207920792079208,0.997093462148743,1.0,8/11,45.77%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;SLC2A5;SLC50A1;AQP9
prerank,RNA modification (GO:0009451),0.21221133411003368,0.5879503595340978,0.9606396063960639,1.0,1.0,7/54,9.85%,NOP2;LCMT2;ELP5;TRIT1;AARS1;THG1L;ANKRD16
prerank,vacuolar acidification (GO:0007035),-0.19779698906334553,-0.5878517848596516,0.9727272727272728,0.9961615491850999,1.0,8/21,26.58%,ATP6V1H;CLN3;CCDC115;TMEM9;CLN6;DMXL1;ATP6V0A4;SLC11A1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.22106154238929565,-0.5876678679204022,0.9588688946015425,0.9952650561783859,1.0,8/15,39.69%,SEL1L;SYVN1;FAF2;OS9;DERL1;UFD1;HERPUD1;VCP
prerank,negative regulation of establishment of protein localization (GO:1904950),0.28305836101288234,0.5869108471071887,0.9092436974789916,1.0,1.0,2/10,12.26%,WWP2;SNX12
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.22454678279316767,0.5866740127461986,0.9401820546163849,1.0,1.0,6/37,13.88%,SIDT2;XRN2;DNASE1L2;RNASE3;MTREX;DNASE1L1
prerank,innate immune response in mucosa (GO:0002227),0.28774593187597264,0.5865427808274455,0.9226973684210527,1.0,1.0,1/10,10.04%,RNASE3
prerank,apoptotic nuclear changes (GO:0030262),-0.19457697165985466,-0.5863293362105853,0.9700996677740864,0.9948370762588278,1.0,9/24,25.02%,CECR2;DNASE2;HMGB1;EXOG;ACVR1C;TOP2A;DICER1;FOXL2;BLCAP
prerank,glial cell development (GO:0021782),0.24201319842370328,0.5861695570734125,0.9445255474452555,1.0,1.0,2/25,6.35%,CDK6;EIF2B2
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.22661179875749218,-0.5860585217445158,0.946949602122016,0.9939722371674433,1.0,3/14,21.59%,TRAF6;CSF1;TYROBP
prerank,cytoplasmic translation (GO:0002181),0.1999981210279838,0.5859004565492556,0.9790055248618784,1.0,1.0,29/91,27.42%,TMA7;RPS4X;RPSA;RPL31;RPL22;GSPT2;RPL28;RPS26;RPL10A;EIF3M;EIF4A1;RPL14;RPS27A;EIF4A2;RPL6;RPS28;ETF1;RPL41;RPLP1;RPL7;RPL21;RPL26;FTSJ1;RPS27;RPL18;RPS12;RPS17;RPS3;RPL22L1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.19260837802470804,-0.5849920228092322,0.9664634146341463,0.9934587168913394,1.0,5/22,21.98%,DTX1;B2M;NEPRO;BMP7;HEY1
prerank,lipoxygenase pathway (GO:0019372),0.2651507851542414,0.5848969214992258,0.9051321928460342,1.0,1.0,2/14,10.86%,ALOX5;PON3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.23197904219266266,0.584440050002004,0.9334257975034674,1.0,1.0,2/29,9.25%,ACOT8;ACSM3
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.23197904219266266,0.584440050002004,0.9334257975034674,1.0,1.0,2/29,9.25%,ACOT8;ACSM3
prerank,RNA catabolic process (GO:0006401),0.2143231919899677,0.583940592006109,0.9584905660377359,1.0,1.0,5/46,10.22%,FEN1;SIDT2;XRN2;RNASE3;MTREX
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.26585059635907105,0.5823295946273119,0.9162640901771336,1.0,1.0,12/12,73.43%,PRKCQ;NLRP10;IL1B;CLEC6A;IL23R;IL12B;IL23A;ZBTB1;CARD9;IL12RB1;CCR2;SLC11A1
prerank,response to molecule of bacterial origin (GO:0002237),0.20813922265035392,0.582210689588496,0.9786476868327402,1.0,1.0,11/69,17.82%,SMAD6;SLPI;LBP;FZD5;TLR4;PELI1;IRAK1;FOXP1;MAPKAPK2;F2R;TAB2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.18842163107068988,-0.5813866637939786,0.9721254355400697,0.9940117441662957,1.0,4/25,14.20%,SRSF4;SRSF10;TXNL4A;WDR83
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.24894508326313952,0.580742288126219,0.9398148148148148,1.0,1.0,3/17,21.80%,ANK3;KCNRG;VAMP2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.25017804728823484,0.5789375147432122,0.9307359307359307,1.0,1.0,4/19,18.47%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.17658259650371994,-0.577819046920081,0.9851851851851852,0.9945214218057271,1.0,2/32,5.04%,CEMIP;PKD2
prerank,rRNA 3'-end processing (GO:0031125),0.2806469888002382,0.5765009062498626,0.9067103109656302,1.0,1.0,2/10,9.40%,EXOSC3;ERI3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.24466719048654023,0.5750375321344099,0.9425625920471281,1.0,1.0,2/20,8.15%,TARBP2;TSNAX
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.23331304515435566,-0.5749037545962915,0.9521531100478469,0.9937739653538998,1.0,5/11,28.37%,SYNJ2;INPP1;IMPA2;PTEN;INPP5J
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.23331304515435566,-0.5749037545962915,0.9521531100478469,0.9937739653538998,1.0,5/11,28.37%,SYNJ2;INPP1;IMPA2;PTEN;INPP5J
prerank,regulation of protein localization to cell periphery (GO:1904375),0.2512769411057315,0.5748872842232587,0.936267071320182,1.0,1.0,6/18,19.13%,ACTB;ABCA2;VTI1B;VPS4A;MISP;MMP14
prerank,DNA recombination (GO:0006310),0.21977421882556553,0.5738625239506661,0.9609375,1.0,1.0,3/37,8.23%,RECQL4;MRE11;RAD54L
prerank,myeloid cell differentiation (GO:0030099),0.21162860866640323,0.5738211382477316,0.9697732997481109,1.0,1.0,6/47,12.36%,ACIN1;EPO;ZBTB16;ATP5IF1;SLC25A38;PTPN2
prerank,methylguanosine-cap decapping (GO:0110156),-0.24435233916333943,-0.5734839487828083,0.9595238095238096,0.9933346910126061,1.0,2/10,13.03%,DCP1B;EDC4
prerank,organonitrogen compound catabolic process (GO:1901565),0.20168518864683133,0.5731483795727647,0.9718482252141983,1.0,1.0,14/57,22.21%,NAGK;GGACT;NPEPPS;ADO;LTA4H;SMPD2;TXN2;PLA2G6;SIAH1;PDXDC1;IDE;LVRN;GNPDA2;SGPL1
prerank,cellular response to increased oxygen levels (GO:0036295),0.2702006650495734,0.5719698432976946,0.9163879598662207,1.0,1.0,1/11,2.71%,CAV1
prerank,regulation of transposition (GO:0010528),0.25770607068868095,0.5713965897170866,0.9358974358974359,1.0,1.0,13/13,74.25%,MYBL1;SIRT7;TEX15;SMYD5;AICDA;UBR2;PIWIL1;BTBD18;SPOCD1;PIWIL4;DDX4;TDRD9;PIWIL2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.2651795253097473,0.5712012450825714,0.9307692307692308,1.0,1.0,4/12,22.98%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.2651795253097473,0.5712012450825714,0.9307692307692308,1.0,1.0,4/12,22.98%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.2651795253097473,0.5712012450825714,0.9307692307692308,1.0,1.0,4/12,22.98%,NSMCE2;ANAPC4;RB1;CDC23
prerank,Golgi inheritance (GO:0048313),0.2692132465917167,0.5708690152184774,0.934640522875817,1.0,1.0,2/11,11.72%,PLK3;YWHAZ
prerank,regulation of catabolic process (GO:0009894),-0.2046720508771915,-0.5699543788501834,0.9666666666666667,0.993710863957364,1.0,10/18,39.83%,FAP;HPGD;RARRES2;TMEM9;FAF1;ZDHHC7;ZDHHC2;FAM83D;SNF8;HGS
prerank,glucan biosynthetic process (GO:0009250),-0.23183875442605906,-0.5694944813250774,0.949238578680203,0.991955558467657,1.0,6/12,28.79%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),-0.23183875442605906,-0.5694944813250774,0.949238578680203,0.991955558467657,1.0,6/12,28.79%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,acyl-CoA metabolic process (GO:0006637),0.21990320665322857,0.5693490951662553,0.965194109772423,1.0,1.0,8/35,22.54%,ACOT8;ACSM3;ACACA;OGDH;DLST;HMGCS1;SUCLA2;MLYCD
prerank,telomere maintenance via recombination (GO:0000722),0.27304083087420217,0.5692314216088281,0.9339774557165862,1.0,1.0,4/11,19.88%,NSMCE2;SMC6;RAD50;ERCC4
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.23210164382864582,0.5687128100292773,0.9586776859504132,1.0,1.0,8/24,17.82%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;UBC;RPS27A;TAB2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.22310672500355166,0.5673524153108955,0.9663072776280324,1.0,1.0,13/32,28.49%,NUP93;NDC1;NOL6;RAE1;AAAS;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133;NUP35
prerank,tRNA export from nucleus (GO:0006409),0.22310672500355166,0.5673524153108955,0.9663072776280324,1.0,1.0,13/32,28.49%,NUP93;NDC1;NOL6;RAE1;AAAS;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133;NUP35
prerank,regulation of T cell activation (GO:0050863),0.21274286796321595,0.5673083056454273,0.967866323907455,1.0,1.0,6/42,18.29%,CCL5;LGALS3;ABL1;DUSP3;PRKCQ;GPNMB
prerank,nucleoside salvage (GO:0043174),-0.24193303971908728,-0.5669792438877826,0.9393939393939394,0.9919951817072037,1.0,4/10,22.79%,HPRT1;DCK;CDA;UCK1
prerank,positive regulation of DNA repair (GO:0045739),0.2117691996416814,0.5669249761678905,0.9641025641025641,1.0,1.0,8/46,16.20%,EYA2;FOXM1;EYA1;TIGAR;ABRAXAS1;DHX9;PCNA;UBE2N
prerank,positive regulation of hormone secretion (GO:0046887),-0.20538050148200893,-0.5661518524472638,0.9792899408284024,0.9913354635086256,1.0,12/17,50.43%,EDN1;SOX11;EDN3;GRP;RASL10B;VAMP8;NMB;C1QTNF3;PLA2G3;TFR2;CYP19A1;HCAR2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2231326535918729,0.5650297574205585,0.952063914780293,1.0,1.0,6/34,15.05%,LGR4;NLRP2B;RAB7B;TLR6;TLR4;TLR3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.2578208666718305,0.5625709987776314,0.9409090909090909,1.0,1.0,2/13,9.70%,EIF6;SDAD1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2722214204095112,0.5625643618268753,0.9329805996472663,1.0,1.0,2/10,18.80%,ATRX;STOML2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.23619501182550867,0.5611726362028581,0.9472934472934473,1.0,1.0,3/22,9.40%,PES1;EXOSC3;ERI3
prerank,positive regulation of cell division (GO:0051781),0.20912600747902374,0.558345429879462,0.9656050955414013,1.0,1.0,7/38,19.75%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,fibrinolysis (GO:0042730),0.2614727854855924,0.5579413075374139,0.9416403785488959,1.0,1.0,13/13,73.87%,PLAT;SERPINE1;PLAUR;SERPINF2;FGG;KRT1;F2;GP1BA;CPB2;SERPINB2;PLG;HRG;PLAU
prerank,response to lipopolysaccharide (GO:0032496),0.18781661833561528,0.557553347460717,0.9956521739130435,1.0,1.0,19/138,17.82%,VIM;SMAD6;ZC3H12A;SLPI;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;PELI1;IRAK1;MEF2C;FOXP1;PABPN1;MAPKAPK2;GIT1;F2R;TAB2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.23125891739693621,0.5568940259402028,0.9494219653179191,1.0,1.0,7/23,24.46%,DNASE1L2;DNASE1L1;REXO4;KPNA1;CASP3;DFFA;FBH1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.22296309018066407,0.5566502263445487,0.9672578444747613,1.0,1.0,8/26,17.82%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;UBC;RPS27A;TAB2
prerank,regulation of DNA damage checkpoint (GO:2000001),0.26373951257824224,0.5552914596480515,0.9419568822553898,1.0,1.0,2/10,11.24%,DDX39B;FEM1B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.22575048179253152,0.5527350874242727,0.9652294853963839,1.0,1.0,5/25,13.61%,DDX39B;WDR43;ELL;HMGN1;TCEA2
prerank,sulfate transport (GO:0008272),0.2465917091946686,0.5512721228987266,0.9339622641509434,1.0,1.0,3/14,13.86%,SLC13A4;SLC25A14;SLC26A4
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2554351284068284,0.5511728675590545,0.9388714733542319,1.0,1.0,3/13,16.85%,UBE2G2;BCAP31;UBE2J1
prerank,pinocytosis (GO:0006907),0.2612425967019308,0.5505766181820952,0.9393442622950819,1.0,1.0,2/10,17.33%,SNX33;MAPKAPK2
prerank,inner dynein arm assembly (GO:0036159),0.2647501883002763,0.54962661511009,0.9413680781758957,1.0,1.0,10/10,73.54%,DNAAF5;DNAAF4;CFAP73;ZMYND10;DNAI3;DNAAF1;DNAH1;CCDC40;CFAP100;CCDC39
prerank,positive regulation of bone resorption (GO:0045780),0.26756684932861063,0.5493049133450995,0.9381270903010034,1.0,1.0,5/11,31.26%,PLEKHM1;ATP6AP1;PRKCA;SPP1;SYK
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.1963931678983461,0.5492323313662119,0.9929161747343566,1.0,1.0,14/57,24.19%,GLUL;PES1;SDAD1;NIP7;HEATR3;PAK1IP1;RPL14;METTL17;RPS28;BYSL;WDR74;RPL7;SHQ1;RPL26
prerank,TOR signaling (GO:0031929),0.22373132281839272,0.5480965675565148,0.9684499314128944,1.0,1.0,11/26,29.09%,EIF4EBP1;MAPKAP1;GATA3;FLCN;CCDC88A;EIF4EBP2;TIPRL;SYAP1;AKT1;LARP1;RPS6
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2672929515959599,0.5472148260497863,0.9448946515397083,1.0,1.0,1/10,5.26%,PIH1D1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.18105066004347192,-0.5470735496113138,0.9840255591054313,0.9968766022296999,1.0,5/24,19.08%,TNKS;NAT10;GNL3L;STN1;CTC1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.24502717724455436,0.5467804532153011,0.9533132530120482,1.0,1.0,9/16,35.14%,DAZAP1;CELF4;RBM3;RBMXL1;TRA2B;NCL;NUP98;RBMX;PRDX6
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.20797948666711036,0.5463651331721581,0.9808429118773946,1.0,1.0,16/40,30.35%,CENPS;ATRX;MMS22L;DONSON;ATR;PCNA;NUCKS1;THOC1;CDK9;FANCM;FBH1;POLD1;SETMAR;DDX11;PRIMPOL;ZRANB3
prerank,pseudouridine synthesis (GO:0001522),-0.2086157517961388,-0.5459760749767344,0.9734748010610079,0.9962620943126043,1.0,3/13,19.61%,PUS7;DKC1;NOP10
prerank,cranial nerve development (GO:0021545),-0.2256707985980544,-0.5455616674560334,0.9565217391304348,0.9954153961533964,1.0,2/11,8.41%,SALL1;CHD7
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.2620512176751192,0.5451985165089702,0.9428571428571428,1.0,1.0,10/10,73.81%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,DNA dealkylation (GO:0035510),0.2620512176751192,0.5451985165089702,0.9428571428571428,1.0,1.0,10/10,73.81%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,ncRNA 3'-end processing (GO:0043628),0.24824536735992475,0.5446867065548574,0.9436392914653784,1.0,1.0,3/14,18.71%,INTS2;TRNT1;INTS6
prerank,sensory perception of taste (GO:0050909),0.26274165202108957,0.5426232449254639,0.9362745098039216,1.0,1.0,10/10,73.74%,PKD2L1;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3
prerank,snRNA processing (GO:0016180),0.2407712966444503,0.5416504681156161,0.9521604938271605,1.0,1.0,5/16,22.09%,INTS2;INTS3;INTS6;TUT1;INTS1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.24589246249714572,0.5415312965684707,0.9571428571428572,1.0,1.0,1/14,3.60%,FOXO3
prerank,negative regulation of innate immune response (GO:0045824),0.2104023055834976,0.5404360717475498,0.9826666666666667,1.0,1.0,6/34,18.31%,MUL1;TRIM21;NMI;PTPN2;SERPING1;YTHDF3
prerank,regulation of protein localization (GO:0032880),0.19148377959801074,0.5395807108313828,0.9902676399026764,1.0,1.0,15/58,22.86%,TRIM25;TRIM21;DVL3;CSNK1E;VPS4A;SLC26A4;HSP90AA1;TESK1;AAK1;KDM1A;RAB9A;FBXW7;TRIM5;ADCYAP1;TPR
prerank,glutathione metabolic process (GO:0006749),0.2093785291937825,0.5391096053533762,0.9838709677419355,1.0,1.0,6/38,18.32%,HAGH;CTNS;HPGDS;GSTK1;GSTM2;PARK7
prerank,pyroptosis (GO:0070269),0.23814385298678015,0.5377366388762573,0.9461538461538461,1.0,1.0,4/15,19.25%,GSDME;DHX9;ZBP1;APIP
prerank,DNA replication checkpoint signaling (GO:0000076),-0.19252593915682314,-0.5356151610817801,0.9838274932614556,0.9972652354794141,1.0,8/16,37.31%,TIPIN;HUS1;ORC1;CDC45;DNA2;NAE1;RAD9B;TICRR
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.250329546167849,0.5350124770917961,0.9336650082918739,1.0,1.0,11/11,74.98%,FOXP3;HFE;PTPRC;XCL1;KLRC1;KLRD1;IL4I1;LILRB1;CEACAM1;SMAD7;AHR
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.22659451051112434,-0.5344835175220728,0.9530026109660574,0.9966045793415347,1.0,5/10,38.53%,THAP7;NOC2L;BRCA1;KLF15;TAF7
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.24941152565672145,0.5320519624886675,0.943089430894309,1.0,1.0,1/11,4.85%,AHCYL1
prerank,global genome nucleotide-excision repair (GO:0070911),0.21366185062438114,0.5315031924056166,0.9652677279305355,1.0,1.0,6/26,19.88%,RBX1;DDB1;ERCC2;UBC;RPS27A;ERCC4
prerank,regulation of cilium movement (GO:0003352),0.25850165367558364,0.5308921657967813,0.9419354838709677,1.0,1.0,3/10,24.38%,CFAP206;ODAD2;DRC1
prerank,mitotic sister chromatid segregation (GO:0000070),0.1812621323089959,0.5308393060177229,0.9965909090909091,1.0,1.0,30/98,26.87%,PSRC1;CHMP4A;CHMP4B;TENT4A;NCAPD3;ZW10;VPS4B;PINX1;CHMP1A;VPS4A;SET;CHMP2A;NCAPH2;PDCD6IP;ZWINT;RB1;PHF13;NUDC;NCAPH;KMT5A;SMC4;CDC23;TUBG1;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.23759374519401627,0.5301513496755004,0.9626749611197511,1.0,1.0,3/15,16.80%,MAGEL2;WASHC1;ARPC2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.23492835785038574,0.527988614459661,0.96,1.0,1.0,2/15,11.74%,PMAIP1;IRS2
prerank,V(D)J recombination (GO:0033151),-0.21956194176120508,-0.5278625377161118,0.979328165374677,0.997303617553005,1.0,2/11,16.42%,LIG1;HMGB1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.18957475432643234,0.5256320492619307,0.9949494949494949,1.0,1.0,12/54,19.66%,NLRP2B;PYDC1;TNFRSF1A;CARD16;PTPN2;CHUK;SPPL2B;RNF31;IKBKG;OTULIN;SPPL2A;ADAM17
prerank,protein monoubiquitination (GO:0006513),0.19999466929757762,0.5249898993942823,0.9837618403247632,1.0,1.0,5/36,12.39%,TRIM25;TRIM21;RBX1;UBE2B;RNF126
prerank,cellular modified amino acid catabolic process (GO:0042219),0.2372566535106964,0.5246624701666489,0.9542586750788643,1.0,1.0,1/15,3.44%,GGACT
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.2064054749496416,-0.5226992081248134,0.9641025641025641,0.9975760596711379,1.0,1/11,6.76%,UBQLN1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.25291691288817014,0.5218608979395133,0.9500831946755408,1.0,1.0,5/10,26.36%,VPS9D1;ATP5PD;ATP5MC3;ATP5F1C;ATP5F1D
prerank,protein localization to chromosome (GO:0034502),0.2010069375796895,0.5217173970710439,0.9782016348773842,1.0,1.0,9/34,20.87%,PARP3;ATRX;PINX1;MCM8;TNKS2;ATR;WAPL;RB1;TERF2
prerank,cotranslational protein targeting to membrane (GO:0006613),0.17544903540218268,0.5200024846214261,0.9955106621773289,1.0,1.0,26/91,26.93%,SIL1;RPS4X;RPSA;SSR1;RPL31;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;ARL6IP1;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPL18;RPS12;RPS17;RPS3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.18914381968815386,-0.5197792202630139,0.9913294797687862,0.9972992711773095,1.0,7/17,30.87%,IK;ZWILCH;BOD1;BUB3;KNL1;SPDL1;CENPA
prerank,inositol phosphate catabolic process (GO:0071545),-0.20349794005318833,-0.519140669548316,0.9760765550239234,0.9964748409739651,1.0,5/12,28.37%,SYNJ2;INPP1;IMPA2;PTEN;INPP5J
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.1914631861743024,0.5190977662558558,0.9856584093872229,1.0,1.0,17/45,29.64%,FOXO3;GCNT2;MEX3D;EIF2B4;APP;GEMIN5;ZC3H7A;EIF2A;PER1;TCOF1;ZC3H10;RBM3;LARP1;PUM2;TRIM71;METTL18;CYFIP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.23075790353576447,0.5185763766522598,0.9757575757575757,1.0,1.0,3/15,18.31%,MUL1;PTPN2;YTHDF3
prerank,regulation of double-strand break repair (GO:2000779),0.19934822630377796,0.5182563125879808,0.9812834224598931,1.0,1.0,6/39,16.74%,SHLD2;FOXM1;PML;TWIST1;UBR5;KDM1A
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.23824381589986887,0.5176136491524533,0.9623567921440261,1.0,1.0,3/13,17.59%,KPNA7;KPNA4;KPNA1
prerank,regulation of water loss via skin (GO:0033561),-0.1894659255397138,-0.5158598587302463,0.9763313609467456,0.9952813679232635,1.0,6/15,36.02%,CLDN1;UGCG;HRNR;SFN;ALOXE3;TMEM79
prerank,establishment of skin barrier (GO:0061436),-0.1894659255397138,-0.5158598587302463,0.9763313609467456,0.9952813679232635,1.0,6/15,36.02%,CLDN1;UGCG;HRNR;SFN;ALOXE3;TMEM79
prerank,lipid droplet organization (GO:0034389),-0.17013053455127514,-0.5149411326815221,0.9935275080906149,0.9945306649703997,1.0,5/22,22.74%,CDS2;PNPLA3;PLA2G4C;FITM2;RAB3GAP1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.23924960857391717,0.5136920019728569,0.9597523219814241,1.0,1.0,6/14,29.21%,TRPT1;TSEN2;CLP1;FAM98B;CSTF2;RTCB
prerank,hexose transmembrane transport (GO:0008645),0.21559080624124138,0.5136854803013332,0.9754224270353302,1.0,1.0,3/21,12.91%,SLC2A12;SLC2A8;SLC2A9
prerank,determination of left/right symmetry (GO:0007368),0.19908337066390444,0.5123639101147927,0.9825268817204301,1.0,1.0,9/36,23.97%,SMO;DAND5;ODAD3;MKKS;GALNT11;ODAD2;DNAH5;DNAAF4;ARL6
prerank,protein localization to condensed chromosome (GO:1903083),-0.20906083568055273,-0.5096941076633752,0.9794344473007712,0.9946857411016975,1.0,4/12,22.25%,IK;ZWILCH;BUB3;KNL1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2131354111993537,0.5095761745118156,0.9793672627235214,1.0,1.0,4/21,18.32%,ABCD1;COA8;HDAC6;PARK7
prerank,piRNA metabolic process (GO:0034587),0.21754831432947247,0.5069171493204389,0.9716417910447761,1.0,1.0,2/19,13.00%,MOV10L1;MYBL1
prerank,autophagy of mitochondrion (GO:0000422),-0.14342303822937627,-0.5065376089843481,1.0,0.9943700229849182,1.0,38/38,85.70%,ATG5;FIS1;FUNDC2;MAP1LC3A;GABARAP;PHB2;AMBRA1;ATG14;ULK2;ATG7;USP30;BECN1;MARK2;GABARAPL1;FUNDC1;ATG9B;ATG9A;SPATA18;SQSTM1;PINK1;ATG2A;WDR45B;BNIP3;ATG13;PRKN;WDR45;WIPI1;ATG12;CISD2;ATG2B;FBXO7;WIPI2;GABARAPL2;ATG3;CTSK;RB1CC1;MAP1LC3B;ULK1
prerank,maintenance of protein localization in organelle (GO:0072595),0.21350141318612453,0.5052364686644562,0.9691833590138675,1.0,1.0,5/19,23.55%,PML;HK1;ARL2BP;TAF8;TAPT1
prerank,female gonad development (GO:0008585),0.21306262714966195,0.5045499902426794,0.9739507959479016,1.0,1.0,2/19,7.71%,EIF2B2;ANG
prerank,osteoclast differentiation (GO:0030316),0.20637853882706347,0.501281819414694,0.9898255813953488,1.0,1.0,3/22,14.22%,ANXA2;SBNO2;FOXP1
prerank,positive regulation of cilium assembly (GO:0045724),0.21753336634228726,0.5011716015135362,0.9880418535127056,1.0,1.0,6/18,23.55%,MARK4;SEPTIN9;CCDC88A;CROCC;CEP120;TAPT1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.22225542681984226,0.4997813843319181,0.9730941704035875,1.0,1.0,2/16,8.14%,CHMP4A;CHMP4B
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.18694046655229213,0.49692967830260093,0.9949109414758269,1.0,1.0,13/45,23.38%,NABP2;BMP4;ZW10;BTG2;PLK2;ZWINT;WEE1;TOM1L2;NABP1;CHFR;BCL6;BTG3;AURKAIP1
prerank,regulation of microtubule nucleation (GO:0010968),0.23670846957747496,0.4964785949860143,0.9656862745098039,1.0,1.0,2/10,17.42%,EML2;GIT1
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.15811790205658333,-0.49579110805295296,0.9892086330935251,0.9953564268447218,1.0,9/29,28.73%,TENT5A;EIF4ENIF1;AXIN2;TENT5D;NOCT;FMR1;SLC11A1;RBM24;ELAVL1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.19828644634525766,0.49464387015735134,0.9749303621169917,1.0,1.0,4/27,14.52%,CMPK1;AK6;AK5;CTPS2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.20431156626806085,0.4946432261921841,0.9827338129496402,1.0,1.0,2/22,9.43%,ZDHHC12;GOLGA7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.20431156626806085,0.4946432261921841,0.9827338129496402,1.0,1.0,2/22,9.43%,ZDHHC12;GOLGA7
prerank,protein modification process (GO:0036211),0.17301418596751655,0.49348428966781055,0.9976771196283392,1.0,1.0,14/76,18.07%,WWP2;DUSP12;PHKA2;TGM5;CPE;MANBA;ST3GAL6;NTAQ1;ABL1;UBE2D3;USP25;RPN2;FBXL2;YES1
prerank,male meiosis I (GO:0007141),0.21699302933078468,0.49061973854003343,0.9659442724458205,1.0,1.0,4/16,23.54%,MOV10L1;MYBL1;BRDT;FOXJ2
prerank,modulation by symbiont of host process (GO:0044003),-0.2029604863794925,-0.48733968588505105,0.9948849104859335,0.9958137267286478,1.0,6/10,40.95%,B2M;MRC1;UBB;UBA52;HGS;TLR2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.15512250077834883,-0.48611724001957063,0.9965397923875432,0.9950402024609233,1.0,7/27,26.03%,IL6R;NCKAP1L;ICAM1;EDN3;CSF1;ADAM8;JAM3
prerank,ribosomal small subunit biogenesis (GO:0042274),0.1836579753172489,0.4854487337825881,0.9936708860759493,1.0,1.0,7/39,21.27%,MRPS7;RPSA;PWP2;UTP4;METTL17;RPS28;DDX52
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2333668089379865,0.48484658226739197,0.9681208053691275,1.0,1.0,10/10,76.68%,NPLOC4;C1QBP;SEC14L1;RNF125;GPATCH3;TSPAN6;RIOK3;UFD1;DHX58;TKFC
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.17041813541443646,0.484465359637304,0.9928741092636579,1.0,1.0,16/70,24.95%,PSMD11;PSMD4;PSMF1;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;FCGR1A;SNAP23;PSMA7;IKBKB;TAPBP
prerank,mitotic nuclear division (GO:0140014),0.17000236065643567,0.4833031750163093,0.9988151658767772,1.0,1.0,21/71,25.54%,NDEL1;KIF2A;PPP2R2D;CHMP4B;ZW10;RHOA;ABRAXAS1;CHMP2A;FLNA;CHEK2;AAAS;ZWINT;MISP;SMC4;CEP192;TUBG1;SMC3;KLHDC8B;MIS12;NUP62;KIFC2
prerank,mitotic spindle assembly (GO:0090307),0.1815705114148146,0.48267600858638443,0.9920948616600791,1.0,1.0,12/42,25.54%,KIF2A;AURKC;RHOA;ABRAXAS1;FLNA;CHEK2;AAAS;MISP;CEP192;SMC3;RACGAP1;KIFC2
prerank,histone exchange (GO:0043486),0.18489658154059155,0.48161281479217316,0.9972936400541272,1.0,1.0,7/37,18.05%,CENPS;CENPT;SRCAP;CENPH;CENPO;SPTY2D1;ZNHIT1
prerank,histone ubiquitination (GO:0016574),0.1990221932987253,0.47991732287913536,0.9777777777777777,1.0,1.0,7/21,27.11%,UBE2B;UBE2N;USP22;UBE2E1;CTR9;LEO1;RNF8
prerank,regulation of stem cell proliferation (GO:0072091),0.21071999868461988,0.4793489916441034,0.9759036144578314,1.0,1.0,1/17,5.33%,FBLN1
prerank,protein targeting to ER (GO:0045047),0.16160594346833254,0.47736811159065823,1.0,1.0,1.0,27/99,26.93%,RPS4X;RPSA;CHMP4A;CHMP4B;RPL31;RPL22;SPCS3;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SRP14;SGTA;RPL7;RPL21;RPL26;RPS27;RPL18;RPS12;RPS17;RPS3
prerank,regulation of chromosome organization (GO:0033044),0.19355243082527976,0.47000899381680866,0.9872340425531915,1.0,1.0,9/22,29.16%,MYC;WAPL;MAPT;RB1;TERF2;HDAC8;XRCC5;SETMAR;TERF2IP
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.1650269899260388,0.46759436646698527,0.997624703087886,1.0,1.0,15/67,24.95%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;FCGR1A;SNAP23;PSMA7;IKBKB;TAPBP
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.21331249160035387,0.4654834764773164,0.9693251533742331,1.0,1.0,3/15,16.96%,TRPT1;TSEN2;CLP1
prerank,P-body assembly (GO:0033962),0.2178113319592538,0.46448546066868235,0.9857369255150554,1.0,1.0,3/12,17.56%,LSM4;DYNC1H1;PATL1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.20562231954735238,0.4580331617865249,0.9860896445131375,1.0,1.0,3/18,16.90%,RNF5;UBC;RPS27A
prerank,coenzyme A metabolic process (GO:0015936),0.20794026893522138,0.457199593906259,0.9781591263650546,1.0,1.0,4/14,24.85%,DCAKD;PPCDC;ACLY;PANK1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.21388122401993934,0.45705179238663374,0.9882352941176471,1.0,1.0,2/11,15.68%,GSTO1;GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.21388122401993934,0.45705179238663374,0.9882352941176471,1.0,1.0,2/11,15.68%,GSTO1;GSTM2
prerank,oogenesis (GO:0048477),-0.17153350562676548,-0.4562583349019229,0.9971264367816092,0.9977742819467537,1.0,5/15,32.41%,MARF1;PIWIL2;NANOS3;TRIP13;MEI4
prerank,mitochondrion disassembly (GO:0061726),0.17670970463083407,0.4556112061119165,0.9973262032085561,1.0,1.0,13/34,28.13%,ULK1;MAP1LC3B;RB1CC1;CTSK;ATG3;GABARAPL2;WIPI2;FBXO7;ATG2B;CISD2;ATG12;WIPI1;WDR45
prerank,mitotic DNA replication (GO:1902969),0.22234582187630603,0.45489985631677676,0.9849246231155779,1.0,1.0,4/10,26.18%,MCM6;GINS3;MCM4;MCM2
prerank,positive regulation of lipid transport (GO:0032370),-0.18110483364720653,-0.45186554591678035,0.9973890339425587,0.9972311361128884,1.0,12/12,81.91%,ABCA3;LRP1;ABCA12;CYP19A1;PRELID1;PRAP1;APOE;DBI;ADIPOQ;SPP1;ABCB4;TRIAP1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.1970885890320213,0.451673913988281,0.9881831610044313,1.0,1.0,2/17,10.53%,TGFB2;ARL6IP5
prerank,regulation of centriole replication (GO:0046599),0.19701088740650244,0.4508564308654046,0.9970457902511078,1.0,1.0,5/17,25.32%,CEP76;PLK2;TRIM37;PLK4;NUP62
prerank,2-oxoglutarate metabolic process (GO:0006103),0.20946660398600442,0.44982997350482057,0.9878234398782344,1.0,1.0,5/13,25.62%,OGDH;DLST;IDH1;GPT2;IDH2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.19430900045576738,0.44673843474013736,0.9908536585365854,1.0,1.0,4/18,19.97%,FCER1G;BCAR1;GPLD1;CMKLR1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.21125624082273442,0.4416121739532389,0.9834983498349835,1.0,1.0,1/11,11.60%,PKD2L1
prerank,positive regulation of dephosphorylation (GO:0035306),0.17667308352129876,0.4411653832253482,0.9944444444444445,1.0,1.0,7/27,26.15%,DLC1;SPPL3;CDH5;PTBP1;MTMR9;CALM2;ANKLE2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.1848572828825759,0.44023967844102946,0.992412746585736,1.0,1.0,6/20,22.86%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.1848572828825759,0.44023967844102946,0.992412746585736,1.0,1.0,6/20,22.86%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.1848572828825759,0.44023967844102946,0.992412746585736,1.0,1.0,6/20,22.86%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,nucleocytoplasmic transport (GO:0006913),0.16793246157550717,0.4398866393854052,0.9973579920739762,1.0,1.0,13/40,27.80%,SNRPB;NXT2;GEMIN6;AAAS;RITA1;SNUPN;DDX20;GEMIN5;GEMIN2;GEMIN8;RBM15B;SNRPD2;SNRPD1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.17593588624261633,0.4379499912528513,0.9944211994421199,1.0,1.0,9/27,24.76%,SYT6;VAMP7;SYT11;SYT12;SYT3;SYT2;VAMP2;ARL8B;SYT13
prerank,defense response to fungus (GO:0050832),0.1903296703296702,0.43468702402625436,0.9891304347826086,1.0,1.0,17/17,80.99%,GAPDH;RNASE7;FAM3A;BCL10;NLRP10;DEFB119;CLEC4E;LTF;CLEC6A;S100A8;CLEC4D;CARD9;S100A9;HRG;PLCG2;CX3CR1;RARRES2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18001470055601385,0.43203662827316563,0.9956268221574344,1.0,1.0,8/23,28.37%,TECPR2;NPLOC4;PREB;SEC16A;TMEM129;LMAN1;HSP90B1;DERL2
prerank,snRNA 3'-end processing (GO:0034472),0.18523188954187442,0.4299772727307148,0.9955156950672646,1.0,1.0,5/19,22.09%,EXOSC3;INTS2;INTS6;TUT1;INTS1
prerank,regulation of dopamine secretion (GO:0014059),0.17658155691247926,0.4272318014315751,0.9956709956709957,1.0,1.0,6/25,21.18%,GDNF;SYT6;SYT11;SYT12;SYT3;SYT2
prerank,coenzyme A biosynthetic process (GO:0015937),0.20306155608223725,0.4250504810748843,0.9966499162479062,1.0,1.0,2/11,16.34%,DCAKD;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.20306155608223725,0.4250504810748843,0.9966499162479062,1.0,1.0,2/11,16.34%,DCAKD;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.20306155608223725,0.4250504810748843,0.9966499162479062,1.0,1.0,2/11,16.34%,DCAKD;PPCDC
prerank,positive regulation of mRNA processing (GO:0050685),0.18127002072734114,0.4242966038705291,0.9956268221574344,1.0,1.0,21/21,81.90%,DAZAP1;CELF4;LEO1;RBM3;RBMXL1;TRA2B;CDC73;NCL;NUP98;RBMX;PRDX6;SNW1;TRA2A;CIRBP;THRAP3;CELF3;NCBP2;DHX36;SF3B4;NCBP1;PAF1
prerank,positive regulation of DNA recombination (GO:0045911),0.16860023924944073,0.42053325243153006,0.998589562764457,1.0,1.0,2/27,9.45%,SHLD2;RIF1
prerank,T cell activation involved in immune response (GO:0002286),0.19570880678326538,0.42041615949943906,0.9935064935064936,1.0,1.0,2/12,17.21%,FCER1G;EIF2AK4
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.14265720940779528,0.41913135720551087,1.0,1.0,1.0,23/87,26.93%,RPS4X;RPSA;RPL31;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPL18;RPS12;RPS17;RPS3
prerank,cellular response to hydroxyurea (GO:0072711),0.20386554848654367,0.4188682617815829,0.989983305509182,1.0,1.0,3/10,24.23%,ATRX;DDI2;RTF2
prerank,regulation of chromosome segregation (GO:0051983),0.18585960065301996,0.41586577862150736,0.9922958397534669,1.0,1.0,16/16,81.43%,SMC6;NUMA1;IHO1;CDC6;PUM2;PUM1;MKI67;HORMAD1;AURKB;KIF2C;BUB1;CSNK2A2;CSNK2A1;RMI2;RAD18;SMC5
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.1860073093627161,0.4129583611775653,0.995334370139969,1.0,1.0,5/16,26.97%,GSK3A;NECAB2;GPER1;PRKCA;CHGA
prerank,regulation of catecholamine secretion (GO:0050433),0.16626115244872053,0.4128222215736068,0.9958333333333333,1.0,1.0,10/29,26.97%,KCNB1;GRK2;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA;CHGA
prerank,DNA biosynthetic process (GO:0071897),0.17918989161294058,0.41276677631529557,0.9984639016897081,1.0,1.0,3/16,17.33%,POLH;POLD2;CDKN2D
prerank,cellular response to oxygen levels (GO:0071453),0.19665256641598564,0.4091326403498899,0.9928952042628775,1.0,1.0,6/10,33.26%,ATP6V0D1;ATP6AP1;TMEM199;ATP6V0A2;CPEB4;NDUFS2
prerank,regulation of T cell mediated immunity (GO:0002709),0.1950608498287967,0.40768491662642237,0.9934102141680395,0.9999855692998928,1.0,2/10,20.63%,TRPM4;AGER
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.1943698947682719,0.4074526981101243,0.9932546374367622,0.9996326387342982,1.0,4/12,25.85%,MAD1L1;RMDN1;MIS12;SEH1L
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.17560291285212276,0.39986695853430215,0.9939301972685888,0.9997874085307451,1.0,8/18,33.28%,AQP1;PCK2;UBE2L3;ZFP36L1;FAM107A;ANXA1;REST;HNRNPU
prerank,meiosis I (GO:0007127),-0.13371818679925396,-0.39554894939086777,0.9938650306748467,0.999356173085165,1.0,12/23,42.05%,ING2;BCL2L11;ZSCAN21;HSF2BP;SGO1;SYCP3;TDRD9;DDX4;MEIOB;ZCWPW1;SLC25A31;PTTG1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.17259998744270733,0.38157909189946826,0.9938556067588326,1.0,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.17259998744270733,0.38157909189946826,0.9938556067588326,1.0,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.16865394379789025,0.37951686999880985,1.0,0.9997920777241273,1.0,6/17,28.37%,NPLOC4;HM13;RHBDD1;TMEM129;HSP90B1;DERL2
prerank,regulation of RNA export from nucleus (GO:0046831),0.172036183138733,0.3630332109892312,1.0,0.9999690390011181,1.0,3/11,23.08%,DHX9;TPR;NRDE2
prerank,B cell mediated immunity (GO:0019724),0.17568183714260707,0.3609082253236124,0.99830220713073,0.999654100376322,1.0,1/10,11.87%,FCER1G
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.16628246243340772,0.3538564262929673,0.9984779299847792,0.9994450761648613,1.0,6/11,32.60%,SETDB1;TPR;PPHLN1;ATF7IP;TRIM28;RESF1
